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VPreface
The term Tissue Engineering was initially defined at the National Science Foundation (NSF) 
meeting in 1988 as the “application of the principles and methods of engineering and life 
sciences toward fundamental understanding of structure-function relationships in normal 
and pathological mammalian tissues and the development of biological substitutes for the 
repair or regeneration and to restore, maintain or improve tissue or organ function” (Shalak 
and Fox, 1988). Researchers at that time recognized the potential of Tissue Engineering to 
facilitate the first medical therapy where engineered tissues become fully integrated within 
the patient, thus offering a permanent cure for many diseases. 
Over the following years Tissue Engineering progressed rapidly and first biological 
substitutes were developed for several tissues in the body. Today, Tissue Engineering is 
one of the major approaches of Regenerative Medicine and a growing and exciting field of 
research. In combination with better understanding of structure, biology, physiology and cell 
culture techniques Tissue Engineering may offer new treatment options for patients in need 
for replacement or repair of a deteriorated organ.  The concept of Tissue Engineering has been 
applied clinically for a variety of disorders, for example artificial skin for burn patients, tissue 
engineered trachea, cartilage for knee-replacement procedures, injectable chondrocytes for 
the treatment of vesico-ureteric reflux and urinary incontinence to name a few.
The classical approaches of Tissue Engineering have not changed over the last three decades. 
The principle is to dissociate cells from a tissue biopsy, to expand these cells in culture, and 
to seed them onto the scaffold material in vitro in order to form a living tissue construct 
prior to implantation into the recipient’s organism. In the appropriate biochemical and 
biomechanical environment these tissues will unfold their full functional potential and serve 
as native tissue equivalents. Tissue Engineering products may be fully functional at the time 
of treatment, or else have potential to integrate and evolve into the expected functional tissue 
after implantation.
The Tissue Engineering approach has major advantages over traditional organ transplantation 
and circumvents the problem of organ shortage. Tissues that closely match the patient’s needs 
can be reconstructed from readily available biopsies and subsequently be implanted with 
minimal or no immunogenicity. This eventually conquers several limitations encountered in 
tissue transplantation approaches.
This book serves as a good starting point for anyone interested in the application of Tissue 
Engineering. It offers a colorful mix of topics, which explain the obstacles and possible 
solutions for TE applications.  The first part covers the use of stem cells and adult stem 
cells and their applications. The following chapters offer an insight into the development 
VI
of a tailored biomaterial for organ replacement and highlight the importance of cell-
biomaterial interaction. As more and more applications move toward clinical application, 
a reliable preclinical model system to evaluate the developed techniques becomes crucial. 
Several animal models and Tissue Engineering approaches for a variety of organ systems are 
presented in the final chapters. In summary, this book offers insights into a wide variety of 
cells, biomaterials, interfaces and applications of the next generation biotechnology, which is 
Tissue Engineering.
Finally, I would like to thank all authors who have contributed to this book and hope that the 
readers will enjoy its reading.
Daniel Eberli MD. PhD. 
University Zürich, Switzerland
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1. Fracture treatment and bone tissue engineering 
Although bone is a dynamic and well-vascularized tissue with innate healing and 
remodeling capacities (Salgado et al., 2004) , up to 10% of the bony fractures are complicated 
by non-union (Einhorn, 1995; Hayda et al., 1998; Marsh, 1998; Salgado et al., 2004; Bongso, 
2005) , which require additional treatment with bone grafts in order to achieve defect union 
and healing. In fact, bone grafts has become the second most transplanted tissue in the 
world after blood, with approximately one million cases of bone graft transplantation 
occurring in United States alone annually (Salgado et al., 2004; Bongso, 2005).  
Bone grafts can be categorized into three types: autografts, allografts, and synthetic grafts, 
with their relative frequency of use illustrated in Figure 1 and a comparison of their 
advantages and disadvantages in Table 1. Autografts are harvested from a secondary site 
from the patient’s own body, commonly the iliac crest. This strategy has been described 
initially by Chutro and later Phemister in early 20th century (Connolly et al., 1991) , and has 
been considered the gold standard for many decades. This is because the use of autografts 
results in the the best clinical outcomes by providing both osteogenic cells and essential 
osteoinductive factors required for bone healing. However, the use of autografts has been 
limited by its availability, difficulty in fashioning of grafts to fit defects, an unpredictable 
efficacy and complexity of two surgeries (Banwart et al., 1995; Fowler et al., 1995; Goulet et 
al., 1997; Salgado et al., 2004; Hollinger et al., 2005). Futhermore, significant donor site 
morbidity such as chronic pain, hypersensitivity, infection and paraesthesia occur in up to a 
third of patients (Prolo and Rodrigo, 1985; Damien and Parsons, 1991; Arrington et al., 1996; 
Lane et al., 1999). Allografts, bone grafts harvested from another donor (mainly from 
cadavers), are an alternative with enhanced flexibility of graft size and shapes. However, 
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they introduce the possibility of immune rejection and pathogen transmission. Moreover, 
processing techniques, such as demineralization, strip the tissue of osteoinductive factors 
necessary for stimulating bone repair, resulting in impeded healing times, as compared to 
autografts (Parikh, 2002) . Synthetic grafts are made from metals or ceramics, which can be 
fashioned to different shapes and sizes and are non-immunogenic, but thus far have been 
hampered by their poor speed of healing and inability to remodel in tandem with the 
natural healing process (Salgado et al., 2004).  
 
Fig. 1. Breakdown of the current used bone grafts: autograft, allograft and synthetic graft.  
 
 Healing Remodelling Immuno-genicity Availability 
Surgery 
simplicity Others 
Autografts +++ +++ - + + donor-site 
morbidities 
Allografts ++ ++ + +++ +++ disease 
transmission 
Synthetic 
grafts + 0 - +++ +++ 
fatigue, 
fracture, 
wear 
Tissue 
engineered 
grafts 
+++ +++ - +++ +++  
Table 1. Comparison of different bone grafts 
 
Thus, in order to fulfill this increasing but unmet clinical need for effective bone grafts, 
recent research efforts have turned to a tissue engineering approach to develop tissue 
engineered grafts, which not only have off-the-shelf availability in various shapes and sizes 
(like allografts and synthetic grafts), but have the ability to stimulate rapid bone healing and 
undergo remodeling, achieving a better or similar clinical outcome than or as autografts 
(Table 1).   
 
2. Cell based strategy vs. Growth factor based strategy 
Tissue Engineering was first coined by Langer and Vacanti in 1993 as “an interdisciplinary 
field of research that applies the principles of engineering and the life sciences towards the 
development of biological substitutes that restore, maintain, or improve tissue 
function”(Langer and Vacanti, 1993).  Since then, several different bone tissue engineering 
(BTE) approaches have been proposed and explored. In essence, they can be classified into 
 
two main categories of a cell or a growth factor based strategy. Both approaches seek to 
create an optimized bone growing bed with a biological microenvironment suitable for bone 
regeneration through introducing a critical mass of osteogenic cells onto the scaffold matrix 
and modulating intercellular communication and cell-matrix interactions. However, the 
manner in which the introduction of osteogenic cells is different. Cell-based approaches 
supply exogenous osteogenic cells while relying on the autologous growth factors from the 
repair site to stimulate bone regeneration, whereas growth factor-based approaches rely on 
the delivery of growth factors to recruit osteogenic cells from the local environment into the 
repair site. (Kimelman et al., 2007; Lanza et al., 2007). 
The use of growth factor-based BTE approaches has been shown to be efficacious in small 
animal models. However, the translation from small animal models, through large animal 
models, to humans has proven to be difficult and the optimal dose of growth factors for 
human clinical therapy is difficult to determine, because of the large variation of efficacy 
between small to big animals (up to 100 fold). Another problem relates to the problem of 
develping an effective delivery and release approach, given the short half-life of the majority 
of the growth factors are (Hollinger et al., 1996; Bruder and Fox, 1999). In addition, growth 
factor-based approaches work indirectly by attracting and stimulating the proliferation and 
differentiation of local osteogenic stem cells to repair bone defect, therefore its effectiveness 
will be greatly compromised in the absence of sufficient osteogenic stem cell pool (Service, 
2000). In contrast, a cell-based approach works independently of the presence of local 
osteogenic cells, and therefore is an attractive therapy for patients with a diminished pool of 
osteogenic progenitors such as those with severe trauma, diabetes, a history of tobacco use, 
irradiation, aging, osteoporosis or other metabolic derangements (Bruder and Fox, 1999). 
Furthermore, delivering the right quantity of different growth factors in a sequential 
manner reflecting the different phases of bone growth faces multiple technical challenges 
(Marsh and Li, 1999; Giannoudis et al., 2007). In contrast, cell-based strategies utilize 
osteogenic cells which secrete a wide spectrum of growth factors at physiological doses, 
establishing temporal-spatial microgradients necessary for effective bone regeneration 
(Rouwkema et al., 2008). Thus, cell based strategies have been pursued in our group. 
Two distinct typical cell-based approaches have been proposed to use cultured osteogenic 
cells in combination with scaffold matrix to engineer bone grafts (Hollinger et al., 2005; 
Lieberman and Friedlaender, 2005; Lanza et al., 2007). The first approach is to seed cells on 
the scaffold matrix and the immediate implantation of the resulting construct (Figure 2 A). 
In the second approach, a period of in vitro culture is performed for cellular expansion and 
osteogenic pre-differentiation (Figure 2 B), which has been shown to result in significantly 
higher degree of bone defect healing compared to an immediate implantation approach 
(Mendes et al., 2002; Sikavitsas et al., 2003; De et al., 2006; Dudas et al., 2006) . In this delay 
implantation approach, osteogenic cells are seeded into three dimensional highly porous 
biodegradable scaffolds with the desired shape to fit the bone defect. These cellular scaffolds 
are then cultured and matured in a suitable in vitro environment for cellular expansion and 
proper pre-differentiation to obtain bone-like constructs with extracellular mineralized 
matrix and pre-differentiated cells. Finally, the grafts are implanted into the defect to induce 
and direct the growth of new bone with the controlled degradation of the scaffold matrix 
(Figure 2B).  
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Fig. 2. Two cell based BTE approaches.   
 
3. Polycaprolactone based scaffolds for BTE application 
To generate an effective TE bone grafts, three dimensional (3D) scaffolds are required to 
function as a supportive matrix for cell proliferation, extracellular matrix deposition and 
consequent bone in-growth and at the same time define the overall shape of the tissue 
engineered transplant (Laurencin et al., 1999). Moreover, the 3D scaffolds should have rigid 
mechanical properties to protect the defect area from collapse of surrounding tissue, and 
proper macroporous structure to prevent the invasion of fibrous tissue but allow the 
infiltration of blood vessels. Scaffolds should also actively contribute to the regenerative 
process by enhancing the proliferation and osteogenic differentiation of the cells grew on 
their surface through the cell-scaffold interaction (Agrawal and Ray, 2001). 
Our group has extensively investigated the use of Fused Deposition Modeling (FDM) 
technique to fabricate the porous three dimensional (3D) scaffolds for BTE applicaiton 
(Hutmacher et al., 2001; Zein et al., 2002).  A polycaprolactone and tricalcium phosphate 
composite material was selected for the scaffold fabrication.  Poly (ε-caprolactone) (PCL) is a 
semicrystalline, bioresorbable polymer belonging to the aliphatic polyester family. It is 
highly processable, with low glass-transition temperature (–60C) and melting point (60C) 
but high decomposition temperature of 350C. It has been previously exploited for drug 
delivery material (Coombes et al., 2004)  and demonstrated great biocompatibility with US 
A 
B 
 
Food and Drug Administration (FDA) approval for its use in several medical and drug 
delivery devices. It has slow degradation kinetics of only seven percent over a six month in 
vivo (Lam et al., 2008) , and thus is suitable for utilisation in load bearing bone grafting 
applications, which requires a prolonged period of mechanical support. In addition, 
chemical hydrolysis as opposed to enzymatic reactions is responsible for degradation of 
polymeric chains in vivo; thus degradation does not vary from patient to patient.  
However, PCL is not without drawbacks, as with all synthetic polymers, PCL implants 
experience fibrosis and gradually become isolated from the surrounding bone. 
Consequently, they do not adhere to bone and this has been a critical problem in their use in 
bone repair (Kokubu et al., 2003). In addition, a common problem to biodegradable 
polyesters family is that the bulk release of acidic degradation products can cause acidosis 
(Ciapetti et al., 2003). This led to the search for additional compounds to modify PCL for 
BTE applications.  
β-tricalcium phosphate (TCP), a synthetic ceramic material, is one such compound. Firstly, 
TCP is bioactive and can generate a carbonated hydroxyapatite layer on its surface that is 
equivalent chemically and structurally to the biological mineral of nature bone, known as 
the determining step for the biointegration (Kokubo et al., 2003). Secondly, TCP is 
osteoconductive and can promote the cellular adhesion, function and expression leading to 
formation of new bone and a uniquely strong bone-TCP biomaterial interface. Finally, TCP 
is reported to be osteoinductive, and capable of binding and concentrating endogenous bone 
morphogenetic proteins from the circulation (LeGeros, 2002). However, pure TCP is a brittle 
material with very poor mechanical properties, leading to difficulties with its processing for 
BTE applications. To overcome these shortcomings, a bioactive composite material 
comprising of a biodegradable polymeric phase (PCL) and a bioactive inorganic phase 
(TCP) has been developed. This construct takes advantage of the flexibility and 
processability of the bulk PCL polymer phase, combined with TCP bioactive phase, 
allowing the scaffold to bond and integrate with bone spontaneously and possess both 
osteoconductive and osteoinductive properties. Furthermore, the acidic release from the 
polymer can be compensated by the alkaline calcium phosphate (Blaker et al., 2003; Maquet 
et al., 2004) . (Figure 3) 
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experience fibrosis and gradually become isolated from the surrounding bone. 
Consequently, they do not adhere to bone and this has been a critical problem in their use in 
bone repair (Kokubu et al., 2003). In addition, a common problem to biodegradable 
polyesters family is that the bulk release of acidic degradation products can cause acidosis 
(Ciapetti et al., 2003). This led to the search for additional compounds to modify PCL for 
BTE applications.  
β-tricalcium phosphate (TCP), a synthetic ceramic material, is one such compound. Firstly, 
TCP is bioactive and can generate a carbonated hydroxyapatite layer on its surface that is 
equivalent chemically and structurally to the biological mineral of nature bone, known as 
the determining step for the biointegration (Kokubo et al., 2003). Secondly, TCP is 
osteoconductive and can promote the cellular adhesion, function and expression leading to 
formation of new bone and a uniquely strong bone-TCP biomaterial interface. Finally, TCP 
is reported to be osteoinductive, and capable of binding and concentrating endogenous bone 
morphogenetic proteins from the circulation (LeGeros, 2002). However, pure TCP is a brittle 
material with very poor mechanical properties, leading to difficulties with its processing for 
BTE applications. To overcome these shortcomings, a bioactive composite material 
comprising of a biodegradable polymeric phase (PCL) and a bioactive inorganic phase 
(TCP) has been developed. This construct takes advantage of the flexibility and 
processability of the bulk PCL polymer phase, combined with TCP bioactive phase, 
allowing the scaffold to bond and integrate with bone spontaneously and possess both 
osteoconductive and osteoinductive properties. Furthermore, the acidic release from the 
polymer can be compensated by the alkaline calcium phosphate (Blaker et al., 2003; Maquet 
et al., 2004) . (Figure 3) 
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Fig. 3. PCL-TCP composite material, incorporates the strength of PCL and TCP while 
neutralizes their individual drawbacks 
 
FDM, as a solvent-free rapid prototyping technique, was utilized to fabricate the PCL-TCP 
composite material into 3D scaffolds (Hutmacher et al., 2001; Zein et al., 2002)  in three steps. 
Firstly, the PCL-TCP filament were fabricated by physically blending the PCL pellets with 
TCP granules in a desired ratio (e.g. 80% PCL to 20% TCP), melting in a high temperature 
(190C) and extruding through spinnerets with a die exit diameter of 1.63 mm. Secondly, the 
size and shape of the scaffolds were designed through computer assisted design (CAD) 
systems, for example, patient-specific scaffolds can be created based on the 3D computed 
tomography(CT) images, then these CAD models were imported into the Stratasys 
QuickSlice software and sliced into the horizontal layers. The deposition path were created 
and downloaded to the FDM machine, the 3D Modeler RP system from Stratasys Inc. (Eden 
Prairie, MN). Lastly, PCL-TCP filament prepared were fed into the FDM head, melted down 
in the liquefier and extrude out through the nozzle tip and deposit on a platform layer by 
layer according to the preprogrammed deposition path.  
We have fabricated PCL-TCP scaffolds to achieve a honeycomb architecture, with a fully 
interconnected matrix, and mechanical properties close to cancellous bone. This should 
allow rapid vascularization to occur and maintain the defect space and the structural 
integrity of tissue engineered bone grafts in load-bearing applications (Hutmacher et al., 
2001; Schantz et al., 2002) (Figure 4). In addition, use of the highly reproducible and 
computer-controlled FDM technique allows the fabrication of tissue-engineered grafts that 
have been designed on the basis of computed tomography (CT) scans of individual defect 
sites(Hutmacher, 2000; Endres et al., 2003) . PCL-TCP scaffolds have a favourable profile for 
achieving effective cellular adhesion, proliferation and differentiation in vitro (Rai et al., 
2004; Zhang et al., 2009; Zhang et al., 2009) , and serve as an osteoconductive matrix for new 
bone regeneration in both critical-sized rat femoral (Rai et al., 2007)  and canine mandibular 
defects (Rai et al., 2007). 
 
 
 
Fig. 4. Scanning Electronic Microscopy (SEM) image of PCL-TCP scaffolds 
 
4. Human fetal mesenchymal stem cells for BTE application 
4.1 Available cellular sources for cell based BTE 
Cells are the central players for most biological process in human body. As the critical 
component in the BTE strategy, they play the most essential role and are directly involved in 
bone regeneration. The selection of cell sources will eventually determine the success of any 
BTE strategy. An ideal cellular source for cell-based BTE approach should include the 
following characteristics: (1) no immunogenicity, (2) no tumorigenicity, (3) immediate 
availability, (4) availability in pertinent quantities, (5) rapid cell proliferation rate, (6) 
predictable and consistent osteogenic potential as well as; (7) controlled integration into the 
surrounding tissues (Logeart-Avramoglou et al., 2005) . Different cell sources have been 
exploited for BTE applications, and can be divided into three categories with the respect to 
their differentiation status: fresh bone marrow, differentiated osteoblasts and mesenchymal 
stem cells (Bruder and Fox, 1999; Pioletti et al., 2006)  (Table 2).  
Fresh bone marrow (BM) has been introduced to heal nonunion bone defects some three 
decades ago (Connolly et al., 1989; Connolly et al., 1991; Caplan, 2005). BM are readily 
harvested and contain the osteogenic progenitors, which can enhance bone regeneration. As 
they are autologous tissues, immunorejection is not an issue, nor are they subject to the 
regulation by the Food and Drug Administration (FDA) (Bruder and Fox, 1999) . However, 
their effectiveness is highly dependent on the number of the osteogenic progenitors, which 
represent approximately 0.001% of the nucleated cell in the healthy bone marrow at best 
(Bruder et al., 1997) and decreases dramatically with aging or disease process (Pioletti et al., 
2006). Thus, this approach may be least applicable in those situations where it is most 
needed, as fractures tend to occur more frequently in an old age group. Moreover, the use of 
unmatched allogenic BM is not suitable, as it is beset by problems of either graft rejection or 
graft-versus-host syndrome (Weissman, 2000).  
Osteoblasts participate in bone formation processes via the synthesis and secretion of 
collagen fibres to form unmineralized bone matrix (osteoid), and have been implicated in 
osteoid calcification. The use of osteoblasts for the cellular source for BTE applications has 
demonstrated enhancement in the rate and extent of bone regeneration compared with the 
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Cells are the central players for most biological process in human body. As the critical 
component in the BTE strategy, they play the most essential role and are directly involved in 
bone regeneration. The selection of cell sources will eventually determine the success of any 
BTE strategy. An ideal cellular source for cell-based BTE approach should include the 
following characteristics: (1) no immunogenicity, (2) no tumorigenicity, (3) immediate 
availability, (4) availability in pertinent quantities, (5) rapid cell proliferation rate, (6) 
predictable and consistent osteogenic potential as well as; (7) controlled integration into the 
surrounding tissues (Logeart-Avramoglou et al., 2005) . Different cell sources have been 
exploited for BTE applications, and can be divided into three categories with the respect to 
their differentiation status: fresh bone marrow, differentiated osteoblasts and mesenchymal 
stem cells (Bruder and Fox, 1999; Pioletti et al., 2006)  (Table 2).  
Fresh bone marrow (BM) has been introduced to heal nonunion bone defects some three 
decades ago (Connolly et al., 1989; Connolly et al., 1991; Caplan, 2005). BM are readily 
harvested and contain the osteogenic progenitors, which can enhance bone regeneration. As 
they are autologous tissues, immunorejection is not an issue, nor are they subject to the 
regulation by the Food and Drug Administration (FDA) (Bruder and Fox, 1999) . However, 
their effectiveness is highly dependent on the number of the osteogenic progenitors, which 
represent approximately 0.001% of the nucleated cell in the healthy bone marrow at best 
(Bruder et al., 1997) and decreases dramatically with aging or disease process (Pioletti et al., 
2006). Thus, this approach may be least applicable in those situations where it is most 
needed, as fractures tend to occur more frequently in an old age group. Moreover, the use of 
unmatched allogenic BM is not suitable, as it is beset by problems of either graft rejection or 
graft-versus-host syndrome (Weissman, 2000).  
Osteoblasts participate in bone formation processes via the synthesis and secretion of 
collagen fibres to form unmineralized bone matrix (osteoid), and have been implicated in 
osteoid calcification. The use of osteoblasts for the cellular source for BTE applications has 
demonstrated enhancement in the rate and extent of bone regeneration compared with the 
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use of undifferentiated bone marrow (Okumura et al., 1997; Bruder and Fox, 1999; 
Montjovent et al., 2004). However, autologous isolation of the osteoblasts is considerably 
more difficult and complex than fresh bone marrow or mesenchymal stem cells. In addition, 
they posses a limited capacity for proliferation, and thus do not support in the generation of 
significant cell numbers for clinical use (Bruder and Fox, 1999; Montjovent et al., 2004; 
Pioletti et al., 2006). 
Mesenchymal stem cells (MSC) are also known as marrow stromal cell or colony forming 
unit – fibroblast (CFU-F) or more recently named as multipotent mesenchymal stromal cells 
by International Society for Cellular Therapy (ISCT) (Dominici et al., 2006) . They were first 
identified and isolated from adult bone marrow (Friedenstein et al., 1966; Friedenstein et al., 
1968)  and demonstrated a series of favorable advantages for BTE application over other cell 
sources. Firstly, MSC are easily isolated through plastic adhesion method or simple 
antibody selection techniques (Simmons and Torok-Storb, 1991) . Secondly, the osteogenic 
differentiation pathway is well defined and MSC have been shown to generate greater 
amount of bone tissue than fresh bone marrow in preclinical studies (Kahn et al., 1995; Inoue 
et al., 1997; Pioletti et al., 2006). Thirdly, both undifferentiated and differentiated MSC have 
been reported as non-immunogenic, and are thus suitable for allogeneic applications (Le 
Blanc et al., 2003) . Finaly, cryostorage does not affect the osteogenic potential of MSC, 
which greatly facilitates their storage (Bruder et al., 1997).    
 Collection Expansion Storage Allogenic 
applications 
Osteogenic 
potential 
Fresh bone 
marrow 
+++ N.A. N.A. N.A.* + 
Osteoblast + + + N.A.* +++ 
MSC ++ ++ +++ ++ ++ 
N.A.*: allogenic applications can be achieved by proper HLA matching 
Table 2. Comparison of different cellular source for BTE. 
 
4.2 MSC biology 
Although there are no specific cell markers to distinguish MSC from other cell types, MSC 
are generally defined by their capabilities to (1) adhere to the plastic surface of tissue culture 
flask; (2) express D105, CD73 and CD90, with absence of CD45, CD34, CD14 or CD11b, 
CD79a or CD19 and HLA II; and (3) differentiate into the osteoblasts, adipocytes and 
chondroblasts under standard in vitro differentiating conditions (Dominici et al., 2006). MSC 
are rare cells, and exist at low frequencies in human adult BM, accounting for 0.00001% to 
0.001% of mononuclear cells (MNC) in BM. They are non-haemopoietic and can be 
separated from the haemopoietic fraction in BM by their adherence to plastic and ability to 
grow from an initial heterogeneous population into a more homogenous spindle-shaped cell 
type. MSC have been demonstrated to contain a heterogeneous population of cells. 
Properties including colony size, proliferation rate, cellular morphology, and multipotency 
both in vitro and in vivo have been routinely observed to differ in single colony-derived MSC 
strains (Muraglia et al., 2000; Mauney et al., 2005) . Other techniques for isolation of MSC 
include immuno-depletion (Baddoo et al., 2003)  or immuno-selection techniques with 
STRO-1 and CD 271 antibodies (Simmons and Torok-Storb, 1991; Jones and McGonagle, 
2008). However, the resulting cultures are still heterogeneous, ranging from spindle shaped 
cells to broad stromal-like cells (Digirolamo et al., 1999; Colter et al., 2000; Colter et al., 2001) 
 
This is also reflected in intra-sample and inter-species differences in the capacity of MSC to 
self-renew or form CFU-F in low-density cultures (Digirolamo et al., 1999; Phinney et al., 
1999; Banfi et al., 2000; Javazon et al., 2001).  
MSC are not inherently immunogenic, making them highly attractive for allogeneic 
transplantation strategies (Caplan, 2007). MSC are HLA Class I positive and Class II 
negative and do not express co-stimulatory molecules CD40, CD40L, CD80, or CD86 
(Klyushnenkova et al., 2005) . This phenotype is widely regarded as non-immunogenic and 
suggests that MSC may be effective at inducing tolerance. In the mixed lymphocyte cultures 
(MLC) assay, MSC do not elicit a proliferation response of allogeneic lymphocytes 
(Bartholomew et al., 2002; Le Blanc et al., 2003). After interferon γ (INF-γ) induction of HLA 
II expression, MSC are still capable of escaping recognition by alloreactive T-cells (Le Blanc 
et al., 2003; Klyushnenkova et al., 2005). Similarly, after cellular differentiation into along the 
adipogenic, chondrogenic and osteogenic lineages, they remain non-immunogenic (Le Blanc, 
2003). MSC have been found to escape lysis by cytotoxic T-cells and alloreactive killer 
inhibitory receptor mismatched natural killer cells (Le Blanc, 2003; Rasmusson et al., 2003; 
Gotherstrom, 2007) , making them uniquely suited for allogeneic transplantation 
applications. 
In addition to being non-immunogenic, MSC have been shown to possess 
immunomodulatory properties both in vitro and in vivo. In vitro, they exhibit 
immunosuppressive effects and inhibit T-cell alloreactivity (Pittenger et al., 1999; 
Bartholomew et al., 2002; Krampera et al., 2003; Maitra et al., 2004; Beyth et al., 2005). This 
suppression effect of MSC is dose dependent and not only influence T cell but also affect the 
differentiation and maturation of dendritic cells from monocytes (Aggarwal and Pittenger, 
2005). In vivo, infusion of ex vivo-expanded MSC has been shown to prolong the survival of 
allogeneic major histocompatibility mismatched skin allografts in immunocompetent out-
bred baboons (Bartholomew et al., 2002). Further evidence was provided by Djouad et al, 
who found that subcutaneously injected melanoma cells in allogeneic immunocompetent 
mice formed tumors only when co-injected with MSC, suggesting that the presence of MSC 
prevented immune rejection of the tumor cells (Djouad et al., 2003). More recently MSC 
have been used to treat graft-versus-host disease (GvHD) after allogeneic hematopoietic 
stem cell transplantation (Le Blanc et al., 2008). The mechanism governing those effects is 
not yet understood. However, it is quite likely that the paracrine effect of MSC will play a 
significant role in it, for example, it was shown that MSC may strongly inhibit T-cell 
recognition and expansion via inhibiting TNF-α and INF-γ production and, thus, increasing 
IL-10 levels. (Aggarwal and Pittenger, 2005; Beyth et al., 2005; Caplan, 2007)  
MSC are currently defined by their trilineage differentiation capacity (osteogenic, 
adipogenic and chondrogenic differentiation). In addition, they have been shown to be able 
to differentiate to muscle, marrow stroma and other connective tissues (Caplan, 1991; 
Caplan, 2005; Caplan, 2007). Several reports have now expanded repertoire to 
neuroectodermal lineages such as neurons (Woodbury et al., 2000; Zhao et al., 2002) , 
hepatocyte (Ong et al., 2006; Banas et al., 2007; Sgodda et al., 2007)  and endothelial cell 
(Oswald et al., 2004; Gang et al., 2006) . A subset of MSC, termed Multipotent adult 
progenitor cells (MAPC), have been isolated from a number of species. MAPCs have greater 
differentiation potential than MSC, and have been shown to be pluripotent (Reyes et al., 
2001; Jiang et al., 2002). However they are difficult to isolate and have not been reliably 
reproduced by other laboratories.  
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neuroectodermal lineages such as neurons (Woodbury et al., 2000; Zhao et al., 2002) , 
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differentiation potential than MSC, and have been shown to be pluripotent (Reyes et al., 
2001; Jiang et al., 2002). However they are difficult to isolate and have not been reliably 
reproduced by other laboratories.  
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The osteogenic differentiation pathway is the default pathway for MSC, which is retained 
regardless of cell passage number until senescence (Digirolamo et al., 1999). MSC are 
heterogenous in nature, and consist of subpopulations of cells with tri-potent (osteogenic, 
adipogenic and chondrogenic), bi-potent (osteogenic and chondrogenic) and uni-potent 
(osteogenic) differentiation capacities as demonstrated through clonal analysis (Muraglia et 
al., 2000). Clones have been found to progressively lose their adipogenic and chondrogenic 
differentiation potential at increasing cell doublings, although osteogenic differentiation 
ability is retained till senescence (Digirolamo et al., 1999; Muraglia et al., 2000) .  
 
Fig. 5. Osteogenic differentiation pathway of MSC 
 
Under the osteogenic differentiation pathway, MSC can be fully differentiated into 
osteoblasts, bone lining cells and osteocytes, which is a highly regulated and multi-step 
process with a sophisticated hierarchy as illustrated in Figure 5. MSC is likely to occupy the 
top position in this hierarchy, followed by osteoprogenitors, which are osteogenic 
committed progenitor cells with limited self-renewal and restricted differentiation capacity, 
but still maintaining substantial proliferation capacity. Further downstream are the 
preosteoblasts with more limited proliferation capacity. Mature osteoblasts are the 
terminally differentiated and functional cells, which will finally become the bone lining cells 
or osteocytes. With the progress of the osteogenic differentiation, proliferation of the cells is 
decreased while the osteogenic differentiation is increased. (Aubin, 1998; Aubin, 2001; 
Bilezikian, 2002)  
 
4.3 Limitations of adult BM derived MSC and alternative MSC sources 
The adult BM is the first tissue source where MSC are found and isolated, and are thus most 
investigated. They have been exploited as an autologous cell source for BTE applications, 
and demonstrated their effectiveness for fracture healing not only in animal but also in a 
number of reported human clinical trials (Quarto et al., 2001; Schimming and Schmelzeisen, 
2004; Ueda et al., 2008; Yamada et al., 2008) . However, several barriers currently exist, 
limiting their further clinical applications. Firstly, adult BM-MSC are rare cells with a very 
low frequency, accounting for 0.00001% to 0.001% of mononuclear cells (MNC) in the adult 
bone marrow (BM). Furthermore, they have limited proliferative capacity, only undergoing 
an average approximately 38 ± 4 population doublings before reaching cellular senescence 
(Bruder et al., 1997). As a result, in order to obtain clinically significant cell numbers, a large 
amount of bone marrow aspiration is required initially. Secondly, for autologous usage, the 
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derivation and expansion of MSC require a long period (4-6 weeks) for ex vivo expansion, 
limiting their clinical use, especially where the cells are required acutely. Secondly, the 
frequency of MSC within bone marrow and the proliferative capacity decrease dramatically 
as a function of donor age (it can drop from 0.001-0.0004% before the ages of 30 to 0.00025-
0.00005% after the ages of 50) (Caplan, 2007) , with systemic diseases adversely affecting 
their numbers and function (Suzuki et al., 2001) . Similarly, the osteogenic differentiation 
ability in vitro and in vivo has also been found to be inversely correlated with donor age 
(Mueller and Glowacki, 2001)  and reduced in several disease phenotypes (Rodriguez et al., 
2000). 
More recently, MSC with osteogenic potential have been isolated from a diverse range of 
other tissue types and ontogeny: (1) In postnatal tissue, MSC have been isolated from 
tissues as diverse as periosteum(Nakahara et al., 1991) , trabecular bone (Sakaguchi et al., 
2004) , synovial membrane (De et al., 2001) , adipose tissue (Zuk et al., 2001)  and peripheral 
blood (Eghbali-Fatourechi et al., 2005). (2) In perinatal tissues, MSC have been found in the 
umbilical cord (Sarugaser et al., 2005) , umbilical cord blood (Bieback et al., 2004; Lee et al., 
2004) , amniotic fluid (in't Anker, P; Scherjon, S A; Kleijburg-van, Keur C; Noort, W A; Claas, 
F H; Willemze, R; Fibbe, W E; Kanhai, 2003; De et al., 2007) . (3) In the prenatal tissue, 
human fetal MSC have been isolated and characterized from first-trimester fetal blood, liver, 
and bone marrow (Campagnoli et al., 2001) , second trimester bone marrow, spleen and 
lung (in't Anker P ; Noort, W A; Scherjon, S A; Kleijburg-van, Keur C; Kruisselbrink, A B; 
van, Bezooijen R; Beekhuizen, W; Willemze, R; Kanhai, H H; Fibbe, 2003) , fetal 
metanephros (Almeida-Porada et al., 2002) , dermis (Zhao et al., 2005) , pancreas (Hu et al., 
2003)  and thymus (Rzhaninova et al., 2005) . While investigations into their basic biology, 
immunogenicity and osteogenic potential have been reported, MSC have not been 
systematically compared for bone tissue engineering applications. Hence, it remains unclear 
how these novel prenatal, perinatal and postnatal MSC sources compare with their standard 
adult BM MSC counterparts for osteogenic differentiation and potential for tissue 
engineering. 
 
4.4 Human fetal BM derived MSC (hfMSC) as a promising cellular source for BTE 
Recently, we reported a systematic investigation into four types of MSC from different 
ontological and anatomical origins in a direct head-to-head manner for BTE applications 
(Zhang et al., 2009). In this study, MSC were isolated from prenatal (human fetal bone 
marrow (hfMSC)), perinatal (human umbilical cord (hUCMSC)) and postnatal sources 
(human adult adipose tissue (hATMSC) and human adult bone marrow (haMSC)). In vitro 
comparative studies were performed in monolayer cultures and three dimensional bioactive 
scaffold cultures to investigate their proliferation capacity, osteogenic differentiation and 
mineralization, and in vivo ectopic bone formation.  
hfMSC, haMSC, hUCMSC and hATMSC adopted a similar spindle-shaped morphology 
when cultured in monolayers, and expressed a consistent MSC immunophenotype which 
was negative for haemopoietic (CD14, CD34, CD45) and endothelial markers (CD31, and 
vWF), and positive for mesenchymal markers (CD105 (SH2), CD73 (SH3, SH4)), intracellular 
markers (Vimentin and Laminin) and cell adhesion molecules (CD29, CD44, CD 106, CD 90).  
All the four MSC types expressed HLA-I but not HLA-II and possessed the typical trilinage 
differentition capacities. However, compared with other MSC, hfMSC expressed a lower 
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The osteogenic differentiation pathway is the default pathway for MSC, which is retained 
regardless of cell passage number until senescence (Digirolamo et al., 1999). MSC are 
heterogenous in nature, and consist of subpopulations of cells with tri-potent (osteogenic, 
adipogenic and chondrogenic), bi-potent (osteogenic and chondrogenic) and uni-potent 
(osteogenic) differentiation capacities as demonstrated through clonal analysis (Muraglia et 
al., 2000). Clones have been found to progressively lose their adipogenic and chondrogenic 
differentiation potential at increasing cell doublings, although osteogenic differentiation 
ability is retained till senescence (Digirolamo et al., 1999; Muraglia et al., 2000) .  
 
Fig. 5. Osteogenic differentiation pathway of MSC 
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or osteocytes. With the progress of the osteogenic differentiation, proliferation of the cells is 
decreased while the osteogenic differentiation is increased. (Aubin, 1998; Aubin, 2001; 
Bilezikian, 2002)  
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van, Bezooijen R; Beekhuizen, W; Willemze, R; Kanhai, H H; Fibbe, 2003) , fetal 
metanephros (Almeida-Porada et al., 2002) , dermis (Zhao et al., 2005) , pancreas (Hu et al., 
2003)  and thymus (Rzhaninova et al., 2005) . While investigations into their basic biology, 
immunogenicity and osteogenic potential have been reported, MSC have not been 
systematically compared for bone tissue engineering applications. Hence, it remains unclear 
how these novel prenatal, perinatal and postnatal MSC sources compare with their standard 
adult BM MSC counterparts for osteogenic differentiation and potential for tissue 
engineering. 
 
4.4 Human fetal BM derived MSC (hfMSC) as a promising cellular source for BTE 
Recently, we reported a systematic investigation into four types of MSC from different 
ontological and anatomical origins in a direct head-to-head manner for BTE applications 
(Zhang et al., 2009). In this study, MSC were isolated from prenatal (human fetal bone 
marrow (hfMSC)), perinatal (human umbilical cord (hUCMSC)) and postnatal sources 
(human adult adipose tissue (hATMSC) and human adult bone marrow (haMSC)). In vitro 
comparative studies were performed in monolayer cultures and three dimensional bioactive 
scaffold cultures to investigate their proliferation capacity, osteogenic differentiation and 
mineralization, and in vivo ectopic bone formation.  
hfMSC, haMSC, hUCMSC and hATMSC adopted a similar spindle-shaped morphology 
when cultured in monolayers, and expressed a consistent MSC immunophenotype which 
was negative for haemopoietic (CD14, CD34, CD45) and endothelial markers (CD31, and 
vWF), and positive for mesenchymal markers (CD105 (SH2), CD73 (SH3, SH4)), intracellular 
markers (Vimentin and Laminin) and cell adhesion molecules (CD29, CD44, CD 106, CD 90).  
All the four MSC types expressed HLA-I but not HLA-II and possessed the typical trilinage 
differentition capacities. However, compared with other MSC, hfMSC expressed a lower 
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level of HLA-I and a higher level of Stro-1 with the implication of lower immunogenicity 
and higher osteogenic capacity.  
In two-dimensional (2D) monolayer cultures, hfMSC proliferated fastest (population 
doubling time 32.3±2.5 hours), followed by hUCMSC (54.7±4.3 hours), hATMSC (70.4±3.6 
hours), with the slowest being haMSC (116.6±22.4 hours, n=3, p<0.01) (Figure 6A). In 
addition, hfMSC had significantly higher self-renewal ability, with 75.1± 5.0% of cells 
forming colonies, compared to 37.5-47.5% of other three MSC (Figure 6B). When cultured in 
3D bioactive scaffold, hfMSC proliferated rapidly and reached confluence within the 
scaffold, taking up all available spaces by Day 7, while other MSC types achieved 
confluence only at the end of the 28  day experimental period as shown by a double-
stranded DNA (dsDNA) quantification method (Figure 6C). Furthermore, hfMSC mediated 
scaffold constructs showed more robustly upregulated of key osteogenic genes, deposited 
significantly higher mineralizaton and demonstrated greater osteogenic capacity compared 
to other MSC scaffold constructs, as evaluated by a series of assay methods including von-
Kossa staining, ALP activity, calcium deposition, calcium visualized on micro-CT and 
scanning electron-microscopy, and osteogenic gene expression (Figure 6D). Finally, 
subcutaneous implantation of these 3D constructs in immunodeficient NOD/SCID mice 
was performed to compare the osteogenic potential of MSC scaffolds in vivo. MSC scaffolds 
were cultured for two weeks in vitro as osteogenic pre-induction before implantation. Two 
months after implantation, all MSC scaffolds demonstrated neo-vascularization, with blood 
vessels infiltrating the scaffolds from the surrounding tissue macroscopically, and shared a 
similar chimerism rate of human cells in the murine tissue (60 to 67% chimerism) as 
demonstrated by human specific nuclear stain (lamins A/C), with infiltration of murine 
cells accounting for a third of the cellular population within the internal spaces of the 
scaffolds. Compared to other MSC scaffolds, hfMSC-mediated scaffolds generated more 
ectopic bone formation in vivo (1.8-13.3x, p<0.01) through micro-CT quantification (Zhang 
et al., 2009). 
 
 
 
Fig. 6. Comparison of different MSC for BTE application. (A) hfMSC proliferated faster than 
other MSCs with the shortest doubling time, and had higher self-renewal capacity on CFU-F 
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forming colonies, compared to 37.5-47.5% of other three MSC (Figure 6B). When cultured in 
3D bioactive scaffold, hfMSC proliferated rapidly and reached confluence within the 
scaffold, taking up all available spaces by Day 7, while other MSC types achieved 
confluence only at the end of the 28  day experimental period as shown by a double-
stranded DNA (dsDNA) quantification method (Figure 6C). Furthermore, hfMSC mediated 
scaffold constructs showed more robustly upregulated of key osteogenic genes, deposited 
significantly higher mineralizaton and demonstrated greater osteogenic capacity compared 
to other MSC scaffold constructs, as evaluated by a series of assay methods including von-
Kossa staining, ALP activity, calcium deposition, calcium visualized on micro-CT and 
scanning electron-microscopy, and osteogenic gene expression (Figure 6D). Finally, 
subcutaneous implantation of these 3D constructs in immunodeficient NOD/SCID mice 
was performed to compare the osteogenic potential of MSC scaffolds in vivo. MSC scaffolds 
were cultured for two weeks in vitro as osteogenic pre-induction before implantation. Two 
months after implantation, all MSC scaffolds demonstrated neo-vascularization, with blood 
vessels infiltrating the scaffolds from the surrounding tissue macroscopically, and shared a 
similar chimerism rate of human cells in the murine tissue (60 to 67% chimerism) as 
demonstrated by human specific nuclear stain (lamins A/C), with infiltration of murine 
cells accounting for a third of the cellular population within the internal spaces of the 
scaffolds. Compared to other MSC scaffolds, hfMSC-mediated scaffolds generated more 
ectopic bone formation in vivo (1.8-13.3x, p<0.01) through micro-CT quantification (Zhang 
et al., 2009). 
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assay (B-C) hfMSC expanded at a faster rate, reaching confluence by day 7 and have a 
higher final cellularity than other MSC mediated scaffolds. (D) hfMSC mediated scaffolds 
underwent more robust osteogenic differentiation and mineralization compared to others as 
seen through light microscopy and scanning electron microscopy (SEM).  
Through this study, it was found that the ontological and anatomical origins of MSC have 
profound influences on the proliferative and osteogenic capacity of MSC. MSC from the 
ontologically more primitive source have higher proliferative capacities, while MSC from 
BM related origin showed more osteogenic potential than MSC from other origins. In 
summary, hfMSC had the most proliferative and osteogenic capacity of MSC sources, as 
well as being the least immunogenic, suggesting they are superior candidates for BTE 
applications. 
 
4.5 hfMSC as an off-the-shelf cellular source for BTE application 
hfMSC have different immunologic properties to haMSC, as illustrated in Table 3. hfMSC 
not only express significantly lower levels of HLA Class I than haMSC, they do express any 
intracellular HLA Class II, which are found haMSC. hfMSC require 7 days of interferon-
gamma for the induction of HLA II expression, compared to 2 days for haMSC 
(Gotherstrom et al., 2003; Le Blanc, 2003) , alluding to their utility for allogeneic 
transplantation. In fact, hfMSC have been exploited for intrauterine cell therapy (Chan et al., 
2007; Guillot et al., 2008; Kennea et al., 2009) , with the first successful clinical applications of 
hfMSC has been reported through allogeneic hfMSC transplantation in a fetus with 
osteogenesis imperfecta  (Le Blanc et al., 2005).  
 
Immunologic properties Fetal MSC Adult MSC 
HLA Class I expression 0- (+ +)* + + + 
Intracellular deposits of 
HLA Class II 
0 + + + 
Induction time to epxress 
HLA Class II 
+ + (7 days) + + + (2 days) 
 
Table 3. Immunologic properties of fetal and adult MSC  
 
Aside from their lower immunogenicity, faster proliferation rate and more robust osteogenic 
potential, hfMSC possess other favorable advantages over other cellular source, making 
them become an ideal off-the-shelf cellular candidate for BTE application (Table 4).  Firstly, 
fetal tissues have a lower risk of viral and bacterial contamination compared to adult tissues 
as the fetus resides in an immunoprivileged environment within the uterus. Secondly, 
hfMSC have a higher proliferative capacity, and can undergo over 70 population doublings 
without senescence, compared to haMSC which typically senesces after 38 population 
doublings (Bruder et al., 1997; Campagnoli et al., 2001; Chan et al., 2005) . Theoretically, an 
unlimited number of cells can be derived from one hfMSC donor. With a proliferation 
capacity of more than 70 population doublings, theoretically one single cell isolated at 
Passage 0 can be proliferated to 1.2x 1021 (270) cells at Passage 70 and can be utilised more 
than 1012 patients (utilizing a dose of 1 x 109 cells). “Single-cell banks” can be established 
using cells derived from a single cell colony with well-investigated biological properties and 
 “+” means positive, and “0” means no expression. *: no expression or lower 
i  
 
greatly minimized variation; moreover, all the cells can be frozen down and made available 
off-the-shelf, eliminating the precious waiting time for patients. Lastly, the ethical 
conundrum faced with cells derived from embryonic stem cells are less of a problem with 
the use of fetal stem cells, considering that various human fetal cell types have been 
explored for therapeutic applications in the clinic already, such as the use of fetal neural 
progenitors for the treatment of Huntington’s (Rosser and Dunnett, 2003)  or Parkinson’s 
disease (Clarkson, 2001) , and the use of human fetal liver cells to treat severe 
immunodeficiencies, haematological disorders and inborn errors of metabolism (Touraine et 
al., 1993) . More recently human fetal skin cells have been utilized for constructing a tissue 
engineered skin graft (Hohlfeld et al., 2005; Pioletti et al., 2006).  
 
 Collection Expansion Storage Allogenic applications 
Osteogenic 
potential 
Fresh bone 
marrow +++ N.A. N.A. N.A.* + 
Differentiated 
osteoblast + + + N.A.* +++ 
MSC from 
adult BM ++ ++ +++ ++ ++ 
MSC from 
fetal BM ++ +++ +++ +++ +++ 
N.A.*: allogenic applications can be achieved by proper HLA matching 
Table 4. Comparison of hfMSC with other cellular source for BTE.  
 
5. Biaxial rotating bioreactors for BTE application 
Bioreactors are the biomechanical devices with closely monitored and tightly controlled 
environmental and operating conditions. Bioreactors have been widely used in industries 
for fermentation processing, wastewater treatment, food processing and production of 
pharmaceuticals. Recently bioreactors have been introduced to tissue engineering field in 
order to mimic the native in vivo environment and provide cellular tissue engineered 
constructs with physiologically relevant stimuli that facilitate and orchestrate the conversion 
of a “collection of cells” into a specific tissue phenotype (Lanza et al., 2007).  Specifically, 
they can increase the mass transport to mitigate the diffusion limitation of 3D scaffolds, 
providing adequate nutrient, oxygen and regulatory molecules to the cells while removing 
metabolites and CO2 away. Bioreactors can provide proper physiological stimuli, especially 
the mechanical cues to trigger the mechanotransduction signaling pathway for the 
differentiation of cellular constructs, and can be used to enable efficient and homogenous 
cellular seeding in the complex 3D scaffolds. (Martin et al., 2004; Bilodeau and Mantovani, 
2006; Chen and Hu, 2006)  
Currently, several types of bioreactors such as spinner flasks, perfusion bioreactors and 
rotating wall vessel (RWV) bioreactors have been investigated for BTE applications. 
However, various limitations have been reported with the use of these bioreactors. Spinner 
flasks can improve fluid flow, which can lead to the enhanced cell proliferation, distribution 
and osteogenic differentiation (Mygind et al., 2007; Song et al., 2008; Stiehler et al., 2008), but 
the turbulence generated by stirring can be detrimental for seeded cells and newly laid 
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assay (B-C) hfMSC expanded at a faster rate, reaching confluence by day 7 and have a 
higher final cellularity than other MSC mediated scaffolds. (D) hfMSC mediated scaffolds 
underwent more robust osteogenic differentiation and mineralization compared to others as 
seen through light microscopy and scanning electron microscopy (SEM).  
Through this study, it was found that the ontological and anatomical origins of MSC have 
profound influences on the proliferative and osteogenic capacity of MSC. MSC from the 
ontologically more primitive source have higher proliferative capacities, while MSC from 
BM related origin showed more osteogenic potential than MSC from other origins. In 
summary, hfMSC had the most proliferative and osteogenic capacity of MSC sources, as 
well as being the least immunogenic, suggesting they are superior candidates for BTE 
applications. 
 
4.5 hfMSC as an off-the-shelf cellular source for BTE application 
hfMSC have different immunologic properties to haMSC, as illustrated in Table 3. hfMSC 
not only express significantly lower levels of HLA Class I than haMSC, they do express any 
intracellular HLA Class II, which are found haMSC. hfMSC require 7 days of interferon-
gamma for the induction of HLA II expression, compared to 2 days for haMSC 
(Gotherstrom et al., 2003; Le Blanc, 2003) , alluding to their utility for allogeneic 
transplantation. In fact, hfMSC have been exploited for intrauterine cell therapy (Chan et al., 
2007; Guillot et al., 2008; Kennea et al., 2009) , with the first successful clinical applications of 
hfMSC has been reported through allogeneic hfMSC transplantation in a fetus with 
osteogenesis imperfecta  (Le Blanc et al., 2005).  
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HLA Class I expression 0- (+ +)* + + + 
Intracellular deposits of 
HLA Class II 
0 + + + 
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Aside from their lower immunogenicity, faster proliferation rate and more robust osteogenic 
potential, hfMSC possess other favorable advantages over other cellular source, making 
them become an ideal off-the-shelf cellular candidate for BTE application (Table 4).  Firstly, 
fetal tissues have a lower risk of viral and bacterial contamination compared to adult tissues 
as the fetus resides in an immunoprivileged environment within the uterus. Secondly, 
hfMSC have a higher proliferative capacity, and can undergo over 70 population doublings 
without senescence, compared to haMSC which typically senesces after 38 population 
doublings (Bruder et al., 1997; Campagnoli et al., 2001; Chan et al., 2005) . Theoretically, an 
unlimited number of cells can be derived from one hfMSC donor. With a proliferation 
capacity of more than 70 population doublings, theoretically one single cell isolated at 
Passage 0 can be proliferated to 1.2x 1021 (270) cells at Passage 70 and can be utilised more 
than 1012 patients (utilizing a dose of 1 x 109 cells). “Single-cell banks” can be established 
using cells derived from a single cell colony with well-investigated biological properties and 
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greatly minimized variation; moreover, all the cells can be frozen down and made available 
off-the-shelf, eliminating the precious waiting time for patients. Lastly, the ethical 
conundrum faced with cells derived from embryonic stem cells are less of a problem with 
the use of fetal stem cells, considering that various human fetal cell types have been 
explored for therapeutic applications in the clinic already, such as the use of fetal neural 
progenitors for the treatment of Huntington’s (Rosser and Dunnett, 2003)  or Parkinson’s 
disease (Clarkson, 2001) , and the use of human fetal liver cells to treat severe 
immunodeficiencies, haematological disorders and inborn errors of metabolism (Touraine et 
al., 1993) . More recently human fetal skin cells have been utilized for constructing a tissue 
engineered skin graft (Hohlfeld et al., 2005; Pioletti et al., 2006).  
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marrow +++ N.A. N.A. N.A.* + 
Differentiated 
osteoblast + + + N.A.* +++ 
MSC from 
adult BM ++ ++ +++ ++ ++ 
MSC from 
fetal BM ++ +++ +++ +++ +++ 
N.A.*: allogenic applications can be achieved by proper HLA matching 
Table 4. Comparison of hfMSC with other cellular source for BTE.  
 
5. Biaxial rotating bioreactors for BTE application 
Bioreactors are the biomechanical devices with closely monitored and tightly controlled 
environmental and operating conditions. Bioreactors have been widely used in industries 
for fermentation processing, wastewater treatment, food processing and production of 
pharmaceuticals. Recently bioreactors have been introduced to tissue engineering field in 
order to mimic the native in vivo environment and provide cellular tissue engineered 
constructs with physiologically relevant stimuli that facilitate and orchestrate the conversion 
of a “collection of cells” into a specific tissue phenotype (Lanza et al., 2007).  Specifically, 
they can increase the mass transport to mitigate the diffusion limitation of 3D scaffolds, 
providing adequate nutrient, oxygen and regulatory molecules to the cells while removing 
metabolites and CO2 away. Bioreactors can provide proper physiological stimuli, especially 
the mechanical cues to trigger the mechanotransduction signaling pathway for the 
differentiation of cellular constructs, and can be used to enable efficient and homogenous 
cellular seeding in the complex 3D scaffolds. (Martin et al., 2004; Bilodeau and Mantovani, 
2006; Chen and Hu, 2006)  
Currently, several types of bioreactors such as spinner flasks, perfusion bioreactors and 
rotating wall vessel (RWV) bioreactors have been investigated for BTE applications. 
However, various limitations have been reported with the use of these bioreactors. Spinner 
flasks can improve fluid flow, which can lead to the enhanced cell proliferation, distribution 
and osteogenic differentiation (Mygind et al., 2007; Song et al., 2008; Stiehler et al., 2008), but 
the turbulence generated by stirring can be detrimental for seeded cells and newly laid 
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down ECM (Sikavitsas et al., 2002; Chen and Hu, 2006). Perfusion bioreactors have been 
shown to enhance MSC proliferation and osteogenic differentiation in scaffold constructs 
(Sikavitsas et al., 2003; van et al., 2003; Gomes et al., 2006), however, they have been beset by 
non-homogenous cellular distributions, with cells at the frontal zones being washed away 
by the oncoming perfusion flow (Singh et al., 2007). Rotating wall vessel (RWV) bioreactors 
(Molnar et al., 1997; Granet et al., 1998; Yu et al., 2004), which generates low shear forces and 
three dimensional high mass transfer capacity, are prone to problems of non-homogenous 
cellular growth and ECM deposition (Goldstein et al., 2001; Sikavitsas et al., 2002; Chen and 
Hu, 2006). Moreover, the free floating culture of RWV bioreactors usually lead to the 
collision between the scaffolds and the bioreactor walls, which can induce cellular damage 
and disrupt cellular attachment and matrix deposition on the scaffolds (Goldstein et al., 2001; 
Sikavitsas et al., 2002; Chen and Hu, 2006).  
Consequently, we designed and developed an biaxial rotating bioreactor (Figure 7) to 
address the deficiencies found in current bioreactor designs. Firstly, a perfusion system was 
included to allow the media circulation between the vessel and reservoir, allowing maximal 
mass transfer with consequential low shear stress, and minimizing the washout problem 
associated with RWV bioreactors. Secondly, the improvement of biaxial rotation movement 
upon uni-axial rotating, leads to more homogenous cellular and ECM distribution of the 
scaffold, as previously predicted from in-silico simulation (Singh et al., 2005). Lastly, cellular 
scaffolds were secured by pins and were not kept in free suspension, avoiding the risk of 
scaffold collisions with the vessel walls.   
 
Fig. 7. The working mechanism of biaxial rotating bioreactor. This biaxial bioreactor can 
rotate in two perpendicular axes simultaneously with an inbuilt perfusion system.  
 
In a recent study, we investigated the performance of this biaxial rotating bioreactor for 
generation of highly osteogenic bone graft using hfMSC mediated polycaprolactone-
tricalcium phosphate (PCL-TCP) scaffolds. hfMSC-scaffolds were cultured and matured in 
either bioreactor or static cultures, and evaluated for their cellular viability, proliferation 
 
 
and osteogenic differentiation in vitro, and after transplantation into immunodeficient mice. 
Compared with traditional static culture, biaxial bioreactor culture enhanced cellular 
proliferation, with hfMSC-scaffolds reached cellular confluence earlier (Day 7 vs Day 28) 
with greater cellularity (2x, p<0.01) (Figure 8). Over 28 days of in vitro culture, the biaxial 
bioreactor enabled the maintenance of high cellular viability throughout the scaffolds, 
including the core, 2 mm from the surface of the scaffold. Thus the use of this bioreactor  
enabled a ten-fold improvement of mass transfer of nutrients, generally taken to be around 
150-200 nm. In contrast, the static culture only allowed the cellular survival at a surface 
region of the thick scaffolds, with massive cell necrosis within the core of the scaffolds.  
Biaxial bioreactor cultured-cellular scaffolds were associated with greater osteogenic 
induction as indicated by in vitro assays such as higher ALP expression (1.5x p<0.01), more 
calcium deposition (5.5x, p<0.001) and bony nodule formation observed under scanning 
electron microscopy (SEM) (Figure 8A), and the in vivo ectopic bone formation in 
immunodeficient mice (3.2x, p<0.001) compared with static-cultured scaffolds.  
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non-homogenous cellular distributions, with cells at the frontal zones being washed away 
by the oncoming perfusion flow (Singh et al., 2007). Rotating wall vessel (RWV) bioreactors 
(Molnar et al., 1997; Granet et al., 1998; Yu et al., 2004), which generates low shear forces and 
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mass transfer with consequential low shear stress, and minimizing the washout problem 
associated with RWV bioreactors. Secondly, the improvement of biaxial rotation movement 
upon uni-axial rotating, leads to more homogenous cellular and ECM distribution of the 
scaffold, as previously predicted from in-silico simulation (Singh et al., 2005). Lastly, cellular 
scaffolds were secured by pins and were not kept in free suspension, avoiding the risk of 
scaffold collisions with the vessel walls.   
 
Fig. 7. The working mechanism of biaxial rotating bioreactor. This biaxial bioreactor can 
rotate in two perpendicular axes simultaneously with an inbuilt perfusion system.  
 
In a recent study, we investigated the performance of this biaxial rotating bioreactor for 
generation of highly osteogenic bone graft using hfMSC mediated polycaprolactone-
tricalcium phosphate (PCL-TCP) scaffolds. hfMSC-scaffolds were cultured and matured in 
either bioreactor or static cultures, and evaluated for their cellular viability, proliferation 
 
 
and osteogenic differentiation in vitro, and after transplantation into immunodeficient mice. 
Compared with traditional static culture, biaxial bioreactor culture enhanced cellular 
proliferation, with hfMSC-scaffolds reached cellular confluence earlier (Day 7 vs Day 28) 
with greater cellularity (2x, p<0.01) (Figure 8). Over 28 days of in vitro culture, the biaxial 
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including the core, 2 mm from the surface of the scaffold. Thus the use of this bioreactor  
enabled a ten-fold improvement of mass transfer of nutrients, generally taken to be around 
150-200 nm. In contrast, the static culture only allowed the cellular survival at a surface 
region of the thick scaffolds, with massive cell necrosis within the core of the scaffolds.  
Biaxial bioreactor cultured-cellular scaffolds were associated with greater osteogenic 
induction as indicated by in vitro assays such as higher ALP expression (1.5x p<0.01), more 
calcium deposition (5.5x, p<0.001) and bony nodule formation observed under scanning 
electron microscopy (SEM) (Figure 8A), and the in vivo ectopic bone formation in 
immunodeficient mice (3.2x, p<0.001) compared with static-cultured scaffolds.  
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Fig. 8. Comparison of the biaxial bioreactor culture and static culture. (A) Biaxial bioreactor 
cultured hfMSC scaffolds proliferated faster and underwent more robust osteogenic 
differentiation compared to static cultured ones, and (B) resulted in significantly higher 
cellularity in the cellular scaffolds (*** p<0.001). 
 
6. Conclusion –Generating effective TE bone grafts 
By combining an inter-disciplinary approach in scaffold technology, bioreactor development 
and stem cell biology, we have generated an effective bone graft through the seeding of 
highly proliferative and osteogenic hfMSC onto the osteoconductive PCL-TCP scaffold 
matrix, and maturing the hfMSC mediated PCL-TCP scaffold under biaxial rotating 
bioreactor (Figure 9).  Our ongoing animal experiment showed that this hfMSC mediated TE 
bone graft can be used to heal critical sized femoral defect in a rat model (unpublished 
observations), paving the way for clinical trials to be initiated. This strategy presents a 
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promising solution to fulfill the increasing need for bone grafts and provides effective TE 
bone grafts, which are available off-the-shelf like allografts and synthetic grafts and can 
stimulate rapid healing like autografts.  
 
 
Fig. 9. Generation effective bone grafts with the combinational use of hfMSC, PCL-TCP 
scaffold and biaxial rotating bioreactor. 
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1. Introduction 
Cardiovascular disease remains a major cause of morbidity and mortality worldwide, 
resulting 16.7 million deaths each year, accounting for 29% of all deaths globally (WHO, 
2006). The major modality of death due to cardiovascular disease remains acute myocardial 
infarctions (MI) and sudden cardiac death with more than one third of first time MI not 
making it to the hospital. MIs are mostly caused by sudden occlusion of a coronary artery 
secondary to plaque rupture and acute thrombosis resulting in loss of oxygen supply to the 
territory affected; if flow is not restored in a timely fashion, myocardial death ensues. The 
resultant of that is loss of contractile function, cardiac remodeling and eventual heat failure. 
The resultant compensatory mechanism however, is cardiac remodeling with fibrous tissue 
replacing the damaged myocardium early on and overcompensation of the remaining 
myocardium to maintain cardiac output. This eventually leads to negative remodeling, 
ventricular dilatation, and eventual loss of pump function and heart failure ensues. 
Furthermore, fibrous tissue deposition and structural remodeling of the heart in the setting 
of heart failure leads to electrical uncoupling of myocardium from fibrous tissue and 
development of re-entrant electrical circuits that lead to the development of significant 
ventricular dysrrythmias. This increases the risk of sudden cardiac death in patients with 
heart failure whether this is due to myocyte loss from heart attacks or other causes of heart 
failure (Leor J 2000; Anversa P 2002; Li SC 2009).  Scar formation secondary to cardiac 
remodeling and fibrosis results in increased risk of fatal dysrrythmias as this tissue becomes 
a nidus for dyrrthmia origination and propagation. (Strauer BE 2002; Stamm C 2003; 
Galiñanes M 2004; Pittenger MF 2004; Wollert KC 2004; Dib N 2005; Dimmeler S 2005; Patel 
AN 2005; Deindl E 2006; Engelmann MG 2006; Schächinger V 2006; Tse HF 2006; Wu KH 
2006; Kissel CK 2007; Stamm C 2007; Theiss HD 2007; Yerebakan C 2008). 
 
Although there have been great advances in the knowledge of the mechanisms and 
treatments of myocardial, therapies for cardiac regeneration and repair are still not available 
for end stage heart disease. Our current treatments for heart failure are only temporizing 
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whether it is medications such as beta blockers, angiotensin converting enzyme (ACE) 
inhibitors, diuretics and other classes or devices such as implantable defibrillators and bi-
ventricular pacemakers (Moss AJ 2009). Once end stage heart failure ensues, one year 
survival rates can be as low as 50% for New York Heart Association (NYHA) class III and IV 
heart failure; the only options then to restore pump function are mechanical ventricular 
devices (VADs) (Birks EJ 2006) as destination therapy or ultimately open heart 
transplantation. However, due to the high cost of VADs and the shortage of donor organs 
these are not viable options as demand for a transplant is ever increasing with a relatively 
fixed supply of donor hearts. 
 
The concept of the heart as being a post mitotic organ with no cardiomyocyte cell generation 
and turnover has been challenged over the past decade with culminating evidence that there 
is slow process of cell turnover in the heart postnatally. This process appears to be slow with 
a 1% per year turnover rate at the age of 20 decreasing to about 0.45% per year at the age of 
75. Fewer than 50% of cardiomyocytes are exchanged during a normal life span (Bergmann 
O 2009). Although there appears to be postnatal cardiomyocyte turnover and generation, 
this is insufficient to replenish lost heart cells (myocytes) post MIs and in the setting of non-
ischemic cardiomyopathies. Therefore the need for regenerative therapies for heart failure is 
becoming even more so important with an aging population as more patients are surviving 
their heart attacks and progressing on to develop heart failure (Akins 2002; Wu KH 2006; Li 
SC 2009). 
 
2. Tissue Engineering 
It is well known that the heart is one of the least regenerative organs in the human body 
(Wu KH 2006). Nevertheless, in recent years many scientists have envisioned the possibility 
of regeneration of the myocardium and reproduction of autologous heart tissue in vitro or in 
vivo (Zund G 1996; Shimizu T 2002; Leor J 2004; Shin M 2004; Zammaretti P 2004; Leor J 
2005; Shaoping Zhong 2005; Ishii O 2006; Sekine H 2006; Zimmerman WH 2006). Heart 
tissue is composed of myocytes that are arranged in parallel and series so that contraction 
will generate a coordinated force to empty the ventricle. In brief, myocytes are elongated 
cells that are dedicated to contraction with most of the cellular cytoplasm occupied by 
actin/myosin chains, the structures responsible for contraction. They are connected by 
intercalated discs which conduct electrochemical potentials directly between the cytoplasms 
of the adjunct cells via gap junctions.  
Gap junctions allow action potentials to spread directly between cells by depolarizing the 
heart via K+/Na+ exchange channels. This coordinated wave of electrical discharge coupled 
with mechanical contraction of the myocardium with each cardiac cycle is essential for 
normal pump function (Jansen JA 2009). Therefore, one can foresee that any regenerative 
therapy whether it is cell or tissue implantation will have to ensure appropriate 
incorporation of the transplanted tissue in a geometric fashion to ensure synchronous 
contraction with electrical and mechanical coupling. Additionally, the heart also utilizes a 
unique system for vascularization of the metabolically demanding tissues with a complex 
vascular bed (Chang AC 2006; Zimmerman WH 2006). This network would be essential for 
the survival, engraftment and functional incorporation of transplanted tissue.  
Tissue engineering in general terms is a process that involves the reconstruction of tissue 
equivalents by combining biomaterials and living cells, to be used together in repair, 
maintenance and replacement and augmentation of native tissues or organs (Lanza RP 
2000). The complexity of the human heart highlights the current hurdles that need to be 
overcome before the potential for regenerative therapies and tissue engineering for heart 
failure are fully realized. These challenges include, but are not limited to, the choice of 
cells/stem cells, processing, differentiation, engraftment, electrical and mechanical coupling 
of transplanted and native tissue and appropriate vascularization of the newly incorporated 
tissue, to name a few. The ideal myocardial construct should mimic the morphological, 
physiological and functional properties of the native cardiac muscle it intends to replace and 
needs to remain viable and functional long term after implantation.  
 
Cardiovascular tissue engineering is an emerging field with an enormous potential for 
revolutionizing the next generation of heart failure therapies; we are witnessing the 
evolution of therapies from pharmaceuticals and device treatments to the era of biological 
therapies with cell and engineered tissue. This may eventually become a standard therapy 
for all heart failure patients post MI and also in the setting of non-ischemic 
cardiomyopathies to replace damaged and lost myocardium and prevent progression to end 
stage heart failure. For cell replacement therapy and tissue regeneration to be successful, it is 
essential to generate sufficient cells in a reliable and reproducible manner with the 
appropriate functional phenotype to replace the damaged tissue.  
Not only do replacement cells or tissues need to be functional (for e.g. contraction in the case 
of cardiomyocytes, secretory in the case of pancreatic islet cells), these cells have to interact 
with their environment. This can be secretion of extracellular matrix, or maintenance of 
tissue and organ homeostasis through regulatory feedback mechanisms (Leor J 2004; 
Zammaretti P 2004; Leor J 2005; Zhong S 2005; Zimmerman WH 2006). Therefore, selecting 
the appropriate biomaterials and suitable cell source will be critical for the success of this 
strategy. 
 
Cardiovascular tissue engineering is a materials-based approach and involves preformed 
three-dimensional (3D) scaffolds in the form of mesh, patch, or foam. This inert 
biocompatible material will then implanted with differentiated cells to form appropriate 
functional tissue to be transplanted in-vivo. This has been the focus of intense research in 
the cardiovascular tissue regeneration field over the past decade. (Zund G 1996; Shimizu T 
2002; Leor J 2004; Shin M 2004; Zammaretti P 2004; Leor J 2005; Shaoping Zhong 2005; Ishii 
O 2006; Sekine H 2006; Zimmerman WH 2006).  
 
The challenges of producing engineered tissues for in vivo use are considerable. The 
engineered tissue must provide an effective, durable, non-thrombogenic and non-
immunogenic substitute that will display functional and morphological properties of the 
cardiovascular system. Furthermore, this material must possess repair and remodeling 
capabilities, and retain its viability after implantation (Langer R 1993; Lanza RP 2000; Atala 
A 2002).  
 
In order for a potential cell source to represent a suitable candidate for the construction of 
engineered grafts, several criteria must be considered. The ideal cell should be autologous 
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whether it is medications such as beta blockers, angiotensin converting enzyme (ACE) 
inhibitors, diuretics and other classes or devices such as implantable defibrillators and bi-
ventricular pacemakers (Moss AJ 2009). Once end stage heart failure ensues, one year 
survival rates can be as low as 50% for New York Heart Association (NYHA) class III and IV 
heart failure; the only options then to restore pump function are mechanical ventricular 
devices (VADs) (Birks EJ 2006) as destination therapy or ultimately open heart 
transplantation. However, due to the high cost of VADs and the shortage of donor organs 
these are not viable options as demand for a transplant is ever increasing with a relatively 
fixed supply of donor hearts. 
 
The concept of the heart as being a post mitotic organ with no cardiomyocyte cell generation 
and turnover has been challenged over the past decade with culminating evidence that there 
is slow process of cell turnover in the heart postnatally. This process appears to be slow with 
a 1% per year turnover rate at the age of 20 decreasing to about 0.45% per year at the age of 
75. Fewer than 50% of cardiomyocytes are exchanged during a normal life span (Bergmann 
O 2009). Although there appears to be postnatal cardiomyocyte turnover and generation, 
this is insufficient to replenish lost heart cells (myocytes) post MIs and in the setting of non-
ischemic cardiomyopathies. Therefore the need for regenerative therapies for heart failure is 
becoming even more so important with an aging population as more patients are surviving 
their heart attacks and progressing on to develop heart failure (Akins 2002; Wu KH 2006; Li 
SC 2009). 
 
2. Tissue Engineering 
It is well known that the heart is one of the least regenerative organs in the human body 
(Wu KH 2006). Nevertheless, in recent years many scientists have envisioned the possibility 
of regeneration of the myocardium and reproduction of autologous heart tissue in vitro or in 
vivo (Zund G 1996; Shimizu T 2002; Leor J 2004; Shin M 2004; Zammaretti P 2004; Leor J 
2005; Shaoping Zhong 2005; Ishii O 2006; Sekine H 2006; Zimmerman WH 2006). Heart 
tissue is composed of myocytes that are arranged in parallel and series so that contraction 
will generate a coordinated force to empty the ventricle. In brief, myocytes are elongated 
cells that are dedicated to contraction with most of the cellular cytoplasm occupied by 
actin/myosin chains, the structures responsible for contraction. They are connected by 
intercalated discs which conduct electrochemical potentials directly between the cytoplasms 
of the adjunct cells via gap junctions.  
Gap junctions allow action potentials to spread directly between cells by depolarizing the 
heart via K+/Na+ exchange channels. This coordinated wave of electrical discharge coupled 
with mechanical contraction of the myocardium with each cardiac cycle is essential for 
normal pump function (Jansen JA 2009). Therefore, one can foresee that any regenerative 
therapy whether it is cell or tissue implantation will have to ensure appropriate 
incorporation of the transplanted tissue in a geometric fashion to ensure synchronous 
contraction with electrical and mechanical coupling. Additionally, the heart also utilizes a 
unique system for vascularization of the metabolically demanding tissues with a complex 
vascular bed (Chang AC 2006; Zimmerman WH 2006). This network would be essential for 
the survival, engraftment and functional incorporation of transplanted tissue.  
Tissue engineering in general terms is a process that involves the reconstruction of tissue 
equivalents by combining biomaterials and living cells, to be used together in repair, 
maintenance and replacement and augmentation of native tissues or organs (Lanza RP 
2000). The complexity of the human heart highlights the current hurdles that need to be 
overcome before the potential for regenerative therapies and tissue engineering for heart 
failure are fully realized. These challenges include, but are not limited to, the choice of 
cells/stem cells, processing, differentiation, engraftment, electrical and mechanical coupling 
of transplanted and native tissue and appropriate vascularization of the newly incorporated 
tissue, to name a few. The ideal myocardial construct should mimic the morphological, 
physiological and functional properties of the native cardiac muscle it intends to replace and 
needs to remain viable and functional long term after implantation.  
 
Cardiovascular tissue engineering is an emerging field with an enormous potential for 
revolutionizing the next generation of heart failure therapies; we are witnessing the 
evolution of therapies from pharmaceuticals and device treatments to the era of biological 
therapies with cell and engineered tissue. This may eventually become a standard therapy 
for all heart failure patients post MI and also in the setting of non-ischemic 
cardiomyopathies to replace damaged and lost myocardium and prevent progression to end 
stage heart failure. For cell replacement therapy and tissue regeneration to be successful, it is 
essential to generate sufficient cells in a reliable and reproducible manner with the 
appropriate functional phenotype to replace the damaged tissue.  
Not only do replacement cells or tissues need to be functional (for e.g. contraction in the case 
of cardiomyocytes, secretory in the case of pancreatic islet cells), these cells have to interact 
with their environment. This can be secretion of extracellular matrix, or maintenance of 
tissue and organ homeostasis through regulatory feedback mechanisms (Leor J 2004; 
Zammaretti P 2004; Leor J 2005; Zhong S 2005; Zimmerman WH 2006). Therefore, selecting 
the appropriate biomaterials and suitable cell source will be critical for the success of this 
strategy. 
 
Cardiovascular tissue engineering is a materials-based approach and involves preformed 
three-dimensional (3D) scaffolds in the form of mesh, patch, or foam. This inert 
biocompatible material will then implanted with differentiated cells to form appropriate 
functional tissue to be transplanted in-vivo. This has been the focus of intense research in 
the cardiovascular tissue regeneration field over the past decade. (Zund G 1996; Shimizu T 
2002; Leor J 2004; Shin M 2004; Zammaretti P 2004; Leor J 2005; Shaoping Zhong 2005; Ishii 
O 2006; Sekine H 2006; Zimmerman WH 2006).  
 
The challenges of producing engineered tissues for in vivo use are considerable. The 
engineered tissue must provide an effective, durable, non-thrombogenic and non-
immunogenic substitute that will display functional and morphological properties of the 
cardiovascular system. Furthermore, this material must possess repair and remodeling 
capabilities, and retain its viability after implantation (Langer R 1993; Lanza RP 2000; Atala 
A 2002).  
 
In order for a potential cell source to represent a suitable candidate for the construction of 
engineered grafts, several criteria must be considered. The ideal cell should be autologous 
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and available in large quantities. If not autologous, the cells used must be non-immunogenic 
as to avoid the need for immunosuppression and all the associated difficulties and 
complications that are encountered in the transplant population. These range from the risk 
of graft rejection, increased infection and malignancy in patients on immunosuppression. It 
should also have the capacity to proliferate and differentiate in vitro, in a manner that can be 
reliably reproduced and controlled, and eventually automated for mass production to be 
practically viable in a clinical setting (Atala A 2002).  
There are a number of limitations in the use of differentiated cells in tissue engineering. It is 
a challenge to generate sufficient numbers of a single cell type, to assemble the needed 
mixture of multiple cell phenotypes, and to maintain stable phenotypes as needed (Atala A 
2002). Thus lies the promise of stem cells as an endless source that can be manipulated and 
combined with nanostructures and scaffolds to produce engineered tissue grafts to be used 
in clinical therapies.  
 
Among different pharmaceutical and surgical treatments, the focus of emerging research is 
to use stem cells in order to heal or replace damaged cardiac tissues (Moffett BS 2006; 
Ruvinov E 2008; Segers VF 2008). Several kinds of stem cells are potentially useful because 
of their ability to self renew and differentiate into various types of cells in the body. 
Embryonic stem cells (ESCs) are capable of indefinite expansion and are pluripotent (able to 
differentiate into any cell type). However human embryonic stem cells (hESCs) although are 
immortal and pluripotent, they are burdened with ethical concerns due to their derivation 
from human embryos. Therefore their use has been very controversial and they have been 
limited to a very few lines only used in laboratory settings.  
 
The ethical concerns surrounding these cells prevent them from being used in any clinical 
setting. Furthermore, issues with their immunogenecity, the risk of teratoma formation, the 
difficulties associated with their differentiation fate, and the ethical challenges arising from 
their embryonic origin have all excluded them as prime candidates for regenerative 
medicine (Petersen T 2007). 
 
However, a recent breakthrough has completely revolutionized the field and taken it in a 
whole new direction. Using four transcription factors, Dr Yamanaka’s group was able to 
reprogram mouse fibroblasts to a stem-cell like state creating induced pluripotent stem cells 
(iPS).  Since then, many groups have been able to reprogram human, porcine, rat and 
murine somatic cells into these iPS cells using different approaches (Takahashi K 2006; Okita 
K 2007; Takahashi K 2007; Okita K 2008; Ezashi T 2009; Zhao XY 2009). These iPS cells have 
been differentiated into different tissue types and promise to revolutionize the regenerative 
cell and tissue replacement field.  
 
Adult stem cells have been touted as a potential source of stem cells for cell and tissue 
replacement therapies although these cells present their own unique challenges. They have 
been found to vary in quality depending on the age and health of the donor/patient and 
differentiation is often restricted to the origin lineage of the cell source (multipotent) (Smith 
S 2007). An important consideration is the expansion potential of the adult stem cells to be 
considered as a viable source for regenerative cell therapy potential. Unlike ESCs that have 
an almost unlimited expansion capability, adult stem cells may be capable of only a limited 
number of doubling cycles. Therefore, candidates that are able to provide an abundant 
number of cells that would be required for cell and tissue replacement therapies maybe 
embryonic stem cells, bone marrow derived cells, bone marrow derived mesenchymal stem 
cells, endothelia progenitor cells, skeletal myoblasts, adipose derived stem cells and induced 
pluripotent stem cells.  
This chapter will focus on adipose derived stem cells (ASCs) and induced pluripotent stem 
cells (iPS). 
 
3. Adipose Derived Stem Cells 
For the production of clinically useful tissue-engineered constructs to replace cardiovascular 
structures, it is critical to identify a suitable cell source that is autologous and capable of 
differentiating into the desired cell types. Adipose tissue represents an easily accessible and 
abundant source of cells. Furthermore, this source represents a potential adult stem cell 
reservoir for each individual (Aust L 2004). In recent years, interest has rapidly grown in the 
developmental plasticity and therapeutic potential of stromal cells isolated from human 
subcutaneous adipose tissue. 
 
Adipose tissue represents an abundant, practical, and appealing source of donor tissue for 
autologous cell replacement (Planat-Benard V 2004a; Planat-Benard V 2004b; Katz AJ 2005). 
Adipose tissue is of mesodermic origin, consisting of mature adipocytes and the stromal 
vascular fraction (SVF). SVF is a heterogeneous cell population, consisting of vascular cells 
(endothelial cells (ECs) and smooth muscle cells (SMCs)), blood cells, and a fibroblast-like 
multipotential stem cell population, termed adipose-derived stem cells (ASCs).  
These cells can be isolated in large numbers with minimally invasive techniques from 
liposuctions and grown easily under standard tissue culture conditions (Zuk PA 2001; Zuk 
PA 2002), and therefore represent an excellent abundant stem cell source with a high 
therapeutic potential. Since its initial characterization, several groups have demonstrated the 
ASC population of stem cells within the SVF of subcutaneous adipose tissue displays 
multilineage developmental plasticity in vitro and in vivo.  
 
It has been shown that adult stem cells from white adipose tissues can differentiate into 
multiple cell phenotypes, including the adipocyte, chondrocyte, epithelial, hematopoietic, 
hepatocyte, neuronal, myogenic, and osteoblast lineages (Halvorsen YC 2000; Halvorsen YD 
2001; Zuk PA 2001; Erickson GR 2002; Mizuno H 2002; Safford KM 2002; Zuk PA 2002; 
Cousin B 2003; Gimble J 2003a; Gimble JM 2003b; Kang SK 2003; Kim DH 2003; Rangappa S 
2003; Miranville A 2004; Planat-Benard V 2004a; Planat-Benard V 2004b; Rodriguez LV 
2006).  
Research efforts towards understanding the nature of how ASCs differentiate into cells of 
the cardiovascular lineage, including ECs and SMCs, have become more intensive in the 
past years. Recent studies have shown that ASCs are capable of differentiating into either 
SMCs (Lee WC 2006; Rodriguez LV 2006) or cells of an EC phenotype (Planat-Benard V 
2004; Dimuzio P 2006; Wosnitza M 2007). However, the differentiation protocols employed 
in those studies are rather diverse, using complex cell culture media that are supplemented 
with various growth factors. Moreover, the culture time periods that were reported to be 
necessary for a successful differentiation of ASCs into cardiac cells were rather exhaustive, 
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and available in large quantities. If not autologous, the cells used must be non-immunogenic 
as to avoid the need for immunosuppression and all the associated difficulties and 
complications that are encountered in the transplant population. These range from the risk 
of graft rejection, increased infection and malignancy in patients on immunosuppression. It 
should also have the capacity to proliferate and differentiate in vitro, in a manner that can be 
reliably reproduced and controlled, and eventually automated for mass production to be 
practically viable in a clinical setting (Atala A 2002).  
There are a number of limitations in the use of differentiated cells in tissue engineering. It is 
a challenge to generate sufficient numbers of a single cell type, to assemble the needed 
mixture of multiple cell phenotypes, and to maintain stable phenotypes as needed (Atala A 
2002). Thus lies the promise of stem cells as an endless source that can be manipulated and 
combined with nanostructures and scaffolds to produce engineered tissue grafts to be used 
in clinical therapies.  
 
Among different pharmaceutical and surgical treatments, the focus of emerging research is 
to use stem cells in order to heal or replace damaged cardiac tissues (Moffett BS 2006; 
Ruvinov E 2008; Segers VF 2008). Several kinds of stem cells are potentially useful because 
of their ability to self renew and differentiate into various types of cells in the body. 
Embryonic stem cells (ESCs) are capable of indefinite expansion and are pluripotent (able to 
differentiate into any cell type). However human embryonic stem cells (hESCs) although are 
immortal and pluripotent, they are burdened with ethical concerns due to their derivation 
from human embryos. Therefore their use has been very controversial and they have been 
limited to a very few lines only used in laboratory settings.  
 
The ethical concerns surrounding these cells prevent them from being used in any clinical 
setting. Furthermore, issues with their immunogenecity, the risk of teratoma formation, the 
difficulties associated with their differentiation fate, and the ethical challenges arising from 
their embryonic origin have all excluded them as prime candidates for regenerative 
medicine (Petersen T 2007). 
 
However, a recent breakthrough has completely revolutionized the field and taken it in a 
whole new direction. Using four transcription factors, Dr Yamanaka’s group was able to 
reprogram mouse fibroblasts to a stem-cell like state creating induced pluripotent stem cells 
(iPS).  Since then, many groups have been able to reprogram human, porcine, rat and 
murine somatic cells into these iPS cells using different approaches (Takahashi K 2006; Okita 
K 2007; Takahashi K 2007; Okita K 2008; Ezashi T 2009; Zhao XY 2009). These iPS cells have 
been differentiated into different tissue types and promise to revolutionize the regenerative 
cell and tissue replacement field.  
 
Adult stem cells have been touted as a potential source of stem cells for cell and tissue 
replacement therapies although these cells present their own unique challenges. They have 
been found to vary in quality depending on the age and health of the donor/patient and 
differentiation is often restricted to the origin lineage of the cell source (multipotent) (Smith 
S 2007). An important consideration is the expansion potential of the adult stem cells to be 
considered as a viable source for regenerative cell therapy potential. Unlike ESCs that have 
an almost unlimited expansion capability, adult stem cells may be capable of only a limited 
number of doubling cycles. Therefore, candidates that are able to provide an abundant 
number of cells that would be required for cell and tissue replacement therapies maybe 
embryonic stem cells, bone marrow derived cells, bone marrow derived mesenchymal stem 
cells, endothelia progenitor cells, skeletal myoblasts, adipose derived stem cells and induced 
pluripotent stem cells.  
This chapter will focus on adipose derived stem cells (ASCs) and induced pluripotent stem 
cells (iPS). 
 
3. Adipose Derived Stem Cells 
For the production of clinically useful tissue-engineered constructs to replace cardiovascular 
structures, it is critical to identify a suitable cell source that is autologous and capable of 
differentiating into the desired cell types. Adipose tissue represents an easily accessible and 
abundant source of cells. Furthermore, this source represents a potential adult stem cell 
reservoir for each individual (Aust L 2004). In recent years, interest has rapidly grown in the 
developmental plasticity and therapeutic potential of stromal cells isolated from human 
subcutaneous adipose tissue. 
 
Adipose tissue represents an abundant, practical, and appealing source of donor tissue for 
autologous cell replacement (Planat-Benard V 2004a; Planat-Benard V 2004b; Katz AJ 2005). 
Adipose tissue is of mesodermic origin, consisting of mature adipocytes and the stromal 
vascular fraction (SVF). SVF is a heterogeneous cell population, consisting of vascular cells 
(endothelial cells (ECs) and smooth muscle cells (SMCs)), blood cells, and a fibroblast-like 
multipotential stem cell population, termed adipose-derived stem cells (ASCs).  
These cells can be isolated in large numbers with minimally invasive techniques from 
liposuctions and grown easily under standard tissue culture conditions (Zuk PA 2001; Zuk 
PA 2002), and therefore represent an excellent abundant stem cell source with a high 
therapeutic potential. Since its initial characterization, several groups have demonstrated the 
ASC population of stem cells within the SVF of subcutaneous adipose tissue displays 
multilineage developmental plasticity in vitro and in vivo.  
 
It has been shown that adult stem cells from white adipose tissues can differentiate into 
multiple cell phenotypes, including the adipocyte, chondrocyte, epithelial, hematopoietic, 
hepatocyte, neuronal, myogenic, and osteoblast lineages (Halvorsen YC 2000; Halvorsen YD 
2001; Zuk PA 2001; Erickson GR 2002; Mizuno H 2002; Safford KM 2002; Zuk PA 2002; 
Cousin B 2003; Gimble J 2003a; Gimble JM 2003b; Kang SK 2003; Kim DH 2003; Rangappa S 
2003; Miranville A 2004; Planat-Benard V 2004a; Planat-Benard V 2004b; Rodriguez LV 
2006).  
Research efforts towards understanding the nature of how ASCs differentiate into cells of 
the cardiovascular lineage, including ECs and SMCs, have become more intensive in the 
past years. Recent studies have shown that ASCs are capable of differentiating into either 
SMCs (Lee WC 2006; Rodriguez LV 2006) or cells of an EC phenotype (Planat-Benard V 
2004; Dimuzio P 2006; Wosnitza M 2007). However, the differentiation protocols employed 
in those studies are rather diverse, using complex cell culture media that are supplemented 
with various growth factors. Moreover, the culture time periods that were reported to be 
necessary for a successful differentiation of ASCs into cardiac cells were rather exhaustive, 
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making this an unpractical and unfavorable option for potential clinical applications. 
However, there has yet to be significant research into the relationship between patient’s age, 
gender, comorbidities and the differentiation capabilities of these adipose derived cells.  
 
We have focused on the differentiation of hASCs towards the endothelial and SMC lineage. 
We have been able to identify specific parameters that are crucial for an efficient and easily 
reproducible differentiation of human ASCs into ECs and SMCs within 14 days of in vitro 
culture. We found that hASCs, which were cultured in endothelial specific growth medium-
2 (EGM-2), exhibited morphological features of mature ECs and expressed EC-specific 
markers including CD31, CD144 and vWF (Heydarkhan-Hagvall S 2008).  
This differentiation pattern appeared to be specific to EGM-2-treated hASCs, cultured in a 
high-density environment. It has been reported that cell-cell junctions between ECs through 
CD31 and CD144 are critical for the establishment of a primary vascular network (Dejana E 
1995; Baldwin HS 1996; Dejana 1996; Drake CJ 1998).  
The failure of hASCs that were cultured in Dulbecco’s modified Eagle’s medium-20% 
(DMEM-20%) FBS to form such tubular network may, in part, be due to the absence of these 
necessary cell-to-cell contacts. Our immunocytochemistry and fluorescence-activated cell 
sorter (FACS) analyses demonstrated the presence of both immature and mature EC 
markers, such as CD34, Flk-1/KDR, CD144, CD31 and vWF, in the specifically induced 
hASCs (Heydarkhan-Hagvall S 2008).  
 
Previous studies have identified three markers, CD133, CD34 and Flk-1/KDR, in early 
endothelial progenitor cells. In addition, mature ECs are known to express high levels of 
Flk-1/KDR, CD31, CD144, and vWF, suggesting that our EGM-2-induced hASCs may be 
assuming a more mature EC phenotype. To date, it is not completely understood as to when 
an endothelial progenitor cell turns into mature, fully differentiated ECs in vivo. One 
possibility could be the loss of CD133 and a parallel or subsequent expression of vWF in 
conjunction with the appearance of other endothelial characteristics (Hristov M 2003; Urbich 
C 2004). An interesting observation was that the differentiation capacity of hASCs towards 
ECs was significantly diminished when the cells were passaged, whereas the age of the 
donor was not a critical factor.  
In contrast, when hASCs were cultured for 14 days in DMEM-20% FBS they expressed SMC-
specific markers including SM myosin, h-caldesmon, basic calponin and SM--actin a 
phenomenon that was independent of passage number, yet affected by the donor age 
(Heydarkhan-Hagvall S 2008). As the primary function of mature SMC is contraction, the 
complement of contractile, structural, and regulatory proteins expressed in fully 
differentiated SMC provides markers of differentiation status (Kuro-o M 1989; Sobue K 
1999). These include SM myosin, h-caldesmon, basic calponin, and SM--actin. SM--actin is 
an important protein for SMCs structure and contraction, and it is upregulated with 
differentiation. Indeed, SM--actin has been used as a marker of early SMC differentiation, 
followed by calponin, h-caldesmon and SM myosin (Owens GK 1995; Hungerford JE 1996; 
Katoh Y 1996; Thyberg J 1996; Hungerford JE 1999).  
It is well known that SMCs grown in vitro can undergo a phenotypic cell transition from the 
normally quiescent ‘contractile’ status observed in vivo to a proliferative-secretory state 
(Thyberg J 1996; Opitz F 2004). The general feature of cultured SMCs is the downregulation 
of SM myosin expression, particularly of SM2 concomitant with upregulation of nonmuscle 
myosin variants MyHC-A pla1, MyHC-A, and MyHC-B (Somlyo AP 1993). These tendencies 
depend, however, on cellular density, serum concentration, and substrate for attachment. 
Myosin gene expression can be regulated during early development (effect on the 
differentiation phase of the SMC lineage program) or in adulthood (alteration of the stability 
of the fully differentiated SMC phenotype) (Zanellato AMC 1990; Somlyo AP 1993). The 
general feature of cultured SMCs is the downregulation of SM myosin expression, 
particularly of SM2 concomitant with upregulation of non-muscle myosin variants MyHC-A 
pla1, MyHC-A, and MyHC-B (Somlyo AP 1993). These tendencies depend, however, on 
cellular density, serum concentration, and substrate for attachment. Myosin gene expression 
can be regulated during early development (effect on the differentiation phase of the SMC 
lineage program) or in adulthood (alteration of the stability of the fully differentiated SMC 
phenotype) (Zanellato AMC 1990; Somlyo AP 1993). High levels of SM--actin and basic 
calponin in particular were observed in the present study, with lower levels of SM myosin 
and h-caldesmon-expressing cells. Rodriguez et al. (Rodriguez LV 2006) demonstrated an 
optimal smooth muscle differentiation, phenotypically and functionally, when hASCs were 
cultured in specific smooth muscle-inductive medium after 6 weeks. However, our data 
have shown that a prolonged culture time did not increase the number of SMC marker 
expressing cells, since a plateau was reached after 14 days of culture.  
 
4. Induced Pluripotent Stem Cells  
One of the most exciting and revolutionary breakthroughs in stem cell research has been the 
induction of pluripotent stem cells from mature somatic cells. It has been shown that four 
factors present in ESC are sufficient to re-induce a pluripotent state in somatic cells. The 
reprogramming of somatic cells to a pluripotent state can be achieved by simple retroviral 
overexpression of specific transcription factors, resulting in induced pluripotent stem (iPS) 
cells that are almost indistinguishable from ESC (Okita K 2007; Mauritz C 2008; Narazaki G 
2008; Winkler ME 2008).  
Transduction of fibroblasts with only four transcription factors, Oct4, Sox2, cMyc and Klf4, 
could dedifferentiate the fibroblasts to cells with almost all features of ESC. The key 
transcription factors needed for reprogramming appear to be Sox2 and Oct4, whereas the 
other transcription factor used allow for increasing the efficiency of reprogramming likely 
by opening up the closed chromatin typical of somatic cells ESC (Mitsui K 2003; Silva J 2006; 
Takahashi K 2006; Takahashi K 2007; Yu J 2007; Park IH 2008).  
 
Initially, reprogramming was accomplished using integrating retroviral or lentiviral vectors, 
however these vectors carry the risk of insertional mutagenesis, which will make this 
method of reprogramming unacceptable for use clinically in patients due to increased risk of 
tumor formation. However, the problem of using retroviral integrating vectors has been 
overcome as reprogramming has been achieved by many groups using different modalities 
as a series of very recent studies demonstrate that this can also be achieved using short term 
overexpression of the transcription factor using plasmids, nonintegrating adenoviral 
vectors, or using transposons that are subsequently removed. In contrast to reprogramming 
by somatic cell nuclear transfer (SCNT) or ESC fusion which were the original methods of 
inducing pluripotency and were very laborious, technically difficult and time consuming, 
reprogramming via defined transcription factor requires 3 to 4 weeks, suggesting that many 
The	Future	of	Cell	Therapy	and	Tissue	Engineering		
in	Cardiovascular	Disease:	The	New	Era	of	Biological	Therapeutics 37
making this an unpractical and unfavorable option for potential clinical applications. 
However, there has yet to be significant research into the relationship between patient’s age, 
gender, comorbidities and the differentiation capabilities of these adipose derived cells.  
 
We have focused on the differentiation of hASCs towards the endothelial and SMC lineage. 
We have been able to identify specific parameters that are crucial for an efficient and easily 
reproducible differentiation of human ASCs into ECs and SMCs within 14 days of in vitro 
culture. We found that hASCs, which were cultured in endothelial specific growth medium-
2 (EGM-2), exhibited morphological features of mature ECs and expressed EC-specific 
markers including CD31, CD144 and vWF (Heydarkhan-Hagvall S 2008).  
This differentiation pattern appeared to be specific to EGM-2-treated hASCs, cultured in a 
high-density environment. It has been reported that cell-cell junctions between ECs through 
CD31 and CD144 are critical for the establishment of a primary vascular network (Dejana E 
1995; Baldwin HS 1996; Dejana 1996; Drake CJ 1998).  
The failure of hASCs that were cultured in Dulbecco’s modified Eagle’s medium-20% 
(DMEM-20%) FBS to form such tubular network may, in part, be due to the absence of these 
necessary cell-to-cell contacts. Our immunocytochemistry and fluorescence-activated cell 
sorter (FACS) analyses demonstrated the presence of both immature and mature EC 
markers, such as CD34, Flk-1/KDR, CD144, CD31 and vWF, in the specifically induced 
hASCs (Heydarkhan-Hagvall S 2008).  
 
Previous studies have identified three markers, CD133, CD34 and Flk-1/KDR, in early 
endothelial progenitor cells. In addition, mature ECs are known to express high levels of 
Flk-1/KDR, CD31, CD144, and vWF, suggesting that our EGM-2-induced hASCs may be 
assuming a more mature EC phenotype. To date, it is not completely understood as to when 
an endothelial progenitor cell turns into mature, fully differentiated ECs in vivo. One 
possibility could be the loss of CD133 and a parallel or subsequent expression of vWF in 
conjunction with the appearance of other endothelial characteristics (Hristov M 2003; Urbich 
C 2004). An interesting observation was that the differentiation capacity of hASCs towards 
ECs was significantly diminished when the cells were passaged, whereas the age of the 
donor was not a critical factor.  
In contrast, when hASCs were cultured for 14 days in DMEM-20% FBS they expressed SMC-
specific markers including SM myosin, h-caldesmon, basic calponin and SM--actin a 
phenomenon that was independent of passage number, yet affected by the donor age 
(Heydarkhan-Hagvall S 2008). As the primary function of mature SMC is contraction, the 
complement of contractile, structural, and regulatory proteins expressed in fully 
differentiated SMC provides markers of differentiation status (Kuro-o M 1989; Sobue K 
1999). These include SM myosin, h-caldesmon, basic calponin, and SM--actin. SM--actin is 
an important protein for SMCs structure and contraction, and it is upregulated with 
differentiation. Indeed, SM--actin has been used as a marker of early SMC differentiation, 
followed by calponin, h-caldesmon and SM myosin (Owens GK 1995; Hungerford JE 1996; 
Katoh Y 1996; Thyberg J 1996; Hungerford JE 1999).  
It is well known that SMCs grown in vitro can undergo a phenotypic cell transition from the 
normally quiescent ‘contractile’ status observed in vivo to a proliferative-secretory state 
(Thyberg J 1996; Opitz F 2004). The general feature of cultured SMCs is the downregulation 
of SM myosin expression, particularly of SM2 concomitant with upregulation of nonmuscle 
myosin variants MyHC-A pla1, MyHC-A, and MyHC-B (Somlyo AP 1993). These tendencies 
depend, however, on cellular density, serum concentration, and substrate for attachment. 
Myosin gene expression can be regulated during early development (effect on the 
differentiation phase of the SMC lineage program) or in adulthood (alteration of the stability 
of the fully differentiated SMC phenotype) (Zanellato AMC 1990; Somlyo AP 1993). The 
general feature of cultured SMCs is the downregulation of SM myosin expression, 
particularly of SM2 concomitant with upregulation of non-muscle myosin variants MyHC-A 
pla1, MyHC-A, and MyHC-B (Somlyo AP 1993). These tendencies depend, however, on 
cellular density, serum concentration, and substrate for attachment. Myosin gene expression 
can be regulated during early development (effect on the differentiation phase of the SMC 
lineage program) or in adulthood (alteration of the stability of the fully differentiated SMC 
phenotype) (Zanellato AMC 1990; Somlyo AP 1993). High levels of SM--actin and basic 
calponin in particular were observed in the present study, with lower levels of SM myosin 
and h-caldesmon-expressing cells. Rodriguez et al. (Rodriguez LV 2006) demonstrated an 
optimal smooth muscle differentiation, phenotypically and functionally, when hASCs were 
cultured in specific smooth muscle-inductive medium after 6 weeks. However, our data 
have shown that a prolonged culture time did not increase the number of SMC marker 
expressing cells, since a plateau was reached after 14 days of culture.  
 
4. Induced Pluripotent Stem Cells  
One of the most exciting and revolutionary breakthroughs in stem cell research has been the 
induction of pluripotent stem cells from mature somatic cells. It has been shown that four 
factors present in ESC are sufficient to re-induce a pluripotent state in somatic cells. The 
reprogramming of somatic cells to a pluripotent state can be achieved by simple retroviral 
overexpression of specific transcription factors, resulting in induced pluripotent stem (iPS) 
cells that are almost indistinguishable from ESC (Okita K 2007; Mauritz C 2008; Narazaki G 
2008; Winkler ME 2008).  
Transduction of fibroblasts with only four transcription factors, Oct4, Sox2, cMyc and Klf4, 
could dedifferentiate the fibroblasts to cells with almost all features of ESC. The key 
transcription factors needed for reprogramming appear to be Sox2 and Oct4, whereas the 
other transcription factor used allow for increasing the efficiency of reprogramming likely 
by opening up the closed chromatin typical of somatic cells ESC (Mitsui K 2003; Silva J 2006; 
Takahashi K 2006; Takahashi K 2007; Yu J 2007; Park IH 2008).  
 
Initially, reprogramming was accomplished using integrating retroviral or lentiviral vectors, 
however these vectors carry the risk of insertional mutagenesis, which will make this 
method of reprogramming unacceptable for use clinically in patients due to increased risk of 
tumor formation. However, the problem of using retroviral integrating vectors has been 
overcome as reprogramming has been achieved by many groups using different modalities 
as a series of very recent studies demonstrate that this can also be achieved using short term 
overexpression of the transcription factor using plasmids, nonintegrating adenoviral 
vectors, or using transposons that are subsequently removed. In contrast to reprogramming 
by somatic cell nuclear transfer (SCNT) or ESC fusion which were the original methods of 
inducing pluripotency and were very laborious, technically difficult and time consuming, 
reprogramming via defined transcription factor requires 3 to 4 weeks, suggesting that many 
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more factors may take part in the very quick reprogramming seen by SCNT or fusion (Yu J 
2007; Okita K 2008; Shi Y 2008a; Stadtfeld M 2008a; Shi Y 2008b; Woltjen K 2009; Yu J 2009). 
 
The ability of iPS cells to differentiate into all somatic cell typeshas attracted much interest 
in the field of regenerative medicine and has been a topic of intense research in recent years 
(Dai W 2006). This interest has become even more relevant from a clinical practical 
perspective as these reprogrammed fibroblasts exhibit growth and differentiation 
characteristics comparable to those of murine ES cells. Ease of generation and lack of 
immunologic and ethical restrictions will likely make iPS cells a highly valuable cell source 
for applications in regenerative medicine. 
 
Given the appropriate extracellular signals, murine iPS cells differentiate with high 
efficiency into multipotent mesodermal progenitor cells that possess the potential to 
differentiate into functional cells of the cardiovascular and hematopoietic lineages (Schenke-
Layland K 2008). When exposed to Collagen IV (ColIV), ESC and iPS cells differentiated into 
cells that showed expression of genes associated with early mesodermal, cardiovascular, 
and hematopoietic cells.  
A cell capable of differentiating into all cardiovascular cell types has a theoretical advantage 
for more complete tissue regeneration over transplanting cardiomyocytes alone, as has been 
demonstrated for ESC derivatives (Dai W 2006). Transplanting partially differentiated 
cardiovascular progenitor cells, such as the Flk1-positive cells which are committed to a 
cardiovascular lineage will not be associated with the risk of tumor formation as seen with 
transplanting undifferentiated ES cells into the heart (Behfar A 2007). Flk1-positive 
progenitor cells have been identified in both iPS cell-derived embryonic bodies (EBs) and 
ColIV-differentiated iPS cells, most likely representing a population of multipotent 
mesodermal progenitor cells (Park C 2005; Kattman SJ 2006; Moretti A 2006; Wu SM 2006). 
To confirm that those Flk1-expressing cells were capable of generating all cardiovascular cell 
types, ColIV differentiated Flk1-positive cells have been isolated and been exposed to 
cardiac, smooth muscle, and endothelial cell-specific differentiation conditions. This 
resulted in the production of spontaneously beating cell clusters and cells expressing cardiac 
markers as well as hallmark morphological characteristics of mature cardiomyocytes, 
including the typical cross-striation and generation of Ca2+ (Schenke-Layland K 2008).  
Gene expression analysis, immunocytochemistry, contractility, and in vitro tube formation 
assays, as well as acLDL uptake tests, further revealed the successful differentiation of iPS 
cell-derived Flk1-progenitor cells into functional SMC and EC, findings that were similar to 
those previously reported for murine ES cells (Nishikawa SI 1998; Yamashita J 2000; 
McCloskey KE 2006). Although iPS cells contributed to mature cardiovascular cells in vivo as 
well, it will be important to determine in future experiments whether transplanted iPS cells 
can also integrate and differentiate into adult myocardium. In addition, co-culture of the 
Flk1-positive cells with OP9-GFP stromal cells in hematopoietic cytokine-containing culture 
medium conferred differentiation into hematopoietic progenitor cells that expressed c-kit, 
CD41, and the pan-hematopoietic marker CD45 (Mikkola HK 2006).  
Furthermore, these ES and iPS cell-derived hematopoietic progenitors demonstrated a 
multilineage myeloerythroid differentiation potential. Although ColIV-differentiated iPS 
cell-derived Flk1-positive progenitor cells had properties comparable to those of the ES cell-
derived progenitors, differences did exist (Yamashita J 2000; Kattman SJ 2006; McCloskey 
KE 2006; Moretti A 2006; Wu SM 2006). Flk1-positive progenitor cells isolated from the 
ColIV-exposed cultures also possessed hematopoietic differentiation potential when 
cultured on OP9 stromal cells or in methylcellulose. In addition, Flk1-positive cells were 
more frequent in ColIV-differentiated iPS cell cultures compared with ES cell cultures, but 
whether this is a general property of iPS cells or is specific to the 2D4 iPS cell line will 
require further study and comparison of multiple lines (Schenke-Layland K 2008). 
 
5. Discussion and Conclusion 
The use of living cells as a therapeutic option presents several challenges including 
identification of a suitable source, development of adequate derivation, maintenance and 
differentiation methods, and very importantly proof of safety and efficacy.  One of the major 
issues for cardiovascular tissue engineering is determining the ideal cell type for use in 
regenerative therapies.Many clinical trials have used bone marrow derived mononuclear 
cells (BM-MNC) (Schächinger V 2006). These clinical trials have not shown any significant 
cardiomyocyte regeneration and the results have been mixed at best with no robust 
improvement in cardiac function (Coombs 2008). However, this trial and others have 
provided a proof of concept that intracoronary or intramyocardial transplant of autologous 
adult stem cells is safe with out any evidence of increased mortality in the treated patients.  
The next generation of clinical studies will need to demonstrate robust cardiomyocyte 
regeneration, definite improvement of cardiac pump function, and ultimately improved 
patient survival as the ultimate goal. The availability of the proposed cell type for 
regenerative medicine and tissue engineering in sufficient and relatively easily derivable 
quantities is also critical. To date, engineered tissue constructs containing adult and stem 
cells have exhibited problems with physical properties, maintenance of cell phenotypes and 
the host immune response to the engrafted construct. Ideally, the cells used for tissue 
engineering should have the capacity to proliferate and differentiate in vivo in a manner 
that can be reproducibly controlled and predicted (Atala A 2002). Due to the high number of 
cells that is needed for culturing, isolation and expansion require invasive procedures it 
remains a challenge to generate sufficient numbers of a single cell type, to assemble the 
needed mixture of multiple cell phenotypes, and to maintain stable phenotypes as needed 
(Atala A 2002). Furthermore, this process will need to be automated to mass produce 
sufficient amounts of cells and tissue constructs for clinical therapies on a wide scale.  
 
This discussion also highlights the ushering in of a new era of personalized medicine. One 
of the possibilities for cell therapies is patient-specific iPS cells generated from his/her own 
somatic cells to be used to treat that person. These designer iPS cells will be differentiated 
into the desired tissue types and transplanted in an autologous manner to avoid immune 
rejection. Although pluripotent hESCs or hiPS cells are non-immunogenic, they loose this 
characteristic as they become more differentiated with increased risk of immune mediated 
rejection if transplanted into a non-compatible patient.  ASCs derived from patients may be 
a potential source to use to either differentiate into desired cells and re-transplant into the 
patient or develop and differentiate iPS cells that would be used in an autologous manner to 
ensure immunocompatibility as it has been shown that ASCs are much more easily induced 
into hiPS cells compared to fibroblasts (Sun N 2009).  
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more factors may take part in the very quick reprogramming seen by SCNT or fusion (Yu J 
2007; Okita K 2008; Shi Y 2008a; Stadtfeld M 2008a; Shi Y 2008b; Woltjen K 2009; Yu J 2009). 
 
The ability of iPS cells to differentiate into all somatic cell typeshas attracted much interest 
in the field of regenerative medicine and has been a topic of intense research in recent years 
(Dai W 2006). This interest has become even more relevant from a clinical practical 
perspective as these reprogrammed fibroblasts exhibit growth and differentiation 
characteristics comparable to those of murine ES cells. Ease of generation and lack of 
immunologic and ethical restrictions will likely make iPS cells a highly valuable cell source 
for applications in regenerative medicine. 
 
Given the appropriate extracellular signals, murine iPS cells differentiate with high 
efficiency into multipotent mesodermal progenitor cells that possess the potential to 
differentiate into functional cells of the cardiovascular and hematopoietic lineages (Schenke-
Layland K 2008). When exposed to Collagen IV (ColIV), ESC and iPS cells differentiated into 
cells that showed expression of genes associated with early mesodermal, cardiovascular, 
and hematopoietic cells.  
A cell capable of differentiating into all cardiovascular cell types has a theoretical advantage 
for more complete tissue regeneration over transplanting cardiomyocytes alone, as has been 
demonstrated for ESC derivatives (Dai W 2006). Transplanting partially differentiated 
cardiovascular progenitor cells, such as the Flk1-positive cells which are committed to a 
cardiovascular lineage will not be associated with the risk of tumor formation as seen with 
transplanting undifferentiated ES cells into the heart (Behfar A 2007). Flk1-positive 
progenitor cells have been identified in both iPS cell-derived embryonic bodies (EBs) and 
ColIV-differentiated iPS cells, most likely representing a population of multipotent 
mesodermal progenitor cells (Park C 2005; Kattman SJ 2006; Moretti A 2006; Wu SM 2006). 
To confirm that those Flk1-expressing cells were capable of generating all cardiovascular cell 
types, ColIV differentiated Flk1-positive cells have been isolated and been exposed to 
cardiac, smooth muscle, and endothelial cell-specific differentiation conditions. This 
resulted in the production of spontaneously beating cell clusters and cells expressing cardiac 
markers as well as hallmark morphological characteristics of mature cardiomyocytes, 
including the typical cross-striation and generation of Ca2+ (Schenke-Layland K 2008).  
Gene expression analysis, immunocytochemistry, contractility, and in vitro tube formation 
assays, as well as acLDL uptake tests, further revealed the successful differentiation of iPS 
cell-derived Flk1-progenitor cells into functional SMC and EC, findings that were similar to 
those previously reported for murine ES cells (Nishikawa SI 1998; Yamashita J 2000; 
McCloskey KE 2006). Although iPS cells contributed to mature cardiovascular cells in vivo as 
well, it will be important to determine in future experiments whether transplanted iPS cells 
can also integrate and differentiate into adult myocardium. In addition, co-culture of the 
Flk1-positive cells with OP9-GFP stromal cells in hematopoietic cytokine-containing culture 
medium conferred differentiation into hematopoietic progenitor cells that expressed c-kit, 
CD41, and the pan-hematopoietic marker CD45 (Mikkola HK 2006).  
Furthermore, these ES and iPS cell-derived hematopoietic progenitors demonstrated a 
multilineage myeloerythroid differentiation potential. Although ColIV-differentiated iPS 
cell-derived Flk1-positive progenitor cells had properties comparable to those of the ES cell-
derived progenitors, differences did exist (Yamashita J 2000; Kattman SJ 2006; McCloskey 
KE 2006; Moretti A 2006; Wu SM 2006). Flk1-positive progenitor cells isolated from the 
ColIV-exposed cultures also possessed hematopoietic differentiation potential when 
cultured on OP9 stromal cells or in methylcellulose. In addition, Flk1-positive cells were 
more frequent in ColIV-differentiated iPS cell cultures compared with ES cell cultures, but 
whether this is a general property of iPS cells or is specific to the 2D4 iPS cell line will 
require further study and comparison of multiple lines (Schenke-Layland K 2008). 
 
5. Discussion and Conclusion 
The use of living cells as a therapeutic option presents several challenges including 
identification of a suitable source, development of adequate derivation, maintenance and 
differentiation methods, and very importantly proof of safety and efficacy.  One of the major 
issues for cardiovascular tissue engineering is determining the ideal cell type for use in 
regenerative therapies.Many clinical trials have used bone marrow derived mononuclear 
cells (BM-MNC) (Schächinger V 2006). These clinical trials have not shown any significant 
cardiomyocyte regeneration and the results have been mixed at best with no robust 
improvement in cardiac function (Coombs 2008). However, this trial and others have 
provided a proof of concept that intracoronary or intramyocardial transplant of autologous 
adult stem cells is safe with out any evidence of increased mortality in the treated patients.  
The next generation of clinical studies will need to demonstrate robust cardiomyocyte 
regeneration, definite improvement of cardiac pump function, and ultimately improved 
patient survival as the ultimate goal. The availability of the proposed cell type for 
regenerative medicine and tissue engineering in sufficient and relatively easily derivable 
quantities is also critical. To date, engineered tissue constructs containing adult and stem 
cells have exhibited problems with physical properties, maintenance of cell phenotypes and 
the host immune response to the engrafted construct. Ideally, the cells used for tissue 
engineering should have the capacity to proliferate and differentiate in vivo in a manner 
that can be reproducibly controlled and predicted (Atala A 2002). Due to the high number of 
cells that is needed for culturing, isolation and expansion require invasive procedures it 
remains a challenge to generate sufficient numbers of a single cell type, to assemble the 
needed mixture of multiple cell phenotypes, and to maintain stable phenotypes as needed 
(Atala A 2002). Furthermore, this process will need to be automated to mass produce 
sufficient amounts of cells and tissue constructs for clinical therapies on a wide scale.  
 
This discussion also highlights the ushering in of a new era of personalized medicine. One 
of the possibilities for cell therapies is patient-specific iPS cells generated from his/her own 
somatic cells to be used to treat that person. These designer iPS cells will be differentiated 
into the desired tissue types and transplanted in an autologous manner to avoid immune 
rejection. Although pluripotent hESCs or hiPS cells are non-immunogenic, they loose this 
characteristic as they become more differentiated with increased risk of immune mediated 
rejection if transplanted into a non-compatible patient.  ASCs derived from patients may be 
a potential source to use to either differentiate into desired cells and re-transplant into the 
patient or develop and differentiate iPS cells that would be used in an autologous manner to 
ensure immunocompatibility as it has been shown that ASCs are much more easily induced 
into hiPS cells compared to fibroblasts (Sun N 2009).  
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The isolation of hESCs more than two decades ago was hailed as the beginning of the end of 
many diseases; but as we can see this potential many years later has not been realized. It 
was hoped that creating differentiated cells from hESCs might lead to tissue replacement 
treatments for diseases such as Parkinson’s, diabetes, cardiovascular diseases etc. However, 
the ethical concerns with the use of hESCs due to their origin from human embryos have 
limited their use to very restricted research with no translational applications to date.  
Another obstacle to the use of ESC and iPS derived cells and tissues is the risk of teratoma 
formation in patients post cell/tissue transplant. The first ever clinical trial to use hESCs was 
to be done in spinal cord injury patients and was to be launched in 2009 by the 
biotechnology firm Geron and had FDA approval; before any patients were enrolled, it was 
put on hold by the FDA due to concerns with results from animal studies regarding higher 
than acceptable rates of tumor formation in the animal models post ESC transplants. 
Moreover, other concerns with ESC based therapies is allogenicity of ESC derived cells 
which would necessitate life long immunosuppressive therapy so the donor would not 
reject the transplanted cells or tissue grafts. This is not a favorable option as 
immunosuppression has many undesirable side effects, such as increased risk of infection 
and malignancy, and all the side effects of these medications. Thus lies the promise and 
potential of cells or tissue grafts derived from autologous derived ASCs or patient derived 
iPS cells, as immunocompatibilty with the host would negate the need for 
immunosuppression. Although generating patient specific stem cells is, at the current costs 
to generate good manufacturing processing (GMP) grade cells, not financially tenable, it is 
not unreasonable to speculate that costs, as with any new technology, will decrease with 
time making personalized stem cell therapy for at least some diseases possible. One other 
possibility would be HLA matched banks of hiPs that will be available to use for clinical use 
that can be matched to the patient of interest.  
 
One other potential for the use of autologous iPS cells lies in the fact that they would encode 
for the same genetic defects of the patient whether inherited or caused by sporadic genetic 
mutations. This ability to generate cells with pluripotent characteristics that differentiate 
into most cell types will also make it possible to generate in vitro models of human disease 
(Dimos JT 2008; Park IH 2008; Wernig M 2008). This presents a great opportunity, for the 
first time, to study human disease models in vitro and drug discovery directly on diseased 
or normal human cells derived from iPS cells. Already iPS cells from patient with 
Parkinson’s disease have been generated and differentiated into neurons (Park IH 2008). The 
other exciting possible application of patient derived iPS cells is the potential for repair of 
disease causing genetic defects by in situ repair of the defect using homologous 
recombination and re-transplant of these modified cells back into the patient. This has been 
demonstrated in a mouse model of sickle cell anemia with cure of the mouse from the 
disease (Hanna J 2007).  
 
Although a number of differentiation protocols induce lineage specification in vitro, 
engraftment of the pluripotent stem cell-derived differentiated cells in vivo has been 
disappointing (Kyba M 2002; Rideout WM 3rd 2002). The availability of pluripotent stem 
cells will however in the near future influence medicine far and beyond the realm of tissue 
engineering and replacement. For instance, availability of cells that can generate many 
differentiated cell types, may lead to the development of protein or small molecule drugs 
that influence differentiation not only from pluripotent stem cells but also of multipotent 
stem cells residing in different tissues. The ability to generate cells with pluripotent 
characteristics that differentiate in most cell types will also make it possible to generate in 
vitro models of human disease (Dimos JT 2008; Park IH 2008; Wernig M 2008). The 
identification of optimized protocols for the differentiation of ESCs iPS cells into multiple 
functional cell types in vitro and their proper long term engraftment and fate tracking in vivo 
will be the next generation of challenges once the issue of reprogramming and optimal 
sources of cells is resolved. 
 
Moreover, the risk of oncogenic events caused by the use of potent oncogenes to induce 
reprogramming to pluripotency and by the random integration of delivery vectors into the 
genome is a major problem that needs to be overcome before translating iPS cell technology 
into the clinic. (Marson A 2008; Huangfu D 2008a; Shi Y 2008a; Huangfu D 2008b; Shi Y 
2008b)  Murine and human iPS cells have recently been derived by using nonintegrative 
transient expression strategies of the reprogramming factors (Okita K 2008; Okita K 2008; 
Stadtfeld M 2008a; Stadtfeld M 2008b; Stadtfeld M 2008c).  
Regardless of these uncertainties, direct reprogramming of somatic cells to generate patient-
matched pluripotent stem cells has the potential to address many of the current limitations 
and could revolutionize the treatment of many diseases. As with other non-embryonic 
derived tissue sources, iPS cells escape all of the ethical issues surrounding ESC therapy. 
The development of efficient, reliable, and easily reproducible differentiation protocols for 
generating human iPS cell-derived cardiovascular and hematopoietic progenitor cells will 
facilitate the development of patient-tailored cardiovascular and hematopoietic regenerative 
therapies as the next generation of approach to these diseases. 
 
It has been shown that hASCs differentiate into different cell types (Halvorsen YC 2000; Zuk 
PA 2001; Zuk PA 2002; Gimble J 2003a; Gimble J 2003b; Planat-Benard V 2004a; Planat-
Benard V 2004b; Zhu Y 2008) and recent work has shown that these hASCs can be induced 
much more easily into iPS cells than terminally differentiated fibroblasts. This is quite 
exciting and clinically relevant as hASC-derived hiPS cells can be differentiated into any 
type of desired cell type (Sun N 2009). ASCs can be a potential alternative cell source for 
producing iPS cells as they are widely available and easily obtainable from patients.  
The expression of the transcription factors that have been used in reprogramming of 
fibroblasts to iPS is normally very low in adult cells such as fibroblasts. On the other hand 
these stem cell-related transcription factors, Nanog, Oct-4, Sox-2, and Rex-1 are positively 
expressed in ASCs (Zhu Y 2008); this makes ASCs easier to reprogram back to an earlier 
state than fibroblasts since they are not as far along on the differentiation pathway.  
The gene expression profiles of the ASCs could be used to identify a subpopulation that is 
the least differentiated and most easily reprogrammed to pluripoteny (Sun N 2009). The 
recent advances in iPS cell identification and differentiation and eventual transplant of these 
iPS derived cells and tissues has ushered in the new era of biological therapeutics to 
complement the current pharmaceutical modalities. In addition, further development of iPS 
cell technology may provide a more substantial and dynamic stem cell population available 
to overcome current stem cell shortages and will very likely be a standard of tissue 
engineering and patient therapy in the not so distant future. 
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and malignancy, and all the side effects of these medications. Thus lies the promise and 
potential of cells or tissue grafts derived from autologous derived ASCs or patient derived 
iPS cells, as immunocompatibilty with the host would negate the need for 
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to generate good manufacturing processing (GMP) grade cells, not financially tenable, it is 
not unreasonable to speculate that costs, as with any new technology, will decrease with 
time making personalized stem cell therapy for at least some diseases possible. One other 
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Regardless of these uncertainties, direct reprogramming of somatic cells to generate patient-
matched pluripotent stem cells has the potential to address many of the current limitations 
and could revolutionize the treatment of many diseases. As with other non-embryonic 
derived tissue sources, iPS cells escape all of the ethical issues surrounding ESC therapy. 
The development of efficient, reliable, and easily reproducible differentiation protocols for 
generating human iPS cell-derived cardiovascular and hematopoietic progenitor cells will 
facilitate the development of patient-tailored cardiovascular and hematopoietic regenerative 
therapies as the next generation of approach to these diseases. 
 
It has been shown that hASCs differentiate into different cell types (Halvorsen YC 2000; Zuk 
PA 2001; Zuk PA 2002; Gimble J 2003a; Gimble J 2003b; Planat-Benard V 2004a; Planat-
Benard V 2004b; Zhu Y 2008) and recent work has shown that these hASCs can be induced 
much more easily into iPS cells than terminally differentiated fibroblasts. This is quite 
exciting and clinically relevant as hASC-derived hiPS cells can be differentiated into any 
type of desired cell type (Sun N 2009). ASCs can be a potential alternative cell source for 
producing iPS cells as they are widely available and easily obtainable from patients.  
The expression of the transcription factors that have been used in reprogramming of 
fibroblasts to iPS is normally very low in adult cells such as fibroblasts. On the other hand 
these stem cell-related transcription factors, Nanog, Oct-4, Sox-2, and Rex-1 are positively 
expressed in ASCs (Zhu Y 2008); this makes ASCs easier to reprogram back to an earlier 
state than fibroblasts since they are not as far along on the differentiation pathway.  
The gene expression profiles of the ASCs could be used to identify a subpopulation that is 
the least differentiated and most easily reprogrammed to pluripoteny (Sun N 2009). The 
recent advances in iPS cell identification and differentiation and eventual transplant of these 
iPS derived cells and tissues has ushered in the new era of biological therapeutics to 
complement the current pharmaceutical modalities. In addition, further development of iPS 
cell technology may provide a more substantial and dynamic stem cell population available 
to overcome current stem cell shortages and will very likely be a standard of tissue 
engineering and patient therapy in the not so distant future. 
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1. Introduction − growing antler as a model of tissue regeneration in 
mammals 
Antlers are present in all males in 39 species of the deer family (Cervidae) and are a bony 
product, unlike horns which originate from epidermis in artiodactyls (Bovidae). Among 
reindeer antlers are also present in females, helping them to find fodder. The size and 
symmetry of the antlers in males are decisive for their hierarchy in a herd, manifest their 
actual condition and affect the selection of appropriate mating partners. Every year antlers 
of the deer family are shed and regrown over a short period of time. They develop as 
elongations of osseous pedicles present in the frontal bone of the skull. The pedicle arises 
from a specialised region in the frontal bone, the so-called antlerogenic periosteum (Price & 
Allen, 2004; Price et al., 2005a). Xenogeneic and allogeneic ectopic grafts of the antlerogenic 
periosteum confirm its antlerogenic potential. At the sites of the implantation a pedicle is 
formed and in some cases antlers develop. Both organs are built from a specific chondro-
osseous tissue which is a mixture of cartilage and bone (Goss & Powel, 1985; Kierdorf & 
Kierdorf, 2000; Li et al., 2001). During growth of the pedicle, some of the cells of the 
antlerogenic periosteum migrate to the apical region of the pedicle, where they build its 
periosteum and participate in creating antler growth centres (Kierdorf et al., 2003; Li & 
Suttie, 2001). Histological studies of the early stages of the antler regeneration show that 
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these centres create undifferentiated and proliferating clusters of mesenchymal cells 
(Kierdorf et al., 2003; Li et al., 2005; Price et al., 2005a). The antlerogenic periosteum, the 
antlerogenic cells of the pedicle and antlers retain their features of embryonic cells for they 
contain large amounts of glycogen granules (Cegielski et al., 2006; Li & Suttie, 1998; Li & 
Suttie, 2001). Among the cells of the antlerogenic periosteum, pedicle and mesenchyme of 
the growing antlers are stem cells, which can differentiate into cartilage, bone and adipose 
tissue (Berg et al., 2007; Cegielski et al., 2006; Kierdorf et al., 2009; Rolf et. al, 2008). 
During the reproduction period, antlers cease to grow and the skin covering them (velvet) is 
shed. This process coincides with the parallel growth of testosterone concentration, which 
converts into oestrogen in antler tissues (Bubenik et al., 2005; Muir et al., 1988). Oestrogen 
inhibits cell proliferation and increases cartilage mineralization via its receptors (Barrell et 
al., 1999). Until next spring the old antlers remain fixed to the osseous stem and next, they 
are cast as a result of bone resorption by osteoclasts on the antler-pedicle border. This 
process is parallel with the decrease in testosterone levels (Goss et al., 1992). The ossified 
antlers are not a dead structure, because one month before they are cast, inside of them, 
there are still blood vessels and bone remodelling processes by osteoclasts still take place 
(Rolf & Enderle, 1999). In red deer, as soon as the old set of antlers is cast, a new one is 
grown. The antler regenerating process begins before the old set is cast, which can be seen in 
the ring created around the apical region of the pedicle (Kierdorf et al., 1994). The antler 
growth is rapid: within three months the daily increments of 2 cm cause that the growing 
antlers represent one of the most rapidly growing organs in mammals. The most recent 
studies demonstrate that testosterone is responsible for antler growth in mature stags. IGF-1 
is responsible mainly for body mass increase and its role in regulating antler growth is 
limited to young specimens (Bartos et al., 2009). Other factors affecting the antler growth are 
factors synthesised by its tissues: BMP2 and BMP4 (bone morphogenetic protein 2, 4) (Feng 
et al., 1995; Feng et al., 1997), TGFβ1 and TGFβ2 (transforming growth factor β1, β2) (Francis 
& Suttie, 1998), PTHrP (parathyroid hormone related peptide) (Faucheux et al., 2004), 
retinoic acid (Allen et al., 2002), FGF-2 (fibroblast growth factor 2) (Lai et al., 2007), VEGF 
(vascular endothelial growth factor) (Lai et al., 2007), EGF (epidermal growth factor) 
(Barling et al., 2005), pleiotropin (Clark et al., 2006), PEDF (pigment epithelium-derived 
factor) (Lord et al., 2007), NGF (nerve growth factor) (Li et al., 2007) as well as IGF-1 
(insulin-like growth factor-1) (Gu et al., 2007). Altogether, nearly 800 proteins are present in 
a growing antler. Among them, there are antler-specific growth factors: MEKK1 (mitogen-
activated protein kinase 1), SRP72 (signal recognition particle 72 kDa protein) as well as 
DRG1 (developmentally regulated GTP-binding protein 1) (Park et al., 2004). The apical 
region of the antler is the site in which growth and modified endochondral ossification 
processes take place, while membranous ossification occurs around the antler shaft (Price & 
Allen, 2004). The apical region of the antler consists of several layers: distal perichondrium 
and respectively – mesenchyme, transient layer, cartilage and bone (Cegielski et al., 2009; Li 
et al., 2002). Worth noticing is the mesenchyme, which consists of numerous 
undifferentiated and actively proliferating cells. They are characterised by low levels of type 
I collagen and alkaline phosphatase expression and no expression of type II collagen (Price 
et al., 1994; Price et al., 1996). In vitro studies show that IGF-1, IGF-2 and FGF-2 stimulate 
their proliferation, however BMP-2 and TGFβ-1 inhibit their proliferation (Price et al., 
2005b). The mesenchymal cells possess a great potential to proliferate, which has been 
confirmed by presence of extracellular matrix protein – matrilin-2 – which is a marker 
characteristic for differentiating cells (Korpos et al., 2005). Moreover, the mesenchymal cells 
synthesize many growth factors and other substances, which may affect the mesenchyme 
itself or adjacent layers of cells: PTHrP (Faucheux et al., 2004), retinoic acid (Allen et al., 
2002), FGF-2 (Lai et al., 2007), EGF (Barling et al., 2005), pleiotropin (Clark et al., 2006) and 
PEDF (Lord et al., 2007). The mesenchyme participates in antler growth because constantly 
provides cells which differentiate into chondroblasts and next, into mature cartilage cells. 
The newly added cartilage undergoes mineralization and transforms into a bone (Szuwart et 
al., 1998). The transformation, as well as modelling of the cartilage, take place in the 
presence of osteoclasts (found in perivascular spaces of the cartilage) which derive from 
osteoclast progenitor cells influenced by locally secreted PTHrP (Faucheux et al., 2002). 
Apoptotic processes also play a vital role in antler growth and shaping processes, just as it 
happens during skeletal development, bone growth and remodelling (Colitti et al., 2005). 
 
2. Histology of growing and mature antler 
The terminal fragment of a growing antler (Fig. 1) consists of several layers. Microscopically, 
from the outside, we can distinguish: 
A – hairy skin 
B – perichondrium 
C – mesenchyme and chondroprogenitor area 
D – blood vessels and chondrocyte columns 
 
 
Fig. 1. Cross-section of terminal fragments of the growing antler showing following layers: 
(A) hairy skin, (B) perichondrium, (C) mesenchyme-chondroprogenitors, (D) central shaft 
formed of numerous blood vessels and chondrocyte columns. H+E staining, ×40 
 
Antlers are covered by hairy skin, the so-called velvet, consisting of three basic layers: 
epidermis, dermis and subcutaneous tissue (Fig. 2a). Epidermis is keratinized stratified 
squamous epithelium built from five layers of cells: basal, squamous, granular, clear and 
horny (Fig. 2b). Dermis consists of proper connective tissue and has two layers: papillary 
and reticular. The wave-like organisation of the first layer constitutes the basis of good 
connection with epidermis (Fig. 2b). The second layer possesses numerous bundles of 
collagen fibres, hair roots and sebaceous glands (Fig. 2a). The subcutaneous layer has 
numerous blood vessels, collagen fibres and connective tissue cells. Below the skin region, 
there is a darker staining zone of tissue constituting the perichondrium (Fig. 2c), the outer 
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Fig. 1. Cross-section of terminal fragments of the growing antler showing following layers: 
(A) hairy skin, (B) perichondrium, (C) mesenchyme-chondroprogenitors, (D) central shaft 
formed of numerous blood vessels and chondrocyte columns. H+E staining, ×40 
 
Antlers are covered by hairy skin, the so-called velvet, consisting of three basic layers: 
epidermis, dermis and subcutaneous tissue (Fig. 2a). Epidermis is keratinized stratified 
squamous epithelium built from five layers of cells: basal, squamous, granular, clear and 
horny (Fig. 2b). Dermis consists of proper connective tissue and has two layers: papillary 
and reticular. The wave-like organisation of the first layer constitutes the basis of good 
connection with epidermis (Fig. 2b). The second layer possesses numerous bundles of 
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numerous blood vessels, collagen fibres and connective tissue cells. Below the skin region, 
there is a darker staining zone of tissue constituting the perichondrium (Fig. 2c), the outer 
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part of which is fibrous and the inner part contains cells. Below the perichondrium, there is 
a wide layer of undifferentiated cells constituting the mesenchyme of the antler. It 
surrounds the so-called central shaft built from numerous blood vessels stretching from 
base to apex of the growing antler. Among these vessels, there are chondrocytes organised 
in characteristic columns (Fig. 2d). 
 
 
                 a                                       b                                         c                                         d 
Fig. 2. a-d Histology of the apical fragment of the growing antler, longitudinal section. a – 
hairy skin (velvet) consisting of epidermis, dermis with hair and sebaceous glands, 
connective tissue, ×100; b – epidermis built from 5 layers of cells and papillary layer of 
dermis, ×300; c – perichondrium as a darker stained line below which, there is a wide layer 
of mesenchyme (M), ×100; d – numerous blood vessels and chondrocyte columns lying in 
the central shaft of the growing antler, ×200. All H+E staining 
 
Immunohistochemical reactions allowed us to identify presence of cells expressing markers 
characteristic for stem cells (Bcrp1, c-kit) in the zone of intense proliferation – the 
mesenchyme (Fig. 3a). A large number of Ki-67- and PCNA-positive cells could be observed 
in the basal layer of epidermis, in skin glands, directly below secretory sections of skin 
glands, mesenchyme as well as within and in the vicinity of central blood vessels (Fig. 3b-d). 
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Fig. 3. a-d Immunohistochemical reactions for presence of stem cell markers and 
proliferating cell markers. a – stem cells (c-kit+) within mesenchyme of the growing antler, 
×400; b – proliferating cells of the reproductive layer of epidermis and glands of the growing 
antler (Ki-67+), ×100; c – proliferating cells of the reproductive layer of epidermis as well as 
hair papillae of the antler (PCNA+), ×100; d – layer of undifferentiated cells constituting 
antler mesenchyme (Ki-67+), ×100 
 
Unlike growing antlers, mature antlers consist of mineralized lamellar osseous tissue. The 
architectural unit is the osteon, which is built from the Haversian canal, around which two 
or three systemic plates are concentrically arranged (Figs. 4a, b). Both in and among these 
plates, there are osseous lacunae which possess osteocytes. All osseous lacunae within an 
osteon are connected by a network of bone canaliculi in which osteocyte processes are 
located. 
 
 
a                                                      b 
Figs. 4. a, b Cut of an ossified antler shows a typical organisation of lamellar osseous tissue. 
Around the blood vessel systemic plates, osteocytes (↑) and bone canaliculi can be seen. 
Stained with silver nitrate, ×400 
 
3. Derivation of MIC-1 cell lineage 
To start a culture of antlerogenic cells, we used fragments (100-900 μm) of mechanically 
disintegrated growing deer antler from which the hairy skin had been removed. By means 
of cell migration, proliferating cells were isolated and later placed in culture flasks. The 
culture medium used was DMEM (Dulbecco's Modified Eagle Medium) supplemented with 
L-glutamine (1 mM/ml), penicillin (100 U/ml) and streptomycin (0.1 mg/ml). The cells 
were cultured under standard conditions of 5% CO2 and temperature of 37°C. The culture 
was maintained over 4 months, with yield of 5 × 106/week per one 75 cm2 culture flask. 
Obtained cells were frozen and stored in liquid nitrogen. For study purposes, they were 
again thawn.   
Evaluation of antlerogeneic cells: 
 Under an inverted phase contrast microscope. Cells growing in culture are spindle-
shaped (fibroblast-like) (Fig. 5a) and their microscopic image is comparable to that of 
cultured human mesenchymal stem cells obtained from bone marrow (Ryan et al., 
2005). The cells possess high proliferative potential (within 72 hours their number in 
culture doubles). Among cultured cells, there are small, round, undifferentiated, 
opalescent cells not attached to the surface and possessing no processes or any 
characteristic morphological features (Fig. 5b). 
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part of which is fibrous and the inner part contains cells. Below the perichondrium, there is 
a wide layer of undifferentiated cells constituting the mesenchyme of the antler. It 
surrounds the so-called central shaft built from numerous blood vessels stretching from 
base to apex of the growing antler. Among these vessels, there are chondrocytes organised 
in characteristic columns (Fig. 2d). 
 
 
                 a                                       b                                         c                                         d 
Fig. 2. a-d Histology of the apical fragment of the growing antler, longitudinal section. a – 
hairy skin (velvet) consisting of epidermis, dermis with hair and sebaceous glands, 
connective tissue, ×100; b – epidermis built from 5 layers of cells and papillary layer of 
dermis, ×300; c – perichondrium as a darker stained line below which, there is a wide layer 
of mesenchyme (M), ×100; d – numerous blood vessels and chondrocyte columns lying in 
the central shaft of the growing antler, ×200. All H+E staining 
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characteristic for stem cells (Bcrp1, c-kit) in the zone of intense proliferation – the 
mesenchyme (Fig. 3a). A large number of Ki-67- and PCNA-positive cells could be observed 
in the basal layer of epidermis, in skin glands, directly below secretory sections of skin 
glands, mesenchyme as well as within and in the vicinity of central blood vessels (Fig. 3b-d). 
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hair papillae of the antler (PCNA+), ×100; d – layer of undifferentiated cells constituting 
antler mesenchyme (Ki-67+), ×100 
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plates, there are osseous lacunae which possess osteocytes. All osseous lacunae within an 
osteon are connected by a network of bone canaliculi in which osteocyte processes are 
located. 
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To start a culture of antlerogenic cells, we used fragments (100-900 μm) of mechanically 
disintegrated growing deer antler from which the hairy skin had been removed. By means 
of cell migration, proliferating cells were isolated and later placed in culture flasks. The 
culture medium used was DMEM (Dulbecco's Modified Eagle Medium) supplemented with 
L-glutamine (1 mM/ml), penicillin (100 U/ml) and streptomycin (0.1 mg/ml). The cells 
were cultured under standard conditions of 5% CO2 and temperature of 37°C. The culture 
was maintained over 4 months, with yield of 5 × 106/week per one 75 cm2 culture flask. 
Obtained cells were frozen and stored in liquid nitrogen. For study purposes, they were 
again thawn.   
Evaluation of antlerogeneic cells: 
 Under an inverted phase contrast microscope. Cells growing in culture are spindle-
shaped (fibroblast-like) (Fig. 5a) and their microscopic image is comparable to that of 
cultured human mesenchymal stem cells obtained from bone marrow (Ryan et al., 
2005). The cells possess high proliferative potential (within 72 hours their number in 
culture doubles). Among cultured cells, there are small, round, undifferentiated, 
opalescent cells not attached to the surface and possessing no processes or any 
characteristic morphological features (Fig. 5b). 
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a                                                        b 
Figs. 5. a, b Primary culture of antlerogenic cells growing in a monolayer. a – differentiating 
and processes producing antlerogenic stem cells, ×200, b – numerous small, opalescent, non- 
adherent, undifferentiated cells, ×100. Inverted phase contrast microscopy 
 
 Under light microscopy. Small, oval undifferentiated cells can be observed in fixed 24-h 
microcultures stained with H+E (Fig. 6). 
 
 
 
Fig. 6. Microculture of undifferentiated small, oval antlerogenic cells (↑), more mature cells 
possess processes, H+E staining, ×200 
 
 Under scanning electron microscopy we observed cell morphology (Fig. 7). 
 
 
 
Fig. 7. In vitro culture of antlerogenic cells. Scanning electron microscopy, ×6600  
 
 Immunohistochemical reactions for presence of stem cell markers: c-kit, Thy-1. Specific 
positive membranous reaction with anti-c-kit and anti-Thy1 antibodies was obtained 
only in small, oval frequently dividing cells (Fig. 8a, b). No expression of the above 
mentioned antigens was shown in more differentiated cells with processes. 
 
 
                                                                             a                                                       b 
Fig. 8. a, b Microculture: a – immunocytochemical membranous reaction to c-kit (↑) protein 
presence in small, oval antlerogenic cells, ×400; b – immunocytochemical membranous 
reaction to Thy1 (↑) protein presence in small, oval antlerogenic cells, ×400 
 
 Using PCR reaction we demonstrated expression of following genes: POU5F1, c-myc, 
MHC I as well as no expression of MHC II (Fig. 9a, b). From MIC-1 antlerogeneic cells 
we isolated the total RNA, conducted an  reverse transcription and performed the PCR 
reaction with following primer pairs on the cDNA template (Table 1): 
 
 Primer sequence PCR product 
size 
References 
POU5F1 
(OCT4) 
5’-ATGACTTGTGTGGAGGGATGG-3’ 
5’-GAACACCTTTCCAAAGAGAACC-3’ 
338 bp Berg et al., 
2007 
c-myc 5’-GAGGGTCAAGTTGGACAGTGTCAG-
3’ 
3’-CTTGGACGGACAGGATGTATGCTG-
5’ 
254 bp Francis & 
Suttie, 1998 
MHC I 5’-GGATGAAGCATCACTCAG-3’ 
3’-CGCTGCTGCGCGCAGACC-5’ 
530 bp Holmes et 
al., 2003 
MHC II 5’-GTGTTACTTCACCAACGGGACG-3’ 
3’-GTTGTGGTGGTTTAGAGCCTC-3’ 
207 bp Swarbrick 
& 
Crawford, 
1997 
Table 1. Sequence of primers used in PCR reactions 
 
 
Characteristics	of	antlerogenic	stem	cells	and	their	potential	application 57
 
a                                                        b 
Figs. 5. a, b Primary culture of antlerogenic cells growing in a monolayer. a – differentiating 
and processes producing antlerogenic stem cells, ×200, b – numerous small, opalescent, non- 
adherent, undifferentiated cells, ×100. Inverted phase contrast microscopy 
 
 Under light microscopy. Small, oval undifferentiated cells can be observed in fixed 24-h 
microcultures stained with H+E (Fig. 6). 
 
 
 
Fig. 6. Microculture of undifferentiated small, oval antlerogenic cells (↑), more mature cells 
possess processes, H+E staining, ×200 
 
 Under scanning electron microscopy we observed cell morphology (Fig. 7). 
 
 
 
Fig. 7. In vitro culture of antlerogenic cells. Scanning electron microscopy, ×6600  
 
 Immunohistochemical reactions for presence of stem cell markers: c-kit, Thy-1. Specific 
positive membranous reaction with anti-c-kit and anti-Thy1 antibodies was obtained 
only in small, oval frequently dividing cells (Fig. 8a, b). No expression of the above 
mentioned antigens was shown in more differentiated cells with processes. 
 
 
                                                                             a                                                       b 
Fig. 8. a, b Microculture: a – immunocytochemical membranous reaction to c-kit (↑) protein 
presence in small, oval antlerogenic cells, ×400; b – immunocytochemical membranous 
reaction to Thy1 (↑) protein presence in small, oval antlerogenic cells, ×400 
 
 Using PCR reaction we demonstrated expression of following genes: POU5F1, c-myc, 
MHC I as well as no expression of MHC II (Fig. 9a, b). From MIC-1 antlerogeneic cells 
we isolated the total RNA, conducted an  reverse transcription and performed the PCR 
reaction with following primer pairs on the cDNA template (Table 1): 
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size 
References 
POU5F1 
(OCT4) 
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338 bp Berg et al., 
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207 bp Swarbrick 
& 
Crawford, 
1997 
Table 1. Sequence of primers used in PCR reactions 
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a                                            b                                            c 
Fig. 9. a, b Expression of various genes in MIC-1 antlerogenic cells.  a – lane 1: Molecular 
weight marker (50-1000 bp, Promega), lane 2 – POU5F1 (338 bp); b – lane 1: Molecular 
weight marker (50-1000 bp), lane 2: c-myc (254 bp); c – lane 1: MHCI (530 bp), lane 2: MHCI 
1:10 cDNA (530 bp), lane 3: MHCII, lane 4: MHCII 1:10 cDNA, lane 5: Molecular weight 
marker (100-1000 bp, Promega) 
 
 Under electron microscopy. Active cells possess a large nucleus with loose chromatin 
and nucleoli. The small amount of cytoplasm surrounding the nucleus contained vast 
amounts of rough endoplasmic reticulum, mitochondria and vacuoles. The presence of 
glycogen granules makes these cells similar to embryonic cells. The cell surface was 
covered by numerous microvilli (Fig. 10). 
 
 
 
Fig. 10. Undifferentiated antler cell from an in vitro culture. Cell nucleus contains loose, 
transcriptively active chromatin (↑) and a nucleolus (↑↑). The cytoplasm contains rough 
endoplasmic reticulum (■) and mitochondria (*). Cell membrane forms numerous short 
processes. EM ×15000 
 
 Marking of antlerogenic cells using a retroviral vector pMINV EGFP. Analysis 
conducted in a flow cytometer demonstrated 30% of EGFP+ cells (Fig. 11) Transduction 
of antlerogenic stem cells with an EGFP gene marker enabled us to follow the fates of 
cells engrafted into auricular cartilage defects. 
 
a                                                  b 
Fig. 11. Evaluation of EGFP expression in antlerogenic cells transducted with a pMINV 
EGFP by means of flow cytometry. a – no expression of EGFP in non-transduced cells; b – 
EGFP protein fluorescence level in transduced cells 
 
4. Xenogeneic engraftment of antlerogenic cells and tissue regeneration 
Autologous cartilage and bone tissue are commonly used materials for transplants in facial  
reconstructive surgery. The limited amount of tissue possible to obtain in children, surgical 
procedures conducted during its collection and, additionally – in case of bone graft – the 
risk of no graft adhesion with the host's tissue and its resorption, emphasise the 
imperfection of this method (Rotter et al., 2005). Despite common use of allogeneic cartilage 
and bone in regeneration of defects, the limiting factor may constitute their availability and 
possibility of losing them (Komender et al., 2001; Więcko et al., 1980). Chondrocytes 
amplified in vitro and used in tissue engineering may undergo differentiation (Barbero et al., 
2003). Studies over the application of in vitro amplified osteoblasts show on the other hand, 
that differentiated cells do not provide proper environment for autogeneic cell regeneration 
and they require being administered together with growth factors (Sakata et al., 2006; 
Schliephake et al., 2001). 
Another problem we addressed was the aseptic inflammation of the digital flexor 
muscles and tendons and interosseus muscle inflammation in horses. It affects about 10% of 
horses from the overall number of orthopaedic patients and constitutes, nowadays, a serious 
problem for doctors and horse owners. It causes long-term exclusion of horses from their 
previous activities. The most recent therapies rely on intratendonous injections under 
ultrasonographic control of: growth factors (platelet-rich plasma, IGF-1), bone marrow and 
autologous stem cells (Aspenberg, 2007). The last of the mentioned methods is exceptionally 
difficult to perform. It is necessary to collect the bone marrow, which constitutes an 
additional procedure. Time required for cell amplification is 3 to 4 weeks, which makes it 
difficult to administer the cells into the tendon at an optimal moment for after this time, the 
haematoma formed at the site of injury already undergoes organisation (Richardson et al., 
2007). 
In recent years, new possibilities for application of various stem cell types in regeneration 
and reconstruction of all types of tissues, including the connective tissue, appeared (Phinney 
& Prockop, 2007). Among others, a technology of obtaining chondrocytes from human stem 
cells and technology of obtaining mesenchymal cell precursors able to trigger cartilage 
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procedures conducted during its collection and, additionally – in case of bone graft – the 
risk of no graft adhesion with the host's tissue and its resorption, emphasise the 
imperfection of this method (Rotter et al., 2005). Despite common use of allogeneic cartilage 
and bone in regeneration of defects, the limiting factor may constitute their availability and 
possibility of losing them (Komender et al., 2001; Więcko et al., 1980). Chondrocytes 
amplified in vitro and used in tissue engineering may undergo differentiation (Barbero et al., 
2003). Studies over the application of in vitro amplified osteoblasts show on the other hand, 
that differentiated cells do not provide proper environment for autogeneic cell regeneration 
and they require being administered together with growth factors (Sakata et al., 2006; 
Schliephake et al., 2001). 
Another problem we addressed was the aseptic inflammation of the digital flexor 
muscles and tendons and interosseus muscle inflammation in horses. It affects about 10% of 
horses from the overall number of orthopaedic patients and constitutes, nowadays, a serious 
problem for doctors and horse owners. It causes long-term exclusion of horses from their 
previous activities. The most recent therapies rely on intratendonous injections under 
ultrasonographic control of: growth factors (platelet-rich plasma, IGF-1), bone marrow and 
autologous stem cells (Aspenberg, 2007). The last of the mentioned methods is exceptionally 
difficult to perform. It is necessary to collect the bone marrow, which constitutes an 
additional procedure. Time required for cell amplification is 3 to 4 weeks, which makes it 
difficult to administer the cells into the tendon at an optimal moment for after this time, the 
haematoma formed at the site of injury already undergoes organisation (Richardson et al., 
2007). 
In recent years, new possibilities for application of various stem cell types in regeneration 
and reconstruction of all types of tissues, including the connective tissue, appeared (Phinney 
& Prockop, 2007). Among others, a technology of obtaining chondrocytes from human stem 
cells and technology of obtaining mesenchymal cell precursors able to trigger cartilage 
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growth and regeneration were devised (Barberi et al., 2005; Vats et al., 2006). More and more 
often, also mesenchymal stem cells (MSC) are used in combination with natural or synthetic 
carriers, as well as BMP proteins, for bone reconstruction (Jafarian et al., 2008; Seto et al., 
2001). The MSC cells can be obtained, among others, from bone marrow, adipose tissue, 
periosteum and dental pulp. Their advantages are their great proliferating potential, 
multipotentiality, as well as little immunogenicity and lack of tendencies to neoplasia 
(Shanti et al., 2007). Bearing in mind the common difficulties in obtaining the proper 
material for engraftment and searching for alternatives for human or autologous stem cells, 
we made an attempt to use a xenogeneic graft of cells obtained from a growing antler of the 
red deer (Cervus elaphus) to reconstruct of auricular cartilage and mandibular bone in 
rabbits, as well as tendons in horses (Cegielski et al., 2008a; Cegielski & Kalisiak, 2008). A 
stable MIC-1 antlerogenic cell line (name of the line introduced in patents) – mesenchymal 
stem cells –  was derived from a growing antler of the red deer (Cegielski et al., 2006). The 
cells cultured by us are characterised by rapid growth and are practically "immortal," 
require uncomplicated standard procedures, which are generally accepted and used in cell 
culture laboratories. They can easily be transported, frozen and stored in liquid nitrogen 
and, if necessary, used for studies. The use of specific antibodies in immunocytochemical 
reactions allowed us to mark and localise these stem cells both in vivo in a growing antler, as 
well as in vitro in cell cultures (Cegielski et al., 2006). 
 
4.1 Cartilage tissue 
The aim of this study was application of a xenogeneic graft of stem cells obtained from a 
growing red deer antler (Cervus elaphus) to regenerate defects of ear auricular cartilage in 
rabbits. 
For the experiment, we chose California white rabbits – 8-month-old females weighing each 
about 4 kg. The Spongostan® fragments matched the size of the defect and constituted 
scaffolding for antlerogenic cells. The cells in the amount of 2 × 106 cell/ml, rinsed in MEM 
medium without serum, were placed on Spongostan® through delicate centrifugation (Fig. 
12). 
 
 
 
Fig. 12. Cultured antlerogenic cells (↑) placed on Spongostan® (↑↑) and prepared for 
engraftment. H+E staining, ×200 
 
Surgical procedures included performing a defect half-way up the outer, dorsal part of the 
right ear auricle. At surgical site a centrally peduncled skin/perichondrium flap measuring 
1.5 cm × 1.5 cm was prepared. The exposed cartilage fragment measuring 1 cm × 1 cm was 
excised and removed. The animals had the cartilage defects implanted with antlerogenic 
cells suspended on Spongostan®, antlerogenic cells transduced with a retroviral pMINV 
EGFP vector or Spongostan® alone saturated solely with physiological saline solution 
(control). The implants were covered with skin/perichondrium flaps. Using clinical 
observations as guidelines, after a period of 4 and 9 weeks from the surgery, we obtained 
specimens from the implantation sites, including the implant as well as endogenous 
cartilage. The collected material was then assessed under optical microscopy (H+E, 
toluidine blue), electron microscopy and by immunohistochemical examinations (reactions 
against antigens: Thy1, CXCR4, EGFP, CD3, CD20, CD68).  
The implanted cells participated in cartilage reconstruction as a new cartilaginous 
scaffolding had been created from fibrous cartilage in which sporadic intracartilaginous 
ossification was observed. Peripherally, in the sites of recovery, there was a visible border 
between the old and the newly formed cartilage (Fig. 13). Numerous dividing chondrocytes 
and forming isogeneic groups were present (Fig. 14). After four weeks, the growth in 
cartilage thickness decreased, however, after nine weeks, the cartilage defect was completely 
and even excessively reconstructed. Vascularised, mixed chondro-osseous tissue was 
formed, just like the one participating in formation of deer antlers (Price et al., 2005a). The 
cartilage reconstruction process (calcification and ossification centres) resembled the 
remodelling processes taking place after engraftment of auto- and allogeneic cartilage 
(Lattyak et al., 2003; Więcko et al., 1980). As in application of autogeneic chondrocytes 
suspended on a polyethylene carrier, after the implantation of antlerogenic cells, we 
observed no connective-tissue capsule (Wellisz, 1993). In rabbits, at the sites where 
Spongostan® saturated solely with physiological saline solution was engrafted, we observed 
no cartilage regeneration, but only a scar formation process.  
 
              
Fig. 13                                              Fig.14 
Fig. 13. Engraftment of antlerogenic cells within rabbit's ear auricle. Visible border between 
the old (*) and the newly formed (■) cartilage, H+E staining, ×200 
Fig. 14. Engraft, antlerogenic cells taking part in regeneration of rabbit's cartilage defect. 
Visible numerous chondroblasts (*), dividing chondrocytes (■) as well as mature cartilage 
cells (↑), H+E staining, ×200 
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growth and regeneration were devised (Barberi et al., 2005; Vats et al., 2006). More and more 
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Fig. 13. Engraftment of antlerogenic cells within rabbit's ear auricle. Visible border between 
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Fig. 14. Engraft, antlerogenic cells taking part in regeneration of rabbit's cartilage defect. 
Visible numerous chondroblasts (*), dividing chondrocytes (■) as well as mature cartilage 
cells (↑), H+E staining, ×200 
 
 
Tissue	Engineering62
Conducted immunocytochemical reactions allowed us to localize, at the implantation site, 
cells showing expression of proteins characteristic of stem cells: Thy1 and CXCR4. The 
marked cells were located in the vicinity and within blood vessels as well as in the area of 
proliferating, undifferentiated cells at the implantation/autologous ear auricle cartilage 
border (Fig. 15a, b). To confirm the participation of antlerogenic stem cells in cartilage 
regeneration, we engrafted into defect areas cells transduced with a vector containing EGFP 
marker gene. Stem cells transduction with a retroviral vector containing EGFP marker gene 
constitutes one of the most commonly used methods to follow the fate of engrafted cells 
(Szyda et al., 2006). The immunohistochemical reaction conducted four weeks from the 
engraftment, showed the presence of EGFP-positive cells within the area of cartilage 
reconstruction (Fig. 15c). The reaction was specific only for small, undifferentiated cells, 
which proves that antlerogenic stem cells were not destroyed by the cells of the host. 
Moreover, they did not require any environment (tissue niches) to retain their 
undifferentiated state and stimulated the rabbit's cartilage to regenerate. 
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Figs. 15. a-c Immunohistochemical reactions demonstrating presence of antlerogenic stem 
cells within the implant. a – immunohistochemical localization of CXCR4+ cells (↑), ×200; b – 
immunohistochemical localization of Thy1+ cells (↑), ×200; c – immunohistochemical 
localization of EGFP+ transduced antlerogenic cells (↑), ×400  
 
Participation of antlerogenic stem cells in reconstruction of the damaged tissue may be 
complex. The reconstruction always occurred from the periphery of the implant outwards 
and it is possible that stem cells could participate in regeneration of the damaged tissue not 
by differentiation into cells required for its reconstruction, but by local production of trophic 
factors modelling the microenvironment at the site of damage as well as inducing survival 
and proliferation of host cells. To these factors may belong, among others, proteins 
regulating hematopoesis, angiogenesis, wound healing and immune response (Barbash et 
al., 2003; Phinney & Prockop, 2007). Nakamura et al. observed regeneration of damaged 
cardiomyocytes in immunosuppressed mice after implantation of swine MSC. The authors 
suggest that regeneration is the effect of influence of the trophic MSC-released substances on 
native tissues (Nakamura et al., 2007). The in vitro studies demonstrated that MSC cells 
secrete cytokines which influence survival and secretory functions of other cells (Le Visage 
et al., 2004; Parekkadan et al., 2007). While an antler regenerates, certain growth factors are 
expressed and these are: EGF, FGF-2, VEGF and BMP (Barling et al., 2005; Feng et al., 1995; 
Lai et al., 2007). In our opinion, engrafted antlerogenic cells may participate in formation of 
proper environment for growth of host's cells together with the above mentioned factors. In 
natural conditions, cartilage is a non-vascularised tissue and it is chondrocytes which 
probably produce the angiogenesis inhibiting factor (Moses et al., 1990). After implantation 
of antlerogenic cells into a cartilage defect, we observed numerous small blood vessels on 
the border of regeneration. This may show that angiogenesis is taking place, creating good 
conditions for the graft to be accepted. It is worth mentioning that abundant vascularisation 
of the antler constitutes the most striking difference between its morphology and 
morphology of other cartilages (Lai et al., 2007). Rich blood supply is necessary here so as to 
meet high metabolic requirements imposed by rapid cartilage growth. The fact that antlers 
constitute a valuable model for angiogenesis studies has recently been suggested by Clark 
and Lai, who demonstrated the presence of VEGF and its receptor VEGFR as well as 
pleiotropin in tissues of a growing antler (Clark et al., 2006; Lai et al., 2007). 
The experiment we conducted did not use immunosupression, and the engrafted 
xenogenous antlerogenic cells were in direct contact to the perichondrium and remaining 
cartilage of the host's auricle. Despite this fact, clinically, we observed every time proper 
wound healing per primam and visible increase in cartilage thickness. In an experiment 
conducted by Ulusal et al. (Ulusal et al., 2005) first, appearing already in the period of 4 to 6 
days after the end of immunosupression, symptoms of complete auriculae's allogeneic 
implant rejection in rats were: edema, localized epidermal desquamation, and formation of 
erythema. A typical reaction of the host to introduction of an allogeneic implant are massive 
lymphocyte concentration and the presence of plasma cells (Brown et al., 1980; Romaniuk et 
al., 1995). On no stage of the conducted experiment, we could observe inflammatory 
reactions, only in the fourth week we observed minor localized clusters of lymphocytes at 
the site of cell engraftment. Additionally, immunohistochemical reactions characteristic for 
T lymphocytes (CD3), B lymphocytes (CD20) and macrophages (CD68) showed none of the 
mentioned cells at the implantation site, confirming that the host's immune response was 
minimal (Fig. 16a-c). Because antlerogenic cells are poorly differentiated, they cause minor 
induction of immune response and good reception of xenogeneic graft. One explanation of 
the phenomenon responsible for no rejection of the allogeneic grafts with stem cells is the 
lack of major histocompatibility complex class II antigens (MHC II) and inhibition of T and 
B lymphocytes activity (Chamberlain et al., 2007; Ryan et al., 2005). Only 6 weeks after 
Spongostan® with cells or Spongostan® alone were engrafted, we could observe foreign 
body giant cells (FBGCs) on the surface of the remaining carrier fragments (Fig. 17). In 
parallel studies, we observed that the FBGCs are produced in the process of macrophage 
fusion in response to the introduction of a foreign body to an organism (Cegielski et al., 
2008b). The carrier we used was completely degraded and resorbed as a result of activity of 
giant cells. It is probable that Spongostan® had no influence on the survival rate of cells it 
carried. 
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a                                                 b                                              c 
Figs. 16. a-c Negative immunohistochemical reactions for presence within the implant of: a – 
T lymphocytes (CD3+), ×200; b – B lymphocytes (CD20+), ×200; c – macrophages (CD68+), 
×200 
 
 
Fig. 17. Spongostan® (S) degradation by multinuclear foreign body giant cells  (FBGC) (↑). 
These cells are visible in the vicinity of the degraded Spongostan®, which takes a typical 
star-like shape. Toluidine Blue staining, ×200 
 
Electron microscopy analysis of the material collected from implantation sites showed a 
great number of collagen fibres and relatively numerous chondroblasts and fibroblasts. 
Active cells contained large amounts of rough endoplasmic reticulum with frequently 
distended cisterns, vacuoles as well as nuclei with large amounts of loosely packed 
chromatin (Fig. 18a). Some of the cells underwent apoptosis and membrane-bound 
cytoplasm fragments separated from them participated in production of extracellular 
substance (Fig. 18b). Apoptosis plays a vital role during skeletal development as well as 
bone growth and remodelling. Active apoptotic processes are also responsible for regulation 
of antler regeneration process, among others – by limiting excessive cell proliferation which 
may lead to initiation of neoplastic processes (Colitti et al., 2005). 
 
 
a                                             b 
Fig. 18. a, b  9th week after antlerogenic cells implantation: a – numerous collagen fibres (↑), 
EM ×15000; b – cell containing a nucleus with condensed marginal chromatin, membrane-
bound cytoplasm fragments (↑) by separating from the cell become part of extracellular 
substance, in which numerous collagen fibres are visible, EM ×15000 
 
4.2 Osseous tissue  
The aim of the study was the use of a xenogenous stem cell graft from a growing antler of 
the red deer to regenerate mandibular bone defects in rabbits. 
The mandibular bone defect measuring 0.5 cm was performed with a steel surgical drill 
boring the bone along with the periosteum and reaching the marrow cavity. In the 
experimental group, inside the bore-hole we placed a fragment of Spongostan® of a 
matching size saturated with the suspension of antlerogenic cells in the amount of 2 × 106 
cell/ml. In the control group, rabbits were implanted with Spongostan® saturated with 
physiological saline solution. After a period of 1, 2 and 6 months after engraftment, we 
collected the mandibles for examination.  
Preliminary results show, that in the control group autoregeneration of lesion occurred (Fig. 
19). In the experimental group antlerogenic cells participated in regeneration of mandibular 
bone (Fig. 20).  
 
 
Fig. 19. Control bore-hole, bone autoregeneration after one month, H+E staining, ×40 
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Fig. 20. Bone regeneration with antlerogenic cells at implantation site after one month, H+E 
staining, ×100   
 
However, between the new periosteum and the muscle layer, we observed oval aggregates 
of undifferentiated proliferating cells with large amounts of collagen fibres surrounded by a 
thin connective-tissue capsule (Fig. 21). Isolation of certain areas may be a sign of 
application of the xenogeneic cells or a carrier. A living organism can react to an xenograft 
with chronic inflammation, indicating the lack of biocompatibility or can try to isolate the 
given material by surrounding it with a fibrous capsule of various thickness (usually 0.1-10 
μm). The thinner the connective-tissue capsule, the bigger the biocompatibility of the carrier 
and host cells (Kos et al., 2003). In our experiment, this phenomenon was sporadically 
observed and probably it did not affect the regenerative processes. On the periphery of the 
defect, there were well visible ossification areas as well as gradually reconstructed 
periosteum. In the centre of the regeneration site, there was well vascularized mesenchymal 
tissue present in a form of a membrane. Angiogenesis constitutes a necessary condition for 
proper bone formation process. Formation of blood vessels can be a result of the activity of 
angiogenic factors (VEGF) secreted by antlerogenic cells, just like it takes place in a growing 
antler (Clark et al., 2006; Lai et al., 2007). The process of formation and mineralisation of the 
bone occurs from the periphery towards the centre of the regeneration area (Fig. 22). 
 
 
Fig. 21. Two months after implantation, along the mandibular arm we observe the engrafted 
cells together with a large number of collagen fibres forming oval aggregates surrounded by 
a thin connective-tissue capsule, H+E staining, ×100  
 
 
Fig. 22. The area of regeneration of a 1-month bore-hole after implantation of antlerogenic 
cells. The muscle layer (■) and a visible osseous tissue lying underneath (*). Dark finely 
flocculating material is the site of early vesicle crystallization and mineralization (↑), H+E 
staining 
 
After two months, at the implantation site, we observed a reconstructed, two-layered 
periosteum and a fibrous bone possessing an irregular system of bone plates, containing 
blood vessels and marrow cavities filled with red marrow. The histological image of the 
regenerated osseous tissue in our experiment resembles the bone formed after engraftment 
of autologous MSC of the bone marrow into defects of mandibular bone in dog and monkey. 
In these experiments, the material collected from implantation sites after respectively 6 and 
16 weeks contained trabecular bone with marrow cavity (Jafarian et al., 2008; Seto et al., 
2001). 6 months after implantation, we observed the progressing remodelling of the fibrous 
bone into a more organised lamellar osseous tissue.  
The regeneration method in our study proceeded similarly to another long-term xenogeneic 
model. Human MSC inserted into cranial and mandibular bone defects in mice participated 
in regeneration of the damaged tissue without inflammatory reaction. MSC cells modulate 
the function of B lymphocytes and inhibit T lymphocytes proliferation, which induces 
tolerance for example to allogeneic grafts (Ryan et al., 2005). Both, histological and 
immunohistochemical evaluations, were performed after 1, 2 and 6 months, and confirmed 
participation of xenogeneic cells in the regeneration processes, as well as a lack of rejection 
of the implants. The deficiencies in the bones were replaced by newly formed, thick fibrous 
bony tissue, that underwent mineralization process and was later remodelled into trabecular 
bone. Antlerogenic cells participated in regeneration of mandibular bone most probably 
together with tolerating them host cells. In our opinion, the engrafted cells could have 
participated in forming of an environment favourable to host's cell growth just like it 
happened during cartilage tissue regeneration. The results of the experiment with rabbits 
allow us to believe that the antlerogenic cells could be used in reconstruction of bony tissues 
in other species as well.  
 
4.3 Tendinous tissue 
The aim of the study was the use of a xenogeneic graft of stem cells from a growing antler of 
red deer to regenerate tendons in horses. Antlerogenic cells synthesize great amounts of 
collagen (Fig. 23), which is used in a dynamic remodelling of an antler (Price et al., 1996). 
Tendons and ligaments are built from thick bundles of collagen fibres, among which lie 
tendinous cells – tenocytes. They are surrounded by loose connective tissue, forming the 
internal peritendineum. Outside of the tendon, there is the external peritendineum, which 
participates in formation of a synovial tendon sheath. Guided intratendinous injection of 
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antlerogenic cells with great regenerative potential could rapidly start reconstruction 
processes. 
Considering the results of preliminary studies, we knew that administration of antlerogenic 
cells to horses does not induce the immune response or lead to development of local 
inflammatory reaction. Despite the fact that horses are animals greatly susceptible to allergic 
responses, the test we performed on three horses, which was based on subcutaneous 
injection of 1.5 ml antlerogenic cells suspension into points of the middle 1/3 of horse's neck 
(injection sites were shaved and sterilized with 70% alcohol) after three-week-long 
observation was successful. There was no inflammatory reaction at the site where the cells 
were injected or hypersensitivity of anaphylactic type. Next, we performed intratendinous 
injections of antlerogenic cells in two horses suffering from tendon inflammation: in the 
former peripheral inflammation of superficial digital flexor tendon and muscle occurred, in 
the latter – interosseous muscle inflammation in the middle of the metacarpus. During six-
week-long observation after administration of the cells, we noticed no reaction, despite 
slight painfulness at the sites of the injection present during 2 first weeks. Follow-up 
ultrasound examinations conducted at two-week intervals showed intense remodelling of 
the damaged structures (Fig. 24a-c). In order to assess objectively the effectiveness of this 
new method, further eighteen-month-long observation of patients lasts and clinical 
examinations on a bigger number of horses are necessary. However, the preliminary results 
are promising and encourage further studies. 
 
 
Fig. 23. Growing antler cell (chondroblast) containing numerous canaliculi of the 
endoplasmic reticulum, mitochondria and collagen fibres 
 
a                                                       b                                                      c 
Fig. 24. a – ultrasound image of digital flexor muscle tendon and interosseous muscle in a 
horse. Arrows indicate the injury of the interosseous muscle; b – ultrasound image of the 
same horse 4 weeks after the injection; c – ultrasound image of the same horse 8 weeks after 
the injection. Visible reconstructing processes around the site of antlerogenic cells injection 
 
5. Perspectives of antlerogenic cells application in medicine 
More and more often stem cells are used in treatment of injured tissues and organs. In 
reconstructive surgery of the skull and face, autologous stem cells are successfully used to 
regenerate bones: mandibular and cranial bones (Lendeckel et al., 2004; Shayesteh et al., 
2008; Warnke et al., 2004). A visible improvement has also been gained in the case of using 
them in treatments of osteogenesis imperfecta and knee joint cartilage defect in human 
(Horwitz et al., 2002; Kuroda et al., 2007). An alternative for human cells could be properly 
modified xenogeneic cells. The participation of antlerogenic cell in reconstruction of 
damaged tissues, poor immunogenicity, good integration of the reconstructed tissues with 
host's own tissue, rapid in vitro amplification as well as low production cost of the engraft 
constitute its advantages. From the results of the experiments concerning the participation 
of antlerogenic stem cells in regeneration of cartilaginous and osseous tissue defects in 
rabbits we know that after the completed reconstruction process,  majority of the 
administered cells undergoes apoptosis and the remaining cells are eliminated by 
neutrophils. A two-year-long period of observation of experimental animals and lack of any 
undesirable responses allows us to conclude that there is great probability in using these 
cells in widely understood regenerative medicine. Our concept is confirmed by studies 
conducted by other authors, who prove that specificity of the stem cells differentiation 
process depends on the site of their engraftment. For example, swine mesenchymal stem 
cells implanted into a heart of a rat do not differentiate into chondroblasts or osteoblasts (as 
results from their purpose), but stimulate regeneration of injured cardiomyocytes 
(Nakamura et al., 2007). Full application of stem cells in regenerative medicine will require, 
however, learning about the differentiation and behaviour of these cells both in vitro and in 
vivo, as well as selecting proper carrier for them.   
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host's own tissue, rapid in vitro amplification as well as low production cost of the engraft 
constitute its advantages. From the results of the experiments concerning the participation 
of antlerogenic stem cells in regeneration of cartilaginous and osseous tissue defects in 
rabbits we know that after the completed reconstruction process,  majority of the 
administered cells undergoes apoptosis and the remaining cells are eliminated by 
neutrophils. A two-year-long period of observation of experimental animals and lack of any 
undesirable responses allows us to conclude that there is great probability in using these 
cells in widely understood regenerative medicine. Our concept is confirmed by studies 
conducted by other authors, who prove that specificity of the stem cells differentiation 
process depends on the site of their engraftment. For example, swine mesenchymal stem 
cells implanted into a heart of a rat do not differentiate into chondroblasts or osteoblasts (as 
results from their purpose), but stimulate regeneration of injured cardiomyocytes 
(Nakamura et al., 2007). Full application of stem cells in regenerative medicine will require, 
however, learning about the differentiation and behaviour of these cells both in vitro and in 
vivo, as well as selecting proper carrier for them.   
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1. Introduction  
The initial cellular events that take place at the biomaterials interface mimic to a certain 
extent the natural adhesive interaction of cells with the extracellular matrix (ECM) (Spie, 
2002; Griffin & Naughton, 2002; Grinnell, 1986). In fact, the living cells cannot interact 
directly with foreign materials, but they readily attach to the adsorbed layer of proteins 
(upon contact with physiological fluids in vivo or culture medium in vitro) such  as 
fibronectin (FN), vitronectin (VN), fibrinogen (FG), representing the so-called soluble matrix 
proteins in the biological fluids (Grinnell 1986). Upon longer contact with tissues many 
other ECM proteins, such as collagens and laminins, will also associate with the surfaces, 
affecting the cellular interaction. The concentration, distribution, and mobility of the 
adsorbed protein layer on a surface play a fundamental role in the biofunctionality of a 
synthetic material and are clue factors to understand the biological response of a substrate 
(Anselme, 2000).   Cells recognize these matrix proteins via integrins - a family of cell surface 
receptors – that provide trans-membrane links between the ECM and the actin cytoskeleton 
(Hynes, 2002). When integrins are occupied they cluster and develop focal adhesions; 
discrete supramolecular complexes that contain structural proteins such as vinculin, talin, -
actinin, and signalling molecules, including FAK, Src and paxilin that actually anchorage the 
cells to the surface and trigger the subsequent cellular response (Geiger et al., 2001). 
Abnormalities in the cell-ECM integrin mediated interactions are associated with pathologic 
situations that include tumour formation (Wehrle-Haller & Imhof, 2003). Besides, integrin 
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 2. Protein-material interaction 
Proteins are considered to be clue factors in mediating the cell-material interaction and their 
status (the amount, conformation and strength of interaction) on a material surface 
determine the biocompatibility of the system. Even if the design of antifouling surfaces for 
the repulsion of proteins is an important field of activity (Chen et al, 2008), we are focused in 
this chapter on the effect of material properties on adsorption of matrix proteins and the 
influence on cell response. 
Protein adsorption on material surfaces is a process driven both by the intensity of the 
energetic interactions between the molecular groups of the substrate’s surface and of the 
protein (i.e., hydrogen bonding, electrostatic, van der Waals interactions) and by entropic 
changes as a consequence of the unfolding of the protein as bound water is released from 
the surface (García, 2006; Werner et al, 2006). Clearly, the amount of protein adsorbed and 
its conformation depend on the chemical groups of the substrate, which determine the 
energetic and entropic interactions with the adsorbed proteins. Protein adsorption on 
different substrates has been extensively investigated in the literature by different 
techniques. FN, albumin, laminin, collagen, lysozyme, fibrinogen, hemoglobin, and several 
other proteins were adsorbed on different substrates—mostly, model surfaces such as mica, 
glass, and self-assembled monolayers—and were investigated by different techniques that 
include atomic force microscopy, ellipsometry, quartz crystal microbalance, sodium dodecyl 
sulfate gel electrophoresis, FT-IR, spectroscopic imaging, electron microscopy, and 
fluorescence probe techniques (Keselowsky et al., 2003; Michael et al., 2003; Tsapikouni & 
Missirlis, 2007; Benesch et al., 2007; Weber et al., 2007; Steiner et al., 2007; Lord et al., 2006; 
Noh & Vogler, 2006; Prime & Whitesides, 2006; Sousa et al., 2007). It is convenient to 
describe the main adhesion proteins –and its behaviour on material surfaces- for the sake of 
(auto)completeness of the chapter.  
fibronectin 
FN is a glycoprotein found in blood, extracellular fluids, and connective tissues and 
attached to the cell surfaces. Both plasma FN and the cell surface forms are dimers, 
consisting of two subunits of 220 kDa, linked by a single disulfide bond near the carboxyl 
termini (Erickson & McDonagh, 1981; Erickson & Carell, 1983). Each subunit contains three 
types of repeating modules (types I, II, and III) that mediate interactions with other FN 
molecules, other extracellular matrix (ECM) proteins, and cell-surface receptors (Pankov & 
Yamada, 2002). The importance of FN as a mediator of cell adhesion to a substrate was 
recognized earlier (Pearlstein, 1980). Since then, many studies have shown the role of FN in 
promoting cell adhesion and regulating cell survival and phenotype expression on different 
surfaces (García & Boettiger, 1999; Toworfe et al., 2004; Baugh & Vogel, 2004; Lan et al., 
2005; Grinnell & Feld, 1982; Altankov et al., 2000). It has been stressed that, for a fixed 
surface chemistry, the initial density of integrin–FN bonds is proportional to the surface 
density of adsorbed FN (García & Boettiger, 1999); moreover, the nature of the surface 
chemistry is able to modulate FN conformation (Keselowsky et al., 2003). It has been 
suggested that FN adsorbs preferentially on hydrophobic surfaces (Toworfe et al., 2004) and 
that it undergoes greater extension of its dimer arms on hydrophilic glass (Baugh & Vogel, 
2004) in a conformation that favors the binding of antibodies (Grinnell & Feld, 1982) and 
strength the cell–material interaction (Kowalczynska et al., 2006). Even the micro/nano 
surface roughness has been shown to influence FN adsorption (Khang et al., 2007; Costa 
Martínez et al., 2008). The integrin-FN interaction, governed mainly by the 5β1 dimer, also 
 
leads to the formation of extracellular matrix fibrils from the newly secreted FN (Mao & 
Schwarzbauer, 2005) and even arrangement of those protein molecules adsorbed on the 
substratum (Altankov & Groth, 1996; Altankov et al., 1996). The thickness of FN matrix 
fibrils ranges from 10 to 1000 nm in diameter and consists of a few to hundreds of FN 
molecules across (Singer, 1979). FN binding to integrins induces reorganization of the actin 
cytoskeleton and activates intracellular signaling complexes. Cell contractility facilitates FN 
conformational changes, and it allows for the unfolding of the native globular FN structure, 
thus exposing cryptic domains that were not available in the compact form of soluble FN. 
Finally, fibrils are formed through FN-FN interactions, usually through binding of I1-5 to 
either III1-2 or III12-14 domains (Geiger et al, 2001). Cell-mediated FN reorganization, when 
adsorbed on a synthetic surface, seems to be also an important factor in determining the 
biocompatibility of a material, because poor cell adhesion and spreading has been found in 
cases when integrin-mediated rearrangement of FN did not occur at the material interface 
(Altankov & Groth, 1994; Altankov & Groth, 1996). 
It has been shown that the existence of mechanical tension is necessary for efficient integrin-
mediated FN fibrillogenesis (Erickson, 2002; Smith et al., 2007). Although it is generally 
agreed that FN fibrillogenesis is cell-dependent process, fibrillar networks of FN have been 
generated also in the absence of cells by means of interactions with the underlying substrate 
that involves mechanical events at the molecular scale. FN fibrillogenesis upon contact with 
a lipid monolayer was explained through mechanical tension caused by domain separation 
in the lipid monolayer that pulls the protein into an extended conformation (Baneyx & 
Vogel, 1999). The assembly of FN into fibers was obtained also by applying forces to FN 
molecules via poly(dimethylsiloxane) (PDMS) micropillars at different stages of 
fibrillogenesis (Ulmer et al, 2008). We have recently shown that FN fibrillogenesis can take 
place as a consequence of the sole interaction between the protein molecules and a material 
surface with the appropriate surface chemistry; in concrete, a spontaneous formation of 
biologically active FN network was found in vitro after its adsorption on poly(ethylacrylate) 
(PEA) (Gugutkov et al., 2009; Rico et al., 2009). 
fibrinogen 
FG is a large, complex, fibrous glycoprotein normally present in human blood plasma 
essential for many biological functions which include haemostasis, wound healing, 
inflammation, and angiogenesis (Weisel, 2005). It is made up of three pairs of polypeptide 
chains, designated as A, B, and , with molecular masses of 66, 52, and 46 kDa, 
respectively, which are held together by 29 disulfide bonds (Weisel, 2005). These six 
polypeptides are organized into independently folded units: a central E-domain, which 
includes the N-terminus of all six polypeptide chains, and two terminal D-domains, which 
include the Bß and  chains. The carboxy-terminal of the A chain, the aC domain, departs 
from the D fragment and either associates to the E-domain to constitute a single globular 
domain close to it or, on the contrary, they form appendages with a certain degree of 
mobility. In its native form the aC association to the central domain is more common; 
however, there is equilibrium between these two situations (Veklich, 1993). The cleavage of 
the small A and B sequences from the A and B chains by thrombin in the E-domain yields 
fibrin, which is able to associate and polymerize. The length of an individual FG molecule is 
45–50 nm (Weisel  et al., 1985; Gorman et al., 1985). 
FG–surface interactions have been investigated on many substrates with different 
experimental techniques (Brash & Horbett, 1995). Atomic force microscopy (AFM), which is 
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a technique able to provide direct observation of protein conformation on different 
substrates has been extensively used in recent years, mainly on model surfaces, such as 
silica, mica, titanium graphite, and self-assembled monolayers (SAMs), flat enough so that 
the height magnitude is able to reveal the trinodular structure of single-adsorbed FG 
molecules (Toscano & Santore, 2006; Marchin & Berrie, 2003; Agnihotri & Siedlecki, 2004; 
Cacciafesta et al., 2000; Tunc et al., 2005; Gettens et al., 2005; Gettens & Gilbert, 2007; Ta & 
McDermott, 2000; Ishizaki et al, 2007; Ortega-Vinuesa et al., 1998; Mitsakakis et al., 2007; Sit 
& Marchant, 1999). 
The effect of surface wettability, as one of the most important parameters that affects the 
biological response to a material, on FG adsorption has lead to different, nonconsistent 
conclusions. Even if there is general agreement in the decrease of FG adsorption with the 
increase of wettability of the substrate, (Slack & Horbett, 1992; Rodrigues et al., 2006) it is 
not the case concerning FG conformation. Marchin et al. observed dramatic differences in 
the conformation of FG adsorbed on hydrophilic mica and hydrophobic graphite: globular 
conformations were observed on mica, whereas on graphite the trinodular structure of the 
extended molecule was clearly observed (Marchin & Berrie, 2003). Sit et al. suggested that 
the spreading of FG increases with the hydrophobicity of the surface (Sit & Marchant, 1999). 
In addition, Wertz and Santore have shown through total internal reflection fluorescence 
that the footprint of a FG molecule is larger when adsorbed on a hydrophobic surface 
(graphite) than on a hydrophilic one (mica) (Wertz & Santore, 2001; Wertz & Santore, 2002). 
However, other authors have found the trinodular conformation both on graphite and mica 
(Agnihotri & Siedlecki, 2004). The adhesion force between FG and the substrate has also 
been investigated by AFM and it has been found to depend on the surface wettability. By 
functionalizing AFM tips with the protein, Kidoaki et al. found that the strength of adhesion 
to a hydrophobic SAM was larger than to hydrophilic ones (Kidoaki & Matsuda, 1999). Xu 
et al. measured adhesion forces to a series of surfaces over a broad wettability range through 
glow-discharge plasma modification, by using protein modified AFM tips (Xu & Siedlecki); 
showing a marked transition between protein adherent materials and protein nonadherent 
materials over the range of water contact angles of 60–65 º. 
laminin 
Laminins are trimeric molecules of , , and  chains with molecular masses of 140–400 kDa. 
Several laminin isomorphs are known, with a large number of genetically distinct chains (1 
to 5, 1 to 3, and 1 to 3) (Burgeson et al., 2004). The laminins are important glycoprotein 
components of basement membranes, where they provide interaction sites for many other 
constituents, including cell surface receptors (Mercurio, 1995; Beck et al., 1990; Sasaki et al., 
2004). Laminin plays an important role in neural cell migration, differentiation, and neurite 
growth (Kleiman et al., 1987; Heiduschka et al., 2001; Luckenbill-Edds, 1997; He & 
Bellamkonda, 2005) and it has been used as a coating for improving nerve cell adhesion and 
growth on different substrates (Rogers et al., 1983; Liesi et al., 1984). 
Among the different material properties that influence protein adsorption (and, 
consequently, cell adhesion and functionality) the hydrophilicity of the system is an 
important one. The system based on the copolymerisation of ethyl acrylate and 
hydroxyethyl acrylate provides controlled hydrophilicity maintaining the same chemistry. It 
consists of a vinyl backbone chain with the side groups -COOCH2CH3 and -
COOCH2CH2OH, respectively. Their copolymerization gives rise to a substrate in which 
the surface density of -OH groups can be varied without modifying any other chemical 
 
functionality of the system. The concentration of -OH groups determines both the surface 
energy and the hydrophilicity of the substrate (Table 1). The interaction of the protein 
domains with the chemical functionalities of the substrate and with water determines the 
molecule’s adsorbed conformation.  
 
xOH EWC WCA (º) 
0 (pure PEA) 1.7 ±0.4 89±1 
0.3 7.6±0.9 80±2 
0.5 18.2±1.7 67±1 
0.7 40.6±0.4 55±1 
1 (pure PHEA) 134±5 45±2 
Table 1. Equilibrium water content (EWC) and water contact angle (WCA) for the different 
substrates. 
 
The amount of protein adsorbed on the different surfaces was quantified by image analysis 
of the Western blot bands obtained by analysing the supernatant after adsorption on the 
material surface (Rodríguez Hernandez et al., 2009; Rico et al., 2009). Two different curves 
have been observed (included in Figure 1) corresponding to FN and FG adsorption from a 
solution of concentration 20 g/mL. The adsorbed FN depends non-monotonically on the -
OH density of the substrate, and FN surface density shows a minimum at approximately 
xOH=0.5. Both higher and lower concentrations of hydroxyl groups in the substrate result in 
higher amounts of the adsorbed protein. For all concentrations of the original solution, the 
highest protein adsorption occurs on the most hydrophilic substrate. The situation is 
completely different when FG is adsorbed on the same family of substrates. The amount of 
adsorbed protein diminishes monotonically as the OH density increases. The difference of 
adsorbed FG between pure PEA (OH0) and OH30 is approx. 0.9 g/cm2, a huge fall for such 
a small OH increment, whereas these differences tend to diminish as substrata become more 
hydrophilic (<0.1 g/cm).  
 
Fig. 1. Surface density of fibronectin (FN, squares) and fibrinogen (FG, circles) adsorbed on 
substrates with controlled OH density. 
 
The conformation of the protein adsorbed on the substrate can be directly observed by 
Atomic Force Microscopy. AFM studies of the adsorption of protein on non-model surfaces 
in cases where the roughness of the substrate is of a size of the order of the protein height 
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cannot be conclusive if monitored with the height signal since the protein features are 
usually blurred; one would have to polish the neat material to get a surface flat enough 
(Veklich et al., 1993) Instead of the height, the phase signal of AFM, which is a magnitude 
sensitive to the different viscoelastic behaviors, (Tamayo & García, 1997; Cleveland et al., 
1998; Tamayo & García, 1998; García et al., 1998) can be used to distinctly reveal protein 
conformation under conditions of usual, non-model polymer surfaces (Holland & Marchant, 
2000; Rodríguez-Hernández, 2007). Figure 2 shows protein conformation and distribution 
after adsorption on the different substrates from a 20 g/mL protein solution, which is the 
concentration typically employed when coating a substrate with the protein for cell culture 
purposes (Keselowsky et al., 2003; Erickson & Carell, 1983; Altankov et al., 2000; Altankov & 
Groth, 1994; Altankov & Groth, 1996). The more hydrophobic surfaces induce the formation 
of protein networks, whose density decreases as the fraction of -OH groups increases. FN 
network is well developed on the PEA (-OH0) and -OH10. Protein aggregates with elongated 
shape are still formed on the -OH30 surface, but only weakly connected protein filaments are 
identified. A higher amount of hydroxyl groups (from xOH=0.5 on) prevents the formation of 
a protein network on the materials surface, and only disperse (micro) aggregates of the 
protein are observed on the -OH50, -OH70, and PHEA (-OH100) substrates. The surface 
density of these globular FN aggregates seems to increase with the fraction of hydroxyl 
groups from xOH=0.5 to 1. 
FG distribution after adsorption on the different substrata at different magnifications reveals 
rather than single FG molecules, AFM images show protein patterns with different 
topologies. Nevertheless, some differences between the conformations of FG on the different 
substrates are worth mentioning. The formation of a FG network takes place on pure PEA 
(OH0), but the co-continuity of the protein network is lost when small amounts of OH are 
introduced in the system (OH10 and OH20). However, from this hydroxy content on, FG–FG 
interactions are somehow enhanced and variable fibril network topologies show up again. 
FN conformation on the substrate is not related to the total amount of protein adsorbed on 
it. This nonmonotonic dependence of adsorbed protein on -OH fraction can be understood if 
protein adsorption on a substrate’s surface is analyzed in terms of the number of available 
sites on the surface; it is clear that not only the energetic interactions between the substrate 
and the protein play a role in the adsorption process, but also the conformation of the 
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FN and FG stands for a situation in which similar distribution and conformation of the 
protein is observed on the substrates (Figure 2) but very different tends in the amount of 
adsorbed protein are found (Figure 1).  When laminin is adsorbed on this set of substrates, 
protein molecules show globular like morphology on the hydrophilic PHEA and gradually 
extend as the amount of –OH groups on the surface diminishes, up to a point in which the 
protein conformation tends again to a more compact, less extended conformation. 
Additionally, the formation of a laminin network takes place on the 50:50 copolymer in 
which the N-terminal domain of all three chains of the protein are linked. This polymerized 
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supramolecular aggregation is the typical form of laminin in the basement membrane and 
its formation depends on time, temperature, and concentration (Luckenbill-Edds, 1997). The 
formation of protein networks on our surfaces must be conditioned not only by the different 
conformation of the molecule on the substrate, but also by the surface density of adsorbed 
protein. 
 
 
 
Fig. 3. AFM phase image of laminin molecues adsorbed on substrates with controlled 
hydroxyl density. Globular protein molecules are observed both on the hydrophilic and 
hydrophobic polymers while the protein tends to extend their arms for intermediate 
hydroxyl densities (extracted –with permission- from ref. Rodríguez Hernández et al., 2007). 
 
3. Development of provisional extracellular matrix on biomaterials interface 
Cell-matrix interaction in vivo is a complex bi-directional and dynamic process. Cells in the 
tissues are constantly accepting information on their environment from cues in the ECM 
(Altankov & Groth, 1994) and, at the same time, cells are producing and frequently 
remodelling their matrix (Grinnel, 1986; Hynes, 2002; Avnur & Geiger, 1981). Therefore, it is 
not surprising that many cells cannot adapt and poorly survive in vitro and, conversely, 
when a foreign material is implanted in the body, the adjacent tissue cells do not interact 
properly because of lack of their ECM. 
A large and growing body of evidence shows that the cells in vivo need to accept distinct 
physico-chemical signals from the surrounding ECM and because a tight connection 
between the cytoskeleton and ECM the cells also respond to these properties. Mechanical 
properties are also important. For instance, as the stiffness of the surrounding ECM is in the 
same order of magnitude as cells, they are able to reorganize this matrix (Rhees & Grinnel, 
2007; Kolakna et al., 2007). However, on stiffer materials cells may fail to do so, and it is an 
obstacle for their biocompatibility. A line of previous investigations has shown that 
fibroblasts and endothelial cells tend to rearrange adsorbed matrix proteins, such as FN and 
FG (Altankov et al., 1997; Tzoneva et al., 2002), as well as collagen (Maneva-Radicheva et al., 
2008) in a fibril-like pattern. Using model surfaces –mostly self-assembled monolayers 
(SAMs) - it has been shown that this cellular activity is abundantly dependent on the surface 
properties of materials, such as wettability (Altankov et al., 1996), surface chemistry and 
charge (Pompe et al., 2005; Altankov et al., 2000). It has been shown that for this kind of 
substrates (SAMs) fibroblast on hydrophilic surfaces may reorganise FN in ECM-like 
structures whereas on hydrophobic surfaces almost no rearrangement of FN occurs (Fig. 4).  
 
 
 
 
                      
Fig. 4. Reorganization of adsorbed FITC-fibronectin on different wettable model substrates: 
a) glass (WCA=230); b) aminopropyl silane (WCA=670); c) octadecyl silane (WCA=870); d) 
silicon (WCA=1070). 
 
These experiments suggests that loosely adsorbed FN on hydrophilic surfaces provide a 
better substrate for cell growth presumably due to the fact that cells need to modify 
adsorbed FN for their normal function. Therefore, they remove and organise FN from the 
substrate into specific fibrillar structures, similar to FN matrix fibrils. Early events of 
integrin receptor 1 functioning is also different on hydrophilic and hydrophobic materials. 
It is known that 51 binds FN to the cell surface and induced conformational changes 
required for FN polymerisation (Smith et al., 2007). It has been shown that clusters of1 
integrin might organise in a specific linear pattern on the dorsal cell surface of adhering 
fibroblasts on hydrophilic glass, presumably matching the initial positional organisation of 
FN matrix. However, on hydrophobic glass, even if the cells formed normal focal adhesions 
–similar to those on FN-coated glass- they did not develop a linear organisation of the FN 
receptor (Altankov et al., 1997). This evidence raises the possibility that tissue compatibility 
of such materials may be connected with the allowance of cells to remodel surface 
associated proteins presumably as an attempt to form their own matrix, e.g. materials that 
bind proteins loosely will support the organization of a provisional ECM. This view 
however does not consider the real molecular architecture of the adsorbed proteins layer 
and also causes limitations to the materials selection. 
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FN matrix. However, on hydrophobic glass, even if the cells formed normal focal adhesions 
–similar to those on FN-coated glass- they did not develop a linear organisation of the FN 
receptor (Altankov et al., 1997). This evidence raises the possibility that tissue compatibility 
of such materials may be connected with the allowance of cells to remodel surface 
associated proteins presumably as an attempt to form their own matrix, e.g. materials that 
bind proteins loosely will support the organization of a provisional ECM. This view 
however does not consider the real molecular architecture of the adsorbed proteins layer 
and also causes limitations to the materials selection. 
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Fig. 5. Organization of 1 integrins on the dorsal (B,D) and ventral (A,C) cell surface of 
fibroblasts adhering on hydrophilic glass (A,B) and hydrophobic ODS (C,D) surfaces. Note: 
Focal adhesions are well developed on both hydrophilic and hydrophobic substrata (A and 
C) while linear arrangement of ß1 integrins are visible on hydrophilic glass only (B) and 
absent on hydrophobic ODS (D).  
 
The arrangement of natural FN matrix is also dependent on the ability of cells to reorganize 
the adsorbed FN layer on the material substrate. When hydrophilic and hydrophobic glass 
are culture with human fibroblast for longer time (72 h), significant amounts of FN are 
deposited by cells on the hydrophilic substrate, organised in fibrils and clusters, oriented in 
the direction of the cell polarization. However, on the hydrophobic glass, less FN fibril 
formation was observed although cell spreading was almost in the same extent as on the 
hydrophilic glass (Altankov & Groth, 1996). Figure 6 shows organization of extracellular 
fibronectin matrix on different wettable model substrates of increasing hydrophobicity as 
measured by the water contact angle (WCA): glass (WCA=23º) aminopropyl silane 
(WCA=67º), octadecylsilane (WCA=87º), and silicon (WCA=107º). A clear trend for less FN 
matrix formation with increasing the hydrophobicity of substratum is demonstrated on 
Figure 6 below. 
 
                   
Fig. 6. Organization of extracellular fibronectin matrix on different wettable model 
substrates: a) glass (WCA=230); b) aminopropyl silane (WCA=670); c) octadecyl silane 
(WCA=870); d) silicon (WCA=1070). 
 
Recent investigations however, have shown that even if cells need the adequate 
environment to synthesize their own matrix at the cell material interface, it is not mandatory 
that this happens only on hydrophilic substrata. The system based on the copolymerisation 
of ethyl acrylate and hydroxyethyl acrylate, that we have already commented concerning 
protein adsorption in the previous section, is an example of how things can happen in a 
different way. There, it was found that the cells are able to synthesize and deposit FN matrix 
fibrils on some of the material surfaces. The formation of FN fibrils, the so-called 
fibrillogenesis, is a process either mediated by integrins or, as it is accounted for previously, 
induced by the substrate. However, FN fibrils could not be found on the more hydrophilic 
samples (-OH100 and -OH70) while on the sample with intermediate composition, -OH50 the 
fibroblasts deposit only small fibrils, located mostly beneath the cells. As the hydroxyl 
fraction decreases (and the surface becomes more hydrophobic) the FN deposition increases, 
which moreover is organized into a typical matrix-like structure similar to those on the 
hydrophilic glass (Altankov et al. 1996). Nevertheless, FN reorganisation does not happen as 
expected anymore: no reorganization of FN takes place whatever the hydroxyl fraction of 
groups in the sample, that is, FN reorganization does not depend on the hydrophilicity for 
this family of substrates. It is noteworthy, however, that the values for the wettability of the 
PHEA samples (WCA 45º) correspond to values that are optimal for the cellular interaction 
in other systems. Conversely, surfaces with about 90º WCA, characteristic for pure PEA, and 
where the best cellular interaction was found, usually abrogate cellular interaction (Garcia, 
2006; Grinnell & Feld, 1982; Arima & Iwata, 2007). Collectively this suggests that even 
unable to organize the preadsorbed FN on the substrate, the fibroblasts respond on the FN 
network previously formed during protein adsorption on the substrate (Figure 2), 
presumably because the conformation of the protein provides the adequate signals which 
stimulate their normal matrix-forming activity. 
These results suggest that the distinction between hydrophilic and hydrophobic features of 
a substrate is insufficient to explain the general trends underlying the cell-material 
interaction, and more factors must be taken into account. For instance, the conclusion that 
the ability of fibroblasts to secrete ECM proteins is greatly reduced on hydrophobic 
substrates (Altankov et al., 1996) even if cell adhesion takes place clearly differs from the 
results in this recent work. Rather, fibroblast functional behaviour on a synthetic substrate 
depends in a subtle way on the particular substrate chemistry that triggers the process of 
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protein adsorption. Both protein conformation on the substrate and the intensity of the 
protein-material interaction play a fundamental role on cell behavior: the adequate protein 
conformation on the substrate—leading to a substrate induced FN fibrillogenenis—results in 
excellent cell adhesion and matrix formation (for low -OH contents ), even if preadsorbed 
FN cannot be removed by cells. Alternatively, if protein conformation is good enough so as 
to support initial cell adhesion, cells will be able to remove the initial FN layer and secrete 
their own extracellular matrix (as it happens in the control glass). Higher -OH fractions in 
the substrate lead to inadequate protein conformation on the substrate, which does not 
support good cell adhesion and consequently leads to diminished functionality. 
Despite our knowledge on ECM organization, relatively little is known about the fate of 
these already arranged matrix proteins. Recent data indicate that polymerized forms of the 
matrix proteins have properties distinct from protomeric, non-polymerized ones. For 
example, the state of collagen polymerization has been shown to alter its growth regulatory 
properties (Schofield, 1978). Emerging evidence also indicates that the ECM form of FN 
(matrix fibrils) is functionally distinct from the soluble FN (Hynes, 1990; Wagenaar-Mller et 
al., 2007), having implications on the long-term behaviour of this protein. Thus, depending 
on the allowance of materials surface to support the development of fibrillar matrix, the 
biological properties of a material may be altered. Much is known about the interactions 
between different ECM proteins, but surprisingly less is our knowledge about the ECM 
composition, organization, and stability at the biomaterials interface. Can it be regulated? A 
distinct hierarchy of matrix remodelling is already evident from the in vitro studies (Velling 
et al., 2002). Integrin-mediated assembly of FN into fibrils is well documented (Mosher  et 
al., 1992; Christopher et al., 1997; Sottile & Hocking, 2002), but the fact that FN may tether 
other matrix proteins to the cell surface, and therefore is required for their organization, is 
new in the field (Maneva-Radicheva et al., 2008; Dzamba, 2008). It provides also new 
insights on the mechanisms for other fibrillar matrix proteins assembly, such as collagen and 
trombospondin (Velling et al., 2002; Sottile & Hocking, 2002). It has been also shown that FN 
fibrillogenesis is also required for rearrangement of substratum associated fibrinogen 
(Tzoneva et al., 2002). That is to say, it has been observed that endothelial cells were able to 
reorganise both adsorbed (on the substrate) and soluble (added to solution after cell 
adhesion to the substrate) FG in specific fibrillar structures only on hydrophilic glass, while 
this phenomenon is inhibited on hydrophobic substrata. Thus, endothelial cells mediated 
fibrinogen fibrillogenesis is altered on hydrophobic substrata, in the same way that FN 
fibrillogenesis is. Additionally, it was reported that endothelial cell spreading on FG was 
affected by cell synthesized FN (Dejana et al, 1990). This finding was supported with the 
observation of a different pattern of integrin organisation during the interaction with 
substratum-bound soluble FNG (Tzoneva et al., 2002). 
It is known that the adhesion on endothelial cells to adsorbed FG is mediated by v3 
integrin (Cheresh et al, 1989). Indeed, the 3 integrin clusterizes in structures resembling 
focal adhesion contacts when endothelial cells adhere to FG-coated substrata. Conversely, 
on the dorsal cell surface FG fibrils were not co-localized with 3 integrin, representing a 
punctuate distribution, in contrast to 1 integrin, which showed a well-pronounced linear 
pattern of organisation. The absence of 1 integrin from the focal adhesion plaques is an 
indication that the FN receptor does not participate in endothelial cell adhesion to FG. 
Integrin 1, however, has clearly shown to be involved in FN fibril formation (Dejana et al, 
1990). The co-localisation of FN and FG fibrils was found on the dorsal cell surface of 
 
endothelial cells (Tzoneva et al., 2002). Also, the incorporation of FN fibrils into matrix 
fibrils starts from the distinct place at the cell periphery, near to the focal adhesions, 
suggesting the leading role of FN in this process. The existence of this joint fibrillogenesis, 
i.e. coassembly of FG and FN, found for endothelial cells have been reported also for 
epithelial cells (Guadiz et al., 1989) and fibroblasts (Pereira et al., 2002). Even collagen IV, 
which is a non-fibrillar protein could undergo fibril-like linear rearrangement along with FN 
as we recently show (Maneva-Radicheva et al., 2008), a fact that needs to be further 
elucidated.  
In the last decade many studies have been focused on the modifications of biomaterials 
surfaces with synthetic or natural ECM fragments to provoke an adequate recruitment of 
cells for in vivo tissue regeneration (Massia & Hubel, 1990; Werner et al., 2006; Ma et al., 
2007). However, when a foreign material is implanted in the body, it hampers the local 
organization of ECM and alters the biocompatibility of the implant, a process further 
complicated from the non-specific inflammatory response. A possible reason for the lack of 
adequate tissue response is attributed by many authors to the different dimensionality of the 
implant. Nowadays tissue engineering strives to replace the damaged tissues with natural 
or synthetic scaffolds designed to mimic the 3D organization and mechanical properties of 
ECM. Nevertheless, many of the bioengineered devices such as stents, prosthesis, 
membranes, metal implants, etc, simply can not avoid the 2D contact with cells. Therefore 
we argue, if this 3D architecture is always obligatory. When epithelial or endothelial cells 
reside on the basement membrane, they meet a rather flat environment, which they assess 
more as topography and as source of positional signals that guide their functionality. The 
basement membrane is actually a two dimensional structure, common to many types of 
tissues, providing underlinement for baso lateral cell attachment and functional polarization 
(Campbell & Teranova, 1988). Therefore, a future prospective for the development of 
biohybrid organs may require the construction of modules based on 2D permeable 
membranes colonized with cells that will mimic to a maximal extent the functional 
arrangement of basal membrane. On the other hand however, dimensionality of cell-
material interaction raises a number of obstacles that need to be solved. For example, the 
blood contacting devices such as small diameter vascular grafts, stents, synthetic heart 
valves and assist systems, have suffered from a common problem, the lack of significant 
endothelial cells in-growth and function. While endothelial cells procurement technologies 
for seeding implants have improved, adhering endothelial cells usually dedifferentiate and 
act in a counterproductive manner, very often accelerating device failure (Ludwig et al., 
2007).  Thus, it seems that endothelial cells do not meet an adequate environment, as on the 
natural basal membrane, but what they are actually missing remains unclear.  
 
4. Remodelling of the extracellular matrix 
Except organization, the ECM undergoes proteolytic degradation, which is a mechanism for 
the removal of the excess ECM usually approximated with remodelling. Remodelling of 
ECM occurs in various physiological and pathological processes, such as normal 
development, wound healing and angiogenesis, but also in atherosclerosis, fibrosis, 
ischemic injury and cancer. Thus, matrix remodelling is a subject of an extensive biomedical 
research, but how it relates to the biocompatibility of materials remains unclear. Upon 
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example, the state of collagen polymerization has been shown to alter its growth regulatory 
properties (Schofield, 1978). Emerging evidence also indicates that the ECM form of FN 
(matrix fibrils) is functionally distinct from the soluble FN (Hynes, 1990; Wagenaar-Mller et 
al., 2007), having implications on the long-term behaviour of this protein. Thus, depending 
on the allowance of materials surface to support the development of fibrillar matrix, the 
biological properties of a material may be altered. Much is known about the interactions 
between different ECM proteins, but surprisingly less is our knowledge about the ECM 
composition, organization, and stability at the biomaterials interface. Can it be regulated? A 
distinct hierarchy of matrix remodelling is already evident from the in vitro studies (Velling 
et al., 2002). Integrin-mediated assembly of FN into fibrils is well documented (Mosher  et 
al., 1992; Christopher et al., 1997; Sottile & Hocking, 2002), but the fact that FN may tether 
other matrix proteins to the cell surface, and therefore is required for their organization, is 
new in the field (Maneva-Radicheva et al., 2008; Dzamba, 2008). It provides also new 
insights on the mechanisms for other fibrillar matrix proteins assembly, such as collagen and 
trombospondin (Velling et al., 2002; Sottile & Hocking, 2002). It has been also shown that FN 
fibrillogenesis is also required for rearrangement of substratum associated fibrinogen 
(Tzoneva et al., 2002). That is to say, it has been observed that endothelial cells were able to 
reorganise both adsorbed (on the substrate) and soluble (added to solution after cell 
adhesion to the substrate) FG in specific fibrillar structures only on hydrophilic glass, while 
this phenomenon is inhibited on hydrophobic substrata. Thus, endothelial cells mediated 
fibrinogen fibrillogenesis is altered on hydrophobic substrata, in the same way that FN 
fibrillogenesis is. Additionally, it was reported that endothelial cell spreading on FG was 
affected by cell synthesized FN (Dejana et al, 1990). This finding was supported with the 
observation of a different pattern of integrin organisation during the interaction with 
substratum-bound soluble FNG (Tzoneva et al., 2002). 
It is known that the adhesion on endothelial cells to adsorbed FG is mediated by v3 
integrin (Cheresh et al, 1989). Indeed, the 3 integrin clusterizes in structures resembling 
focal adhesion contacts when endothelial cells adhere to FG-coated substrata. Conversely, 
on the dorsal cell surface FG fibrils were not co-localized with 3 integrin, representing a 
punctuate distribution, in contrast to 1 integrin, which showed a well-pronounced linear 
pattern of organisation. The absence of 1 integrin from the focal adhesion plaques is an 
indication that the FN receptor does not participate in endothelial cell adhesion to FG. 
Integrin 1, however, has clearly shown to be involved in FN fibril formation (Dejana et al, 
1990). The co-localisation of FN and FG fibrils was found on the dorsal cell surface of 
 
endothelial cells (Tzoneva et al., 2002). Also, the incorporation of FN fibrils into matrix 
fibrils starts from the distinct place at the cell periphery, near to the focal adhesions, 
suggesting the leading role of FN in this process. The existence of this joint fibrillogenesis, 
i.e. coassembly of FG and FN, found for endothelial cells have been reported also for 
epithelial cells (Guadiz et al., 1989) and fibroblasts (Pereira et al., 2002). Even collagen IV, 
which is a non-fibrillar protein could undergo fibril-like linear rearrangement along with FN 
as we recently show (Maneva-Radicheva et al., 2008), a fact that needs to be further 
elucidated.  
In the last decade many studies have been focused on the modifications of biomaterials 
surfaces with synthetic or natural ECM fragments to provoke an adequate recruitment of 
cells for in vivo tissue regeneration (Massia & Hubel, 1990; Werner et al., 2006; Ma et al., 
2007). However, when a foreign material is implanted in the body, it hampers the local 
organization of ECM and alters the biocompatibility of the implant, a process further 
complicated from the non-specific inflammatory response. A possible reason for the lack of 
adequate tissue response is attributed by many authors to the different dimensionality of the 
implant. Nowadays tissue engineering strives to replace the damaged tissues with natural 
or synthetic scaffolds designed to mimic the 3D organization and mechanical properties of 
ECM. Nevertheless, many of the bioengineered devices such as stents, prosthesis, 
membranes, metal implants, etc, simply can not avoid the 2D contact with cells. Therefore 
we argue, if this 3D architecture is always obligatory. When epithelial or endothelial cells 
reside on the basement membrane, they meet a rather flat environment, which they assess 
more as topography and as source of positional signals that guide their functionality. The 
basement membrane is actually a two dimensional structure, common to many types of 
tissues, providing underlinement for baso lateral cell attachment and functional polarization 
(Campbell & Teranova, 1988). Therefore, a future prospective for the development of 
biohybrid organs may require the construction of modules based on 2D permeable 
membranes colonized with cells that will mimic to a maximal extent the functional 
arrangement of basal membrane. On the other hand however, dimensionality of cell-
material interaction raises a number of obstacles that need to be solved. For example, the 
blood contacting devices such as small diameter vascular grafts, stents, synthetic heart 
valves and assist systems, have suffered from a common problem, the lack of significant 
endothelial cells in-growth and function. While endothelial cells procurement technologies 
for seeding implants have improved, adhering endothelial cells usually dedifferentiate and 
act in a counterproductive manner, very often accelerating device failure (Ludwig et al., 
2007).  Thus, it seems that endothelial cells do not meet an adequate environment, as on the 
natural basal membrane, but what they are actually missing remains unclear.  
 
4. Remodelling of the extracellular matrix 
Except organization, the ECM undergoes proteolytic degradation, which is a mechanism for 
the removal of the excess ECM usually approximated with remodelling. Remodelling of 
ECM occurs in various physiological and pathological processes, such as normal 
development, wound healing and angiogenesis, but also in atherosclerosis, fibrosis, 
ischemic injury and cancer. Thus, matrix remodelling is a subject of an extensive biomedical 
research, but how it relates to the biocompatibility of materials remains unclear. Upon 
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implantation, foreign materials often trigger an uncontrolled deposition of fibrous matrix 
that, difficult to be predicted, hampers the biocompatibility of the implant.  
In fact, ECM remodelling is a dynamic process which consists of two opposite events: 
assembly and degradation. These processes are mostly active during development and 
regeneration of tissues but, when miss-regulated, can contribute to diseases. Perturbing 
matrix remodelling, for example by preventing the turnover of collagen type I or altering the 
level of matrix-degrading proteases, has been shown to result in fibrosis, arthritis, reduced 
angiogenesis, and developmental abnormalities (Schofield, 1978; Wagenaar-Mller et al., 
2007; Heyman et al., 2006; Holmbeck et al., 1999). The invasive behaviour of cancer cells is 
also due to up-regulation of matrix remodelling (Reisenawer  et al., 2007; Carino  et al., 
2005). ECM organization in vivo is regulated by the 3D environment and the cellular tension 
that is transmitted through integrins (Hynes, 2002). It is difficult, however, to create such an 
environment on the biomaterials surface. Thus, identifying factors that control matrix 
deposition on the materials interface is an essential step for understanding the mechanisms 
involved in the pathological host response.  
The proteolytic remodelling of matrix proteins such as FN, VN and FG, as well as, collagens 
and laminins at the biomaterials interface has only recently received attention, although the 
pericellular proteolysis is extensively studied in various pathological conditions. The 
proteolytic cleavage of ECM components represents a main mechanism for ECM 
degradation and removal (Koblinski et al., 2000; Mohamed & Sloane 2006). Several families 
of proteases operate at the ECM level, including matrix metalloproteinases (MMPs), cysteine 
proteases and serine proteases. Proteolysis may also regulate the ECM assembly, editing the 
excess ECM components. During enzymatic remodelling of ECM structures, bioactive 
fragments and growth factors can be released that will affect cell growth, morphogenesis, 
tissue repair, and also various pathological processes. The major enzymes that degrade ECM 
and cell surface associated proteins are MMPs, a family of secreted and membrane bound 
proteinases. The role of MMPs in both development and diseases has been recently 
extensively studied and reviewed because is tightly linked with the mechanisms for tumour 
invasion and metastasis (Page-McCaw et al., 2007). MMPs are family (20 members) of zinc 
dependent endopeptidases, which together with adamalysin-related membrane proteinases 
that contain disintegrin and metalloproteinase domains (ADAMs or MDCs), such as 
thrombin, tissue plasminogen activator (tPA), urokinase (uPA) and plasmin are involved in 
the degradation of ECM proteins. MMPs are either secreted or anchored to the cell 
membrane by a transmembrane domain or by their ability to bind directly uPAR and 
integrin v3 (Buck et al., 1982). 
In fact, the basement membrane is the most altered structure during remodelling and it 
depends particularly on the degradation of type IV collagen that is a primary structural 
component of basement membrane, integrating laminin and nidogen into a microscopically 
visible two-dimensional network. Assembly of the basement membrane, a strongly 
specialized form of ECM that underlies epithelial and endothelial cells, but is also in contact 
with many other cell types, is initiated by laminin. It self-assembles into heterotrimers that 
bind to the cell surface integrin receptors. The network-forming collagen type IV is the next 
main component of the basement membrane, however the mechanism of its assembly 
remains unclear. It is widely accepted that collagen IV also self-assembles into a meshwork 
by antiparallel interactions and extensive disulfide bounding of four molecules to form 7S 
domains. The lateral interactions between C-terminal globular domains create an irregular 
 
two-dimensional meshwork that is actually the main constructive element of the basement 
membrane. Observations have been made however, that collagen IV may be linearly 
organized during early basement membrane assembly (Fleischmajer et al., 1998) suggesting 
another type of cell-dependent arrangement. While the molecular mechanisms which 
endow the spatial distribution and organization of collagen IV in basement membrane are 
still debatable, our recent results (Maneva-Radicheva et al., 2008) surprisingly suggest that 
material surface-associated collagen IV also undergo cell dependent rearrangement through 
reversible association with FN fibrils. It is obvious that ECM remodelling is poorly 
understood at the biomaterials level.  
 
5. Substrate engineering 
Different model substrates have been prepared in the recent years aiming to learn more 
about cell-material interaction, especially in what cell adhesion is concerned. These works 
are mainly focused on the effect of material properties on the biological performance of the 
substrate and, only a few of them, investigate this effect by addressing first protein 
adsorption and conformation on the material surface and then by correlating this 
phenomenon with cell behavior. Despite the belief that the issue of cell-protein-material 
interaction is critical to the engineering of new biomaterials, clear links between the 
material, the adsorbed protein layer and their influence on the cell remain far from being 
understood; in particular the behaviour of surface associated matrix proteins is generally 
missing.   Even if the cell material interaction is not a direct one, but it is mediated by ECM 
proteins previously adsorbed on the substrate’s surface, it is said that cells response to three 
different kinds of surface parameters: chemical, topographical and mechanical. The 
influence of surface chemistry on protein adsorption and cell adhesion has been addressed 
mostly on surfaces with well controlled chemistry, in order to investigate the role of 
concrete chemical groups in self-assembly monolayers SAM (e.g. OH, COOH, NH2, CH3 and 
their mixtures) (Keselowsky et al., 2003; Keselowsky et al., 2004; Faucheux et al.; 2004; Lee et 
al., 2006; Barrias  et al., 2009). Studies on fibronectin (FN) and vitronectin (VN) adsorption 
under non-competitive and competitive (multi-protein solutions, including FBS) conditions 
suggested the major role of VN in cell-materials interaction. Different chemistries in SAM 
substrates were shown to modulate the structure and composition of focal adhesion 
complexes and fibrillar adhesions, closely linked to the capacity of cells to polymerise FN 
into fibrils (Keselowsky et al., 2004; Faucheux et al.; 2004). Other attempts to correlate 
surface chemistry with protein adsorption and cell adhesion were done by preparing 
substrates based on copolymers, that allow to modulate the material properties (wettability, 
hydrophilicity, substratum charge, topography, etc.) within the same chemical family (Allen 
et al., 2006). The response of cells to different material chemistries is a complex process and 
even minute changes in composition of the substrate produce amplified differences in cell 
responses (Bae et al., 2006). Plasma surface modifications have allowed to introduce 
different chemical groups in order to improve cell adhesion and study the effect on the ECM 
proteins conformation as well as focal adhesion formation (Silva et al., 2008; van Kooten et 
al., 2004; Pompe et al., 2007) and it is a versatile technique that allows one to produce 
chemical gradients in the same substrate so that the response to a large range of different 
chemistries on a single sample can be investigated as well as the effect not only of surface 
properties but their variations (Zelzer et al., 2008). It has been argued that sequence of 
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implantation, foreign materials often trigger an uncontrolled deposition of fibrous matrix 
that, difficult to be predicted, hampers the biocompatibility of the implant.  
In fact, ECM remodelling is a dynamic process which consists of two opposite events: 
assembly and degradation. These processes are mostly active during development and 
regeneration of tissues but, when miss-regulated, can contribute to diseases. Perturbing 
matrix remodelling, for example by preventing the turnover of collagen type I or altering the 
level of matrix-degrading proteases, has been shown to result in fibrosis, arthritis, reduced 
angiogenesis, and developmental abnormalities (Schofield, 1978; Wagenaar-Mller et al., 
2007; Heyman et al., 2006; Holmbeck et al., 1999). The invasive behaviour of cancer cells is 
also due to up-regulation of matrix remodelling (Reisenawer  et al., 2007; Carino  et al., 
2005). ECM organization in vivo is regulated by the 3D environment and the cellular tension 
that is transmitted through integrins (Hynes, 2002). It is difficult, however, to create such an 
environment on the biomaterials surface. Thus, identifying factors that control matrix 
deposition on the materials interface is an essential step for understanding the mechanisms 
involved in the pathological host response.  
The proteolytic remodelling of matrix proteins such as FN, VN and FG, as well as, collagens 
and laminins at the biomaterials interface has only recently received attention, although the 
pericellular proteolysis is extensively studied in various pathological conditions. The 
proteolytic cleavage of ECM components represents a main mechanism for ECM 
degradation and removal (Koblinski et al., 2000; Mohamed & Sloane 2006). Several families 
of proteases operate at the ECM level, including matrix metalloproteinases (MMPs), cysteine 
proteases and serine proteases. Proteolysis may also regulate the ECM assembly, editing the 
excess ECM components. During enzymatic remodelling of ECM structures, bioactive 
fragments and growth factors can be released that will affect cell growth, morphogenesis, 
tissue repair, and also various pathological processes. The major enzymes that degrade ECM 
and cell surface associated proteins are MMPs, a family of secreted and membrane bound 
proteinases. The role of MMPs in both development and diseases has been recently 
extensively studied and reviewed because is tightly linked with the mechanisms for tumour 
invasion and metastasis (Page-McCaw et al., 2007). MMPs are family (20 members) of zinc 
dependent endopeptidases, which together with adamalysin-related membrane proteinases 
that contain disintegrin and metalloproteinase domains (ADAMs or MDCs), such as 
thrombin, tissue plasminogen activator (tPA), urokinase (uPA) and plasmin are involved in 
the degradation of ECM proteins. MMPs are either secreted or anchored to the cell 
membrane by a transmembrane domain or by their ability to bind directly uPAR and 
integrin v3 (Buck et al., 1982). 
In fact, the basement membrane is the most altered structure during remodelling and it 
depends particularly on the degradation of type IV collagen that is a primary structural 
component of basement membrane, integrating laminin and nidogen into a microscopically 
visible two-dimensional network. Assembly of the basement membrane, a strongly 
specialized form of ECM that underlies epithelial and endothelial cells, but is also in contact 
with many other cell types, is initiated by laminin. It self-assembles into heterotrimers that 
bind to the cell surface integrin receptors. The network-forming collagen type IV is the next 
main component of the basement membrane, however the mechanism of its assembly 
remains unclear. It is widely accepted that collagen IV also self-assembles into a meshwork 
by antiparallel interactions and extensive disulfide bounding of four molecules to form 7S 
domains. The lateral interactions between C-terminal globular domains create an irregular 
 
two-dimensional meshwork that is actually the main constructive element of the basement 
membrane. Observations have been made however, that collagen IV may be linearly 
organized during early basement membrane assembly (Fleischmajer et al., 1998) suggesting 
another type of cell-dependent arrangement. While the molecular mechanisms which 
endow the spatial distribution and organization of collagen IV in basement membrane are 
still debatable, our recent results (Maneva-Radicheva et al., 2008) surprisingly suggest that 
material surface-associated collagen IV also undergo cell dependent rearrangement through 
reversible association with FN fibrils. It is obvious that ECM remodelling is poorly 
understood at the biomaterials level.  
 
5. Substrate engineering 
Different model substrates have been prepared in the recent years aiming to learn more 
about cell-material interaction, especially in what cell adhesion is concerned. These works 
are mainly focused on the effect of material properties on the biological performance of the 
substrate and, only a few of them, investigate this effect by addressing first protein 
adsorption and conformation on the material surface and then by correlating this 
phenomenon with cell behavior. Despite the belief that the issue of cell-protein-material 
interaction is critical to the engineering of new biomaterials, clear links between the 
material, the adsorbed protein layer and their influence on the cell remain far from being 
understood; in particular the behaviour of surface associated matrix proteins is generally 
missing.   Even if the cell material interaction is not a direct one, but it is mediated by ECM 
proteins previously adsorbed on the substrate’s surface, it is said that cells response to three 
different kinds of surface parameters: chemical, topographical and mechanical. The 
influence of surface chemistry on protein adsorption and cell adhesion has been addressed 
mostly on surfaces with well controlled chemistry, in order to investigate the role of 
concrete chemical groups in self-assembly monolayers SAM (e.g. OH, COOH, NH2, CH3 and 
their mixtures) (Keselowsky et al., 2003; Keselowsky et al., 2004; Faucheux et al.; 2004; Lee et 
al., 2006; Barrias  et al., 2009). Studies on fibronectin (FN) and vitronectin (VN) adsorption 
under non-competitive and competitive (multi-protein solutions, including FBS) conditions 
suggested the major role of VN in cell-materials interaction. Different chemistries in SAM 
substrates were shown to modulate the structure and composition of focal adhesion 
complexes and fibrillar adhesions, closely linked to the capacity of cells to polymerise FN 
into fibrils (Keselowsky et al., 2004; Faucheux et al.; 2004). Other attempts to correlate 
surface chemistry with protein adsorption and cell adhesion were done by preparing 
substrates based on copolymers, that allow to modulate the material properties (wettability, 
hydrophilicity, substratum charge, topography, etc.) within the same chemical family (Allen 
et al., 2006). The response of cells to different material chemistries is a complex process and 
even minute changes in composition of the substrate produce amplified differences in cell 
responses (Bae et al., 2006). Plasma surface modifications have allowed to introduce 
different chemical groups in order to improve cell adhesion and study the effect on the ECM 
proteins conformation as well as focal adhesion formation (Silva et al., 2008; van Kooten et 
al., 2004; Pompe et al., 2007) and it is a versatile technique that allows one to produce 
chemical gradients in the same substrate so that the response to a large range of different 
chemistries on a single sample can be investigated as well as the effect not only of surface 
properties but their variations (Zelzer et al., 2008). It has been argued that sequence of 
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events –contact, attachment, spreading and proliferation- is similar among different surfaces 
but with very different dynamics, leading in the case of poorly compatible surfaces to long 
induction periods in which cells are in a life-or-death struggle to improve the pericellular 
environment by excretion of matrix proteins (Liu et al., 2007). 
Surface topography is also a key parameter that is able to modify cell response 
independently of the chemical composition of the substrate. Even though sometimes 
topography is only a manifestation of material chemistry, it can be modulated in an 
independent way. The effect of topography on cell adhesion has been widely studied. 
Different microtopograhies can promote changes in cell adhesion pattern, cell orientation 
and cell shape on the substrate (Anselme et al., 2000). Cells cultured on smooth surfaces 
tend to generate a more organized ECM, with a more homogeneous distribution of focal 
adhesions. However, on rougher surfaces, focal adhesions are located at cell edges, where 
the contact with the substrate takes place (Brunette, 1986). Micro and nano patterned 
surfaces have been prepared for a better understanding of the cell response to topographic 
features, mainly in what cell adhesion is concerned. Anisotropic surfaces prepared by 
lithographic and microfabrication techniques can induce cell reorientation following 
microgrooves, the so-called contact guidance phenomenon (Ohara & Buck, 1979; Lim, 2007); 
and the scale of anisotropic topography plays an important role in deciding cell alignment 
(Affrossman et al., 2000). Different techniques have been used to produce controlled 
isotropic topographies at different scales which include photolithography, electron beam 
lithography, colloidal lithography, polymer solvent demixing techniques during a high 
speed spin-casting process (Denis et al., 2002; View et al., 2000; Kriparamanan  et al., 2006; 
Dalby et al., 2004). Polymer solvent demixing techniques make use of phase separation 
during a high speed spin-casting process. This technique allows obtaining nanotopographic 
motifs in a broad range (from 9 to 100 nm); however the effect of nanotopography on cell 
response remains an open question. It seems that the interval 10-30 nm gives rise to better 
adhesion and higher stimulation of intracellular signaling than going up to 100 nm (Lim  et 
al., 2008; Dalby et al., 2008; Zinger  et al., 2005). Cell differentiation and gene expression 
have also been described to be influenced by surface topography (Dalby et al., 2007; Dalby et 
al., 2006; Pirouz-Dolatshahi et al., 2008). The effect of surface nanotopography on cell 
behavior should be a consequence of different protein adsorption patterns. Scarce 
experimental data exist on the effect of surface nanotopography on protein adsorption but it 
seems that nanotopography is able to enhance protein adsorption as compared to the same 
plane chemistry (Khor et al., 2007). Nevertheless, the effect of surface nanotopography on 
matrix remodelling has not been investigated in the literature and only some qualitative 
effect has been recently shown (Costa Martínez et al., 2008; Pegueroles et al., 2009). We have 
developed the technology to prepare different microtopographies with tailored surface 
chemistry which lead to different cell function as a consequence of the extracellular matrix 
organisation at the cell-material interface (González-García et al., 2009; Pelham & Wang, 
1997). 
Mechanical properties of the substrate play also an important role in cell response 
regardless surface chemistry and topography but it is not completely understood. Cell 
behaviour depends sensitively on the rigidity of the extracellular matrix. When cells are 
cultured on classic (rigid) polystyrene dishes, they develop micron-sized focal adhesions 
connected by actin fibers. However, these structures are gradually lost as cells are cultured 
on softer substrates, as prepared for example by changing the crosslinking density of gels 
 
and, more recently, polyelectrolyte multilayers (Ryan et al., 2001). Cell spreading and 
motility are higher in stiff substrates than soft ones, what favours cell-cell interaction 
compared to the cell-material one and leads to more organised cell aggregates (Wong et al., 
2003). Cell proliferation increases on stiff surfaces and, in the case of a rigidity gradient on 
the substrate, cells migrate to stiffer regions (Lo et al., 2000; Bischofs et al., 2003; Pegueroles 
et al., 2009). This kind of cell behaviour has been found for different cells types (fibroblasts, 
muscular VSMC cells, chondrocytes and neurons) independently of the protein coating of 
the substrate (fibronectin, collagen, etc). It is thought that cells are able to react to 
substratum rigidity by means of a real tactile exploration, by contractile forces and 
interpreting the substrate deformation. Because the stiffness of the environment is a passive 
quantity, it has to be actively sensed by the cell by contracting it and measuring some kind 
of mechanical response (Schwarz, 2007; Shin, 2008). The relationship between the 
mechanical properties of the matrix and the activity of cells must lead to the maintenance of 
a functional mechanical state. The effect of substrate stiffness on the dynamic behaviour of 
surface associated matrix proteins is generally missing, i.e. is protein conformation 
determined by substrate stiffness? What is the role of the strength of interaction between the 
protein layer and the substrate on matrix remodelling as a function of the stiffness of the 
underlying substrate? Recent studies have indicated that the cells not only detect the 
roughness, chemistry, or stiffness of the substrates, but can also detect dimensionality 
(Hollister, 2005). For example, pore sizes of engineered trabecular bone depend on the initial 
scaffold geometry. Because it is clear that the ECM can affect cell fate and differentiation, 
tissue engineering is looking toward cells and the developmental biology for guidance in the 
design of scaffolds (Wnek, 2003).  
 
6. Conclusions and future trends 
Understanding the cell-protein-material interaction is fundamental for developing more 
powerful tools in tissue engineering and regenerative medicine strategies. The design of 
model substrates including the presence of well defined properties (chemistry, topography, 
stiffness) and even the gradient of these properties in three dimensional environments must 
lead in the near future to learn more about the specific roles of protein adsorption and the 
very dynamic process related to the cell fate of synthetic substrates: cell adhesion, matrix 
reorganisation, deposition and degradation at the cell-material interface. 
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events –contact, attachment, spreading and proliferation- is similar among different surfaces 
but with very different dynamics, leading in the case of poorly compatible surfaces to long 
induction periods in which cells are in a life-or-death struggle to improve the pericellular 
environment by excretion of matrix proteins (Liu et al., 2007). 
Surface topography is also a key parameter that is able to modify cell response 
independently of the chemical composition of the substrate. Even though sometimes 
topography is only a manifestation of material chemistry, it can be modulated in an 
independent way. The effect of topography on cell adhesion has been widely studied. 
Different microtopograhies can promote changes in cell adhesion pattern, cell orientation 
and cell shape on the substrate (Anselme et al., 2000). Cells cultured on smooth surfaces 
tend to generate a more organized ECM, with a more homogeneous distribution of focal 
adhesions. However, on rougher surfaces, focal adhesions are located at cell edges, where 
the contact with the substrate takes place (Brunette, 1986). Micro and nano patterned 
surfaces have been prepared for a better understanding of the cell response to topographic 
features, mainly in what cell adhesion is concerned. Anisotropic surfaces prepared by 
lithographic and microfabrication techniques can induce cell reorientation following 
microgrooves, the so-called contact guidance phenomenon (Ohara & Buck, 1979; Lim, 2007); 
and the scale of anisotropic topography plays an important role in deciding cell alignment 
(Affrossman et al., 2000). Different techniques have been used to produce controlled 
isotropic topographies at different scales which include photolithography, electron beam 
lithography, colloidal lithography, polymer solvent demixing techniques during a high 
speed spin-casting process (Denis et al., 2002; View et al., 2000; Kriparamanan  et al., 2006; 
Dalby et al., 2004). Polymer solvent demixing techniques make use of phase separation 
during a high speed spin-casting process. This technique allows obtaining nanotopographic 
motifs in a broad range (from 9 to 100 nm); however the effect of nanotopography on cell 
response remains an open question. It seems that the interval 10-30 nm gives rise to better 
adhesion and higher stimulation of intracellular signaling than going up to 100 nm (Lim  et 
al., 2008; Dalby et al., 2008; Zinger  et al., 2005). Cell differentiation and gene expression 
have also been described to be influenced by surface topography (Dalby et al., 2007; Dalby et 
al., 2006; Pirouz-Dolatshahi et al., 2008). The effect of surface nanotopography on cell 
behavior should be a consequence of different protein adsorption patterns. Scarce 
experimental data exist on the effect of surface nanotopography on protein adsorption but it 
seems that nanotopography is able to enhance protein adsorption as compared to the same 
plane chemistry (Khor et al., 2007). Nevertheless, the effect of surface nanotopography on 
matrix remodelling has not been investigated in the literature and only some qualitative 
effect has been recently shown (Costa Martínez et al., 2008; Pegueroles et al., 2009). We have 
developed the technology to prepare different microtopographies with tailored surface 
chemistry which lead to different cell function as a consequence of the extracellular matrix 
organisation at the cell-material interface (González-García et al., 2009; Pelham & Wang, 
1997). 
Mechanical properties of the substrate play also an important role in cell response 
regardless surface chemistry and topography but it is not completely understood. Cell 
behaviour depends sensitively on the rigidity of the extracellular matrix. When cells are 
cultured on classic (rigid) polystyrene dishes, they develop micron-sized focal adhesions 
connected by actin fibers. However, these structures are gradually lost as cells are cultured 
on softer substrates, as prepared for example by changing the crosslinking density of gels 
 
and, more recently, polyelectrolyte multilayers (Ryan et al., 2001). Cell spreading and 
motility are higher in stiff substrates than soft ones, what favours cell-cell interaction 
compared to the cell-material one and leads to more organised cell aggregates (Wong et al., 
2003). Cell proliferation increases on stiff surfaces and, in the case of a rigidity gradient on 
the substrate, cells migrate to stiffer regions (Lo et al., 2000; Bischofs et al., 2003; Pegueroles 
et al., 2009). This kind of cell behaviour has been found for different cells types (fibroblasts, 
muscular VSMC cells, chondrocytes and neurons) independently of the protein coating of 
the substrate (fibronectin, collagen, etc). It is thought that cells are able to react to 
substratum rigidity by means of a real tactile exploration, by contractile forces and 
interpreting the substrate deformation. Because the stiffness of the environment is a passive 
quantity, it has to be actively sensed by the cell by contracting it and measuring some kind 
of mechanical response (Schwarz, 2007; Shin, 2008). The relationship between the 
mechanical properties of the matrix and the activity of cells must lead to the maintenance of 
a functional mechanical state. The effect of substrate stiffness on the dynamic behaviour of 
surface associated matrix proteins is generally missing, i.e. is protein conformation 
determined by substrate stiffness? What is the role of the strength of interaction between the 
protein layer and the substrate on matrix remodelling as a function of the stiffness of the 
underlying substrate? Recent studies have indicated that the cells not only detect the 
roughness, chemistry, or stiffness of the substrates, but can also detect dimensionality 
(Hollister, 2005). For example, pore sizes of engineered trabecular bone depend on the initial 
scaffold geometry. Because it is clear that the ECM can affect cell fate and differentiation, 
tissue engineering is looking toward cells and the developmental biology for guidance in the 
design of scaffolds (Wnek, 2003).  
 
6. Conclusions and future trends 
Understanding the cell-protein-material interaction is fundamental for developing more 
powerful tools in tissue engineering and regenerative medicine strategies. The design of 
model substrates including the presence of well defined properties (chemistry, topography, 
stiffness) and even the gradient of these properties in three dimensional environments must 
lead in the near future to learn more about the specific roles of protein adsorption and the 
very dynamic process related to the cell fate of synthetic substrates: cell adhesion, matrix 
reorganisation, deposition and degradation at the cell-material interface. 
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1. Introduction  
Tissue engineering, a relatively new field, combines a multitude of separate disciplines: 
clinical medicine, cell biology, engineering, materials science, biochemistry and also 
biophysics. With such a diverse pool of research backgrounds, tissue engineers seek a 
common goal: to replace or repair part of or whole tissues and organs, with functional man-
made tissue constructs.  
To date, there have been attempts to tissue-engineer bone, cartilage, liver and various other 
tissues and organs. The more successful tissue engineered constructs have been simpler 
tissues such as artificial skin, bladder and recently, tissue engineered airway (Macchiarini et. 
al. 2008). As tissue complexity increases, achieving fully functional tissue constructs 
becomes exponentially more difficult.   
Conventional tissue-engineering strategies can be broadly classified into cell-free and cell-
based therapies. Both strategies typically utilize scaffolds, with or without cells, and 
typically provide biologically active molecules to enhance integration into the body. 
Scaffolds serve many purposes: mechanical support, cell migration and attachment, cell 
retention and delivery at the site of repair, and even sequester biochemical factors and/or 
genes, while allowing for diffusion of nutrients from the host tissue into the construct. 
Essentially, an ideal scaffold will act as a man-made emulation of the natural extracellular 
matrix found (ubiquitously) in the body.  
Scaffold materials come in many different forms, from synthetic to nature-derived materials, 
each with a set of properties defining their intrinsic advantages and limitations for 
application. Polymer scaffold materials have been a mainstay of tissue-engineered 
constructs, however there has been an increasing awareness of the advantages of 
biomimicry or nature-derived scaffolds often fabricated from native and denatured 
“collagen”, fibrin, chitosan and glycosaminoglycans. These scaffolds are more 
biocompatible but remain simplified copies of the complex extracellular milieu in living 
tissue.  
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The extracellular matrix is a complex supramolecular assembly of a variety of glycoproteins 
and proteoglycans. Extracellular matrix provides tissue integrity, acts as a native scaffold for 
cell attachment and interaction and also serves as a reservoir for growth factors. For most 
connective tissues, collagen makes up the bulk of the extracellular matrix. Collagen 
functions in the extracellular matrix as a structural protein as well as a binding partner for 
ligands that store growth factors. The term collagen encompasses a family of glycoproteins 
characterised by a particular amino acid signature and triplehelicity. The most abundant 
collagens are type I, found in skin, tendon and capsules, type IV, found in all basement 
membranes, and type VII, which is specific for the basement membrane of skin, oral mucosa 
and cornea. Depending on their tissue location and function, collagen assemblies in the 
extracellular matrix are often heterotypic. For example, collagen fibers in the dermis 
represent an alloy of types I, III and V, while cartilage matrix contains types II, IX, and XI 
(Kielty & Grant, 2002). Depending on the wear and tear of a given tissue, extracellular 
matrix continuously undergoes remodeling and replacement.  
Tissue engineers have long underestimated the capacity of cells to manufacture their own 
extracellular matrix. We show in the following text, ways to control and augment this 
cellular capacity to create a well-developed extracellular matrix that can provide cellular 
cohesion and tissue strength. This cellular ability is an important quality required for 
downstream applications of tissue engineering. Enhancing the deposition of collagen in 
tissue-engineered constructs will aid in the maturity of the tissue construct in vitro prior to 
clinical application as well as provide a functional model for the study of fibrogenic 
processes for therapeutic purposes. 
 
2. Application of Macromolecular Crowding (MMC) in Enhancing Matrix 
Deposition  
2.1 In vitro collagen matrix formation (deposition) is tardy 
The typical signature of a collagen molecule is its quaternary structure – the triplehelix. It is 
a trimer of -chains that is assembled intracellulary (Kielty & Grant, 2002) and secreted by 
fibrogenic cells into the extracellular space as soluble procollagen. Taking procollagen type I 
as the most abundant representative, one can envision the polypeptide as a dumbbell-
shaped molecule with a central triple helical region of rod-like stiffness and globular 
propeptide at either end.  Once in the extracellular space, both propeptides of procollagen 
are cleaved off by procollagen N-proteinase and procollagen C-proteinase respectively. The 
resulting collagen molecules will then self-assemble in vivo at pH 7-7.4 into quarter-
staggered arrays, thus initiating fibrillogenesis (Kielty & Grant, 2002).  
When adequately provided with ascorbic acid (AcA), fibrogenic cells secrete substantial 
amounts of procollagen (Murad et. al., 1981). However, the enzymatic conversion of 
procollagen to collagen is extremely tardy under contemporary aqueous cell culture 
conditions, a fact that is not widely known. Consequently, only small amounts of an 
insoluble collagen matrix are formed, while most of the (water soluble) procollagen is lost 
during culture medium change and in bioreactor outflows (Lareu et. al., 2007a, b).  
 
 
2.2 In vitro collagen biosynthesis is enhanced by MMC – effects of negatively charged 
crowders 
We have found that the addition of negatively-charged macromolecules for two days during 
the culture of fibroblasts reduces procollagen content in the culture medium and enhances 
the amount of (processed) collagen molecules deposited at the cell layer.  
Fibroblasts were first grown in culture medium with or without AcA and macromolecules. 
The procollagen in the culture medium and the collagen found in the adherent cell layer 
were isolated by pepsin and quantified by sodium dodecyl sulfate polyacrylamide gel 
electrophoresis and densitometry as described by Lareu et. al. 2007a, b. Fibroblasts that were 
not treated with AcA secreted little procollagen into the culture medium and therefore 
showed no appreciable deposition of collagen deposited into the matrix.1 Under AcA 
supplementation the amount of procollagen secreted into the culture medium was 
substantially increased. However, there was little insoluble collagen at the adherent cell 
layer. However, with the addition of 100µg/ml of 500kDa dextran sulfate (DxS) for two 
days, the presence of procollagen in the medium was much reduced, while the amount of 
collagen associated with the cell layer was dramatically increased (Fig. 1.).  
 
 
Fig. 1. Addition of 100µg/ml of 500kDa DxS resulted in the reduction of procollagen in the 
culture medium and the increase of insoluble collagen at the fibroblast cell layer. Note the 
predominance of collagen V in the non-crowded cell layer. Reprinted from Lareu et. al., 
2007a, with permission from the publisher, Mary Ann Liebert 
 
DxS concentrations ranging from 10µg/ml to 500µg/ml were applied to fibroblast cultures. 
It was observed that collagen bands from cell layer samples became more intense with an 
                                                                 
1 AcA is an essential cofactor for prolyl-4-hydroxylase, an enzyme that catalyses a crucial 
posttranslational modification to the -chains resulting in thermal stability (at body 
temperature) of the folded procollagen triplehelix in the endoplasmic reticulum. In the 
absence of AcA, prolyl residues of individual -chains are not sufficiently hydroxylated of 
form a thermostable triplehelix that can be secreted. (Murad et. al., 1981). Therefore, the 
omission of ascorbate causes the equivalent of scurvy in culture. Similar to the clinical 
condition, this can be remedied easily.  
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1 AcA is an essential cofactor for prolyl-4-hydroxylase, an enzyme that catalyses a crucial 
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temperature) of the folded procollagen triplehelix in the endoplasmic reticulum. In the 
absence of AcA, prolyl residues of individual -chains are not sufficiently hydroxylated of 
form a thermostable triplehelix that can be secreted. (Murad et. al., 1981). Therefore, the 
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increasing concentration of DxS up to 100µg/ml (Fig. 2.). At 500µg/ml, the intensity of 
collagen bands decreased sharply and, hence, we concluded that the optimum concentration 
for crowding with DxS was 50-100µg/ml.  
 
Fig. 2. Collagen deposition was enhanced with increasing concentration of DxS up to 
100µg/ml. At 500µg/ml, collagen deposition decreased sharply. The optimum concentration 
of DxS was determined to be 50-100µg/ml. Reprinted from Lareu et. al., 2007a, with 
permission from the publisher, Mary Ann Liebert 
 
We also found a marked increase of collagen deposition with 200kDa polysodium-4-styrene 
sulfonate (PSS), a negatively-charged macromolecule, at a final concentration of  100µg/ml 
culture medium in fibroblast cultures for two days. Collagen in the adherent cell layer was 
again isolated by pepsin digestion and analyzed by sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis. Densitometric analysis of collagen 1(I) and 2(I) bands (Fig. 3A) 
revealed that the addition of DxS increased collagen deposition by >20-fold, and the 
addition of PSS increased collagen deposition by >35-fold (Fig. 3B). We have also tested the 
efficacy of other macromolecules in increasing collagen deposition.. These macromolecules, 
50mg/ml of 400kDa Ficoll (Fc 400), 50mg/ml of 70kda Ficoll (Fc 70) and 100µg/ml of 10kDa 
DxS (DxS 10), did not induce a significant increase in collagen deposition at the cell layer in 
the time window of 2 days (Fig. 3A.)  
 
Fig. 3. 100µg/ml of DxS increased collagen deposition by >20-fold. 100µg/ml of PSS was 
also shown to induce an increase in collagen deposition by >35-fold. Reprinted from Lareu 
et. al., 2007b, with permission from the publisher, Elsevier 
 
 
2.3 MMC via negatively charged macromolecules results in a granular collagen 
deposition 
Immunocytochemical analyses of fibroblast cultures treated with DxS or PSS corroborated 
the SDS-PAGE results. There were significantly stronger signals of collagen immunostaining 
in these fibroblast cultures compared to the uncrowded control (Fig. 4A.). With regard to the 
deposition pattern, we noted that the collagen aggregated in a granular form, co-localized 
with fibronectin staining, whereas the minimal collagen deposited in the uncrowded control 
was reflected by weakly stained wispy strands. 
Transmission electron microscopy revealed that these aggregates produced under DxS 
crowding contained cross-striated collagen nanofibers surrounded by a three dimensional 
arrangement of other matrix components (Fig 4B.) We therefore address these aggregates as 
“microgels”.  
 
 
Fig. 4. Morphological analysis of fibroblast cultures in the absence and presence of DxS. (A) 
Double immunfluorescence staining for collagen and fibronectin reveals granular 
morphology for DxS-crowded and PSS-crowded fibroblast cell layers. The uncrowded 
control showed wispy strands of collagen and fibronectin. All magnifications at 10X, scale 
bar100µm; (B) Transmission electron micrograph of the pericellular matrix in the absence 
and presence of DxS. Arrows indicate typical collagen fibrillar formation in the presence of 
DxS. In the presence of DxS, fibroblast cell layer samples showed cross-striated collagen 
nanofibers, which were absent in non-crowded fibroblast cultures. Fig. 4B was reprinted 
from Lareu et. al., 2007b, with permission from the publisher, Elsevier 
 
2.4 In vitro collagen biosynthesis is enhanced by MMC – effects of neutral crowders 
Although we initially found that Fc 400 and Fc 70 as monocrowders were unable to enhance 
collagen production significantly in two days, we discovered that a combination of Fc 400 
and Fc 70 added as a cocktail to the fibroblast cultures increased collagen deposition >10-
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fold in six days compared to non-crowded controls (Fig. 5A and 5B). Fc 400 and Fc 70 were 
used at concentrations of 25mg/ml and 37.5mg/ml, respectively.  
However, we noted with interest that under this cocktail, collagen matrices started out in a 
granular pattern (not shown) but transformed into a reticular pattern reminiscent of the 
pattern seen with fibronectin staining in the uncrowded controls. This observation is in 
keeping with the notion that fibronectin serves as a primordial template for collagen 
deposition (Sottile et. al., 2007). Staining of collagen in Fc-supplemented fibroblast cultures 
was much stronger in comparison to non-crowded controls. In accordance to earlier 
observations (see section 2.3), collagen deposits induced by DxS and PSS supplementation 
showed a coarse granular appearance also after six days (Fig. 5C).  
 
 
Fig. 5. Application of a mixture of neutral macromolecules Fc 400 and Fc 70 to fibroblast 
culture medium is also able to increase collagen deposition over the course of 6 days, 
resulting in a reticular network of collagen deposition rather than the granular collagen 
deposition observed with negatively charged crowders 
 
2.5 How MMC works - enhancing key enzymatic activities in collagen matrix formation 
MMC is a biophysical principle in which inert macromolecules in solution occupy a 
significant volume of the medium and hence impact on biochemical reactions both in vivo 
and in vitro (Minton, 2001). This principle is highly conserved throughout evolution for the 
interior of cells and the extracellulular environment in multicellular organisms (Zimmerman 
& Minton, 1993). The density or crowdedness of macromolecules is best determined first by 
approximation as solute content. To date, the concentrations of macromolecules in the 
interior of cells have been determined in a range from 50 to 400mg/ml (Minton, 2001). This 
concentration refers to the cumulative concentration of all species of macromolecules 
present, rather than the concentration of any single macromolecule. The presence of these 
macromolecules means that they must significantly occupy space in the given medium, and 
biophysicists refer to such medium as “crowded” or “confining”(Minton, 2001).  
In order to illustrate the principle of MMC, picture a simplified scenario where 
macromolecules (blue) are confined in a given amount of space (box) (Fig. 6.). When a 
 
reactant molecule (red) of a similar size is introduced to such a system, the presence of these 
macromolecules limit the space available (white area) to the reactant molecule. It is obvious 
that the limitation is due to the fact that no two molecules can overlap in the given space. 
Additionally, the limitation is also due to the dead space (black area) in between 
macromolecules that the reactant molecule is unable to pass through. Hence the excluded 
volume is the sum of the occupied space and the dead (or unavailable) space. In such a 
scenario, there are two consequences on the reactant molecule. Firstly, the reduction in 
volume will increase the effective concentration of the reactant molecule, and hence the 
thermodynamic activity of the reactant. Secondly, the diffusion rate and correspondingly 
the rate of encounter of a reactant molecule with another is also reduced (Chebotareva et. 
al., 2004).  The first consequence will manifest in reactions where the stability of the 
transition state is limiting, resulting in increased reaction rates. On the other hand, the 
second consequence will manifest in reactions where the encounter rates are limiting, 
resulting in decreased reaction rates (Ellis, 2001). 
 
 
Fig. 6. Macromolecules (blue) limit the space available (white) for the reactant molecule 
(red) by occupying space and creating dead space (black) in between macromolecules. Both 
crowder volume and dead space volume contribute to the excluded volume available for the 
reactant molecule 
 
In addition to the molecular size and shape attributes of a macromolecule, the hydration 
shells around such crowders also contribute to the total volume of exclusion as they are in 
an aqueous solvent. In addition, the surface charge on many of the ionic crowders, imparts 
an electrostatic contribution to this steric exclusion, as a result of like-charge repulsion, thus 
amplifying the steric exclusion effects. 
Finally, the most effective increase in thermodynamic activities is exerted by like-sized 
molecules on each other (Ellis, 2001). If the reactant molecule is much larger or much smaller 
than the macromolecule, the effect is less significant. 
In contrast to living systems, typical in vitro methods involving all kinds of settings (tube, 
cuvette, ELISA plate, cell culture dish) are done in aqueous solutions with concentrations of 
macromolecules ranging from 1 to 10 mg/ml (Ellis, 2001). Fibroblasts and other cells are 
typically cultured on plain or thinly coated tissue culture plastic, bathed in large volumes of 
non-crowded aqueous medium. This situation is far from physiological. In the body, 
extracellular space comprises of dense arrays of extracellular matrix macromolecules. Even 
blood plasma shows solute concentrations of around 80mg/ml (Ellis, 2001). In contrast, 
typical cell cultures employ supplements of 5%-20% fetal bovine serum resulting in solute 
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fold in six days compared to non-crowded controls (Fig. 5A and 5B). Fc 400 and Fc 70 were 
used at concentrations of 25mg/ml and 37.5mg/ml, respectively.  
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concentration of 4- 16 mg/ml. Obviously, such culture conditions - the current norm - do 
not provide a crowded environment.  
In 1986, Bateman et. al. reported that when polyethylene glycol (PEG), dextran T-40 or 
polyvinylpyrrolidone were added to fibroblast cultures, no collagen or procollagen was 
found in the medium but instead was associated with the cell layer (Bateman et.al., 1986). In 
1994, Hojima et. al. found that either the presence of 500kDa dextran sulfate or PEG 
increased the respective activities of purified procollagen C-proteinase and purified 
procollagen N-proteinase in vitro in a cell-free system (Hojima et.al., 1994). However, there 
was no follow-up on these publications until 2007, when we set out to use this system for 
translational purposes.  
Under our control, the addition of inert macromolecules was able to dramatically enhance 
collagen deposition (Lareu et. al. 2007a,b). The macromolecules employed exerted a 
crowding effect on the pathways involved in collagen deposition. We have identified at least 
two enzymatic reactions that are boosted under MMC. 
 
 
Fig. 7. Proteolytic cleavage of procollagen is enhanced by MMC. (A) Immunoblot for the 
central portion of collagen showing increased collagen staining from the cell layer fraction 
under MMC. In the absence of MMC, procollagen remained unprocessed and in the 
medium fraction. (B) Immunoblot for PCP showed little significant change in quantity of 
PCP but immunoblot for PCOLCE1, an enhancer of PCP, showed increased activation. (C) 
Immunoblot for the C-propeptide showed the presence of higher molecular weight 
 
procollagen in the medium of uncrowded controls, and the presence of lower molecular 
weight C-propeptide in the medium of crowded fibroblast cultures. Fig. 7A was reprinted 
from Lareu et. al., 2007a, with permission from the publisher, Mary Ann Liebert.  Fig. 7B 
was reprinted from Lareu et. al., 2007b, with permission from the publisher, Elsevier 
 
Firstly, we observed an increase in procollagen conversion in the presence of DxS through 
Western blot analysis (Fig. 7). An antibody that recognizes only the central portion of the 
collagen molecule was used. Control cultures contained only procollagen in the medium, 
with little collagen detected in the cell layer. In the presence of DxS, procollagen in the 
medium was reduced. On the other hand, procollagen-processed collagen was present in the 
cell layer, indicating increased procollagen conversion into collagen and subsequent 
deposition at the cell layer (Fig. 7a). Western blot analysis of procollagen C-proteinase 
(PCP), the enzyme required for procollagen cleavage into collagen, revealed no significant 
changes in its amount (Fig. 7B) Therefore, we infer that its activity must have changed, 
which can be confirmed using antibodies against the C-propeptide (Fig 7C). Interestingly, 
we noted a proteolytic fragmentation under crowding with PCOLCE1, the allosteric 
enhancer of PCP-procollagen-specific activity (Fig. 7B). Only in the presence of DxS, did we 
detect a 36kDa active form of PCOLCE along with a C-terminal fragment, which was shown 
to inhibit matrix metalloproteinase 2 (MMP2) (Mott et.al., 2000).  
 
A second identified enzymatic reaction is the lysyl oxidase-catalyzed reaction which 
produces large molecular weight dimers, 11 and 12, resulting in covalent crosslinking of 
collagen assemblies. Under crowded conditions, we determined via densitometry an 
increase of the ratio of  bands versus  bands, suggesting an increased lysyl oxidase-
mediated crosslinking of the deposited collagen. (Chen et. al., 2009) 
Hence, we hypothesize that MMC influences collagen production and turnover, and thus 
extracellular matrix production and retention, by at least three ways (Fig. 8). Under the 
influence of MMC, there is increased proteolytic conversion of a procollagen C-proteinase 
allosteric enhancer, PCOLCE1, into its 36kDa active form and a 16.5kDa fragment that acts 
as a MMP2 inhibitor. The former will then enhance PCP enzymatic activity, resulting in 
increased procollagen cleavage in the extracellular space, thereby producing water-insoluble 
collagen molecules. These collagen molecules will then self-assemble in a quarter-staggered 
array at the cell layer. Moreover, the binding of PCOLCE1 to procollagen C-proteinase 
would be enhanced by MMC. MMC also enhances lysyl oxidase activity, which catalyzes 
the  crosslinks between the collagen molecules, and so stabilizing these collagen molecules. 
The other by-product of PCOLCE1 conversion results in a MMP2 inhibitor, which aids in 
reducing the collagen turnover and thus maintaining the collagen matrix. Finally, crowding 
might also drive the supramolecular assembly of collagen, as we have observed in gel 
forming assays (unpublished). 
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Fig. 8. Mechanisms by which MMC  augments extracellular matrix (ECM) production and 
retention 
 
Other macromolecules that were tried include 100µg/ml of 670kDa neutral dextran (NDx), 
50mg/ml of Fc 400, 50mg/ml of Fc 70 and 100µg/ml of 10kDa DxS. These additional 
macromolecules were unable to significantly increase collagen deposition. As explained 
earlier in section 2.5, several factors determine the total excluded-volume effect. By 
definition, all crowder macromolecules are hydrophilic and therefore the hydrodynamic 
size (RH), a parameter that captures the effects of size and hydration, as is, becomes a critical 
determinant of the volume of exclusion. In addition, for anionic macromolecules, the surface 
charge further adds on to the effects of size and hydration. We can illustrate this by a simple 
comparison of the hydrodynamic radii of charged and neutral macromolecules. Anionic 
Dextran Sulfate of molecular weight 500kDa with an RH of 46 nm (Table 1) far exceeds the 
RH of a neutral Dextran (21nm) that has a much larger molecular weight at 670kDa. This 2.2-
fold greater increase in radius translates to a 10-fold increase in volume per molecule and 
when calculated to the entire population of macromolecules in solution, this translates into a 
substantial increase in volume occupancy for the charged crowder. Another similar analogy 
can be described when we compare PSS (200kDa) with the neutral Dextran (670kDa). 
Although PSS is three times lower in MW than NDx, both have a similar RH,  (21nm). This 
highlights the significance of charge to determining the hydrodynamic radius. These 
biophysical findings highlighting the role of charge were corroborated by the cell culture 
results, which demonstrated the inability of NDx and Fc 70 and Fc 400 as monocrowders to 
elicit the same degree of collagen deposition when compared with the charged crowders in 
similar conditions.  
Combination of Fc 70 and 400 at 37.5mg/ml and 25mg/ml, respectively, yielded enhanced 
collagen production due to the synergistic effects of such a mixed crowder cocktail , as 
described by Harve et. al., 2008.  
 
When the effects of two Dextran Sulfate species, one at 500kDa and another at 10 kDa, were 
compared, biophysically it was found that the smaller DxS species was undetectable in DLS 
as the size of this crowder was below the detection threshold. The DxS10 was 
understandably found to yield minimal amounts of collagen in comparison to its heavier 
and bigger counterpart. Thus size also does matter when the excluded-volume effects are 
compared between two charged macromolecules of similar chemical structure. 
 
 
DxS 
500kDa 
PSS 
200kDa 
NDx 
670kDa 
Fc 
400kDa 
Fc 
700kDa 
DxS 
10kDa 
Net Charge Negative Negative Neutral Neutral Neutral Negative 
Hydro. Radius 
(nm) 
46 22 21 4.5 3 <1 
Table 1. Hydrodynamic radii of macromolecules 500kDa DxS, PSS, NDx, Fc 400, Fc 70 and 
10kDa DxS 
 
2.6 Why MMC is not equivalent to a simple volume reduction of culture medium  
A question often posed by audiences worldwide is since MMC creates a concentration effect 
via volume exclusion, why not grow the cells in reduced volumes of culture medium? 
Would this not lead to a similar concentration of secreted factors like enzymes and 
reactants? 
We designed an experiment to address this question. We grew 50,000 fibroblasts in each 
well of a 24 well culture dish (15 mm diameter) varying the volumes of culture medium 
from 500 l to 100 l. In parallel, we ran one DxS-crowded set of cells in 500 l. As to be 
expected, in the smallest volumes, cell cultures dried out, resulting in cell death. 
Interestingly, there was an increase of collagen deposition in the 200 l well by 2.2-fold (Fig. 
9A). However, this was not substantial compared to the collagen deposition induced in the 
500 l well by DxS, which was increased by an order of magnitude in this experiment (Fig. 
9A). We calculated the thermodynamic activity of reactants procollagen and its enzymes 
procollagen C-proteinase in the case of 500µl of DxS-supplemented culture medium, 200µl 
of uncrowded medium and 100µl of uncrowded medium and found an order of magnitude 
difference in the 500µl crowded medium in comparison with the latter two cases (Fig. 9B). 
Such a large difference in the thermodynamic activities could explain the much-enhanced 
collagen deposition of the crowded culture.   
Thus, MMC and the resulting excluding volume effect are far more powerful than simply 
reducing the volume of medium, and still allow for ample nutrient-rich culture medium in 
static or bioreactor settings. We should mention here that MMC in our system did not cause 
appreciable changes of viscosity (Lareu et. al., 2007a) to the culture medium thus 
eliminating concerns with diffusion issues. 
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Fig. 9. The reduction of medium volume was unable to enhance collagen deposition to the 
same degree as the application of MMC. (A) Fibroblast cultures were grown under non-
crowded conditions with reduced volumes of medium and showed at best, a 2.2-fold 
collagen deposition using 200µl of medium. In contrast, DxS-crowded fibroblasts showed a 
much more enhanced collagen deposition at 17.3-fold. When medium volume was reduced 
to 100µl and 50µl, the wells dried out, resulting in cell death. (B) Thermodynamic activities 
in 500µl of DxS-crowded medium far exceeds that of 200µl and 100µl of uncrowded 
fibroblast cultures 
 
2.7 Increased collagen biosynthesis by MMC for application in connective tissue 
engineering 
We have shown that MMC can be employed to increase collagen biosynthesis in fibroblast 
cultures. Because collagen comprises the majority of the extracellular matrix components in 
vivo, we are able to produce an extracellular matrix in vitro that is more physiological. Our 
research has brought a technological advancement to the field of connective tissue 
engineering and other tissue engineering fields as well.  
Additionally, we have shown that MMC can be applied in conventional tissue engineering 
systems comprising scaffolds cultured under static or bioreactor conditions (Lareu et.al. 
2007b). We have successfully supplemented DxS into the culture medium of fibroblasts 
seeded onto Biobrane scaffolds. In comparison to the control, the presence of DxS increased 
collagen production by >6-fold (Fig. 10A.). Biobrane is a biosynthetic wound dressing 
comprising a silicone film with a nylon fabric partially embedded into the film. Small 
collagen peptides are coated onto the nylon fabric, which would be broken down during our 
pepsin-isolation protocol and hence will not contribute to our collagen detection method. 
The use of Biobrane as a scaffold is a proof-of-concept of the efficacy of employing MMC in 
connective tissue engineering. 
In another culture system, DxS was supplemented into the culture medium of fibroblasts 
seeded onto poly-L-lactic acid scaffolds under either static conditions in petri dishes, or 
 
under bioreactor conditions. Under both conditions, DxS was able to increase collagen 
production by >6 fold and 3-fold respectively (Fig. 10B.).  
 
 
Fig. 10. DxS induced increased collagen production in fibroblast cultures on scaffolds (A) 
Biobrane and (B) PLLA. PLLA fibroblast cultures were grown under both static and 
bioreactor conditions. Reprinted from Lareu et. al., 2007b, with permission from the 
publisher, Elsevier 
 
Thus, we have shown that collagen deposition can be enhanced by the application of MMC 
in two different scaffold fibroblast culture systems as well as under bioreactor conditions. 
The application of a biophysical principle, MMC, to solve a tissue engineering problem, is a 
fine example of how important it is to adopt a multi-disciplinary approach towards solving 
tissue engineering problems.   
The increase in collagen has the potential to benefit most if not all tissue engineering 
constructs because the protein serves to create cohesion between single cells and cell layers, 
thereby contributing to mechanical support. Moreover, applying MMC results in an 
extracellular matrix more similar to that found in vivo, which has the potential to provide 
biochemical cues such as growth factors, fulfilling a more physiological role in directing the 
cells.  
 
2.8 Side observations on crowding – growth behaviour 
We noted significant differences in cell proliferation depending on the crowders used. In the 
presence of negatively charged DxS, cell proliferation halted, such that there was 12% less 
cells in comparison to the uncrowded control in 2 days (unpublished data). In contrast, in 
the presence of neutral crowders in the Fc cocktail, cell proliferation was increased by 15% 
in a time window of 6 days (unpublished data).  A possible explanation for this 
phenomenon could be that these observations do not reflect a true stimulation of 
proliferation by Fc, but rather a longer proliferation slow-down time as it takes longer under 
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Fig. 9. The reduction of medium volume was unable to enhance collagen deposition to the 
same degree as the application of MMC. (A) Fibroblast cultures were grown under non-
crowded conditions with reduced volumes of medium and showed at best, a 2.2-fold 
collagen deposition using 200µl of medium. In contrast, DxS-crowded fibroblasts showed a 
much more enhanced collagen deposition at 17.3-fold. When medium volume was reduced 
to 100µl and 50µl, the wells dried out, resulting in cell death. (B) Thermodynamic activities 
in 500µl of DxS-crowded medium far exceeds that of 200µl and 100µl of uncrowded 
fibroblast cultures 
 
2.7 Increased collagen biosynthesis by MMC for application in connective tissue 
engineering 
We have shown that MMC can be employed to increase collagen biosynthesis in fibroblast 
cultures. Because collagen comprises the majority of the extracellular matrix components in 
vivo, we are able to produce an extracellular matrix in vitro that is more physiological. Our 
research has brought a technological advancement to the field of connective tissue 
engineering and other tissue engineering fields as well.  
Additionally, we have shown that MMC can be applied in conventional tissue engineering 
systems comprising scaffolds cultured under static or bioreactor conditions (Lareu et.al. 
2007b). We have successfully supplemented DxS into the culture medium of fibroblasts 
seeded onto Biobrane scaffolds. In comparison to the control, the presence of DxS increased 
collagen production by >6-fold (Fig. 10A.). Biobrane is a biosynthetic wound dressing 
comprising a silicone film with a nylon fabric partially embedded into the film. Small 
collagen peptides are coated onto the nylon fabric, which would be broken down during our 
pepsin-isolation protocol and hence will not contribute to our collagen detection method. 
The use of Biobrane as a scaffold is a proof-of-concept of the efficacy of employing MMC in 
connective tissue engineering. 
In another culture system, DxS was supplemented into the culture medium of fibroblasts 
seeded onto poly-L-lactic acid scaffolds under either static conditions in petri dishes, or 
 
under bioreactor conditions. Under both conditions, DxS was able to increase collagen 
production by >6 fold and 3-fold respectively (Fig. 10B.).  
 
 
Fig. 10. DxS induced increased collagen production in fibroblast cultures on scaffolds (A) 
Biobrane and (B) PLLA. PLLA fibroblast cultures were grown under both static and 
bioreactor conditions. Reprinted from Lareu et. al., 2007b, with permission from the 
publisher, Elsevier 
 
Thus, we have shown that collagen deposition can be enhanced by the application of MMC 
in two different scaffold fibroblast culture systems as well as under bioreactor conditions. 
The application of a biophysical principle, MMC, to solve a tissue engineering problem, is a 
fine example of how important it is to adopt a multi-disciplinary approach towards solving 
tissue engineering problems.   
The increase in collagen has the potential to benefit most if not all tissue engineering 
constructs because the protein serves to create cohesion between single cells and cell layers, 
thereby contributing to mechanical support. Moreover, applying MMC results in an 
extracellular matrix more similar to that found in vivo, which has the potential to provide 
biochemical cues such as growth factors, fulfilling a more physiological role in directing the 
cells.  
 
2.8 Side observations on crowding – growth behaviour 
We noted significant differences in cell proliferation depending on the crowders used. In the 
presence of negatively charged DxS, cell proliferation halted, such that there was 12% less 
cells in comparison to the uncrowded control in 2 days (unpublished data). In contrast, in 
the presence of neutral crowders in the Fc cocktail, cell proliferation was increased by 15% 
in a time window of 6 days (unpublished data).  A possible explanation for this 
phenomenon could be that these observations do not reflect a true stimulation of 
proliferation by Fc, but rather a longer proliferation slow-down time as it takes longer under 
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these conditions to build up a critical mass of ECM that could move cells into a quiescent 
state. 
 
2.9 Current immediate application of MMC in cell culture 
The ability to rapidly create matrix in vivo allowed us to use this technology to build a drug 
screening tool, the Scar in a Jar (Chen et al, 2009), therefore enabling us to emulate collagen 
biosynthesis, secretion and deposition in a compressed time window. Thus we can emulate 
scar formation and test antifibrotic substances in a high content screening setting (Wang et. 
al., 2009).   
 
3. Future Challenges 
One of the current challenges faced by tissue engineers is the size and complexity of tissue 
constructs. We envision that macromolecular crowding can enhance both static and 
bioreactor settings and induce cells to coat polymeric biomaterials with their own matrix. 
Organ printing is an emerging field, where pieces of pelleted tissue are printed onto a 
hydrogel or substrate and fuse together to form a larger construct. Currently, organ printing 
has enabled the formation of capillary-like tubes from pellets of endothelial cells (Mironov, 
2009). The biggest obstacle to this technique is keeping the printed cell constructs stable. 
These constructs are most likely unstable due to their lack of structural matrix components 
after printing. Printing into a scaffold is technically challenging, and hence a less preferred 
option.  However, we propose that exposing printed or extruded cell constructs to 
macromolecular crowders could enhance collagen deposition by these cell pellets 
themselves, thereby reducing the period of instability and creating a more cohesive tissue 
construct. A particular way to create coherent cell sheets was pioneered by Teruo Okano 
and coworkers (Yang et. al., 2007). This technique is based on thermosensitive polymers that 
switch hydrophilicity according to temperature. This has led to the discovery that cells 
grown as a hyperconfluent monolayer can be lifted of as a coherent cell sheet by cooling the 
culture plates. This elegant technique is dependent on a basic ECM containing of fibronectin 
and collagen V that lend cohesion to the cell sheet. Unfortunately, it does not appear 
possible currently to generate matrix-enhanced cell layers and to lift them off the Okano 
material, as the cells adhere extremely firmly onto the deposited ECM, and the ECM in turn 
to the polymer. However, we are confident that crowding and cell sheet technology can be 
combined by designing novel temperature-sensitive cell culture polymers that have a lower 
critical solution temperature, between 4°C and 10°C and would be predicted to release a 
matrix-cell- layer completely. This work is currently work in progress. 
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switch hydrophilicity according to temperature. This has led to the discovery that cells 
grown as a hyperconfluent monolayer can be lifted of as a coherent cell sheet by cooling the 
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and collagen V that lend cohesion to the cell sheet. Unfortunately, it does not appear 
possible currently to generate matrix-enhanced cell layers and to lift them off the Okano 
material, as the cells adhere extremely firmly onto the deposited ECM, and the ECM in turn 
to the polymer. However, we are confident that crowding and cell sheet technology can be 
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1. Introduction 
Tissue or organ loss resulting from traumatic or non-traumatic destruction causes major 
health problems, severely affecting patient’s quality and length of life. Traditionally surgical 
treatment offers use of autologous tissues from a second site to repair or replace the 
functions of affected tissues or organs, with various outcomes. For some organs, including 
kidney, liver and pancreas, allogenic transplantation allows for functional restoration. 
However, the supply of allografts is limited and long waiting lists for tissue and organ 
transplantations indicate the need for new strategies to overcome the limitations of 
traditional therapies. 
Tissue engineering (TE), one of the major approaches of regenerative medicine, is a rapidly 
growing and exciting field of research. In combination with better understanding of 
structure, biology and physiology cell culture techniques or TE may offer new treatment 
options for patients needing replacement or repair of an organ. The principle is to dissociate 
cells from a tissue biopsy, to expand these cells in culture, and to seed them onto the scaffold 
material in vitro in order to form a live tissue construct prior to reimplantation into the 
recipient’s organism. In the appropriate biochemical and biomechanical environment these 
tissues will achieve their full functional potential and serve as native tissue equivalents. The 
TE approach has major advantages over traditional organ transplantation. Tissues that 
closely match the patient’s needs can be reconstructed from a generally readily obtainable 
biopsy. Moreover the new reconstruct can be transplanted into the patient’s body without 
donor site morbidity and with minimal or no immunogenicity. This eventually conquers 
several limitations, encountered in tissue transplantation approaches.  
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1.1 Urinary bladder disease 
Severe bladder dysfunction can be induced by disease or surgical intervention altering the 
normal pattern of storage and voiding. This might then lead to an unstable, a non-compliant 
or a smaller bladder that cannot hold normal volumes of urine. Bladder failure can result in 
clinical problems ranging from mild to severe chronic urinary incontinence leading to 
irreversible kidney damage caused by increased upper urinary tract pressure. Severe cases 
of bladder failure typically do not respond to the most conservative treatment options such 
as bladder retraining or anticholinergic medications and severely affects the patient’s 
quality of life. Currently, the treatment of choice in these patients is an enterocystoplasty, a 
surgical enlargement of the bladder using intestinal tissue. The primary aim of the surgical 
reconstruction is to increase bladder capacity and compliance. This improves continence, 
reduces intravesical storage pressure and thereby protects the upper urinary tract but fails 
to restore emptying function. Furthermore, enterocystoplasty is associated with numerous 
complications such as metabolic disturbance, increased mucus production, urolithiasis, 
infections and even malignant diseases. Many alternative sources of materials for 
reconstruction have been proposed to avoid the above mentioned complications however so 
far with only limited success. 
 
1.2 Application 
Tissue engineering, using autologous cells for implantation might offer a solution to this 
problem. Recently, several studies have confirmed feasibility of bladder reconstruction 
using engineered segments which were formed using biomaterials seeded with autologous 
cells in vitro (Yoo, Meng et al. 1998; Atala, Bauer et al. 2006, Oberpenning, Meng et al. 1999). 
This basic approach was first examined in a canine subtotal cystectomy model, where 
bladder constructs configured from natural or synthetic scaffolds and seeded with expanded 
autologous bladder-derived cells were successfully implanted (Yoo, Meng et al. 1998). This 
approach provided improved findings when compared with earlier attempts. Encouraged 
by the promising results of several animal studies, a similar approach was applied more 
recently to a small series of patients with severe neuropathic bladder dysfunction by Antony 
Atala et al. in 2006 (Atala, Bauer et al. 2006). They reported the results of 7 patients aged 4 to 
19 years, with a mean follow up of 4 years. All three patients with the engineered tissues 
made with composite-scaffolds (collagen-PGA) showed a significant increase in bladder 
capacity and compliance. Tissue biopsies of the engineered bladder segments were 
described as showing an adequate structural architecture and phenotype of the different 
cells. Although some patients benefit was reported, clinical improvement was minimal. So 
far efficacy of this novel approach does not compare favorable with conventional 
reconstruction methods using bowel segments as source of material. To date, the clinical 
application of engineered tissues has been hampered by slow vascularization, poor nutrition 
leading to cell death and consecutive tissue fibrosis (Oberpenning, Meng et al. 1999, Ko, 
Milthorpe et al. 2007). For successful bladder reconstruction revascularization of the 
construct is essential to support short and long term survival. Furthermore, to restore 
physiological bladder function reinnervation is indispensable. 
The concept of tissue engineering has been applied clinically for a variety of disorders, for 
example artificial skin for burn patients (Metcalfe and Ferguson 2007), cartilage for knee-
replacement procedures (Brittberg, Lindahl et al. 1994), injectable chondrocytes for the 
treatment of vesico-ureteric reflux (Atala, Cima et al. 1993, Caldamone and Diamond 2001) 
 
and urinary incontinence (Bent, Tutrone et al. 2001, Chancellor, Yokoyama et al. 2000). For 
hollow organs such as bladder, urethra, oesophagus, intestine, vagina, or blood vessels the 
strategies generally include implantation of either a biomaterial, which subsequently 
becomes integrated into the host organism through immigration of cells from surrounding 
tissues, or, with the technical advances in TE preferably an in vitro precombined construct 
of materials and cells. The basic requirements to achieve functional tissue are proper 
scaffolds, a suitable environment and appropriate cells. 
The ambitious goal to reconstruct a functional, contractile bladder responsive to voluntary 
control is an ongoing challenge for the future. Our ability to use donor tissue efficiently, to 
provide the optimal conditions for cultivation, long-term survival, differentiation and 
growth will lay the foundation for success. 
 
1.3 Scaffold 
The purpose of the scaffold is to serve as a temporary supporting structure allowing not 
only 3-dimensional support of tissue growth and formation but also providing the biological 
environment needed for cellular growth, differentiation and tissue formation. 
In the early days of TE stiff or non-compliant materials have been investigated for their use 
in tissue engineering. These materials were not suitable to support the formation of healthy 
tissue due to biomechanical failure and biological incompatibility (Kudish 1957, Bono and 
De Gresti 1966 Fujita 1978). 
The ideal biomaterial for hollow organs should therefore possess adequate mechanical, 
biomechanical and physical properties while being non-toxic, biocompatible, promoting 
cellular interactions and tissue development. 
Two main classes of scaffold materials have been utilized for the engineering of hollow 
organs; acellular matrices derived from donor tissues, (e.g., bladder submucosa and small 
intestinal submucosa), and synthetic polymers such as polyglycolic acid (PGA), polylactic 
acid (PLA), and poly(lactic-co-glycolic acid) (PLGA). The use of composite scaffolds, 
composed of acellular matrices together with synthetic polymers for bladder reconstruction 
is promising, as it combines the advantages of the two types of materials. These different 
strategies will be discussed in detail later in this chapter. 
 
1.4 Environment 
Successful TE approaches depend on meeting a variety of critical experimental conditions. 
One is to create an environment conductive to cell growth, differentiation and eventually 
enabling the integration of an implanted TE-construct with the surrounding host tissue. In 
order to achieve this, the TE-constructs shouldn’t induce an immune response i.e. the host 
cells do not recognize it as a foreign body. Furthermore TE-constructs aim to mimique 
mechanical and biochemical properties of the native extracellular matrix (ECM). The ECM is 
the optimized natural milieu that directs tissue development and maintains tissue 
homeostasis. The ECM refers to a complex network of molecules that provide 2D- or 3D-
mechanical support for cells, serves as a barrier between different compartments or cell 
types and provides guidance cues during development, tissue repair or wound healing. On 
the individual cell basis ECM induces cell polarity, allows or inhibits cell adhesion, 
promotes or slows down migration and induces cell and tissue differentiation and might 
also induce programmed cell death (Cheresh and Stupack 2008). The ECM is composed of 
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1.1 Urinary bladder disease 
Severe bladder dysfunction can be induced by disease or surgical intervention altering the 
normal pattern of storage and voiding. This might then lead to an unstable, a non-compliant 
or a smaller bladder that cannot hold normal volumes of urine. Bladder failure can result in 
clinical problems ranging from mild to severe chronic urinary incontinence leading to 
irreversible kidney damage caused by increased upper urinary tract pressure. Severe cases 
of bladder failure typically do not respond to the most conservative treatment options such 
as bladder retraining or anticholinergic medications and severely affects the patient’s 
quality of life. Currently, the treatment of choice in these patients is an enterocystoplasty, a 
surgical enlargement of the bladder using intestinal tissue. The primary aim of the surgical 
reconstruction is to increase bladder capacity and compliance. This improves continence, 
reduces intravesical storage pressure and thereby protects the upper urinary tract but fails 
to restore emptying function. Furthermore, enterocystoplasty is associated with numerous 
complications such as metabolic disturbance, increased mucus production, urolithiasis, 
infections and even malignant diseases. Many alternative sources of materials for 
reconstruction have been proposed to avoid the above mentioned complications however so 
far with only limited success. 
 
1.2 Application 
Tissue engineering, using autologous cells for implantation might offer a solution to this 
problem. Recently, several studies have confirmed feasibility of bladder reconstruction 
using engineered segments which were formed using biomaterials seeded with autologous 
cells in vitro (Yoo, Meng et al. 1998; Atala, Bauer et al. 2006, Oberpenning, Meng et al. 1999). 
This basic approach was first examined in a canine subtotal cystectomy model, where 
bladder constructs configured from natural or synthetic scaffolds and seeded with expanded 
autologous bladder-derived cells were successfully implanted (Yoo, Meng et al. 1998). This 
approach provided improved findings when compared with earlier attempts. Encouraged 
by the promising results of several animal studies, a similar approach was applied more 
recently to a small series of patients with severe neuropathic bladder dysfunction by Antony 
Atala et al. in 2006 (Atala, Bauer et al. 2006). They reported the results of 7 patients aged 4 to 
19 years, with a mean follow up of 4 years. All three patients with the engineered tissues 
made with composite-scaffolds (collagen-PGA) showed a significant increase in bladder 
capacity and compliance. Tissue biopsies of the engineered bladder segments were 
described as showing an adequate structural architecture and phenotype of the different 
cells. Although some patients benefit was reported, clinical improvement was minimal. So 
far efficacy of this novel approach does not compare favorable with conventional 
reconstruction methods using bowel segments as source of material. To date, the clinical 
application of engineered tissues has been hampered by slow vascularization, poor nutrition 
leading to cell death and consecutive tissue fibrosis (Oberpenning, Meng et al. 1999, Ko, 
Milthorpe et al. 2007). For successful bladder reconstruction revascularization of the 
construct is essential to support short and long term survival. Furthermore, to restore 
physiological bladder function reinnervation is indispensable. 
The concept of tissue engineering has been applied clinically for a variety of disorders, for 
example artificial skin for burn patients (Metcalfe and Ferguson 2007), cartilage for knee-
replacement procedures (Brittberg, Lindahl et al. 1994), injectable chondrocytes for the 
treatment of vesico-ureteric reflux (Atala, Cima et al. 1993, Caldamone and Diamond 2001) 
 
and urinary incontinence (Bent, Tutrone et al. 2001, Chancellor, Yokoyama et al. 2000). For 
hollow organs such as bladder, urethra, oesophagus, intestine, vagina, or blood vessels the 
strategies generally include implantation of either a biomaterial, which subsequently 
becomes integrated into the host organism through immigration of cells from surrounding 
tissues, or, with the technical advances in TE preferably an in vitro precombined construct 
of materials and cells. The basic requirements to achieve functional tissue are proper 
scaffolds, a suitable environment and appropriate cells. 
The ambitious goal to reconstruct a functional, contractile bladder responsive to voluntary 
control is an ongoing challenge for the future. Our ability to use donor tissue efficiently, to 
provide the optimal conditions for cultivation, long-term survival, differentiation and 
growth will lay the foundation for success. 
 
1.3 Scaffold 
The purpose of the scaffold is to serve as a temporary supporting structure allowing not 
only 3-dimensional support of tissue growth and formation but also providing the biological 
environment needed for cellular growth, differentiation and tissue formation. 
In the early days of TE stiff or non-compliant materials have been investigated for their use 
in tissue engineering. These materials were not suitable to support the formation of healthy 
tissue due to biomechanical failure and biological incompatibility (Kudish 1957, Bono and 
De Gresti 1966 Fujita 1978). 
The ideal biomaterial for hollow organs should therefore possess adequate mechanical, 
biomechanical and physical properties while being non-toxic, biocompatible, promoting 
cellular interactions and tissue development. 
Two main classes of scaffold materials have been utilized for the engineering of hollow 
organs; acellular matrices derived from donor tissues, (e.g., bladder submucosa and small 
intestinal submucosa), and synthetic polymers such as polyglycolic acid (PGA), polylactic 
acid (PLA), and poly(lactic-co-glycolic acid) (PLGA). The use of composite scaffolds, 
composed of acellular matrices together with synthetic polymers for bladder reconstruction 
is promising, as it combines the advantages of the two types of materials. These different 
strategies will be discussed in detail later in this chapter. 
 
1.4 Environment 
Successful TE approaches depend on meeting a variety of critical experimental conditions. 
One is to create an environment conductive to cell growth, differentiation and eventually 
enabling the integration of an implanted TE-construct with the surrounding host tissue. In 
order to achieve this, the TE-constructs shouldn’t induce an immune response i.e. the host 
cells do not recognize it as a foreign body. Furthermore TE-constructs aim to mimique 
mechanical and biochemical properties of the native extracellular matrix (ECM). The ECM is 
the optimized natural milieu that directs tissue development and maintains tissue 
homeostasis. The ECM refers to a complex network of molecules that provide 2D- or 3D-
mechanical support for cells, serves as a barrier between different compartments or cell 
types and provides guidance cues during development, tissue repair or wound healing. On 
the individual cell basis ECM induces cell polarity, allows or inhibits cell adhesion, 
promotes or slows down migration and induces cell and tissue differentiation and might 
also induce programmed cell death (Cheresh and Stupack 2008). The ECM is composed of 
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chemically very different macromolecules that are assembled into organized structures 
remaining in close association with the surface of the cells that secreted them. The main 
components are space filling proteoglycans, containing collagen fibers and non-collagenous 
glycoproteins such as elastin. Integrated into this hydrogel-like matrix are signaling 
molecules such as growth factors, cytokines and hormones (Schonherr and Hausser 2000, 
Uebersax, Merkle et al. 2009). The ECM occurs in many different forms depending on the 
requirements of the surrounding tissue. In many cases it is a 3D-strucuture of ECM 
surrounding cells which maintains the tissue specific 3D-architecture. In other cases ECM 
forms flexible sheet-like structures between 40-120 nm thickness that serve as solid support 
layers composed of network forming laminin-entactin complexes, type IV collagen and 
heapran sulphate proteoglycans. This sheet-like ECM called basal lamina is frequently 
found in hollow organs such as blood vessels or bladder tissue. The ECM is tissue specific 
and the components self assemble to form spontaneous 2D- or 3D-structures under 
physiological conditions. Therefore, a great effort has been made to understand the 
appropriate biological, physical, and chemical cues, with the aim to mimic the ECM to guide 
morphogenesis in tissue repair (Ghosh and Ingber 2007). 
Moreover, the ECM is constantly changing in composition and structure as tissues develop, 
remodel, repair, and age (Furth, Atala et al. 2007). All body cells, except the blood cells 
interact directly and in a very specific manner with their surrounding ECM. Specific 
receptor-ligand contacts are established that enable mutual communication between the 
ECM and the interior of the cell thus regulating matrix assembly, specific remodeling and 
local removal or disassembly of the matrix (Ghosh and Ingber 2007). Cell-matrix contacts are 
mainly formed between different integrins assembled into giant transmembrane protein 
complexes that regulate and specify their ligand binding affinity as well as matrix assembly. 
Integrins are transmembrane heterodimeric glycoproteins consisting of one α and one β 
subunit forming at least 24 integrin-heterodimers known in humans. Many integrins require 
divalent cations (Ca2+, Mg2+ or Mn2+) for structural integrity and ligand binding as well as 
activation through cluster formation in order to be fully functional (Hynes 2002, Yamada 
and Even-Ram 2002, Luo and Springer 2006, Takada, Ye et al. 2007, Banno and Ginsberg 
2008, Moser, Legate et al. 2009). Although many cell-matrix contacts are formed and enable 
the cell to respond to their immediate 2D- or 3D-environment, these contacts are transient 
and strongly regulated. After implantation of a TE-construct cell-matrix interactions are 
governed by surface properties of the scaffold material and their imperative interactions 
found to occur. In addition to these cell-matrix interactions several growth factors and 
biological molecules are also involved in cell adhesion, cell-cell communication and cell-
matrix interaction. This very complex field was covered by recent reviews (e.g. Murugan 
and Ramakrishna 2007), and will therefore not be further discussed in this chapter  
 
1.5 Cells 
The basic bricks of living organisms, the cells, are a predominant factor for successful TE. 
Tissue renewal requires an adequate number of regeneration-competent cells that do not 
elicit immune response. Therefore autologous cells are the ideal choice, as their use 
circumvents many of the inflammatory and rejection issues associated with a nonself donor 
approach (Atala 2008). With the past decade, major advances in the expansion of a variety of 
primary human cells have been achieved. The different types of cells commonly used for TE 
applications can be categorized as differentiated non-stem or adult cells and as 
 
undifferentiated stem cells. Each of these cell types brings along its own advantages and 
disadvantages. 
In the field of bladder reconstruction it has been shown that adult urothelial and smooth 
muscle cells can be efficiently harvested from biopsy material, expanded extensively in 
culture and reimplanted into the same host (Oberpenning, Meng et al. 1999, Zhang, 
Ludwikowski et al. 2001, Atala 2001, Yoo, Park et al. 2000). Their differentiation 
characteristics, growth requirements and other biological properties have been widely 
studied (Southgate, Hutton et al. 1994, Turner, Subramaniam et al. 2008, Ludwikowski, 
Zhang et al. 1999). However, for elderly patients or patients with extensive end stage organ 
failure, a tissue biopsy may not yield enough normal cells for expansion and 
transplantation. Therefore adult progenitor cells may not be sufficient or appropriate for 
tissue engineering and transplantation in all cases (Heath 2000). 
Although adult progenitors remain important for TE, the use of pluripotent stem cells has 
recently been recognized as a promising alternative source of cells from which the desired 
tissue can be derived. Stem cells, by definition, are immature or undifferentiated cells with 
the potential to go through numerous cycles of self-renewal, thus replenishing the pool of 
stem cells as well as to differentiate into more specialized, tissue-/organ-specific cells. Stem 
cells can be categorized into embryonic, fetal or adult cells according to their source of 
origination (NIH). 
Embryonic stem cells exhibit two remarkable properties: the ability to proliferate in an 
undifferentiated, but still pluripotent state (self-renewal), and the ability to differentiate into 
a large number of specified cells (Brivanlou, Gage et al. 2003). As their name implies, 
embryonic stem cells are derived from the early stage embryo. Although embryonic stem 
cells research is thought to have much greater potential than adult stem cells, several ethical 
and legal controversies still exist concerning their use in humans. Furthermore, embryonic 
stem cells have been shown to transdifferentiate into a malignant phenotype, forming 
teratomas (Przyborski 2005, Yang, Lin et al. 2008). 
Fetal stem cells derived form amniotic fluid and placentas have recently been described and 
represent a novel source of stem cells (De Coppi, Callegari et al. 2007). The principle stem 
cell type isolated from amniotic fluid and placentas is mesenchymal, but they have an 
expansion potential that is superior to that of adult stem cells. They are less immunogenic as 
they do not express human leukocyte antigen (HLA) and they do not form teratomas in 
vivo. Fetal stem cells are multipotent and they have been shown do differentiate into 
myogenic, adipogenic, osteogenic, nephrogenic, neural, and endothelial cells. In addition, 
the cells have a high replicative potential and could be stored for future use, without the risk 
of rejection and without ethical concerns (Fauza 2004). 
Adult stem cells are basically undifferentiated cells found among differentiated cells in a 
tissue or organs. They are present in all adult tissues and are critical to tissue health, 
maintenance, and response to injury or disease throughout life. When compared with 
embryonic stem cells adult stem cells are more committed but still have the plasticity to 
differentiate into all three germ layers (Eberli and Atala 2006). However, they demonstrate 
considerable advantages, including; stable differentiation into specific cell lineages, no 
transdifferentiation into a malignant phenotype (teratomas), no requirement for the sacrifice 
of human embryos for their isolation and no or little immune rejection. Furthermore certain 
ethical and legal issues can also be conquered. 
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found to occur. In addition to these cell-matrix interactions several growth factors and 
biological molecules are also involved in cell adhesion, cell-cell communication and cell-
matrix interaction. This very complex field was covered by recent reviews (e.g. Murugan 
and Ramakrishna 2007), and will therefore not be further discussed in this chapter  
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primary human cells have been achieved. The different types of cells commonly used for TE 
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undifferentiated stem cells. Each of these cell types brings along its own advantages and 
disadvantages. 
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recently been recognized as a promising alternative source of cells from which the desired 
tissue can be derived. Stem cells, by definition, are immature or undifferentiated cells with 
the potential to go through numerous cycles of self-renewal, thus replenishing the pool of 
stem cells as well as to differentiate into more specialized, tissue-/organ-specific cells. Stem 
cells can be categorized into embryonic, fetal or adult cells according to their source of 
origination (NIH). 
Embryonic stem cells exhibit two remarkable properties: the ability to proliferate in an 
undifferentiated, but still pluripotent state (self-renewal), and the ability to differentiate into 
a large number of specified cells (Brivanlou, Gage et al. 2003). As their name implies, 
embryonic stem cells are derived from the early stage embryo. Although embryonic stem 
cells research is thought to have much greater potential than adult stem cells, several ethical 
and legal controversies still exist concerning their use in humans. Furthermore, embryonic 
stem cells have been shown to transdifferentiate into a malignant phenotype, forming 
teratomas (Przyborski 2005, Yang, Lin et al. 2008). 
Fetal stem cells derived form amniotic fluid and placentas have recently been described and 
represent a novel source of stem cells (De Coppi, Callegari et al. 2007). The principle stem 
cell type isolated from amniotic fluid and placentas is mesenchymal, but they have an 
expansion potential that is superior to that of adult stem cells. They are less immunogenic as 
they do not express human leukocyte antigen (HLA) and they do not form teratomas in 
vivo. Fetal stem cells are multipotent and they have been shown do differentiate into 
myogenic, adipogenic, osteogenic, nephrogenic, neural, and endothelial cells. In addition, 
the cells have a high replicative potential and could be stored for future use, without the risk 
of rejection and without ethical concerns (Fauza 2004). 
Adult stem cells are basically undifferentiated cells found among differentiated cells in a 
tissue or organs. They are present in all adult tissues and are critical to tissue health, 
maintenance, and response to injury or disease throughout life. When compared with 
embryonic stem cells adult stem cells are more committed but still have the plasticity to 
differentiate into all three germ layers (Eberli and Atala 2006). However, they demonstrate 
considerable advantages, including; stable differentiation into specific cell lineages, no 
transdifferentiation into a malignant phenotype (teratomas), no requirement for the sacrifice 
of human embryos for their isolation and no or little immune rejection. Furthermore certain 
ethical and legal issues can also be conquered. 
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Today, pluripotent stem cells, or differentiable adult stem cells, can be harvested from many 
different tissues, including bone marrow (Angele, Kujat et al. 1999, Pittenger, Mackay et al. 
1999), striated muscle (Bosch, Musgrave et al. 2000, Lee, Qu-Petersen et al. 2000), fat (Zuk, 
Zhu et al. 2001), skin (Toma, Akhavan et al. 2001), synovial membrane (De Bari, Dell'Accio 
et al. 2001), and, more recently, testicles (Guan, Nayernia et al. 2006, Kossack, Meneses et al. 
2009). These cells can differentiate into committed cells of other tissues, a feature defined as 
plasticity. This would allow for engineering of composite tissues composed of multiple cell 
types using one single source of adult stem cells. Therefore, adult stem cells are particularly 
suitable for cellular therapy and for the engineering of tissues and organs. 
Bladder reconstruction using stem cells seeded on a scaffold has recently been shown to be a 
promising alternative for bladder engineering (Chung, Krivorov et al. 2005),(Zhang, Lin et 
al. 2005, De Coppi, Callegari et al. 2007, Frimberger, Morales et al. 2006, Oottamasathien, 
Wang et al. 2007). Recent progress suggests that engineered tissues and cell based therapies 
using adult stem cells may have an expanded clinical applicability in the future and may 
represent a viable therapeutic option for those who require tissue replacement or repair. 
The most intensively investigated adult stem cells are mesenchymal stem cells (MSCs). This 
cell type holds significant promise for the engineering of musculoskeletal structures. Bone 
marrow represents the major source of MSCs. Chung et al. performed studies in a rat model 
that examined the ability of MSCs to aid in the regeneration of bladder tissue on an acellular 
matrix scaffold (Chung, Krivorov et al. 2005). The cells were seeded onto an acellular matrix 
(small intestinal submucosa) and used in bladder augmentation studies. The number of 
smooth muscle containing bundles was dramatically increased in the seeded grafts versus 
the unseeded controls, suggesting that the mesenchymal stem cells (MSCs) have 
differentiated into smooth muscle cells (SMCs) and have contributed to the regeneration of 
the graft. In a similar study Zhang et al. described the isolation and expansion of bone 
marrow MSCs from dogs for use as an alternative cellular source for autologous bladder 
grafts using small intestinal submucosa (SIS) (Zhang, Lin et al. 2005). These authors 
demonstrated the ability of MSCs to differentiate into SMCs and provide a contractile force 
on collagen matrices in vitro. MSCs also enhanced the regenerative process when seeded 
onto SIS for augmentation cystoplasty by enhancing smooth muscle bundle formation 
(Zhang, Lin et al. 2005). However, in both studies, the cells were not labeled and therefore 
were indistinguishable from cells that may have migrated in from the surrounding normal 
tissue. 
Another source of adult stem cells is fat tissue. Unlike bone marrow stem cells, which are 
difficult to isolate and relatively scarce, adipose stem cells (ASCs) are tremendously 
abundant and easily accessible (Jack, Zhang et al. 2009). Jack et al. demonstrated the 
feasibility of bladder tissue engineered from adipose stem cells. They showed that ASCs 
differentiated into bladder smooth muscle cells and showed contractile function in vivo. The 
vast availability of ASCs combined with their ease of procurement and ability to 
differentiate into contractile smooth muscle make them a competitive non-embryonic 
alternative for regeneration of the bladder and other smooth muscle tissues (Jack, Zhang et 
al. 2009). 
Although stem cells are believed to be the key factor for the future of TE, one of the major 
challenges associated with the use of these cells is to provide appropriate cellular 
environment cues that regulate cell growth and subsequent tissue formation in a controlled 
and efficient manner (Murugan and Ramakrishna 2007). A deeper understanding of the 
 
complex interplay of stem cells and environment might allow for new strategies where stem 
cells actively participate in functional tissue and organ formation. Stem cells will 
differentiate into various cell types in situ depending on the requirements of the 
regenerating tissue, or they remain stem cells that generate progeny to maintain the tissue. 
In addition stem cells could be used to secrete factors that enhance cellular ingrowth, neo-
vascularisation, and re-innervation. 
 
2. Biomaterials 
By providing a temporary supporting structure for growing cells, the scaffold is an 
important determining factor for the success of TE. Scaffold materials can be of natural or 
synthetic origin. The underlying principle for the design of scaffolds for TE is similar for 
different types of tissues. The scaffold preferably mimics the structure and biological 
functions of native ECM, both in terms of chemical composition and physical properties. 
Native ECM is a complex and dynamic environment filled with nano-features such as fibers 
displaying a certain pore size and interconnectivity that should ideally exhibit tissue-specific 
structures and properties. When naturally derived scaffolds are used they provide specific 
ligands for cell adhesion and migration, as well as various growth factors inducing specific 
cell proliferation and functions. 
Currently, a variety of materials are available for manufacturing scaffolds for TE, including 
native and synthetic polymers and their composites. The choice of material depends on the 
type of tissue to be reconstructed. Most hollow organs are organized in a similar fashion, 
consisting of epithelium surrounded by a collagen type I-rich connective tissue and a 
smooth muscle layer. The epithelial or endothelial layer serves as a barrier preventing the 
content of the lumen from permeating into the body. The collagen type-I rich layer and the 
muscle layer maintain the structural and functional integrity of the organ. The cells within 
these layers interact with each other and with structural proteins to regulate cellular 
differentiation and function (Ziats, Miller et al. 1988, Bacakova, Filova et al. 2004). 
The following characteristics are desirable for scaffolds used for TE in general.  
The scaffold should 
 be biocompatible, meaning that it should not provoke any rejection, inflammation, 
immune responses or foreign body reactions. 
 provide a 3D template for the cells to attach and to guide their growth. 
 have a porous architecture with a high surface area for the maximum loading of cells, cell-
surface interaction, tissue ingrowth, and transportation of nutrients and oxygen. 
 be degradable under physiological conditions and the degradation rate should match the 
rate of tissue regeneration to sustain tissue functionality. 
 be mechanically strong to withstand in vivo biological forces. 
 support the cells in synthesizing tissue specific extracellular matrix components and 
growth factors required for healthy tissue growth. 
 be sterilizable to avoid toxic contaminations without compromising any structural and 
mechanical properties.  
Finally, the production process of the scaffold with all the above unique characteristics must 
be accomplished in a reproducible, economical, and up-scalable manner (Murugan and 
Ramakrishna 2007). 
In respect to bladder TE the ideal scaffold material should 
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 support the cells in synthesizing tissue specific extracellular matrix components and 
growth factors required for healthy tissue growth. 
 be sterilizable to avoid toxic contaminations without compromising any structural and 
mechanical properties.  
Finally, the production process of the scaffold with all the above unique characteristics must 
be accomplished in a reproducible, economical, and up-scalable manner (Murugan and 
Ramakrishna 2007). 
In respect to bladder TE the ideal scaffold material should 
Tissue	Engineering126
 
 provide structural support for distinct cell layers, including an adequate surface for stable 
attachment of urothelial cells. 
 give adequate biomechanical support to harbor a high density of smooth muscle cells on 
the exterior surface without inducing premature collapse of the hollow organ. 
 serve as a barrier between luminal contents and the body cavity. 
 support the formation of unidirectional muscle tissue in defined layers and allow for rapid 
innervation and vascularisation. 
Since each of the different cell types favors different conditions for optimal growth and 
differentiation, tissue engineering using multiple cell types must take these factors into 
account. 
Two main classes of biomaterials have been utilized for the engineering of hollow organs; 
acellular matrices derived from donor tissues, (e.g. bladder submucosa and small intestinal 
submucosa), and synthetic polymers such as polyglycolic acid (PGA), polylactic acid (PLA), 
and poly(lactic-co-glycolic acid) (PLGA). These materials have been tested in respect to their 
biocompatibility in the host tissues (Scriven, Trejdosiewicz et al. 2001; Pariente, Kim et al. 
2002). Both types of material were able to support the formation of bladder like tissue. 
Acellular tissue matrices are extracted form native tissue and therefore contain growth 
factors, hormones and other signaling factors (Ziats, Miller et al. 1988, Brown, Brook-Allred 
et al. 2005, Chun, Lim et al. 2007) that promote tissue development and have adhesion 
domain sequences (e.g. RGD) that may support the phenotype and activity of many types of 
cells (Dawson, Goberdhan et al. 1996). These matrices are known to slowly degrade upon 
implantation and are usually replaced and remodeled by ECM proteins synthesized and 
secreted by transplanted or ingrowing cells (Daniels, Chang et al. 1990; Aharoni, Meiri et al. 
1997; Ashammakhi and Rokkanen 1997; Talja, Valimaa et al. 1997; Hodde 2002; Santucci and 
Barber 2005; Daley, Peters et al. 2008; Mohamed and van der Walle 2008). In contrast, 
synthetic polymers can be manufactured reproducibly on a large scale with controlled 
properties of their strength, degradation rate and ultra structure (Hutmacher, Schantz et al. 
2007; Ma, Mao et al. 2007). Both classes of biomaterials have been used either with or 
without cells for the tissue engineering of hollow organs, including bladder (Kropp, Rippy 
et al. 1996, Yoo, Meng et al. 1998, Oberpenning, Meng et al. 1999), urethra (Olsen 1992, 
Kropp, Ludlow et al. 1998), oesophagus (Urita, Komuro et al. 2007, Penkala and Kim 2007), 
intestine (Penkala and Kim 2007), vagina (De Filippo, Yoo et al. 2003), or blood vessels 
(Amiel, Komura et al. 2006, Lee, Choo et al. 2007). 
 
2.1 Native Acellular Matrices  
Native acellular matrices are pioneering materials and offer many potential advantages over 
synthetic scaffold materials (Southgate, Cross et al. 2003). These collagen-rich matrices are 
extracted from native tissue by mechanical or chemical decellularization (Chen, Yoo et al. 
1999, Dahms, Piechota et al. 1998, Piechota, Dahms et al. 1998). They are either derived from 
bladder (bladder acellular matrix (BAM)) (Sutherland, Baskin et al. 1996) or from small 
intestine (SIS) (Kropp, Ludlow et al. 1998, Kropp, Rippy et al. 1996). The tensile backbone of 
the scaffold consists of fibrillar collagen type I, and the basement membrane, serving as a 
cyto- and tissue-compatible polymeric scaffold for recellularisation. One important 
advantage over synthetic materials is the fact that acellular matrices retain their biological 
activity. They provide specific integrin binding sites and contain endogenous growth factors 
encouraging the in-growth of tissue (Badylak 2004, Santucci and Barber 2005). Furthermore, 
 
given that the composition and structure of the ECM is unique to individual tissues, there 
may be advantages in orthotopic-derived matrices: BAM may be expected to contain more 
appropriate growth factors for bladder TE than SIS (Bolland, Korossis et al. 2007). Once 
implanted into the body, they slowly degrade supporting the ingrowth of host cells which 
then start to produce new ECM proteins. 
In bladder reconstruction acellular matrices have been used either as a graft alone or seeded 
with urothelial and smooth muscle cells (Kropp, Rippy et al. 1996; Yoo, Meng et al. 1998; 
Oberpenning, Meng et al. 1999; Sievert, Bakircioglu et al. 2000; Sievert, Amend et al. 2007, 
Probst, Piechota et al. 2000, Zhang, Frimberger et al. 2006, Reddy, Barrieras et al. 2000). 
Analysis of unseeded SIS patches after implantation in dogs showed replacement by normal 
bladder tissue, vascularisation and re-innervation (Kropp, Rippy et al. 1996). However, 
successful bladder regeneration using SIS appears to be dependent on the revascularization 
rate of the graft and the extent of the original bladder damage. SIS was not able to support 
functional tissue regeneration when used in animals with inflamed and contracted bladder 
remnants (Zhang, Frimberger et al. 2006).  
Implanting BAM into the bladder of rats, rabbits, dogs and pigs resulted in the regeneration 
of urothelial and muscle layers with innervation and vascularisation of the graft (Probst, 
Piechota et al. 2000, Sievert, Bakircioglu et al. 2000, Reddy, Barrieras et al. 2000). Moreover, 
BAM was shown to release exogenous basic fibroblast growth factor (bFGF) in a rat model 
of bladder augmentation. bFGF is an important growth factor supporting tissue formation 
and reducing graft shrinkage (Kanematsu, Yamamoto et al. 2003). 
However, problems with poor vascularisation, graft shrinkage and incomplete or 
disorganized smooth muscle development have been associated with the use of 
decellularised matrices (Zhang, Frimberger et al. 2006, Brown, Farhat et al. 2002, Kropp, 
Cheng et al. 2004). Graft shrinkage occurs due to the fast ingrowth of fibroblasts (Brown, 
Farhat et al. 2002). It seems to be a frequent finding of a scaffold when used as a graft for 
bladder or other hollow structures. Researchers agree that the larger the graft, the more 
pronounced the shrinkage due to the activity of smooth muscle actin-positive fibroblasts 
(Brown, Farhat et al. 2002, Kropp, Cheng et al. 2004). Omental coverage, endothelial cell 
seeding, or application of exogenous angiogenic growth factors were reported to allow 
ingrowth of capillaries to the graft (Kanematsu, Yamamoto et al. 2003, Baumert, Simon et al. 
2007). However, establishment and maintenance of a permanent and sufficiently robust 
vascular supply to sustain a large graft for the human bladder remains to be demonstrated. 
The above mentioned problems led to the concept of ex vivo seeding of autologous cells 
onto different scaffold materials, with the aim of enhancing tissue integration following 
implantation. This would minimize the inflammatory response toward the matrix, thus 
avoiding graft contracture and shrinkage. Yoo et al. showed that there was a major 
difference between BAM used with autologous cells and matrices used without cells (Yoo, 
Meng et al. 1998). 
A major disadvantage of these systems is the routine variability in protein composition 
among the batches. There may also be ethical issues regarding their availability, although 
most naturally derived scaffolds are porcine xenografts. 
 
2.2 Synthetic polymers 
Historically the attempt to incorporate of synthetic materials alone into the bladder has 
mostly failed, primarily as a result of biological and mechanical incompatibilities. Amongst 
Scaffolds	for	the	Engineering	of	Functional	Bladder	Tissues 127
 
 provide structural support for distinct cell layers, including an adequate surface for stable 
attachment of urothelial cells. 
 give adequate biomechanical support to harbor a high density of smooth muscle cells on 
the exterior surface without inducing premature collapse of the hollow organ. 
 serve as a barrier between luminal contents and the body cavity. 
 support the formation of unidirectional muscle tissue in defined layers and allow for rapid 
innervation and vascularisation. 
Since each of the different cell types favors different conditions for optimal growth and 
differentiation, tissue engineering using multiple cell types must take these factors into 
account. 
Two main classes of biomaterials have been utilized for the engineering of hollow organs; 
acellular matrices derived from donor tissues, (e.g. bladder submucosa and small intestinal 
submucosa), and synthetic polymers such as polyglycolic acid (PGA), polylactic acid (PLA), 
and poly(lactic-co-glycolic acid) (PLGA). These materials have been tested in respect to their 
biocompatibility in the host tissues (Scriven, Trejdosiewicz et al. 2001; Pariente, Kim et al. 
2002). Both types of material were able to support the formation of bladder like tissue. 
Acellular tissue matrices are extracted form native tissue and therefore contain growth 
factors, hormones and other signaling factors (Ziats, Miller et al. 1988, Brown, Brook-Allred 
et al. 2005, Chun, Lim et al. 2007) that promote tissue development and have adhesion 
domain sequences (e.g. RGD) that may support the phenotype and activity of many types of 
cells (Dawson, Goberdhan et al. 1996). These matrices are known to slowly degrade upon 
implantation and are usually replaced and remodeled by ECM proteins synthesized and 
secreted by transplanted or ingrowing cells (Daniels, Chang et al. 1990; Aharoni, Meiri et al. 
1997; Ashammakhi and Rokkanen 1997; Talja, Valimaa et al. 1997; Hodde 2002; Santucci and 
Barber 2005; Daley, Peters et al. 2008; Mohamed and van der Walle 2008). In contrast, 
synthetic polymers can be manufactured reproducibly on a large scale with controlled 
properties of their strength, degradation rate and ultra structure (Hutmacher, Schantz et al. 
2007; Ma, Mao et al. 2007). Both classes of biomaterials have been used either with or 
without cells for the tissue engineering of hollow organs, including bladder (Kropp, Rippy 
et al. 1996, Yoo, Meng et al. 1998, Oberpenning, Meng et al. 1999), urethra (Olsen 1992, 
Kropp, Ludlow et al. 1998), oesophagus (Urita, Komuro et al. 2007, Penkala and Kim 2007), 
intestine (Penkala and Kim 2007), vagina (De Filippo, Yoo et al. 2003), or blood vessels 
(Amiel, Komura et al. 2006, Lee, Choo et al. 2007). 
 
2.1 Native Acellular Matrices  
Native acellular matrices are pioneering materials and offer many potential advantages over 
synthetic scaffold materials (Southgate, Cross et al. 2003). These collagen-rich matrices are 
extracted from native tissue by mechanical or chemical decellularization (Chen, Yoo et al. 
1999, Dahms, Piechota et al. 1998, Piechota, Dahms et al. 1998). They are either derived from 
bladder (bladder acellular matrix (BAM)) (Sutherland, Baskin et al. 1996) or from small 
intestine (SIS) (Kropp, Ludlow et al. 1998, Kropp, Rippy et al. 1996). The tensile backbone of 
the scaffold consists of fibrillar collagen type I, and the basement membrane, serving as a 
cyto- and tissue-compatible polymeric scaffold for recellularisation. One important 
advantage over synthetic materials is the fact that acellular matrices retain their biological 
activity. They provide specific integrin binding sites and contain endogenous growth factors 
encouraging the in-growth of tissue (Badylak 2004, Santucci and Barber 2005). Furthermore, 
 
given that the composition and structure of the ECM is unique to individual tissues, there 
may be advantages in orthotopic-derived matrices: BAM may be expected to contain more 
appropriate growth factors for bladder TE than SIS (Bolland, Korossis et al. 2007). Once 
implanted into the body, they slowly degrade supporting the ingrowth of host cells which 
then start to produce new ECM proteins. 
In bladder reconstruction acellular matrices have been used either as a graft alone or seeded 
with urothelial and smooth muscle cells (Kropp, Rippy et al. 1996; Yoo, Meng et al. 1998; 
Oberpenning, Meng et al. 1999; Sievert, Bakircioglu et al. 2000; Sievert, Amend et al. 2007, 
Probst, Piechota et al. 2000, Zhang, Frimberger et al. 2006, Reddy, Barrieras et al. 2000). 
Analysis of unseeded SIS patches after implantation in dogs showed replacement by normal 
bladder tissue, vascularisation and re-innervation (Kropp, Rippy et al. 1996). However, 
successful bladder regeneration using SIS appears to be dependent on the revascularization 
rate of the graft and the extent of the original bladder damage. SIS was not able to support 
functional tissue regeneration when used in animals with inflamed and contracted bladder 
remnants (Zhang, Frimberger et al. 2006).  
Implanting BAM into the bladder of rats, rabbits, dogs and pigs resulted in the regeneration 
of urothelial and muscle layers with innervation and vascularisation of the graft (Probst, 
Piechota et al. 2000, Sievert, Bakircioglu et al. 2000, Reddy, Barrieras et al. 2000). Moreover, 
BAM was shown to release exogenous basic fibroblast growth factor (bFGF) in a rat model 
of bladder augmentation. bFGF is an important growth factor supporting tissue formation 
and reducing graft shrinkage (Kanematsu, Yamamoto et al. 2003). 
However, problems with poor vascularisation, graft shrinkage and incomplete or 
disorganized smooth muscle development have been associated with the use of 
decellularised matrices (Zhang, Frimberger et al. 2006, Brown, Farhat et al. 2002, Kropp, 
Cheng et al. 2004). Graft shrinkage occurs due to the fast ingrowth of fibroblasts (Brown, 
Farhat et al. 2002). It seems to be a frequent finding of a scaffold when used as a graft for 
bladder or other hollow structures. Researchers agree that the larger the graft, the more 
pronounced the shrinkage due to the activity of smooth muscle actin-positive fibroblasts 
(Brown, Farhat et al. 2002, Kropp, Cheng et al. 2004). Omental coverage, endothelial cell 
seeding, or application of exogenous angiogenic growth factors were reported to allow 
ingrowth of capillaries to the graft (Kanematsu, Yamamoto et al. 2003, Baumert, Simon et al. 
2007). However, establishment and maintenance of a permanent and sufficiently robust 
vascular supply to sustain a large graft for the human bladder remains to be demonstrated. 
The above mentioned problems led to the concept of ex vivo seeding of autologous cells 
onto different scaffold materials, with the aim of enhancing tissue integration following 
implantation. This would minimize the inflammatory response toward the matrix, thus 
avoiding graft contracture and shrinkage. Yoo et al. showed that there was a major 
difference between BAM used with autologous cells and matrices used without cells (Yoo, 
Meng et al. 1998). 
A major disadvantage of these systems is the routine variability in protein composition 
among the batches. There may also be ethical issues regarding their availability, although 
most naturally derived scaffolds are porcine xenografts. 
 
2.2 Synthetic polymers 
Historically the attempt to incorporate of synthetic materials alone into the bladder has 
mostly failed, primarily as a result of biological and mechanical incompatibilities. Amongst 
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others polyvinyl sponges, silicone, polytetrafluoroethylene (Teflon) and resin-sprayed paper 
have been used to reconstruct the bladder with variable results, but none of the methods 
have been pursued to the present day (Kudish 1957, Bono and De Gresti 1966, Fujita 1978). 
Modern synthetic polymers such as PGA, PLA and PLGA are widely used in tissue 
engineering and have been applied in bladder reconstruction. These polymers received FDA 
approval for a variety of applications in human, including suture material. The ester bonds 
in these polymers are hydrolytically labile, thus allowing degradation by non enzymatic 
hydrolysis.  
The degradation products of PGA, PLA, and PLGA are nontoxic natural metabolites and are 
eventually eliminated from the body in the form of carbon dioxide and water (Hutmacher 
2000). The degradation rate of these polymers can be tailored from several weeks to several 
years by altering the crystalinity, initial molecular weight, and the copolymer ratio of lactic 
to glycolic acids. Since these polymers are thermoplastics, they can be easily formed into a 
3D scaffold with a desired microstructure, gross shape, and dimension by various 
techniques, including molding, extrusion (Freed, Vunjak-Novakovic et al. 1994), solvent 
casting (Mikos, Lyman et al. 1994), phase separation techniques, gas foaming techniques 
(Harris, Kim et al. 1998) and electrospinning (Bini, Gao et al. 2004, Zong, Bien et al. 2005). 
Many applications in tissue engineering require a scaffold with high porosity and high ratio 
of surface area to volume. Other biodegradable synthetic polymers, including 
poly(anhydrides) and poly(ortho-esters) can also be used to fabricate scaffolds for tissue 
engineering with controlled properties (Peppas and Langer 1994).  
Bladder-derived cells have been propagated on biodegradable synthetic scaffolds (Atala, 
Bauer et al. 2006, Oberpenning, Meng et al. 1999; Scriven, Trejdosiewicz et al. 2001; 
Danielsson, Ruault et al. 2006). Compared to natural materials, the advantage of producing 
a synthetic scaffold material is the full control over processing properties such as strength, 
biodegradability, microstructure and permeability, however, a fundamental feature of these 
materials is that they lack the natural signals that regulate cell attachment, growth and 
differentiation (Danielsson, Ruault et al. 2006, Vacanti and Langer 1999). 
Atala and colleagues first demonstrated the feasibility of cells seeding onto a purely 
synthetic matrix for implantation in vivo (Oberpenning, Meng et al. 1999). PLGA is a well 
characterized biomaterial with predictable degradation properties, which is widely used as 
Vicryl® sutures and meshes. It is non-toxic and biocompatible with both urothelial and 
bladder smooth muscle cells (Pariente, Kim et al. 2002, Scriven, Trejdosiewicz et al. 2001). 
These qualities make PLGA an attractive candidate for combination with natural materials 
to form implantable constructs for bladder reconstruction. Oberpenning et al. also used PGA 
meshes, molded into the shape of a bladder and surface-coated with PLGA. The constructs 
were seeded with autologous smooth muscle cells on the outer and urothelial cells on the 
inner surfaces of the scaffold material (Oberpenning, Meng et al. 1999). After subtotal 
cystectomy in dogs the bladder constructs were then implanted onto the bladder base 
(trigone) and the neo-bladder was then coated with fibrin glue and surrounded with 
omentum. The animals were monitored for up to 11 months. There were no complications 
and at three months, the polymer had degraded. Functionally, the reconstructed bladders 
provided an adequate capacity with good compliance. Histologically and 
immunocytochemically, the bladders showed an adequate structural architecture, and 
phenotypically, the urothelium and muscle retained their program of normal differentiation. 
 
As previously mentioned, synthetic biodegradable polymers lack the presence of extra-
cellular matrix components, and therefore of cell adhesion sequences and signaling 
molecules. However, modification of the polymer scaffolds’ chemistry and the method of 
manufacturing allow improvement of cell adherence potential, growth rate and phenotype 
regulation (Bisson, Hilborn et al. 2002, Kim, Nikolovski et al. 1999). It is essential that the 
structural features of the produced scaffolds resemble the natural ECM in order to provide 
tissue formation and promote rapid clinical translation. Recently, numerous investigations 
have explored the possibility of producing scaffolds similar to natural ECM (Yang, Murugan 
et al. 2005, Murugan and Ramakrishna 2006, Xu, Inai et al. 2004). These scaffolds possess a 
high surface area, high porosity, small pore size, and a low density, all of which are features 
essential for the improvement of cell adhesion, mandatory for cell migration, proliferation, 
and differentiation. Polymeric nanofibres matrices are among the most promising ECM-
mimetic biomaterials because their physical structure is similar to that of fibrous proteins in 
native ECM. They are increasingly being used in TE and have advantages over traditional 
scaffolds due to increased surface-to-volume ratio, which is supposed to be advantageous 
for cell-scaffold interaction promoting cellular adhesion, proliferation, migration and 
function. 
Additionally, providing a scaffold made of nanofibres may guide the growth of muscle cells 
in three dimensions. Attitude and orientation of these fibers are considered to be one of the 
important features of a functional tissue scaffold containing muscle cells. This leads to the 
concept of nano-fibrous scaffolds for tissue engineering applications. Further, fiber 
orientation of the scaffolds greatly influences cell orientation and phenotypic expression 
(Ma, Kotaki et al. 2005, Yang, Murugan et al. 2005). For instance, Xu et al. (Xu, Inai et al. 
2004) have evaluated electrospun synthetic biomaterials (poly(l-lactid-co-ε-caprolactone), 
P(LLA-CL)) using smooth muscle cells. The diameter of the generated fibers was around 
500nm with an aligned topography mimicking the circumferential orientation of cells and 
fibrils found in the medial layer of a native artery. The results show that the cells adhered 
and migrated along the axis of aligned scaffolds while expressing a spindle-like phenotype. 
The cytoskeleton organization inside these cells was also parallel to the orientation of the 
fibrous assembly. A study by Baker et al. showed that smooth muscle cells adapted a more 
natural organization when grown on electrospun polystyrene scaffolds as compared to 
collagen fibers in vivo (Baker, Atkin et al. 2006). 
Therefore, engineering scaffolds while controlling the fiber orientation is essential for 
mimicking structural and functional aspects of the native ECM, controlling cell orientation 
and tissue growth. Currently, there are a number of methods available for manufacturing 
tissue scaffolds, which include electrospinning, self-assembly, phase separation, solvent-
casting and particulate-leaching, freeze drying, melt molding, template synthesis, drawing, 
gas foaming, and solid-free forming (Murugan and Ramakrishna 2007). Among them, only 
electrospinning offers the capability to design nanofibrous scaffolds in the form of 
nonwoven structures that can meet the demands of scaffold-based tissue engineering 
applications. 
 
2.3 Composite scaffold 
Methods to improve cell attachment and proliferation on synthetic materials have already 
been explored. One approach is to coat a synthetic material with biological substances such 
as collagen, serum or to use surface modification procedures prior to cell seeding to 
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others polyvinyl sponges, silicone, polytetrafluoroethylene (Teflon) and resin-sprayed paper 
have been used to reconstruct the bladder with variable results, but none of the methods 
have been pursued to the present day (Kudish 1957, Bono and De Gresti 1966, Fujita 1978). 
Modern synthetic polymers such as PGA, PLA and PLGA are widely used in tissue 
engineering and have been applied in bladder reconstruction. These polymers received FDA 
approval for a variety of applications in human, including suture material. The ester bonds 
in these polymers are hydrolytically labile, thus allowing degradation by non enzymatic 
hydrolysis.  
The degradation products of PGA, PLA, and PLGA are nontoxic natural metabolites and are 
eventually eliminated from the body in the form of carbon dioxide and water (Hutmacher 
2000). The degradation rate of these polymers can be tailored from several weeks to several 
years by altering the crystalinity, initial molecular weight, and the copolymer ratio of lactic 
to glycolic acids. Since these polymers are thermoplastics, they can be easily formed into a 
3D scaffold with a desired microstructure, gross shape, and dimension by various 
techniques, including molding, extrusion (Freed, Vunjak-Novakovic et al. 1994), solvent 
casting (Mikos, Lyman et al. 1994), phase separation techniques, gas foaming techniques 
(Harris, Kim et al. 1998) and electrospinning (Bini, Gao et al. 2004, Zong, Bien et al. 2005). 
Many applications in tissue engineering require a scaffold with high porosity and high ratio 
of surface area to volume. Other biodegradable synthetic polymers, including 
poly(anhydrides) and poly(ortho-esters) can also be used to fabricate scaffolds for tissue 
engineering with controlled properties (Peppas and Langer 1994).  
Bladder-derived cells have been propagated on biodegradable synthetic scaffolds (Atala, 
Bauer et al. 2006, Oberpenning, Meng et al. 1999; Scriven, Trejdosiewicz et al. 2001; 
Danielsson, Ruault et al. 2006). Compared to natural materials, the advantage of producing 
a synthetic scaffold material is the full control over processing properties such as strength, 
biodegradability, microstructure and permeability, however, a fundamental feature of these 
materials is that they lack the natural signals that regulate cell attachment, growth and 
differentiation (Danielsson, Ruault et al. 2006, Vacanti and Langer 1999). 
Atala and colleagues first demonstrated the feasibility of cells seeding onto a purely 
synthetic matrix for implantation in vivo (Oberpenning, Meng et al. 1999). PLGA is a well 
characterized biomaterial with predictable degradation properties, which is widely used as 
Vicryl® sutures and meshes. It is non-toxic and biocompatible with both urothelial and 
bladder smooth muscle cells (Pariente, Kim et al. 2002, Scriven, Trejdosiewicz et al. 2001). 
These qualities make PLGA an attractive candidate for combination with natural materials 
to form implantable constructs for bladder reconstruction. Oberpenning et al. also used PGA 
meshes, molded into the shape of a bladder and surface-coated with PLGA. The constructs 
were seeded with autologous smooth muscle cells on the outer and urothelial cells on the 
inner surfaces of the scaffold material (Oberpenning, Meng et al. 1999). After subtotal 
cystectomy in dogs the bladder constructs were then implanted onto the bladder base 
(trigone) and the neo-bladder was then coated with fibrin glue and surrounded with 
omentum. The animals were monitored for up to 11 months. There were no complications 
and at three months, the polymer had degraded. Functionally, the reconstructed bladders 
provided an adequate capacity with good compliance. Histologically and 
immunocytochemically, the bladders showed an adequate structural architecture, and 
phenotypically, the urothelium and muscle retained their program of normal differentiation. 
 
As previously mentioned, synthetic biodegradable polymers lack the presence of extra-
cellular matrix components, and therefore of cell adhesion sequences and signaling 
molecules. However, modification of the polymer scaffolds’ chemistry and the method of 
manufacturing allow improvement of cell adherence potential, growth rate and phenotype 
regulation (Bisson, Hilborn et al. 2002, Kim, Nikolovski et al. 1999). It is essential that the 
structural features of the produced scaffolds resemble the natural ECM in order to provide 
tissue formation and promote rapid clinical translation. Recently, numerous investigations 
have explored the possibility of producing scaffolds similar to natural ECM (Yang, Murugan 
et al. 2005, Murugan and Ramakrishna 2006, Xu, Inai et al. 2004). These scaffolds possess a 
high surface area, high porosity, small pore size, and a low density, all of which are features 
essential for the improvement of cell adhesion, mandatory for cell migration, proliferation, 
and differentiation. Polymeric nanofibres matrices are among the most promising ECM-
mimetic biomaterials because their physical structure is similar to that of fibrous proteins in 
native ECM. They are increasingly being used in TE and have advantages over traditional 
scaffolds due to increased surface-to-volume ratio, which is supposed to be advantageous 
for cell-scaffold interaction promoting cellular adhesion, proliferation, migration and 
function. 
Additionally, providing a scaffold made of nanofibres may guide the growth of muscle cells 
in three dimensions. Attitude and orientation of these fibers are considered to be one of the 
important features of a functional tissue scaffold containing muscle cells. This leads to the 
concept of nano-fibrous scaffolds for tissue engineering applications. Further, fiber 
orientation of the scaffolds greatly influences cell orientation and phenotypic expression 
(Ma, Kotaki et al. 2005, Yang, Murugan et al. 2005). For instance, Xu et al. (Xu, Inai et al. 
2004) have evaluated electrospun synthetic biomaterials (poly(l-lactid-co-ε-caprolactone), 
P(LLA-CL)) using smooth muscle cells. The diameter of the generated fibers was around 
500nm with an aligned topography mimicking the circumferential orientation of cells and 
fibrils found in the medial layer of a native artery. The results show that the cells adhered 
and migrated along the axis of aligned scaffolds while expressing a spindle-like phenotype. 
The cytoskeleton organization inside these cells was also parallel to the orientation of the 
fibrous assembly. A study by Baker et al. showed that smooth muscle cells adapted a more 
natural organization when grown on electrospun polystyrene scaffolds as compared to 
collagen fibers in vivo (Baker, Atkin et al. 2006). 
Therefore, engineering scaffolds while controlling the fiber orientation is essential for 
mimicking structural and functional aspects of the native ECM, controlling cell orientation 
and tissue growth. Currently, there are a number of methods available for manufacturing 
tissue scaffolds, which include electrospinning, self-assembly, phase separation, solvent-
casting and particulate-leaching, freeze drying, melt molding, template synthesis, drawing, 
gas foaming, and solid-free forming (Murugan and Ramakrishna 2007). Among them, only 
electrospinning offers the capability to design nanofibrous scaffolds in the form of 
nonwoven structures that can meet the demands of scaffold-based tissue engineering 
applications. 
 
2.3 Composite scaffold 
Methods to improve cell attachment and proliferation on synthetic materials have already 
been explored. One approach is to coat a synthetic material with biological substances such 
as collagen, serum or to use surface modification procedures prior to cell seeding to 
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encourage attachment. In vitro cultured SMCs for example have been shown to attach and 
proliferate extensively on a biodegradable polyesterurethane foam, which was pre-treated 
with fetal bovine serum (Danielsson, Ruault et al. 2006) as well as on plasma coated, 
electrospun polystyrene (Baker, Atkin et al. 2006). 
An alternative approach is to combine different scaffold materials with diverse qualities. 
The so called composite scaffolds can be fabricated with two or more completely different 
polymer systems for engineering of hollow organs. Scaffolds designed for hollow organs 
require a special consideration of their barrier function between the cavity and the 
surrounding tissues while accommodating sufficient amounts of cells that facilitate tissue 
development. In recent reports a composite scaffold composed of synthetic PGA and a 
native acellular matrix (collagen) proved to be optimal for the engineering of bladder tissue 
combining the advantages of the different materials (Eberli, Freitas Filho et al. 2009).  
Collagen hybrid matrices have been used with mixed results in vitro. In one study, PLGA 
mesh was combined with collagen and processed to become either a sponge or a gel 
(Nakanishi, Chen et al. 2003). Cultured porcine urothelial and bladder smooth muscle cells 
were seeded onto each of the constructs. Smooth muscle cells were able to proliferate and 
retain expression of differentiation markers when cultured on the on the gel-based 
construct, but not on the sponge. The opposite was the case for urothelial cells, which 
stratified on a sponge but not gel, although unequivocal immunohistochemical markers of 
differentiation were not tested on the urothelium (Nakanishi, Chen et al. 2003). More 
promising were the results of Eberli and colleges (Eberli, Freitas Filho et al. 2009), who used 
a composite scaffolding system of a native acellular collagen matrix bonded to PGA 
polymer meshes. The acellular matrix served as a barrier that would prevent the luminal 
content from permeating into the body cavity while providing an optimal surface for 
epithelial cell adherence and growth. The synthetic polymer layer with large pores was 
designed to accommodate sufficient numbers of muscle cells and maintained structural 
integrity of the scaffold at the same time. The study showed that this composite scaffold 
remained biocompatible, possessed ideal physical and structural characteristics for hollow 
organ applications and formed bladder tissue in vivo (Eberli, Freitas Filho et al. 2009). 
Composite scaffolds seem to be an ideal approach for the TE of hollow organs, meeting the 
demands for a biomaterial addressing the unique needs of the different cells used. 
 
3. Vascularisation and Innervation 
Although many studies demonstrated tissue formation similar to native bladder the 
functionality of these constructs has never been demonstrated. The two main issues limiting 
the constructs to be both contractile and capable of physiologic voiding are proper 
innervation and vascularisation of the tissue engineered construct. 
Rapid neo-vascularisation is essential for graft survival, and complete restoration of the 
organ structure and functionality. The two main mechanisms forming new blood vessels are 
angiogenesis (proliferation and migration of endothelial cells from pre-existing vasculature) 
and vasculogenesis (formation of new vessels by in situ incorporation, differentiation, 
migration and/or proliferation of endothelial progenerator cells recruited from peripheral 
blood). Transplanted matrices relay on vascular ingrowth from the surrounding tissue to 
support previously seeded cells and promote migration of native cells onto the grafted 
region (Pope, Davis et al. 1997, Ko, Milthorpe et al. 2007). 
 
The engineering of large organs will require a vascular network of arteries, veins, and 
capillaries to deliver sufficient nutrients and oxygen to each cell. One possible method to 
artificially induce re-vascularisation in engineered tissue might be through application of 
angiogenic agents such as vascular endothelial growth factors (VEGFs) or the implantation 
of vascular endothelial cells (EC). VEGF is a multifunctional growth factor that functions as 
an inducer of vascular permeability and endothelial cell specific mitogen (Ferrara and 
Davis-Smyth 1997). In addition to its angiogenic function, VEGF also functions as anti-
apoptotic factor for smooth muscle (Yamanaka, Shirai et al. 2002) and endothelial cells 
(Gerber, Dixit et al. 1998). Skeletal myoblasts from adult rats were cultured and transduced 
with an adenovirus encoding VEGF165. These cells were injected into a rat with ischemic 
cardiomyopathy. Neovascularization was assessed histologically four weeks after therapy. 
A significantly greater increase in vascular density was seen in these animals compared to 
the control animals treated with adenoviral VEGF165 alone. These results indicate that a 
combination of VEGF and endothelial cells may be useful for inducing neo-vascularisation 
and volume preservation in engineered tissues (Askari, Unzek et al. 2004). 
As graft shrinkage seems to be a natural process of a scaffold material for a hollow organ, 
enhancement of vascular supply to the graft has been conceived as a measure to sustain the 
viability of regenerated bladder. In bladder augmentation, omental coverage (Oberpenning, 
Meng et al. 1999), application of exogenous angiogenic growth factors (Kanematsu, 
Yamamoto et al. 2003, Kanematsu, Yamamoto et al. 2004, Nomi, Atala et al. 2002) and 
endothelial cell seeding (Schultheiss, Gabouev et al. 2005) were reported to allow ingrowth 
of capillaries to the graft, but may still be lacking the ability to provide a permanent and 
sufficiently robust vascular supply to sustain a large graft for the human bladder. 
Innervation of the regenerated bladder tissue is mandatory for long term functional 
survival of the graft and to avoid secondary degeneration of the smooth muscle. 
Unfortunately, one of the major obstacles in engineering bladders for clinical use has been 
the lack of functional innervation.  
The influence of different neurotrophic factors in neural development, survival, outgrowth 
and branching has been investigated by different research groups (McConnell, Dhar et al. 
2004, Levenberg, Burdick et al. 2005, Sondell, Sundler et al. 2000). Mitsui et al. transplanted 
immortalized neural stem cells, neuronal and glial restricted precursors, or fibroblasts 
expressing neurotrophic factors to contused spinal cord, and reported improved bladder 
function (Mitsui, Shumsky et al. 2005). NGF is the first and best-characterised member of 
the neurotrophin family. NGF supports survival, outgrowth, and branching of sensory and 
autonomic neurons, but does not promote motor neuron regeneration (Kingham and 
Terenghi 2006). Gene therapy for peripheral nerve regeneration has been used by Sasaki et 
al. They injected nerve growth factor (NGF) to the bladder wall with a replication-defective 
adenovirus for the treatment of adult diabetic cystopathy and reported a markedly 
improved bladder function (Sasaki, Chancellor et al. 2004). This viral vector system has 
been shown to restore decreased NGF expression in the bladder. However, increased levels 
of NGF in bladder afferent neurons lead to hyperreflexia, which was significantly reduced 
when NGF levels were neutralized with anti-NGF antibodies (Seki, Sasaki et al. 2002). 
Moreover, high doses of NGF delay nerve regeneration by retarding GAP 43 (Hirata, 
Masaki et al. 2002). Therefore, it is equally important to consider optimal dose and release 
kinetics for the application of such therapeutic growth factors. Glial cell line-derived 
neurotrophic factor (GDNF) is a potent survival factor for motor neurons (Henderson, 
Scaffolds	for	the	Engineering	of	Functional	Bladder	Tissues 131
 
encourage attachment. In vitro cultured SMCs for example have been shown to attach and 
proliferate extensively on a biodegradable polyesterurethane foam, which was pre-treated 
with fetal bovine serum (Danielsson, Ruault et al. 2006) as well as on plasma coated, 
electrospun polystyrene (Baker, Atkin et al. 2006). 
An alternative approach is to combine different scaffold materials with diverse qualities. 
The so called composite scaffolds can be fabricated with two or more completely different 
polymer systems for engineering of hollow organs. Scaffolds designed for hollow organs 
require a special consideration of their barrier function between the cavity and the 
surrounding tissues while accommodating sufficient amounts of cells that facilitate tissue 
development. In recent reports a composite scaffold composed of synthetic PGA and a 
native acellular matrix (collagen) proved to be optimal for the engineering of bladder tissue 
combining the advantages of the different materials (Eberli, Freitas Filho et al. 2009).  
Collagen hybrid matrices have been used with mixed results in vitro. In one study, PLGA 
mesh was combined with collagen and processed to become either a sponge or a gel 
(Nakanishi, Chen et al. 2003). Cultured porcine urothelial and bladder smooth muscle cells 
were seeded onto each of the constructs. Smooth muscle cells were able to proliferate and 
retain expression of differentiation markers when cultured on the on the gel-based 
construct, but not on the sponge. The opposite was the case for urothelial cells, which 
stratified on a sponge but not gel, although unequivocal immunohistochemical markers of 
differentiation were not tested on the urothelium (Nakanishi, Chen et al. 2003). More 
promising were the results of Eberli and colleges (Eberli, Freitas Filho et al. 2009), who used 
a composite scaffolding system of a native acellular collagen matrix bonded to PGA 
polymer meshes. The acellular matrix served as a barrier that would prevent the luminal 
content from permeating into the body cavity while providing an optimal surface for 
epithelial cell adherence and growth. The synthetic polymer layer with large pores was 
designed to accommodate sufficient numbers of muscle cells and maintained structural 
integrity of the scaffold at the same time. The study showed that this composite scaffold 
remained biocompatible, possessed ideal physical and structural characteristics for hollow 
organ applications and formed bladder tissue in vivo (Eberli, Freitas Filho et al. 2009). 
Composite scaffolds seem to be an ideal approach for the TE of hollow organs, meeting the 
demands for a biomaterial addressing the unique needs of the different cells used. 
 
3. Vascularisation and Innervation 
Although many studies demonstrated tissue formation similar to native bladder the 
functionality of these constructs has never been demonstrated. The two main issues limiting 
the constructs to be both contractile and capable of physiologic voiding are proper 
innervation and vascularisation of the tissue engineered construct. 
Rapid neo-vascularisation is essential for graft survival, and complete restoration of the 
organ structure and functionality. The two main mechanisms forming new blood vessels are 
angiogenesis (proliferation and migration of endothelial cells from pre-existing vasculature) 
and vasculogenesis (formation of new vessels by in situ incorporation, differentiation, 
migration and/or proliferation of endothelial progenerator cells recruited from peripheral 
blood). Transplanted matrices relay on vascular ingrowth from the surrounding tissue to 
support previously seeded cells and promote migration of native cells onto the grafted 
region (Pope, Davis et al. 1997, Ko, Milthorpe et al. 2007). 
 
The engineering of large organs will require a vascular network of arteries, veins, and 
capillaries to deliver sufficient nutrients and oxygen to each cell. One possible method to 
artificially induce re-vascularisation in engineered tissue might be through application of 
angiogenic agents such as vascular endothelial growth factors (VEGFs) or the implantation 
of vascular endothelial cells (EC). VEGF is a multifunctional growth factor that functions as 
an inducer of vascular permeability and endothelial cell specific mitogen (Ferrara and 
Davis-Smyth 1997). In addition to its angiogenic function, VEGF also functions as anti-
apoptotic factor for smooth muscle (Yamanaka, Shirai et al. 2002) and endothelial cells 
(Gerber, Dixit et al. 1998). Skeletal myoblasts from adult rats were cultured and transduced 
with an adenovirus encoding VEGF165. These cells were injected into a rat with ischemic 
cardiomyopathy. Neovascularization was assessed histologically four weeks after therapy. 
A significantly greater increase in vascular density was seen in these animals compared to 
the control animals treated with adenoviral VEGF165 alone. These results indicate that a 
combination of VEGF and endothelial cells may be useful for inducing neo-vascularisation 
and volume preservation in engineered tissues (Askari, Unzek et al. 2004). 
As graft shrinkage seems to be a natural process of a scaffold material for a hollow organ, 
enhancement of vascular supply to the graft has been conceived as a measure to sustain the 
viability of regenerated bladder. In bladder augmentation, omental coverage (Oberpenning, 
Meng et al. 1999), application of exogenous angiogenic growth factors (Kanematsu, 
Yamamoto et al. 2003, Kanematsu, Yamamoto et al. 2004, Nomi, Atala et al. 2002) and 
endothelial cell seeding (Schultheiss, Gabouev et al. 2005) were reported to allow ingrowth 
of capillaries to the graft, but may still be lacking the ability to provide a permanent and 
sufficiently robust vascular supply to sustain a large graft for the human bladder. 
Innervation of the regenerated bladder tissue is mandatory for long term functional 
survival of the graft and to avoid secondary degeneration of the smooth muscle. 
Unfortunately, one of the major obstacles in engineering bladders for clinical use has been 
the lack of functional innervation.  
The influence of different neurotrophic factors in neural development, survival, outgrowth 
and branching has been investigated by different research groups (McConnell, Dhar et al. 
2004, Levenberg, Burdick et al. 2005, Sondell, Sundler et al. 2000). Mitsui et al. transplanted 
immortalized neural stem cells, neuronal and glial restricted precursors, or fibroblasts 
expressing neurotrophic factors to contused spinal cord, and reported improved bladder 
function (Mitsui, Shumsky et al. 2005). NGF is the first and best-characterised member of 
the neurotrophin family. NGF supports survival, outgrowth, and branching of sensory and 
autonomic neurons, but does not promote motor neuron regeneration (Kingham and 
Terenghi 2006). Gene therapy for peripheral nerve regeneration has been used by Sasaki et 
al. They injected nerve growth factor (NGF) to the bladder wall with a replication-defective 
adenovirus for the treatment of adult diabetic cystopathy and reported a markedly 
improved bladder function (Sasaki, Chancellor et al. 2004). This viral vector system has 
been shown to restore decreased NGF expression in the bladder. However, increased levels 
of NGF in bladder afferent neurons lead to hyperreflexia, which was significantly reduced 
when NGF levels were neutralized with anti-NGF antibodies (Seki, Sasaki et al. 2002). 
Moreover, high doses of NGF delay nerve regeneration by retarding GAP 43 (Hirata, 
Masaki et al. 2002). Therefore, it is equally important to consider optimal dose and release 
kinetics for the application of such therapeutic growth factors. Glial cell line-derived 
neurotrophic factor (GDNF) is a potent survival factor for motor neurons (Henderson, 
Tissue	Engineering132
 
Phillips et al. 1994). Variations in GDNF release influenced the rate of functional motor 
nerve recovery in rat primary peripheral nerve repair (Piquilloud, Christen et al. 2007). 
VEGF a potent angiogenetic factor also serves as neurotrophic factor for nerve regeneration 
(Sondell, Sundler et al. 2000). 
Application of multiple growth factors rather than a single factor may hold great promise 
to support target organ innervation. The complex neural mechanism regulating bladder 
function includes various neural subpopulations, which are responsive for different 
neurotrophic factors. For example, lumbar dorsal root ganglion (DRG) neurons were found 
to express 65% Ret and 35% TrkA receptors for GDNF and NGF, respectively and 9% of 
receptors positive for both GDNF and NGF (Kashiba, Hyon et al. 1998). Madduri et al. 
demonstrated the synergistic effect of GNDF and NGF on axonal elongation and branching 
form DRG neurons (Madduri, Papaloizos et al. 2009).  
NGF combined with VEGF enhanced regeneration of bladder acellular matrix grafts in 
spinal cord injury induced neurogenic rat bladders and protein gene product 9.5 (PGP) 
positive nerve fibers were observed most abundantly in the groups treated with combined 
factors rather than single factor treated groups (Kikuno, Kawamoto et al. 2009). However, 
the optimal combination of neurotrophic factors supporting bladder regeneration still 
remains unclear. 
Axonal growth direction is well regulated by topographical features. Longitudinally 
aligned nanofibres guided the axons unidirectionally compared to random fibres, which 
showed axonal growth distributed in all directions (Corey, Lin et al. 2007). 
 
4. Summery and Perspective 
An ideal biomaterial for the engineering of functional bladder should be biocompatible and 
support tissue formation as well as provide adequate structural support to the neo-organ 
during tissue development. Many research groups were able to show tissue formation 
similar to native bladder. However, the functionality of these constructs has never been 
demonstrated.  
The two main issues hampering the tissue engineered constructs to be contractile and allow 
physiologic voiding are proper innervation and vascularisation.  
In near future, tissue engineered scaffolds with controlled topography and multiple neural 
and angiogenetic factors will provide a potential option to introduce proper biological 
function to the engineered artificial bladder. 
 
5. Table 
Natually derived scaffolds 
eg. Bladder submucosa 
+ Mainly collagen, naturally derived 
+ Absorbable 
+ Cell recognition sites 
+ Growth Factors  
- Low elasticity 
- High variability 
Synthetic scaffolds 
eg. PGA 
+ Absorbable 
+ High porosity (up to 95%) 
+ Low variability 
- Synthetic, no recognition sites 
 
Table 1. Comparison between the 2 main classes of biomaterials utilized for TE of hollow 
organs 
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1. Introduction  
The dearth of availability of tissues and organs for transplantation as well as inconvenience 
associated with their transplantation such as donor site morbidity, immune rejection and 
pathogen transfer led to the emergence of the discipline of tissue engineering. Following its 
inception in the scientific community since the last two decades, the research and 
development in this emerging field of tissue engineering and regenerative medicine has 
progressed in a very rapid rate (Kretlow & Mikos, 2008). Tissue engineering is an 
interdisciplinary field that applies the principles of engineering and life sciences toward the 
development of biological substitutes that restore, maintain, or improve function of tissue or 
whole organ (Chen et al., 1997; Bhatia et al., 1999; Huang & Ingber, 2000; Chiu et al., 2000; 
2003). Tissue engineering has emerged as a new method involving the combining of cells, 
scaffold, and bioactive agents to fabricate functional new tissue to replace damaged tissue 
(Flanagan et al., 2006 Chen et al., 2002, Solchaga et al., 2001).  
A well-designed three-dimensional scaffold is one of the fundamental tools to guide tissue 
formation in vitro and in vivo. Frontiers areas in medicine is changing rapidly from utilizing 
synthetic implants and tissue grafts to a tissue engineering approach that uses degradable 
porous material scaffolds integrated with biological cells or molecules to regenerate tissues 
(Hollister et al., 2005). Therefore, the selection of scaffold is important to enable the cells to 
behave in the desired manner to generate tissues and organs of the desired shape and size.  
Characteristics of scaffolds  
 (1) Biocompatibility, to avoid unwanted host tissue responses to the implant (Ma, & Langer, 
1999). 
 (2) It should have the excellent surface chemistry to allow attachment, migration, 
proliferation, and differentiation of the cells (Mandal and Kundu, 2008b; 2009a; 2009b). 
 (3) Interconnected pores with proper pore size to support cell infiltration and 
vascularization (Hutmacher 2001; Karageorgiou & Kaplan, 2005). 
 (4) Controlled biodegradability to aid the formation of new tissue (Cima et al., 1991; 
Kweona et al., 2003).  
7
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(5) Adequate mechanical properties to maintain the structure and function immediately 
after implantation and during remodelling of the implants (Karande & Agrawal, 2008; Kim 
et al., 2000; Lee et al., 2001).  
 (6) It should acquire the sufficient mechanical properties to provide the better environment 
for cells, deliver inductive molecules or cells to the repair site and provide cues to control 
the structure and function of newly formed tissue (Hutmacher 2000; 2001). 
 (7) It should support the formation of ECM by promoting cellular functions, and have the 
ability to provide the bimolecular signals to the cells (Ito et al., 2003).  
 (8) Scaffolds used for tissue engineering should mimic in part the structure and biological 
function of the extracellular matrix (Ma, 2008; Li & Shi, 2007).  
Many techniques have been developed to fabricate three-dimensional porous architectures 
to fill this role, such as by particle leaching (Ma & Langer, 1999; Lu et al., 2000), phase 
separation (Sachlos & Czernuszka, 2003; Smith et al., 2006) and textile technology. However, 
scaffolds fabricate by these  techniques do not adequately mimic the structure of the natural 
extracellular matrix in terms of architecture, which may be one of the reasons for suboptimal 
outcome in generating functional tissues (Lavik, & Langer, 2004; Laurencin et al., 1999; 
Hutmacher 2001). Therefore, new designs and manufacture technologies are required to 
improve the function and architecture of scaffolds. This chapter discusses the different 
scaffold fabrication methodologies/techniques utilizing several synthetic and natural 
polymers, including solvent casting, particulate leaching, gas foaming, phase separation, 
electrospinning, porogen leaching, fiber mesh, fiber bonding, self assembly, rapid 
prototyping, melt molding, membrane lamination and freeze drying.  
 
2. Fabrication techniques 
In the body, cells and tissue are organized into three-dimensional architecture. To engineer 
these functional tissue and organs, scaffolds have to be fabricated by different methodology 
to facilitate the cell distribution and guide their growth into three-dimensional space. The 
main techniques for scaffolds fabrication are mentioned here. 
 
2.1 Solvent casting  
Solvent casting property for the scaffolds preparation is very simple, easy and inexpensive. 
It does not require any large equipment; it is totally based upon the evaporation of some 
solvent in order to form scaffolds by one of the two routes. One method is to dip the mold 
into polymeric solution and allow sufficient time to draw off the solution; as a result a layer 
of polymeric membrane is created. Other method is to add the polymeric solution into a 
mold and provide the sufficient time to evaporate the solvent that create a layer of 
polymeric membrane, which adhere to the mold (Mikos et al., 2004).  
One of the main drawbacks of this technique, the toxic solvent denatures the protein and 
may affect other solvents. There is a possibility that the scaffolds designed by these 
techniques may also retain some of the toxicity. To overcome these problems scaffolds are 
fully dried by vacuum process to remove toxic solvent. However, this is very time 
consuming technique and to overcome these problems some researchers have combined it 
with particulate leaching techniques (Mikos et al., 1993a; 1993b; 1996) for the fabrication of 
scaffolds.  
 
2.2 Particulate-leaching techniques 
Particulate leaching is one of the popular techniques that are widely used to fabricate 
scaffolds for tissue engineering applications (Ma & Langer, 1999; Lu et al, 2000). Salt, wax or 
sugars known as porogens are used to create the pores or channels. Here salt is grounded 
into small particles and those particles that have desired size are poured into a mold and 
filled with the porogen. A polymer solution is then cast into the salt-filled mold. After the 
evaporation of the solvent, the salt crystals are leached away using water to form the pores 
of the scaffold.  
The process is easy to carry out. The pore size can be controlled by controlling the amount of 
porogen added, the size and shape of the porogen (Plikk et al., 2009). The particulate 
leached scaffold possesses pore size (~500 µm), percentage porosity (around 94-95%) and 
desired crystallinity.  The advantage of this method is the requirement of very less amount 
of polymer to fabricate the scaffold. However, certain critical variables such as pore shape 
and inter-pore openings are not controlled. To conquer these drawback new technologies, 
are being developed. 
 
2.3 Gas foaming  
Many of the fabrication techniques require use of organic solvents and high temperature. 
The residues that remains after completion of process can damage cells and nearby tissues. 
This may also denature the biologically active molecules incorporated  within the scaffolds. 
The gas foaming scaffold fabrication techniques does not require the utilization of organic 
solvents and high temperature. 
This technique uses high pressure carbon dioxide gas for the fabrication of highly porous 
scaffolds. The porosity and porous structure of the scaffolds depend upon the amount of gas 
dissolved in the polymer. This process involves exposing highly porous polymer with 
carbon dioxide at high pressure (800 psi) to saturate the polymer with gas (Sachlos & 
Czernuszka, 2003). Under this condition, dissolved carbon dioxide becomes unstable and 
will phase separates from the polymer. The carbon dioxide molecule becomes cluster to 
minimize the free energy; as a result pore nucleation is created. These pores cause the 
significant expansion of polymeric volume and decrease in polymeric density. A three-
dimensional porous structure (scaffolds) is formed after completion of foaming process.  
The porosity of the scaffolds is controlled by the use of porogens like sugar, salts and wax 
(Ikada, 2006). The polymer (eg, PLGA) that expands in foaming process fused together 
around the porogen to create a continuous polymeric matrix, and also entrap any other 
molecule which is present in the mixture. The mix polymer and porogen are exposed to high 
pressure until they have completed its saturation with carbon dioxide, followed by foaming 
process porogen is removed and a highly interconnected pore structure is formed (Huang & 
Mooney, 2005). 
 
2.4 Phase separation 
Phase separation technique for scaffolds designing requires temperature change that 
separates the polymeric solution in two phases, one having low polymer concentration 
(polymer lean phase) and other having the high polymer concentration (polymer rich 
phase). Polymer is dissolved in phenol or naphthalene, followed by dispersion of 
biologically active molecule in these solutions. By lowering the temperature liquid-liquid 
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(5) Adequate mechanical properties to maintain the structure and function immediately 
after implantation and during remodelling of the implants (Karande & Agrawal, 2008; Kim 
et al., 2000; Lee et al., 2001).  
 (6) It should acquire the sufficient mechanical properties to provide the better environment 
for cells, deliver inductive molecules or cells to the repair site and provide cues to control 
the structure and function of newly formed tissue (Hutmacher 2000; 2001). 
 (7) It should support the formation of ECM by promoting cellular functions, and have the 
ability to provide the bimolecular signals to the cells (Ito et al., 2003).  
 (8) Scaffolds used for tissue engineering should mimic in part the structure and biological 
function of the extracellular matrix (Ma, 2008; Li & Shi, 2007).  
Many techniques have been developed to fabricate three-dimensional porous architectures 
to fill this role, such as by particle leaching (Ma & Langer, 1999; Lu et al., 2000), phase 
separation (Sachlos & Czernuszka, 2003; Smith et al., 2006) and textile technology. However, 
scaffolds fabricate by these  techniques do not adequately mimic the structure of the natural 
extracellular matrix in terms of architecture, which may be one of the reasons for suboptimal 
outcome in generating functional tissues (Lavik, & Langer, 2004; Laurencin et al., 1999; 
Hutmacher 2001). Therefore, new designs and manufacture technologies are required to 
improve the function and architecture of scaffolds. This chapter discusses the different 
scaffold fabrication methodologies/techniques utilizing several synthetic and natural 
polymers, including solvent casting, particulate leaching, gas foaming, phase separation, 
electrospinning, porogen leaching, fiber mesh, fiber bonding, self assembly, rapid 
prototyping, melt molding, membrane lamination and freeze drying.  
 
2. Fabrication techniques 
In the body, cells and tissue are organized into three-dimensional architecture. To engineer 
these functional tissue and organs, scaffolds have to be fabricated by different methodology 
to facilitate the cell distribution and guide their growth into three-dimensional space. The 
main techniques for scaffolds fabrication are mentioned here. 
 
2.1 Solvent casting  
Solvent casting property for the scaffolds preparation is very simple, easy and inexpensive. 
It does not require any large equipment; it is totally based upon the evaporation of some 
solvent in order to form scaffolds by one of the two routes. One method is to dip the mold 
into polymeric solution and allow sufficient time to draw off the solution; as a result a layer 
of polymeric membrane is created. Other method is to add the polymeric solution into a 
mold and provide the sufficient time to evaporate the solvent that create a layer of 
polymeric membrane, which adhere to the mold (Mikos et al., 2004).  
One of the main drawbacks of this technique, the toxic solvent denatures the protein and 
may affect other solvents. There is a possibility that the scaffolds designed by these 
techniques may also retain some of the toxicity. To overcome these problems scaffolds are 
fully dried by vacuum process to remove toxic solvent. However, this is very time 
consuming technique and to overcome these problems some researchers have combined it 
with particulate leaching techniques (Mikos et al., 1993a; 1993b; 1996) for the fabrication of 
scaffolds.  
 
2.2 Particulate-leaching techniques 
Particulate leaching is one of the popular techniques that are widely used to fabricate 
scaffolds for tissue engineering applications (Ma & Langer, 1999; Lu et al, 2000). Salt, wax or 
sugars known as porogens are used to create the pores or channels. Here salt is grounded 
into small particles and those particles that have desired size are poured into a mold and 
filled with the porogen. A polymer solution is then cast into the salt-filled mold. After the 
evaporation of the solvent, the salt crystals are leached away using water to form the pores 
of the scaffold.  
The process is easy to carry out. The pore size can be controlled by controlling the amount of 
porogen added, the size and shape of the porogen (Plikk et al., 2009). The particulate 
leached scaffold possesses pore size (~500 µm), percentage porosity (around 94-95%) and 
desired crystallinity.  The advantage of this method is the requirement of very less amount 
of polymer to fabricate the scaffold. However, certain critical variables such as pore shape 
and inter-pore openings are not controlled. To conquer these drawback new technologies, 
are being developed. 
 
2.3 Gas foaming  
Many of the fabrication techniques require use of organic solvents and high temperature. 
The residues that remains after completion of process can damage cells and nearby tissues. 
This may also denature the biologically active molecules incorporated  within the scaffolds. 
The gas foaming scaffold fabrication techniques does not require the utilization of organic 
solvents and high temperature. 
This technique uses high pressure carbon dioxide gas for the fabrication of highly porous 
scaffolds. The porosity and porous structure of the scaffolds depend upon the amount of gas 
dissolved in the polymer. This process involves exposing highly porous polymer with 
carbon dioxide at high pressure (800 psi) to saturate the polymer with gas (Sachlos & 
Czernuszka, 2003). Under this condition, dissolved carbon dioxide becomes unstable and 
will phase separates from the polymer. The carbon dioxide molecule becomes cluster to 
minimize the free energy; as a result pore nucleation is created. These pores cause the 
significant expansion of polymeric volume and decrease in polymeric density. A three-
dimensional porous structure (scaffolds) is formed after completion of foaming process.  
The porosity of the scaffolds is controlled by the use of porogens like sugar, salts and wax 
(Ikada, 2006). The polymer (eg, PLGA) that expands in foaming process fused together 
around the porogen to create a continuous polymeric matrix, and also entrap any other 
molecule which is present in the mixture. The mix polymer and porogen are exposed to high 
pressure until they have completed its saturation with carbon dioxide, followed by foaming 
process porogen is removed and a highly interconnected pore structure is formed (Huang & 
Mooney, 2005). 
 
2.4 Phase separation 
Phase separation technique for scaffolds designing requires temperature change that 
separates the polymeric solution in two phases, one having low polymer concentration 
(polymer lean phase) and other having the high polymer concentration (polymer rich 
phase). Polymer is dissolved in phenol or naphthalene, followed by dispersion of 
biologically active molecule in these solutions. By lowering the temperature liquid-liquid 
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phase is separated and quenched to form a two phase solid and the solvent has removed by 
extraction, evaporation and sublimation (Mikos et al., 2004) to give porous scaffolds with 
bioactive molecules integrated in to that structure (Sachlos & Czernuszka, 2003; Hua et al., 
2002).  
An appropriate liquid-liquid phase separation is critical for the preparation of nanofibers 
and does not occur in all solvents that’s why selection of solvent and phase separation 
temperature is crucial for the formation of nanofibers. When the condition are favourable, 
liquid-liquid phase separation produce  three dimensional fibrous structure with nano 
scaled architecture similar to that of  collagen type I, and used in various biomedical 
applications. 
Advantage of the phase separation technique is that, it can easily combine with other 
fabrication technology (Particulate leaching) to design three dimensional structures with 
control pore morphology. It can also be combined with rapid prototyping to create nano 
fibrous scaffolds for tissue engineering applications (Smith et al., 2006). 
 
2.5 Electrospinning 
The electrospinning technique for the scaffolds designing utilizes the electrostatic force for 
the production of polymeric fiber ranging from nanoscale to microscale. This process is 
control by high intensity electric field between two electrodes having electric charges of 
opposite polarity. One electrode is placed in the polymer solution and other is placed in 
collector. Generally polymer solution is pumped as result in forming a drop of solution. 
Afterwards, electric field is generated, which intends to produce a force, due to this the 
droplets results to overcome the surface tension of the solution. A jet of polymer is ejected, 
which produces the fibers, same instant the solvent starts evaporating due to jet formation 
and continues after the nanofibers are deposited to collector.  
More than 200 polymers are used for electrospinning like silk fibroin (Zarkoob et al., 2004; 
Sukigara et al., 2003; Jin et al., 2004), collagen (Mathews et al., 2002), chitosan (Ohkawa et al., 
2004), gelatin (Ma et al., 2005) etc.  In the field of tissue engineering electrospinning 
technique is applied for the preparation of nanofiber scaffold design. The process is very 
versatile in terms of use of polymers, non-invasive and does not require the use of 
coagulation chemistry or high temperature for fiber generation. Basically, in this process a 
high voltage is used to create an electrically charged jet of polymer solution or melt, which 
forms polymer fiber after drying or solidification (Reneker and Chun, 1996; Doshi and 
Reneker, 1995).    
One of the main advantages of this technique is that it can produce the scaffold with main 
structural feature suitable for growth of the cell and subsequent tissue organization (Li & 
Tuan, 2009; Liang et al., 2007; Leong et al., 2008). It can produce the ultra fine fibers with 
special orientation, high aspect ratio, high surface area, and having control over pore 
geometry. These characteristics are favorable for better cellular growth for in vitro and in 
vivo because they directly influence the cell adhesion, cell expression, and transportation of 
oxygen, nutrients to the cells. This provides spatial environment for the growth of new 
tissue with appropriate physiological functions. Cell seeding is the main problem of 
electrospining technology. This is overcome by sacrificial biopolymer or cryospinning, 
which allows creating the hole of desired size in electrospun matrices (Baker et al., 2008; 
Leong et al., 2008). 
 
The nano fibrous scaffolds are widely used in biomedical application for scaffolds 
preparation for tissue engineering (Ma et al., 2005; Yang et al., 2005), wound dressing (Kim 
et al., 2000), artificial blood vessels (Ma et al., 2005), protective clothing material (Lu and 
Ding , 2008), drug release membrane (Katti et al., 2004, Chew et al., 2005; Venugopal et al., 
2008), nanotube material, chemical catalytic apparatus, bio-transplant material, and 
hydrogen storage tank for fuel cell (Cho et al., 2003). 
The nanofibrous scaffolds are prepared for the biomedical application such as 
hydrophilicity, mechanical strength, biodegradability, biocompatibility, interaction of cells , 
which are controlled by chemical composition of the material (Madurantakam et al., 2009). 
On the basis of that by selecting and adjusting the combination of proper component ratio, 
property of electrospinning scaffolds can be customized with desired function.  
 
2.6 Porogen leaching  
Porogen leaching is one of the most common methods used for preparation of scaffolds with 
controlled porosity. The particulate leaching method is totally based upon the dispersion of 
porogen (salt, sugar and wax) either in liquid particulates or powdered materials (Hou et al., 
2003; Lee et al., 2004, Nazarov et al., 2004 Vepari & Kaplan, 2007) by the process of 
evaporation, cross linking or other reaction liquid may be solidified. These porogens act as 
place holder for pore and interconnection of the pores in the actual scaffolds fabrication 
technique. Highly porous scaffold with porosity up to 93 % and pore diameter up to 500 
micrometers can be prepared by using this technique (Mikos et al., 1993 a; b).  
Main objective of this technique is the realization of bigger pore size and increase pore 
interconnectivity. Main advantage of this technique is its simplicity, versatility and easy to 
control the pore size and geometry. Pore geometry is control by the selection of the shape 
for specific porogen agent, where as pore size is control by sieving the porogen particle to 
the specific dimensional range (Mano et al., 2007). One of the main drawbacks of this 
technique is that it can only produce thin wafers or membrane up to 3 mm thick and very 
difficult to design the scaffolds with accurate pore inter-connectivity (Moore et al., 2004). 
 
2.7 Fiber mesh  
Fiber mesh technique for scaffold fabrication consists of individual fiber either woven or 
interweave into three dimensional pattern of variable pore size (Martins et al., 2009). PGA is 
the first biocompatible and biodegradable polymer to spun into the fiber and used as a 
synthetic suture thread. It is prepared by the deposition of polymer solution over a 
nonwoven mesh of another polymer followed by subsequent evaporation (Ikada, 2006). 
Main advantage of this technique is to provide the large surface area for cell attachment and 
rapid diffusion of nutrient that is favourable for cell survival and growth (Chen et al., 2002). 
However one of the main drawbacks of this technique is lack of structural stability which 
can partly be overcome by hot drying of PLLA fiber to improve the structure orientation 
and crystallinity. 
 
2.8 Fiber bonding  
Fiber bonding technique for scaffold fabrication is developed by Mikos and his coworkers 
(Mikos et al., 1993a). Synthetic polymer (PLLA) was dissolved in chloroform followed by 
non-woven mesh of PGA fiber had added. Subsequently solvent was removed by 
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phase is separated and quenched to form a two phase solid and the solvent has removed by 
extraction, evaporation and sublimation (Mikos et al., 2004) to give porous scaffolds with 
bioactive molecules integrated in to that structure (Sachlos & Czernuszka, 2003; Hua et al., 
2002).  
An appropriate liquid-liquid phase separation is critical for the preparation of nanofibers 
and does not occur in all solvents that’s why selection of solvent and phase separation 
temperature is crucial for the formation of nanofibers. When the condition are favourable, 
liquid-liquid phase separation produce  three dimensional fibrous structure with nano 
scaled architecture similar to that of  collagen type I, and used in various biomedical 
applications. 
Advantage of the phase separation technique is that, it can easily combine with other 
fabrication technology (Particulate leaching) to design three dimensional structures with 
control pore morphology. It can also be combined with rapid prototyping to create nano 
fibrous scaffolds for tissue engineering applications (Smith et al., 2006). 
 
2.5 Electrospinning 
The electrospinning technique for the scaffolds designing utilizes the electrostatic force for 
the production of polymeric fiber ranging from nanoscale to microscale. This process is 
control by high intensity electric field between two electrodes having electric charges of 
opposite polarity. One electrode is placed in the polymer solution and other is placed in 
collector. Generally polymer solution is pumped as result in forming a drop of solution. 
Afterwards, electric field is generated, which intends to produce a force, due to this the 
droplets results to overcome the surface tension of the solution. A jet of polymer is ejected, 
which produces the fibers, same instant the solvent starts evaporating due to jet formation 
and continues after the nanofibers are deposited to collector.  
More than 200 polymers are used for electrospinning like silk fibroin (Zarkoob et al., 2004; 
Sukigara et al., 2003; Jin et al., 2004), collagen (Mathews et al., 2002), chitosan (Ohkawa et al., 
2004), gelatin (Ma et al., 2005) etc.  In the field of tissue engineering electrospinning 
technique is applied for the preparation of nanofiber scaffold design. The process is very 
versatile in terms of use of polymers, non-invasive and does not require the use of 
coagulation chemistry or high temperature for fiber generation. Basically, in this process a 
high voltage is used to create an electrically charged jet of polymer solution or melt, which 
forms polymer fiber after drying or solidification (Reneker and Chun, 1996; Doshi and 
Reneker, 1995).    
One of the main advantages of this technique is that it can produce the scaffold with main 
structural feature suitable for growth of the cell and subsequent tissue organization (Li & 
Tuan, 2009; Liang et al., 2007; Leong et al., 2008). It can produce the ultra fine fibers with 
special orientation, high aspect ratio, high surface area, and having control over pore 
geometry. These characteristics are favorable for better cellular growth for in vitro and in 
vivo because they directly influence the cell adhesion, cell expression, and transportation of 
oxygen, nutrients to the cells. This provides spatial environment for the growth of new 
tissue with appropriate physiological functions. Cell seeding is the main problem of 
electrospining technology. This is overcome by sacrificial biopolymer or cryospinning, 
which allows creating the hole of desired size in electrospun matrices (Baker et al., 2008; 
Leong et al., 2008). 
 
The nano fibrous scaffolds are widely used in biomedical application for scaffolds 
preparation for tissue engineering (Ma et al., 2005; Yang et al., 2005), wound dressing (Kim 
et al., 2000), artificial blood vessels (Ma et al., 2005), protective clothing material (Lu and 
Ding , 2008), drug release membrane (Katti et al., 2004, Chew et al., 2005; Venugopal et al., 
2008), nanotube material, chemical catalytic apparatus, bio-transplant material, and 
hydrogen storage tank for fuel cell (Cho et al., 2003). 
The nanofibrous scaffolds are prepared for the biomedical application such as 
hydrophilicity, mechanical strength, biodegradability, biocompatibility, interaction of cells , 
which are controlled by chemical composition of the material (Madurantakam et al., 2009). 
On the basis of that by selecting and adjusting the combination of proper component ratio, 
property of electrospinning scaffolds can be customized with desired function.  
 
2.6 Porogen leaching  
Porogen leaching is one of the most common methods used for preparation of scaffolds with 
controlled porosity. The particulate leaching method is totally based upon the dispersion of 
porogen (salt, sugar and wax) either in liquid particulates or powdered materials (Hou et al., 
2003; Lee et al., 2004, Nazarov et al., 2004 Vepari & Kaplan, 2007) by the process of 
evaporation, cross linking or other reaction liquid may be solidified. These porogens act as 
place holder for pore and interconnection of the pores in the actual scaffolds fabrication 
technique. Highly porous scaffold with porosity up to 93 % and pore diameter up to 500 
micrometers can be prepared by using this technique (Mikos et al., 1993 a; b).  
Main objective of this technique is the realization of bigger pore size and increase pore 
interconnectivity. Main advantage of this technique is its simplicity, versatility and easy to 
control the pore size and geometry. Pore geometry is control by the selection of the shape 
for specific porogen agent, where as pore size is control by sieving the porogen particle to 
the specific dimensional range (Mano et al., 2007). One of the main drawbacks of this 
technique is that it can only produce thin wafers or membrane up to 3 mm thick and very 
difficult to design the scaffolds with accurate pore inter-connectivity (Moore et al., 2004). 
 
2.7 Fiber mesh  
Fiber mesh technique for scaffold fabrication consists of individual fiber either woven or 
interweave into three dimensional pattern of variable pore size (Martins et al., 2009). PGA is 
the first biocompatible and biodegradable polymer to spun into the fiber and used as a 
synthetic suture thread. It is prepared by the deposition of polymer solution over a 
nonwoven mesh of another polymer followed by subsequent evaporation (Ikada, 2006). 
Main advantage of this technique is to provide the large surface area for cell attachment and 
rapid diffusion of nutrient that is favourable for cell survival and growth (Chen et al., 2002). 
However one of the main drawbacks of this technique is lack of structural stability which 
can partly be overcome by hot drying of PLLA fiber to improve the structure orientation 
and crystallinity. 
 
2.8 Fiber bonding  
Fiber bonding technique for scaffold fabrication is developed by Mikos and his coworkers 
(Mikos et al., 1993a). Synthetic polymer (PLLA) was dissolved in chloroform followed by 
non-woven mesh of PGA fiber had added. Subsequently solvent was removed by 
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evaporation as a result a composite material, which consists of non-bonded PGA fiber, 
embedded in PLLA matrix is formed (Chen et al., 2002). The scaffolds were fabricated by 
bonding a collagen matrix to PGA polymers with threaded collagen fiber stitches (Eberli et 
al., 2009). Fiber bonding occurs during post treatments at a temperature above the melting 
temperature of PGA. As a result PLLA matrix of the composite has removed by dissolving 
in methylene chloride agent (Sachlos and Czernuszka, 2003) utilizing the fact that PGA is 
insoluble in this solvent.  
This process yields the scaffolds of PGA fiber that is bonded together by heat treatment. 
PGA mesh provides the high porosity and surface area to polymer mass ratio (Mooney et 
al., 1996). This provides the mechanical stability and allows the tissue ingrowths. One of the 
main advantages of using the fiber is its large surface area, which is suitable for scaffolds 
applications. Therefore, it provides the more surface area for cells attachment and sufficient 
space for the regeneration of extracellular matrix (Moroni et al., 2008)   
 
2.9 Self assembly 
Self assembly is the spontaneous organization of the molecule into well defines into an 
ordered structure required for specific function (Zhang, 2003). Self assembly of natural or 
synthetic molecule produced nanoscale fibers known as nanofibers. 
Amphiphilic peptide sequence is a common method for the fabrication of 3D nanofibrous 
structure for tissue engineering. In aqueous solution the hydrophobic and hydrophilic 
domains within these peptides interact together with the help of weak non covalent bonds 
(Joshi et al., 2009; Zhang et al., 2006) (eg. Hydrogen bond, Van der Waals interactions, ionic 
bond and hydrophobic interaction) this produces distinct fast recovering hydrogel, with the 
hydrophobic interactions as the molecules come together. 
Instead of peptides synthetic polymer nanofibers are also prepared by self assembly of 
diblock polymers (AxBy) when the two blocks separate from one another in bulk due to 
their incompatibility, the volume formation of A and B can be controlled to obtain B domain 
of cylindrical shape with nanoscale diameter that is embedded into matrix A. Polymeric 
dendrimers can also self-assemble into nanofibers (Liu et al., 1996; 1999).  
The di- and tri-block peptide ampholites (PAs) are designed that are self-assembled into a 
rod-like architecture. So a new technique for the self-assembly of PAs into nanofibers by 
controlling pH and by engineering the peptide head group of the PAs is developed 
(Hartgerink et al., 2001). 
According to Hartgerink et al., (2002) and Tambralli et al., (2009) the salient features for 
synthesis of the PA involve the following: 
1. Phosphoserine residue incorporation to increase hydroxyapatite mineralization. 
2. RGD (Arg-Gly-Asp) peptide incorporation to enhance integrin-mediated cell adhesion. 
3. Four consecutive cystine residues incorporation forming inter-molecular disulfide bonds 
that polymerizes to provide improved structural stability. 
4. Flexible linker region incorporation consisting of three glycine residues to provide 
flexibility to the head group. 
By virtue of the modifications in the structure of the PA enables a variety of self-assemblies 
including layered and lamellar structures and by its reversibility properties provides 
flexibility to the system. Therefore, the self-assembly technique shows designing potential 
novel scaffolds for tissue engineering applications.   
 
Self assembly shows several advantages over the electrospinning because it produces the 
much thinner nanofiber with very thin diameter (Ma, 2008). The fabricated nanofibers have 
amino acid residues that may be chemically modified by the addition of bioactive moieties. 
Other advantage of this technique is to avoid the use of organic solvent and reduce the 
cytotoxicity because it is carried out in aqueous salt solution or physiological media (Ma et 
al., 2005). Main disadvantage of this technique is its complicated and elaborated process. 
 
2.10 Rapid prototyping (RP) 
RP is also called as solid free-form technique. This technique is more advanced technique for 
scaffold fabrication. It is computer controlled fabrication technique. It can rapidly produce 
3D object by using layer manufacturing method. RP technique generally comprises the 
design of scaffold model by using the computer added design (CAD) software, which is 
then expressed as a series of cross section (Lin et al., 2008, Woodfield et al., 2009). 
Corresponding to each cross section RP machine lays down a layer of material starting from 
the bottom and moving up a layer at a time to create the scaffolds. In typical example, image 
of bone defect in a patient can be taken and develop 3D CAD computer model. The 
computer then can reduced the model to slice or layers. The 3D objects are constructed layer 
by layer by using RP techniques such as fused deposition modeling (FDM), selective laser 
sintering (SLS), 3D printing (3D-P) or stereolithography. 
Now a day RP is an efficient way for generating the scaffolds of desired property, other 
advantage of this technique is to produce the parts with highly reproducible architecture 
and compositional variations. RP has advantage over other fabrication techniques, it has 
ability to control matrix architecture (size, shape, inter connectivity, branching, geometry 
and orientation) yielding biomimetic structure, that varying in design and material 
composition. It has ability to control the mechanical property, biological effects and 
degradation kinetics of scaffolds (Kai et al., 2009; Hutmacher et al., 2000; 2001). 
RP technique can easily be integrated with the imaging technique to produce the scaffolds 
that are customized in size and shape allowing the tissue engineered graft to be modified for 
particular applications or for individual patient. One of the main drawbacks of this 
technique is achieved low resolution by current systems and types of polymeric materials 
that are used for this technique  
 
2.11 Melt molding 
A large number of techniques are discussed for the fabrication of scaffolds. These scaffolds 
fabrication techniques are developed to control the pore interconnectivity and geometry, 
which are important for the exchange of nutrient/waste from pore to pore. Melt molding 
process involves the filling of teflon mould with PLGA powder and gelatin microspheres of 
specific diameter followed by heating the mould above the glass transition temperature of 
PLGA while applying pressure to the mixture (Thompson et al., 1995a, 1995 b). This action 
causes the PLGA particle to attach together. Once the mould is removed gelatin 
microspheres is dissolved by immersing the mixture into water and scaffolds are then dried.   
Scaffolds produced by this technique assume the shape of the mould. Melt molding process 
was modified to incorporate short fiber of hydroxyapatite (HA). Uniform distribution of HA 
fiber throughout the PLGA scaffolds could only be achieved by using the solvent casting 
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evaporation as a result a composite material, which consists of non-bonded PGA fiber, 
embedded in PLLA matrix is formed (Chen et al., 2002). The scaffolds were fabricated by 
bonding a collagen matrix to PGA polymers with threaded collagen fiber stitches (Eberli et 
al., 2009). Fiber bonding occurs during post treatments at a temperature above the melting 
temperature of PGA. As a result PLLA matrix of the composite has removed by dissolving 
in methylene chloride agent (Sachlos and Czernuszka, 2003) utilizing the fact that PGA is 
insoluble in this solvent.  
This process yields the scaffolds of PGA fiber that is bonded together by heat treatment. 
PGA mesh provides the high porosity and surface area to polymer mass ratio (Mooney et 
al., 1996). This provides the mechanical stability and allows the tissue ingrowths. One of the 
main advantages of using the fiber is its large surface area, which is suitable for scaffolds 
applications. Therefore, it provides the more surface area for cells attachment and sufficient 
space for the regeneration of extracellular matrix (Moroni et al., 2008)   
 
2.9 Self assembly 
Self assembly is the spontaneous organization of the molecule into well defines into an 
ordered structure required for specific function (Zhang, 2003). Self assembly of natural or 
synthetic molecule produced nanoscale fibers known as nanofibers. 
Amphiphilic peptide sequence is a common method for the fabrication of 3D nanofibrous 
structure for tissue engineering. In aqueous solution the hydrophobic and hydrophilic 
domains within these peptides interact together with the help of weak non covalent bonds 
(Joshi et al., 2009; Zhang et al., 2006) (eg. Hydrogen bond, Van der Waals interactions, ionic 
bond and hydrophobic interaction) this produces distinct fast recovering hydrogel, with the 
hydrophobic interactions as the molecules come together. 
Instead of peptides synthetic polymer nanofibers are also prepared by self assembly of 
diblock polymers (AxBy) when the two blocks separate from one another in bulk due to 
their incompatibility, the volume formation of A and B can be controlled to obtain B domain 
of cylindrical shape with nanoscale diameter that is embedded into matrix A. Polymeric 
dendrimers can also self-assemble into nanofibers (Liu et al., 1996; 1999).  
The di- and tri-block peptide ampholites (PAs) are designed that are self-assembled into a 
rod-like architecture. So a new technique for the self-assembly of PAs into nanofibers by 
controlling pH and by engineering the peptide head group of the PAs is developed 
(Hartgerink et al., 2001). 
According to Hartgerink et al., (2002) and Tambralli et al., (2009) the salient features for 
synthesis of the PA involve the following: 
1. Phosphoserine residue incorporation to increase hydroxyapatite mineralization. 
2. RGD (Arg-Gly-Asp) peptide incorporation to enhance integrin-mediated cell adhesion. 
3. Four consecutive cystine residues incorporation forming inter-molecular disulfide bonds 
that polymerizes to provide improved structural stability. 
4. Flexible linker region incorporation consisting of three glycine residues to provide 
flexibility to the head group. 
By virtue of the modifications in the structure of the PA enables a variety of self-assemblies 
including layered and lamellar structures and by its reversibility properties provides 
flexibility to the system. Therefore, the self-assembly technique shows designing potential 
novel scaffolds for tissue engineering applications.   
 
Self assembly shows several advantages over the electrospinning because it produces the 
much thinner nanofiber with very thin diameter (Ma, 2008). The fabricated nanofibers have 
amino acid residues that may be chemically modified by the addition of bioactive moieties. 
Other advantage of this technique is to avoid the use of organic solvent and reduce the 
cytotoxicity because it is carried out in aqueous salt solution or physiological media (Ma et 
al., 2005). Main disadvantage of this technique is its complicated and elaborated process. 
 
2.10 Rapid prototyping (RP) 
RP is also called as solid free-form technique. This technique is more advanced technique for 
scaffold fabrication. It is computer controlled fabrication technique. It can rapidly produce 
3D object by using layer manufacturing method. RP technique generally comprises the 
design of scaffold model by using the computer added design (CAD) software, which is 
then expressed as a series of cross section (Lin et al., 2008, Woodfield et al., 2009). 
Corresponding to each cross section RP machine lays down a layer of material starting from 
the bottom and moving up a layer at a time to create the scaffolds. In typical example, image 
of bone defect in a patient can be taken and develop 3D CAD computer model. The 
computer then can reduced the model to slice or layers. The 3D objects are constructed layer 
by layer by using RP techniques such as fused deposition modeling (FDM), selective laser 
sintering (SLS), 3D printing (3D-P) or stereolithography. 
Now a day RP is an efficient way for generating the scaffolds of desired property, other 
advantage of this technique is to produce the parts with highly reproducible architecture 
and compositional variations. RP has advantage over other fabrication techniques, it has 
ability to control matrix architecture (size, shape, inter connectivity, branching, geometry 
and orientation) yielding biomimetic structure, that varying in design and material 
composition. It has ability to control the mechanical property, biological effects and 
degradation kinetics of scaffolds (Kai et al., 2009; Hutmacher et al., 2000; 2001). 
RP technique can easily be integrated with the imaging technique to produce the scaffolds 
that are customized in size and shape allowing the tissue engineered graft to be modified for 
particular applications or for individual patient. One of the main drawbacks of this 
technique is achieved low resolution by current systems and types of polymeric materials 
that are used for this technique  
 
2.11 Melt molding 
A large number of techniques are discussed for the fabrication of scaffolds. These scaffolds 
fabrication techniques are developed to control the pore interconnectivity and geometry, 
which are important for the exchange of nutrient/waste from pore to pore. Melt molding 
process involves the filling of teflon mould with PLGA powder and gelatin microspheres of 
specific diameter followed by heating the mould above the glass transition temperature of 
PLGA while applying pressure to the mixture (Thompson et al., 1995a, 1995 b). This action 
causes the PLGA particle to attach together. Once the mould is removed gelatin 
microspheres is dissolved by immersing the mixture into water and scaffolds are then dried.   
Scaffolds produced by this technique assume the shape of the mould. Melt molding process 
was modified to incorporate short fiber of hydroxyapatite (HA). Uniform distribution of HA 
fiber throughout the PLGA scaffolds could only be achieved by using the solvent casting 
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technique to prepare the composite material of HA fiber, PLGA matrix and gelatin or salt 
porogen , which are used in melt molding process (Hou et al., 2003). 
 
2.12 Membrane lamination 
Membrane lamination is another SFF-like technique used for constructing three-dimensional 
biodegradable polymeric foam scaffolds with precise anatomical shapes. Membrane 
lamination is prepared by solvent casting and particle leaching and introducing peptide and 
proteins layer by layer during the fabrication process. The membranes with appropriate 
shape are soaked with solvent, and then stacked up in three-dimensional assemblies with 
continuous pore structure and morphology (Maquet & Jerome, 1997).The bulk properties of 
the final 3D scaffolds are identical to those of the individual membrane.  
This method generates the porous 3D polymer foams with defined anatomical shape, since 
it is possible to use the computer assisted modeling to design the template with desired 
implant shape. The disadvantage of this technique is that layering of porous sheets, result in 
lesser pore interconnectivity (Hutmacher et al., 2000; 2001) and other disadvantage of this 
technique is that it is a time consuming process since only thin membrane can be used in 
this process. 
 
2.13 Freeze drying 
Freeze drying technique is use for the fabrication of porous scaffolds (Whang et al., 1995; 
Schoof et al., 2001). This technique is based upon the principle of sublimation. Polymer is 
first dissolved in a solvent to form a solution of desired concentration. The solution is frozen 
and solvent is removed by lyophilization under the  high vacuum that fabricate the scaffold 
with high porosity and inter connectivity (Mandal & Kundu, 2009 a, b).This technique are 
applied to a number of different polymers including silk proteins (Vepari & Kaplan, 2007, 
Altman et al., 2003) PGA, PLLA, PLGA, PLGA/PPF blends. The pore size can be controlled 
by the freezing rate and pH; a fast freezing rate produces smaller pores.  Controlled 
solidification in a single direction has been used to create a homogenous 3D-pore structure 
(Schoof et al., 2001) 
Main advantage of this technique is that, it neither requires high temperature nor separate 
leaching step. The drawback of this technique is smaller pore size and long processing time 
(Boland et al., 2004). A schematic diagram for scaffold fabrication from silk protein by freeze 
drying technique is given as an example in figure 1 (Mandal & Kundu, 2008a; 2008b; 2009b; 
Kundu et al., 2008). 
 
 
 
 
 
 
 
 
 
 
 
 
Methods Merits Demerits References 
Solvent casting/ 
particulate 
leaching 
Control over 
Porosity, pore size 
and crystallinity  
Limited mechanical 
property, residual 
solvents and porogen 
material 
Ma, 2007; 
Xiang et al., 
2006 
Porogen leaching Controlled over 
porosity and pore 
geometry 
Inadequate pore size 
and pore 
interconnectivity 
Mano et al., 
2007 
Gas foaming Free of harsh organic 
solvents, control over 
porosity and pore 
size 
Limited mechanical 
property, inadequate 
pore interconnectivity 
Ikada., 2006 
Self assembly Control over 
porosity, pore size 
and fiber diameter  
Expensive material, 
complex design 
parameters 
Zhang et al., 
2003; 2006 
Electrospinning Control over 
porosity, pore size 
and fiber diameter 
Limited mechanical 
property, pore size 
decrease with fiber 
thickness 
Liang et al., 
2007 
Phase separation No decrease in the  
activity of the 
molecule  
Difficult to control 
precisely scaffold 
morphology  
Smith et al., 
2006 
Rapid   
prototyping  
Excellent control over 
geometry,  porosity, 
no supporting 
material required 
Limited polymer type, 
highly expensive 
equipment  
Hutmacher et 
al., 2000; 2001 
Fiber mesh Large surface area for 
cell attachment, rapid 
nutrient diffusion 
Lack the structural 
stability 
Chen et al., 
2002 
Fiber bonding High surface to 
volume ratio, high 
porosity 
Poor mechanical  
property, limited 
applications to other 
polymers 
Mooney et al., 
1996 
Melt molding Independent control 
over porosity and 
pore size 
Required high 
temperature for non  
amorphous polymer 
Thompson  et 
al., 1995 a; b 
Membrane 
lamination 
Provide 3D matrix Lack required 
mechanical strength, 
inadequate pore 
interconnectivity 
Maquet & 
Jerome, 1997 
Freeze drying 
 
High temperature 
and separate leaching 
step  not required 
Small pore size and long 
processing time 
Boland et al., 
2004; Mandal  
& Kundu, 
2008 
Table 1. Merits and demerits of different fabrication techniques 
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technique to prepare the composite material of HA fiber, PLGA matrix and gelatin or salt 
porogen , which are used in melt molding process (Hou et al., 2003). 
 
2.12 Membrane lamination 
Membrane lamination is another SFF-like technique used for constructing three-dimensional 
biodegradable polymeric foam scaffolds with precise anatomical shapes. Membrane 
lamination is prepared by solvent casting and particle leaching and introducing peptide and 
proteins layer by layer during the fabrication process. The membranes with appropriate 
shape are soaked with solvent, and then stacked up in three-dimensional assemblies with 
continuous pore structure and morphology (Maquet & Jerome, 1997).The bulk properties of 
the final 3D scaffolds are identical to those of the individual membrane.  
This method generates the porous 3D polymer foams with defined anatomical shape, since 
it is possible to use the computer assisted modeling to design the template with desired 
implant shape. The disadvantage of this technique is that layering of porous sheets, result in 
lesser pore interconnectivity (Hutmacher et al., 2000; 2001) and other disadvantage of this 
technique is that it is a time consuming process since only thin membrane can be used in 
this process. 
 
2.13 Freeze drying 
Freeze drying technique is use for the fabrication of porous scaffolds (Whang et al., 1995; 
Schoof et al., 2001). This technique is based upon the principle of sublimation. Polymer is 
first dissolved in a solvent to form a solution of desired concentration. The solution is frozen 
and solvent is removed by lyophilization under the  high vacuum that fabricate the scaffold 
with high porosity and inter connectivity (Mandal & Kundu, 2009 a, b).This technique are 
applied to a number of different polymers including silk proteins (Vepari & Kaplan, 2007, 
Altman et al., 2003) PGA, PLLA, PLGA, PLGA/PPF blends. The pore size can be controlled 
by the freezing rate and pH; a fast freezing rate produces smaller pores.  Controlled 
solidification in a single direction has been used to create a homogenous 3D-pore structure 
(Schoof et al., 2001) 
Main advantage of this technique is that, it neither requires high temperature nor separate 
leaching step. The drawback of this technique is smaller pore size and long processing time 
(Boland et al., 2004). A schematic diagram for scaffold fabrication from silk protein by freeze 
drying technique is given as an example in figure 1 (Mandal & Kundu, 2008a; 2008b; 2009b; 
Kundu et al., 2008). 
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Ikada., 2006 
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and fiber diameter  
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Zhang et al., 
2003; 2006 
Electrospinning Control over 
porosity, pore size 
and fiber diameter 
Limited mechanical 
property, pore size 
decrease with fiber 
thickness 
Liang et al., 
2007 
Phase separation No decrease in the  
activity of the 
molecule  
Difficult to control 
precisely scaffold 
morphology  
Smith et al., 
2006 
Rapid   
prototyping  
Excellent control over 
geometry,  porosity, 
no supporting 
material required 
Limited polymer type, 
highly expensive 
equipment  
Hutmacher et 
al., 2000; 2001 
Fiber mesh Large surface area for 
cell attachment, rapid 
nutrient diffusion 
Lack the structural 
stability 
Chen et al., 
2002 
Fiber bonding High surface to 
volume ratio, high 
porosity 
Poor mechanical  
property, limited 
applications to other 
polymers 
Mooney et al., 
1996 
Melt molding Independent control 
over porosity and 
pore size 
Required high 
temperature for non  
amorphous polymer 
Thompson  et 
al., 1995 a; b 
Membrane 
lamination 
Provide 3D matrix Lack required 
mechanical strength, 
inadequate pore 
interconnectivity 
Maquet & 
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High temperature 
and separate leaching 
step  not required 
Small pore size and long 
processing time 
Boland et al., 
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Fig. 1. Schematic diagram of scaffold fabrication from silk fibroin protein by freeze drying 
technique. The silk fibroin proteins may be obtained from two different silkworm sources 
either from the silk gland of non mulberry late 5th instar silkworm larva as an example from 
Indian tropical tasar silkworm (Antheraea mylitta). It is difficult to obtain sufficient amount of 
fibroin from cocoon sources of non mulberry (Mandal & Kundu, 2008a; 2008b; 2009 a) or 
from cocoons of mulberry silkworm, Bombyx mori (Altman et al., 2003; Mandal and Kundu, 
2009b; Kundu et al., 2008). 
 
 
3. Conclusion 
Scaffolds are used to provide sites for cells attachment, proliferation, differentiation and 
migration by up regulating and down regulating the synthesis of protein and growth 
factors. They provide mechanical support, deliver inductive molecules or cells to the repair 
site. Scaffolds also provide cues to control the structure and function of newly formed tissue. 
Recently decellularized extracellular matrix has been suggested as a scaffold for heart valve 
tissue engineering or direct implantation. However, cell removal damages the physical and 
biochemical properties of the valve leaflet structure. Matrix /polymer hybrid scaffold with 
improved biomechanical characteristics may be advantageous for many tissue engineering 
aspects such as heart valve tissue engineering (Hao et al., 2008). Equilibrium is needed 
between highly porous scaffolds that allow rapid tissue ingrowths and minimize diffusion 
limitations and less porous materials that retain both construct shape and the ability to bear 
mechanical loads in a complex biochemical and mechanical environment. 
The incorporation of the bioactive molecules like the growth factor, enzymes, ECM proteins, 
DNA is another vital consideration while designing the scaffolds. The fabrication 
methodologies that do not inactivate the biological activity of the bioactive molecule within the 
scaffolds need to be used judiciously. Scaffolds can be made by different types of fabrication 
techniques. The fabrication techniques provide the regular architectures; allow mechanical and 
finite element analyses to be carried out, which permit quantification of suitable mechanical 
and chemical microenvironments for cells and tissues assisting in the development of the next 
generation of tissue engineered scaffolds. The fabrication technique for the tissue engineered 
scaffold is directly related to the bulk and surface properties of the polymer and the proposed 
function of the scaffold. While each technique has its inherent merits and demerits, the 
appropriate selection of the methodologies must satisfy the requirements of the specific tissue 
to be repaired or engineered. Another hindrance in the tissue engineering research and 
scaffold design is the ignorance of the researchers on the possible interactions that exists 
between different cell types, such as the communication between the scaffold and the cells 
seeded within, cells and the different soluble factors, the typical behaviour of cells under the 
physical forces (shear, compression and vibration forces)  
The different techniques are developed to improve the current scaffold design by controlling 
the regular pore size, pore interconnectivity, porosity and pore characterizations that is 
suitable for rapid nutrient diffusion and cell attachment. Table 1 shows the most commonly 
used scaffolds fabrication technologies for potential tissue engineering applications 
indicating their merits and demerits of each technique. Some references given below in this 
chapter allow interested readers to go through the detail of fabrication techniques. Recent 
advances in both computational topology design (CTD) and solid free-form fabrication (SFF) 
have made it possible to create scaffolds with controlled architecture (Hollister, 2005). 
Finally, future directions are utilization of modelled scaffolds with in vivo experimentation 
to optimize tissue-engineering treatments, and coupling scaffolds with cells, genes and 
proteins optimized to create smart scaffolds for tissue regeneration and controlling their 
delivery through the scaffold with spatial and temporal resolution. 
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2009b; Kundu et al., 2008). 
 
 
3. Conclusion 
Scaffolds are used to provide sites for cells attachment, proliferation, differentiation and 
migration by up regulating and down regulating the synthesis of protein and growth 
factors. They provide mechanical support, deliver inductive molecules or cells to the repair 
site. Scaffolds also provide cues to control the structure and function of newly formed tissue. 
Recently decellularized extracellular matrix has been suggested as a scaffold for heart valve 
tissue engineering or direct implantation. However, cell removal damages the physical and 
biochemical properties of the valve leaflet structure. Matrix /polymer hybrid scaffold with 
improved biomechanical characteristics may be advantageous for many tissue engineering 
aspects such as heart valve tissue engineering (Hao et al., 2008). Equilibrium is needed 
between highly porous scaffolds that allow rapid tissue ingrowths and minimize diffusion 
limitations and less porous materials that retain both construct shape and the ability to bear 
mechanical loads in a complex biochemical and mechanical environment. 
The incorporation of the bioactive molecules like the growth factor, enzymes, ECM proteins, 
DNA is another vital consideration while designing the scaffolds. The fabrication 
methodologies that do not inactivate the biological activity of the bioactive molecule within the 
scaffolds need to be used judiciously. Scaffolds can be made by different types of fabrication 
techniques. The fabrication techniques provide the regular architectures; allow mechanical and 
finite element analyses to be carried out, which permit quantification of suitable mechanical 
and chemical microenvironments for cells and tissues assisting in the development of the next 
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function of the scaffold. While each technique has its inherent merits and demerits, the 
appropriate selection of the methodologies must satisfy the requirements of the specific tissue 
to be repaired or engineered. Another hindrance in the tissue engineering research and 
scaffold design is the ignorance of the researchers on the possible interactions that exists 
between different cell types, such as the communication between the scaffold and the cells 
seeded within, cells and the different soluble factors, the typical behaviour of cells under the 
physical forces (shear, compression and vibration forces)  
The different techniques are developed to improve the current scaffold design by controlling 
the regular pore size, pore interconnectivity, porosity and pore characterizations that is 
suitable for rapid nutrient diffusion and cell attachment. Table 1 shows the most commonly 
used scaffolds fabrication technologies for potential tissue engineering applications 
indicating their merits and demerits of each technique. Some references given below in this 
chapter allow interested readers to go through the detail of fabrication techniques. Recent 
advances in both computational topology design (CTD) and solid free-form fabrication (SFF) 
have made it possible to create scaffolds with controlled architecture (Hollister, 2005). 
Finally, future directions are utilization of modelled scaffolds with in vivo experimentation 
to optimize tissue-engineering treatments, and coupling scaffolds with cells, genes and 
proteins optimized to create smart scaffolds for tissue regeneration and controlling their 
delivery through the scaffold with spatial and temporal resolution. 
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1. Abstract  
Electrospinning, a high-voltage driven spinning technique, has the ability to produce 
nanofibers with diameter down to nanometer scale from a variety of materials. Although it 
is predominantly applied to polymeric materials including synthetic and natural polymers, 
it also allows the functionalization of nanofibers by introducing pores, and incorporating 
functional elements such as drugs, growth factors, or nanoparticles while electrospinning. 
Anisotropic nanofibrous scaffolds with spatial orientation of the electrospun nanofibers can 
be achieved by using the electrode configurations or the rotated collection apparatus. Three 
dimensional cell-rich nanofibrous constructs can be fabricated while wet electrospinning 
using the layer-by-layer assembly approach. Taken together, the relatively high production 
rate and low cost of electrospinning have drawn a great attention in materials and life 
sciences, especially in tissue engineering research.  
 
2. Introduction    
Tissue engineering has proven to be a promising alternative therapy to replace the lost 
functions of diseased tissues or organs in clinical application (Langer & Vacanti, 1993) and 
can provide a well defined in vitro model for drug screening or tissue related studies 
(Griffith & Swartz, 2006). In tissue engineering, scaffolds with high porosity and 
interconnectivity are normally used to provide the cells with a temporary substrate to 
adhere, proliferate and form new tissues. It has been recognized that the initial cell-scaffold 
interaction plays a critical role in regulating the later cellular phenotypic expression. Many 
factors, such as the surface chemistry and topography of the scaffold are involved in the cell-
scaffold interaction. In this regard, more and more efforts in scaffold fabrication are now 
made to incorporate many instructive external cues in the scaffolds, such as immobilization 
of cell adhesion domains like Arginine-Glycine-Aspartic acid (RGD) on the scaffold surface 
or inclusion of growth factors in the scaffolds for a guided tissue formation (Lutolf & 
Hubbell, 2005).  
In order to maintain the proper cell phenotype similar to that in the native tissues, we have 
proposed the biomimetic design of scaffolds to maximally recapture the major features of 
the native extracellular matrix (ECM) at a multiscale level, from the composition, 
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morphology, topography, to spatial organization. In many cases, the cells in native tissues 
either are embedded in ECM fibres, such as the dermal fibroblasts in skin tissue, or reside on 
the top of basement membrane consisting of tightly cross-linked ECM fibres with pores, 
such as the endothelial cells on the luminal surface of blood vessels (Abrams et al., 2000). 
Clearly, nanofibrous scaffolds will be preferred due to their similarity to ECM fibrils in both 
dimension and morphology. Indeed, the advantages of nanofibrous scaffold in promoting 
cell growth and maintaining the proper cell phenotype have been demonstrated in a 
number of studies (Woo et al., 2007; Min et al., 2004; Ji et al., 2006; Chua et al., 2005), which 
is considered as the synergistic result of both nanotopography and chemical signalling of 
the scaffolds (Patel et al., 2007; Wang et al., 2003). Several approaches are available to 
fabricate nanofibers including self assembly (Zhang 2003), phase separation (Woo et al., 
2007; Barnes et al., 2007) and electrospinning (Formhals 1934; Telemeco et al., 2005; 
Matthews et al., 2002; Michel et al., 1999; Pham et al., 2006). Compared to other techniques, 
electrospinning represents a simple yet effective approach for preparing non-woven 
nano/microsized fibres.  
Electrospinning, a high voltage driven spinning technique, has been widely used to produce 
nanofibers due to its easiness for use (Pham et al 2006). The setup of electrospinning is 
rather simple, composed of a high-voltage power supply, solution reservoir with the 
spinneret and a grounded collection surface. By far, many polymers including synthetic 
polymer, natural polymer, and the blend of synthetic and natural polymers have been 
successfully electrospun into micro/nanosize fibres (Chua et al., 2005; Matthews et al., 2002; 
Li et al., 2005; Yoshimoto et al., 2003; Moroni et al., 2006; Geng et al 2005).  Depending on the 
materials used and electrospinning conditions, nonwoven fibrous meshes with microscale 
variation, for instance, in pore size and fibre diameter (Pham et al., 2006), have been 
successfully produced.  However, it remains highly active to fabricate 3D multifunctional 
scaffolds with electrospun nanofibers to maximally match the native cell growing 
extracellular matrix. In particular, many in vivo tissues and organs exhibit hierarchical 
layered structures with distinct ECM composition and arrangement in each layer. These 
anisotropic properties not only offer the cells with distinct signalling information, but also 
provide the tissues with a unique mechanical performance to accommodate the 
physiological requirement. Taking as an example, three distinctive layers, i.e., ventricularis, 
spongiosa, and fibrosa are clearly recognized in heart valve (Schoen & Levy 1999). Densely 
packed collagen fibres are found in the fibrosa layer to provide the predominant strength 
and stiffness, and prevent excessive stretching of valve. Spongiosa, composed of loosely 
arranged collagen and abundant hydrophilic glycosaminoglycans (GAG), lubricates the 
relative movement between the ventricularis and fibrosa layers. Ventricularis is rich with 
elastin and shows radial aligned elastic fibres to enable the recoil and stretch of valve in 
response to the diastole and systole of heart. Therefore, it is highly desirable to incorporate 
these hierarchical features into our multiscale design of elaborate scaffolds using the 
electrospun nanofibers. Additionally, the spatial organization of various types of cells in the 
hierarchically layered tissues is often recognized, which offers the tissue with specialized 
function for each layer. For instance, two distinct cell layers are identified in the skin, where 
the epidermal layer (mainly keratinocytes) stays at the outmost region of the skin and is 
connected to the underneath dermal layer (mainly fibroblasts) via basement membrane. In 
this regard, it is also preferred for the scaffolds to help the organization of cells with a 
distinct and controllable spatial distribution. Electrospinning holds a great promise in 
 
allowing the bottom-up assembly of various types of cells into layered nanofiber/cells 
constructs.  
Synergistic regulation of cell behaviour by growth factors is critical for functional tissue 
formation (Frenz et al 1994; Wei et al., 2007). Supplement of soluble bioactive molecules in 
the culture medium can deliver the stimulation to the cells; however, it remains challenging 
to separately deliver the distinct stimulation to different types of cells in the same culture. In 
general, the inclusion of bioactive molecules directly into the scaffolds is considered as a 
practical solution to the aforementioned matter (Corden et al., 2000). Therefore, in the 
multiscale design of scaffolds to support functional tissue formation, it is critical to combine 
the hierarchical spatial arrangement nanofibers along with the incorporation of various 
bioactive molecules in the fibres. 
In this chapter, we would like to present the feasibility of fabricating multifunctional 
nanofibrous scaffolds appropriate for engineering hierarchical tissue construct using 
electrospun nanofibers, which is a concise summary of the papers recently published from 
our laboratory (Yang et al., 2008 & 2009a and b) and non-published results. In these papers, 
polycaprolactone (PCL), a biodegradable and biocompatible synthetic polymer (Kweon et 
al., 2003; Ball et al., 2004), was used as the base material to explore all the possibilities. 
Bioactive nanofibers containing either collagen type I, bovine serum albumin (BSA) or 
fibronectin (FN) were obtained by electrospinning of the PCL mixture. Uniform distribution 
and bioactivity of these molecules in nanofibers were observed. The release of small 
molecules from nanofibers was controlled by the fibre diameter and initial loading amount. 
Nanofiber meshes with various topographical patterns resulted in various cellular 
responses. Multilayered 3D scaffolds with distinct distribution of bioactive molecules in 
between were successfully fabricated and demonstrated using PCL/Collagen and PCL/BSA 
nanofibers. More importantly, the cells of the same type or of different types could be 
assembled together with nanofibers to form 3D cell-rich constructs with either uniform cell 
distribution or distinct spatial arrangement.     
 
3. Electrospinning and characterization 
 
Fig. 1. Illustration of the electrospinning setup with vertical collection of fibers. Copyright 
2008 Taylor & Francis Group 
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morphology, topography, to spatial organization. In many cases, the cells in native tissues 
either are embedded in ECM fibres, such as the dermal fibroblasts in skin tissue, or reside on 
the top of basement membrane consisting of tightly cross-linked ECM fibres with pores, 
such as the endothelial cells on the luminal surface of blood vessels (Abrams et al., 2000). 
Clearly, nanofibrous scaffolds will be preferred due to their similarity to ECM fibrils in both 
dimension and morphology. Indeed, the advantages of nanofibrous scaffold in promoting 
cell growth and maintaining the proper cell phenotype have been demonstrated in a 
number of studies (Woo et al., 2007; Min et al., 2004; Ji et al., 2006; Chua et al., 2005), which 
is considered as the synergistic result of both nanotopography and chemical signalling of 
the scaffolds (Patel et al., 2007; Wang et al., 2003). Several approaches are available to 
fabricate nanofibers including self assembly (Zhang 2003), phase separation (Woo et al., 
2007; Barnes et al., 2007) and electrospinning (Formhals 1934; Telemeco et al., 2005; 
Matthews et al., 2002; Michel et al., 1999; Pham et al., 2006). Compared to other techniques, 
electrospinning represents a simple yet effective approach for preparing non-woven 
nano/microsized fibres.  
Electrospinning, a high voltage driven spinning technique, has been widely used to produce 
nanofibers due to its easiness for use (Pham et al 2006). The setup of electrospinning is 
rather simple, composed of a high-voltage power supply, solution reservoir with the 
spinneret and a grounded collection surface. By far, many polymers including synthetic 
polymer, natural polymer, and the blend of synthetic and natural polymers have been 
successfully electrospun into micro/nanosize fibres (Chua et al., 2005; Matthews et al., 2002; 
Li et al., 2005; Yoshimoto et al., 2003; Moroni et al., 2006; Geng et al 2005).  Depending on the 
materials used and electrospinning conditions, nonwoven fibrous meshes with microscale 
variation, for instance, in pore size and fibre diameter (Pham et al., 2006), have been 
successfully produced.  However, it remains highly active to fabricate 3D multifunctional 
scaffolds with electrospun nanofibers to maximally match the native cell growing 
extracellular matrix. In particular, many in vivo tissues and organs exhibit hierarchical 
layered structures with distinct ECM composition and arrangement in each layer. These 
anisotropic properties not only offer the cells with distinct signalling information, but also 
provide the tissues with a unique mechanical performance to accommodate the 
physiological requirement. Taking as an example, three distinctive layers, i.e., ventricularis, 
spongiosa, and fibrosa are clearly recognized in heart valve (Schoen & Levy 1999). Densely 
packed collagen fibres are found in the fibrosa layer to provide the predominant strength 
and stiffness, and prevent excessive stretching of valve. Spongiosa, composed of loosely 
arranged collagen and abundant hydrophilic glycosaminoglycans (GAG), lubricates the 
relative movement between the ventricularis and fibrosa layers. Ventricularis is rich with 
elastin and shows radial aligned elastic fibres to enable the recoil and stretch of valve in 
response to the diastole and systole of heart. Therefore, it is highly desirable to incorporate 
these hierarchical features into our multiscale design of elaborate scaffolds using the 
electrospun nanofibers. Additionally, the spatial organization of various types of cells in the 
hierarchically layered tissues is often recognized, which offers the tissue with specialized 
function for each layer. For instance, two distinct cell layers are identified in the skin, where 
the epidermal layer (mainly keratinocytes) stays at the outmost region of the skin and is 
connected to the underneath dermal layer (mainly fibroblasts) via basement membrane. In 
this regard, it is also preferred for the scaffolds to help the organization of cells with a 
distinct and controllable spatial distribution. Electrospinning holds a great promise in 
 
allowing the bottom-up assembly of various types of cells into layered nanofiber/cells 
constructs.  
Synergistic regulation of cell behaviour by growth factors is critical for functional tissue 
formation (Frenz et al 1994; Wei et al., 2007). Supplement of soluble bioactive molecules in 
the culture medium can deliver the stimulation to the cells; however, it remains challenging 
to separately deliver the distinct stimulation to different types of cells in the same culture. In 
general, the inclusion of bioactive molecules directly into the scaffolds is considered as a 
practical solution to the aforementioned matter (Corden et al., 2000). Therefore, in the 
multiscale design of scaffolds to support functional tissue formation, it is critical to combine 
the hierarchical spatial arrangement nanofibers along with the incorporation of various 
bioactive molecules in the fibres. 
In this chapter, we would like to present the feasibility of fabricating multifunctional 
nanofibrous scaffolds appropriate for engineering hierarchical tissue construct using 
electrospun nanofibers, which is a concise summary of the papers recently published from 
our laboratory (Yang et al., 2008 & 2009a and b) and non-published results. In these papers, 
polycaprolactone (PCL), a biodegradable and biocompatible synthetic polymer (Kweon et 
al., 2003; Ball et al., 2004), was used as the base material to explore all the possibilities. 
Bioactive nanofibers containing either collagen type I, bovine serum albumin (BSA) or 
fibronectin (FN) were obtained by electrospinning of the PCL mixture. Uniform distribution 
and bioactivity of these molecules in nanofibers were observed. The release of small 
molecules from nanofibers was controlled by the fibre diameter and initial loading amount. 
Nanofiber meshes with various topographical patterns resulted in various cellular 
responses. Multilayered 3D scaffolds with distinct distribution of bioactive molecules in 
between were successfully fabricated and demonstrated using PCL/Collagen and PCL/BSA 
nanofibers. More importantly, the cells of the same type or of different types could be 
assembled together with nanofibers to form 3D cell-rich constructs with either uniform cell 
distribution or distinct spatial arrangement.     
 
3. Electrospinning and characterization 
 
Fig. 1. Illustration of the electrospinning setup with vertical collection of fibers. Copyright 
2008 Taylor & Francis Group 
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The typical electrospinning setup is shown in Figure 1. Using this setup, collagen-containing 
PCL nanofibers were successfully obtained by electrospinning the collagen-PCL blended 
solution (1:1 volume ratio) as reported previously (Yang et al., 2008). A common solvent of 
1,1,1,3,3,3-hexafluoro isopropanol (HFIP) was used to dissolve both type I collagen and PCL 
solution for a well-mixed electrospinning solution in this case. The electrospinning solution 
was transferred to a syringe with a tip-blunt capillary (inner diameter = 0.9mm). The 
solution pushed out of the capillary tip by syringe pump was continuously pulled and 
formed the ultrathin filament under a strong electric field as shown in Figure 2A. Due to the 
small size of electrospun nanofibers, scanning electron microscope (SEM) was used to 
examine the fibres collected on Si wafer. The average diameter of electrospun fibres was 
determined using randomly selected SEM images. Upon optimization, the following 
electrospinning conditions could be used to prepare the PCL-collagen nanofibers, i.e., a flow 
rate between 5 μL/min and 15 μL/min, electric field strength from 0.8 kV/cm to 2.0 kV/cm 
and the fibre collection distance between 7 cm and 10 cm. The average diameter of PCL-
collagen nanofibers was 454.5 ± 84.9 nm, and meanwhile, the surface of electrospun fibres 
was smooth by close examination with a SEM (Figure 2B). In addition, the pore size of the 
PCL/collagen nanofiber meshes that was randomly collected on Si wafer for 1 min, was 
noticeably below 5 µm (Figure 2A). This small interfiber distance could limit the penetration 
of cells to the interior of the fibrous meshes and led to the tissue formation on the peripheral 
surface of the meshes (Powell & Boyce, 2008).    
 
4. Cell response to electrospun nanofibers 
 
Fig. 2. Growth of neonatal human dermal fibroblasts on electrospun nanofibers. SEM image 
of 1:1 (w/w) PCL/collagen fibers at a low magnification (A) and high magnification (B). 
Confocal microscopy images of cells cultured on PCL-collagen fiber meshes (C). Cells were 
stained with TRITC-phalloidin for F-Actin (red) and with DAPI for cell nuclei (blue). Scale 
bar: 20 m. Copyright 2008 Mary Ann Liebert Publishers 
 
The inclusion of collagen into PCL nanofibers was considered favourable to cell attachment. 
In this regard, human neonatal dermal fibroblasts (HDF, passage 4-6) were used to test the 
cellular response to the electrospun PCL-collagen nanofibers. In this experiment, 0.5 mL of 
HDF cell suspension (2×104 cells/mL) was seeded onto the electrospun nanofiber meshes 
collected on glass coverslips. After 24-hour culture at 37 ºC in a humidified incubator 
containing 5% CO2, the culture was fixed in 4% formaldehyde/PBS fixative for 4 hours at 
room temperature and the cells were then stained with TRITC conjugated phalloidin 
 
(cytoskeleton) and DAPI (cell nuclei). The stained cells were examined at 
ex360nm/em460nm (DAPI) and ex540nm/em570nm (TRITC) using a confocal microscope. 
Staining for cytoskeleton protein, F-actin, showed that human dermal fibroblast spread 
nicely on the surface of PCL/collagen fibrous meshes with a spindle-like morphology 
(Figure. 2C). In contrast, cells on PCL fibrous meshes remained limited spreading within the 
investigated time (data not shown), despite that prolonged culture could improve the cell 
stretch.  
The biological superiority of the inclusion of collagen into electrospun nanofibers was 
demonstrated by the improvement of fibroblast adhesion and rapid spreading with spindle-
like cell morphology. The selective attachment of dermal fibroblasts onto PCL-Collagen 
nanofibers instead of PCL nanofibers demonstrated the advantage of collagen as it can 
promote the cell-nanofibers interaction via cell membrane integrin receptors such as 21 
(Tulla et al., 2001; Nykvist et al., 2000; Orr et al,. 2006). Although pure collagen can be 
electrospun into nanofibers (Nykvist et al., 2000; Matthews et al., 2002) and proved 
favorable for cell attachment (Shih et al., 2006; Rho et al., 2006), its rapid degradation leads 
to mechanical instability (Wang et al., 2005). The composite PCL/collagen nanofibers are 
considered better to mimic the native ECM in both topology and composition and have a 
good with mechanical stability.  
 
5. Functional electrospun nanofibers with the potential to incorporate drug 
and growth factor  
It is always desirable to locally release drug or growth factors from the scaffold to the 
attached cells. To demonstrate the possibility of incorporating drugs in electrospun 
nanofibers, bovine serum albumin (BSA), a model protein for drug or growth factors, was 
successfully incorporated into the PCL nanofibers by electrospinning the PCL solution 
containing different amount of BSA (BSA:PCL =1:1, 1:60 to 1:600). The collected nanofiber 
meshes were cut into discs (1.3 cm in diameter, n=3) and placed in a 24-well plate with 1ml 
phosphate buffer solution (PBS) for release study. The well plate was incubated at 37ºC 
under gently shaking (80 RPM). Samples (10 L) were taken from the supernatant at 1 hour 
intervals for the first 24 hours and 24 hour intervals afterwards in the cumulative release. In 
continuous release study, supernatant was replaced with fresh PBS at each harvesting time 
point.   
Uniform distribution of BSA in the electrospun fibres was confirmed by using FITC-labelled 
BSA at a PCL/BSA ratio of 60:1 (Figure. 3A). A rapid release of BSA from PCL nanofibers 
was observed for those with 1:1 BSA/PCL ratio in the continuous release experiment. 
Majority of BSA (about 90%) was released within the first 3 hours in 1:1 BSA/PCL 
nanofibers, and the release of BSA was still detectable even after 24 hours (Figure. 3B). In the 
cumulative release experiment, BSA release reached its plateau at about 8 hours and 
remained the same for rest of the experimental time (Figure. 3B). The amount of BSA 
released into supernatant was proportional to the initial amount loaded into the PCL fibres 
(Figure. 3C). When the BSA/PCL ratio decreased down to 1:60, the peak release started at 
approximately 24 hour in the continuous release experiment and lasted more than 6 days 
(Figure. 3C).  
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The typical electrospinning setup is shown in Figure 1. Using this setup, collagen-containing 
PCL nanofibers were successfully obtained by electrospinning the collagen-PCL blended 
solution (1:1 volume ratio) as reported previously (Yang et al., 2008). A common solvent of 
1,1,1,3,3,3-hexafluoro isopropanol (HFIP) was used to dissolve both type I collagen and PCL 
solution for a well-mixed electrospinning solution in this case. The electrospinning solution 
was transferred to a syringe with a tip-blunt capillary (inner diameter = 0.9mm). The 
solution pushed out of the capillary tip by syringe pump was continuously pulled and 
formed the ultrathin filament under a strong electric field as shown in Figure 2A. Due to the 
small size of electrospun nanofibers, scanning electron microscope (SEM) was used to 
examine the fibres collected on Si wafer. The average diameter of electrospun fibres was 
determined using randomly selected SEM images. Upon optimization, the following 
electrospinning conditions could be used to prepare the PCL-collagen nanofibers, i.e., a flow 
rate between 5 μL/min and 15 μL/min, electric field strength from 0.8 kV/cm to 2.0 kV/cm 
and the fibre collection distance between 7 cm and 10 cm. The average diameter of PCL-
collagen nanofibers was 454.5 ± 84.9 nm, and meanwhile, the surface of electrospun fibres 
was smooth by close examination with a SEM (Figure 2B). In addition, the pore size of the 
PCL/collagen nanofiber meshes that was randomly collected on Si wafer for 1 min, was 
noticeably below 5 µm (Figure 2A). This small interfiber distance could limit the penetration 
of cells to the interior of the fibrous meshes and led to the tissue formation on the peripheral 
surface of the meshes (Powell & Boyce, 2008).    
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Fig. 2. Growth of neonatal human dermal fibroblasts on electrospun nanofibers. SEM image 
of 1:1 (w/w) PCL/collagen fibers at a low magnification (A) and high magnification (B). 
Confocal microscopy images of cells cultured on PCL-collagen fiber meshes (C). Cells were 
stained with TRITC-phalloidin for F-Actin (red) and with DAPI for cell nuclei (blue). Scale 
bar: 20 m. Copyright 2008 Mary Ann Liebert Publishers 
 
The inclusion of collagen into PCL nanofibers was considered favourable to cell attachment. 
In this regard, human neonatal dermal fibroblasts (HDF, passage 4-6) were used to test the 
cellular response to the electrospun PCL-collagen nanofibers. In this experiment, 0.5 mL of 
HDF cell suspension (2×104 cells/mL) was seeded onto the electrospun nanofiber meshes 
collected on glass coverslips. After 24-hour culture at 37 ºC in a humidified incubator 
containing 5% CO2, the culture was fixed in 4% formaldehyde/PBS fixative for 4 hours at 
room temperature and the cells were then stained with TRITC conjugated phalloidin 
 
(cytoskeleton) and DAPI (cell nuclei). The stained cells were examined at 
ex360nm/em460nm (DAPI) and ex540nm/em570nm (TRITC) using a confocal microscope. 
Staining for cytoskeleton protein, F-actin, showed that human dermal fibroblast spread 
nicely on the surface of PCL/collagen fibrous meshes with a spindle-like morphology 
(Figure. 2C). In contrast, cells on PCL fibrous meshes remained limited spreading within the 
investigated time (data not shown), despite that prolonged culture could improve the cell 
stretch.  
The biological superiority of the inclusion of collagen into electrospun nanofibers was 
demonstrated by the improvement of fibroblast adhesion and rapid spreading with spindle-
like cell morphology. The selective attachment of dermal fibroblasts onto PCL-Collagen 
nanofibers instead of PCL nanofibers demonstrated the advantage of collagen as it can 
promote the cell-nanofibers interaction via cell membrane integrin receptors such as 21 
(Tulla et al., 2001; Nykvist et al., 2000; Orr et al,. 2006). Although pure collagen can be 
electrospun into nanofibers (Nykvist et al., 2000; Matthews et al., 2002) and proved 
favorable for cell attachment (Shih et al., 2006; Rho et al., 2006), its rapid degradation leads 
to mechanical instability (Wang et al., 2005). The composite PCL/collagen nanofibers are 
considered better to mimic the native ECM in both topology and composition and have a 
good with mechanical stability.  
 
5. Functional electrospun nanofibers with the potential to incorporate drug 
and growth factor  
It is always desirable to locally release drug or growth factors from the scaffold to the 
attached cells. To demonstrate the possibility of incorporating drugs in electrospun 
nanofibers, bovine serum albumin (BSA), a model protein for drug or growth factors, was 
successfully incorporated into the PCL nanofibers by electrospinning the PCL solution 
containing different amount of BSA (BSA:PCL =1:1, 1:60 to 1:600). The collected nanofiber 
meshes were cut into discs (1.3 cm in diameter, n=3) and placed in a 24-well plate with 1ml 
phosphate buffer solution (PBS) for release study. The well plate was incubated at 37ºC 
under gently shaking (80 RPM). Samples (10 L) were taken from the supernatant at 1 hour 
intervals for the first 24 hours and 24 hour intervals afterwards in the cumulative release. In 
continuous release study, supernatant was replaced with fresh PBS at each harvesting time 
point.   
Uniform distribution of BSA in the electrospun fibres was confirmed by using FITC-labelled 
BSA at a PCL/BSA ratio of 60:1 (Figure. 3A). A rapid release of BSA from PCL nanofibers 
was observed for those with 1:1 BSA/PCL ratio in the continuous release experiment. 
Majority of BSA (about 90%) was released within the first 3 hours in 1:1 BSA/PCL 
nanofibers, and the release of BSA was still detectable even after 24 hours (Figure. 3B). In the 
cumulative release experiment, BSA release reached its plateau at about 8 hours and 
remained the same for rest of the experimental time (Figure. 3B). The amount of BSA 
released into supernatant was proportional to the initial amount loaded into the PCL fibres 
(Figure. 3C). When the BSA/PCL ratio decreased down to 1:60, the peak release started at 
approximately 24 hour in the continuous release experiment and lasted more than 6 days 
(Figure. 3C).  
 
Tissue	Engineering164
 
 
Fig. 3.The release profile of bovine serum albumin (BSA) from electrospun PCL fibers. (A) 
Fluorescence image of the PCL/FITC-BSA. Scale bar: 10 m. (B) BSA release from PCL/BSA 
(1:1, w/w) nanofibers into PBS, measured by Lowry assay. (C) BSA released into PBS from 
PCL nanofibers with 1:60 or 1:600 FITC-BSA/PCL ratios, determined by fluorescent 
intensity. Copyright 2008 Taylor & Francis Group 
 
Fig. 4. Cell morphology on different nanofibrous meshes at 1 and 10 hours after cell seeding. 
Cells were stained with methylene blue (blue). Scale bar: 100 m. Copyright 2008 Taylor & 
Francis Group 
 
To investigate if the incorporated biomolecules into PCL fibres remain their biological 
activity after all the procedures for electrospinning, fibronectin (FN) (0.0125% w/w) was 
similarly incorporated into the electrospun PCL nanofibers as BSA. Electrospun PCL 
nanofibers coated with 10 g/mL fibronectin in PBS for 1 hour were used as the positive 
controls and pure PCL nanofibers were used as the negative controls. Human dermal 
fibroblasts were seeded and cultured on all three fibrous meshes for up to 10 hours. The cell 
morphology on each fibrous mesh at different times was visualized by staining the fixed 
cells with 0.1% methylene blue. The staining results showed varying cell response to the 
fibres. Compared to PCL only, both PCL/FN electrospun fibres PCL/FN coated fibres 
showed a rapid cell spreading as early as 30 min after cell seeding (Figure 4). Majority of the 
cells showed spindle like morphology 10 hours after the culture on FN containing 
 
nanofibers; in contrast, most cells still remained round shape or minimal spreading on the 
PCL nanofibers. To quantify the difference in cell adhesion onto different fibrous meshes, 
MTS assay was performed on the cells cultured on the meshes for 1 and 10 hours. Clearly, 
the cell adhesion onto FN containing nanofibers was significantly improved and this was 
observed as early as 1 hour after cell seeding (Figure 5). With the culture extended to 10 
hours, more cells attached to all the investigated surfaces, but still remained a similar trend 
in cell adhesion, i.e., more cells were detected on the FN containing nanofibers.  Necessary 
to mention, it seems that PCL/FN electrospun nanofibers are more favourable to cell 
adhesion than PCL/FN coated fibres although the mechanism is not clearly known 
 
 
Fig. 5. Cell adhesion to different nanofiber meshes, determined by MTS assay. 
Representative figure out of 3 separate experiments. * P<0.05. ** P<0.001. No significant 
difference was observed between PCL and TCP groups. Copyright 2008 Taylor & Francis 
Group 
 
It has been shown that bioactive molecules can be easily incorporated into the nanofibers by 
mixing them into the polymer solution. More importantly, the bioactivity remains after 
processing as confirmed in both collagen containing nanofibers and FN containing 
nanofibers. Fibroblasts similarly adhered and spread on both PCL/FN electrospun 
nanofibers and the PCL nanofibers coated with FN. FN enhances fibroblast adhesion and 
spreading mainly through the interaction with cell membrane integrins such as 51 
(Akiyama 1996). Although we did not stain for 51, the comparable results between the 
two FN containing nanofibers suggest the bioactivity still remains intact after the 
electrospinning. This is a very important evidence for further using electrospun fibers in 
creation of functional scaffolds, especially for local release bioactive molecules to the 
attached cells. Thus, the inclusion of bioactive molecules in the nanofibers will allow us to 
better mimic the native ECM where numerous insoluble or soluble molecules anchor in the 
ECM fibers to mediate temporal cascades of cell function. Different from collagen, rapid 
release of BSA from the nanofibers would take place upon contact with medium.  The 
various BSA release profiles indicate that release of bioactive molecules can be tuned to 
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activity after all the procedures for electrospinning, fibronectin (FN) (0.0125% w/w) was 
similarly incorporated into the electrospun PCL nanofibers as BSA. Electrospun PCL 
nanofibers coated with 10 g/mL fibronectin in PBS for 1 hour were used as the positive 
controls and pure PCL nanofibers were used as the negative controls. Human dermal 
fibroblasts were seeded and cultured on all three fibrous meshes for up to 10 hours. The cell 
morphology on each fibrous mesh at different times was visualized by staining the fixed 
cells with 0.1% methylene blue. The staining results showed varying cell response to the 
fibres. Compared to PCL only, both PCL/FN electrospun fibres PCL/FN coated fibres 
showed a rapid cell spreading as early as 30 min after cell seeding (Figure 4). Majority of the 
cells showed spindle like morphology 10 hours after the culture on FN containing 
 
nanofibers; in contrast, most cells still remained round shape or minimal spreading on the 
PCL nanofibers. To quantify the difference in cell adhesion onto different fibrous meshes, 
MTS assay was performed on the cells cultured on the meshes for 1 and 10 hours. Clearly, 
the cell adhesion onto FN containing nanofibers was significantly improved and this was 
observed as early as 1 hour after cell seeding (Figure 5). With the culture extended to 10 
hours, more cells attached to all the investigated surfaces, but still remained a similar trend 
in cell adhesion, i.e., more cells were detected on the FN containing nanofibers.  Necessary 
to mention, it seems that PCL/FN electrospun nanofibers are more favourable to cell 
adhesion than PCL/FN coated fibres although the mechanism is not clearly known 
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It has been shown that bioactive molecules can be easily incorporated into the nanofibers by 
mixing them into the polymer solution. More importantly, the bioactivity remains after 
processing as confirmed in both collagen containing nanofibers and FN containing 
nanofibers. Fibroblasts similarly adhered and spread on both PCL/FN electrospun 
nanofibers and the PCL nanofibers coated with FN. FN enhances fibroblast adhesion and 
spreading mainly through the interaction with cell membrane integrins such as 51 
(Akiyama 1996). Although we did not stain for 51, the comparable results between the 
two FN containing nanofibers suggest the bioactivity still remains intact after the 
electrospinning. This is a very important evidence for further using electrospun fibers in 
creation of functional scaffolds, especially for local release bioactive molecules to the 
attached cells. Thus, the inclusion of bioactive molecules in the nanofibers will allow us to 
better mimic the native ECM where numerous insoluble or soluble molecules anchor in the 
ECM fibers to mediate temporal cascades of cell function. Different from collagen, rapid 
release of BSA from the nanofibers would take place upon contact with medium.  The 
various BSA release profiles indicate that release of bioactive molecules can be tuned to 
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achieve a programmable release by varying the initial drug loading, fiber diameter, spatial 
arrangement and fibre configuration. 
 
6. Controlled spatial arrangement of nanofibers into various topographical 
patterns 
In native tissues, ECM fibres with preferred orientation are often observed, leading to the 
anisotropic mechanical performance. The electrospinning technique allows us to control the 
spatial arrangement of collected nanofibers. Figure 6 (top panel) shows the 
PCL/collagen/BSA-FITC nanofibers collected on glass coverslips with different electric field 
modification. Without modifying the electric field, PCL/collagen nanofibers randomly 
deposited on the collecting surface. By manipulating the intensity distribution of electric 
field on the collecting surface, a gradient deposition of PCL/collagen nanofibers on the glass 
coverslip could be obtained. The aligned PCL/collagen nanofibers were achieved by 
applying parallel grounded metal wires on the collecting surface described previously (Ball 
& Shuttleworth 2004). The aligned fibres were deposited across the wires. Similarly to the 
aligned fibres, cross-aligned fibres with two different compositions (PCL/Collagen/FITC-
BSA, and PCL/Collagen/TRITC-BSA) were obtained by using parallel wires for the first 
TRITC fibre and then turning the wire pair 90 for the second FITC-fibre layer.   
 
 
Fig. 6. Cell growth on PCL/Collagen fibrous meshes with distinctive topographical patterns. 
Fluorescent images of nanofibers collected on glass coverslips (Top). Green fibres labelled 
with FITC-BSA and red fibres labelled with TRITC-BSA. Cells cultured overnight were 
stained with methylene blue (blue) (Bottom). Arrow indicates the gradient direction. Scale 
bar: 100 m. Copyright 2008 Taylor & Francis Group 
 
It has been shown that the surface properties of substrates play a critical role in regulating 
the cell attachment. In this regard, human dermal fibroblasts were cultured on these 
nanofiber meshes for overnight and then stained with methylene blue. The staining results 
showed that cells had various distribution and spatial orientation in response to the surface 
configuration of collected nanofibers (Figure 6 bottom panel). On the aligned nanofibers 
cells oriented themselves along the direction of nanofiber alignment. However, no obvious 
cell orientation was observed on the randomly collected fibres. When culturing the cells on 
the meshes with gradient nanofiber deposition, a gradient cell distribution was 
 
consequently achieved and higher cell number was observed in the area with high density 
of PCL/collagen nanofibers. Despite only a few micrometers away between green and red-
fluorescent layers, the cells cultured on the cross aligned bi-layer nanofibers could only 
sense the nanofiber pattern with direct contact, but not the underneath one. This contact 
guidance inevitably includes the formation of focal adhesion composed of cytoskeletal 
proteins and integrin receptors (Meyle et al., 1993), and the involvement of integrin 
receptors can initiate the intracellular cascades to determine further cell function such as 
anchorage, traction for migration, differentiation, and possibly growth (Dedhar et al., 1987; 
Zhao et al., 2006). It has been reported that cell alignment could subsequently determine the 
orientation of newly deposited ECM (Manwaring et al., 2004). This implies that anisotropic 
new tissue formation can be controlled by designing an anisotropic scaffold. Mechanical 
anisotropy of aligned fibers was previously reported in several studies (Li et al., 2006; 
Courtey et al., 2006). A significant increase of aligned fibrous meshes in both Young’s 
modulus (about 33 fold) and tensile modulus (about 5 fold) was measured compared to 
randomly collected meshes (Li et al., 2006). Ascribed to its anisotropic mechanical 
performance, biomechanical mimicking of soft tissues or musculoskeletal tissues using 
aligned fibers has multi-fold advantages and it holds tremendous promises for elaborate 
tissue formation with multi-functionality (see Figure 7 for the demonstration of spatial 
control of cell organization (non-published data)). This free control of fibre orientation can 
accommodate the requirements of native tissues with orientated ECM fibers changing from 
location to location. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7. Fluorescence images of the human cardiomyocytes cultured on the aligned 
PCL/collagen nanofibrous meshes (inset) for 24 hours. Cells were stained with TRITC-
phalloidin for F-Actin (red) and with DAPI for cell nuclei (blue).  Green: PCL/collagen-
FITC. Scale bar: 50 m. 
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achieve a programmable release by varying the initial drug loading, fiber diameter, spatial 
arrangement and fibre configuration. 
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BSA, and PCL/Collagen/TRITC-BSA) were obtained by using parallel wires for the first 
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showed that cells had various distribution and spatial orientation in response to the surface 
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Fig. 7. Fluorescence images of the human cardiomyocytes cultured on the aligned 
PCL/collagen nanofibrous meshes (inset) for 24 hours. Cells were stained with TRITC-
phalloidin for F-Actin (red) and with DAPI for cell nuclei (blue).  Green: PCL/collagen-
FITC. Scale bar: 50 m. 
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7. “Layer-by-layer” 3D tissue formation 
7.1 Anisotropic scaffolds with hierarchical structure  
To test the capability of manipulating sequential deposition of different layers of fibres into 
a spatially graded scaffold, a study was performed using PCL only and PCL/Collagen 
containing FITC-BSA (Yang et al., 2008). The sequence was shown in Figure 8 and 
sequentially deposited multiple layers were directly collected on aluminium foil (substrate). 
The cross sections of collected scaffolds were examined under a fluorescence microscope. It 
was found that different nanofibers were layered into 3D meshes with an identical sequence 
as designed. By controlling the electrospinning time at a constant flow rate (10l/min), the 
thickness of each material layer could be controlled with the designated thickness, from 
several micro meters to several tens of micro meters. A more confirmative result was 
obtained by using PCL nanofibers containing either TRITC-labelled BSA (in red color) or 
FITC-labelled BSA (in green color) for sequential deposition as shown in Figure 8C. The 
results also indicate that bioactive molecules can be incorporated into nanofibers and 
thereafter spatially arranged in a high order to form multifunctional scaffolds. In addition, it 
is intriguing to arrange cells with spatial distribution controlled by materials composition. 
Collagen containing nanofibers favoured the attachment of fibroblasts; therefore we 
hypothesized that fibroblasts would primarily attach to PCL/collagen nanofibers instead of 
PCL nanofibers, and lead to the controllable spatial arrangement of cells. To test this, human 
dermal fibroblasts were seeded and cultured in between the PCL/collagen and PCL only 
nanofiber layers for 24 hours. Examination of the cross-sections of cultured constructs 
revealed that cells only adhered to PCL/collagen nanofibers but not to the PCL ones (data 
not shown).  
 
 
Fig. 8. Fluorescence images of transverse sections of the nanofibrous meshes. (A) and (B), 
multifunctional scaffolds prepared by sequentially electrospinning of solutions as 
designated. (B), high magnification highlighting the clear layers.  (C), fluorescence images of 
the transverse section of a three-layer nanofibrous mesh. Red: PCL/BSA-TRITC. Green: 
PCL/BSA-FITC. Scale bar: (A) 50 m; (B) 20 m; (C) 100 m. Copyright 2008 Mary Ann 
Liebert Publishers 
 
Cells in native tissue not only experience the anisotropy from ECM fiber arrangement, but 
also respond to various chemistry changes from the surrounding environment. The 
chemical stimulation can come from the direct contact or from neighbors, and greatly 
depends on the spatial concentration distribution. By changing the composition of 
nanofibers while electrospinning, multilayered scaffolds with specified chemistry and 
thickness for each layer were made as designed in our study. This demonstrates the 
potentials to use the layer-by-layer deposition approach towards creation of cell-specific 3D 
microenvironment by careful selection of the nanofiber composition and the bioactive 
molecules incorporated into the fibres.  
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7.2 Layer- by- layer assembly of cell/scaffold construct  
 
Fig. 9. A schematic illustration of the “layer-by-layer (L-b-L)” cell assembly while 
electrospinning. As indicated by different colours, both fibre and cell layers can be varied 
during the cell assembly to create a customized final 3D construct according to the design. 
Copyright 2008 Mary Ann Liebert Publishers 
 
Layer-by-layer assembly of cell/nanofibers into 3D cell rich construct was recently 
developed in our lab (Yang et al., 2009b). While assembling the cells together with collected 
nanofibers to form 3D constructs as shown in Figure 9, a key step is to collect the fibre 
meshes on the liquid surface that is, keeping the meshes hydrated. Thus, a wet 
electrospinning was first developed in our lab (Yang et al., 2009b). The setup of wet 
electrospinning was very similar to that of conventional electrospinning (Figure 1), but with 
a slight modification on the fibre collection surface. In the wet electrospinning, grounded 
liquid was used to collect the electrospun fibres instead of using a solid metal surface. It was 
found the fibres deposited directly onto the liquid surface (we have tested many different 
liquids including the cell culture medium, phosphate buffered saline (PBS) and distilled 
water), and the morphology of nanofibrous meshes was very similar to those collected on 
the metal surface. Although the PCL/collagen fibres rapidly hydrated after depositing on 
the liquid surface, they remained stretched on the liquid surface without noticeable 
contraction. So far we have tested several other materials such as chitosan, PLGA and 
PCL/elastin using our wet electrospinning, and the nanofibrous meshes have been 
successfully obtained on the grounded water surface.  
  
There is one potential concerns for this on site “L-b-L” cell assembly. That is, the presence of 
trace amount of solvent (HFIP) in the electrospun nanofibers may cause an adverse effect on 
the cellular function despite that most of the HFIP would evaporate during the 
electrospinning process. To determine the adversity to the cells, human dermal fibroblasts 
 
were seeded and cultured on the electrospun nanofibers right after they were collected on 
either the medium surface or on the glass coverslip surface without further vacuum 
treatment as reported previously (Yoshimoto et al., 2003). The staining of cells with a dead-
live kit showed negligible cell death, and most cells remained viable (Fig. 10A). Further 
quantification of the potential toxicity of trace HFIP was performed, in which nanofibrous 
meshes collected on the medium surface were left in the same culture medium and 
incubated for different times. The supernatants were correspondently collected and tested 
for cytotoxicity using MTT assay. The test result showed that no significant cytotoxicity was 
observed in all collected supernatants (Fig. 9B).  
 
 
Fig. 10. Cytotoxicity of electrospun nanofibers based on a live/dead cell staining (A) and 
MTT assay (B). Green = live and red=dead. In MTT assay, medium samples used to extract 
nanofibers for different times (0 min, 15 min, 30 min, 45 min and 12h) were added to the 
cells along with cell seeding (white bar) or 12 hours after cell attachment (striped bar). Fresh 
culture medium served as controls. Data were presented as average  SD (n = 3). Copyright 
2008 Mary Ann Liebert Publishers 
 
The feasibility of on site forming a multilayered cell structure was first evaluated by “L-b-L” 
assembly of human dermal fibroblasts with PCL/collagen fibres exactly following the steps 
as shown in Figure 9. The small inter-fibre pore size (less than 5 m in Figure 2A) could 
prevent the seeded cells from escaping into the underneath medium. A total of 15 cell/fibre 
layers were built into a three-dimensional structure. After cultured for 2 days in Dulbecco's 
Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% 
Penicillin / Streptomycin, the multilayered structure was harvested and cut into thin frozen 
cross-sections. The staining of sections with DAPI for cell nuclei (blue) allows us to better 
visualize the cell spatial distribution across the full thickness of the multilayered structure. 
Figure 11A shows three-dimensional and yet homogeneous distribution of cells throughout 
the full thickness of the construct and multiple cell layers among electrospun PCL/collagen 
fibres could be recognized (Figure 11 A). In addition, cells in the multi-layered constructs 
showed elongated morphology and embedded among fibres.  Figure 11B&C are the cross-
sections of 7-layer fibroblast/fibre structures but with different electrospinning time for the 
PCL/collagen/FITC-BSA fibre layers. When the electrospinning time was 30 seconds, then 
around 5 m-thick fibre layer was yielded (Figure 11B). When the electrospinning time was 
increased to 1 min, the thickness of nanofiber layer was correspondently increased to 
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around 10 m (Figure 11C). The final shape of the built construct was defined by the metal 
wire loop (circular, and square loops were tested) and remained unchanged during the 
prolonged culture period (Figure 12).  
 
 
Fig. 11. Microscopic images of multilayered cell-fibre constructs: (A) Fluorescent micrograph 
of DAPI stained cross-sections of fibre-cell constructs cultured for 2 days.  Nuclei = blue. 
Scale: 200 μm. (B) and (C) Confocal microscopic images of cross-sections of formed cell-fibre 
constructs with controlled thickness of fibre layer. Scale: 20 μm.  Fibres were labelled with 
FITC (green) and cells were stained blue by DAPI. The images shown are representative of 
three separate experiments. Copyright 2008 Mary Ann Liebert Publishers 
 
Fig. 12. Images of multilayered cell-fibre constructs cultured for 7 days on the metal wire 
loop with various shapes. Copyright 2008 Mary Ann Liebert Publishers 
 
Clearly, this “L-b-L” cell assembly represents a bottom-up approach with a great degree to 
control the spatial distribution of cells. Most importantly, this approach provides a unique 
solution to the big challenge confronted with the use of electrospun nanofibrous meshes, i.e., 
the difficulty in penetrating the cells into the interior of the meshes.  
 
7.3 Skin tissue formation from “L-b-L” built cell-fiber construct 
As shown above, human dermal fibroblasts could be easily incorporated into the 
electrospun fibrous meshes along the electrospinning and form a 3D structure with uniform 
cell distribution. Using the same approach, we have assembled the dermal fibroblasts with 
PCL/collagen nanofibers into 10-layer fibroblast-PCL/collagen fibre constructs, which can 
be used as the dermal substitutes.  The constructs were further cultured for 3 and 7 days to 
 
study the new tissue formation. The cross sections of cultured constructs were examined 
under a fluorescent microscope. It was found that the cell/fibre construct became packed 
over a prolonged culture (Figure 13A and B). The staining of the cross-sections of the 
cultured constructs with hematoxylin and eosin (H & E) showed that fibroblasts evenly 
distributed in between the fibres without clear recognition of the layers. Meanwhile, the 
fibroblasts in the construct showed the elongated spindle morphology. 
 
Fig. 13. Formation of dermal tissue from fibroblasts/fibre layered constructs.  Fluorescent 
images of 10-layer fibroblasts/PCL-collagen fibre constructs (see Materials and Methods) 
cultured for 3 days (A) and 7 days (B). Cell nuclei stained blue, and fibres showed weak red 
fluorescence, though without labelling. (C) H&E stained cross-section of the construct 
cultured for 7 days. Arrow head indicates fibroblasts and asterisk shows fibres. Scale: 50µm. 
The images shown are representative of three separate experiments. Copyright 2008 Mary 
Ann Liebert Publishers 
 
Using the similar layer-by-layer assembly approach, fibroblasts and keratinocytes were built 
with the PCL/collagen nanofibers into 3D full-thickness skin substitutes, in which 18 layers 
of fibroblast/fibre in the lower part were first assembled and then 2 layers of 
keratinocyte/fibre were assembled on the top. After culturing for three days, a bi-layer skin 
structure (epidermal and dermal layer) was clearly seen on the H&E stained cross sections 
(Figure 14A). The seeded keratinocytes remained on the surface and formed a continuous 
epidermal layer, and fibroblasts retained in the lower part with a uniform distribution. A 
tight binding between the epidermal layer and dermal layer was observed. The bi-layer 
structure remained the same even after culture for 7 days. With the successful assembly of 
two distinct types of skin cells into bi-layer skin substitutes, it is further demonstrated the 
flexibility of this bottom-up approach in creating multicellular and multifunctional tissues.  
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Fig. 14. H & E stained cross-sections of bi-layer skin constructs composed of epidermal (E) 
and dermal (D) layers and formed by culturing “L-b-L” cell assembled constructs for 3 days 
(A) and 7 days (B). Green broken line outlines the border between E and D. Scale: 50µm. The 
images shown are representative of three separate experiments. Copyright 2008 Mary Ann 
Liebert Publishers 
 
7.4 Mineralized bone-like tissue formation from “L-b-L” assembled cell-fibre construct 
Using this “L-b-L” bottom-up assembly approach, we have recently assembled the mouse 
osteoblastic cells with chitosan-containing PCL nanofibers for bone-like tissue formation 
(Yang et al., 2009a). The constructs composed of multilayers of chitosan/PCL nanofibers and 
mouse osteoblasts (MC3T3-E1 cells) were prepared and cultured for up to 28 days to 
determine whether chitosan-containing nanofibers could support bone-like tissue formation 
in a 3D setting. SEM examination of the constructs cultured for 28 days showed that the 
construct surface was fully covered by cells and newly formed ECM (data not shown). 
Examination of the cross section indicated the formation of an integral tissue across the 
entire thickness (Figure 15A.) and no individual nanofibers could be identified any more. 
The cell distribution, tissue formation and mineralization were further evaluated by 
histological and biochemical analyses.  H & E staining of the cross-sections of the cultured 
constructs showed that cells uniformly distributed through the entire constructs with 
elongated morphology and formed an integral tissue without recognition of chitosan/PCL 
nanofibers (Figure 15A). Quantitative measurement of calcium content in the constructs by 
alizarin red staining indicated that mineralization increased with the incubation time and a 
significant increase in calcium deposition was observed around 21 days (data not shown). 
The calcium amount on Day 28 was almost 5.7 folds of that on Day 3 and only 1.6 folds of 
that on Day 21. Von Kossa staining of the cross-sections further revealed that mineral 
deposition (brownish precipitates) mainly occurred inside the cells (Figure 15B), indicating 
the osteogenic differentiation of MC3T3-E1.   
 
 
Fig. 15. (A) H&E staining of the cross-sections of 3D constructs with mouse osteoblasts 
(MC3T3-E1 cells) and chitosan-containing PCL nanofibers cultured for 14 days. (B) von 
Kossa staining of the cross-sections of 3D constructs with MC3T3-E1 cells and nanofibers 
cultured for 14 days. Dark brownish dots show the mineral deposition. Scale bar: A = 50µm 
and B = 25µm. Copyright 2009 American Chemical Society 
 
8. Conclusions 
With all the results presented in this chapter, it clearly demonstrates the feasibility of 
producing multiscale scaffolds with diverse functionality and tuneable distribution of 
bioactive molecules across the scaffold using electrospun nanofibres. This multifunctional 
scaffold can offer the cells with specific and customized microenvironment depending on 
the cell type and therefore achieve various phenotypic expressions for functional tissue 
formation. With the assistance of electrospun nanofibres, a new layer-by-layer bottom-up 
approach was developed to assemble the cells with nanofibres into 3D constructs. In this 
approach, cell/fibre constructs with single or multiple cell types could be assembled in an 
alternating manner, i.e., alternating cell layer and nanofiber layer on site of electrospinning. 
This new approach has multi-fold advantages, including 1) providing a uniform cell 
distribution throughout the nanofiber scaffold, 2) formulating the composition of each fibre 
layer, 3) controlling cell type for each cell layer, 4) allowing the co-culture of multiple cell 
types with distinct spatial arrangement. This layering process for tissue formation can 
provide a useful tool for engineering tissues with hierarchical structure and for in vitro 
studying the cell-cell or cell-materials interaction. In all, electrospinning has created a new 
avenue in designing biomimetic scaffolds for supporting the cell and tissue growth. With 
the continuous improvement of this technology, electrospinning will have many other 
promising applications in materials and life sciences far beyond the demonstrations 
presented in this chapter.   
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With all the results presented in this chapter, it clearly demonstrates the feasibility of 
producing multiscale scaffolds with diverse functionality and tuneable distribution of 
bioactive molecules across the scaffold using electrospun nanofibres. This multifunctional 
scaffold can offer the cells with specific and customized microenvironment depending on 
the cell type and therefore achieve various phenotypic expressions for functional tissue 
formation. With the assistance of electrospun nanofibres, a new layer-by-layer bottom-up 
approach was developed to assemble the cells with nanofibres into 3D constructs. In this 
approach, cell/fibre constructs with single or multiple cell types could be assembled in an 
alternating manner, i.e., alternating cell layer and nanofiber layer on site of electrospinning. 
This new approach has multi-fold advantages, including 1) providing a uniform cell 
distribution throughout the nanofiber scaffold, 2) formulating the composition of each fibre 
layer, 3) controlling cell type for each cell layer, 4) allowing the co-culture of multiple cell 
types with distinct spatial arrangement. This layering process for tissue formation can 
provide a useful tool for engineering tissues with hierarchical structure and for in vitro 
studying the cell-cell or cell-materials interaction. In all, electrospinning has created a new 
avenue in designing biomimetic scaffolds for supporting the cell and tissue growth. With 
the continuous improvement of this technology, electrospinning will have many other 
promising applications in materials and life sciences far beyond the demonstrations 
presented in this chapter.   
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1. Introduction 
Bone replacements are frequently required to fix damaged tissue due to trauma, tumor 
resection, and more generally in many surgeries (Navarro et al. 2004). This requirement for 
new bone is a major clinical and socioeconomic need. There is a driving need in tissue 
engineering (TE) field to develop scaffolds that guide bone regeneration across defects that 
are too large to heal naturally. This may be achieved by a multidisciplinary field: bone tissue 
engineering (BTE) which seeks to apply the scientific principles to engineering of viable 
substitutes that restore and maintain the function of human bone tissue. There are three key 
elements for regenerating bone tissues, namely, osteogenic progenitor cells, osteoinductive 
growth factors and osteoconductive scaffolds (Schieker et al. 2006). The function of scaffolds 
is to direct the growth of cells seeded within the porous structure of the scaffold or of cells 
migrating from surrounding environments. The majority of mammalian cell types are 
anchorage-dependent resulting in dying if an adhesive surface is not provided. A successful 
scaffold should balance mechanical strength with biomolecular delivery capacity, providing 
an environment in which the regenerated tissue assumes function as the scaffold degrades 
(Hollister 2005). The success of BTE depends, to a large extent, on the performance of the 3D 
porous biodegradable scaffolds. The BTE scaffolds will fit into the anatomical defect, so they 
must have some strength and stiffness to keep their integrity at the initial in vivo stage. In 
TE, the selection of appropriate biomaterials for scaffold production is very important 
because the scaffold properties are largely determined by the intrinsic properties of the 
materials. Also, the scaffold design and processing method will play an important role in 
the scaffold properties. 
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Rapid prototyping (RP) is an excellent alternative compared with conventional methods as 
it can provide the consistency, flexibility in geometry and reproducibility in scaffold 
physical properties (Wiria et al. 2007). Among various RP technologies, selective laser 
sintering (SLS) has been found to be advantageous for TE scaffolds fabrication due to its 
ability to process a wide range of biocompatible and biodegradable materials (Chua et al. 
2004). SLS appears to be useful primarily for bone implants production and it has been used 
to sinter poly(methyl methacrylate) coated calcium phosphate (Lee & Barlow 1993) and 
hydroxyapatite reinforced polyethylene composites (known commercially as HAPEX™) for 
bone implants (Hao et al. 2006). 
Disadvantages of SLS include a process more mechanically complex than most other RP 
techniques and powdery surface may complicate sterilization and cell culture (Venuvinod & 
Ma 2004). As a layer additive technique, SLS parts also suffer from the stair-stepping 
problem. The first layers may need a base anchor to reduce thermal effects such as curling. 
For scaffold production, the resolution of SLS is limited by the laser beam diameter (spot 
size) and the particle size. Due to heat dissipation, particles outside the laser scan path are 
sometimes also fused (“growth” effect), causing an irregular boundary and roughness on 
the part surface (Yang et al. 2002); however, rough surface may attract some types of cells to 
attach and grow. Furthermore, when building porous scaffolds, the loose, unsintered 
powder trapped inside of the pores needs to be removed. The “growth” effect can make the 
cleaning of the loose powder difficult. 
So far, only one hydrophobic biodegradable polymer, poly--caprolactone (PCL), has been 
used to produce TE scaffold by conventional SLS machine because PCL is significantly less 
expensive and supplied in the fine powder form. Ciardelli et al. (2004) used a CO2 SLS 
machine (SYNRAD model J48-5S, Italy) to fabricate scaffolds with the overall size of 
15x15x3.3 mm (length x breadth x height) from PCL slurries. Those SLS scaffolds have a 
pore size of about 300 m (height) x 700 m (width). Williams et al. (2005) fabricated 
sintered PCL cylindrical porous scaffolds (5.0 mm diameter, 4.5 mm height) by 
Sinterstation® 2000 at University of Michigan. The pore sizes of these scaffolds varied from 
1.75 mm to 2 mm. In vitro and in vivo results showed that laser sintered PCL scaffolds 
enhance tissue in-growth and their mechanical properties are within the lower range of 
trabecular bone. From the same group, Partee et al. (2006) optimized the SLS processing 
parameters for PCL powder using the systematic factorial experimental design method. The 
scaffolds were in the form of square prism with an overall size of 11.5x14.2x10.8 mm and a 
pore size of 2 mm. The optimized PCL scaffolds showed designed porous channels and 
achieved a dimensional accuracy to within 3- 8% of the design specifications and 94% of full 
density. Using optimal SLS processing parameters, BTE scaffolds were fabricated based on 
actual minipig and human condyle models. 
Recently, Wiria et al. (2007) applied the SLS technique to first fabricate biodegradable 
composite scaffolds from physically blended PCL with micro-sized hydroxyapatite using 
Sinterstation® 2500 (3D Systems). The scaffolds were in the form of circular disc with a 
diameter and thickness of 15 mm and 1 mm respectively. This overall size is good for fitting 
into a cell culture well. As compared to neat PCL, it was harder to sinter the PCL/HAp 
biocomposite blends. Similar observation was made by Fan et al. (2001) with other 
composite materials and they attributed the phenomenon to the increased viscosity of the 
composite materials. Chua et al. (2004) developed SLS scaffolds on poly(vinyl alcohol) 
(PVA) blended with micro-sized HAp, intending for craniofacial and joint defects repair. 
 
PVA was chosen due to the cheap price and the approximate particle size for SLS process. 
PVA is a hydrophilic biodegradable polymer which limits its use in cartilage and corneal 
tissue engineering (Sinha et al. 2007). Also, other materials, such as polyetheretherketone 
(PEEK) (Tan et al. 2003) and polyamide (Das et al. 2003), were used for building TE 
scaffolds. However, these materials are non-biodegradable, which limit their applications as 
stated earlier.  
SLS has been developed primarily for industrial applications and it is still not financially 
viable to use the technology to produce TE scaffolds from a wide range of biomaterials due 
to limited availability of biomaterial powders suitable for SLS and extremely high costs of 
most biomaterial powders. With our success in modifying an existing Sinterstation® 2000 
SLS machine to allow small quantities of biopolymer powders to be processed (Lee et al. 
2006) and preparation of poly(L-lactide) (PLLA) and PLLA/carbonated hydroxyapatite 
(CHAp) nanocomposite microspheres (Zhou et al. 2007), we were able to build porous 
PLLA and PLLA/CHAp TE scaffolds for further investigation.  
The effects of sintering conditions; namely, laser power, part bed temperature and scan 
spacing, on the overall quality of PLLA scaffolds were first studied in this chapter. Then, the 
results were used to formulate a recommended list of sintering parameters for building 
good quality PLLA and PLLA/CHAp scaffolds. Finally, the structure and properties, e.g. 
porosity, compression properties, in vitro degradation behaviour and osteoconductivity 
(such as cell adhesion and growth), of these scaffolds were evaluated.   
 
2. Materials and Processing 
2.1 Materials 
The PLLA used was 100L 1A with an intrinsic viscosity of 1.9 dL/g (Lakeshore Biomaterials, 
Birmingham, AL, USA). It was supplied in the form of macro-sized pellets, 1 mm in 
diameter and 3 mm in length, for conventional extrusion and moulding processes. The 
emulsifier used in our study was poly(vinyl alcohol) which was cold water soluble and with 
an average molecular weight of 30,000-70,000 (Sigma-Aldrich). CHAp nanospheres were 
synthesized by a nanoemulsion method (Zhou et al. 2008). Dichloromethane or methylene 
dichloride (DCM, Uni-Chem®, Orientalab, China) was used as the organic solvent to 
dissolve PLLA.  
 
2.2 Preparation of PLLA microspheres  
PLLA microspheres were prepared using a normal oil-in-water (O/W) emulsion solvent 
evaporation technique. In brief, the PLLA was dissolved in DCM to form a solution first and 
then rapidly added to aqueous PVA solution and stirred for sometime to allow the solvent 
to evaporate. The hardened microspheres were centrifuged, washed three times with de-
ionized water and lyophilized to obtain dry powder.  
 
2.3 Preparation of PLLA/CHAp nanocomposite microspheres 
The PLLA/CHAp nanocomposite microspheres were prepared using a solid-in-oil-in-water 
(S/O/W) emulsion solvent evaporation method (Zhou et al. 2007). Briefly, the CHAp 
nanospheres were dispersed in the PLLA-dichloromethane solution by ultrasonification 
(Barnstead Lab-Line ultrasonic cleaner, USA) and homogenization (Ultra-Turrax® T25 basic, 
Selective	Laser	Sintering	of	Poly(L-Lactide)/Carbonated		
Hydroxyapatite	Nanocomposite	Porous	Scaffolds	for	Bone	Tissue	Engineering 181
 
Rapid prototyping (RP) is an excellent alternative compared with conventional methods as 
it can provide the consistency, flexibility in geometry and reproducibility in scaffold 
physical properties (Wiria et al. 2007). Among various RP technologies, selective laser 
sintering (SLS) has been found to be advantageous for TE scaffolds fabrication due to its 
ability to process a wide range of biocompatible and biodegradable materials (Chua et al. 
2004). SLS appears to be useful primarily for bone implants production and it has been used 
to sinter poly(methyl methacrylate) coated calcium phosphate (Lee & Barlow 1993) and 
hydroxyapatite reinforced polyethylene composites (known commercially as HAPEX™) for 
bone implants (Hao et al. 2006). 
Disadvantages of SLS include a process more mechanically complex than most other RP 
techniques and powdery surface may complicate sterilization and cell culture (Venuvinod & 
Ma 2004). As a layer additive technique, SLS parts also suffer from the stair-stepping 
problem. The first layers may need a base anchor to reduce thermal effects such as curling. 
For scaffold production, the resolution of SLS is limited by the laser beam diameter (spot 
size) and the particle size. Due to heat dissipation, particles outside the laser scan path are 
sometimes also fused (“growth” effect), causing an irregular boundary and roughness on 
the part surface (Yang et al. 2002); however, rough surface may attract some types of cells to 
attach and grow. Furthermore, when building porous scaffolds, the loose, unsintered 
powder trapped inside of the pores needs to be removed. The “growth” effect can make the 
cleaning of the loose powder difficult. 
So far, only one hydrophobic biodegradable polymer, poly--caprolactone (PCL), has been 
used to produce TE scaffold by conventional SLS machine because PCL is significantly less 
expensive and supplied in the fine powder form. Ciardelli et al. (2004) used a CO2 SLS 
machine (SYNRAD model J48-5S, Italy) to fabricate scaffolds with the overall size of 
15x15x3.3 mm (length x breadth x height) from PCL slurries. Those SLS scaffolds have a 
pore size of about 300 m (height) x 700 m (width). Williams et al. (2005) fabricated 
sintered PCL cylindrical porous scaffolds (5.0 mm diameter, 4.5 mm height) by 
Sinterstation® 2000 at University of Michigan. The pore sizes of these scaffolds varied from 
1.75 mm to 2 mm. In vitro and in vivo results showed that laser sintered PCL scaffolds 
enhance tissue in-growth and their mechanical properties are within the lower range of 
trabecular bone. From the same group, Partee et al. (2006) optimized the SLS processing 
parameters for PCL powder using the systematic factorial experimental design method. The 
scaffolds were in the form of square prism with an overall size of 11.5x14.2x10.8 mm and a 
pore size of 2 mm. The optimized PCL scaffolds showed designed porous channels and 
achieved a dimensional accuracy to within 3- 8% of the design specifications and 94% of full 
density. Using optimal SLS processing parameters, BTE scaffolds were fabricated based on 
actual minipig and human condyle models. 
Recently, Wiria et al. (2007) applied the SLS technique to first fabricate biodegradable 
composite scaffolds from physically blended PCL with micro-sized hydroxyapatite using 
Sinterstation® 2500 (3D Systems). The scaffolds were in the form of circular disc with a 
diameter and thickness of 15 mm and 1 mm respectively. This overall size is good for fitting 
into a cell culture well. As compared to neat PCL, it was harder to sinter the PCL/HAp 
biocomposite blends. Similar observation was made by Fan et al. (2001) with other 
composite materials and they attributed the phenomenon to the increased viscosity of the 
composite materials. Chua et al. (2004) developed SLS scaffolds on poly(vinyl alcohol) 
(PVA) blended with micro-sized HAp, intending for craniofacial and joint defects repair. 
 
PVA was chosen due to the cheap price and the approximate particle size for SLS process. 
PVA is a hydrophilic biodegradable polymer which limits its use in cartilage and corneal 
tissue engineering (Sinha et al. 2007). Also, other materials, such as polyetheretherketone 
(PEEK) (Tan et al. 2003) and polyamide (Das et al. 2003), were used for building TE 
scaffolds. However, these materials are non-biodegradable, which limit their applications as 
stated earlier.  
SLS has been developed primarily for industrial applications and it is still not financially 
viable to use the technology to produce TE scaffolds from a wide range of biomaterials due 
to limited availability of biomaterial powders suitable for SLS and extremely high costs of 
most biomaterial powders. With our success in modifying an existing Sinterstation® 2000 
SLS machine to allow small quantities of biopolymer powders to be processed (Lee et al. 
2006) and preparation of poly(L-lactide) (PLLA) and PLLA/carbonated hydroxyapatite 
(CHAp) nanocomposite microspheres (Zhou et al. 2007), we were able to build porous 
PLLA and PLLA/CHAp TE scaffolds for further investigation.  
The effects of sintering conditions; namely, laser power, part bed temperature and scan 
spacing, on the overall quality of PLLA scaffolds were first studied in this chapter. Then, the 
results were used to formulate a recommended list of sintering parameters for building 
good quality PLLA and PLLA/CHAp scaffolds. Finally, the structure and properties, e.g. 
porosity, compression properties, in vitro degradation behaviour and osteoconductivity 
(such as cell adhesion and growth), of these scaffolds were evaluated.   
 
2. Materials and Processing 
2.1 Materials 
The PLLA used was 100L 1A with an intrinsic viscosity of 1.9 dL/g (Lakeshore Biomaterials, 
Birmingham, AL, USA). It was supplied in the form of macro-sized pellets, 1 mm in 
diameter and 3 mm in length, for conventional extrusion and moulding processes. The 
emulsifier used in our study was poly(vinyl alcohol) which was cold water soluble and with 
an average molecular weight of 30,000-70,000 (Sigma-Aldrich). CHAp nanospheres were 
synthesized by a nanoemulsion method (Zhou et al. 2008). Dichloromethane or methylene 
dichloride (DCM, Uni-Chem®, Orientalab, China) was used as the organic solvent to 
dissolve PLLA.  
 
2.2 Preparation of PLLA microspheres  
PLLA microspheres were prepared using a normal oil-in-water (O/W) emulsion solvent 
evaporation technique. In brief, the PLLA was dissolved in DCM to form a solution first and 
then rapidly added to aqueous PVA solution and stirred for sometime to allow the solvent 
to evaporate. The hardened microspheres were centrifuged, washed three times with de-
ionized water and lyophilized to obtain dry powder.  
 
2.3 Preparation of PLLA/CHAp nanocomposite microspheres 
The PLLA/CHAp nanocomposite microspheres were prepared using a solid-in-oil-in-water 
(S/O/W) emulsion solvent evaporation method (Zhou et al. 2007). Briefly, the CHAp 
nanospheres were dispersed in the PLLA-dichloromethane solution by ultrasonification 
(Barnstead Lab-Line ultrasonic cleaner, USA) and homogenization (Ultra-Turrax® T25 basic, 
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IKA, Germany) to form an S/O nanosuspension. The nanosuspension was mixed with 1 
wt% PVA solution to form S/O/W emulsion. The resultant S/O/W emulsion was stirred 
overnight at 800 rpm and then filtered, washed three times with de-ionized water, and 
freeze-dried to yield a white PLLA/CHAp biocomposite powder. Nanocomposite 
microspheres of 10 wt% CHAp in PLLA were used in the SLS process. 
 
2.4 Morphology characterization of microspheres 
The surface morphologies of the PLLA microspheres and PLLA/CHAp nanocomposite 
microspheres were examined using a scanning electron microscope (SEM, Stereoscan 440, 
Cambridge, UK). The internal structure of the composite microspheres was revealed by the 
focused ion beam (FIB) milling technique. A focused ion beam (Quanta 200 3D, FEI, USA) 
was applied to section the PLLA/CHAp composite microspheres for internal examination. 
The ion beam was tilted 52o with respect to the electron beam and was only used for milling, 
not for imaging. The FIB milling process was carried out with a Ga+ ion beam current of 3 
nA and the acceleration voltage was 5 KeV. The milled faces were then polished with a low 
beam current of 0.3 and 0.1 nA prior to SEM imaging. 
 
2.5 Modification of Sinterstation® 2000 system 
In order to reduce the consumption of biomaterial powders for TE scaffold construction in 
the SLS process, modifications were made to an existing Sinterstation® 2000 SLS machine 
(3D Systems, Valencia, CA, USA). The CO2 laser of the system has a maximum power 
output of 50 watts. The CO2 laser energy intensity across the beam diameter very nearly 
follows the Gaussian distribution (Nelson et al. 1993). A miniature sintering platform, which 
consisted primarily of a miniature build cylinder and two powder supply chambers, was 
designed, fabricated and installed in the build cylinder of the existing SLS machine (Lee 
2006; Zhou et al. 2007; Zhou et al. 2008). The miniature build cylinder had a diameter of 50 
mm and the movement of its base was directly linked to the base of the existing build 
cylinder of Sinterstation® 2000. The two powder supply chambers were driven by two 
additional stepping motors beneath the miniature sintering platform. In the sintering 
processes, the original powder supply tanks of Sinterstation® 2000 were empty and small 
amounts of biomaterial powder were fed from the miniature powder supply chambers. The 
roller positions were sensed and the signals were fed to an additional control panel which 
controlled the movement of stepping motors and the temperature of the small build 
cylinder. Other sintering parameters were controlled by the existing Sinterstation® 2000 
system and this would ensure good quality of the scaffolds built. 
 
2.6 Design of bone tissue engineering scaffolds 
The scaffold models were designed by an extrude-cut patterning method using SolidWorks® 
(version 2005). They had a tetragonal shape with the ratio of height (H) to width (W) or 
length (L) equal to 2 (ASTM D695-02a; ASTM D1621-04a). Rectangular channels were cut in 
all three dimensions to form 3D symmetrical scaffold models. This simple design contains 
the typical features and feature sizes found in BTE scaffolds (Partee et al. 2006). Type 1 
model contained channels of size 0.8×0.8 mm2 and Type 2 model contained channels of size 
0.6×0.6 mm2. The width of the solid pillar was kept at 0.3 mm in both Type 1 and Type 2 
 
models. The designed porosities for Types 1 and 2 were 78.4% and 70.0% respectively. The 
detailed design parameters of the scaffold models are listed in Table 1. 
In SLS of porous scaffolds, the spot size of the laser beam is very important for building the 
small features of the scaffolds. The spot size or beam width is defined as the smallest 
diameter of the focused laser beam. According to the manufacturer of Sinterstation® 2000 
system, the spot size of this SLS machine is 0.018” (~457µm). To facilitate handling of the 
sintered scaffolds, a solid base (993 mm3) was incorporated in the scaffold design. If this 
base was not provided, the first few porous layers would tend to warp significantly, 
affecting the overall quality of the scaffolds (Partee et al. 2006).  
In order to speed up production and to produce scaffolds with similar quality for tests, 
multiple scaffold models were assembled based on the single scaffold models. Four and 
nine models were assembled. Then, the data file was exported in an STL format and 
transferred to the Sinterstation® 2000 system for the sintering process.  
 
Type 
Overall Size 
(mm3)* 
Channel Width 
(mm) 
Pillar Width 
(mm) 
Porosity  
(%) 
1 8816 0.8 
0.3 
78.4 
2 6.66.613.2 0.6 70.0 
Table 1. Design parameters of porous bone tissue engineering scaffolds. 
 
2.7 Production of 3D porous scaffolds by modified Sinterstation® 2000 system  
The build orientation (angle between the laser scanning direction and “L” dimension of the 
scaffold) was 45o. Significant variation in density and anisotropic properties were found in 
DuraForm™ polyamide (a common SLS material) parts built in 0o and 90o orientations 
(Caulfield et al. 2007). The 45o build orientation was chosen to reduce the anisotropy, also it 
was found to be effective in reducing warpage of porous scaffolds (Lee et al. 2004). 
In SLS, the laser energy density (ED) level significantly affects the scaffold properties. The 
ED level is a measure of the amount of energy supplied to the powder particles per unit area 
of the powder bed surface. The relationship between ED and laser power (P), scan spacing 
(SS) and beam speed (BS) can be expressed by the following equation (Nelson et al. 1993): 
 
PED SS BS                                                                   (1) 
It is obvious that too low a laser power will render low strength or even incomplete 
sintering of the scaffold, while too high a laser power will cause the biopolymer to degrade 
and the scaffold to warp due to high residual stresses. Scan spacing (SS) means the distance 
between two parallel laser scans during a fill. In this study, the beam speed (BS) was fixed at 
1257 mm/s and the effects of laser power, scan spacing and part bed temperature (PBT) 
were investigated. Prior to this study, DuraForm™ polyamide was used as the reference 
material for initial settings of the sintering parameters (Lee 2006). After some trials, a 
workable set of sintering parameters was obtained for PLLA and PLLA/CHAp 
nanocomposite as shown in Table 2. Fig. 1 shows the SLS process in progress. Four scaffold 
bases were being sintered and the powder used was a PLLA/CHAp nanocomposite. Also, 
the powder delivery appeared to be smooth during the sintering process. The production 
time for one batch of scaffolds was about 2.5 hours.  
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wt% PVA solution to form S/O/W emulsion. The resultant S/O/W emulsion was stirred 
overnight at 800 rpm and then filtered, washed three times with de-ionized water, and 
freeze-dried to yield a white PLLA/CHAp biocomposite powder. Nanocomposite 
microspheres of 10 wt% CHAp in PLLA were used in the SLS process. 
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The surface morphologies of the PLLA microspheres and PLLA/CHAp nanocomposite 
microspheres were examined using a scanning electron microscope (SEM, Stereoscan 440, 
Cambridge, UK). The internal structure of the composite microspheres was revealed by the 
focused ion beam (FIB) milling technique. A focused ion beam (Quanta 200 3D, FEI, USA) 
was applied to section the PLLA/CHAp composite microspheres for internal examination. 
The ion beam was tilted 52o with respect to the electron beam and was only used for milling, 
not for imaging. The FIB milling process was carried out with a Ga+ ion beam current of 3 
nA and the acceleration voltage was 5 KeV. The milled faces were then polished with a low 
beam current of 0.3 and 0.1 nA prior to SEM imaging. 
 
2.5 Modification of Sinterstation® 2000 system 
In order to reduce the consumption of biomaterial powders for TE scaffold construction in 
the SLS process, modifications were made to an existing Sinterstation® 2000 SLS machine 
(3D Systems, Valencia, CA, USA). The CO2 laser of the system has a maximum power 
output of 50 watts. The CO2 laser energy intensity across the beam diameter very nearly 
follows the Gaussian distribution (Nelson et al. 1993). A miniature sintering platform, which 
consisted primarily of a miniature build cylinder and two powder supply chambers, was 
designed, fabricated and installed in the build cylinder of the existing SLS machine (Lee 
2006; Zhou et al. 2007; Zhou et al. 2008). The miniature build cylinder had a diameter of 50 
mm and the movement of its base was directly linked to the base of the existing build 
cylinder of Sinterstation® 2000. The two powder supply chambers were driven by two 
additional stepping motors beneath the miniature sintering platform. In the sintering 
processes, the original powder supply tanks of Sinterstation® 2000 were empty and small 
amounts of biomaterial powder were fed from the miniature powder supply chambers. The 
roller positions were sensed and the signals were fed to an additional control panel which 
controlled the movement of stepping motors and the temperature of the small build 
cylinder. Other sintering parameters were controlled by the existing Sinterstation® 2000 
system and this would ensure good quality of the scaffolds built. 
 
2.6 Design of bone tissue engineering scaffolds 
The scaffold models were designed by an extrude-cut patterning method using SolidWorks® 
(version 2005). They had a tetragonal shape with the ratio of height (H) to width (W) or 
length (L) equal to 2 (ASTM D695-02a; ASTM D1621-04a). Rectangular channels were cut in 
all three dimensions to form 3D symmetrical scaffold models. This simple design contains 
the typical features and feature sizes found in BTE scaffolds (Partee et al. 2006). Type 1 
model contained channels of size 0.8×0.8 mm2 and Type 2 model contained channels of size 
0.6×0.6 mm2. The width of the solid pillar was kept at 0.3 mm in both Type 1 and Type 2 
 
models. The designed porosities for Types 1 and 2 were 78.4% and 70.0% respectively. The 
detailed design parameters of the scaffold models are listed in Table 1. 
In SLS of porous scaffolds, the spot size of the laser beam is very important for building the 
small features of the scaffolds. The spot size or beam width is defined as the smallest 
diameter of the focused laser beam. According to the manufacturer of Sinterstation® 2000 
system, the spot size of this SLS machine is 0.018” (~457µm). To facilitate handling of the 
sintered scaffolds, a solid base (993 mm3) was incorporated in the scaffold design. If this 
base was not provided, the first few porous layers would tend to warp significantly, 
affecting the overall quality of the scaffolds (Partee et al. 2006).  
In order to speed up production and to produce scaffolds with similar quality for tests, 
multiple scaffold models were assembled based on the single scaffold models. Four and 
nine models were assembled. Then, the data file was exported in an STL format and 
transferred to the Sinterstation® 2000 system for the sintering process.  
 
Type 
Overall Size 
(mm3)* 
Channel Width 
(mm) 
Pillar Width 
(mm) 
Porosity  
(%) 
1 8816 0.8 
0.3 
78.4 
2 6.66.613.2 0.6 70.0 
Table 1. Design parameters of porous bone tissue engineering scaffolds. 
 
2.7 Production of 3D porous scaffolds by modified Sinterstation® 2000 system  
The build orientation (angle between the laser scanning direction and “L” dimension of the 
scaffold) was 45o. Significant variation in density and anisotropic properties were found in 
DuraForm™ polyamide (a common SLS material) parts built in 0o and 90o orientations 
(Caulfield et al. 2007). The 45o build orientation was chosen to reduce the anisotropy, also it 
was found to be effective in reducing warpage of porous scaffolds (Lee et al. 2004). 
In SLS, the laser energy density (ED) level significantly affects the scaffold properties. The 
ED level is a measure of the amount of energy supplied to the powder particles per unit area 
of the powder bed surface. The relationship between ED and laser power (P), scan spacing 
(SS) and beam speed (BS) can be expressed by the following equation (Nelson et al. 1993): 
 
PED SS BS                                                                   (1) 
It is obvious that too low a laser power will render low strength or even incomplete 
sintering of the scaffold, while too high a laser power will cause the biopolymer to degrade 
and the scaffold to warp due to high residual stresses. Scan spacing (SS) means the distance 
between two parallel laser scans during a fill. In this study, the beam speed (BS) was fixed at 
1257 mm/s and the effects of laser power, scan spacing and part bed temperature (PBT) 
were investigated. Prior to this study, DuraForm™ polyamide was used as the reference 
material for initial settings of the sintering parameters (Lee 2006). After some trials, a 
workable set of sintering parameters was obtained for PLLA and PLLA/CHAp 
nanocomposite as shown in Table 2. Fig. 1 shows the SLS process in progress. Four scaffold 
bases were being sintered and the powder used was a PLLA/CHAp nanocomposite. Also, 
the powder delivery appeared to be smooth during the sintering process. The production 
time for one batch of scaffolds was about 2.5 hours.  
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Sintering Condition PLLA PLLA/CHAp 
Scan Spacing (mm) 0.15-0.21 0.15-0.21 
Part Bed Temperature (oC) 30-40 30-60 
Layer Thickness (mm) 0.10 0.10 
Roller Speed (mm/s) 127 127 
Scan Speed (mm/s) 1257 1257 
Stepping Motor Delay (ms) 120 160 
Fill Laser Power (W) 11-15 11-19 
Table 2. Recommended sintering conditions for PLLA and PLLA/CHAp microspheres. 
 
 
Fig. 1. Selective laser sintering of PLLA/CHAp powder in progress. 
 
2.8 Characterization of 3D porous laser sintered PLLA and PLLA/CHAp 
nanocomposite scaffolds 
 
2.8.1 Porosity determination  
The scaffold porosity was determined using a specific gravity measurement kit and an 
electronic balance (Shimadzu, AW220, Japan). The detailed procedures and calculation were 
reported previously (Zhou et al. 2007). 
 
2.8.2 Compression test 
Compressive properties of the sintered scaffolds were determined using a MicroTester 
(Instron 5848, USA) with a load cell of 100 N. The crosshead speed was 0.5 mm/min. The 
compressive modulus was determined from the initial linear region of compressive stress-
strain curve. The compressive yield strength was determined from the first point on the 
stress-strain curve at which an increase in strain was observed without an increase in stress. 
The compressive modulus and yield strength for any given set of specimens were obtained 
by an average of five measurements and expressed as mean ± standard deviation (SD). 
 
 
2.8.3 In vitro degradation test 
Specimens containing 4 sintered layers cut from the sintered scaffolds were used in 
degradation test. The test specimens were accurately weighed, numbered and sterilized by 
70% ethanol. The specimens were incubated at 37 °C for 1, 3, 6 and 8 weeks in phosphate 
buffered saline (PBS) solution (pH 7.4). The PBS solution was changed fresh once a week. At 
weeks 1, 3, 6, and 8, three samples of each type of scaffold were removed and rinsed with 
de-ionized water 3 times and then air dried at room temperature. The level of degradation 
was assessed macroscopically in terms of weight loss and change in compressive properties. 
The results reported are averages of three measurements. The weight loss (WL) after in vitro 
degradation was calculated by the following equation: 
 
0 0(%) ( ) / 100tWL W W W                                               (2) 
 
where W0 and Wt are specimen weights before and after degradation respectively. 
 
2.8.4 In vitro cell culture 
Human osteoblast-like Saos-2 cells harvested from patients in the Department of 
Orthopedics and Traumatology (O&T), the University of Hong Kong were used in this 
research. The cells were cultured and proliferated in a new cell culture plate for one day 
prior to seeding. The scaffolds were sterilized by immersion in 70% ethanol for 1 day (Wiria 
et al. 2007). After sterilization, the scaffolds were washed and immersed in PBS for 1 day. 
Cells were trypsinized out of the plate at 37 oC (1ml trypsin to 1 plate/bottle), 5ml culture 
medium was added to stop trypsin action, and calculated using haemocytometer. 1x105 
cells/mL were added to each scaffold and allowed to attach to the matrix for 30 min before 
adding enough medium to submerge the scaffolds (Borden et al. 2003). The medium was 
changed every 3 days. Cell culture was allowed to continued for 7 and 14 days (Shen et al. 
2006). Then, the scaffolds were transferred for SEM examination after fixation with 
glutaraldehyde solution. 
  
3. Results and Discussion 
3.1 Morphology of PLLA and PLLA/CHAp microspheres 
Some PLLA microspheres and PLLA/CHAp nanocomposite microspheres are shown in Fig. 
2 (a) and (b), respectively. Both types of microsphere exhibited a generally similar range of 
particle sizes between 5 and 30 µm and which were suitable for SLS process. The pure PLLA 
microspheres appeared very smooth while some CHAp nanospheres were found partially 
embedded on the PLLA/CHAp nanocomposite microspheres and this may impart 
bioactivity (osteoconductivity) for the scaffolds built. Fig. 2 (c) shows the FIB-milled section 
of a PLLA/CHAp composite microsphere. The CHAp nanospheres were generally well 
distributed both on and inside the microsphere, forming a nanocomposite structure. The 
rough surfaces of the nanocomposite microspheres likely facilitate cell attachment. In 
addition, the nanocomposite microspheres flowed more easily than the pure PLLA 
microspheres, making powder deposition easier during SLS process.  
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where W0 and Wt are specimen weights before and after degradation respectively. 
 
2.8.4 In vitro cell culture 
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Orthopedics and Traumatology (O&T), the University of Hong Kong were used in this 
research. The cells were cultured and proliferated in a new cell culture plate for one day 
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et al. 2007). After sterilization, the scaffolds were washed and immersed in PBS for 1 day. 
Cells were trypsinized out of the plate at 37 oC (1ml trypsin to 1 plate/bottle), 5ml culture 
medium was added to stop trypsin action, and calculated using haemocytometer. 1x105 
cells/mL were added to each scaffold and allowed to attach to the matrix for 30 min before 
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Some PLLA microspheres and PLLA/CHAp nanocomposite microspheres are shown in Fig. 
2 (a) and (b), respectively. Both types of microsphere exhibited a generally similar range of 
particle sizes between 5 and 30 µm and which were suitable for SLS process. The pure PLLA 
microspheres appeared very smooth while some CHAp nanospheres were found partially 
embedded on the PLLA/CHAp nanocomposite microspheres and this may impart 
bioactivity (osteoconductivity) for the scaffolds built. Fig. 2 (c) shows the FIB-milled section 
of a PLLA/CHAp composite microsphere. The CHAp nanospheres were generally well 
distributed both on and inside the microsphere, forming a nanocomposite structure. The 
rough surfaces of the nanocomposite microspheres likely facilitate cell attachment. In 
addition, the nanocomposite microspheres flowed more easily than the pure PLLA 
microspheres, making powder deposition easier during SLS process.  
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Fig. 2. SEM images of microspheres: (a) PLLA, (b) PLLA/CHAp nanocomposite and (c) an 
FIB-milled section of a PLLA/CHAp nanocomposite microsphere. 
 
3.2 Effects of sintering parameters on scaffold structure 
 
3.2.1 Effect of laser power 
Sintering work was carried out on both PLLA and PLLA/CHAp microspheres covering a 
range of fill laser power (P) from 7W to 19W. It was found that when P<7W, the scaffolds 
could not take shape and they fell apart during handling. Fig. 3 (a) is an SEM image 
showing a surface layer of a Type 1 PLLA scaffold sintered at 19W. It can be seen that the 
struts of the scaffold were well sintered. The designed dimension of the struts was 300 m, 
however, the actual size turned out to be 490±33 m. The discrepancy was due to “growth”, 
which is a common phenomenon in SLS. When the laser penetrates beyond the design scan 
range, some polymer particles are either fully or partially melted and adhere onto the 
designed scaffold structure. Fig. 3 (b) shows a high magnification SEM image of a design 
pore area. Although the trapped PLLA microspheres still appeared to be in powder form, 
they were in fact partially fused together and necks were formed between them. It was quite 
possible when sintering with a high laser power, the temperature of the design pore areas 
increased to near or even above the melting point of the polymer and caused necking of the 
microspheres. These trapped microspheres could not be removed by the air-pressure gun 
and would therefore defeat the function of the porous scaffolds as originally designed. 
Obviously, a laser power of 19 W was too high and it should be adjusted down so that the 
powder in the pores could be removed. Finally, a proper set of sintering parameters was 
obtained and it is shown in Table 2. 
 
  
Fig. 3. SEM images of a Type 1 PLLA scaffold sintered at 19W: (a) low magnification 
showing the overall surface layer structure and (b) high magnification showing necking of 
PLLA microspheres in the design pore area (on the right side of image).  
 
3.2.2 Effect of part bed temperature 
Fig. 4 shows the effect of part bed temperature (PBT) on the structure of scaffolds built from 
the pure PLLA microspheres. When PBT was within the range as shown in Table 2, the 
unsintered powder within the pores could be removed easily by an air gun and the resultant 
scaffolds exhibited a distinctive porous structure (sample a). When PBT was higher than the 
recommended range however it was difficult to remove all the unsintered powder from the 
pores (sample b). In normal SLS processes, PBT should be set near the Tg of amorphous 
polymers and just below the Tm of semi-crystalline polymers, at the time the laser only 
provides small amounts of extra heat energy for powder fusion. Too high a PBT caused the 
powder in the pores to partially fuse with the design structure and difficult to be removed. 
On the other hand, too low a PBT would result in low strength of the scaffolds and they 
tended to fall apart during handling.  
 
3.2.3 Effect of scan spacing 
Fig. 5 shows the effect of scan spacing (SS). Too small an SS would result in excessive 
amount of laser energy to be deposited on the powder bed surface and cause blocking of the 
pores (sample a). When SS was too large, the laser energy density became too low for 
complete sintering of the scaffold structure and hence it could not take shape. In general, 
extreme values of the processing parameters should be avoided in order to obtain a 
desirable porous structure (sample b).  
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Fig. 2. SEM images of microspheres: (a) PLLA, (b) PLLA/CHAp nanocomposite and (c) an 
FIB-milled section of a PLLA/CHAp nanocomposite microsphere. 
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Fig. 6. Selective laser sintered porous scaffolds (Type 1) from (a) PLLA microspheres and (b) 
PLLA/CHAp nanocomposite microspheres. 
 
3.3 Morphology of scaffolds built under recommended conditions 
 
3.3.1 General appearances 
The general appearances of the PLLA and PLLA/CHAp porous scaffolds built under the 
recommended conditions are shown in Fig. 6 (a) and (b), respectively. After removal of the 
excessive powder, the pores could be easily recognized and the layers were firmly attached 
together. Such scaffolds were used for subsequent structural, mechanical, degradation and 
biological assessments.  
 
3.3.2 Layer morphology  
Fig. 7 shows the typical layer morphologies of the PLLA and PLLA/CHAp scaffolds 
sintered under the recommended conditions. It can be seen that the PLLA microspheres 
were well fused in the scanned areas, Fig. 7 (a). Nevertheless, the sintered material was not 
fully dense and some very fine pores were present, resulting in a porous structure 
possessing a combination of meso-pores (due to design) and micro-pores (due to incomplete 
fusion of the sintered material). This structure likely facilitates the flow of body fluid and 
promotes nutrition and metabolism waste exchange, and hence is more beneficial to cell 
growth than a scaffold with only micro-pores, for example the PCL/HAp disc scaffolds 
reported by Wiria et al. (2007). Also, the powder preparation methods used in the two 
studies were different. In this study, the nanocomposite was prepared by emulsion 
microencapsulation method and the nano-sized CHAp particles were well encapsulated in 
the PLLA/CHAp microspheres even before sintering, on the other hand the PCL/HAp 
composites used by Wiria et al. (2007) were physically blended. Furthermore, the 
biopolymers used in the two studies were different; therefore, the scaffolds produced likely 
have different in vitro and in vivo properties. In the laser sintered scaffolds built by Williams 
et al. (2005) with PCL, the smallest pore size reported was 1.75 mm in diameter. As can be 
seen from Fig. 7 (b), the pores size of the PLLA scaffold is around 200 m which is much 
 
smaller than the laser spot size of 457 m. This study showed that it is possible to build 
scaffolds with pore sizes below the limitation of laser beam width. 
When the PLLA and PLLA/CHAp scaffolds were sintered with the respective conditions as 
shown in Table 2, there was no problem in removing the excessive trapped powder from the 
pores. For the PLLA scaffolds, a low pressure air gun was needed to remove the excessive 
powder. The layers were generally well preserved afterward and the pores of the scaffolds 
could be clearly identified. For the PLLA/CHAp nanocomposite scaffolds, the loose powder 
could be shaken off by hand. It has been reported in the literature that removing the 
excessive powder from the pores is a major obstacle for porous scaffold production using 
the SLS process (Tan et al. 2003). Here, the PLLA/CHAp nanocomposite microspheres seem 
to offer a solution to the problem provided the sintering conditions are properly set. 
There is a difference between the design and actual pore sizes. When the design pore size 
was 0.8 mm, the actual pore size of sintered scaffolds was only about 438±52 m as shown in 
Fig. 7 (a). In Type 2 scaffolds, the pore size was even smaller compared with the design pore 
size (Fig. 7 (b)). Obviously the reduction in pore size was a result of “growth” which was 
caused by the penetration of the laser energy beyond the design scan area. Therefore, it is 
important to take into consideration the effect of “growth” in designing the pore size of the 
scaffolds built by SLS. 
 
  
Fig. 7. SEM images showing the layer structures of (a) PLLA scaffold (Type 1) and (b) 
PLLA/CHAp nanocomposite scaffold (Type 2); sintering condition: P=15W.  
 
3.3.3 Comparison of fusion behavior  
It can also be seen from Fig. 8 (a) and (b) that the degree of fusion of the PLLA/CHAp 
nanocomposite powder was lower than that of the pure PLLA powder. This could be 
explained by the increased viscosity of the composite material. It has been postulated that a 
filled polymer will sinter at a different rate as the same polymer without filler, in inverse 
proportion to the viscosities of the filled and unfilled materials (Childs & Tontowi 2001). Fan 
et al. studied the material movement and fusion behavior of SiO2 and glass sphere (GS) 
filled TrueForm™ composites during selective laser sintering (Fan et al. 2001; Fan 2003). 
They found that  for a given volume fraction of the additive, a smaller particle size of the 
fillers in dry mixed polymer composites would obstruct fusion of molten polymer particles 
more significantly and result in weak parts. The embedded fillers increased the material 
viscosity and adversely affected the densification of the powder bed. Also the CHAp 
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When the PLLA and PLLA/CHAp scaffolds were sintered with the respective conditions as 
shown in Table 2, there was no problem in removing the excessive trapped powder from the 
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powder. The layers were generally well preserved afterward and the pores of the scaffolds 
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could be shaken off by hand. It has been reported in the literature that removing the 
excessive powder from the pores is a major obstacle for porous scaffold production using 
the SLS process (Tan et al. 2003). Here, the PLLA/CHAp nanocomposite microspheres seem 
to offer a solution to the problem provided the sintering conditions are properly set. 
There is a difference between the design and actual pore sizes. When the design pore size 
was 0.8 mm, the actual pore size of sintered scaffolds was only about 438±52 m as shown in 
Fig. 7 (a). In Type 2 scaffolds, the pore size was even smaller compared with the design pore 
size (Fig. 7 (b)). Obviously the reduction in pore size was a result of “growth” which was 
caused by the penetration of the laser energy beyond the design scan area. Therefore, it is 
important to take into consideration the effect of “growth” in designing the pore size of the 
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PLLA/CHAp nanocomposite scaffold (Type 2); sintering condition: P=15W.  
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It can also be seen from Fig. 8 (a) and (b) that the degree of fusion of the PLLA/CHAp 
nanocomposite powder was lower than that of the pure PLLA powder. This could be 
explained by the increased viscosity of the composite material. It has been postulated that a 
filled polymer will sinter at a different rate as the same polymer without filler, in inverse 
proportion to the viscosities of the filled and unfilled materials (Childs & Tontowi 2001). Fan 
et al. studied the material movement and fusion behavior of SiO2 and glass sphere (GS) 
filled TrueForm™ composites during selective laser sintering (Fan et al. 2001; Fan 2003). 
They found that  for a given volume fraction of the additive, a smaller particle size of the 
fillers in dry mixed polymer composites would obstruct fusion of molten polymer particles 
more significantly and result in weak parts. The embedded fillers increased the material 
viscosity and adversely affected the densification of the powder bed. Also the CHAp 
Tissue	Engineering190
 
nanoparticles on the powder surface might act as a barrier against fusion. Another possible 
reason for the lower degree of fusion of the PLLA/CHAp nanocomposite microspheres was 
the relatively high specific heat capacity of hydroxyapatite. According to Cruz et al. (2005), 
the molar heat capacity (Cp,m) of HAp is 694 ± 68 J mol-1 K-1  in the temperature range 298-
1298 K, which is much higher than that of PLLA, from 145.4 to 156.7 J mol-1 K-1 in the 
temperature range from 332.5K (Tg) to 480 K (Tm) (Pyda et al. 2004; Malmgren et al. 2006). 
Therefore, CHAp (a hydroxyapatite based ceramic) can be regarded as a huge energy 
reservoir to absorb laser energy. So the amount of laser energy input into the PLLA matrix 
of the composite powder was reduced, resulting in a lower degree of fusion of PLLA/CHAp 
particles.  
Some PLLA microspheres were present in Fig. 8 (a), and most probably bonded to the 
surface during powder deposition when the sintered material was still hot; as a result they 
could not be completely removed by the compressed air gun. Such microspheres would 
increase the surface roughness of the scaffold and this might be advantageous to cell 
attachment. Underneath the microspheres, the polymer was generally well sintered; 
nevertheless, some micro-pores were present due to incomplete fusion. This renders a 
porous structure consisting of both meso-pores (by design) and micro-pores.  
 
  
Fig. 8. Comparison of fusion behavior of laser sintered scaffolds (Type 1): (a) PLLA and (b) 
PLLA/CHAp; sintering condition: P=15W. 
 
3.3.4 Importance of meso-scale feature  
As seen above, the scaffolds have similar meso-scale feature compared with some recently 
developed scaffolds. The 3D channels created into the scaffolds played an important role in 
cell attachment and proliferation and enhanced nutrient transfer and waste exchange (Rose 
et al. 2004; Mahoney et al. 2005). A common problem encountered with scaffolds based 
tissue engineering strategies is the rapid formation of tissue on the outer edge of the scaffold 
whilst the tissue in the centre becomes necrotic. A way of addressing this problem is to 
incorporate a specific meso-scale feature design into the scaffold to improve nutrient and 
cell transfer to the scaffold centre. Recently, Rekow et al. (2006) reviewed that scaffold 
features at different length scales can have dramatic influences on bone tissue response. 
Nano-scale features (< 1 m) of the scaffolds may control interactions at the protein level 
and thus influence the biocompatibility. Micro-scale scaffold features (1-20 m) will 
modulate cell behavior, affecting both the type of cells that adhere to a scaffold surface. 
 
Meso-scale features (200-1000 m) will influence the structural support of the scaffold and 
the amount of bone that can develop. The meso-scale has been largely overlooked. Macro-
scale features (> 1mm) will define the anatomic shape. 
Meso-scale scaffold feature may be achieved by inserting 3D interconnected channels into 
the body of a scaffold creating a porous structure with different length scales. Frosch and co-
workers (2002) assessed the infiltration of human osteoblasts into a range of channel 
diameters (from 300 to 1000 μm) within titanium implants containing no other form of 
porosity. They found that cell ingrowth and subsequent matrix formation increased with 
increasing channel diameter up to 600 μm; however matrix production was sub-optimal in 
the 1000 μm channel. Xu et al. (2007) pointed out that porous scaffolds should have 
branched channels to ensure uniform cell feeding and even flow of culture medium through 
the scaffold to promote uniform cell attachment and growth. Precise control of scaffold 
architecture (e.g. porosity, pore geometry, size, interconnectivity, orientation, and 
branching) is needed to optimize the scaffold properties for nutrient diffusion, cell growth 
and tissue regeneration. 
 
3.4 Properties of scaffolds built under recommended conditions 
 
3.4.1 Effect of laser power on porosity 
The porosities of the sintered scaffolds were determined based on the measurement of 
specific gravity and plotted in Fig. 9 as a function of fill laser power. As expected, the 
porosities decreased with increasing laser power for both Type 1 (0.8 mm pores) and Type 2 
(0.6 mm pores) PLLA and PLLA/CHAp scaffolds. The relationships were almost linear 
within the recommended range of laser power (see Table 2). All measured porosities of the 
scaffolds were below the design values. The phenomenon was due to excessive “growth” 
(especially when sintering was done at high laser power) and the difficulty in removing the 
unwanted powder from the pores (especially for Type 2 scaffolds). Nevertheless, the 
measured and design porosities were relatively close for scaffolds sintered at a fill laser 
power of 11 W, i.e. the lowest value within the recommended range. Apparently, a lower 
laser power is preferred in terms of controlling the porosity. Furthermore, it is noted that the 
difference between the measured and design porosities of PLLA scaffolds is much larger 
than that of the PLLA/CHAp scaffolds, especially in Type 2 scaffolds (i.e. with a smaller 
design pore size). This indicates that, in order to control the porosity, one not only has to 
consider the sintering condition, but also the material used and scaffold design. In this 
respect, PLLA/CHAp seems to be a better material choice than pure PLLA. This can be 
attributed to its higher viscosity and microsphere surface morphology (containing high 
content of CHAp nanoparticles) which tend to limit the amount of “growth” and therefore 
the unsintered powder can be removed more easily. However, it should be pointed out that 
such material characteristics may affect the fusion behavior (see Fig. 8) and other scaffold 
properties which will be discussed later. 
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Fig. 9. Effect of fill laser power on porosity of selective laser sintered PLLA and 
PLLA/CHAp scaffolds, the design porosities of Type 1 and Type 2 scaffolds are 78.4% and 
70.0%, respectively. 
 
3.4.2 Effect of laser power on compression properties 
Models describing the mechanical behavior of cellular solids such as open-cell foams are 
well developed (Harley et al. 2007). A typical stress-strain curve for low-density, elastomeric 
open-cell foam in compression is characterized by three distinct regimes: a linear elastic 
regime which corresponds to strut bending, a collapse plateau regime which corresponds to 
strut buckling and pore collapse and a densification regime which corresponds to complete 
pore collapse throughout the material. Lee (2006) reported two modes of failure of porous 
selective laser sintered scaffolds built from DuraFormTM PA. Buckling was found to occur 
when the vertical struts had a higher slenderness ratio or larger pore size, and the scaffold 
collapsed layer by layer almost vertically. Meanwhile shearing occurred with a lower 
slenderness ratio of the vertical struts, and the scaffold was compressed into an “S” shape. 
In this study, shearing was found to be the predominant mode of failure and the scaffolds 
were compressed into an “S” shape. Fig. 10 shows a typical compressive stress-strain curve 
of Type 1 PLLA/CHAp scaffolds. It exhibits three regimes which, to a large extent, resemble 
those commonly observed in cellular structures (Gibson & Ashby 1997). A similar linear 
elastic regime first appears, from which the compressive modulus can be measured. Beyond 
this zone, unlike the smooth plateau for low-density, elastomeric open-cell foam, a peaky 
plateau regime is observed. This peaky plateau can be attributed to sequential collapses of 
layers due to shearing. Each peak involves a number of layers. Once the shear deformation 
reaches a critical value, the vertical struts may break causing the compressive load to drop 
while the heavily deformed layers are collapsing. When all the layers have collapsed, further 
compressing will give rise to the final regime of densification with further increase of stress.  
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Fig. 10. Typical compressive stress-strain 
curve of Type 1 PLLA/CHAp scaffold (pore 
size=0.8mm), sintered at 15W. 
 
Fig. 11. Typical compressive stress-strain 
curves of 4-layer PLLA scaffolds (Type 1): 
(a) sintered at 15W and (b) sintered at 13W. 
 
It was found that sintered scaffolds consisting of 4 layers were sufficient for investigation of 
the initial linear elastic regime. Therefore, 4-layer specimens were later used to determine 
the compressive modulus and strength of the different scaffold types in order to save 
material. Fig. 11 shows the typical compressive stress-strain curves of two such PLLA 
scaffolds sintered at different laser power. The initial elastic regimes appear relatively linear. 
It can be seen that the scaffold sintered at 15W has a higher compressive yield strength and 
strain than that sintered at 13W. Furthermore, the compressive yield strength and strain of 
the PLLA scaffolds appear to be much higher than those of the Type 1 PLLA/CHAp 
scaffold shown in Fig. 10. 
The overall effects of fill laser power on the compressive yield strength and modulus of the 
PLLA and PLLA/CHAp scaffolds are shown in Figs. 12 and 13 respectively. It is clear that 
the compressive yield strength increases with increasing fill laser power. Besides, the 
compressive yield strength is also affected by both the scaffold type and material. The 
porosity and fusion behavior are two major factors affecting the mechanical properties of 
the selective laser sintered scaffolds. For the same material, either PLLA or PLLA/CHAp, 
Type 2 scaffolds have a lower porosity and hence the compressive yield strength is higher. 
For the same scaffold type, PLLA gives higher compressive yield strength and modulus 
than the PLLA/CHAp nanocomposite, and this is mainly due to the better fusion behavior 
of the pure polymer. Apart from improving the biological property, the ceramic phase 
(CHAp nanospheres) was added in an attempt also to improve the mechanical property of 
the scaffolds. On the contrary, the results in Figs. 12 and 13 show a reduction in compressive 
properties under the current sintering conditions. Perhaps, some sort of post-sintering 
processing is required to consolidate the structure of the PLLA/CHAp scaffolds before use.  
 
Selective	Laser	Sintering	of	Poly(L-Lactide)/Carbonated		
Hydroxyapatite	Nanocomposite	Porous	Scaffolds	for	Bone	Tissue	Engineering 193
 
10 11 12 13 14 15 16 17 18 19 20
40
50
60
70
80
 
 
 PLLA, Type 1 
 PLLA, Type 2 
 PLLA/CHAp, Type 1 
 PLLA/CHAp, Type 2 
Po
ros
ity
 (%
)
Fill Laser Power (W)
 
Fig. 9. Effect of fill laser power on porosity of selective laser sintered PLLA and 
PLLA/CHAp scaffolds, the design porosities of Type 1 and Type 2 scaffolds are 78.4% and 
70.0%, respectively. 
 
3.4.2 Effect of laser power on compression properties 
Models describing the mechanical behavior of cellular solids such as open-cell foams are 
well developed (Harley et al. 2007). A typical stress-strain curve for low-density, elastomeric 
open-cell foam in compression is characterized by three distinct regimes: a linear elastic 
regime which corresponds to strut bending, a collapse plateau regime which corresponds to 
strut buckling and pore collapse and a densification regime which corresponds to complete 
pore collapse throughout the material. Lee (2006) reported two modes of failure of porous 
selective laser sintered scaffolds built from DuraFormTM PA. Buckling was found to occur 
when the vertical struts had a higher slenderness ratio or larger pore size, and the scaffold 
collapsed layer by layer almost vertically. Meanwhile shearing occurred with a lower 
slenderness ratio of the vertical struts, and the scaffold was compressed into an “S” shape. 
In this study, shearing was found to be the predominant mode of failure and the scaffolds 
were compressed into an “S” shape. Fig. 10 shows a typical compressive stress-strain curve 
of Type 1 PLLA/CHAp scaffolds. It exhibits three regimes which, to a large extent, resemble 
those commonly observed in cellular structures (Gibson & Ashby 1997). A similar linear 
elastic regime first appears, from which the compressive modulus can be measured. Beyond 
this zone, unlike the smooth plateau for low-density, elastomeric open-cell foam, a peaky 
plateau regime is observed. This peaky plateau can be attributed to sequential collapses of 
layers due to shearing. Each peak involves a number of layers. Once the shear deformation 
reaches a critical value, the vertical struts may break causing the compressive load to drop 
while the heavily deformed layers are collapsing. When all the layers have collapsed, further 
compressing will give rise to the final regime of densification with further increase of stress.  
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Fig. 10. Typical compressive stress-strain 
curve of Type 1 PLLA/CHAp scaffold (pore 
size=0.8mm), sintered at 15W. 
 
Fig. 11. Typical compressive stress-strain 
curves of 4-layer PLLA scaffolds (Type 1): 
(a) sintered at 15W and (b) sintered at 13W. 
 
It was found that sintered scaffolds consisting of 4 layers were sufficient for investigation of 
the initial linear elastic regime. Therefore, 4-layer specimens were later used to determine 
the compressive modulus and strength of the different scaffold types in order to save 
material. Fig. 11 shows the typical compressive stress-strain curves of two such PLLA 
scaffolds sintered at different laser power. The initial elastic regimes appear relatively linear. 
It can be seen that the scaffold sintered at 15W has a higher compressive yield strength and 
strain than that sintered at 13W. Furthermore, the compressive yield strength and strain of 
the PLLA scaffolds appear to be much higher than those of the Type 1 PLLA/CHAp 
scaffold shown in Fig. 10. 
The overall effects of fill laser power on the compressive yield strength and modulus of the 
PLLA and PLLA/CHAp scaffolds are shown in Figs. 12 and 13 respectively. It is clear that 
the compressive yield strength increases with increasing fill laser power. Besides, the 
compressive yield strength is also affected by both the scaffold type and material. The 
porosity and fusion behavior are two major factors affecting the mechanical properties of 
the selective laser sintered scaffolds. For the same material, either PLLA or PLLA/CHAp, 
Type 2 scaffolds have a lower porosity and hence the compressive yield strength is higher. 
For the same scaffold type, PLLA gives higher compressive yield strength and modulus 
than the PLLA/CHAp nanocomposite, and this is mainly due to the better fusion behavior 
of the pure polymer. Apart from improving the biological property, the ceramic phase 
(CHAp nanospheres) was added in an attempt also to improve the mechanical property of 
the scaffolds. On the contrary, the results in Figs. 12 and 13 show a reduction in compressive 
properties under the current sintering conditions. Perhaps, some sort of post-sintering 
processing is required to consolidate the structure of the PLLA/CHAp scaffolds before use.  
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Fig. 12. Effect of fill laser power on the 
compressive yield strength of laser sintered 
scaffolds. 
Fig. 13. Effect of fill laser power on the 
compressive modulus of laser sintered 
scaffolds. 
 
Mechanical property is an important requirement for scaffold use in bone tissue 
engineering. As templates to guide tissue regeneration, scaffolds need to have enough 
mechanical strength in order to retain their shape during in vitro and in vivo applications. 
Further requirements for scaffold mechanical properties will differ from applications. For 
example, for regeneration of trabecular bone, the scaffold will deliver cells and growth 
factors to the graft site, to mimic cancellous bone grafting where the mass of bony spicules 
and marrow possess no inherent mechanical strength (Guan & Davies 2004). In such 
strategy, the scaffold only needs to be strong enough to maintain its dimensional integrity 
during cell culture. Human cancellous bone (wet condition) has a reported compressive 
modulus and strength range of 20-900 MPa and 1-15 MPa, respectively. Human cortical 
bone (wet condition) has a reported compressive modulus and strength range of 5-20 GPa 
and 100-200 MPa, respectively (Athanasiou et al. 2000; Kofron et al. 2007). In this study, the 
laser sintered PLLA scaffolds have a compressive modulus and strength range of 15-30 MPa 
and 1-3 MPa, respectively; the laser sintered PLLA/CHAp scaffolds have a compressive 
modulus and strength range of 4-10 MPa and 0.2-2.5 MPa, respectively. It indicates that after 
optimization of the sintering conditions, the SLS scaffolds may achieve mechanical 
properties suitable for cancellous bone tissue engineering application. Guan & Davies (2004) 
fabricated a unique composite scaffold for bone tissue engineering by combining 
poly(lactide-co-glycolide) (PLGA) with bioresorbable calcium phosphate cement particles 
through the process of particle fusion and phase separation/particle leaching. The scaffold 
is characterized by a highly interconnected macro-porosity, with macro-pores of 0.8-1.8 mm 
and porosities ranging from 81 to 91%. The addition of calcium phosphate to the matrix 
prevented scaffold collapse, when placed in media or seeded with cells; however, the 
compressive strength of the scaffold (0.16 MPa) and modulus (6-8 MPa) are below that of 
cancellous bone. Williams et al. (2005) fabricated 3D PCL scaffolds by SLS with a pore size 
1.75-2.5 mm and porosity 37-55%. The cylindrical scaffolds possessed a compressive 
modulus of 52-67 MPa and yield strength of 2-3.2 MPa. Polymeric scaffolds fabricated by 
SLS demonstrated lower mechanical properties when compared with other techniques such 
 
as the heat sintered microsphere scaffolds. On the other hand, SLS can fabricate complex 
scaffolds more easily than microsphere heat sintering method. Kofron et al. (2007) fabricated 
PLGA/HAp microsphere scaffolds by heat sintering and those scaffolds have a compressive 
modulus of 100-200 MPa and strength of 20-80 MPa controlled by sintering time and 
temperature. The difference of mechanical performance for laser sintered microspheres and 
heat sintered microspheres is due to the energy sources and scaffold design. Heating will 
generally cause polymer to adhere or melt more easily than laser sintering. In Laurencin’s 
group (Lu et al. 2003), they used 100-200 m PLGA or PLGA/bioactive glass microspheres 
to form scaffolds. The average porosity and pore diameter of the PLGA and 
PLGA/bioactive glass scaffolds were 31 and 43 % and 116 and 89 m. Thus a lower porosity 
will give scaffolds higher compression properties. The mechanical properties of the scaffolds 
are highly dependent on the geometry too. In clinical applications, scaffold geometry will 
depend on the anatomical location of the injury. 
 
3.4.3 In vitro degradation  
The weight loss of PLLA and PLLA/CHAp scaffolds over 2 months of in vitro degradation 
test in PBS are shown in Figs. 14 and 15, respectively. In general, the weight loss increases 
with increasing degradation time and the scattering of data is quite large. The major loss in 
weight was due to removal of microspheres loosely bonded on the scaffold surface and 
within the pores, such as those shown in Fig. 8. For Type 1 PLLA scaffolds, Fig. 14 (a), the 
effect of fill laser power is not clear and the overall weight loss (over 2 months) is around 4-
6% for all values of laser power used. Nevertheless, it is quite clear that for Type 1 
PLLA/CHAp nanocomposite scaffolds, Fig. 14 (b), the degradation rate decreases with 
increasing laser power. This is expected as a higher laser power will produce a more 
compact structure of the scaffolds, reducing the contact between the phosphate buffered 
saline and the scaffold material. There is a slight trend of abnormal degradation behavior for 
Type 1 PLLA scaffolds as shown in Fig. 14 (a), i.e. the PLLA scaffolds sintered at a higher fill 
laser power suffering a higher weight loss than those sintered at a lower laser power. This 
anomaly was probably due to excessive “growth” under the higher laser power. Although 
the trapped PLLA microspheres could not be removed by the air-pressure gun, they might 
be detached from scaffold in PBS during the 2-month degradation test under continuous 
shaking.  
When comparison is drawn between PLLA and PLLA/CHAp scaffolds sintered at 11 W, the 
nanocomposite scaffolds suffered a much high degradation rate. One possible explanation 
to the phenomenon is that under this relatively lower laser power (lowest within the 
recommended range) and due to the poorer fusion behavior of the nanocomposite 
microspheres, there were a large number of very loosely bonded microspheres within the 
scaffolds. These microspheres would not survive the test and were detached out relatively 
quickly. When the laser power was increased to 15 W, however, some of those loosely 
bonded microspheres became more securely bonded to the solid structure causing the 
weight loss to drop.  
From Fig. 15 (a), Type 2 PLLA scaffolds are found to suffer a much bigger weight loss than 
and Type 1 PLLA scaffolds.  Again, this can be attributed to the larger amount of loosely 
bonded microspheres being dislodged from the scaffolds structure during the degradation 
test. Since Type 2 scaffolds possessed smaller pores and therefore more such particles were 
expected to be trapped within the scaffolds even after the compressed air gun treatment. 
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Fig. 12. Effect of fill laser power on the 
compressive yield strength of laser sintered 
scaffolds. 
Fig. 13. Effect of fill laser power on the 
compressive modulus of laser sintered 
scaffolds. 
 
Mechanical property is an important requirement for scaffold use in bone tissue 
engineering. As templates to guide tissue regeneration, scaffolds need to have enough 
mechanical strength in order to retain their shape during in vitro and in vivo applications. 
Further requirements for scaffold mechanical properties will differ from applications. For 
example, for regeneration of trabecular bone, the scaffold will deliver cells and growth 
factors to the graft site, to mimic cancellous bone grafting where the mass of bony spicules 
and marrow possess no inherent mechanical strength (Guan & Davies 2004). In such 
strategy, the scaffold only needs to be strong enough to maintain its dimensional integrity 
during cell culture. Human cancellous bone (wet condition) has a reported compressive 
modulus and strength range of 20-900 MPa and 1-15 MPa, respectively. Human cortical 
bone (wet condition) has a reported compressive modulus and strength range of 5-20 GPa 
and 100-200 MPa, respectively (Athanasiou et al. 2000; Kofron et al. 2007). In this study, the 
laser sintered PLLA scaffolds have a compressive modulus and strength range of 15-30 MPa 
and 1-3 MPa, respectively; the laser sintered PLLA/CHAp scaffolds have a compressive 
modulus and strength range of 4-10 MPa and 0.2-2.5 MPa, respectively. It indicates that after 
optimization of the sintering conditions, the SLS scaffolds may achieve mechanical 
properties suitable for cancellous bone tissue engineering application. Guan & Davies (2004) 
fabricated a unique composite scaffold for bone tissue engineering by combining 
poly(lactide-co-glycolide) (PLGA) with bioresorbable calcium phosphate cement particles 
through the process of particle fusion and phase separation/particle leaching. The scaffold 
is characterized by a highly interconnected macro-porosity, with macro-pores of 0.8-1.8 mm 
and porosities ranging from 81 to 91%. The addition of calcium phosphate to the matrix 
prevented scaffold collapse, when placed in media or seeded with cells; however, the 
compressive strength of the scaffold (0.16 MPa) and modulus (6-8 MPa) are below that of 
cancellous bone. Williams et al. (2005) fabricated 3D PCL scaffolds by SLS with a pore size 
1.75-2.5 mm and porosity 37-55%. The cylindrical scaffolds possessed a compressive 
modulus of 52-67 MPa and yield strength of 2-3.2 MPa. Polymeric scaffolds fabricated by 
SLS demonstrated lower mechanical properties when compared with other techniques such 
 
as the heat sintered microsphere scaffolds. On the other hand, SLS can fabricate complex 
scaffolds more easily than microsphere heat sintering method. Kofron et al. (2007) fabricated 
PLGA/HAp microsphere scaffolds by heat sintering and those scaffolds have a compressive 
modulus of 100-200 MPa and strength of 20-80 MPa controlled by sintering time and 
temperature. The difference of mechanical performance for laser sintered microspheres and 
heat sintered microspheres is due to the energy sources and scaffold design. Heating will 
generally cause polymer to adhere or melt more easily than laser sintering. In Laurencin’s 
group (Lu et al. 2003), they used 100-200 m PLGA or PLGA/bioactive glass microspheres 
to form scaffolds. The average porosity and pore diameter of the PLGA and 
PLGA/bioactive glass scaffolds were 31 and 43 % and 116 and 89 m. Thus a lower porosity 
will give scaffolds higher compression properties. The mechanical properties of the scaffolds 
are highly dependent on the geometry too. In clinical applications, scaffold geometry will 
depend on the anatomical location of the injury. 
 
3.4.3 In vitro degradation  
The weight loss of PLLA and PLLA/CHAp scaffolds over 2 months of in vitro degradation 
test in PBS are shown in Figs. 14 and 15, respectively. In general, the weight loss increases 
with increasing degradation time and the scattering of data is quite large. The major loss in 
weight was due to removal of microspheres loosely bonded on the scaffold surface and 
within the pores, such as those shown in Fig. 8. For Type 1 PLLA scaffolds, Fig. 14 (a), the 
effect of fill laser power is not clear and the overall weight loss (over 2 months) is around 4-
6% for all values of laser power used. Nevertheless, it is quite clear that for Type 1 
PLLA/CHAp nanocomposite scaffolds, Fig. 14 (b), the degradation rate decreases with 
increasing laser power. This is expected as a higher laser power will produce a more 
compact structure of the scaffolds, reducing the contact between the phosphate buffered 
saline and the scaffold material. There is a slight trend of abnormal degradation behavior for 
Type 1 PLLA scaffolds as shown in Fig. 14 (a), i.e. the PLLA scaffolds sintered at a higher fill 
laser power suffering a higher weight loss than those sintered at a lower laser power. This 
anomaly was probably due to excessive “growth” under the higher laser power. Although 
the trapped PLLA microspheres could not be removed by the air-pressure gun, they might 
be detached from scaffold in PBS during the 2-month degradation test under continuous 
shaking.  
When comparison is drawn between PLLA and PLLA/CHAp scaffolds sintered at 11 W, the 
nanocomposite scaffolds suffered a much high degradation rate. One possible explanation 
to the phenomenon is that under this relatively lower laser power (lowest within the 
recommended range) and due to the poorer fusion behavior of the nanocomposite 
microspheres, there were a large number of very loosely bonded microspheres within the 
scaffolds. These microspheres would not survive the test and were detached out relatively 
quickly. When the laser power was increased to 15 W, however, some of those loosely 
bonded microspheres became more securely bonded to the solid structure causing the 
weight loss to drop.  
From Fig. 15 (a), Type 2 PLLA scaffolds are found to suffer a much bigger weight loss than 
and Type 1 PLLA scaffolds.  Again, this can be attributed to the larger amount of loosely 
bonded microspheres being dislodged from the scaffolds structure during the degradation 
test. Since Type 2 scaffolds possessed smaller pores and therefore more such particles were 
expected to be trapped within the scaffolds even after the compressed air gun treatment. 
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The results in Fig. 15 (b) are somewhat unclear. It is suspected that excessive “growth” and 
different degrees of damage caused during powder removal and degradation test might 
have contributed to the large variations in the test results. 
In general, the degradation time of PLLA is around 2-3 years and there are four steps 
involved in the degradation process: (1) swelling and hydration of PLLA; (2) breakage of the 
ester bonds; (3) diffusion of the soluble degradation products; and (4) disappearance of the 
polymer scaffold struts (Gong et al. 2007). In this study, due to time limit, the degradation 
tests only lasted for 2 months. Primarily, only the first step was involved and the weight loss 
was mainly due to detachment of loosely bonded microspheres. There may be some 
swelling and hydration of PLLA involved too. With regard to the degradation mechanism of 
PLLA, the commonly held believe is that PLLA is a hydrolyzable polymer that follows a 
bulk degradation (Gong et al. 2007). The study by von Burkersroda et al. (2002) showed that 
all degradable polymers can undergo surface degradation or bulk degradation. The way a 
polymer matrix degrades all depends on the diffusion of water inside the matrix, the 
degradation rate of the polymer’s functional groups and the matrix dimension. The 
dimension is an important factor. If a matrix is larger than a critical device dimension, it will 
undergo surface degradation; if not, it will be bulk degradation. Polyanhydrides were found 
to be surface degradation down to a size of approximately 10-4 m while poly(-hydroxy 
esters) matrices need to be larger than 10-1 m to lose their bulk degradation properties. The 
strut and microsphere sizes of the sintered PLLA and PLLA/CHAp scaffolds are all less 
than 0.1 m in this study which would show bulk degradation characteristics. The ester 
bonds in the backbone chain break randomly to generate carboxyl groups, which in turn 
autocatalytically accelerate the degradation reaction, resulting in an exponential (Park 1995) 
or linear (Gong et al. 2007) decrease of the molecular weight of a bulk PLLA material with 
degradation time. The intermediate degradation products are trapped inside the material 
before their molecular weights decrease to a critical value of about 1100 to be soluble in 
water. The loss of the precise shape of the tissue engineering scaffold after implantation is a 
common problem (Shieh et al. 2004). This study showed that the laser sintered scaffolds 
could maintain their original shapes after 2 months in vitro degradation which may be 
beneficial for implantation of the scaffolds in vivo. However, compared with the degradation 
in vitro, the degradation rate of the PLLA scaffolds in vivo was much faster (Dijk et al. 2002; 
Gong et al. 2007). The in vivo environment, including the easy exchange of substances, the 
enzymes and loading condition, is usually regarded to accelerate the degradation of the 
polymer scaffold. In vitro degradation of biodegradable implants has been commonly used 
to predict their in vivo behavior, but it is difficult to take all the in vivo environmental 
variables into account. In order to optimize the scaffolds for real tissue engineering 
applications, ideally in vivo experiments should be performed. However, such experiments 
involve animal tests and it is beyond the scope of this study. 
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Fig. 14. Weight loss of porous laser sintered Type 1 scaffolds during degradation in PBS: (a) 
PLLA scaffolds and (b) PLLA/CHAp scaffolds; sampling size n=3. 
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Fig. 15. Weight loss of porous laser sintered Type 2 scaffolds during degradation in PBS: 
(a) PLLA scaffolds and (b) PLLA/CHAp scaffolds; sampling size n=3. 
 
3.4.4 Compression properties after in vitro degradation 
The compressive yield strength and modulus of the PLLA and PLLA/CHAp scaffolds were 
measured through the 2-month in vitro degradation test and the results are shown in Figs. 16 
and 17. In general, the compression properties decreased with increasing degradation time. 
The modulus dropped more significantly within the first week of the degradation test and 
then followed by a more gradual decrease. This trend coincides with the rate of weight loss 
as shown in Figs. 14 and 15. Furthermore, it can be seen that the change of compressive 
modulus was much bigger than that of compressive strength. Similar effect was observed by 
Yang et al.  (2006). One possible explanation was that the modulus was more dependent on 
the amount of loose particles trapped within the scaffold structure. When under 
compression, some of these particles were squeezed more tightly together giving a support 
to the scaffold structure, particularly at the early stage of the compression test in which the 
modulus was determined. Once these particles were removed after the degradation test 
there was a significant drop in the modulus. In comparison, compressive yielding of the 
scaffolds occurred at a later stage and under a more complex loading situation. Shearing 
and bending of the vertical struts would likely involve local tensile stresses and cracking. 
Selective	Laser	Sintering	of	Poly(L-Lactide)/Carbonated		
Hydroxyapatite	Nanocomposite	Porous	Scaffolds	for	Bone	Tissue	Engineering 197
 
The results in Fig. 15 (b) are somewhat unclear. It is suspected that excessive “growth” and 
different degrees of damage caused during powder removal and degradation test might 
have contributed to the large variations in the test results. 
In general, the degradation time of PLLA is around 2-3 years and there are four steps 
involved in the degradation process: (1) swelling and hydration of PLLA; (2) breakage of the 
ester bonds; (3) diffusion of the soluble degradation products; and (4) disappearance of the 
polymer scaffold struts (Gong et al. 2007). In this study, due to time limit, the degradation 
tests only lasted for 2 months. Primarily, only the first step was involved and the weight loss 
was mainly due to detachment of loosely bonded microspheres. There may be some 
swelling and hydration of PLLA involved too. With regard to the degradation mechanism of 
PLLA, the commonly held believe is that PLLA is a hydrolyzable polymer that follows a 
bulk degradation (Gong et al. 2007). The study by von Burkersroda et al. (2002) showed that 
all degradable polymers can undergo surface degradation or bulk degradation. The way a 
polymer matrix degrades all depends on the diffusion of water inside the matrix, the 
degradation rate of the polymer’s functional groups and the matrix dimension. The 
dimension is an important factor. If a matrix is larger than a critical device dimension, it will 
undergo surface degradation; if not, it will be bulk degradation. Polyanhydrides were found 
to be surface degradation down to a size of approximately 10-4 m while poly(-hydroxy 
esters) matrices need to be larger than 10-1 m to lose their bulk degradation properties. The 
strut and microsphere sizes of the sintered PLLA and PLLA/CHAp scaffolds are all less 
than 0.1 m in this study which would show bulk degradation characteristics. The ester 
bonds in the backbone chain break randomly to generate carboxyl groups, which in turn 
autocatalytically accelerate the degradation reaction, resulting in an exponential (Park 1995) 
or linear (Gong et al. 2007) decrease of the molecular weight of a bulk PLLA material with 
degradation time. The intermediate degradation products are trapped inside the material 
before their molecular weights decrease to a critical value of about 1100 to be soluble in 
water. The loss of the precise shape of the tissue engineering scaffold after implantation is a 
common problem (Shieh et al. 2004). This study showed that the laser sintered scaffolds 
could maintain their original shapes after 2 months in vitro degradation which may be 
beneficial for implantation of the scaffolds in vivo. However, compared with the degradation 
in vitro, the degradation rate of the PLLA scaffolds in vivo was much faster (Dijk et al. 2002; 
Gong et al. 2007). The in vivo environment, including the easy exchange of substances, the 
enzymes and loading condition, is usually regarded to accelerate the degradation of the 
polymer scaffold. In vitro degradation of biodegradable implants has been commonly used 
to predict their in vivo behavior, but it is difficult to take all the in vivo environmental 
variables into account. In order to optimize the scaffolds for real tissue engineering 
applications, ideally in vivo experiments should be performed. However, such experiments 
involve animal tests and it is beyond the scope of this study. 
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Fig. 14. Weight loss of porous laser sintered Type 1 scaffolds during degradation in PBS: (a) 
PLLA scaffolds and (b) PLLA/CHAp scaffolds; sampling size n=3. 
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Fig. 15. Weight loss of porous laser sintered Type 2 scaffolds during degradation in PBS: 
(a) PLLA scaffolds and (b) PLLA/CHAp scaffolds; sampling size n=3. 
 
3.4.4 Compression properties after in vitro degradation 
The compressive yield strength and modulus of the PLLA and PLLA/CHAp scaffolds were 
measured through the 2-month in vitro degradation test and the results are shown in Figs. 16 
and 17. In general, the compression properties decreased with increasing degradation time. 
The modulus dropped more significantly within the first week of the degradation test and 
then followed by a more gradual decrease. This trend coincides with the rate of weight loss 
as shown in Figs. 14 and 15. Furthermore, it can be seen that the change of compressive 
modulus was much bigger than that of compressive strength. Similar effect was observed by 
Yang et al.  (2006). One possible explanation was that the modulus was more dependent on 
the amount of loose particles trapped within the scaffold structure. When under 
compression, some of these particles were squeezed more tightly together giving a support 
to the scaffold structure, particularly at the early stage of the compression test in which the 
modulus was determined. Once these particles were removed after the degradation test 
there was a significant drop in the modulus. In comparison, compressive yielding of the 
scaffolds occurred at a later stage and under a more complex loading situation. Shearing 
and bending of the vertical struts would likely involve local tensile stresses and cracking. 
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Under these circumstances, the loose particles trapped within the scaffold structure would 
not contribute significantly to the yield strength.  
 
   
Fig. 16. Change of compression properties of Type 1 PLLA scaffolds produced by different 
laser powers during in vitro degradation. 
 
   
Fig. 17. Change of compression properties of Type 1 PLLA/CHAp scaffolds produced by 
different laser powers through in vitro degradation test. 
 
3.4.5 In vitro cell culture 
The cells used were Saos-2, the human epithelial-like osteosarcoma cell line. These cells are 
widely used in studies on bone cell differentiation, proliferation and metabolism and are 
known to be capable of bone production (Causa et al. 2006; Wiria et al. 2007). The Saos-2 
cells possess several osteoblastic features and could be useful as a permanent line of human 
osteoblast-like cells and as a source of bone-related molecules. In vitro studies with these 
osteoblast-like cells have offered insights into the biological performance of bone implant 
materials. Figs. 18 and 19 show the SEM images of the cell-seeded Type 1 PLLA and 
PLLA/CHAp scaffolds respectively after culturing for 7 and 14 days. It can be seen that 
Saos-2 cells were able to attach to both scaffolds. However, the cells did not spread well on 
the PLLA scaffold surface and the outlines of many microspheres were still easily 
observable. In the case of the PLLA/CHAp scaffold, however, the cells were well spread 
and connected with each other covering most of the scaffold surface. Borden et al. (2003) 
attached human osteoblast cells on the heat sintered PLGA microsphere scaffolds. Their 
results, after culturing for 7 and 16 days, showed that the cells had bypassed the top surface 
of the microspheres and only formed a layer covering the surface of the microspheres within 
the pores. In another study on laser sintered PCL/HAp scaffolds (Wiria et al. 2007), the 
Saos-2 cells also did not cover the scaffold surface extensively. Therefore, the result obtained 
strongly indicates that the PLLA/CHAp nanocomposite microspheres offer a more 
biomimetic environment for attachment and proliferation of osteoblast-like cells. 
 
 
  
  
Fig. 18. SEM images of Type 1 PLLA scaffold seeded with Saos-2 cells: (a) 7 days after 
seeding and (b) close-up view of centre region in (a); (c) 14 days after seeding and (d) close-
up view of centre region in (c), scaffold sintered at 15 W. 
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Under these circumstances, the loose particles trapped within the scaffold structure would 
not contribute significantly to the yield strength.  
 
   
Fig. 16. Change of compression properties of Type 1 PLLA scaffolds produced by different 
laser powers during in vitro degradation. 
 
   
Fig. 17. Change of compression properties of Type 1 PLLA/CHAp scaffolds produced by 
different laser powers through in vitro degradation test. 
 
3.4.5 In vitro cell culture 
The cells used were Saos-2, the human epithelial-like osteosarcoma cell line. These cells are 
widely used in studies on bone cell differentiation, proliferation and metabolism and are 
known to be capable of bone production (Causa et al. 2006; Wiria et al. 2007). The Saos-2 
cells possess several osteoblastic features and could be useful as a permanent line of human 
osteoblast-like cells and as a source of bone-related molecules. In vitro studies with these 
osteoblast-like cells have offered insights into the biological performance of bone implant 
materials. Figs. 18 and 19 show the SEM images of the cell-seeded Type 1 PLLA and 
PLLA/CHAp scaffolds respectively after culturing for 7 and 14 days. It can be seen that 
Saos-2 cells were able to attach to both scaffolds. However, the cells did not spread well on 
the PLLA scaffold surface and the outlines of many microspheres were still easily 
observable. In the case of the PLLA/CHAp scaffold, however, the cells were well spread 
and connected with each other covering most of the scaffold surface. Borden et al. (2003) 
attached human osteoblast cells on the heat sintered PLGA microsphere scaffolds. Their 
results, after culturing for 7 and 16 days, showed that the cells had bypassed the top surface 
of the microspheres and only formed a layer covering the surface of the microspheres within 
the pores. In another study on laser sintered PCL/HAp scaffolds (Wiria et al. 2007), the 
Saos-2 cells also did not cover the scaffold surface extensively. Therefore, the result obtained 
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Fig. 18. SEM images of Type 1 PLLA scaffold seeded with Saos-2 cells: (a) 7 days after 
seeding and (b) close-up view of centre region in (a); (c) 14 days after seeding and (d) close-
up view of centre region in (c), scaffold sintered at 15 W. 
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Fig. 19. SEM images of Type 1 PLLA/CHAp scaffold seeded with Saos-2 cells: (a) 7 days 
after seeding and (b) close-up view of centre region in (a); (c) 14 days after seeding and (d) 
close-up view of centre region in (c), scaffold sintered at 15 W. 
 
4. Conclusions 
From this study, the following conclusions could be drawn: 
 (1) The custom-made miniature sintering platform allowed small quantities of the 
biomaterial powders to be processed in a commercial Sinterstation® 2000 SLS machine. With 
this platform, prototypes of bone tissue engineering scaffolds with meso-scale feature were 
successfully built from PLLA microspheres and PLLA/CHAp nanocomposite microspheres.  
 (2) The effects of laser power, scan spacing and part bed temperature on the scaffold 
structure were studied and discussed. In general, extreme values of the processing 
parameters should be avoided in order to obtain desirable scaffold properties.  
 (3) The actual pore sizes obtained were smaller than the design values due to the 
phenomenon of “growth”. Since “growth” cannot be avoided entirely, it should be 
accounted for in the design stage.  
 (4) The porosities of laser sintered PLLA and PLLA/CHAp scaffolds decreased almost 
linearly with increasing fill laser power within the recommended range. Furthermore, the 
sintered material was not fully dense. The degree of fusion of the PLLA/CHAp 
nanocomposite microspheres was lower than that of the pure PLLA powder. The 
phenomenon was caused by an increase in the molar heat capacity and viscosity of the 
nanocomposite powder after the addition of CHAp. 
 (5) The stress-strain curves of the scaffolds exhibited three regimes, i.e. linear elasticity, 
plateau and densification. The PLLA/CHAp scaffolds were found to have lower 
compressive yield strength and modulus than the PLLA scaffolds of the same type and 
sintering conditions. This could generally be attributed to the insufficient fusion of the 
PLLA/CHAp nanocomposite microspheres. Their compressive strength after optimization 
of the sintering condition would only match those of human cancellous bone. 
 (6) In the in vitro degradation test, most weight loss occurred in the first 2 weeks and it was 
mostly due to detachment of the microspheres loosely bonded on the scaffold surface and 
within the pores. This caused a corresponding drop in the compressive properties and the 
drop was more significant in modulus than in compressive yield strength for both the PLLA 
and PLLA/CHAp scaffolds.  
 
 (7)  Saos-2 cells were able to attach to both the PLLA and PLLA/CHAp scaffolds during the 
in vitro cell culture experiments. The PLLA/CHAp nanocomposite scaffolds showed a 
higher osteoconductivity than the neat PLLA scaffolds. The results strongly suggested that 
the PLLA/CHAp nanocomposite microspheres offered a more biomimetic environment 
than the pure PLLA microspheres for attachment and proliferation of osteoblast-like cells. 
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Abstract 
Chitin and its deacetylated derivative, chitosan, are non-toxic, biodegradable biopolymers 
currently being developed for use in biomedical applications such as tissue engineering 
scaffolds, wound dressings, separation membranes, antibacterial coatings, stent coatings, 
and sensors. Recently, nano fibrous scaffolds based on chitin or chitosan have potential 
applications in tissue engineering. Tissue engineering is one of the most exciting 
interdisciplinary and multidisciplinary research areas today, and there has been exponential 
growth in the number of research publications in this area in recent years. It involves the use 
of living cells, manipulated through their extracellular environment or genetically to 
develop biological substitutes for implantation into the body and/or to foster remodeling of 
tissues in some active manners. Electrospun chitin and chitosan nano fibrous scaffolds 
would be used to produce tissue engineering scaffolds with improved cytocompatibility, 
which could mimic the native extracellular matrix (ECM). Electrospinning is truly a feasible 
means of producing nano fibrous scaffolds that resemble the ECM, however, moreover than 
this, it is imperative that the effects of an artificial matrix has on cell growth, proliferation, 
and differentiation. This review summarizes the recent progress in chitin and chitosan based 
nano fibrous scaffolds with an emphasis in tissue engineering applications.  
 
1. Introduction   
Chitin, the second most abundant natural polysaccharide, is synthesized by a number of 
living organisms. Chitin occurs in nature as ordered microfibrils, and is the major structural 
component in the exoskeleton of arthropods and cell walls of fungi and yeast. The main 
commercial sources of chitin are crab and shrimp shells, which are abundantly supplied as 
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waste products of the seafood industry. Because chitin is not readily dissolved in common 
solvents, it is often converted its more deacetylated derivative, chitosan (Kurita, 2001; 
Rinaudo, 2006; Pillai et al., 2009). Chitosan is often identified by its degree of deacetylation 
(DD), a percentage measurement of free amine groups along the chitosan backbone. 
Generally, the material is considered chitosan when it becomes soluble in dilute acidic 
solutions, which occurs when DD  60% (Roberts, 1992). Because of its ease of solubility, 
chitosan is preferred over chitin for a wide range of applications. 
Chitin and chitosan are biocompatible, biodegradable, and nontoxic, and are anti-microbial 
and hydrating agents. Chitin and chitosan are easily processed into gels (Nagahama et al., 
2008a; 2008b), membranes (Jayakumar et al., 2005; Jayakumar et al., 2007; Jayakumar et al., 
2009; Madhumathi et al., 2009a; Madhumathi et al., 2009b), nanofibers (Schiffman  & 
Schauer, 2007a; Shalumon et al., 2009), beads (Jayakumar et al., 2006), microparticles 
(Prabaharan & Mano, 2005), nanoparticles (Anitha et al., 2009), scaffolds (Madhumathi et al., 
2009c; Maeda et al., 2009) and sponges (Muramatsu et al., 2003; Portero et al., 2007) forms.  
There are a number of promising applications of nanoscale thin films and fibers of 
chitin/chitosan (Wang & Hon, 2003; Rinaudo, 2006; Pillai et al., 2009).  
Recently, much attention has been paid to electrospinning process as a unique technique 
because it can produce polymer nanofibers with diameter in the range from several 
micrometers down to tens of nanometers, depending on the polymer and processing 
conditions. In electrospinning, a high voltage is applied to create electrically charged jets of 
a polymer solution. These jets dry to form nanofibers, which are collected on a target as a 
non-woven fabric. These nanofibers are of considerable interest for various kinds of 
applications, because they have several useful properties such as high specific surface area 
and high porosity. Nanofibrous non-woven fibers, containing chitin or chitosan, yield 
potential applications in areas such as filtrations, recovery of metal ions, drug release, 
dental, tissue engineering, catalyst and enzyme carriers, wound healing, protective clothing, 
cosmetics, biosensors, medical implants and energy storage (Zhang et al., 2005; Fang et al., 
2008).  In this review, we are reporting about the different preparation and tissue 
engineering applications of electrospun chitin and chitosan based nanofibers in detail.  
 
2. Electrospinning of chitin and chitosan  
2. 1. Electrospinning of chitin  
Chitin is insoluble in most of the organic solvents. Due to its insolubility, its applications are 
limited in many applications. Chitin dissolves only in specific solvents such as N, N-
dimethylacetamide (DMAC)–LiCl (Cho et al., 2000), hexafluoroacetone, 1,1,1,3,3,3-
hexafluoro-2-propanol (HFIP) (Kurita, 2001) and saturated calcium solvent (Jayakumar & 
Tamura, 2008; Nagahama et al., 2008a; Nagahama et al., 2008b). Min et al., 2004 performed 
electrospinning of chitin using HFIP solvent. Before electrospinning the chitin was 
depolymerized by gamma radiation to improve the solubility. Although as-spun chitin 
nanofibers had the broad fiber diameter distribution, most of the fiber diameters are less 
than 100 nm. Junkasem et al. 2006 reported that nanocomposite fiber mats composed of 
electrospun poly(vinyl alcohol) (PVA) containing α-chitin whiskers prepared from shells of 
Penaeus merguiensis shrimps have been fabricated. This research was conducted since both 
PVA had previously been electrospun (Ding et al., 2002) in water and chitin/PVA 
nanocomposite films containing α-chitin whiskers have also been fabricated (Sriupayo et al., 
 
2005a; Sriupayo et al., 2005b). A maximum tensile strength value of 5.7 ± 0.6 MPa was 
obtained when the chitin whisker to PVA ratio was approximately 5.1%, after this point, 
increasing the chitin content decreased the strength of the mats.  
Park et al. 2006a developed electrospun chitin/poly(glycolic acid) (PGA) blend nanofibers in 
HFIP was investigated to fabricate biodegradable and biomimetic nanostructured scaffolds 
for tissue engineering. PGA was chosen because it was a biocompatible and biodegradable 
polymer. The PGA/chitin blend fibers have average diameters of around 140 nm, and their 
diameters have a distribution in the range 50−350 nm. In vitro degradation studies, 
conducted in phosphate-buffered saline (PBS), pH 7.2 demonstrated that the blend fibers 
degraded faster than pure PGA fibers. Also, electrospun chitin/silk fibroin (SF) nanofibers 
in HFIP solvent was reported (Park et al., 2006b). The average diameters of chitin/SF blend 
fibers decreased from 920 to 340 nm, with the increase of chitin content in blend 
compositions. Shalumon et al., 2009 developed a novel electrospun water-soluble 
carboxymethyl chitin (CMC)/PVA blend was successfully prepared by electrospinning 
technique. The concentration of CMC (7%) with PVA (8%) was optimized, blended in 
different ratios (0–100%) and electrospun to get nanofibers. Fibers were made water 
insoluble by cross-linking with glutaraldehyde vapors followed by thermal treatment. 
 
2. 2. Electrospinning of chitosan  
The electrospinning process is determining the optimal and suitable solvent system. Since 
chitosan is soluble in most of the acids. However, the protonation of chitosan changes it into 
a polyelectrolyte in acidic solutions. Chitosan is the only psuedonatural cationic polymer 
(Kurita 2001; Rinaudo, 2006; Pillai et al., 2009) and in general there are only a few reports on 
ionic polymers or polyelectrolytes that have successfully been electrospun (Duan et al., 
2004). It has been theorized by Min et al., 2004 that the repulsive force, between ionic groups 
within polymer backbone that arise due to the application of a high electric field during 
electrospinning, restrict the formation of continuous fibers and often produce particles. 
There has been some work (Mckee et al. 2004; Mckee et al. 2006) towards developing an 
empirical equation for fiber diameter and the effects that the intermolecular associations 
state of a polyelectrolyte have on electrospinning was reported.  
An electrospun nonwoven fabric of chitosan, was successfully prepared (Ohkawa et al., 
2004). This study focuses on the effect of the electrospinning solvent and the chitosan 
concentration on the morphology of the resulting nonwoven fabrics. The solvents tested 
were diluted hydrochloric acid, acetic acid, formic acid and trifluoroacetic acid (TFA). As the 
chitosan concentration was increased, the morphology of the deposition on the collector 
changed from spherical beads to interconnected fibrous networks. The addition of 
dichloromethane to the chitosan-TFA solution was improved the homogeneity of the 
electrospun chitosan fiber. Under optimized conditions, homogenous (not interconnected) 
chitosan fibers with a mean diameter of 330 nm were prepared. Ohkawa et al., 2004 
proposed that TFA is the main constituent in the successful solvent system for chitosan 
because the amino groups of the chitosan can form salts (Hasegawa et al., 1992) with the 
TFA, which can effectively destroy the rigid interactions between the chitosan molecules 
thus facilitating electrospinning. Similarly, Haider & Park, 2009 developed electrospun 
chitosan nanofibers for absorbing metal ions. A follow-up study was conducted by Ohkawa 
et al. 2006 which focused on idealizing the viscosity of their solutions (Baumgarten et al., 
1971; Fridrikh et al., 2003) in order to decrease the average fiber diameter. It was determined 
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that fiber diameter and polymer concentration have an inverse relationship, there was a 
linear increase of fiber diameter as the concentration of chitosan in solution decreased. In 
another study, Homayoni et al., 2009 developed electrospinning of chitosan. The problem of 
chitosan high viscosity, which limits its spinability, is resolved through the application of an 
alkali treatment which hydrolyzes chitosan chains and so decreases its their molecular 
weight. Solutions of the treated chitosan in aqueous 70–90% acetic acid produce nanofibers 
with appropriate quality and processing stability. Decreasing the acetic acid concentration in 
the solvent increases the mean diameter of the nanofibers. Optimum nanofibers are 
achieved with chitosan, which is hydrolyzed for 48 h. Such nanofibers result in a moisture 
regain, which is 74% greater than that of treated and untreated chitosan powder. The 
diameter of this nanofiber, 140 nm, is strongly affected by the electrospinning conditions as 
well as by the concentration of the solvent.  
The electrospun various grades of chitosan and cross-linked them using glutaraldehyde 
vapor, utilizing an Schiff base imine functionality by Schiffman  & Schauer, 2007a. Chemical, 
structural, and mechanical analyses have been conducted. Additionally, the solubilities of 
the as spun and cross-linked chitosan mats have also studied. The solubility was greatly 
improved after cross-linking. The as-spun medium molecular weight chitosan nanofibers 
have a Young's modulus of 154.9 ± 40.0 MPa and display a pseudo-yield point that arose 
due to the transition from the pulling of a fibrous mat with high cohesive strength to the 
sliding and elongation of fibers. As-spun mats were highly soluble in acidic and aqueous 
solutions. After cross-linking, the medium molecular weight fibers increased in diameter by 
an average of 161 nm, have a decreased Young's modulus of 150.8 ± 43.6 MPa, and were 
insoluble in basic, acidic, and aqueous solutions. Schiffman  & Schauer, 2007b demonstrated 
that Schiff base cross-linked chitosan fibrous mats was produced by a one-step 
electrospinning process that is 25 times faster and, therefore, more economical than a 
previously reported two-step vapor-cross-linking method. These fibrous mats were 
insoluble in acidic, basic, and aqueous solutions for 72 h. This improved production method 
results in a decreased average fiber diameter, which measures 128 ± 40 nm.  
Sangsanoh & Supaphol, 2006 reported an additional method for cross-linking or 
neutralizing electrospun chitosan nanofiber mats. Further utilization of chitosan 
nanofibrous membranes that are electrospun from chitosan solutions in TFA with or 
without dichloromethane (DCM) as the modifying co solvent is limited by the loss of the 
fibrous structure as soon as the membranes are in contact with neutral or weak basic 
aqueous solutions due to complete dissolution of the membranes. Dissolution occurs as a 
result of the high solubility in these aqueous media of −NH3+CF3COO- salt residues that are 
formed when chitosan is dissolved in TFA. Traditional neutralization with a NaOH aqueous 
solution only maintained partial fibrous structure. Much improvement in the neutralization 
method was achieved with the saturated Na2CO3 aqueous solution with an excess amount 
of Na2CO3(s) in the solution. Sangsanoh & Supaphol, 2006 also reported that electrospun 
chitosan nanofibrous mats, after neutralization in the Na2CO3 aqueous solution, could 
maintain its fibrous structure even after continuous submersion in phosphate buffer saline 
(pH = 7.4) or distilled water for 12 weeks.  
Besides electrospinning chitosan in TFA, the second solvent system that has been 
demonstrated to effectively produce nanofibers is concentrated acetic acid. Geng et al., 2005 
attempted to electrospin three kinds of demineralized and deproteinized chitosan powders. 
However, uniform fibers were only fabricated from 7% chitosan in 90% aqueous acetic acid 
 
solutions. It was noted that the surface tension and charge density were the key factors in 
determining the spinnability of the system. In preliminary attempts to produce chitosan 
nanofibers for wound or alternate medical applications, or the removal of metals from 
solutions for environmental applications, Vrieze et al., 2007 conducted a feasibility study 
concerning the electrospinning of chitosan in formic, acetic, lactic and hydrochloric acids. It 
was determined that only the use of concentrated aq acetic acid solutions resulted in fibers. 
It is notable that the electrospun chitosan in acetic acid has been reported (Li & Hsieh, 2006; 
Sangsanoh & Supaphol, 2006). Torres-Giner et al., 2008 developed electrospun chitosan 
nanofibers using TFA and dicholomethane solvent. In addition, Torres-Giner et al., 2008a 
also developed porous electrospun chitosan nanofibers using pure trichloromethane 
solvent. 
Recently, electrospun chitosan composite nanofibrous mats have been fabricated using 
synthetic biodegradable polymers such as PVA (Miya et al., 1994; Zheng et al., 2001), 
poly(ethylene oxide) (PEO) (Yilmaz et al., 2003), poly(vinyl pyrrolidine) (PVP) (Ignatova et 
al., 2007), poly(lactic acid) (PLA) (Peesan et al., 2006; Torres-Giner et al., 2008b) and 
poly(ethylene terpthalate (PET) (Jung et al., 2007). These composite fiber mats have more 
advantageous over the electrospinning of pure chitosan. Because, the mechanical, 
biocompatible, antibacterial and other properties of the chitosan nanofibers was drastically 
enhanced by the addition of PVA, PEO, PLA, PVP and PET.  Researchers have electrospun 
composite nanofibers to try to increase their understanding of the role that chitosan plays 
during electrospinning. Finally, in order for chitosan-containing non-wovens to be 
applicable for a variety of biomaterial applications, particular mechanical, chemical, 
biocompatible, and other properties are required. Each of the composite fibrous mats 
created contain their specific properties and the applications are widen. 
PVA is used for a variety of biomedical applications such as bone implants (Allen et al., 
2004; Zhang et al., 2005), and artificial organs (Chen et al., 1994). Several researchers have 
developed nanofibers of PVA with chitosan by electrospinning because PVA has good fiber-
forming characteristics (Li & Hsieh, 2006; Zhou et al., 2006; Huang et al., 2007; Jia et al., 2007; 
Zhou et al., 2007). The electrospun composite chitosan/PVA nanofibers in different ratios 
for biomedical applications were reported (Ding et al., 2002; Koski et al., 2004; Ohkawa et al. 
2004; Zhang et al., 2005; Lin et al. 2006; Zhang et al. 2007; Zhou et al., 2008). Chitosan can be 
used as a thickener to improve the rheological properties of an aq solution to be electrospun 
because chitosan is compatible with other biocompatible polymers such as PVA (Miya et al., 
1994; Zheng et al., 2001), PEO (Yilmaz et al., 2003) etc.  A common defect observed when 
electrospinning is the formation of beads, to counter this, additives such as salts (Fong et al., 
1999) or surfactants (Lin et al., 2004) are added. Alternatively, the addition of cationic and 
anionic polyelectrolytes (Son et al., 2004) would also increase the conductivity of a solution 
and thus decrease fiber diameter. Since chitosan is a linear cationic polymer, it was 
determined that the polyelectrolyte chitosan can act like other ionic additives and does 
reduce fiber diameter thus producing thinner, uniform, bead free fibers was noted (Lin et 
al., 2006; Jia et al., 2007). It was also noted by Jia et al., 2007 that the formation of a crystalline 
microstructure is restricted during electrospinning because the stretched molecular chains 
solidify rapidly and at high elongation rates. This effect has additionally been noted 
elsewhere (Deitzel et al., 2001; Zong et al., 2002).  
Zhou et al., 2007 developed electrospun fibers from chitosan/PVA in aqueous acrylic acid 
solutions and in a second article (Zhou et al., 2006) they thermally cross-linked the fibrous 
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solutions for environmental applications, Vrieze et al., 2007 conducted a feasibility study 
concerning the electrospinning of chitosan in formic, acetic, lactic and hydrochloric acids. It 
was determined that only the use of concentrated aq acetic acid solutions resulted in fibers. 
It is notable that the electrospun chitosan in acetic acid has been reported (Li & Hsieh, 2006; 
Sangsanoh & Supaphol, 2006). Torres-Giner et al., 2008 developed electrospun chitosan 
nanofibers using TFA and dicholomethane solvent. In addition, Torres-Giner et al., 2008a 
also developed porous electrospun chitosan nanofibers using pure trichloromethane 
solvent. 
Recently, electrospun chitosan composite nanofibrous mats have been fabricated using 
synthetic biodegradable polymers such as PVA (Miya et al., 1994; Zheng et al., 2001), 
poly(ethylene oxide) (PEO) (Yilmaz et al., 2003), poly(vinyl pyrrolidine) (PVP) (Ignatova et 
al., 2007), poly(lactic acid) (PLA) (Peesan et al., 2006; Torres-Giner et al., 2008b) and 
poly(ethylene terpthalate (PET) (Jung et al., 2007). These composite fiber mats have more 
advantageous over the electrospinning of pure chitosan. Because, the mechanical, 
biocompatible, antibacterial and other properties of the chitosan nanofibers was drastically 
enhanced by the addition of PVA, PEO, PLA, PVP and PET.  Researchers have electrospun 
composite nanofibers to try to increase their understanding of the role that chitosan plays 
during electrospinning. Finally, in order for chitosan-containing non-wovens to be 
applicable for a variety of biomaterial applications, particular mechanical, chemical, 
biocompatible, and other properties are required. Each of the composite fibrous mats 
created contain their specific properties and the applications are widen. 
PVA is used for a variety of biomedical applications such as bone implants (Allen et al., 
2004; Zhang et al., 2005), and artificial organs (Chen et al., 1994). Several researchers have 
developed nanofibers of PVA with chitosan by electrospinning because PVA has good fiber-
forming characteristics (Li & Hsieh, 2006; Zhou et al., 2006; Huang et al., 2007; Jia et al., 2007; 
Zhou et al., 2007). The electrospun composite chitosan/PVA nanofibers in different ratios 
for biomedical applications were reported (Ding et al., 2002; Koski et al., 2004; Ohkawa et al. 
2004; Zhang et al., 2005; Lin et al. 2006; Zhang et al. 2007; Zhou et al., 2008). Chitosan can be 
used as a thickener to improve the rheological properties of an aq solution to be electrospun 
because chitosan is compatible with other biocompatible polymers such as PVA (Miya et al., 
1994; Zheng et al., 2001), PEO (Yilmaz et al., 2003) etc.  A common defect observed when 
electrospinning is the formation of beads, to counter this, additives such as salts (Fong et al., 
1999) or surfactants (Lin et al., 2004) are added. Alternatively, the addition of cationic and 
anionic polyelectrolytes (Son et al., 2004) would also increase the conductivity of a solution 
and thus decrease fiber diameter. Since chitosan is a linear cationic polymer, it was 
determined that the polyelectrolyte chitosan can act like other ionic additives and does 
reduce fiber diameter thus producing thinner, uniform, bead free fibers was noted (Lin et 
al., 2006; Jia et al., 2007). It was also noted by Jia et al., 2007 that the formation of a crystalline 
microstructure is restricted during electrospinning because the stretched molecular chains 
solidify rapidly and at high elongation rates. This effect has additionally been noted 
elsewhere (Deitzel et al., 2001; Zong et al., 2002).  
Zhou et al., 2007 developed electrospun fibers from chitosan/PVA in aqueous acrylic acid 
solutions and in a second article (Zhou et al., 2006) they thermally cross-linked the fibrous 
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mats using triethylene glycol dimethcrylate (TEGDMA) utilizing a higher concentration of 
an alterative acid than all of the previously mentioned researchers whom electrospun 
chitosan/PVA. Zhou et al., 2007 was also capable of spinning up to a 90/10 ratio of 
chitosan/PVA in as high as a 90% concentration of aqueous acrylic acid. To allow for 
utilization of the chitosan/PVA mats in a variety of applications, the amount of TEGDMA 
can be chosen to match the desired mechanical properties. It was found that by adding 
TEGDMA prior to spinning followed by heat-treating the as-spun mats for 2 hr at 80°C 
cross-linked fibrous mats could be fabricated.  
The development of bioinspired or biomimetic materials is essential and has formed one of 
the most important paradigms in today’s tissue engineering research. Zhang et al., 2008a 
reported a novel biomimetic nanocomposite nanofibers of hydroxyapatite (HAp)/chitosan 
was prepared by combining an in situ co-precipitation synthesis approach with an 
electrospinning process. A model HAp/chitosan with the HAp mass ratio of 30 wt% was 
also synthesized through the co-precipitation method so as to attain homogenous dispersion 
of the spindle-shaped HAp nanoparticles (ca. 100-30 nm) within the chitosan matrix. 
Similarly, biocomposite nanofibers were also prepared using of HAp with chitosan/PVA for 
biomedical applications (Yang et al., 2008). 
PEO is also a biocompatible polymer (Griffith, 2000) that has been used as a wound dressing 
(Yoshii et al., 1999) and cartilage tissue repair (Sims et al., 1996; Subramanian et al., 2005). 
The PEO had previously been electrospun (Doshi & Renekar, 1995; Fong et al., 1999; Deitzel 
et al., 2001a; Deitzel et al., 2001b) with chitosan. Duan et al. 2004 electrospun chitosan/PEO 
based on previous research showing that PEO aided in the electrospinning of silk and 
collagen (Huang et al., 2001; Jin et al., 2002). The authors stated that the conductivity, surface 
tension, and moreover the solution viscosity is what allowed for electrospinning to occur 
when there was a mass ratio of PEO/chitosan of 2/1 or 1/1. Spasova et al. 2004; Duan et al. 
2004; Desai et al., 2009, reported the electrospinning of chitosan/PEO system. It was 
observed that as the proportion of chitosan increased, the fiber diameter was decreased. 
Bhattarai et al., 2005 also developed electrospun chitosan with PEO. When PEO was added 
specifically to reduce the viscosity of solution so a higher polymer concentration within a 
solution would be spinable. It was found that a chitosan/PEO ratio of 9/1 was an 
appropriate candidate for bone tissue engineering because these mats retained good 
structural integrity in water and promoted good adhesion of chonrocyte and osteoblast cells. 
In addition, Vondran, 2007 has also studied the mechanical properties of chitosan/PEO 
nanofibrous mat as well as mats that were cross-linked by glutaraldehyde vapor. 
Chitosan/PEO nanofibers with surfactants for filtration applications was reported (Kriegel 
et al., 2009a; Kriegel et al., 2009b).    
Zhang et al., 2008b demonstrated that the preparation of nanofibers by introducing an ultra 
high-molecular-weight PEO (UHMWPEO) into aqueous chitosan solution. This system 
leads for certain the chitosan nanofibers good structural stability and handling property 
during practical applications compared to previous higher PEO loadings. Because of the 
excellent electrospinnability of the current solution system, it was able to electrospin both 
the extremely thin nanofibers (<100 nm in diameters) and large microfibers (few tens of 
micrometers in diameters), which have significant implications in developing biomimetic 
and bioactive 3-D cell-scaffold complex for engineering tissues. The results suggest that 
current eco-friendly and easily electrospinnable chitosan formulation could provide great 
potential for robust and scale-up production of the chitosan nanofibers for efficient practical 
 
applications in wound dressings, tissue engineering, drug delivery, and other industrial 
uses. 
PET is used in the textile and plastic industry, its antibacterial properties have been studied 
(Huh et al., 2001; Yang et al., 2002). Jung et al., 2007 reported that the electrospinning of 
chitosan with PET was useful for medical applications of the fibrous mats. Chitosan/PET 
and chitin/PET were electrospun in a TFA/HFIP solution. Antibacterial activity 
experiments indicated that chitosan/PET nanofibers inhibited the growth much more 
effectively than both the pure PET and the chitin/PET fibrous mats. Torres-Giner et al., 2008 
developed chitosan/PLA blend nanofibers by electrospinning in TFA and 
tricholoromethane mixture.   
Collagen has also been used previously for electrospinning using HFIP solvent (Matthews et 
al., 2002; Matthews et al., 2003; Rho et al., 2006). To develop a better biomimetic extracellular 
matrix for the tissue engineering of functional biomaterials, a matrix fibrous mat of 
chitosan/collagen was electrospun and reported (Chen et al., 2007; Chen et al., 2008). Mo et 
al., 2007 reported about the electrospun chitosan/collagen in HFIP/TFA. Composite 
nanofibrous membranes of type I collagen, chitosan, and polyethylene oxide was fabricated 
by electrospinning, which could be further cross-linked by glutaraldehyde vapor (Chen et 
al., 2008). Nanofiber diameter was found to be 134±42 nm, which increased to 398±76 nm 
after cross-linking. The Young’s modulus was increased after cross-linking, however, the 
ultimate tensile strength, tensile strain, and water sorption capability decreased after cross-
linking.  
Zein is a relatively straightforward biopolymer to electrospin (Miyoshi, Toyohara, & 
Minematsu, 2005; Torres-Giner et al., 2008b). Additionally, zein has low toxicity and has also 
being studied in a broad range of areas, such as the food, pharmaceutical, and 
biodegradable plastics industry (Corradini et al., 2006). Torres-Giner et al., 2009 developed 
novel antimicrobial ultrathin structures of zein/chitosan blend by electrospinning for 
biomedical applications. 
SF is the fibrous protein that forms the filaments of silkworm silk. Due to its 
biocompatibility, biodegradability, low inflammatory responses, and good oxygen and 
water vapor permeability, it has been used for several biomedical applications (Santin et al., 
1999; Park et al., 2001). The novel biomimetic nanofibrous scaffolds were prepared using 
chitosan/SF in formic acid (Park et al., 2004). While a pure chitosan system could not be 
electrospun, up to a 30/70 chitosan/SF in formic acid could be spun. The influence of a 
methanol treatment on the secondary structure of as-spun SF versus chitosan/SF was also 
investigated. 
Recently, the chitosan derivatives based nanofibers has also been prepared for biomedical 
applications. Carboxymethyl (Vondran, 2007), carboxyethyl (Mincheva et al., 2007) and 
hexanoyl chitosan (Peesan et al., 2006; Neamnark et al., 2006) derivatives were used for the 
preparation of nanofibers. Hexanoyl chitosan was used for medical applications since it has 
been proven to be resistant to hydrolysis by lysosome (Lee et al., 1995) and is anti-
thrombogenic (Hirano & Noishiki, 1985). Neamnark et al., 2006, prepared hexanoyl chitosan 
nanofibers in chloroform solvent. The prepared nanofibers displayed ribbon-like 
morphology with diameters ranging from 0.64 to 3.93 μm. O-Carboxymethyl chitosan (O-
CMCS) is a water-soluble derivative of chitosan (Muzzarelli et al., 1994; Chen & Park, 2003). 
O-CMCS has good moisture retention, gel-forming capability, is antibacterial, and non-
cytotoxic, thus making it a good biomaterial (Chen et al., 2002; Chen et al., 2006). Vondran et 
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mats using triethylene glycol dimethcrylate (TEGDMA) utilizing a higher concentration of 
an alterative acid than all of the previously mentioned researchers whom electrospun 
chitosan/PVA. Zhou et al., 2007 was also capable of spinning up to a 90/10 ratio of 
chitosan/PVA in as high as a 90% concentration of aqueous acrylic acid. To allow for 
utilization of the chitosan/PVA mats in a variety of applications, the amount of TEGDMA 
can be chosen to match the desired mechanical properties. It was found that by adding 
TEGDMA prior to spinning followed by heat-treating the as-spun mats for 2 hr at 80°C 
cross-linked fibrous mats could be fabricated.  
The development of bioinspired or biomimetic materials is essential and has formed one of 
the most important paradigms in today’s tissue engineering research. Zhang et al., 2008a 
reported a novel biomimetic nanocomposite nanofibers of hydroxyapatite (HAp)/chitosan 
was prepared by combining an in situ co-precipitation synthesis approach with an 
electrospinning process. A model HAp/chitosan with the HAp mass ratio of 30 wt% was 
also synthesized through the co-precipitation method so as to attain homogenous dispersion 
of the spindle-shaped HAp nanoparticles (ca. 100-30 nm) within the chitosan matrix. 
Similarly, biocomposite nanofibers were also prepared using of HAp with chitosan/PVA for 
biomedical applications (Yang et al., 2008). 
PEO is also a biocompatible polymer (Griffith, 2000) that has been used as a wound dressing 
(Yoshii et al., 1999) and cartilage tissue repair (Sims et al., 1996; Subramanian et al., 2005). 
The PEO had previously been electrospun (Doshi & Renekar, 1995; Fong et al., 1999; Deitzel 
et al., 2001a; Deitzel et al., 2001b) with chitosan. Duan et al. 2004 electrospun chitosan/PEO 
based on previous research showing that PEO aided in the electrospinning of silk and 
collagen (Huang et al., 2001; Jin et al., 2002). The authors stated that the conductivity, surface 
tension, and moreover the solution viscosity is what allowed for electrospinning to occur 
when there was a mass ratio of PEO/chitosan of 2/1 or 1/1. Spasova et al. 2004; Duan et al. 
2004; Desai et al., 2009, reported the electrospinning of chitosan/PEO system. It was 
observed that as the proportion of chitosan increased, the fiber diameter was decreased. 
Bhattarai et al., 2005 also developed electrospun chitosan with PEO. When PEO was added 
specifically to reduce the viscosity of solution so a higher polymer concentration within a 
solution would be spinable. It was found that a chitosan/PEO ratio of 9/1 was an 
appropriate candidate for bone tissue engineering because these mats retained good 
structural integrity in water and promoted good adhesion of chonrocyte and osteoblast cells. 
In addition, Vondran, 2007 has also studied the mechanical properties of chitosan/PEO 
nanofibrous mat as well as mats that were cross-linked by glutaraldehyde vapor. 
Chitosan/PEO nanofibers with surfactants for filtration applications was reported (Kriegel 
et al., 2009a; Kriegel et al., 2009b).    
Zhang et al., 2008b demonstrated that the preparation of nanofibers by introducing an ultra 
high-molecular-weight PEO (UHMWPEO) into aqueous chitosan solution. This system 
leads for certain the chitosan nanofibers good structural stability and handling property 
during practical applications compared to previous higher PEO loadings. Because of the 
excellent electrospinnability of the current solution system, it was able to electrospin both 
the extremely thin nanofibers (<100 nm in diameters) and large microfibers (few tens of 
micrometers in diameters), which have significant implications in developing biomimetic 
and bioactive 3-D cell-scaffold complex for engineering tissues. The results suggest that 
current eco-friendly and easily electrospinnable chitosan formulation could provide great 
potential for robust and scale-up production of the chitosan nanofibers for efficient practical 
 
applications in wound dressings, tissue engineering, drug delivery, and other industrial 
uses. 
PET is used in the textile and plastic industry, its antibacterial properties have been studied 
(Huh et al., 2001; Yang et al., 2002). Jung et al., 2007 reported that the electrospinning of 
chitosan with PET was useful for medical applications of the fibrous mats. Chitosan/PET 
and chitin/PET were electrospun in a TFA/HFIP solution. Antibacterial activity 
experiments indicated that chitosan/PET nanofibers inhibited the growth much more 
effectively than both the pure PET and the chitin/PET fibrous mats. Torres-Giner et al., 2008 
developed chitosan/PLA blend nanofibers by electrospinning in TFA and 
tricholoromethane mixture.   
Collagen has also been used previously for electrospinning using HFIP solvent (Matthews et 
al., 2002; Matthews et al., 2003; Rho et al., 2006). To develop a better biomimetic extracellular 
matrix for the tissue engineering of functional biomaterials, a matrix fibrous mat of 
chitosan/collagen was electrospun and reported (Chen et al., 2007; Chen et al., 2008). Mo et 
al., 2007 reported about the electrospun chitosan/collagen in HFIP/TFA. Composite 
nanofibrous membranes of type I collagen, chitosan, and polyethylene oxide was fabricated 
by electrospinning, which could be further cross-linked by glutaraldehyde vapor (Chen et 
al., 2008). Nanofiber diameter was found to be 134±42 nm, which increased to 398±76 nm 
after cross-linking. The Young’s modulus was increased after cross-linking, however, the 
ultimate tensile strength, tensile strain, and water sorption capability decreased after cross-
linking.  
Zein is a relatively straightforward biopolymer to electrospin (Miyoshi, Toyohara, & 
Minematsu, 2005; Torres-Giner et al., 2008b). Additionally, zein has low toxicity and has also 
being studied in a broad range of areas, such as the food, pharmaceutical, and 
biodegradable plastics industry (Corradini et al., 2006). Torres-Giner et al., 2009 developed 
novel antimicrobial ultrathin structures of zein/chitosan blend by electrospinning for 
biomedical applications. 
SF is the fibrous protein that forms the filaments of silkworm silk. Due to its 
biocompatibility, biodegradability, low inflammatory responses, and good oxygen and 
water vapor permeability, it has been used for several biomedical applications (Santin et al., 
1999; Park et al., 2001). The novel biomimetic nanofibrous scaffolds were prepared using 
chitosan/SF in formic acid (Park et al., 2004). While a pure chitosan system could not be 
electrospun, up to a 30/70 chitosan/SF in formic acid could be spun. The influence of a 
methanol treatment on the secondary structure of as-spun SF versus chitosan/SF was also 
investigated. 
Recently, the chitosan derivatives based nanofibers has also been prepared for biomedical 
applications. Carboxymethyl (Vondran, 2007), carboxyethyl (Mincheva et al., 2007) and 
hexanoyl chitosan (Peesan et al., 2006; Neamnark et al., 2006) derivatives were used for the 
preparation of nanofibers. Hexanoyl chitosan was used for medical applications since it has 
been proven to be resistant to hydrolysis by lysosome (Lee et al., 1995) and is anti-
thrombogenic (Hirano & Noishiki, 1985). Neamnark et al., 2006, prepared hexanoyl chitosan 
nanofibers in chloroform solvent. The prepared nanofibers displayed ribbon-like 
morphology with diameters ranging from 0.64 to 3.93 μm. O-Carboxymethyl chitosan (O-
CMCS) is a water-soluble derivative of chitosan (Muzzarelli et al., 1994; Chen & Park, 2003). 
O-CMCS has good moisture retention, gel-forming capability, is antibacterial, and non-
cytotoxic, thus making it a good biomaterial (Chen et al., 2002; Chen et al., 2006). Vondran et 
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al., 2007 has prepared electrospun composite fibrous mats using CMCS/PEO using water. 
The fibers appear to be continuous and cylindrical, while some beading was observed. The 
average fiber diameter was calculated to be 118.19 ± 40.48 nm. Similarly, Du & Hsieh, 2008 
prepared O-CMCS blended PVA, PEO and poly(acrylic acid) (PAA) nanofibers by 
electrospinning. The optimal fiber formation was observed at equal mass composition of O-
CMCS (89 kDa at 0.36 DS) and PVA, producing nanofibers with an average diameter of 130 
nm. Heat-induced esterification (at 140 ◦C for 30 min) produced inter-molecular covalent 
cross-links within and among fibers, rendering the fibrous membrane water-insoluble. 
Membranes containing higher O-CMCS carboxyl to PVA hydroxyl ratio retained better fiber 
morphology upon extended water exposure, indicating more favorable inter-molecular 
cross-links. The fibrous membranes generated with less substituted O-CMCS were more 
hydrophilic and retained a greater extent of the desirable amine functionality. 
Bicomponent nanofibers of N-carboxyethyl chitosan (N-CECS) and PVA were obtained by 
electrospinning was studied (Mincheva et al., 2007). The electrospinning of N-CECS 
containing nanofibers was enabled by the ability of PVA to form an elastically deformable 
entanglement network based on hydrogen bonds. The average diameters of the 
bicomponent fibers were in the range 100–420 nm. The average fiber diameter was tuned by 
varying the applied field strength and the N-CECS content in the spinning solution. The N-
CECS/PVA nanofibrous mats were easily cross-linked by thermal treatment resulting in 
water-resistant materials, which retain their fibrous structure upon one-week contact with 
water. In addition, a novel biocomposite nanofibers were prepared using of HAp with N-
CECS/PVA for biomedical applications (Yang et al., 2008). 
 Novel quaternized chitosan (QCS)/PVA blend nanofibers were developed for wound-
healing applications (Ignatova et al., 2006). The average fiber diameter is in the range of 60–
200 nm. UV irradiation of the composite electrospun nano-fibrous mats containing 
triethylene glycol diacrylate as cross-linking agent had resulted in stabilising of the nano-
fibres against disintegration in water or water vapors. Ignatova et al., 2007 also prepared 
QCS-containing nanofibers by electrospinning with PVP blending. A significant decrease in 
the fiber diameter of electrospun QCS/PVP mixed fibers and a narrowing of the fiber 
diameter distribution with increasing the QCS content was observed and explained by the 
increase in solution conductivity. An increase of the applied field strength led to greater 
fiber diameters and to broader diameter distribution. The photo-cross-linked QCS/PVP 
fibers irradiated for 10 h proved to be water insoluble. 
The galactosylated chitosan (GC) nanofibrous scaffold was fabricated by electrospinning for 
tissue engineering applications (Feng et al., 2009) with an average diameter of ~160 nm 
using formic acid solvent. Jiang et al., 2004 prepared electrospun membranes composed of 
ibuprofen-loaded poly(lactide-co-glycolide)/poly(ethylene glycol)-g-chitosan (PLGA)/ 
(PEG-g-chitosan) that would be suitable for a trial fibrillation due to the electrospun 
membranes composed of ultrafine fibers, have high porosity, and can conform to 
movements (Reneker & Chun, 1996). In this work, ibuprofen was incorporated into the 
fibrous mats in two different methods: electrostatically conjugated during the 
electrospinning process and covalently conjugated to the PEG-g-chitosan prior to spinning. 
This tri-component system had unique properties of being soluble in organic solvents, while 
being insoluble in neutral pH water (Ouchi et al., 1998). It was also demonstrated that the 
hydrophilicity, membrane shrinkage, and rate of drug release could be controlled within the 
system. The fibrous mats in vitro and in vivo biocompatibility and efficacy need to be 
 
evaluated. Duan et al., 2006; Duan et al., 2007 simultaneously electrospun from two different 
syringes have PLGA and chitosan/PVA onto a rotating drum. The PLGA component is 
expected to enhance the mechanical properties, while the chitosan provides bioactivity and 
biocompatibility. The fibrous mats were cross-linked with 25% aqueous glutaraldehyde 
vapor for 4 hr at 37 ºC (Chen et al., 2003). It was determined that tri-component systems 
might have potential in biomedical applications. 
Wan et al., 2008 prepared novel poly(chitosan-g-DL-lactic acid) (PCLA) copolymeric 
nanofibers using an electro-wet-spinning technique. The diameter of fibers in different 
scaffolds could vary from about 100 nm to around 3 lm. The prepared nanofibrous scaffolds 
exhibited various pore sizes ranging from about 1 lm to less than 30 lm and different 
porosities up to 80%. Two main processing parameters, that is, the concentration of PCLA 
solutions and the composition proportions of coagulation solutions, were optimized for 
obtaining desired scaffolds with well-controlled structures. The tensile properties of the 
scaffolds in both dry and hydrated states were examined. Significantly improved tensile 
strength and modulus for these fibrous scaffolds in their hydrated state were observed. 
 
3. Applications of chitin and chitosan nano-fibers in tissue-engineering 
Polymeric nanofibers that mimic the structure and function of the natural extracellular 
matrix (ECM) are of great interest in tissue engineering as scaffolding materials to restore, 
maintain or improve the function of human tissues. The natural ECMs in the body are 
mainly composed of two classes of extracellular macromolecules: proteoglycans and fibrous 
proteins with fiber diameters ranging from 50 to 150 nm, depending on tissue type (Elsdale 
& Bard, 1972). Studies showed that the material size feature can substantially influence the 
morphology and function of cells grown on the ECM, and that cells attach and proliferate 
well in micro and nanostructured materials (Laurencin et al., 1999;Teixeira et al., 2003). 
Noh et al., 2006 studied the cytocompatibility assessment of chitin nanofibers. Chitin 
nanofibers was found to promote cell attachment and spreading of normal human 
keratinocytes and fibroblasts compared to chitin microfibers. This may be a consequence of 
the high surface area available for cell attachment due to their three-dimensional features 
and high surface area-to volume ratios, which are favorable parameters for cell attachment, 
growth, and proliferation. Cell studies conducted on chitin/PGA (Park et al., 2006a) and 
chitin/SF (Park et al., 2006b) fibrous mats proved that a matrix consisting of 25% PGA or SF 
and 75% chitin had the best results. The chitin/PGA fibers had a bovine serum albumin 
coating and were considered a good candidate for use as a tissue-engineering scaffold 
because normal human epidermal fibroblasts (NHEF) attached and spread. The chitin/SF 
fibrous mats had the highest spreading of NHEF and normal human epidermal 
keratinocytes (NHEK). Therefore, this scaffold was suggested for wound tissue engineering 
applications. Shalumon et al., 2009 developed CMC/PVA blend nanofibrous scaffold for 
tissue engineering applications. The prepared nanofibers were bioactive and biocompatible. 
Cytotoxicity and cell attachement studies of the nanofibrous scaffold were evaluated using 
human mesenchymal stem cells (hMSCs) by the MTT assays. The cell attachment studies 
revealed that cells were able to attach and spread in the nanofibrous scaffolds (Fig. 1). These 
results indicate that the nanofibrous CMC/PVA scaffold supports cell adhesion/attachment 
and proliferation and hence these scaffolds are useful for tissue engineering applications. 
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al., 2007 has prepared electrospun composite fibrous mats using CMCS/PEO using water. 
The fibers appear to be continuous and cylindrical, while some beading was observed. The 
average fiber diameter was calculated to be 118.19 ± 40.48 nm. Similarly, Du & Hsieh, 2008 
prepared O-CMCS blended PVA, PEO and poly(acrylic acid) (PAA) nanofibers by 
electrospinning. The optimal fiber formation was observed at equal mass composition of O-
CMCS (89 kDa at 0.36 DS) and PVA, producing nanofibers with an average diameter of 130 
nm. Heat-induced esterification (at 140 ◦C for 30 min) produced inter-molecular covalent 
cross-links within and among fibers, rendering the fibrous membrane water-insoluble. 
Membranes containing higher O-CMCS carboxyl to PVA hydroxyl ratio retained better fiber 
morphology upon extended water exposure, indicating more favorable inter-molecular 
cross-links. The fibrous membranes generated with less substituted O-CMCS were more 
hydrophilic and retained a greater extent of the desirable amine functionality. 
Bicomponent nanofibers of N-carboxyethyl chitosan (N-CECS) and PVA were obtained by 
electrospinning was studied (Mincheva et al., 2007). The electrospinning of N-CECS 
containing nanofibers was enabled by the ability of PVA to form an elastically deformable 
entanglement network based on hydrogen bonds. The average diameters of the 
bicomponent fibers were in the range 100–420 nm. The average fiber diameter was tuned by 
varying the applied field strength and the N-CECS content in the spinning solution. The N-
CECS/PVA nanofibrous mats were easily cross-linked by thermal treatment resulting in 
water-resistant materials, which retain their fibrous structure upon one-week contact with 
water. In addition, a novel biocomposite nanofibers were prepared using of HAp with N-
CECS/PVA for biomedical applications (Yang et al., 2008). 
 Novel quaternized chitosan (QCS)/PVA blend nanofibers were developed for wound-
healing applications (Ignatova et al., 2006). The average fiber diameter is in the range of 60–
200 nm. UV irradiation of the composite electrospun nano-fibrous mats containing 
triethylene glycol diacrylate as cross-linking agent had resulted in stabilising of the nano-
fibres against disintegration in water or water vapors. Ignatova et al., 2007 also prepared 
QCS-containing nanofibers by electrospinning with PVP blending. A significant decrease in 
the fiber diameter of electrospun QCS/PVP mixed fibers and a narrowing of the fiber 
diameter distribution with increasing the QCS content was observed and explained by the 
increase in solution conductivity. An increase of the applied field strength led to greater 
fiber diameters and to broader diameter distribution. The photo-cross-linked QCS/PVP 
fibers irradiated for 10 h proved to be water insoluble. 
The galactosylated chitosan (GC) nanofibrous scaffold was fabricated by electrospinning for 
tissue engineering applications (Feng et al., 2009) with an average diameter of ~160 nm 
using formic acid solvent. Jiang et al., 2004 prepared electrospun membranes composed of 
ibuprofen-loaded poly(lactide-co-glycolide)/poly(ethylene glycol)-g-chitosan (PLGA)/ 
(PEG-g-chitosan) that would be suitable for a trial fibrillation due to the electrospun 
membranes composed of ultrafine fibers, have high porosity, and can conform to 
movements (Reneker & Chun, 1996). In this work, ibuprofen was incorporated into the 
fibrous mats in two different methods: electrostatically conjugated during the 
electrospinning process and covalently conjugated to the PEG-g-chitosan prior to spinning. 
This tri-component system had unique properties of being soluble in organic solvents, while 
being insoluble in neutral pH water (Ouchi et al., 1998). It was also demonstrated that the 
hydrophilicity, membrane shrinkage, and rate of drug release could be controlled within the 
system. The fibrous mats in vitro and in vivo biocompatibility and efficacy need to be 
 
evaluated. Duan et al., 2006; Duan et al., 2007 simultaneously electrospun from two different 
syringes have PLGA and chitosan/PVA onto a rotating drum. The PLGA component is 
expected to enhance the mechanical properties, while the chitosan provides bioactivity and 
biocompatibility. The fibrous mats were cross-linked with 25% aqueous glutaraldehyde 
vapor for 4 hr at 37 ºC (Chen et al., 2003). It was determined that tri-component systems 
might have potential in biomedical applications. 
Wan et al., 2008 prepared novel poly(chitosan-g-DL-lactic acid) (PCLA) copolymeric 
nanofibers using an electro-wet-spinning technique. The diameter of fibers in different 
scaffolds could vary from about 100 nm to around 3 lm. The prepared nanofibrous scaffolds 
exhibited various pore sizes ranging from about 1 lm to less than 30 lm and different 
porosities up to 80%. Two main processing parameters, that is, the concentration of PCLA 
solutions and the composition proportions of coagulation solutions, were optimized for 
obtaining desired scaffolds with well-controlled structures. The tensile properties of the 
scaffolds in both dry and hydrated states were examined. Significantly improved tensile 
strength and modulus for these fibrous scaffolds in their hydrated state were observed. 
 
3. Applications of chitin and chitosan nano-fibers in tissue-engineering 
Polymeric nanofibers that mimic the structure and function of the natural extracellular 
matrix (ECM) are of great interest in tissue engineering as scaffolding materials to restore, 
maintain or improve the function of human tissues. The natural ECMs in the body are 
mainly composed of two classes of extracellular macromolecules: proteoglycans and fibrous 
proteins with fiber diameters ranging from 50 to 150 nm, depending on tissue type (Elsdale 
& Bard, 1972). Studies showed that the material size feature can substantially influence the 
morphology and function of cells grown on the ECM, and that cells attach and proliferate 
well in micro and nanostructured materials (Laurencin et al., 1999;Teixeira et al., 2003). 
Noh et al., 2006 studied the cytocompatibility assessment of chitin nanofibers. Chitin 
nanofibers was found to promote cell attachment and spreading of normal human 
keratinocytes and fibroblasts compared to chitin microfibers. This may be a consequence of 
the high surface area available for cell attachment due to their three-dimensional features 
and high surface area-to volume ratios, which are favorable parameters for cell attachment, 
growth, and proliferation. Cell studies conducted on chitin/PGA (Park et al., 2006a) and 
chitin/SF (Park et al., 2006b) fibrous mats proved that a matrix consisting of 25% PGA or SF 
and 75% chitin had the best results. The chitin/PGA fibers had a bovine serum albumin 
coating and were considered a good candidate for use as a tissue-engineering scaffold 
because normal human epidermal fibroblasts (NHEF) attached and spread. The chitin/SF 
fibrous mats had the highest spreading of NHEF and normal human epidermal 
keratinocytes (NHEK). Therefore, this scaffold was suggested for wound tissue engineering 
applications. Shalumon et al., 2009 developed CMC/PVA blend nanofibrous scaffold for 
tissue engineering applications. The prepared nanofibers were bioactive and biocompatible. 
Cytotoxicity and cell attachement studies of the nanofibrous scaffold were evaluated using 
human mesenchymal stem cells (hMSCs) by the MTT assays. The cell attachment studies 
revealed that cells were able to attach and spread in the nanofibrous scaffolds (Fig. 1). These 
results indicate that the nanofibrous CMC/PVA scaffold supports cell adhesion/attachment 
and proliferation and hence these scaffolds are useful for tissue engineering applications. 
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Fig. 1. SEM images of hMSCs attached on the surfaces of CMC/PVA scaffolds after (a) 12  
(b) 24 and (c) 48 h of incubation. 
 
Bhattarai et al., 2005 reported that the chitosan/PEO nanofibrous scaffolds were promoted 
the attachment of human osteoblasts and chondrocytes and maintained characteristic cell 
morphology and viability throughout the period of study. This nanofibrous matrix is of 
particular interest in tissue engineering for controlled drug release and tissue remodeling. 
Similarly, Subramaniyan et al., 2005 prepared chitosan/PEO nanofibers for cartilage tissue 
engineering. In this study, chitosan/PEO nanofibers was evaluated the biocompatibility 
with chondrocytes. Cells were attached to the chitosan/PEO nanofiber mats slowly in the 
fist week. After 10 days, the more cells were attached on the surface of the nanofibers. These 
results indicated that the electrospun chitosan/PEO mats have been used for cartilage tissue 
repair. Mo et al., 2007 also reported about that the smooth muscle cells attaching to the 
electrospun chitosan/collagen nanofibers after 30 days of culture.  
The biological evaluations of chitosan/HAp nanfibrous composite scaffolds have been 
reported (Zhang et al., 2008a). The chitosan/HAp nanofibrous scaffolds have significantly 
stimulated the bone forming ability as shown by the cell proliferation, mineral deposition, 
and morphology observation, due to the excellent osteoconductivity of HAp compared to 
the control chitosan. The results obtained from this study highlight the great potential of 
using the chitosan/HAp nanocomposite nanofibers for bone tissue engineering applications. 
A biocomposite of HAp with electrospun nanofibrous scaffolds was prepared by using 
chitosan/PVA and N-CECS/PVA (Fig. 2) for tissue engineering applications (Yang et al., 
2008). The cell attachment of the prepared biocomposite nanofibers was studied using 
mouse fibroblast (L929) cell. The cell studies showed that the L929 cell culture revealed the 
attachment and growth of mouse fibroblast on the surface of biocomposite scaffolds. 
Similarly, the potential use of the N-CECS/PVA electrospun fiber mats as scaffolding 
materials for skin regeneration was evaluated in vitro was using L929 (Zhou et al., 2008). 
Indirect cytotoxicity assessment of the fiber mats indicated that the N-CECS/PVA 
electrospun mat was nontoxic to the L929 cell. Cell culture results showed that fibrous mats 
were good in promoting the cell attachment and proliferation. This novel electrospun matrix 
would be used as potential wound dressing for skin regeneration. 
 
 
 
 
Fig. 2. SEM images of (a) and (b) L929 cells seeded on fibrous membranes of HAp-N-
CECS/PVA after 48 h culture. 
 
Liver tissue engineering requires a perfect extracellular matrix (ECM) for primary 
hepatocytes culture to maintain high level of liver-specific functions and desirable 
mechanical stability. Feng et al., 2009 developed a novel GC nanofibers with surface-
galactose ligands to enhance the bioactivity and mechanical stability of primary hepatocytes 
in culture. The GC nanofibrous scaffolds displayed slow degradation and suitable 
mechanical properties as an ECM for hepatocytes according to the evaluation of 
disintegration and Young’s modulus testing. The hepatocytes cultured on GC nanofibrous 
scaffold formed stably immobilized 3D flat aggregates and exhibited superior cell 
bioactivity with higher levels of liver-specific function maintenance in terms of albumin 
secretion, urea synthesis and cytochrome P-450 enzyme than 3D spheroid aggregates 
formed on GC films. These results suggested that the GC-based nanofibrous scaffolds could 
be useful for various applications such as bioartificial liver-assist devices and tissue 
engineering for liver regeneration as primary hepatocytes culture substrates.  
 
4. Conclusions 
This review summarized the preparation and tissue engineering applications of chitin and 
chitosan based nanofibers.  Additional studies are necessary before clinical applications and 
for commercialization of the chitin and chitosan based nanofibers. We hope that this review 
article will bring new innovative types of chitin and chitosan nanofibers for tissue 
engineering applications in the future. 
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Abstract 
Polymeric biomaterials are used as substitutes for damaged tissue and for the stimulation of 
tissue regeneration. One class of polymeric biomaterials are bioresorbable polymers that 
degrade both in vitro and in vivo and are used as a temporary support for tissue 
regeneration. Among the various types of bioresorbable polymers, -hydroxy acids 
including the different forms of poly(lactic acid) (PLA), such as poly(L-lactic acid), poly(D-
lactic acid) and poly(DL-lactic acid), as well as poly(glycolic acid) and polycaprolactone, 
have been extensively studied. These polymers are well known for their good 
biocompatibility, with their degradation products being eliminated from the body by 
metabolic pathways. Many reports have shown that the different PLA-based substrates do 
not present toxicity since the cells were found to differentiate over the different polymers, as 
demonstrated by the production of extracellular matrix components by various cell types. In 
this chapter, we describe the use of -hydroxy acids, highlighting the different forms of PLA 
scaffolds used as cell culture substrates and their applications in clinical practice. The 
chapter is divided into (1) Introduction; (2) Bioresorbable devices as cell culture substrates; 
(3) Cell adhesion to polymer substrates; (4) Tissue engineering and bioresorbable polymers; 
(5) Cell growth and proliferation on bioresorbable polymers; (6) Bioresorbable polymers for 
cartilage engineering; (7) Bioresorbable polymers for bone tissue engineering; (8) 
Bioresorbable polymers for skin tissue engineering, and (9) Conclusion. 
 
1. Introduction 
For centuries, extensive tissue injuries normally originating from mechanical trauma or 
degenerative diseases have been a challenge because of the scarcity of therapeutic resources. 
Removal of the damaged part was the most common practice, which resulted in a series of 
limitations of the affected patient and in a significant decrease in quality of life. Thus, 
replacement and/or regeneration of the damaged body regions became the new target. The 
increase in life expectancy resulting from the discovery of antibiotics and chemotherapy, as 
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well as from improved sanitary and hygiene conditions, has encouraged the search for 
methods to replace damaged tissues [1]. 
There are two procedures used for the treatment of the failure or loss of tissues and organs: 
transplants and implants. In the case of transplants, tissues or organs are obtained from 
living donors (e.g., heart or kidneys) or from cadavers (e.g., lyophilized and frozen bone). In 
some cases, immunosuppressive drugs are necessary to prevent rejection of the transplanted 
organ, or other medications that minimize possible microbial contamination [1]. In addition, 
transplants have the disadvantage of raising a series of ethical and even religious issues. In 
contrast, devices developed to serve as implants do not present many of the problems 
reported above and are designed to act at the recipient tissue interface in the organism, 
interacting with these tissues [1, 2]. 
Biomaterials were first developed to remain inert in the organism. Thus, studies were aimed 
at investigating how to prevent or minimize undesired tissue reactions. At present, new 
materials are designed to elicit an effective interaction with tissues, provoking physiological 
responses such as cell growth and/or differentiation at the site of implantation [3]. 
Significant advances have been made over the past decades in the understanding of the 
mechanisms underlying the interaction of animal cells with their natural environment, i.e., 
the extracellular matrix, as well as of the influence of this matrix on cell growth and 
differentiation [4, 5]. This knowledge is frequently being used for the development of 
polymers that mimic the characteristics of extracellular matrix, thus playing an active role in 
tissue restoration. 
The biomaterials used can be classified into permanent or temporary materials [6]. 
Permanent materials are used to replace damaged tissue for an undetermined period of time 
and are therefore designed to retain their mechanical and physicochemical properties for 
prolonged periods of time [6]. These types of devices are commonly employed 
experimentally as prostheses, replacing damaged joints, heart valves and intraocular lenses, 
among others. On the other hand, in some situations the support only needs to fill the 
damaged region temporarily until tissue recomposition is completed, or guides the 
regeneration process. Temporary biomaterials are an alternative in this case. 
“Biodegradable” is a term that can be applied to polymers and solid devices that undergo 
dispersion in vivo as a result of macromolecular degradation, but without elimination of 
products and subproducts by the organism [7]. Biodegradable polymers can be attacked by 
biological elements in such a way that the integrity of the system is affected, forming 
fragments and other degradation products that can be removed from the site of action but 
not necessarily from the organism. “Bioabsorbable” is a term that can be applied to 
polymeric materials and devices that dissolve in body fluids without breakdown of the 
macromolecular chain or a reduction in molecular mass [7]. One example is the slow 
dissolution of soluble implants in organic fluids. “Bioresorbable” materials are polymers 
and solid devices that degrade through a reduction in size and that are resorbed in vivo, i.e., 
materials that are eliminated by metabolic pathways of the organism. Bioresorption is a 
concept that reflects the complete elimination of the material and of degradation products 
(compounds of low molar mass) in the absence of residual side effects [7]. The term 
“bioresorption” is applied when complete elimination occurs. A polymer can be 
bioresorbable if its macromolecules are excreted [7,8]. Bioresorbable polymeric materials are 
preferentially used as temporary devices [6]. 
2. Bioresorbable devices as cell culture substrates 
A wide variety of temporary devices have been employed in biological systems, with the 
most widely used materials being based on -hydroxy acid-derived polyesters, such as 
poly(L-lactic acid) (PLLA), poly(D-lactic acid) (PDLA), poly(DL-lactic acid) (PDLLA), 
poly(glycolic acid) (PGA), and polycaprolactone (PCL) [6,8]. During degradation, the 
polymer is broken down into smaller units by simple hydrolysis and its degradation 
products are eliminated from the body by metabolic pathways, such as the citric acid cycle, 
or directly by renal excretion (see Figure 1) [9-12]. 
Although the degradation of bioresorbable polymers mainly occurs by simple hydrolysis, 
there are reports in the literature indicating that degradation of PGA and PLLA, at least in 
part, is also mediated by enzymes [12,13]. Figure 1 is a schematic presentation of the 
degradation of PLLA by hydrolysis [8]. The elimination routes of the degradation products 
of some polyesters are shown in Figure 2. 
 
 
Fig. 1. Degradation of poly(-hydroxy acids) by hydrolysis (From Barbanti et al. [8], with 
authorization). 
 
Other bioresorbable polymers used are polyhydroxyalcanoates, polyesters produced by 
microorganisms. These compounds find applications as raw materials of different devices in 
the areas of biomedicine and tissue engineering [14]. Polyhydroxyalcanoates include poly(3-
hydroxybutyrate) (PHB), poly(3-hydroxybutyrate-co-3-hydroxyvalerate) copolymer 
(PHBV), poly(4-hydroxybutyrate) (P4HB), poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) 
copolymer (PHBHHx), and poly(3-hydroxyoctanoate) (PHO). These compounds have been 
used for the development of sutures, devices to guide tissue repair, heart implants, 
orthopedic pins, stents, tubules for nerve regeneration, and membranes for skin 
regeneration [14]. The use of PLLA/PHBV blends has appeared as a new proposal in the 
literature. The biological evaluation of this compound is relevant for tissue engineering 
[15,16]. 
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Fig. 2. Routes of degradation and excretion of some polyesters: poly(p-dioxane) (PDS), 
poly(glycolic acid) (PGA), poly(lactic acid) (PLA), and poly(hydroxybutyrate) (PHB). 
 
3. Cell adhesion on polymer substrates 
Normally, cell adhesion to the substrate is necessary for a good polymer-cell interaction. 
Although the substrate does not need to present extracellular matrix-like characteristics for 
cell adhesion to occur, physicochemical similarity is often desired when the aim is to 
promote cell differentiation or a more effective interaction of a certain polymer at the 
implantation site [2-4,17]. Thus, polymers presenting physicochemical and/or mechanical 
properties as close as possible to those of the tissues into which they will be implanted are 
currently being developed. These properties include an adequate balance between 
hydrophilicity/hydrophobicity, electrical charge distribution, hardness, elasticity, and 
strength [18]. 
A relationship exists between hydrophilicity and cell adhesion. Among other parameters, 
more hydrophilic substrates tend to provide a better interaction with cells [19-21]. The 
relationship between cell adhesion and polar groups on the material surface has been 
demonstrated for polystyrene. Adhesion of cells was found to increase with increasing 
polarity of the substrate [22]. In a study investigating hepatic cells cultured on different 
substrates, cell adhesion increased proportionally to the surface energy of the growth 
membranes. Adhesion was even higher in the presence of serum proteins adsorbed to the 
substrates and the metabolic activity of hepatic cells increased on hydrophilic membranes 
[23]. Other studies demonstrated a relationship between wettability and cell adhesion. Lee et 
al. [24] prepared a wettability gradient on polyethylene surfaces to investigate the 
interaction of different types of cells (Chinese hamster ovary cells, fibroblasts and 
endothelial cells) with fetal bovine serum proteins, in terms of surface 
hydrophilicity/hydrophobicity. Better adhesion, spreading and growth of cells were 
observed on surfaces with moderate hydrophilicity. Maximum adhesion was found on 
substrates with a water contact angle of approximately 57º, irrespective of the type of cell used. 
Serum proteins also adhered better to substrates presenting moderate hydrophilicity [24]. 
Thus, cell adhesion is an extremely important factor for biomaterials research. Only after 
adhesion do the cells initiate the process of spreading, division and production of new 
extracellular matrix [18,19]. Cell spreading is a complex process that involves modifications 
in cell morphology as a consequence of alterations in the cytoskeleton, thus improving 
interaction with the substrate. These modifications are shown in Figure 3. 
 
  
Fig. 3. Spreading of Vero cells on type I collagen gel. Round cells are observed during 
inoculation, a morphology that is adequate for the state of being in suspension. After 
adhesion, the cells start their interaction with the substrate. Note the onset of the 
phenomenon known as spreading in (A), which is characterized by modifications in the 
cytoskeleton and, consequently, in cell morphology as a result of interactions with the 
growth surface, with the cell flattening on the growth surface. (B) A cell spread on the 
substrate. Magnification bar: A = 15 µm; B = 10 µm (From Santos Jr and Wada [5], with 
authorization). 
 
Good integration of the biomaterial with cells or tissues also depends on the structure of the 
devices itself. Our experience agrees with literature data indicating that porous materials 
promote cell growth and induce the production of extracellular matrix components by the 
cells [21,25]. A uniform distribution and pore interconnections are important to facilitate the 
formation of tissues in the form of an organized network, with a wide range of applications 
in tissue reconstruction [3,26,27]. In vivo, porosity and pore interconnection are essential for 
the proliferation of vessels, facilitating tissue nutrition around the implant. In this respect, 
different types of scaffolds containing PLLA have been developed and tested as substrates 
for cell growth [3]. Kwon et al. [28] evaluated nano- and microfibrous scaffolds with 
different compositions of PLLA, PCL and poly(L-lactic acid-co-caprolactone) (PLCL) (70/30, 
50/50 and 30/70) as cell culture substrate. Human umbilical vein endothelial cells were 
found to adhere and proliferate well on the small-diameter fiber scaffolds (0.3 to 1.2 mm in 
diameter), whereas a marked reduction in cell adhesion and spreading, as well as a low 
proliferative capacity, was observed for large-diameter fiber scaffolds (about 7.0 mm).  
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Normally, cell adhesion to the substrate is necessary for a good polymer-cell interaction. 
Although the substrate does not need to present extracellular matrix-like characteristics for 
cell adhesion to occur, physicochemical similarity is often desired when the aim is to 
promote cell differentiation or a more effective interaction of a certain polymer at the 
implantation site [2-4,17]. Thus, polymers presenting physicochemical and/or mechanical 
properties as close as possible to those of the tissues into which they will be implanted are 
currently being developed. These properties include an adequate balance between 
hydrophilicity/hydrophobicity, electrical charge distribution, hardness, elasticity, and 
strength [18]. 
A relationship exists between hydrophilicity and cell adhesion. Among other parameters, 
more hydrophilic substrates tend to provide a better interaction with cells [19-21]. The 
relationship between cell adhesion and polar groups on the material surface has been 
demonstrated for polystyrene. Adhesion of cells was found to increase with increasing 
polarity of the substrate [22]. In a study investigating hepatic cells cultured on different 
substrates, cell adhesion increased proportionally to the surface energy of the growth 
membranes. Adhesion was even higher in the presence of serum proteins adsorbed to the 
substrates and the metabolic activity of hepatic cells increased on hydrophilic membranes 
[23]. Other studies demonstrated a relationship between wettability and cell adhesion. Lee et 
al. [24] prepared a wettability gradient on polyethylene surfaces to investigate the 
interaction of different types of cells (Chinese hamster ovary cells, fibroblasts and 
endothelial cells) with fetal bovine serum proteins, in terms of surface 
hydrophilicity/hydrophobicity. Better adhesion, spreading and growth of cells were 
observed on surfaces with moderate hydrophilicity. Maximum adhesion was found on 
substrates with a water contact angle of approximately 57º, irrespective of the type of cell used. 
Serum proteins also adhered better to substrates presenting moderate hydrophilicity [24]. 
Thus, cell adhesion is an extremely important factor for biomaterials research. Only after 
adhesion do the cells initiate the process of spreading, division and production of new 
extracellular matrix [18,19]. Cell spreading is a complex process that involves modifications 
in cell morphology as a consequence of alterations in the cytoskeleton, thus improving 
interaction with the substrate. These modifications are shown in Figure 3. 
 
  
Fig. 3. Spreading of Vero cells on type I collagen gel. Round cells are observed during 
inoculation, a morphology that is adequate for the state of being in suspension. After 
adhesion, the cells start their interaction with the substrate. Note the onset of the 
phenomenon known as spreading in (A), which is characterized by modifications in the 
cytoskeleton and, consequently, in cell morphology as a result of interactions with the 
growth surface, with the cell flattening on the growth surface. (B) A cell spread on the 
substrate. Magnification bar: A = 15 µm; B = 10 µm (From Santos Jr and Wada [5], with 
authorization). 
 
Good integration of the biomaterial with cells or tissues also depends on the structure of the 
devices itself. Our experience agrees with literature data indicating that porous materials 
promote cell growth and induce the production of extracellular matrix components by the 
cells [21,25]. A uniform distribution and pore interconnections are important to facilitate the 
formation of tissues in the form of an organized network, with a wide range of applications 
in tissue reconstruction [3,26,27]. In vivo, porosity and pore interconnection are essential for 
the proliferation of vessels, facilitating tissue nutrition around the implant. In this respect, 
different types of scaffolds containing PLLA have been developed and tested as substrates 
for cell growth [3]. Kwon et al. [28] evaluated nano- and microfibrous scaffolds with 
different compositions of PLLA, PCL and poly(L-lactic acid-co-caprolactone) (PLCL) (70/30, 
50/50 and 30/70) as cell culture substrate. Human umbilical vein endothelial cells were 
found to adhere and proliferate well on the small-diameter fiber scaffolds (0.3 to 1.2 mm in 
diameter), whereas a marked reduction in cell adhesion and spreading, as well as a low 
proliferative capacity, was observed for large-diameter fiber scaffolds (about 7.0 mm).  
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Studies from our group have shown an initially slow adhesion to PLLA and PHBV scaffolds 
[21,25]. This finding does not necessarily indicate that the material tested would not be 
useful for tissue engineering. Mann et al. [29] showed that in the case of slow adhesion the 
materials may stimulate the early production of extracellular matrix components, permitting 
cell growth and proliferation. Our observations agree with these authors [21,25]. The 
extracellular matrix exerts a marked influence on the migration, proliferation and 
differentiation of cells cultured on biomaterials. Gunawan and coworkers [30] demonstrated 
the influence of the density of extracellular matrix components on the migration of rat 
intestinal cells (IEC-6 cells). The cells migrated in the direction of the gradient formed, with 
the demonstration of the particular role of laminin in this process. 
Nevertheless, there is a trend to change the architecture of cell culture substrates used for 
tissue engineering [31]. The aim of these surface modifications is to improve the interaction 
with cells both in vitro and in vivo. With respect to cell cultures, increased cell interaction 
means to favor the initial interaction of cells with the substrate, i.e., to increase adhesion. In 
a recent study, nanofibrous PLLA scaffolds were fabricated and tested. The surface 
modifications introduced significantly increased cell adhesion and spreading. In addition, 
cell proliferation was maintained for more than 2 weeks and the modifications also 
increased the production of extracellular matrix components [32]. 
The surface properties of biomaterials can be altered in such a way as to make them more 
adequate for biomedical applications. The most commonly used techniques are chemical 
etching, gas plasma treatment and electron beam radiation [33]. Among these techniques, 
plasma treatment is particularly versatile because the modification is restricted to the 
surface without compromising the material properties as a whole. Plasma treatment can be 
used to modify the polymer surface in a nonspecific manner by introducing a variety of 
functional groups depending on the type of gas used [34,35]. Plasma is considered to be the 
fourth state of matter and consists of highly excited states of atoms, molecules, ions and 
radicals obtained from gases elevated to excited stages by radiofrequency, microwaves or 
electron discharge [35]. Thus, surface modification by plasma treatment is an economic and 
effective technique for biomaterials and is gaining space in the area of biomedicine, with its 
application becoming more frequent. The main advantage of plasma treatment is its 
capacity to modify the surface of materials, making them more biocompatible or permitting 
them to more closely mimic tissue without altering their properties. As a consequence, this 
technique permits a high degree of quality control, offering reliability and reproducing what 
would be difficult to achieve with conventional techniques. Another advantage of plasma 
treatment is that it renders the surface sterile by destruction of microorganisms such as 
bacteria and viruses and is therefore useful for biomedical devices, surgical instruments, 
tissue engineering and clinical applications [35]. Our experience shows that plasma 
treatment increases cell adhesion to PHBV matrices, rendering these scaffolds more 
receptive to cell growth [36]. 
Nakagawa et al. [37] submitted PLLA samples to plasma treatment in a CO2 atmosphere and 
observed an increase in the hydrophilicity of the membrane. The cell response was also 
highly satisfactory for membranes submitted to plasma treatment compared to controls. 
Plasma treatment provided better cell adhesion and proliferation, although the authors had 
used short-term cell cultures (up to 3 days only). Ryu and coworkers [38] submitted 
poly(D,L-lactic acid-co-glycolic acid) (PLGA) membranes to plasma treatment. In that study, 
the PLGA surface was modified in order to increase the interaction of cells with the material 
surface. The results showed that the surface modifications increased hydrophilicity and cell 
adhesion and proliferation. 
Several studies have been conducted to develop materials with biomimetic characteristics. 
Surface modification of biomaterials using bioactive molecules is a relatively simple 
approach to produce biomimetic materials. Long chains of extracellular matrix proteins such 
as fibronectin, vitronectin and laminin have been used for this purpose. Biomaterials coated 
with these proteins normally present increased cell adhesion and proliferation [31,39]. 
Peptides have also been used for surface modifications, with the most frequently used 
sequence being Arg-Gly-Asp (RGD), the binding sequence derived from fibronectin and 
laminin. Other peptide sequences such as Tyr-Ile-Gly-Ser-Arg (YIGSR), Arg-Glu-Asp-Val 
(REDV) and Ile-Lys-Val-Ala-Val (IKVAV) have also been employed for substrates such as 
quartz, glass, metal oxide and polymers [31,39]. 
Porous PDLA and PLLA substrates containing 2-methacryloyloxyethyl phosphorylcholine 
(MPC) and n-butyl methacrylate (BMA) were investigated regarding their capacity to 
interact with fibroblasts. MPC is an analog of phosphatidylcholine, a typical lipid of the 
plasma membrane of cells. The results obtained were quite interesting. The number of 
adhered cells was correlated with PDLA and PLLA content, with the cells presenting a good 
pattern of adhesion and migrating into the substrate within only 24 h of culture. 
Furthermore, cell morphology was influenced by the contact with MPC [40], with the 
addition of MPC rendering the PDLA and PLLA scaffolds more receptive to the initial 
interaction with cells. 
Despite promising results, some investigators have reported discrepancies in the findings 
regarding the addition of bioactive molecules to growth surfaces. In this respect, an 
interesting study was conducted by Harnett et al. [41] who coated various biomaterials with 
different adhesion molecules such as fibronectin, polylysine, polyornithine and collagen in 
order to evaluate changes in surface free energy and the hydrophilicity/hydrophobicity 
balance. Only fibronectin promoted a homogenous coating for all substrates tested, 
producing a monopolar acid surface, whereas polylysine, polyornithine and collagen 
coatings produced hydrophobic or hydrophilic surfaces depending on the underlying 
substrate they were coated on. 
 
4. Tissue engineering and bioresorbable polymers 
Once cell adhesion is established, the material tested is studied as a cell carrier in procedures 
aimed at the restoration of damaged tissues. Tissue engineering can be understood as the 
application of the principles of exact sciences to tissue creation and repair. Three general 
strategies have been adopted to obtain new tissues [17]: 
1) Use of autogenous cells i.e., cells isolated from the individual himself; isogeneic cells, i.e., 
cells obtained from different individuals which, however, are genetically identical or belong 
to the same species; allogeneic cells,  i.e., cells isolated from different individuals of the same 
species, or xenogeneic cells, i.e., cells obtained from different species [42]. These cells are 
expanded in culture and implanted into the body by infusion methods. However, 
limitations of this strategy include the limited capacity of the cells to maintain their 
differentiated characteristics in vitro, the difficulty in sufficiently expanding some cells in 
culture (for example, hepatic and neural cells cannot be expanded in adequate numbers for 
clinical use), and immunological rejection when allogeneic and xenogeneic cells are used.  
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Studies from our group have shown an initially slow adhesion to PLLA and PHBV scaffolds 
[21,25]. This finding does not necessarily indicate that the material tested would not be 
useful for tissue engineering. Mann et al. [29] showed that in the case of slow adhesion the 
materials may stimulate the early production of extracellular matrix components, permitting 
cell growth and proliferation. Our observations agree with these authors [21,25]. The 
extracellular matrix exerts a marked influence on the migration, proliferation and 
differentiation of cells cultured on biomaterials. Gunawan and coworkers [30] demonstrated 
the influence of the density of extracellular matrix components on the migration of rat 
intestinal cells (IEC-6 cells). The cells migrated in the direction of the gradient formed, with 
the demonstration of the particular role of laminin in this process. 
Nevertheless, there is a trend to change the architecture of cell culture substrates used for 
tissue engineering [31]. The aim of these surface modifications is to improve the interaction 
with cells both in vitro and in vivo. With respect to cell cultures, increased cell interaction 
means to favor the initial interaction of cells with the substrate, i.e., to increase adhesion. In 
a recent study, nanofibrous PLLA scaffolds were fabricated and tested. The surface 
modifications introduced significantly increased cell adhesion and spreading. In addition, 
cell proliferation was maintained for more than 2 weeks and the modifications also 
increased the production of extracellular matrix components [32]. 
The surface properties of biomaterials can be altered in such a way as to make them more 
adequate for biomedical applications. The most commonly used techniques are chemical 
etching, gas plasma treatment and electron beam radiation [33]. Among these techniques, 
plasma treatment is particularly versatile because the modification is restricted to the 
surface without compromising the material properties as a whole. Plasma treatment can be 
used to modify the polymer surface in a nonspecific manner by introducing a variety of 
functional groups depending on the type of gas used [34,35]. Plasma is considered to be the 
fourth state of matter and consists of highly excited states of atoms, molecules, ions and 
radicals obtained from gases elevated to excited stages by radiofrequency, microwaves or 
electron discharge [35]. Thus, surface modification by plasma treatment is an economic and 
effective technique for biomaterials and is gaining space in the area of biomedicine, with its 
application becoming more frequent. The main advantage of plasma treatment is its 
capacity to modify the surface of materials, making them more biocompatible or permitting 
them to more closely mimic tissue without altering their properties. As a consequence, this 
technique permits a high degree of quality control, offering reliability and reproducing what 
would be difficult to achieve with conventional techniques. Another advantage of plasma 
treatment is that it renders the surface sterile by destruction of microorganisms such as 
bacteria and viruses and is therefore useful for biomedical devices, surgical instruments, 
tissue engineering and clinical applications [35]. Our experience shows that plasma 
treatment increases cell adhesion to PHBV matrices, rendering these scaffolds more 
receptive to cell growth [36]. 
Nakagawa et al. [37] submitted PLLA samples to plasma treatment in a CO2 atmosphere and 
observed an increase in the hydrophilicity of the membrane. The cell response was also 
highly satisfactory for membranes submitted to plasma treatment compared to controls. 
Plasma treatment provided better cell adhesion and proliferation, although the authors had 
used short-term cell cultures (up to 3 days only). Ryu and coworkers [38] submitted 
poly(D,L-lactic acid-co-glycolic acid) (PLGA) membranes to plasma treatment. In that study, 
the PLGA surface was modified in order to increase the interaction of cells with the material 
surface. The results showed that the surface modifications increased hydrophilicity and cell 
adhesion and proliferation. 
Several studies have been conducted to develop materials with biomimetic characteristics. 
Surface modification of biomaterials using bioactive molecules is a relatively simple 
approach to produce biomimetic materials. Long chains of extracellular matrix proteins such 
as fibronectin, vitronectin and laminin have been used for this purpose. Biomaterials coated 
with these proteins normally present increased cell adhesion and proliferation [31,39]. 
Peptides have also been used for surface modifications, with the most frequently used 
sequence being Arg-Gly-Asp (RGD), the binding sequence derived from fibronectin and 
laminin. Other peptide sequences such as Tyr-Ile-Gly-Ser-Arg (YIGSR), Arg-Glu-Asp-Val 
(REDV) and Ile-Lys-Val-Ala-Val (IKVAV) have also been employed for substrates such as 
quartz, glass, metal oxide and polymers [31,39]. 
Porous PDLA and PLLA substrates containing 2-methacryloyloxyethyl phosphorylcholine 
(MPC) and n-butyl methacrylate (BMA) were investigated regarding their capacity to 
interact with fibroblasts. MPC is an analog of phosphatidylcholine, a typical lipid of the 
plasma membrane of cells. The results obtained were quite interesting. The number of 
adhered cells was correlated with PDLA and PLLA content, with the cells presenting a good 
pattern of adhesion and migrating into the substrate within only 24 h of culture. 
Furthermore, cell morphology was influenced by the contact with MPC [40], with the 
addition of MPC rendering the PDLA and PLLA scaffolds more receptive to the initial 
interaction with cells. 
Despite promising results, some investigators have reported discrepancies in the findings 
regarding the addition of bioactive molecules to growth surfaces. In this respect, an 
interesting study was conducted by Harnett et al. [41] who coated various biomaterials with 
different adhesion molecules such as fibronectin, polylysine, polyornithine and collagen in 
order to evaluate changes in surface free energy and the hydrophilicity/hydrophobicity 
balance. Only fibronectin promoted a homogenous coating for all substrates tested, 
producing a monopolar acid surface, whereas polylysine, polyornithine and collagen 
coatings produced hydrophobic or hydrophilic surfaces depending on the underlying 
substrate they were coated on. 
 
4. Tissue engineering and bioresorbable polymers 
Once cell adhesion is established, the material tested is studied as a cell carrier in procedures 
aimed at the restoration of damaged tissues. Tissue engineering can be understood as the 
application of the principles of exact sciences to tissue creation and repair. Three general 
strategies have been adopted to obtain new tissues [17]: 
1) Use of autogenous cells i.e., cells isolated from the individual himself; isogeneic cells, i.e., 
cells obtained from different individuals which, however, are genetically identical or belong 
to the same species; allogeneic cells,  i.e., cells isolated from different individuals of the same 
species, or xenogeneic cells, i.e., cells obtained from different species [42]. These cells are 
expanded in culture and implanted into the body by infusion methods. However, 
limitations of this strategy include the limited capacity of the cells to maintain their 
differentiated characteristics in vitro, the difficulty in sufficiently expanding some cells in 
culture (for example, hepatic and neural cells cannot be expanded in adequate numbers for 
clinical use), and immunological rejection when allogeneic and xenogeneic cells are used.  
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2) Tissue culture for subsequent implantation and replacement of sick or damaged tissues. 
The most common example used in clinical practice is skin grafts [43]. The main advantage 
of this strategy is its high biocompatibility and biofunctionality. However, this strategy 
presents the same disadvantages as described above. 
3) Use of substances that induce the regeneration of damaged tissue. The success of this 
strategy depends on the large-scale purification and production of appropriate signal 
molecules such as growth factors and adhesion molecules. The proliferation of many cell 
types (which may induce the formation of a new tissue) depends on a combination of 
various growth factors that are highly specific proteins. Some growth factors can be released 
slowly from polymeric capsules and may stimulate the growth of damaged tissue [44]. In 
contrast, adhesion molecules such as fibronectin, vitronectin and laminin are protein 
components of biological fluids and/or extracellular matrix that are adsorbed on the 
material surface and recognized by integrins (cell membrane receptors associated with the 
cytoskeleton) [4]. Integrins bind to the small domains of adhesion molecules [45], such as the 
RGD amino acid sequence of fibronectin and vitronectin or the YIGSR sequence of laminin. 
RGD and other oligopeptides have been incorporated into some biomaterials to stimulate 
adhesion and consequent cell proliferation. 
Autogenous or autograft implants are of special interest. This technique consists of the use 
of healthy cells derived from the patient himself who will receive the polymer implant. 
Autogenous implants have some advantages over organ transplants. Since the cell 
population isolated is expanded in vitro by cell culture, only a small number of donor cells is 
necessary for preparation of the implant. In addition, the use of autogenous cells avoids 
immunological problems such as rejections or allergic processes [3,42,46]. 
 
5. Cell growth and proliferation on bioresorbable polymers 
Bioresorbable devices have been used in vitro as a support for the growth and proliferation 
of different cell types. Endothelial cells have been shown to satisfactorily multiply on PLLA 
scaffolds in the absence of platelet activation [47,48]. Good adhesion to the material and an 
adequate multiplication rate were reported for NIH/3T3 mouse cells cultured on PHBV 
membranes. These parameters improved after the introduction of physicochemical 
modifications (change in polymer hydrophilicity) on the PHBV surface [49]. In another 
study, cell proliferation on a PHBV substrate continued to be similar to that observed for 
collagen sponges for up to 35 days of culture [50]. 
The capacity of a substrate to stimulate cell growth and proliferation is intimately related to 
its ability to absorb proteins. In a recent study, Zhu and coworkers [48] showed that coating 
of the surface of PLLA devices with free amine groups increases the spreading and 
proliferation of endothelial cells. Extracellular matrix proteins such as fibronectin, laminin 
and collagen have also been shown to stimulate the multiplication of cells on substrates 
used for tissue engineering [51]. We showed that Vero cells  produce extracellular matrix 
rich in fibronectin and collagen when cultured on dense or porous PLLA membranes, PHBV 
scaffolds or PLLA/PHBV blends of different proportions [21,25]. This finding may explain 
the observation of a significant proliferation rate despite the initially slow cell adhesion to 
these scaffolds [25,52]. 
6. Bioresorbable devices for cartilage engineering 
The use of bioresorbable materials for articular cartilage repair is currently being 
investigated. Cartilage is an avascular tissue which basically consists of two cell types, 
chondrocytes and chondroblasts. Chondrocytes produce an extracellular matrix that mainly 
consists of collagen and glycosaminoglycans. The proportion of these components depends 
on the type of cartilaginous tissue [53]. Once damaged, cartilage presents little or no 
regenerative capacity and certain injuries may progress to severe degenerative joint diseases 
[46,53]. In addition to the fact that the mechanisms underlying the formation of articular 
cartilage are still unclear, there are few alternative clinical procedures to the replacement of 
joints with prostheses that can fill small defects resulting from trauma or degenerative 
diseases. Current treatments for articular cartilage engineering include 1) the creation of a 
defect by wear or perforation to permit the migration of progenitor cells; 2) arthroscopy; 3) 
autografts; 4) transplantation of perichondrium and periosteum to introduce 
undifferentiated cells with a chondrogenic potential; 5) autogenous cell transplants 
(chondrocytes or undifferentiated cells) previously expanded in vitro and reinjected as an 
autogenous periosteal graft that is able to maintain both chondrogenesis and osteogenesis 
[54]. Studies on cartilage engineering that combine different materials in the production of 
scaffolds used as a support for chondrogenic cells are necessary. In this respect, there is an 
intense search for materials that mimic the biomechanical behavior of articular cartilage and 
thus can be applied to joint repair [46]. Some polymeric materials including both temporary 
and permanent polymers are investigated for this application. Bioresorbable materials 
studied for their use as temporary cartilage matrix include PLLA and PGA polymers and 
their copolymers and blends.  
Chondrocytes cultured on a fibrous PGA matrix and porous PLLA membranes have been 
studied [55]. The results showed the neoformation of cartilage tissue comparable to that 
observed for chondrocytes cultured on collagen substrates obtained from articular cartilage. 
Under these conditions, chondrocytes continued to grow on these polymers for up to 6 
months, maintaining the shape of the original device and producing a tissue with 
characteristics similar to those of cartilage, including the synthesis of glycosaminoglycans 
and types I and II collagen [55]. In addition, it was observed that cartilage cells cultured on 
polyesters such as PLLA and PGA tend to show increased synthesis of proteoglycans and 
collagen when compared to cells cultured on collagen matrix [56]. Puelacher et al. [57] 
studied the in vitro and in vivo growth of chondrocytes on PGA and PLLA scaffolds that 
simulated the morphology of human nasal cartilage. The authors observed the formation of 
hyaline-like cartilage on these substrates. The experimental results indicate that, once 
improved, these tissue reconstruction techniques have potential applications in orthopedic, 
plastic and reconstructive and craniomaxillofacial surgery. In addition, the formation of 
hyaline-like cartilage was observed after 6 weeks when perichondrial cells were cultured on 
PLLA membranes and implanted into the femoral condyle of rabbits [55,58]. 
A study of cells obtained from human articular cartilage and maintained in culture on 
devices consisting of different bioresorbable polyesters showed that the process of adhesion 
was proportional to the hydrophilicity of the polymers. In addition, no variations in cell 
spreading were observed between the different biomaterials. Although the cells studied 
adhered less to the PLLA membranes when compared to PLGA, their proliferative capacity 
was better when grown on the PLLA membrane [59]. In addition, the production of 
cartilaginous matrix and type II collagen was found to be lower for human chondrocytes 
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2) Tissue culture for subsequent implantation and replacement of sick or damaged tissues. 
The most common example used in clinical practice is skin grafts [43]. The main advantage 
of this strategy is its high biocompatibility and biofunctionality. However, this strategy 
presents the same disadvantages as described above. 
3) Use of substances that induce the regeneration of damaged tissue. The success of this 
strategy depends on the large-scale purification and production of appropriate signal 
molecules such as growth factors and adhesion molecules. The proliferation of many cell 
types (which may induce the formation of a new tissue) depends on a combination of 
various growth factors that are highly specific proteins. Some growth factors can be released 
slowly from polymeric capsules and may stimulate the growth of damaged tissue [44]. In 
contrast, adhesion molecules such as fibronectin, vitronectin and laminin are protein 
components of biological fluids and/or extracellular matrix that are adsorbed on the 
material surface and recognized by integrins (cell membrane receptors associated with the 
cytoskeleton) [4]. Integrins bind to the small domains of adhesion molecules [45], such as the 
RGD amino acid sequence of fibronectin and vitronectin or the YIGSR sequence of laminin. 
RGD and other oligopeptides have been incorporated into some biomaterials to stimulate 
adhesion and consequent cell proliferation. 
Autogenous or autograft implants are of special interest. This technique consists of the use 
of healthy cells derived from the patient himself who will receive the polymer implant. 
Autogenous implants have some advantages over organ transplants. Since the cell 
population isolated is expanded in vitro by cell culture, only a small number of donor cells is 
necessary for preparation of the implant. In addition, the use of autogenous cells avoids 
immunological problems such as rejections or allergic processes [3,42,46]. 
 
5. Cell growth and proliferation on bioresorbable polymers 
Bioresorbable devices have been used in vitro as a support for the growth and proliferation 
of different cell types. Endothelial cells have been shown to satisfactorily multiply on PLLA 
scaffolds in the absence of platelet activation [47,48]. Good adhesion to the material and an 
adequate multiplication rate were reported for NIH/3T3 mouse cells cultured on PHBV 
membranes. These parameters improved after the introduction of physicochemical 
modifications (change in polymer hydrophilicity) on the PHBV surface [49]. In another 
study, cell proliferation on a PHBV substrate continued to be similar to that observed for 
collagen sponges for up to 35 days of culture [50]. 
The capacity of a substrate to stimulate cell growth and proliferation is intimately related to 
its ability to absorb proteins. In a recent study, Zhu and coworkers [48] showed that coating 
of the surface of PLLA devices with free amine groups increases the spreading and 
proliferation of endothelial cells. Extracellular matrix proteins such as fibronectin, laminin 
and collagen have also been shown to stimulate the multiplication of cells on substrates 
used for tissue engineering [51]. We showed that Vero cells  produce extracellular matrix 
rich in fibronectin and collagen when cultured on dense or porous PLLA membranes, PHBV 
scaffolds or PLLA/PHBV blends of different proportions [21,25]. This finding may explain 
the observation of a significant proliferation rate despite the initially slow cell adhesion to 
these scaffolds [25,52]. 
6. Bioresorbable devices for cartilage engineering 
The use of bioresorbable materials for articular cartilage repair is currently being 
investigated. Cartilage is an avascular tissue which basically consists of two cell types, 
chondrocytes and chondroblasts. Chondrocytes produce an extracellular matrix that mainly 
consists of collagen and glycosaminoglycans. The proportion of these components depends 
on the type of cartilaginous tissue [53]. Once damaged, cartilage presents little or no 
regenerative capacity and certain injuries may progress to severe degenerative joint diseases 
[46,53]. In addition to the fact that the mechanisms underlying the formation of articular 
cartilage are still unclear, there are few alternative clinical procedures to the replacement of 
joints with prostheses that can fill small defects resulting from trauma or degenerative 
diseases. Current treatments for articular cartilage engineering include 1) the creation of a 
defect by wear or perforation to permit the migration of progenitor cells; 2) arthroscopy; 3) 
autografts; 4) transplantation of perichondrium and periosteum to introduce 
undifferentiated cells with a chondrogenic potential; 5) autogenous cell transplants 
(chondrocytes or undifferentiated cells) previously expanded in vitro and reinjected as an 
autogenous periosteal graft that is able to maintain both chondrogenesis and osteogenesis 
[54]. Studies on cartilage engineering that combine different materials in the production of 
scaffolds used as a support for chondrogenic cells are necessary. In this respect, there is an 
intense search for materials that mimic the biomechanical behavior of articular cartilage and 
thus can be applied to joint repair [46]. Some polymeric materials including both temporary 
and permanent polymers are investigated for this application. Bioresorbable materials 
studied for their use as temporary cartilage matrix include PLLA and PGA polymers and 
their copolymers and blends.  
Chondrocytes cultured on a fibrous PGA matrix and porous PLLA membranes have been 
studied [55]. The results showed the neoformation of cartilage tissue comparable to that 
observed for chondrocytes cultured on collagen substrates obtained from articular cartilage. 
Under these conditions, chondrocytes continued to grow on these polymers for up to 6 
months, maintaining the shape of the original device and producing a tissue with 
characteristics similar to those of cartilage, including the synthesis of glycosaminoglycans 
and types I and II collagen [55]. In addition, it was observed that cartilage cells cultured on 
polyesters such as PLLA and PGA tend to show increased synthesis of proteoglycans and 
collagen when compared to cells cultured on collagen matrix [56]. Puelacher et al. [57] 
studied the in vitro and in vivo growth of chondrocytes on PGA and PLLA scaffolds that 
simulated the morphology of human nasal cartilage. The authors observed the formation of 
hyaline-like cartilage on these substrates. The experimental results indicate that, once 
improved, these tissue reconstruction techniques have potential applications in orthopedic, 
plastic and reconstructive and craniomaxillofacial surgery. In addition, the formation of 
hyaline-like cartilage was observed after 6 weeks when perichondrial cells were cultured on 
PLLA membranes and implanted into the femoral condyle of rabbits [55,58]. 
A study of cells obtained from human articular cartilage and maintained in culture on 
devices consisting of different bioresorbable polyesters showed that the process of adhesion 
was proportional to the hydrophilicity of the polymers. In addition, no variations in cell 
spreading were observed between the different biomaterials. Although the cells studied 
adhered less to the PLLA membranes when compared to PLGA, their proliferative capacity 
was better when grown on the PLLA membrane [59]. In addition, the production of 
cartilaginous matrix and type II collagen was found to be lower for human chondrocytes 
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cultured on PLLA membranes compared to those grown on PLGA membranes. On the other 
hand, cells grown on PLLA scaffolds presented a greater capacity of synthesizing type I 
collagen [60]. Interesting results were also obtained with PLLA scaffolds used for meniscus 
reconstruction. Porous implants were found to guide vascular growth into the injury region 
[61]. Canine meniscus reconstruction using lactic acid/-caprolactone copolymers have also 
been reported [62]. These results demonstrate that the principles of tissue engineering 
employing bioresorbable materials are a promising study area and certainly will yield 
significant results in the near future. 
In an attempt to better mimic the natural environment of cartilage cells, Takagi and 
coworkers [63] developed a scaffold consisting of collagen and a copolymer mesh of PLLA 
and PLGA. Glucuronic acid is one of the components of glycosaminoglycans found in the 
extracellular matrix of tissues. The authors showed that cartilage cells cultured inside the 
scaffold consumed glucose from the culture medium and produced typical extracellular 
matrix components of cartilage tissue. Within this context, another study compared 
hyaluronic acid scaffolds and polyester scaffolds with different degradation rates [64]. The 
study showed that the degradation rate of the scaffolds is critical for the cartilage repair 
process. Cartilage formation was slow with dissolution of the materials, although presenting 
more cracks and discontinuities. Wang et al. [65] tested scaffolds of different origins, such as 
poly(L-lactide), poly(D,L-lactide) and collagen-hydroxyapatite, for the in vitro production of 
cartilage. Porcine chondrocytes were seeded onto the scaffolds. After 15 weeks of culture, a 
layer of viable neo-cartilage was produced on each material, with the collagen-
hydroxyapatite constructs yielding better results in terms of cell viability and integration. 
Another approach was the use of a gelatin scaffold obtained from demineralized bone 
matrix inoculated with rabbit chondrocytes. Neoformation of hyaline-like cartilage was 
demonstrated [66]. 
In a well-conceived experiment, chondrocytes were cultured on PLLA microspheres in a 
bioreactor. In addition, the surface of the microspheres was modified by the addition of 
RGD peptides, small repetitive sequences of the amino acids arginine (Arg or R), glycine 
(Gly or G) and aspartate (Asp or D) which are known to stimulate cell adhesion. PLLA 
degradation was determined after different periods of time (7, 14, 21, 28, 35, 49 and 56 days). 
The authors observed that the materials continued to be stable to support cell growth after 
the periods studied. The use of a bioreactor resulted in a significant increase in the number 
of cells cultured on the biomaterials and the devices studied showed a good capacity to 
stimulate cell adhesion and proliferation. The authors also observed the formation of 
microaggregates, a finding that might indicate the production of extracellular matrix [67]. 
In another study, human mesenchymal stem cells were cultured on a PLDLA scaffold. This 
construct was maintained in chondrogenic medium and the other end was then loaded with 
cells of the same origin but previously induced to undergo osteogenesis. This system was 
then cultured under conditions able to maintain both chondrogenesis and osteogenesis, thus 
producing in vitro a hybrid osteochondral construct [68]. Taken together, these results are 
promising but the search for a polymeric material that better mimics the function of articular 
cartilage still continues. 
 
7. Bioresorbable devices for bone tissue engineering 
Bone is a natural tissue which consists of an organic component (mainly collagen) and a 
mineral component composed of hydroxyapatite. Reconstruction of long bone defects is a 
clinical challenge. Normally, multiple surgeries are required to restore the structure and 
function of the damage site. The development of tissue engineering techniques has led to the 
use of new procedures for bone restoration. Polymeric materials may serve as a support for 
cell growth, permitting the penetration of blood vessels, and even exert morphogenetic 
activity in some cases. In the case of bioresorbable polymers, the materials are often 
enriched with hydroxyapatite, growth factors, bone morphogenetic proteins (BMPs) and 
other bone elements, a fact that renders them highly effective in the stimulation of bone 
neoformation in the damaged areas [10]. 
Transplants consisting of different types of isolated cells cultured on PLLA and PGA 
scaffolds have been investigated as temporary substitutes of damaged tissue portions [17]. 
Implantation of PLGA copolymers into bone resulted in bioresorption of the material and 
concomitant bone neoformation at the site of the implant. An additional advantage of PLGA 
is that its complete degradation is variable and may occur within weeks or years depending 
on the polyester ratio present in the copolymers [69]. 
Osteoblastic cells cultured on PLLA, PGA and PLGA films presented a satisfactory pattern 
of cell adhesion and spreading, in addition to the ability to grow and proliferate on the 
substrate. Furthermore, cells grown on these polymers presented increased alkaline 
phosphatase activity, a marker of osteoblast differentiation, and increased synthesis of 
collagen I [70]. Similar results were obtained when osteoblasts were cultured on PLGA 
scaffolds. In that case, mineralization of the bone matrix produced was also observed 
[71,72]. Interestingly, even bone marrow cells cultured on porous PLGA scaffolds and 
implanted into the rat mesentery were able to initiate ectopic bone formation [71]. 
It has been postulated that porous materials implanted in vivo present a better integration 
with the recipient tissue. Disagreement still exists regarding the ideal diameter of the pores 
for tissue growth. In vitro, low porosity stimulates osteogenesis, suppressing cell 
proliferation by forcing cell aggregation. On the other hand, in vivo, a higher porosity with 
larger pores promotes bone growth. However, these factors result in low mechanical 
properties and, therefore, a functional limit exists for porosity and pore size [73]. On the 
basis of these studies, a minimum pore size of approximately 100 µm was established 
considering cell size, migration requirements and transport. In vitro and in vivo results 
suggest pore sizes and pore interconnections > 300 µm to facilitate vascularization of the 
graft. Some investigators recommend diameter variations of 300 to 400 µm, whereas others 
propose even wider intervals of 200 to 400 µm [74]. Thus, the macrostructure (pre-existing 
macroporosity), microstructure (microporosity, enhanced surface microroughness or 
microtexture) and chemical composition of the material play an important role in 
osteoinduction guided by the biomaterial in vitro. In addition, the model used for in vivo 
study may also markedly influence the results. Osteoinduction is only occasionally observed 
in mice and rats, whereas the same material induces bone formation reproducibly in goats 
and dogs [75]. 
Another interesting approach is the adsorption of factors that stimulate cell differentiation 
on polymer surfaces. In 1965, ectopic bone formation was demonstrated after implantation 
of demineralized bone matrix into muscles of rabbits, rats, mice and guinea pigs [76]. A 
protein, called bone morphogenetic protein (BMP), was found to be involved in the cascade 
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cultured on PLLA membranes compared to those grown on PLGA membranes. On the other 
hand, cells grown on PLLA scaffolds presented a greater capacity of synthesizing type I 
collagen [60]. Interesting results were also obtained with PLLA scaffolds used for meniscus 
reconstruction. Porous implants were found to guide vascular growth into the injury region 
[61]. Canine meniscus reconstruction using lactic acid/-caprolactone copolymers have also 
been reported [62]. These results demonstrate that the principles of tissue engineering 
employing bioresorbable materials are a promising study area and certainly will yield 
significant results in the near future. 
In an attempt to better mimic the natural environment of cartilage cells, Takagi and 
coworkers [63] developed a scaffold consisting of collagen and a copolymer mesh of PLLA 
and PLGA. Glucuronic acid is one of the components of glycosaminoglycans found in the 
extracellular matrix of tissues. The authors showed that cartilage cells cultured inside the 
scaffold consumed glucose from the culture medium and produced typical extracellular 
matrix components of cartilage tissue. Within this context, another study compared 
hyaluronic acid scaffolds and polyester scaffolds with different degradation rates [64]. The 
study showed that the degradation rate of the scaffolds is critical for the cartilage repair 
process. Cartilage formation was slow with dissolution of the materials, although presenting 
more cracks and discontinuities. Wang et al. [65] tested scaffolds of different origins, such as 
poly(L-lactide), poly(D,L-lactide) and collagen-hydroxyapatite, for the in vitro production of 
cartilage. Porcine chondrocytes were seeded onto the scaffolds. After 15 weeks of culture, a 
layer of viable neo-cartilage was produced on each material, with the collagen-
hydroxyapatite constructs yielding better results in terms of cell viability and integration. 
Another approach was the use of a gelatin scaffold obtained from demineralized bone 
matrix inoculated with rabbit chondrocytes. Neoformation of hyaline-like cartilage was 
demonstrated [66]. 
In a well-conceived experiment, chondrocytes were cultured on PLLA microspheres in a 
bioreactor. In addition, the surface of the microspheres was modified by the addition of 
RGD peptides, small repetitive sequences of the amino acids arginine (Arg or R), glycine 
(Gly or G) and aspartate (Asp or D) which are known to stimulate cell adhesion. PLLA 
degradation was determined after different periods of time (7, 14, 21, 28, 35, 49 and 56 days). 
The authors observed that the materials continued to be stable to support cell growth after 
the periods studied. The use of a bioreactor resulted in a significant increase in the number 
of cells cultured on the biomaterials and the devices studied showed a good capacity to 
stimulate cell adhesion and proliferation. The authors also observed the formation of 
microaggregates, a finding that might indicate the production of extracellular matrix [67]. 
In another study, human mesenchymal stem cells were cultured on a PLDLA scaffold. This 
construct was maintained in chondrogenic medium and the other end was then loaded with 
cells of the same origin but previously induced to undergo osteogenesis. This system was 
then cultured under conditions able to maintain both chondrogenesis and osteogenesis, thus 
producing in vitro a hybrid osteochondral construct [68]. Taken together, these results are 
promising but the search for a polymeric material that better mimics the function of articular 
cartilage still continues. 
 
7. Bioresorbable devices for bone tissue engineering 
Bone is a natural tissue which consists of an organic component (mainly collagen) and a 
mineral component composed of hydroxyapatite. Reconstruction of long bone defects is a 
clinical challenge. Normally, multiple surgeries are required to restore the structure and 
function of the damage site. The development of tissue engineering techniques has led to the 
use of new procedures for bone restoration. Polymeric materials may serve as a support for 
cell growth, permitting the penetration of blood vessels, and even exert morphogenetic 
activity in some cases. In the case of bioresorbable polymers, the materials are often 
enriched with hydroxyapatite, growth factors, bone morphogenetic proteins (BMPs) and 
other bone elements, a fact that renders them highly effective in the stimulation of bone 
neoformation in the damaged areas [10]. 
Transplants consisting of different types of isolated cells cultured on PLLA and PGA 
scaffolds have been investigated as temporary substitutes of damaged tissue portions [17]. 
Implantation of PLGA copolymers into bone resulted in bioresorption of the material and 
concomitant bone neoformation at the site of the implant. An additional advantage of PLGA 
is that its complete degradation is variable and may occur within weeks or years depending 
on the polyester ratio present in the copolymers [69]. 
Osteoblastic cells cultured on PLLA, PGA and PLGA films presented a satisfactory pattern 
of cell adhesion and spreading, in addition to the ability to grow and proliferate on the 
substrate. Furthermore, cells grown on these polymers presented increased alkaline 
phosphatase activity, a marker of osteoblast differentiation, and increased synthesis of 
collagen I [70]. Similar results were obtained when osteoblasts were cultured on PLGA 
scaffolds. In that case, mineralization of the bone matrix produced was also observed 
[71,72]. Interestingly, even bone marrow cells cultured on porous PLGA scaffolds and 
implanted into the rat mesentery were able to initiate ectopic bone formation [71]. 
It has been postulated that porous materials implanted in vivo present a better integration 
with the recipient tissue. Disagreement still exists regarding the ideal diameter of the pores 
for tissue growth. In vitro, low porosity stimulates osteogenesis, suppressing cell 
proliferation by forcing cell aggregation. On the other hand, in vivo, a higher porosity with 
larger pores promotes bone growth. However, these factors result in low mechanical 
properties and, therefore, a functional limit exists for porosity and pore size [73]. On the 
basis of these studies, a minimum pore size of approximately 100 µm was established 
considering cell size, migration requirements and transport. In vitro and in vivo results 
suggest pore sizes and pore interconnections > 300 µm to facilitate vascularization of the 
graft. Some investigators recommend diameter variations of 300 to 400 µm, whereas others 
propose even wider intervals of 200 to 400 µm [74]. Thus, the macrostructure (pre-existing 
macroporosity), microstructure (microporosity, enhanced surface microroughness or 
microtexture) and chemical composition of the material play an important role in 
osteoinduction guided by the biomaterial in vitro. In addition, the model used for in vivo 
study may also markedly influence the results. Osteoinduction is only occasionally observed 
in mice and rats, whereas the same material induces bone formation reproducibly in goats 
and dogs [75]. 
Another interesting approach is the adsorption of factors that stimulate cell differentiation 
on polymer surfaces. In 1965, ectopic bone formation was demonstrated after implantation 
of demineralized bone matrix into muscles of rabbits, rats, mice and guinea pigs [76]. A 
protein, called bone morphogenetic protein (BMP), was found to be involved in the cascade 
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of chemotaxis, mitosis, differentiation and bone formation [77]. Since these pioneering 
reports, the role of BMP in bone formation in vitro and in vivo has been extensively studied. 
A recombinant form of human bone morphogenetic protein type 2 (rhBMP-2) was added to 
bioresorbable PLGA substrates. In those studies, a higher production of bone matrix was 
observed for osteoblasts cultured on substrates covered with rhBMP-2 when compared to 
control [78,79]. A similar experiment was conducted by Hollinger et al. [80], who adsorbed 
rhBMP-2 to a collagen I matrix. When this collagen matrix was implanted into fractured 
bone segments, bone neoformation was observed, as well as integration of the implant into 
the damaged bone. Subsequently, various groups have shown that BMPs are able to induce 
endochondral bone formation when implanted at ectopic sites in experimental animals [81]. 
Although the results are promising, this therapeutic approach might be limited by the size 
of the fracture produced [78]. 
The exact mechanism of osteoinduction by biomaterials is still largely unknown. In addition, 
it is unclear whether the mechanisms of osteoinduction by BMPs and biomaterials are the 
same. In a recent review [81], it was demonstrated marked differences in osteoinduction 
mediated by BMPs and biomaterials: 1) biomaterials always induce intramembraneous bone 
formation, whereas BMP mainly induces endochondral bone formation; 2) in small animals 
such as rodents, bone formation is rarely induced by biomaterials but is easily mediated by 
BMPs; 3) newly formed bone is never observed at the periphery of biomaterials but always 
inside their pores, whereas bone formation induced by BMPs regularly occurs outside the 
carrier and soft tissue is observed distant from the surface of this carrier. 
Gugala et al. [82] investigated the adsorption of proteins and activity of osteoblasts cultured 
for up to 3 weeks on porous and non-porous PDLA membranes. The presence of pores did 
not influence protein adsorption. The authors observed that the cells maintained their 
typical phenotype, formed mineralized nodules, i.e., regions where mineralized organic 
matrix is observed, and produced alkaline phosphatase, an enzyme commonly related to the 
process of biomineralization both in vitro and in vivo. The amount of protein, alkaline 
phosphatase activity and number of cells increased over time and were higher for the 
porous than for the non-porous membranes. In another study, osteoblasts were cultured on 
a gradient of PLLA and PDLLA in order to determine whether the gradient alters the 
pattern of cell interaction with the substrate [83]. Cell adhesion was similar at both ends of 
the gradient, but proliferation was more significant in the smoother PDLLA-rich region than 
in the rougher PLLA-rich region of the gradient. These results demonstrate that, in addition 
to the composition of the substrate, its topography also interferes with the behavior of bone 
cells. Thus, PLLA might not be the ideal substrate for the culture of bone cells. It was 
showed that murine osteoblastic cells more intensely adhered to both dense and porous 
PGA scaffolds than to PLLA scaffolds. Nevertheless, the pattern of cell spreading on the 
substrates was similar after 24 h of culture [84]. 
The use of rapidly degrading synthetic or natural polymer matrices with low mechanical 
properties (high porosity) results in grafts with high biological activity but poor structural 
properties, such as low strength and rigidity. One approach to correct this problem is the 
combination of bioactive ceramics, such as calcium phosphate, with bioresorbable polymers 
in order to improve the mechanical properties of the scaffolds. A composite matrix also 
increases the osteoconductive properties of the scaffolds [73]. Various of these compounds 
are investigated for this purpose. Natural polymers combined with hydroxyapatite-
collagen, hydroxyapatite compounds (chitosan-hydroxyapatite), and PLA copolymers 
(PLA-polyethyleneglycol) have been tested.  
Porous PLLA and PLLA-hydroxyapatite composite scaffolds were seeded with osteoblasts 
and cultured. The cells were found to penetrate deep into the PLLA-hydroxyapatite 
scaffolds and were uniformly distributed. Cell viability and proliferation, as well as the 
expression of bone differentiation markers, were higher for the composite scaffolds when 
compared to pure PLLA [85]. 
Other studies have shown that PCL-calcium phosphate composites confer favorable 
mechanical and biochemical properties (the ceramic confers strength and the polymer 
confers hardness and plasticity). In these scaffolds, the ceramic was homogenously 
distributed in the matrix as being exposed on the surface. The composite was more 
hydrophilic and degradation was accelerated when compared to the pure PCL scaffold [86]. 
In addition, the composite was more receptive to cell adhesion [87]. Another study 
investigating PLA-hydroxyapatite and PCL-hydroxyapatite composites showed that cells 
tended to adhere and spread among hydroxyapatite particles exposed on the surface. The 
presence of hydroxyapatite resulted in a higher activity of bone cells [88]. Despite these 
results, further studies are necessary to identify a material that serves as a substrate for the 
growth of bone cells for tissue regeneration since there is still no ideal compound that 
stimulates bone formation. 
 
8. Bioresorbable devices for skin engineering 
Several groups have investigated different methods for the creation of dermal equivalents 
using various substitutes based on biological materials such as collagen, fibrin, culture of 
epidermal layers, or synthetic materials [89]. However, in patients dermal substitutes have 
shown a slow growth of vascular structures into the dermal components. As a consequence, 
a second surgical procedure is necessary to transplant epidermal components into the 
regenerating wound [90]. 
Much of the knowledge about the mechanisms of skin regeneration by tissue engineering 
stems from three-dimensional scaffold-based fibroblast cultures. The mechanism of action of 
these grafts is based on 1) fibroblast colonization, 2) production of growth factors, 3) a 
substrate for keratinocyte migration, and 4) the wound immune response. Another 
important factor is the migration of keratinocytes to the site of injury. A large number of 
keratinocytes is observed around chronic wounds. However, these cells do not migrate onto 
the wound surface. One of the possible explanations is the degradation of extracellular 
matrix by proteases present at high concentrations in many types of injuries. The control of 
the synthesis and/or degradation of extracellular matrix seem to have marked implications 
in the outcomes of wound healing. Genes encoding extracellular matrix components are 
expressed during wound reconstruction. These compounds include tenascin, decorin and 
some types of collagen (I, III, V and VI). A provisional extracellular matrix is expected to 
provide a good substrate for the migration of cells such as keratinocytes and leukocytes. The 
maintenance of this matrix is therefore important [91]. 
Natural polymers, especially collagen, are extensively studied as a substrate for skin 
regeneration. Collagen has been obtained from different xenogenic sources such as cattle, 
swine and horses. Some types of human collagen are used in the United States with 
approval by the Food and Drug Administration (FDA). Collagen is extremely receptive to 
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of chemotaxis, mitosis, differentiation and bone formation [77]. Since these pioneering 
reports, the role of BMP in bone formation in vitro and in vivo has been extensively studied. 
A recombinant form of human bone morphogenetic protein type 2 (rhBMP-2) was added to 
bioresorbable PLGA substrates. In those studies, a higher production of bone matrix was 
observed for osteoblasts cultured on substrates covered with rhBMP-2 when compared to 
control [78,79]. A similar experiment was conducted by Hollinger et al. [80], who adsorbed 
rhBMP-2 to a collagen I matrix. When this collagen matrix was implanted into fractured 
bone segments, bone neoformation was observed, as well as integration of the implant into 
the damaged bone. Subsequently, various groups have shown that BMPs are able to induce 
endochondral bone formation when implanted at ectopic sites in experimental animals [81]. 
Although the results are promising, this therapeutic approach might be limited by the size 
of the fracture produced [78]. 
The exact mechanism of osteoinduction by biomaterials is still largely unknown. In addition, 
it is unclear whether the mechanisms of osteoinduction by BMPs and biomaterials are the 
same. In a recent review [81], it was demonstrated marked differences in osteoinduction 
mediated by BMPs and biomaterials: 1) biomaterials always induce intramembraneous bone 
formation, whereas BMP mainly induces endochondral bone formation; 2) in small animals 
such as rodents, bone formation is rarely induced by biomaterials but is easily mediated by 
BMPs; 3) newly formed bone is never observed at the periphery of biomaterials but always 
inside their pores, whereas bone formation induced by BMPs regularly occurs outside the 
carrier and soft tissue is observed distant from the surface of this carrier. 
Gugala et al. [82] investigated the adsorption of proteins and activity of osteoblasts cultured 
for up to 3 weeks on porous and non-porous PDLA membranes. The presence of pores did 
not influence protein adsorption. The authors observed that the cells maintained their 
typical phenotype, formed mineralized nodules, i.e., regions where mineralized organic 
matrix is observed, and produced alkaline phosphatase, an enzyme commonly related to the 
process of biomineralization both in vitro and in vivo. The amount of protein, alkaline 
phosphatase activity and number of cells increased over time and were higher for the 
porous than for the non-porous membranes. In another study, osteoblasts were cultured on 
a gradient of PLLA and PDLLA in order to determine whether the gradient alters the 
pattern of cell interaction with the substrate [83]. Cell adhesion was similar at both ends of 
the gradient, but proliferation was more significant in the smoother PDLLA-rich region than 
in the rougher PLLA-rich region of the gradient. These results demonstrate that, in addition 
to the composition of the substrate, its topography also interferes with the behavior of bone 
cells. Thus, PLLA might not be the ideal substrate for the culture of bone cells. It was 
showed that murine osteoblastic cells more intensely adhered to both dense and porous 
PGA scaffolds than to PLLA scaffolds. Nevertheless, the pattern of cell spreading on the 
substrates was similar after 24 h of culture [84]. 
The use of rapidly degrading synthetic or natural polymer matrices with low mechanical 
properties (high porosity) results in grafts with high biological activity but poor structural 
properties, such as low strength and rigidity. One approach to correct this problem is the 
combination of bioactive ceramics, such as calcium phosphate, with bioresorbable polymers 
in order to improve the mechanical properties of the scaffolds. A composite matrix also 
increases the osteoconductive properties of the scaffolds [73]. Various of these compounds 
are investigated for this purpose. Natural polymers combined with hydroxyapatite-
collagen, hydroxyapatite compounds (chitosan-hydroxyapatite), and PLA copolymers 
(PLA-polyethyleneglycol) have been tested.  
Porous PLLA and PLLA-hydroxyapatite composite scaffolds were seeded with osteoblasts 
and cultured. The cells were found to penetrate deep into the PLLA-hydroxyapatite 
scaffolds and were uniformly distributed. Cell viability and proliferation, as well as the 
expression of bone differentiation markers, were higher for the composite scaffolds when 
compared to pure PLLA [85]. 
Other studies have shown that PCL-calcium phosphate composites confer favorable 
mechanical and biochemical properties (the ceramic confers strength and the polymer 
confers hardness and plasticity). In these scaffolds, the ceramic was homogenously 
distributed in the matrix as being exposed on the surface. The composite was more 
hydrophilic and degradation was accelerated when compared to the pure PCL scaffold [86]. 
In addition, the composite was more receptive to cell adhesion [87]. Another study 
investigating PLA-hydroxyapatite and PCL-hydroxyapatite composites showed that cells 
tended to adhere and spread among hydroxyapatite particles exposed on the surface. The 
presence of hydroxyapatite resulted in a higher activity of bone cells [88]. Despite these 
results, further studies are necessary to identify a material that serves as a substrate for the 
growth of bone cells for tissue regeneration since there is still no ideal compound that 
stimulates bone formation. 
 
8. Bioresorbable devices for skin engineering 
Several groups have investigated different methods for the creation of dermal equivalents 
using various substitutes based on biological materials such as collagen, fibrin, culture of 
epidermal layers, or synthetic materials [89]. However, in patients dermal substitutes have 
shown a slow growth of vascular structures into the dermal components. As a consequence, 
a second surgical procedure is necessary to transplant epidermal components into the 
regenerating wound [90]. 
Much of the knowledge about the mechanisms of skin regeneration by tissue engineering 
stems from three-dimensional scaffold-based fibroblast cultures. The mechanism of action of 
these grafts is based on 1) fibroblast colonization, 2) production of growth factors, 3) a 
substrate for keratinocyte migration, and 4) the wound immune response. Another 
important factor is the migration of keratinocytes to the site of injury. A large number of 
keratinocytes is observed around chronic wounds. However, these cells do not migrate onto 
the wound surface. One of the possible explanations is the degradation of extracellular 
matrix by proteases present at high concentrations in many types of injuries. The control of 
the synthesis and/or degradation of extracellular matrix seem to have marked implications 
in the outcomes of wound healing. Genes encoding extracellular matrix components are 
expressed during wound reconstruction. These compounds include tenascin, decorin and 
some types of collagen (I, III, V and VI). A provisional extracellular matrix is expected to 
provide a good substrate for the migration of cells such as keratinocytes and leukocytes. The 
maintenance of this matrix is therefore important [91]. 
Natural polymers, especially collagen, are extensively studied as a substrate for skin 
regeneration. Collagen has been obtained from different xenogenic sources such as cattle, 
swine and horses. Some types of human collagen are used in the United States with 
approval by the Food and Drug Administration (FDA). Collagen is extremely receptive to 
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the culture of fibroblasts. We showed that fibroblasts grown on collagen gels produce 
extracellular matrix components such as glycosaminoglycans and fibronectin, forming a 
tissue that resembles reconstituted connective tissue [92]. However, variations in culture 
conditions change the behavior of fibroblasts into that of epithelial cells, with a reduction in 
their migration behavior on the collagen matrix and the production of molecules such as 
collagen IV and laminin [92,93]. Thus, the use of collagen is an interesting model not only 
for the area of tissue reconstruction but also for the study of the differentiation itself of cells 
cultured on it. 
Collagen presents a series of advantages such as availability, biodegradation, bioresorption, 
and resistance to distension. In addition, the properties of collagen can be altered by 
modifying its functional groups. However, there are disadvantages such as rapid 
degradation, high hydrophilicity that may cause significant swelling after implantation, low 
resistance to mechanical compression forces, and high cost of purification, factors limiting 
the use of collagen [94]. The dermal replacement layer of collagen serves as a matrix for the 
growth of macrophages, lymphocytes and endothelial cells derived from the wound. During 
the tissue repair process, an endogenous collagen matrix is deposited, whereas the dermal 
substitute is degraded within approximately 30 days. Furthermore, the skin graft is found to 
be flexible at the site of injury and does not adhere to deeper layers, thus permitting free and 
functional joint movement [95]. 
In view of the positive experiences obtained with collagen, development of an artificial 
dermis was the next target. This type of structure initially consisted of collagen I and 
chondroitin sulfate [96-98]. The so-called artificial dermis is composed of a bilayer 
membrane, in which a matrix of collagen I and chondroitin-6-sulfate is bonded to a layer of 
polysiloxane polymer (silicone). The collagen matrix serves to attract macrophages, 
lymphocytes, fibroblasts and capillaries. In addition to being bioresorbable, the collagen 
matrix is gradually eliminated, permitting the formation of a new dermal matrix. In the 
presence of adequate vascularization, the silicone layer is removed and an epidermal 
autograft is added to the newly formed dermis. The silicone layer represents an additional 
barrier that prevents or minimizes the risk of microbial contamination. The formation of this 
neodermis occurs within 14-21 days. After the completion of regeneration, the neodermis is 
histologically and functionally similar to normal dermis [98,99]. This dermal substitute is 
considered to be an effective treatment for burns and tissue reconstruction in patients with 
cancer [100,101]. 
Since these first results, various research groups have worked to improve the device in an 
attempt to optimize outcomes and to reduce production costs. Among the modifications 
introduced are the removal of chondroitin-6-sulfate and alterations in the storage format of 
the substrate for implantation [102]. Long-term studies have subsequently evaluated the 
efficiency of the implants fabricated, tissue receptivity, degree of regeneration, and strength 
of the skin formed. The data reported were highly satisfactory. The advantages of these 
implants include 1) that the inner layer of the implant spontaneously becomes a structure 
resembling connective tissue, 2) a good long-term postoperative appearance even in the case 
of thin implants, and 3) minimal damage to the donor tissue [43]. 
Intensive research into dermal substitutes and tissue engineering devices has inevitably led 
to bioresorbable polymers. The latter present some advantages over biological substrates: 1) 
since bioresorbable polymers are synthetic, their production can be standardized and 
variations between different production lots are therefore small; 2) these polymers can be 
modified to better fulfill clinical requirements without the loss of their mechanical 
properties; 3) since the possibility of harboring viruses or prions is practically zero, these 
polymers are safer for patients [5,89]. Among the bioresorbable polymers available, the most 
widely used are variations of PLA, such as PLLA, PDLA, PDLLA, PGA, and PLGA. 
Fibroblasts cultured on three-dimensional dense and porous (different pore diameters) 
PLLA membranes were found to adhere to the polymers, to proliferate on them and to 
produce extracellular matrix molecules such as collagen IV and fibronectin [21]. This 
behavior suggests that PLLA can be used as a substrate for skin injuries. However, PLA 
presents low mechanical strength. One alternative would be the formation of copolymers or 
blends to modify the mechanical properties of the material. It was also evaluated the efficacy 
of PLGA membranes with and without plastifier as a dressing for skin injuries. The in vitro 
results showed that the addition of the plastifier reduced the vitreous transition temperature 
(Tg) of the membranes and increased their flexibility. In vivo analysis demonstrated that the 
polymer degraded rapidly when in contact with the skin without causing serious 
inflammation and protected the ulcerated area from the action of external agents. Wound 
healing was faster in the presence of the membranes, a fact indicating their potential use as 
skin dressings [103]. 
Another polymer that is currently gaining interest is poly(hydroxybutyrate-co-
hydroxyvalerate) (PHBV) copolymer, a biodegradable and bioresorbable polymer derived 
from microbial activity. PLLA/PHBV blends are more resistant and, at the same time, more 
malleable than pure PLLA membranes. Since PHBV is more stable, its degradation is slow. 
Thus, the desired strength and degradability are obtained by varying the proportions of 
PLLA and PHBV in the blend. Fibroblasts cultured on different proportions of PLLA/PHBV 
blends (100:0, 60:40, 50:50, 40:60 and 0:100) were found to adhere to the substrates and to 
multiply on them. Again, these cells produced collagen IV and fibronectin on the supports 
[25]. 
New substrates such as poly(ethylene terephthalate)/poly(butylene terephthalate) 
(PEGT/PBT) are also being tested. A fragment of skin equivalent was reconstructed using 
PEGT/PBT scaffolds and cultures of fibroblasts and keratinocytes. The structure formed 
presented various characteristics of differentiated skin, such as an epidermal layer 
expressing several types of keratins on which grew layers of fibroblasts. In addition, 
basement membrane components such as collagen VII, laminin and nidogen were observed 
between these two layers [89]. 
Other alternatives also aimed at dermal regeneration and/or tissue engineering are being 
developed. Some investigators are carefully observing the use of chitosan. Chitosan, or N-
carboxybutylchitosan, is derived from the deacetylation of chitin. Chitosan is a non-
immunogenic compound that presents slow degradation in aqueous medium, even in the 
presence of lysozymes, and its degradation product, glycosamine, is not toxic [104]. 
Chitosan sponges should present, at least in theory, a stable shape and size during the 
period of cell culture. Porous chitosan membranes showed good integrity and favored cell 
spreading [104]. The use of collagen/chitosan blends was proposed taking advantage of the 
characteristics of chitosan and combining them with the properties of collagen. The blends 
were found to present a great water retention capacity, i.e., they were highly hydrophilic, 
and also markedly stimulated the growth of fibroblasts on their surface. Furthermore, the 
addition of chitosan did not reduce the interactivity of cells with collagen. These blends 
support fibroblast infiltration in vivo, a fact facilitating the formation of a neodermis [94]. 
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the culture of fibroblasts. We showed that fibroblasts grown on collagen gels produce 
extracellular matrix components such as glycosaminoglycans and fibronectin, forming a 
tissue that resembles reconstituted connective tissue [92]. However, variations in culture 
conditions change the behavior of fibroblasts into that of epithelial cells, with a reduction in 
their migration behavior on the collagen matrix and the production of molecules such as 
collagen IV and laminin [92,93]. Thus, the use of collagen is an interesting model not only 
for the area of tissue reconstruction but also for the study of the differentiation itself of cells 
cultured on it. 
Collagen presents a series of advantages such as availability, biodegradation, bioresorption, 
and resistance to distension. In addition, the properties of collagen can be altered by 
modifying its functional groups. However, there are disadvantages such as rapid 
degradation, high hydrophilicity that may cause significant swelling after implantation, low 
resistance to mechanical compression forces, and high cost of purification, factors limiting 
the use of collagen [94]. The dermal replacement layer of collagen serves as a matrix for the 
growth of macrophages, lymphocytes and endothelial cells derived from the wound. During 
the tissue repair process, an endogenous collagen matrix is deposited, whereas the dermal 
substitute is degraded within approximately 30 days. Furthermore, the skin graft is found to 
be flexible at the site of injury and does not adhere to deeper layers, thus permitting free and 
functional joint movement [95]. 
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matrix is gradually eliminated, permitting the formation of a new dermal matrix. In the 
presence of adequate vascularization, the silicone layer is removed and an epidermal 
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histologically and functionally similar to normal dermis [98,99]. This dermal substitute is 
considered to be an effective treatment for burns and tissue reconstruction in patients with 
cancer [100,101]. 
Since these first results, various research groups have worked to improve the device in an 
attempt to optimize outcomes and to reduce production costs. Among the modifications 
introduced are the removal of chondroitin-6-sulfate and alterations in the storage format of 
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since bioresorbable polymers are synthetic, their production can be standardized and 
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modified to better fulfill clinical requirements without the loss of their mechanical 
properties; 3) since the possibility of harboring viruses or prions is practically zero, these 
polymers are safer for patients [5,89]. Among the bioresorbable polymers available, the most 
widely used are variations of PLA, such as PLLA, PDLA, PDLLA, PGA, and PLGA. 
Fibroblasts cultured on three-dimensional dense and porous (different pore diameters) 
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produce extracellular matrix molecules such as collagen IV and fibronectin [21]. This 
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Another polymer that is currently gaining interest is poly(hydroxybutyrate-co-
hydroxyvalerate) (PHBV) copolymer, a biodegradable and bioresorbable polymer derived 
from microbial activity. PLLA/PHBV blends are more resistant and, at the same time, more 
malleable than pure PLLA membranes. Since PHBV is more stable, its degradation is slow. 
Thus, the desired strength and degradability are obtained by varying the proportions of 
PLLA and PHBV in the blend. Fibroblasts cultured on different proportions of PLLA/PHBV 
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[25]. 
New substrates such as poly(ethylene terephthalate)/poly(butylene terephthalate) 
(PEGT/PBT) are also being tested. A fragment of skin equivalent was reconstructed using 
PEGT/PBT scaffolds and cultures of fibroblasts and keratinocytes. The structure formed 
presented various characteristics of differentiated skin, such as an epidermal layer 
expressing several types of keratins on which grew layers of fibroblasts. In addition, 
basement membrane components such as collagen VII, laminin and nidogen were observed 
between these two layers [89]. 
Other alternatives also aimed at dermal regeneration and/or tissue engineering are being 
developed. Some investigators are carefully observing the use of chitosan. Chitosan, or N-
carboxybutylchitosan, is derived from the deacetylation of chitin. Chitosan is a non-
immunogenic compound that presents slow degradation in aqueous medium, even in the 
presence of lysozymes, and its degradation product, glycosamine, is not toxic [104]. 
Chitosan sponges should present, at least in theory, a stable shape and size during the 
period of cell culture. Porous chitosan membranes showed good integrity and favored cell 
spreading [104]. The use of collagen/chitosan blends was proposed taking advantage of the 
characteristics of chitosan and combining them with the properties of collagen. The blends 
were found to present a great water retention capacity, i.e., they were highly hydrophilic, 
and also markedly stimulated the growth of fibroblasts on their surface. Furthermore, the 
addition of chitosan did not reduce the interactivity of cells with collagen. These blends 
support fibroblast infiltration in vivo, a fact facilitating the formation of a neodermis [94]. 
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Finally, our experience and the literature data available indicate that bioresorbable polymers 
are a suitable alternative as long as a growth substrate is chosen whose degradation 
coincides with the regeneration of the dermis-epidermis and that permits 
neovascularization of the skin formed at the site of the implant. Dense or porous PLGA 
membranes may show these characteristics. The search for materials with good properties 
might be a promising alternative for the reconstruction of damaged skin. 
 
9. Conclusion 
The advantages of the use of bioresorbable compounds for tissue engineering are numerous 
when compared to other more traditional surgical procedures. Internal fixation devices used 
in orthopedic surgeries lose their function of maintaining tissues together when structural 
recomposition is completed. The use of bioresorbable implants for internal fixation has the 
advantage of eliminating the second surgical intervention necessary for their removal. In 
addition, the risks of metal implants such as corrosion or friction with bone are avoided. 
Although still under study, the use of bioresorbable polymers is highly promising. New 
compounds are being developed and tested every year and their application perspectives 
are immense. The search for materials that are ideal for each tissue and clinical approach 
continues to represent a challenge. 
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1. Introduction 
In humans, the intervertebral disc becomes avascular by the fourth year of life. It has been 
the major target of basic and clinical research on low back pain. Disc degeneration is a 
common cause of chronic low back pain and neurological dysfunction. So far, there have 
been numerous advances in our basic knowledge of the anatomy, biochemistry, physiology, 
and biomechanical features of the disc cells. However, disc cell research and fundamental 
knowledge are certainly lacking in comparison to research on cells of other organs. 
It is generally considered that the notochord gives rise to the nucleus pulposus during 
development of the intervertebral discs. However, it remains unclear why the cells 
composing the nucleus pulposus differ among animal species and stages of maturation and 
what role notochordal cells play in the growth process. Development of the human spinal 
column begins in about embryonic week of 3 (Keys & Compere, 1932). In about week 8 of 
gestation, the cartilaginous vertebral bodies are completed, and the notochord is gradually 
pushed into the gaps between the vertebral bodies, where it later becomes the intervertebral 
discs. In week of 10, the notochord disappears from the vertebral bodies and the nucleus 
pulposus is formed.  Embryonic notochordal cells remain active producers of matrix 
components until the end of the first decade of life, at which time a ‘‘notochordal’’ nucleus 
pulposus can no longer be defined because of its increased collagen content and the loss or 
metaplasia of notochordal cells (Keys & Compere, 1932, Smith, 1930, Coventry, et al., 1945a, 
Peacock, 1952, Taylor & Twomey, 1988). Thus, the notochordal cells disappear from the 
nucleus pulposus during adolescence and are replaced by nonnotochordal (chondrocyte-
like) cells. Although the role of notochordal cells in the nucleus pulposus is unknown, it is 
interesting to note that the loss of these cells from the nucleus pulposus occurs before early 
signs of degeneration appear, and that the combination of notochordal cells and cartilage-
like cells actually determines the properties of this tissue. During weeks 12 to 14 of 
gestation, blood vessels invade the cartilaginous vertebral bodies and primary ossification 
centers begin to appear. Primary cartilaginous ossification remains active until about 
puberty, and a cartilaginous region including the growth plate is observed at the vertebral 
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epiphysis. From the early stage of puberty, small secondary ossification centers appear and 
gradually extend around the periphery of the vertebral body to form a ring apophysis. At 
this stage, the cartilage canal plays an important role in nourishment and growth of the 
intervertebral disc and osteogenesis at the epiphyseal nucleus. The ring apophysis fuses 
completely with the vertebral body to form the vertebral bone at 18 to 25 years of age, if 
growth is normal, and the cartilage canal becomes buried in the bone marrow of vertebral 
body during the process of ossification (Peacock, 1951, Walmsley, 1953, Verbout, 1985). 
The  largely avascular intervertebral disc relies for nutrition on the outer one-third of the 
annulus fibrosus, which contains clearly defined blood vessels, and vascular channels in the 
cartilaginous end plate (Crock & Yoshizawa, 1977). In maintaining the nucleus pulposus, the 
central region of the end plate is probably more important than the outer region since it has 
a relatively higher density of vascular channels. Nutrient supply to the disc is affected by 
the architecture of the vascular buds and the porosity of the subchondral plate. nucleus 
pulposus cells may be up to 8 mm away from the closest blood supply in the adult lumbar 
disc (Bibby, et al., 2001). Steep gradients in metabolites develop with oxygen and glucose 
concentrations low in the disc center and lactic acid concentrations high. The pH in the disc 
center is thus acidic. The endplate does not normally provide a barrier to diffusion. In aging 
and degeneration, however, this end plate tends to calcify by unknown mechanisms and the 
apparent permeability of this plate decreases with age, as the end plate becomes more 
sclelotic (Robert et al., 1993). The consequent fall in supply of nutrients to the disc cells 
inhibits their ability to synthesise and maintain the matrix and even leads to cell death. 
Thus, it is noteworthy that the first signs of the disc degeneration are seen in the disc center.  
There is now an increasing interest in developing biological repair methods for the 
treatment of disc degeneration that achieves the correct biomechanical properties for a 
successful outcome. Many researchers have performed basic studies on regeneration and 
transplantation of intervertebral discs that have applied tissue engineering using cell culture 
methods (Alini et al., 2002, Ganey &b Meisel, 2002, Masuda et al., 2004, Shimer et al., 2004, 
Brisby et al., 2004, Richardson et al. 2007, O’Halloran & Pandit, 2007, Sebastine & Williams, 
2007, Kalson et al., 2008). So far, rat (Walsh et al., 2002, Yoon et al., 2003a, Risbud et al., 
2003), rabbit (Nishida et al., 1999, Okuma et al., 2000, Kroeber et al., 2002, Yoon et al., 2003b, 
Masuda et al., 2003, An H, et al., 2005, Sakai et al., 2006, Iwashina et al., 2006)., porcine (Baer 
et al., 2001, Chen et al., 2004), canine (Thompson et al., 1991, Ganey et al., 2003, Hohaus et 
al., 2008), ovine (Sun et al., 2001, Mizuno et al., 2004), and bovine discs (Osada et al., 1996, 
Matsumoto et al., 2001, Alini et al., 2003, Hamilton et al., 2005) have been used in previous 
studies as tissue sources. However, the effects of aging and degeneration on the metabolism 
of human discs have been less frequently studied because suitable human discs for in vitro 
experiments are difficult to obtain (Alini et al.,2008, Hunter et al., 2003b). Therefore, 
comparison of metabolic activity between notochordal and nonnotochordal cells is 
considered to be important for determining the type of cell to use for transplantation when 
attempting to regenerate intervertebral discs. And also, tissue engineering and biological 
approach for disc degeneration is a potential approach for disc repair. However, these 
attempts to develop tissue with properties similar to those of native disc have been a 
challenge largely because of the difficulty of providing optimum physiological 
environments for the cells and lack of good control of extracellular conditions. The balance 
cellular demand and transport limits the number of cells that can be supported in any tissue 
 
and governs the inverse relationship between thickness and cell density. Such limitations 
apply to all avascular tissues, including tissue-engineered constructs. 
 
2. Nutritional supply to the disc by cartilage canal 
It is well known that a cartilage canal is present in the epiphyseal cartilage of the long bones 
and spine from the fetal to juvenile stages, and this canal plays an important role in 
osteogenesis at the epiphysis as well as in nourishment and growth of the epiphyseal 
cartilage (Strayer, 1943, Brookes, 1971, Gardner & Gray, 1970). It has been variously reported 
that the cartilage canal was derived from differentiation during angiogenesis (Haines, 1933, 
Hurrell, 1934), progression of angiogenesis (Hurrell, 1934, Anderson & Matthiessen, 1966), 
transformation of mesenchymal cells to chondrocytes (Levene, 1964), and extension of the 
perichondrium (Moss-Salentijn, 1975, Wilsman, 1970), but no definitive conclusion has been 
reached. Even at the early stage of vertebral formation, a cartilage canal nourishing the 
unossified cartilaginous part of the vertebrae and intervertebral discs is present in the 
unossified cartilaginous region, and is subsequently buried within the vertebral marrow 
during the progression of ossification (Fig.1A) (Crock & Yoshizawa, 1977, Kobayashi et al., 
2008). During the formation of vertebrae, the cartilage  canal  enlarges  and  undergoes  
anastomosis  to  form  the  bone  marrow  of   the  secondary epiphyseal center (Fig.2A,B). It 
also persists in the unossified cartilaginous region at a suitable location to provide 
nourishment for the proliferating cartilage until the completion of ossification (Haines, 1933, 
Yoshizawa et al., 1986). The cartilage canal made up of arteries, veins, capillaries and 
mesenchymal elements surrounded by chondral tissue (Fig.2C). The blood vessels in the 
cartilage canal have an important role in providing nutrition for intervertebral discs and 
enchondral ossification. True capillaries are classified into 3 types, which are discontinuous, 
fenestrated, and continuous: the capillary permeability increases in this order and the 
morphological features of the endothelium indicate organ specificity (Bennett et al. 1959). 
Fenestrated capillaries are observed in metabolically active tissues, such as endocrine 
glands, the dorsal root ganglion, the kidney, and the intestinal mucosa (Kobayashi et al., 
1993, Kobayashi & Yoshizawa, 2002). In the cartilage canal, fenestrated capillaries were 
observed. This suggests that there was enhanced permeability and active metabolism in the 
canal, with the capillaries providing nutritional support for immature cells surrounding the 
vessels and chondrocytes outside the cartilage canal.  
 A perichondrium exists between the cartilage canal and surrounding cartilage matrix, and 
this is composed of fibroblast-like cells (Fig.2C). Electron microscopy suggested that 
immature chondrocytes observed near the cartilage canal might have originated from the 
perichondrium. A large number of fibroblastic-like cells as well as blood vessels were 
observed in the cartilage canal, and these cells were connected by processes to form an 
intercellular network in the cartilage canal (Fig.2D). Therefore, these cells were assumed to 
be the source of fibroblasts forming the perichondrium and chondrocytes outside the 
cartilage canal (Fig.3). This network was also considered to be involved in intercellular 
signaling that controlled the direction of cell differentiation. Chondroclasts also appeared in 
the cartilage canal to make the bone marrow of the  secondary epiphysial center (Fig.2E). 
Concerning the origin of macrophages and chondroclasts, some hold that they arise from 
osteoprogenitors (Crelin & Koch, 1967), others that they are derived from monocytes 
(Fischman & Hay, 1962). 
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Fig. 1. A schematic drawing to show the developing process of cartilage canal and vascular 
bud in the vertebral end-plate. (Reproduced with permission from Kobayashi S, et al: Fine 
structure of cartilage canal and vascular buds in the vertebral end-plate in rabbit. J 
Neurosurg Spine 2008; 9: 96-103.) 
 
 
Fig. 2. The cartilage canal in the chondral cap of 5th lumbar vertebral body after its birth.  
 
(A) A transparent specimen showing cartilage canal of a thin median sagittal section at 1 
week after its birth. This specimen showing cartilage canal and second ossification 
center. Cartilage canals and second ossification center stained with India ink. CC: 
cartilage canal, FOC: first ossification center, N: nucleus pulposus, PLL: posterior 
longitudinal ligament, SOC: secound (epiphysial) ossification center. 
(B) A hematoxylin and eosin stained medial saggital section showing immature 
chondrocytes around the cartilage canal (arrow).  
(C) A transverse electron photograph of the cartilage canal. The cartilage canal is made 
 
up of vessels of various size and fibroblastic-like cells around vessels. A: arteriole, V: 
venule. 
(D) A high magnification of endothelium. This capillary has many fenestrations with a 
diaphragm in an endothelial cell (arrows). E: vascular endothelium, L: vascular 
lumen, PC: perichondral cell (fibroblast-like cell). 
(E) A fibroblastic-like cell in the cartilage canal. These cells were connected each other 
by gap junction (arrow) and thus forming an intercellular network. Ch: chondroclast, 
E: vascular endothelium, L: vascular lumen, M: macrophage, P1 and P2: process of 
fibroblastic-like cells. 
(F) A chondroclast with ruffled border was presented adjacent to the uncalcified matrix 
in canal. Chondrocytes undergoing apoptosis were seen around cartilage canal, the 
cells and nuclei were reduced in size and chromatin condensation was visible in the 
nuclei (arrow). Ch: chondroclast. (Reproduced with permission from Kobayashi S, et 
al: Fine structure of cartilage canal and vascular buds in the vertebral end-plate in 
rabbit. J Neurosurg Spine 2008; 9: 96-103.) 
 
 
Fig. 3. A schematic drawing to show the developing process of mesenchymal cells in 
cartilage canal and vascular bud.  The mesenchymal cells seen surrounding the cartilage 
canal and vascular bud represent a common precursor for the three main types connective 
tissue cells seen during early vertebral development. (Reproduced with permission from 
Kobayashi S, et al: Fine structure of cartilage canal and vascular buds in the vertebral end-
plate in rabbit. J Neurosurg Spine 2008;9:96-103.) 
 
3. Nutritional supply to the disc by vascular buds and disc degeneration  
Previous histological studies of the bone-disc junction have pointed out that the bone-
cartilage interface is perforated by small holes corresponding to the bone marrow the 
vascular terminations projecting into the cartilage, which are called as capillary beds or 
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vascular buds (Crock & Yoshizawa, 1977, Nachemson et al., 1970, Ogata & Whiteside, 1981, 
Crock et al., 1973, Maroudas et al., 1975). These vascular buds in the bone-disc junction area 
are structurally very similar to the cartilage canal made up of vessels and mesenchymal 
elements (Crock & Goldwasser,1984, Yoshizawa et al., 1986). A segmental arrangement of 
small vessels communicating with the bone marrow cavity is known to exist in the adult 
human vertebral body end-plate, and Crock et al. found a large number of small blood 
vessels that were systematically arranged around the end-plate in clear specimens of adult 
human or canine vertebral bodies, which they termed capillary buds (Crock & Yoshizawa, 
1977, Crock & Goldwasser, 1984). Ogata et al. assigned the term vascular buds to these small 
blood vessels (Ogata & Whiteside, 1981). Thus, capillary buds are identical to vascular buds, 
and these are suggested to be an important nutritional pathway for the intervertebral disc. 
When ossification of vertebral body has progressed and the vertebral end-plate has formed, 
vascular buds appear in small foramina. These vascular buds consist of capillaries and 
mesenchymal cells, with a structural resemblance to the cartilage canal, although smaller in 
size, and their tips are in contact with the intervertebral disc. That is, special tissue 
consisting of blood vessels and mesenchymal cells is present in the undifferentiated and 
unossified part of the vertebra, while the cartilage canal persists in the bone marrow after it 
is buried during the process of ossification of the vertebral body. It then reappears in the 
form of vascular buds occupying numerous small foramina at the vertebral end-plate in 
association with formation of the end-plate, and plays an important role in supplying 
nutrition to the intervertebral discs. These vascular buds are morphologically similar among 
humans, monkeys, and rabbits, and numerous buds are observed in the central part of the 
end-plate corresponding to the nucleus pulposus of the intervertebral disc (Yoshizawa et al., 
1986). This gives us the impression that these vascular buds are important structure for the 
nutrition of the intervertebral disc, especially nucleus pulposus. 
In the case of rabbits, this vascular bud starts to project into the bone cartilage interface 
through the bone plate from the bone marrow about 4 weeks after its birth (Fig. 4A). This 
corresponds to the adolescent period of the human being (Yoshizawa et al., 1986, Kobayashi 
et al., 2008). Mature vascular buds are present in the bony end-plate and their ends are in 
contact with the cartilage of the intervertebral disc, so nutrients are considered to be 
transferred across this junction and distributed to the deeper areas of the intervertebral discs 
by diffusion (Fig.1B, 4B). In maintaining the nucleus pulposus, the central region of the end 
plate is probably more important than the outer region since it has a relatively higher 
density of vascular channels. There are reports that these channels disappear with 
increasing age, and eventually become occluded by calcification (tide mark) (Fig.1C, 4C). 
Schmorl and Junghanns noted “ossification gaps” representing degenerative foci in the 
mature cartilage end plate (Schmorl & Junghanns, 1971). These were seen to appear at the 
same time as the blood vessels disappeared and with the concomitant degeneration of the 
disc, it was assumed that the vessels had a major role in disc nutrition. Histological studies 
of intervertebral disc degeneration conducted by Conventry et al. (Coventry, 1945b, 
Coventry et al., 1945c) and Roberts et al. (Robert et al., 1993). Roberts et al., 1996) have 
demonstrated that degeneration begins near the vertebral end-plate with aging, while a 
study by Ogata et al. demonstrated that blockade of the vertebral route interfered greatly 
with intervertebral disc nutrition (Ogata & Whiteside, 1981). Thus, the tide mark which is 
the certified zone in the cartilage, covers the bone-disc junction by the end of growing 
period and looks to close the nutritional route through these vascular buds. On the other 
 
hand, the tide mark may need to tolerance the body weight with age. These is still 
controversy concerning the role of the vascular buds after the appearance of this tide mark, 
and further studies may be required. 
 
 
Fig. 4. The vascular buds in the vertebral end-plate of adult rabbit.  
 
(A) A transparent specimen showing vascular buds at 6 month after its birth. The 
vascular buds were numerous in number in the central potion of the end-plate.  
(B) A vascular bud in the central portion under the light microscope at 6 month after its 
birth. A vascular bud is contacting directly to the cartilage end-plate (Hematoxylin 
and eosin–stained section). 
(C) A vascular bud in the central portion under the light microscope at 2 year after its 
birth. The tide mark (*) which is the calcified zone in the cartilage plate, covers the 
bone-disc junction by the end of growing period and looks to close the nutritional 
route through the vascular buds.  
(D-F) Transverse sections of transmission electron microscope at 6 month after its birth.  
(D) A photograph of the vascular bud in the center portion. A diameter of a capillary is 
around 10 μm and some fibloblastic-like cells surround it. These cells surrounding 
the capillary were connected each other by gap junction and thus forming an 
intercellular network.  
(E) High magnification shows fenestrae in the endothelium (arrows). The capillary is 
fenestrated type.  
(F) A osteoblastic-like cell that had differentiated from fibroblastic-like cells were 
observed and this cell were bound to the surrounding bone through processes 
(arrow). AF: annulus fibrosus, BP: bone plate, CP: cartilaginous end-plate, E: 
vascular endothelium, F: fibroblastic-like cell, FOC: first ossification center, GP: 
growth plate, L: vascular lumen, N: nucleus pulposus, OB: osteoblastic like cell, PLL: 
posterior longitudinal ligament, SOC: secound (epiphysial) ossification center, VB: 
vascular bud. (Reproduced with permission from Kobayashi S, et al: Fine structure of 
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vascular buds (Crock & Yoshizawa, 1977, Nachemson et al., 1970, Ogata & Whiteside, 1981, 
Crock et al., 1973, Maroudas et al., 1975). These vascular buds in the bone-disc junction area 
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elements (Crock & Goldwasser,1984, Yoshizawa et al., 1986). A segmental arrangement of 
small vessels communicating with the bone marrow cavity is known to exist in the adult 
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human or canine vertebral bodies, which they termed capillary buds (Crock & Yoshizawa, 
1977, Crock & Goldwasser, 1984). Ogata et al. assigned the term vascular buds to these small 
blood vessels (Ogata & Whiteside, 1981). Thus, capillary buds are identical to vascular buds, 
and these are suggested to be an important nutritional pathway for the intervertebral disc. 
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vascular buds appear in small foramina. These vascular buds consist of capillaries and 
mesenchymal cells, with a structural resemblance to the cartilage canal, although smaller in 
size, and their tips are in contact with the intervertebral disc. That is, special tissue 
consisting of blood vessels and mesenchymal cells is present in the undifferentiated and 
unossified part of the vertebra, while the cartilage canal persists in the bone marrow after it 
is buried during the process of ossification of the vertebral body. It then reappears in the 
form of vascular buds occupying numerous small foramina at the vertebral end-plate in 
association with formation of the end-plate, and plays an important role in supplying 
nutrition to the intervertebral discs. These vascular buds are morphologically similar among 
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through the bone plate from the bone marrow about 4 weeks after its birth (Fig. 4A). This 
corresponds to the adolescent period of the human being (Yoshizawa et al., 1986, Kobayashi 
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with intervertebral disc nutrition (Ogata & Whiteside, 1981). Thus, the tide mark which is 
the certified zone in the cartilage, covers the bone-disc junction by the end of growing 
period and looks to close the nutritional route through these vascular buds. On the other 
 
hand, the tide mark may need to tolerance the body weight with age. These is still 
controversy concerning the role of the vascular buds after the appearance of this tide mark, 
and further studies may be required. 
 
 
Fig. 4. The vascular buds in the vertebral end-plate of adult rabbit.  
 
(A) A transparent specimen showing vascular buds at 6 month after its birth. The 
vascular buds were numerous in number in the central potion of the end-plate.  
(B) A vascular bud in the central portion under the light microscope at 6 month after its 
birth. A vascular bud is contacting directly to the cartilage end-plate (Hematoxylin 
and eosin–stained section). 
(C) A vascular bud in the central portion under the light microscope at 2 year after its 
birth. The tide mark (*) which is the calcified zone in the cartilage plate, covers the 
bone-disc junction by the end of growing period and looks to close the nutritional 
route through the vascular buds.  
(D-F) Transverse sections of transmission electron microscope at 6 month after its birth.  
(D) A photograph of the vascular bud in the center portion. A diameter of a capillary is 
around 10 μm and some fibloblastic-like cells surround it. These cells surrounding 
the capillary were connected each other by gap junction and thus forming an 
intercellular network.  
(E) High magnification shows fenestrae in the endothelium (arrows). The capillary is 
fenestrated type.  
(F) A osteoblastic-like cell that had differentiated from fibroblastic-like cells were 
observed and this cell were bound to the surrounding bone through processes 
(arrow). AF: annulus fibrosus, BP: bone plate, CP: cartilaginous end-plate, E: 
vascular endothelium, F: fibroblastic-like cell, FOC: first ossification center, GP: 
growth plate, L: vascular lumen, N: nucleus pulposus, OB: osteoblastic like cell, PLL: 
posterior longitudinal ligament, SOC: secound (epiphysial) ossification center, VB: 
vascular bud. (Reproduced with permission from Kobayashi S, et al: Fine structure of 
Tissue	Engineering254
 
cartilage canal and vascular buds in the vertebral end-plate in rabbit. J Neurosurg 
Spine 2008; 9: 96-103.) 
 
 
Fig. 5. The vascular buds in the annulus fibrosus of adult rabbit (at 6 month of age).  
 
(A) A sagittal section showed some vascular buds in the annulus fibrosis (Hematoxylin and 
eosin–stained section).  
(B) A sagittal constructed photograph of the vascular buds. The vascular buds are made up 
of vessels of various size and fibroblastic cells around vessels.  
(C) Some fibroblastic cells were observed in the wall of vascular buds. Fibroblastic cells 
producing collagen fibers were observed (arrow). AF: annulus fibrosus, BP: bone plate, 
FB: fibroblastic like cell, N: nucleus pulposus, VB: vascular bud. (Reproduced with 
permission from Kobayashi S, et al: Fine structure of cartilage canal and vascular buds 
in the vertebral end-plate in rabbit. J Neurosurg Spine 2008; 9: 96-103.) 
 
Vascular buds are resemble glomerulus-like capillary vessels (Oki et al., 1996). These are 
fenestrated capillaries and show increased vascular permeability like blood vessels in the 
cartilage canal, suggesting active metabolism of tissues around the vertebral end-plate 
(Fig.4D,E). A large number of fibroblastic-like cells were observed around capillaries in the 
vascular buds, and these cells was connected with each other by gap junctions to form an 
intercellular network as seen the cartilage canal. Osteoblast-like cells that had probably 
differentiated from fibroblastic-like cells were also observed, and some of the processes of 
these cells were buried in the bone tissue (Fig.3, 4F). In the vascular buds of the annulus 
fibrosus (Fig.5A,B), fibroblast-like cells produced collagen fibers in the region adjacent to the 
fibrocartilage, a finding which suggests that vascular buds in the annulus fibrosus have a 
marked influence on the composition of the fibrocartilagious matrix (Fig.3, 5C).  Bessett et al. 
cultured mesenchymal cells under various conditions, and reported that bone tissue was 
generated when compression was applied under aerobic conditions and cartilaginous tissue 
was generated when compression was applied under anaerobic conditions (Bassett, 1962). 
When tension was applied under aerobic conditions, connective tissue was formed. 
Although cell differentiation is not only determined by the local oxygen tension and 
mechanical force, this research is interesting because blood vessels are not present in the 
cartilage although abundant vessels are observed in the bone. 
 
 
4. A phenotypic comparison of morphological features of nucleus pulposus 
cells  
It is generally considered that the notochord gives rise to the nucleus pulposus during 
development of the intervertebral discs. However, it remains unclear why the cells 
composing the nucleus pulposus differ among animal species and stages of maturation and 
what role notochordal cells play in the growth process. Morphological changes with aging 
have been actively studied since a report by Luschka in 1858 (von Luschka, 1858), and 
comparative studies of humans and animals have also been performed (Hansen, 1959, 
Bulter, 1988). As a result, it has been demonstrated that the nucleus pulposus of cattle 
(Hansen, 1959), horses (Bulter, 1988), sheep (Carlier, 1890), and chondrodystrophoid dogs 
(e.g., beagles) (Hansen, 1959, Bulter, 1988, Hansen,1952, Braund et al.,1975) shows similar 
changes to that of humans, while the nucleus pulposus of mice (Berry, 1961), rats 
(Williams,1908), rabbits (Souter & Taylar,1970, Scott et al.,1980), pigs (Hansen, 1959, 
Williams,1908), cats (Hansen, 1959, Bulter, 1988, Butler & Smith, 1967) and 
nonchondrodystrophoid dogs (e.g., mongrels) (Hansen, 1959, Bulter, 1988, Hansen,1952, 
Hunter et al.,2003a) retains notochordal cells. These studies have also demonstrated that 
notochordal and cartilaginous nucleus pulposus cells display considerable morphological 
differences. Although the role of notochordal cells in the nucleus pulposus  is unknown, it is 
interesting to note that the loss of these cells from the nucleus pulposus occurs before early 
signs of degeneration appear, and that the combination of notochordal cells and cartilage-
like cells actually determines the properties of this tissue. 
Here, comparison of morphological features between notochordal and nonnotochordal 
cells is considered to be important for determining the type of cell to use for transplantation 
when attempting to regenerate intervertebral discs. In this study, we used notochordal cells 
from the nucleus pulposus of rats (Fig.6A) and rabbits (Fig.6B), as well as chondrocyte-like 
bovine nucleus pulposus cells (Fig.6C). At first, we determined the age of the animals based 
on their skeletal maturity so that nucleus pulposus tissues from different species could be 
compared under similar conditions. The age when skeletal maturity is reached is 2, 4-6, and 
24-30 months after birth for rat (Adler et al., 1983, Moskowitz et al.,1990), rabbits (Kobayashi 
et al., 2008, Scott et al.,1980, Smith & Serafini-Fracassini,1968), and cattle (Lawrence et 
al.,2001), respectively. Loss of notochordal cells occurs at 12 and 6 months after birth in rats 
(Adler et al., 1983, Moskowitz et al.,1990) and rabbits (Scott et al.,1980, Smith & Serafini-
Fracassini,1968), respectively, while notochordal cells are completely replaced by cartilage-
like nucleus pulposus at birth in cattle (Hansen,1956). Accordingly, the discs from 2-month-
old rats, 6-month-old rabbits, and 18 to 24-month-old cattle were considered to correspond 
approximately to the age of adolescence in humans. The cell density of the nucleus pulposus 
was noticeably higher in notochordal discs and was low (4,264 cells/mm3 on average) in 
bovine discs (Fig.6G), which was close to the value (about 6,000 cells/mm3) reported for the 
human nucleus pulposus by Maroudas et al (Maroudas et al., 1975). Butler and Smith et al. 
classified the nucleus pulposus cells into 3 stages: in stage 1, the NP consists entirely of 
notochordal cells; in stage 2, notochordal cells form clusters and the extracellular matrix 
increases; and in stage 3, notochordal cells show a marked decrease and extracellular matrix 
and cartilage-like cells become predominant (Butler & Smith, 1967). According to this 
classification, humans are already in stage 2 at birth and progress to stage 3 in their teens. 
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vascular buds, and these cells was connected with each other by gap junctions to form an 
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differentiated from fibroblastic-like cells were also observed, and some of the processes of 
these cells were buried in the bone tissue (Fig.3, 4F). In the vascular buds of the annulus 
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fibrocartilage, a finding which suggests that vascular buds in the annulus fibrosus have a 
marked influence on the composition of the fibrocartilagious matrix (Fig.3, 5C).  Bessett et al. 
cultured mesenchymal cells under various conditions, and reported that bone tissue was 
generated when compression was applied under aerobic conditions and cartilaginous tissue 
was generated when compression was applied under anaerobic conditions (Bassett, 1962). 
When tension was applied under aerobic conditions, connective tissue was formed. 
Although cell differentiation is not only determined by the local oxygen tension and 
mechanical force, this research is interesting because blood vessels are not present in the 
cartilage although abundant vessels are observed in the bone. 
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It is generally considered that the notochord gives rise to the nucleus pulposus during 
development of the intervertebral discs. However, it remains unclear why the cells 
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Hunter et al.,2003a) retains notochordal cells. These studies have also demonstrated that 
notochordal and cartilaginous nucleus pulposus cells display considerable morphological 
differences. Although the role of notochordal cells in the nucleus pulposus  is unknown, it is 
interesting to note that the loss of these cells from the nucleus pulposus occurs before early 
signs of degeneration appear, and that the combination of notochordal cells and cartilage-
like cells actually determines the properties of this tissue. 
Here, comparison of morphological features between notochordal and nonnotochordal 
cells is considered to be important for determining the type of cell to use for transplantation 
when attempting to regenerate intervertebral discs. In this study, we used notochordal cells 
from the nucleus pulposus of rats (Fig.6A) and rabbits (Fig.6B), as well as chondrocyte-like 
bovine nucleus pulposus cells (Fig.6C). At first, we determined the age of the animals based 
on their skeletal maturity so that nucleus pulposus tissues from different species could be 
compared under similar conditions. The age when skeletal maturity is reached is 2, 4-6, and 
24-30 months after birth for rat (Adler et al., 1983, Moskowitz et al.,1990), rabbits (Kobayashi 
et al., 2008, Scott et al.,1980, Smith & Serafini-Fracassini,1968), and cattle (Lawrence et 
al.,2001), respectively. Loss of notochordal cells occurs at 12 and 6 months after birth in rats 
(Adler et al., 1983, Moskowitz et al.,1990) and rabbits (Scott et al.,1980, Smith & Serafini-
Fracassini,1968), respectively, while notochordal cells are completely replaced by cartilage-
like nucleus pulposus at birth in cattle (Hansen,1956). Accordingly, the discs from 2-month-
old rats, 6-month-old rabbits, and 18 to 24-month-old cattle were considered to correspond 
approximately to the age of adolescence in humans. The cell density of the nucleus pulposus 
was noticeably higher in notochordal discs and was low (4,264 cells/mm3 on average) in 
bovine discs (Fig.6G), which was close to the value (about 6,000 cells/mm3) reported for the 
human nucleus pulposus by Maroudas et al (Maroudas et al., 1975). Butler and Smith et al. 
classified the nucleus pulposus cells into 3 stages: in stage 1, the NP consists entirely of 
notochordal cells; in stage 2, notochordal cells form clusters and the extracellular matrix 
increases; and in stage 3, notochordal cells show a marked decrease and extracellular matrix 
and cartilage-like cells become predominant (Butler & Smith, 1967). According to this 
classification, humans are already in stage 2 at birth and progress to stage 3 in their teens. 
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Fig. 6. Photomicrographs (A–C) and electron micrographs (D-F) of transverse sections of rat, 
rabbit, and bovine lumbar nucleus pulposus.  
 
(A–C) Photomicrographs: Rat and rabbit discs have a gelatinous and well-hydrated nucleus 
pulposus. In contrast, the bovine nucleus pulposus is much more fibrous and cartilage like. 
The rat nucleus pulposus only contains notochordal cells with a number of vacuoles (A). In 
the rabbit nucleus pulposus, a few notochordal cells form clusters surrounded by mucoid 
material (B). In the bovine nucleus pulposus, no notochordal cells are observed, and 
chondrocyte-like cells with lacunae are scattered in a hyaline-like matrix (C) (X40, scale 
bar.50 mm, hematoxylin and eosin–stained sections). 
(D-F) Transmission electron micrographs of the rat nucleus pulposus (D), rabbit nucleus 
pulposus (E), and bovine nucleus pulposus (F). In the rat nucleus pulposus, a number of 
vacuoles of various sizes, which are empty or contain an amorphous substance, can be 
 
observed around the cells. Cells are connected to adjacent cells by tight junctions (white 
arrow) (D). In the rabbit nucleus pulposus , as in rats, notochordal cells with a number of 
vacuoles of varying sizes are observed. The cells are connected with adjacent cells to form an 
intercellular network as in rats (E). Bovine nucleus pulposus cells have larger nuclei than 
notochordal cells. The cytoplasm does not contain vacuoles and the cells are found 
individually in the matrix. Lacunae (*) are observed around the cells (F). The cells are 
completely different from notochordal cells, closely resembling chondrocytes from articular 
cartilage. N: nucleus; V: vacuoles.  
(G) The number of nucleus pulposus cells per unit volume was counted in 10 discs from 
each animal, and the mean values were compared. As a result, the number of cells in the 
bovine nucleus pulposus (chondrocyte-like cells) was significantly lower than that of 
notochordal cells in the nucleus pulposus of rats and rabbits (*, #: p<0.05). (Reproduced 
with permission from Miyazaki T, Kobayashi S, et al. A phenotypic comparison of 
proteoglycan production of intervertebral disc cells isolated from rats, rabbits, and bovine 
tails; Which animal model is most suitable to study tissue engineering and biological repair 
of human disc disorders? Tissue Eng Part A. 2009 Aug 15. [Epub ahead of print] PMID: 
19681728 [PubMed - as supplied by publisher].) 
 
The cells of the adult nucleus pulposus more closely resemble articular chondrocytes. The 
rat, rabbit, and bovine nucleus pulposus used in this study were considered to correspond 
to stages 1, 2, and human stage 3, respectively. Overall, the structure of bovine and human 
discs is similar, but some differences exist with regard to the diameter, height, and thickness 
of the wall of the annulus (Race et al., 2000). Although bovine tails support a lower load 
than human lumbar discs, the swelling pressure of bovine coccygeal discs has been shown 
to be similar to that of the discs in a person resting in the prone position (Ohshima et al., 
1993, Ishihara H, et al. 1996). Biochemically, similar rates of in vitro proteoglycan synthesis 
(Ohshima et al., 1993). and matrix synthesis in response to hydrostatic pressure (Ishihara H, 
et al. 1996, Ohshima et al., 1995) have also been found in human and bovine coccygeal discs. 
Both bovine and human discs are also similar with regard to the types and distribution of 
aggrecan and collagen (Ohshima et al., 1993, Roberts et al., 1991). The bovine disc closely 
resembles the human disc because adult human and adult bovine nucleus pulposus have 
almost no notochordal cells and contain chondrocyte-like nucleus pulposus cells that 
produce a hyaline cartilage-like matrix. It has been demonstrated that notochordal cells 
persist throughout life in rats and rabbits, but decrease with growth, and are replaced by 
hyaline cartilage-like matrix and chondrocyte-like nucleus pulposus cells infiltrating from 
the annulus fibrosus (Keys, & Compere, 1932, Coventry, et al., 1945, Peacock, 1951, Kim et 
al., 2003). It is unknown, however whether this decrease is caused by differentiation of 
notochordal cells into non-notochordal cells, apoptosis, or lack of nutrients diffusing from 
the end plates. Thus, in each animal species, notochordal cells decrease and chondrocyte-
like cells become predominant in the matrix of the nucleus pulposus with aging, but the 
reason for the decrease of notochordal cells and the origin of the chondrocyte-like nucleus 
pulposus cells remain to be elucidated. Therefore, investigation of the relationship between 
the decrease of matrix formation by notochordal cells and the onset of intervertebral disc 
degeneration is an important subject for the future. 
When compared with a report by Trout et al., who observed the human nucleus pulposus at 
various ages from fetal to 91 years by electron microscopy (Trout et al., 1982a, Trout et al., 
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1982b), the morphological characteristics of notochordal cells observed in rats and rabbits in 
this study were similar to those of nucleus pulposus cells observed in human discs up to 
adolescence, while the features of cartilage-like cells observed in bovine discs were similar 
to human nucleus pulposus cells from adolescence onward. That is, the notochordal discs 
contained physaliphorous cells aggregated in close contact with each other (Fig.6D,E), while 
non-notochordal discs contained cartilage-like cells scattered through the matrix and 
characteristically surrounded by lacunae (Fig.6F), which were not observed around 
notochordal cells. The mechanism leading to formation of lacunae and their significance 
remains unclear, but lacunae may reflect the influence of the cell over its immediate 
pericellular matrix, either through accumulation of excreted products or some other process. 
The formation of lacunae may also be related to changes of the nucleus pulposus that occur 
with age, including the apparent increase of some nutrients and substrates, making the 
extracellular matrix less accessible to cell products (Happy & Bradford,1964, Happy, et al. 
1969). Changes in the ability of substances to diffuse in or out of the cell and a reduction in 
the number of viable cells might gradually alter the extracellular matrix and thereby lead to 
age-related changes in the mechanical properties of the disc. 
 
5. Metabolic activities of notochordal cells and non-notochordal cells  
Proteoglycans, particularly the large proteoglycan known as aggrecan, play a major role in 
load-bearing by the intervertebral disc. Because of the high osmotic pressure due to the 
sulphated glycosaminoglycans in aggrecan, it absorbs water that expands the collagen 
network and maintains tissue turgor (Grodzinsky, 1983, Maroudas & Bannon, 1981). The 
stiffness of intervertebral disc tissues is thus strongly dependent on the aggrecan content 
(Kempson et al., 1970, Treppo et al., 2000). Thus, it is necessary to have an adequate content 
of proteoglycans (glycosaminoglycans) when attempting to produce intervertebral disc 
tissue with the mechanical strength to withstand stress of about 2.8-13.0 kN by tissue 
engineering (Adams & Hutton, 1982). The structure and composition of the intervertebral 
discs are intimately related to their function. By studying species differences and 
similarities, many researchers have attempted to define the functions of the discs. However, 
caution is necessary when interpreting and extrapolating to humans from such data, 
because even though all vertebrates have discs, not all discs are the same. For example, 
comparison of proteoglycan synthesis in the discs of chondrodystrophoid dogs (beagles) 
and nonchondrodystrophoid dogs (greyhounds) has revealed significantly lower 
proteoglycan synthesis in chondrodystrophoid dogs (Cole et al., 1985). The relative risk of 
disc herniation is about 10 to 12 times higher in nonchondrodystrophoid dogs than in 
chondrodystrophoid dogs (Gage, 1975, Priester, 1976). Autoradiography with 35S-sulfate, a 
radio label that is largely incorporated by the glycosaminoglycan chains of Proteoglycans, 
has established that notochordal cells also synthesize proteoglycans  (Souter & Taylar, 1970). 
A similar finding has been reported for human fetal and pediatric discs in which 
notochordal cells are more abundant compared with mature discs (Bayliss, et al., 1988, 
Johnstone & Bayliss, 1995). Aguiar et al. have suggested that the notochordal cells found in 
the human nucleus pulposus up to approximately 10 years of age play an active role in 
nucleus pulposus development and in the maintenance of disc integrity through the 
production of soluble factors that induce nucleus pulposus cells to increase proteoglycan 
synthesis (Aguiar et al., 1999). Interestingly, it has been found that co-culture of immature 
 
cells such as mesenchymal stem cells with notochordal cells and adult nucleus pulposus 
cells (chondrocyte-like cells) stimulates proteoglycan synthesis more rapidly, and this 
method has been extensively used in studies on disc regeneration (Sakai et al., 2006, 
Iwashina et al., 2006, Cappello et al., 2006, Erwin & Inman, 2006). However, previous studies 
on proteoglycan production by notochordal cells and chondrocyte-like nucleus pulposus 
cells have only compared proteoglycan synthesis on the basis of sulphate synthesis, and no 
studies have compared glycosaminoglycan accumulated by these cells.  
 
Fig. 7. Metabolic activity of rat, rabbit, and bovine nucleus pulposus cells.  
 
(A) Lactate production rate. Cells were cultured under standard conditions in beads 
containing 4 million cells/ml (1.0ml medium and five beads per well) for up to 5 days, 
with a complete medium change everyday. Representative beads were dissociated for 
cell counting, and the viable cell density per bead was determined. Lactate in the 
medium was measured after each 24-h culture period and production per million 
cells/24 hours is shown. Notochodal nucleus pulposus cells from rats and rabbits 
produced about twice as much lactate as bovine nucleus pulposus cells (*: p<0.05 by the 
paired t-test for rat vs. bovine cells; $: p<0.05 by the paired t-test for rabbit vs. bovine 
cells; +: p=n.s., by the paired t-test for rat vs. rabbit cells.) Lactate production decreased 
over time during culture (#: p<0.05 by two-way ANOVA with repeated measures for 
comparison among days 2 and 5).  
(B) Sulfate incorporation rate. On days 2 and 5, radiolabeled sulfate was added to fresh 
medium in three wells, and the beads were cultured for 4 hours. Then the beads were 
dissociated and cell density and sulfate incorporation were measured. Results are given 
as the mean_standard error of six independent experiments. The sulfate incorporation 
rate decreased over time (#: p<0.05 by two-way ANOVA with repeated measures for 2 
vs. 5 days). The rate was highest for rat cells and lowest for bovine cells up to 5 days of 
culture (*: p<0.05 by the paired t-test for rat vs. bovine cells; $: p<0.05 by the paired t-
test for rabbit vs. bovine cells; +: p=n.s., by the paired t-test for rat vs. rabbit cells.). 
ANOVA, analysis of variance. (Reproduced with permission from Miyazaki T, 
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containing 4 million cells/ml (1.0ml medium and five beads per well) for up to 5 days, 
with a complete medium change everyday. Representative beads were dissociated for 
cell counting, and the viable cell density per bead was determined. Lactate in the 
medium was measured after each 24-h culture period and production per million 
cells/24 hours is shown. Notochodal nucleus pulposus cells from rats and rabbits 
produced about twice as much lactate as bovine nucleus pulposus cells (*: p<0.05 by the 
paired t-test for rat vs. bovine cells; $: p<0.05 by the paired t-test for rabbit vs. bovine 
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comparison among days 2 and 5).  
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medium in three wells, and the beads were cultured for 4 hours. Then the beads were 
dissociated and cell density and sulfate incorporation were measured. Results are given 
as the mean_standard error of six independent experiments. The sulfate incorporation 
rate decreased over time (#: p<0.05 by two-way ANOVA with repeated measures for 2 
vs. 5 days). The rate was highest for rat cells and lowest for bovine cells up to 5 days of 
culture (*: p<0.05 by the paired t-test for rat vs. bovine cells; $: p<0.05 by the paired t-
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ANOVA, analysis of variance. (Reproduced with permission from Miyazaki T, 
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Kobayashi S, et al. A phenotypic comparison of proteoglycan production of 
intervertebral disc cells isolated from rats, rabbits, and bovine tails; Which animal 
model is most suitable to study tissue engineering and biological repair of human disc 
disorders? Tissue Eng Part A. 2009 Aug 15. [Epub ahead of print] PMID: 19681728 
[PubMed - as supplied by publisher].) 
 
We examined that a 3-dementional culture system was employed to compare the 
metabolism of notochordal cells from rat and rabbit nucleus pulposus, as well as 
chondrocyte-like cells from the bovine nucleus pulposus (Miyazaki et al., 2009). As a result, 
notochordal nucleus pulposus cells showed levels of lactate production (Fig.7A) and 
proteoglycan synthesis (Fig.7B) about twice as high as those of chondrocyte-like nucleus 
pulposus cells, indicating the high metabolic activity of notochordal cells.  
 
 
Fig. 8. Morphological changes and glycosaminoglycan production after three-dimensional 
culture. Cells were encapsulated in alginate beads and cultured in Dulbecco’s modified 
Eagle’s medium with 6% serum under air for 5 days. 
 
(A-C) Electron micrographs of rat (A), rabbit (B), and bovine (C) nucleus pulposus cells 
cultured in alginate beads for 5 days. Notochordal (A,B) and non-notochordal 
(cartilaginous)(C) nucleus pulposus cells showed essentially similar findings to those 
observed in vivo. (D) Glycosaminoglycan accumulated/day in rat, rabbit, and bovine 
nucleus pulposus cells. The GAG concentration was measured after 5 days. Pooled data 
from six separate experiments are shown. After culture for 5 days, accumulative 
glycosaminoglycan production was higher in notochordal nucleus pulposus cells than in 
cartilaginous nucleus pulposus cells, being about 156.5, 99.5, and 35.4 μg/ml/day for rat, 
rabbit, and bovine nucleus pulposus cells, respectively. The glycosaminoglycan 
 
accumulated/day was lowest in the bovine cells. Values are the mean ± standard error. ( *, 
#: p<0.05). (Reproduced with permission from Miyazaki T, Kobayashi S, et al. A phenotypic 
comparison of proteoglycan production of intervertebral disc cells isolated from rats, 
rabbits, and bovine tails; Which animal model is most suitable to study tissue engineering 
and biological repair of human disc disorders? Tissue Eng Part A. 2009 Aug 15. [Epub ahead 
of print] PMID: 19681728) 
When nucleus pulposus cells were encapsulated in alginate beads, cultured for 5 days, and 
examined under a electron microscope, notochordal nucleus pulposus cells of rats (Fig.8A) 
and rabbits (Fig.8B) were larger than chondrocyte-like bovine nucleus pulposus cells 
(Fig.8C), and both cell types were surrounded by gaps. However, electron microscopy only 
revealed lacunae around the bovine nucleus pulposus cells (Fig.8C) and not around rat or 
rabbit nucleus pulposus cells, which contained a number of vacuoles. Both types of cell 
showed essentially similar findings to those observed in vivo and contained few 
intracellular organelles. After culture for 5 days, accumulative glycosaminoglycan 
production was higher in notochordal nucleus pulposus cells than in cartilaginous nucleus 
pulposus cells, being about 156.5, 99.5, and 35.4 μg/ml/day for rat, rabbit, and bovine 
nucleus pulposus cells, respectively (Fig.8D). Thus, the notocordal cells were more active 
metabolically than were chondrocyte-like nucleus pulposus cells. One index that in used for 
disc repair and regeneration is the glycosaminoglycan content of the disc. It has been 
reported that a 7-10 % glycosaminoglycan content is required to obtain disc tissue with 
enough strength for clinical application (Urban & Roberts, 1995). Based on the results of the 
present study, it was calculated that it would respectively take at least 1 year, 2 years, and 5 
years for rat, rabbit, and bovine nucleus pulposus cells to produce a 7%-glycosaminoglycan 
content (i.e., 70 mg/ml). This provides important information about prospective autologous 
transplantation of cells with a high proteoglycan production capacity such as notochordal 
cells and mesenchymal stem cells.  
 
6. Which animal model is most suitable to study tissue engineering and 
biological repair of human disc disorders? 
Accordingly, glycosaminoglycan accumulation by chondrocyte-like bovine and adult 
human nucleus pulposus cells is extremely slow compared with that by notochordal cells, 
and in vitro production of a construct with a 7%-glycosaminoglycan content by using 
chondrocyte-like nucleus pulposus cells alone would be assumed to take an extremely long 
time and thus would be impractical. In fact, transformation of the matrix by cells in human 
discs is very slow, and studies have shown that proteoglycan turnover takes about 20 years 
(Roughley, 2004) and collagen turnover takes more than 100 years (Verzijl et al., 2000). 
However, autologous transplantation of cells with a high proteoglycan production capacity 
such as notochordal cells and mesenchymal stem cells may lead to successful repair of 
degenerated discs (Sakai et al., 2006, Iwashina et al., 2006, Aguiar et al.,1999, Cappello et al., 
2006, Erwin & Inman, 2006). Even if the transplantation of cells with a high proteoglycan 
production capacity into the nucleus pulposus is feasible, it is also essential for preventing 
the progression of disc degeneration that the transplanted cells survive in the degenerated 
disc and continue to produce appropriate macromolecules for maintenance of disc 
mechanical strength throughout life.  
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and rabbits (Fig.8B) were larger than chondrocyte-like bovine nucleus pulposus cells 
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revealed lacunae around the bovine nucleus pulposus cells (Fig.8C) and not around rat or 
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disc repair and regeneration is the glycosaminoglycan content of the disc. It has been 
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cells and mesenchymal stem cells.  
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human nucleus pulposus cells is extremely slow compared with that by notochordal cells, 
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chondrocyte-like nucleus pulposus cells alone would be assumed to take an extremely long 
time and thus would be impractical. In fact, transformation of the matrix by cells in human 
discs is very slow, and studies have shown that proteoglycan turnover takes about 20 years 
(Roughley, 2004) and collagen turnover takes more than 100 years (Verzijl et al., 2000). 
However, autologous transplantation of cells with a high proteoglycan production capacity 
such as notochordal cells and mesenchymal stem cells may lead to successful repair of 
degenerated discs (Sakai et al., 2006, Iwashina et al., 2006, Aguiar et al.,1999, Cappello et al., 
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production capacity into the nucleus pulposus is feasible, it is also essential for preventing 
the progression of disc degeneration that the transplanted cells survive in the degenerated 
disc and continue to produce appropriate macromolecules for maintenance of disc 
mechanical strength throughout life.  
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When cells with a high metabolic activity such as notochordal cells are implanted at such a 
location, it is unclear that the cells will be able to obtain enough nutrients to achieve 
adequate regeneration of the extracellular matrix. In fact, notochordal nucleus pulposus cells 
have a higher metabolic activity than chondrocyte-like nucleus pulposus cells, and thus 
should require a larger amount of nutrients to maintain their metabolism than the 
chondrocyte-like cells. It can be assumed from the results of this study that the 
glycosaminoglycan content of the nucleus pulposus decreases when chondrocyte-like cells 
take over the major role of extracellular matrix production from notochordal cells during the 
growth process in humans. The immature disc shows a much higher cell density in vivo 
than the mature nucleus pulposus with chondrocyte-like cells, and lactate and 
glycosaminoglycan production were elevated when culture was done at the same cell 
density (4 x 106 cells/mL). This indicates that notochordal nucleus pulposus cells have a 
higher metabolic activity than chondrocyte-like nucleus pulposus cells and require more 
nutrients. Based on these results, it was considered preferable to study disc regeneration 
using discs from animals with chondrocyte-like cells resembling those in the adult human 
disc. 
One of the initial signs of disc degeneration is said to be a decrease of proteoglycan, 
particularly glycosaminoglycans, in the nucleus pulposus, and one possible cause may be a 
difference of metabolic activity between nucleus pulposus cells with different phenotypes. 
Although such changes are often considered to be signs of degeneration, these changes may 
merely be stages in the normal evolution of discs subjected to mechanical stress. Also, given 
that many degenerated discs are asymptomatic in humans (Boden et al., 1990, Jensen et al., 
1994) identification of the features that distinguish physiological from pathological 
degeneration is critical. That is, the decrease of the proteoglycan content in the nucleus 
pulposus that is observed in human discs during the growth process does not necessarily 
indicate pathological degeneration. Its major cause is considered to be a decline in the 
function of chondrocyte-like nucleus pulposus cells or the death of cells due to impairment 
of nutrient supply from the end plates, which occurs after notochordal cells are completely 
replaced by chondrocytelike cells in the nucleus pulposus from adolescence onward.  
 
7. Changes of physico-chemical environments of the disc cells with aging. 
Nutritional supply to the disc is affected by the architecture of the vascular buds and the 
porosity of the end plate (Fig.9A). Nutrients move from the vascular buds that supply the 
disc, through the end plates and the dense matrix of the disc, to the cells. Its limits transport 
of large molecules into and out of the disc (Roberts et al., 1996). For small solutes such as 
glucose, lactate acid, and oxygen, both experimental and modeling studies have shown that 
solute transport is accomplished mainly by diffusion (Urban et al.,1982, Katz et al., 1986, 
Ferguson et al., 2004, Holm et al.,1981), hence, the movement of fluid in and out of the disc 
as a result of the diurnal loading pattern has little direct influence on transport. Gradients in 
the concentration arise depending on the balance between the rate of supply of glucose or 
oxygen from the blood supply to the cells and the rate of cellular consumption (Holm et 
al.,1981, Sélard, et al., 2003). The intervertebral disc is avascular, and the metabolic activity 
of its cells is regulated by various factors in the extracellular matrix, such as oxygen (Holm 
et al.,1981, Bibby et al., 2005), osmolality (Urban & Maroudas, 1979, Maroudas, 1981, 
Ishihara et al, 1997, Takeno et al., 2007, Negoro et al., 2008), and pH (Ohshima & Urban, 
 
1992, Razaq et al., 2004). The cell density of the normal human nucleus pulposus is 2– 4 x 106 
cells/mL, and the extracellular environment differs markedly from that of other tissues, 
with an oxygen saturation of 1–5%, pH of 7.2–7.4, and extracellular osmolality of 370–
400mOsm. Disc cells activity is regulated by extracellular oxygen concentrations and 
extracellular pH. Synthesis rates appear to be highest at around 5% oxygen, where they are 
greater than the rates found in air (Ishihara & Urban, 1999). However, once oxygen tension 
falls below 5%, synthesis is inhibited appreciably in an oxygen-tension dependent manner. 
Extracellular pH also has a marked effect on the synthesis rates of matrix components. The 
synthesis rates are 40% higher at pH 7.0 than pH 7.4 but fall steeply once the environment 
become acidic (Ohshima & Urban, 1992). Extracellular matrix degradation, however, 
appears less sensitive to pH. In fact, the production of active matrix metalloproteinases is 
similar at pH 7.0 and pH 6.4. Thus, acidic pH levels, by inhibiting synthesis but not 
degradation, may increase the rate of matrix breakdown.  
 
 
Fig. 9. Changes of nutrition and the extracellular environment in nucleus pulposus with 
aging.  (A) Normal disc,  (B) Degenerated disc. 
 
The number of disc cells decreases with aging, but it is unknown whether this decline is 
caused by differentiation of notochordal cells into nonnotochordal cells, apoptosis, or 
insufficient supply of nutrients from the end plate. Ossification of the end plate (tide mark) 
occurs with aging and is one of the major causes of disc degeneration. This leads to 
deterioration of the extracellular environment in the nucleus pulposus and causes cellular 
impairment that is followed by a decline of matrix metabolism, resulting in progression to 
disc degeneration. The nutrient supply for cells and the extracellular environment of the 
disc have a considerable influence on the outcome of treating disc degeneration by 
bioengineering techniques. (Reproduced with permission from Miyazaki T, Kobayashi S, et 
al. A phenotypic comparison of proteoglycan production of intervertebral disc cells isolated 
from rats, rabbits, and bovine tails; Which animal model is most suitable to study tissue 
engineering and biological repair of human disc disorders? Tissue Eng Part A. 2009 Aug 15. 
[Epub ahead of print] PMID: 19681728) 
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Fig. 9. Changes of nutrition and the extracellular environment in nucleus pulposus with 
aging.  (A) Normal disc,  (B) Degenerated disc. 
 
The number of disc cells decreases with aging, but it is unknown whether this decline is 
caused by differentiation of notochordal cells into nonnotochordal cells, apoptosis, or 
insufficient supply of nutrients from the end plate. Ossification of the end plate (tide mark) 
occurs with aging and is one of the major causes of disc degeneration. This leads to 
deterioration of the extracellular environment in the nucleus pulposus and causes cellular 
impairment that is followed by a decline of matrix metabolism, resulting in progression to 
disc degeneration. The nutrient supply for cells and the extracellular environment of the 
disc have a considerable influence on the outcome of treating disc degeneration by 
bioengineering techniques. (Reproduced with permission from Miyazaki T, Kobayashi S, et 
al. A phenotypic comparison of proteoglycan production of intervertebral disc cells isolated 
from rats, rabbits, and bovine tails; Which animal model is most suitable to study tissue 
engineering and biological repair of human disc disorders? Tissue Eng Part A. 2009 Aug 15. 
[Epub ahead of print] PMID: 19681728) 
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In aging, the end plate tends to calcify by unknown mechanisms (Fig.9B). This tide mark 
(calcification) acts as a barrier to nutrients transport and is thought to be a major factor in 
the development of disc degeneration (Urban & Roberts, 1995, Nachemson et al., 1970, 
Rajasekaran et al., 2004). Cellular parameters are very important in regulating nutrient 
levels, with levels of oxygen or pH falling with increases in rates of cell metabolism or cell 
density (Sélard, et al., 2003, Mokhbi-Soukane et al., 2005). For the disc cells to remain viable, 
the levels of extracellular nutrients and pH must remain above critical values.  
 
 
Fig. 10. Effect of extracelluler osmotic change on cell viability and glycosaminoglycan 
production. Cells were isolated from the nucleus pulposus of 18-24 month bovine caudal 
discs. They were cultured for 6 days in alginate beads at 4 million cells/ml in Dulbecco’s 
modified Eagle’s medium containing 6% serum under 21% O2, Medium osmolality was 
altered by NaCl addition over the range 270-570 mOsm and monitored using a freezing 
point osmometer.  
 
(A-C) Electron micrograms of nucleus pulposus cells in the centre of the beads. At 
270mOsm, the cell was swelling with numerous vacuoles and cytoplasmic organelles 
destroyed were visible (A). This cell undergoing oncosis were seen. At 370 mOsm, all cells 
appeared viable (B). At 570mOsm, the cells were reduced in size and budding was visible 
pinching off from the cytoplasm (C). (D) Effect of extracelluler osmotic change on 
glycosaminoglycan produced per million cells. Total glycosaminoglycans  produced per 
million cells was the highest in the 370 mOsm group and the lowest in the hypo-osmolality 
 
(270 mOsm) group. Glycosaminoglycan produced per million cells was significantly 
increased at 370 and 470 mOsm with time in culture (Paired t test between day 2 and day 6 
[*,#: P<0.05]. However, there was no significant values of glycosaminoglycan produced per 
million cells at 270 and 570 mOsm with time in culture. Values are mean ± standard error. 
(Reproduced with permission from Takeno K, Kobayashi S, et al.: Physical limitations to 
tissue engineering of intervertabral disc cells. Effect of extracellular osmotic change on 
glycosaminoglycan production and cell metabolism. J Neurosurg Spine 7: 637-644, 2007). 
 
Because disc cells obtain ATP primarily by glycolysis, glucose is a critical nutrient. The cells 
start to die within twenty-four hours if glucose concentration falls below 0.2 mM and the 
efficiency of glucose transport into the cell is likely reduced at this glucose concentration 
(Windhaber et al., 2003). The rate of cell death increases when pH levels are acidic. The cell 
viability is reduced even with adequate glucose at pH 6.0. The osmotic environment of 
nucleus pulposus cells in the discs changes with loading and pathologic states. The 
osmolality of the extracellular matrix is regulated by negatively charging the 
glycosaminoglycan chains of proteoglycans which adjust ionic composition. Particularly, 
extracellular osmolarity is controlled by negatively charged proteoglycans. It is now evident 
that an increase in the concentration of proteoglycans which control ionic composition 
causes an increase in the osmolality, and conversely, a decrease in proteoglycans reduces 
osmolality (Ishihara et al., 1997, Maroudas, 1981). Urban and Maroudas et al. assessed the 
osmotic pressure across the sagittal section of the discs and noted that the osmolality in the 
nucleus pulposus was about 370-400 mOsm (Maroudas, 1975, Urban & Maroudas, 1979), 
and the osmolality was decreased in degenerated disc. glycosaminoglycan production was 
largest in the 370mOsm, and the capacity for glycosaminoglycan production and cell 
metabolism (lactate production) was low under hypo-osmolality and hyper-osmolality, and 
cell deaths were observed on electron microscopy (Fig. 10) (Takeno et al., 2007). Thus, it may 
be said that osmotic pressure gradient disturbance associated with reduced proteoglycans is 
an important factor contributing to the development of disc degeneration. The results also 
suggest that standard culture mediums do not provide an appropriate ionic and osmotic 
environment for nucleus pulposus cells. 
The physico-chemical environment created and maintained by disc cells in turn has a 
powerful effect on disc cell metabolism. However, the supply of nutrients from vascular 
buds at the end plates to the nucleus pulposus of a degenerative disc is likely to be affected, 
causing the extracellular environment to deteriorate (Urban & Roberts, 1995, Nachemson et 
al.,1970, Rajasekaran et al., 2004). Roberts et al. demonstrated that the cells in degenerate 
discs are senescent (Roberts et al., 2006). This environment is often neglected by it can 
strongly influence matrix turnover or the responses of disc cells to growth factors or other 
external stimuli. Such limitations apply to all avascular tissues including tissue engineered 
constructs. 
 
8. Effect of cell density on the rate of glycosaminoglycan accumulation by 
nucleus pulposus cells 
Glycosaminoglycan accumulation in constructs is dependent on the rate of 
glycosaminoglycan production per cell and on the cell density. It seems intuitive, therefore, 
that increasing cell density should increase rate of glycosaminoglycan deposition, as indeed 
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causing the extracellular environment to deteriorate (Urban & Roberts, 1995, Nachemson et 
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that increasing cell density should increase rate of glycosaminoglycan deposition, as indeed 
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has been shown in several studies (Almarza & Athanasiou, 2005, Mauck et al., 2002, Mauck 
et al., 2003, Saini & Wick, 2003, Williams et al., 2005, Kobayashi et al., 2008). However, it is 
apparent from these studies that glycosaminoglycan accumulation in the construct does not 
increase in proportion to cell density and, indeed, glycosaminoglycan production per cell 
appears to fall at high cell densities. When bovine nucleus pulposus cells were cultured in 
three-dimensional constructs such as alginate beads, the amount of glycosaminoglycan 
accumulated increased with time in culture and also with increase in cell density as 
expected (Fig. 11A) (Kobayashi et al., 2008). However, the rise in cell density did not lead to 
a proportional rise in the amount of glycosaminoglycan accumulated; rather the amount of 
glycosaminoglycan produced per live cell fell with cell density and was significantly lower 
in beads cultured at a density of 22.7 million cells per ml than in those cultured at 2.02 
million cells per ml for nucleus  pulposus  cells  (Fig. 11B).  This  difference  arose  at  least  
in  part  from a fall in metabolic activity of the cells rather than because of increased loss of 
glycosaminoglycan; the rate of energy production (Fig.12A) and of sulfated 
glycosaminoglycan production/viable cell (Fig.12B) was lower in cells cultured at high cell 
densities. 
 
 
Fig. 11. Effect of cell density on glycosaminoglycan production. 
 
Typical results showing effect of cell density on glycosaminoglycan deposition (A) and on 
glycosaminoglycan accumulation per million cells (B) by nucleus pulposus cells. Cells were 
isolated, encapsulated in alginate beads at cell densities ranging from 2.02 to 22.7 million 
cells/ml. Beads were cultured for 7 days at 5 wells/bead in 2 ml medium, 2 wells for each 
cell density and cultured for 7 days in Dulbecco’s modified Eagle’s medium containing 6% 
serum. Beads were then dissociated for cell counting and assay of total glycosaminoglycans.   
(A). Effect of cell density on glycosaminoglycan accumulation per beads (mg/ml). More 
glycosaminoglycan at high cell density than low cell density. Amount of 
 
glycosaminoglycan/bead increased with time in culture at low cell density, but not at high 
cell density. 
(B). Effect of cell density in beads on glycosaminoglycan production per million cells. 
glycosaminoglycan per cell higher at low cell density. Data normalized to results at 4 million 
cells/ml. 
 
Fig. 12. Effect of cell density on lactate production rate (A) and 35S-sulfate incorporation rate 
(B). (A) Cells were cultured under standard conditions in beads containing 4 and 25 million 
cells/ ml (1.0ml medium, 5 beads/well) for up to 7 days, with complete medium change 
daily. Representative beads were dissociated for cell counting and viable cell density/bead 
recorded. Lactate in the medium was measured at days 1,5 and 7, after 24 hours culture and 
rates per million cells/24 hrs reported. High cell density lead to a fall in cellular metabolism 
(+,++,+++: P<0.05, Paired t test between high [25 million cells/ml] and low cell density [4 
million cells/ml]). Lactate production rate fall with time in culture (#: P<0.05, 2 way 
ANOVA with repeated measures among 1, 5 and 7 days). (B) At days 1,5 and 7, tracer 
sulphate was added to the fresh medium of 3 wells, the beads were cultured in the 
radioactive solution for 4 hours, the beads dissociated and cell density and sulphate 
incorporation measured (Fig 3B). Results are given as means standard error of 3 
independent experiments. Sulfate incorporation rates fall with increase in cell density 
(+,++,+++: P<0.05, Paired t test between high [25 million cells/ml] and low cell density [4 
million cells/ml]) and with time in culture (#:P<0.05, 2 way ANOVA with repeated 
measures among 1, 5 and 7 days). (Reproduced with permission from Kobayashi S, Meir A, 
Urban J. Effect of cell density on the rate of glycosaminoglycan accumulation by disc and 
cartilage cells in vitro. J Orthop Res 26:493-503,2008.) 
 
The change in percentage of live and dead cells with time in culture at the periphery and 
centre of beads is shown in Fig.13 for cells cultured at low (4 million cells/ml) and high cell 
densities (25 million cells/ml), respectively. For cells cultured at 4 million cells/ml, 100% of 
the cells were viable at the both the periphery (Fig 13A) and in the centre (Fig 13B). It can be 
seen that by day 2 of culture at high cell densities, while almost all the cells at the periphery 
were alive (Fig.13C,E), 30 percent of the cells in the bead centre were dead (Fig.13D,E). 
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Similar percentages were dead at day 5 of culture, suggesting the profile of viable cells 
across the bead was established early in culture (Fig.13E). At low cell density, transmission 
electron micrographs indicated that all cells appeared viable and active.  
 
Fig. 13. Effect of cell density on cell viability under conforcal (A-E) and electron (F,G) 
microscope.  
 
(A-E) A and B shows the periphery and central region respectively of a typical bead 
cultured at 4 million cells/ml after 5 days. C and D shows the periphery and central region 
of a bead cultured at 25 million cells/ml after 5 days. Cell viability was determined using a 
live/dead assay kit; live cells (green) and dead cells (red) were counted manually. E shows 
the variation of cell viability at the edge and centre of beads with time and cell density. 
Results are means and s.e.ms of percentage of viable cell from 4 representative beads. At 
high cell density (25 million cells/ml), cell viability is lower in the centre than at the edge (+: 
P=0.961, ++: P=0.932, *, **: P<0.05, 2 way ANOVA with repeated measures between edge 
and centre).  
(F,G) Electron micrographs of peripheral (F) and central (G) nucleus pulposus cells (A-D) 
cultured at high cell density. The figures show representative cells from the central and 
peripheral regions of beads cultured at high (25 million cells/ml) for 5 days. In the bead 
periphery, some cells appear normal.  However, the central region showing cells 
undergoing apoptosis (arrows). The cells and nuclei were reduced in size and chromatin 
condensation was seen in the nuclei in comparison of the cells in the periphery. 
(Reproduced with permission from Kobayashi S, Meir A, Urban J. Effect of cell density on 
 
the rate of glycosaminoglycan accumulation by disc and cartilage cells in vitro. J Orthop Res 
26:493-503,2008.) 
Nucleus pulposus cells cultured at high cell density appeared viable at the bead periphery 
(Fig.6F). However cells undergoing apoptosis were seen in the centre; the cells and nuclei 
were reduced in size and chromatin condensation was visible in the nuclei (Fig.6G). These 
results are in agreement with those of others who have found regions of cell death in the 
center of constructs or even of microsphere aggregates (Martin et al., 1999, Mercier et al., 
2004, Obradovic et al., 1999), and that glycosaminoglycan accumulation may highest at the 
construct peripheries. In addition, others have also found that increasing cell density or cell 
number does not necessarily increase matrix accumulation (Mercier et al., 2004). 
These avascular constructs, unless experimentally perfused, rely on diffusion for supply of 
nutrients to the cells (Grunhagen et al., 2006, Obradovic et al., 2000) simulating the condition 
seen in intervertebral disc. In avascular tissues and in constructs, there are steep gradients of 
oxygen and other nutrients between the surface and center of the tissue or constructs 
(Kellner et al., 2002, Malda et al., 2004). The steepness of these gradients, and hence the 
nutrient concentrations in the center of the construct, depend not only on the geometry and 
properties of the tissue or construct but also on the cell density and the cellular activity. 
(Haselgrove et al., 1993, Zhou et al., 2004, Soukane et al., 2005). Thus, in any particular 
construct or tissue, an increase in cell density will lead to a corresponding fall in the 
concentration of nutrients such as oxygen and glucose, and an increase of metabolic by-
products such as lactic acid (Zhou et al., 2004), leading, once cell density has risen 
sufficiently, to a fall in rates of cell metabolism and glycosaminoglycan synthesis (Gray et 
al., 1988, Ysart & Mason, 1994). If cell density is sufficiently great, oxygen and glucose 
concentrations and pH levels can fall to levels which can no longer sustain viable cells 
(Horner & Urban, 2001) leading to the necrotic region in the construct center. Diffusional 
nutrient transport is thus a limitation on the number of viable and active cells which can be 
maintained in any construct or tissue; indeed, viable cell density is inversely related to 
diffusion distance both in disc and in constructs (Horner & Urban, 2001, Stockwell, 1971). 
 
9. Physical limitations to biological repair and tissue engineering 
The interrelationships between cell density, cell viability and activity, and diffusion distance 
resulting from nutrient supply constraints, limit the rate at which glycosaminoglycan can be 
accumulated in three-dimensional constructs. Glycosaminoglycan accumulation depends on 
glycosaminoglycan production per cell and on cell density. At low cell densities, cells may 
be functioning optimally but the low cell density limits the rate of glycosaminoglycan 
accumulation. At high cell densities, more glycosaminoglycan is deposited at least initially, 
but nutrient gradients particularly in the center of constructs, reduce the rate of 
glycosaminoglycan deposition per cell and may even lead to a fall in cell number if cells die. 
Glycosaminoglycan accumulation thus appears necessarily slow, and the general finding 
that cultures of >7 months are required to achieve concentrations of glycosaminoglycan 
similar to those seen in vivo may not be easily overcome (Kellner et al., 2002, Roughley, 
2004). The different maneuvers which have been tried to increase glycosaminoglycan 
production all have limitations. An increase in glycosaminoglycan production rate per cell 
can be induced by addition of growth factors, by providing mechanical or ultrasound 
stimulation or through alterations to scaffold properties (Blunk et al., 2002, Richmon et al., 
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(Haselgrove et al., 1993, Zhou et al., 2004, Soukane et al., 2005). Thus, in any particular 
construct or tissue, an increase in cell density will lead to a corresponding fall in the 
concentration of nutrients such as oxygen and glucose, and an increase of metabolic by-
products such as lactic acid (Zhou et al., 2004), leading, once cell density has risen 
sufficiently, to a fall in rates of cell metabolism and glycosaminoglycan synthesis (Gray et 
al., 1988, Ysart & Mason, 1994). If cell density is sufficiently great, oxygen and glucose 
concentrations and pH levels can fall to levels which can no longer sustain viable cells 
(Horner & Urban, 2001) leading to the necrotic region in the construct center. Diffusional 
nutrient transport is thus a limitation on the number of viable and active cells which can be 
maintained in any construct or tissue; indeed, viable cell density is inversely related to 
diffusion distance both in disc and in constructs (Horner & Urban, 2001, Stockwell, 1971). 
 
9. Physical limitations to biological repair and tissue engineering 
The interrelationships between cell density, cell viability and activity, and diffusion distance 
resulting from nutrient supply constraints, limit the rate at which glycosaminoglycan can be 
accumulated in three-dimensional constructs. Glycosaminoglycan accumulation depends on 
glycosaminoglycan production per cell and on cell density. At low cell densities, cells may 
be functioning optimally but the low cell density limits the rate of glycosaminoglycan 
accumulation. At high cell densities, more glycosaminoglycan is deposited at least initially, 
but nutrient gradients particularly in the center of constructs, reduce the rate of 
glycosaminoglycan deposition per cell and may even lead to a fall in cell number if cells die. 
Glycosaminoglycan accumulation thus appears necessarily slow, and the general finding 
that cultures of >7 months are required to achieve concentrations of glycosaminoglycan 
similar to those seen in vivo may not be easily overcome (Kellner et al., 2002, Roughley, 
2004). The different maneuvers which have been tried to increase glycosaminoglycan 
production all have limitations. An increase in glycosaminoglycan production rate per cell 
can be induced by addition of growth factors, by providing mechanical or ultrasound 
stimulation or through alterations to scaffold properties (Blunk et al., 2002, Richmon et al., 
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2005, van der Kraan et al., 2002,  Kuo & Lin, 2006), but the relative increase which can be 
achieved is limited (usually two–threefold under optimal conditions) and the consequent 
increase in metabolic demand can lead to a fall in pH in the construct center (Razaq et al., 
2004) and thus severely limit growth factor efficacy. Indeed, addition of growth factors to 
constructs was found to have little effect on the concentration of accumulated 
glycosaminoglycan although it increased construct size (Walsh et al., 2002, Yoon et al., 
2003a,  Yoon et al., 2003b, Masuda et al., 2003, An et al., 2005, Malda et al., 2004). In addition, 
glycosaminoglycan production rates appear to fall with time in culture in many different 
systems also limiting glycosaminoglycan accumulation (Mercier et al., 2004). Increasing cell 
density potentially should increase glycosaminoglycan deposition, but leads to a lower 
activity per cell, and also, in general, has not been found to increase glycosaminoglycan 
deposition rates (Panossian et al., 2001). It should also be noted that tissue in vivo cannot 
support too high a cell density, so in vitro culture of constructs at high cell density could 
lead to cell death after implantation.  
Culture conditions such as stirring or perfusion (Freyria et al., 2000, Seidel et al., 2004) 
appear able to overcome diffusive transport initially, but as glycosaminoglycan 
concentrations rise and the hydraulic permeability of the construct falls, convective 
transport also is reduced and rates of glycosaminoglycan deposition slow. 
Glycosaminoglycan concentrations were reported to reach 5%by wet weight within 2 
months but took a further 5 months to increase to 7% glycosaminoglycan. In view of the 
long culture times which appear necessary to achieve the required glycosaminoglycan 
composition in vitro, achievement of in vivo concentration before implantation of a 
construct may be an unrealistic and possibly unnecessary goal for tissue engineered disc.  
Cellular repair using autologous chondrocyte transplantation appears successful even 
though chondrocytes are implanted with no matrix at all. Under these conditions, 
remodeling in vivo appears to produce a cartilage-type matrix under some conditions. 
Tissue engineered composites implanted with low glycosaminoglycan appeared to 
accumulate glycosaminoglycan in vivo, withstand physiological loading, and remodel 
towards a hyaline-type matrix. Perhaps optimization of such processes is a more useful goal. 
 
10. Conclusions 
There is increasing interest in the using biological methods to repair degenerate discs. 
Biological repair depends on the disc maintaining a population of viable and active cells. 
Adequate nutrition of the disc influences the outcome of such therapies and, hence, must be 
considered to be a crucial parameter. Therefore, it is very important to maintain an 
appropriate physicochemical environment to achieve successful disc repair by biological 
methods and tissue engineering procedures. 
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1. Short description of the book chapter 
Dental scientists are eagerly embracing regenerative medicine using tissue engineering 
technology. Enamel, one component of teeth, is the hardest tissue in the body. It cannot 
regenerate by itself, because it is formed by a layer of ameloblasts that is lost by the time the 
tooth crown has completely formed. Although the enamel is spent during lifetime, it is 
vulnerable to wear, damage, and decay. For these reasons, the development of a technique 
that produces artificially-grown enamel using culture and transplantation techniques is 
strongly desired. In this chapter we report a new technique for culturing enamel organ 
epithelial cells that have the capacity to produce enamel. 
After completion of the formation of the tooth crown, which is composed of an 
enamel-dentin complex, tooth root formation begins. Generally, no new ameloblasts or 
enamel is generated from the enamel organ epithelial cells after the tooth root is formed. 
Epithelial cell rests of Malassez, derived from Hertwig’s epithelial root sheath fragments, 
are located in the periodontal ligament, and recently we reported that these cells are also 
capable of enamel production using the same technique. 
Dental epithelial cells including enamel organ epithelial cells and epithelial cell rests of 
Malassez can continue to proliferate when they are subcultured on top of feeder layer cells. 
These subcultured cells were placed onto collagen sponge scaffolds along with dental pulp 
cells and the constructs were transferred into the abdominal cavities of rats. When removed 
after 4 weeks, enamel production was observed in the scaffolds. The key finding of this 
study is that even after multiple divisions, the cells retained the capacity to produce enamel. 
Now that dental epithelial cells can be generated by a culture and transplantation system, 
the next step will be to combine the tissue-engineered enamel with the injured enamel in 
original teeth. 
 
2. Abbreviations 
EOE, enamel organ epithelial; ERM, epithelial cell rests of Malassez; HERS, Hertwig’s 
epithelial root sheath; KLK4, kallikrein-4; MMP-20, enamelysin; PDL, periodontal ligament 
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3. Introduction 
One purpose of studying the development and structure of enamel is to understand how it 
responds to enamel loss caused by caries or fractures. One of frequent dental disease is 
dental caries which is a specific infectious disease of the teeth that results in localized 
dissolution and destruction of the calcified enamel and dentin (1, 2). Enamel is the hardest 
tissue in the body and it does not regenerate because the cells that synthesize the enamel 
matrix are lost during tooth eruption. To replace enamel, dentistry has formulated artificial 
materials that mimic the hardness of enamel but replacing enamel with artificial substitutes 
may not be the most appropriate therapy. The establishment of a novel therapy to engineer 
natural enamel would provide an important approach to repair enamel loss. 
Recently, tissue engineering therapy for tooth replacement has been addressed using 
various strategies and all such attempts share a common feature, which is that odontogenic 
capacity is necessary to generate a tooth structure. The first successful report described tooth 
structures such as the enamel-dentin complex generated in vivo by seeding dissociated 
odontogenic cells from a 6-month porcine third molar onto polyglycolic acid fiber mesh (3). 
The data suggested the presence of epithelial and mesenchymal progenitor/stem cells in the 
early stages of crown formation in the developing tooth. Furthermore, these results 
indicated a high likelihood of developing a technique to generate enamel. Importantly, this 
successful attempt provided one novel strategy to create natural enamel. In this chapter we 
describe our strategy to generate enamel using tissue engineering technology. However, 
many issues still remain to be resolved before we can apply the method to clinical practice. 
So why is it difficult to generate enamel? There are two big obstacles. Firstly, no one has yet 
achieved successful tooth regeneration using subcultured odontogenic cells. One of the 
reasons is that it is difficult to expand the ameloblast-lineage cells that are capable of 
secreting amelogenin which is a constituent of enamel. Recently, dental tissues such as the 
periodontal ligament (PDL), dental papilla and dental follicle have been identified as easily 
accessible sources of undifferentiated cells. Dental mesenchymal stem cells could be feasible 
tools for dental tissue engineering. However, dental epithelial stem cells have not been 
discovered in teeth. Secondly, how can ameloblasts be harvested if they disappear when 
tooth-crown formation is completed? Practically this approach is obviously limited by the 
very small number of cells that can be obtained. 
This article mainly reviews the novel therapy developed to generate natural enamel using a 
subculture and transplantation system, and the new cell sources for enamel regeneration in 
light of the two main difficulties mentioned above.  
 
4. Tooth development 
Tooth development is regulated by inductive signals between ectoderm-derived epithelium 
and neural crest-derived ectomesenchyme (4, 5). Teeth are initiated with an invagination 
from the oral epithelium. The oral epithelium at this stage has been shown to have the 
potential to instruct tooth development. Thereafter, the horseshoe-shaped dental lamina 
generates the future dental arches as the cap stage. During the cap and bell stages, transient 
signaling centers are generated in the epithelium as primary and secondary enamel knots. 
Secondary enamel knots appear at the site of the future cusp tips and contribute to the 
shaping of the tooth crown at the bell stage. At the crown formation stage, the 
enamel-secreting ameloblasts and dentin-secreting odontoblasts differentiate from the inner 
enamel epithelium and dental pulp, respectivelyand dental pulp which being derived from 
the dental papilla, respectively.. Both ameloblasts and odontoblasts are subsequently 
involved in the formation of tooth crowns, which consist of the enamel-dentin complex. 
 
5. Enamel 
Enamel, the most highly mineralized dental tissue, is composed of crystalline calcium 
phosphate and is approximately 96% mineral with the remaining 4% consisting of organic 
components and water. The basic micro-structural unit of enamel is an enamel rod, which is 
tightly packed and adherent to other enamel rods. The interwoven architecture of enamel 
rods contributes to both its strength and resistance to fracture. 
Enamel is generated by ameloblasts which are epithelial cells derived from the enamel 
organ in the developing tooth, which covers the dentin-pulp complex. Differentiation of 
epithelial cells towards ameloblasts is regulated by an interaction between the epithelial and 
mesenchymal cells. The major difference between enamel and mucosa is the absence of any 
epithelial response because the cells that form enamel are lost at the time of tooth eruption, 
which means that enamel is neither replaceable nor repairable after eruption.  
Amelogenin is produced by ameloblasts and is the most abundant protein within the 
enamel, accounting for more than 90% of the total enamel-related proteins. Studies in 
amelogenin knockout mice showed that amelogenin plays an important role in enamel 
biomineralization (6, 7), and while ameloblast differentiation is relatively normal in these 
mice, an abnormally thin enamel layer is formed (8). Amelogenins are essential for the 
formation of hydroxyapatite in enamel (9), and they are also recognized as a key factor in 
controlling the orientation and elongated growth of enamel rods during the mineralization 
process (10). In addition to amelogenin, the developing enamel is composed of several 
structural proteins such as ameloblastin (sheathlin/amelin), enamelin, and tuftelin. They are 
eventually degraded by the action of proteinases such as enamelysin (MMP-20) and 
kallikrein 4 (KLK4) (formerly known as enamel matrix serine proteinase 1). Ameloblastin is 
the most abundant non-amelogenin enamel-specific glycoprotein (11-13), and functions as a 
cell adhesion molecule for ameloblasts, but not for dental epithelial cells (14). Ameloblastin 
expression in ameloblasts peaks at the secretory stage and diminishes at the maturation 
stage, and maintenance of normal levels of ameloblastin in enamel formation is important 
because overexpression of ameloblastin in ameloblasts impairs the enamel structures (15). 
Furthermore, although dental epithelial cells can differentiate into ameloblasts in 
ameloblastin knockout mice, the ameloblasts detach from the matrix surface at the secretory 
stage and lose polarity (14), suggesting that ameloblastin is essential for maintaining normal 
ameloblast differentiation and attachment to the enamel matrix. In a recent study however , 
amelogenin and ameloblastin double knockout mice still showed a very thin layer of enamel, 
which was due to the presence of enamelin which was still expressed in the teeth of these 
double knockout mice. The enamelin gene has also been implicated in human amelogenesis 
imperfecta. Enamelin knockout mice do not form normal enamel, because of the lack of 
mineralization at the secretory surface of the ameloblasts (16), which suggests that enamelin 
is also necessary for enamel formation. 
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6. Enamel organ epithelial cell culture 
Tissue engineering protocols generally involve the proliferation of tissue-specific stem cells 
in vitro that support development of a particular cellular phenotype (17). These cells are 
grown under specific culture conditions and can be transplanted into the body, in order to 
generate new tissue or organs (18). Recently, dental pulp stem cells isolated from post-natal 
pulp (19) and from deciduous tooth pulp (20) have been described. Dental mesenchymal 
stem cells have been highlighted for their ability to form dentin or periodontium (21), 
however, in contrast, the characterization of dental epithelial stem cells has proven to be 
more elusive because they are hard to grow in vitro. To date, it has proved difficult to 
maintain primary enamel organ epithelial (EOE) cells in cultures for prolonged periods with 
the primary phenotype (22). In fact, although the establishment of a primary culture system 
for porcine ameloblasts has been previously reported, the approach involved the 
transformation and immortalization of EOE cells with the transforming genes of simian 
virus 40 (23). Recently, a system for multiplication without transformation has been 
reported, using mouse ameloblasts as the cell source (24). We have tried to develop a 
strategy using only culture techniques to grow EOE cells to generate enamel however there 
are two obstacles that must be overcome in order to successfully grow EOE cells. The first 
obstacle is that porcine epithelial cell growth is disrupted if contaminated with dental 
mesenchymal cells, due to the high proliferation capacity of the mesenchymal cells (22, 25). 
Secondly, expansion of porcine dental epithelial cells in vitro has been problematic due to 
their tendency to terminally differentiate after only a few passages (25). In order to 
overcome these obstacles, we combined two techniques: a non-serum culture system and a 
3T3-J2 feeder layer system, derived from a mouse teratoma (Fig. 1). Den Besten and 
colleagues had previously reported that a non-serum selective medium (LHC-9) enables the 
growth of only EOE cells while the accompanying mesenchymal cells are killed (22), 
however one disadvantage of this non-serum selective medium is the low growth potential 
of the EOE cells. We were encouraged by reports of the adaptation of a feeder layer 
technique for the culture of keratinocytes which enabled the long-term culture of these cells 
during which time they retained an epithelial phenotype (26, 27) and we considered that the 
disadvantages of a non-serum medium could be overcome using the feeder layer technique. 
Then, to determine whether the feeder layer system would be effective for EOE cells, enamel 
organs were harvested from the third molar teeth of a 6-month-old-pig (Fig. 2). Since enamel 
organs are connected to dental follicles, primary cultures of the EOE cells appeared to be 
contaminated with dental follicle cells, as we expected. The EOE cells were isolated from the 
mesenchymal cells using the non-serum medium, and then seeded onto a 3T3-J2 feeder 
layer for sequential subcultures (Fig. 3a). The EOE cell colonies grew with time in culture 
(Fig. 3b) and were able to be maintained for at least 4 passages. The subcultured EOE cells 
from both the primary culture and after 4 passages expressed amelogenin, ameloblastin, 
MMP-20 (28), KLK4 (29), and enamelin (30), but not alkaline phosphatase (Fig. 4a). No 
obvious changes in the expression of ameloblast-related genes were detected during 
long-term culture. Furthermore, expression of amelogenin in subcultured EOE cells was 
shown by fluorescence immunocytochemistry (Fig. 4b), and Western blotting revealed 
secretion of amelogenin by the EOE cells into the culture medium. 
By using 3T3-J2 cells as a feeder layer, we have successfully overcome the limitations of 
odontogenic epithelial cell culture. The passaged cells express the ameloblast-specific 
markers amelogenin, ameloblastin and enamelysin, but not enamelin. The culturing of 
epithelial cells on a feeder layer of 3T3 cells has proven to be a major advance, because this 
provides an environment that considerably improves cell proliferation (26, 27). The 
development and characterization of these cultured epithelial cells is also useful for further 
studies of enamel tissue engineering. 
 
7. Enamel tissue engineering 
Developing a technique to manipulate EOE cells is a significant advance towards enamel 
replacement and therefore we attempted to develop a strategy to generate enamel based on 
subcultured EOE cells using tissue engineering technology. To examine the enamel-forming 
capability of subcultured EOE cells, we made use of techniques we had developed 
previously by transplanting cells onto a biodegradable scaffold in vivo (31-33). Newly 
generated tooth tissue was formed by tissue engineering techniques requiring an interaction 
between dental mesenchymal cells and EOE cells (31). As previously described, the 
constructs were prepared by isolating fresh dental pulp cells from the third molars of pigs 
during the early stage of crown formation (32). Dental pulp cells were first plated on top of a 
scaffold and then subcultured EOE cells were seeded directly on top of the pulp cells. In the 
primary control group, the scaffolds were seeded with subcultured EOE cells alone. In the 
secondary control group, oral epithelial cells obtained from the oral mucosa were 
subcultured (34) and seeded in combination with fresh dental pulp cells onto the scaffolds. 
We had previously determined that the use of a collagen sponge was superior to that of 
polyglycolic acid fiber mesh (Nipro Corporation, Japan), and so collagen sponges were used 
as scaffolds for the dental cells (35). Interestingly, histological analysis showed subcultured 
EOE cells gave rise to ectopic cartilage tissue under the primary control group conditions 
(36), while the implants grown under the conditions of the secondary control group not only 
generated enamel but also cartilage. Amelogenin gene splice products have the ability to 
enhance the transcription factor sox9 (37, 38), therefore, amelogenin secreted from the 
cultured EOE cells may induce chondrocytes from the mesenchymal stem cells in the 
surrounding omentum of the rat host. Four weeks after transplantation of EOE cells 
combined with dental pulp cells in scaffolds, several phenomena related to amelogenesis 
were distinguished in the implants. In the most mature structures, enamel was readily 
found in the implants (Fig. 5a). Furthermore, amelogenin immunoreactivity was detected in 
tall columnar epithelial cells on the surface of the dentin or enamel, indicating that the 
tissue-engineered enamel contains well-developed ameloblasts (Fig. 5b). Together, these 
results indicate that the subcultured EOE cells have the potential to generate enamel. 
Interestingly, enamel formation was always observed after dentin was formed in the 
implants. On the other hand, when subcultured EOE cells were combined with subcultured 
dental pulp cells, enamel-dentin complexes were not observed in any of the implants. In 
addition, the production of enamel by EOE cells was observed within 4 weeks of 
transplantation of the constructs (33), which was markedly earlier than that observed with 
constructs established from non-cultured EOE cells which generated enamel at 15-25 weeks 
after transplantation (3, 31, 39). Enamel production may have been facilitated in our culture 
model because EOE cells were maintained at an undifferentiated stage in the 
ameloblast-lineage cell phenotype by the 3T3 feeder layer. Our culture model provides a 
promising step towards a new therapy for reforming enamel but further study is needed on 
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how to combine the newly-generated enamel with the original dental dentin or enamel in 
the tooth. As EOE cells disappear in adult teeth after tooth eruption we also need to discover 
new cell sources to advance this technology in the clinical setting. 
 
8. New cell sources for enamel tissue engineering 
8.1 Epithelial cell rest of Malassez  
The epithelium surrounding the teeth after eruption is anatomically classified into 4 types of 
epithelium; the oral gingival epithelium, the oral sulcular epithelium, the junctional epithelium, 
and the epithelial cell rests of Malassez (ERM). The epithelium, except for ERM, covers the 
surface, while ERM, developmental residues of Hertwig's epithelial root sheath (HERS), are 
embedded within the PDL tissue. Since ERM are a direct lineage from HERS, derived from the 
enamel organ through the cervical loop structures, we hypothesized that ERM retain their 
original ability to secrete a matrix conducive to generating enamel in a fashion similar to the 
enamel organ in the crown formation stage. Previously, there was a report supporting our 
hypothesis showing that removal of stem cells from their natural milieu may change their 
differentiation properties. A well-studied example of this phenomenon involves hematopoietic 
stem cells. Furthermore, we recently reported that the epithelial cells from HERS can 
differentiate into ameloblasts and produce enamel-dentin complexes when combined with 
non-cultured dental pulp cells in the core of the dental pulp (40). 
The epithelial cell rests of Malassez in the periodontium were thought to be completely 
quiescent (41, 42), however it is now known that ERM can be induced to differentiate into 
cementoblasts (43, 44) with disruption of Patched, the hedgehog receptor, leading to shorter 
roots (45). Moreover, it has been suggested that ERM might prevent resorption of the root 
surface (46) and although ERM are generally in the G0 phase of the cell cycle, ERM can be 
stimulated to proliferate in response to injury (47). ERM also have the potential to 
differentiate in two different directions: squamous metaplasia and formation of cystic 
lesions, and ameloblastic differentiation during the formation of odontogenic tumors (48, 49), 
suggesting that ERM have a mitotic activity (50, 51). In fact, when the ERM cells are cultured 
in vitro, they actively proliferate but there have been no reports of the in vivo behavior of 
subcultured ERM cells. To investigate the potential of ERM cells for generating enamel, we 
established a cell culture system for ERM cells in order to preserve as many of the original 
cellular characteristics as possible, and then designed a study to examine the tissue-forming 
capability of ERM cells(53). 
Firstly, we examined the presence of ERM cells in deciduous incisor teeth. In histological 
sections, clusters of aggregated cells were easily recognized in the PDL of porcine deciduous 
incisor teeth. The clustered cells expressed cytokeratin-14, an epithelial cell marker. 
Interestingly, immunolabeling for amelogenin was not observed in any of the epithelial cell 
clusters.  
We then prepared three types of epithelial cells (ERM, EOE cells, and oral gingival epithelial 
cells) and PDL cells from the same mandible of a 6-month-old pig. The deciduous incisor 
teeth were removed from the mandible and then the PDLs were removed from the middle 
one-third of the incisor tooth roots. The PDLs were placed in culture dishes and then ERM 
cells and PDL cells migrated from the explants. Before the cells reached confluence, the 
serum containing growth medium was replaced with a non-serum epithelial cell-selective 
medium. After replacement with the non-serum medium, the PDL cells were detached from 
the culture dish and the ERM cells subsequently survived. The growth of the ERM cells in 
non-serum medium was quite slow, similar to the behavior of EOE cells. ERM cells were 
then subcultured on 3T3-J2 feeder cell layers with complete-MEM medium, the same 
reagents used in the culture of EOE cells (36) and oral gingival epithelial cells (52). The ERM 
cells colonies increased with time and became confluent after 2 weeks. Subcultured ERM 
cells were passaged and this was repeated ten times with feeder cell layers. All passaged 
cells showed the typical polygonal-shaped epithelial morphology. Interestingly, when ERM 
were subcultured on collagen type I coated without a feeder cell layer, the ERM cells 
displayed an extended morphology. 
We compared the cell characteristics of the subcultured ERM, EOE cells, and oral gingival 
epithelial cells, produced using the same feeder cell layer technique. No appreciable 
differences were found in any of the cell morphologies (Fig. 6a-c), and all cell populations 
were able to grow on the feeder cell layer at similar growth rates. Gene expression patterns 
of the subcultured ERM were then compared to EOE cells using ameloblast-related markers. 
Both ERM and EOE cells expressed ameloblastin and tuftelin, while EOE cells alone 
expressed amelogenin, MMP20, and KLK4. None of the cell populations expressed enamelin. 
The expression patterns of the ameloblast-related genes in ERM were inconsistent with 
those in EOE cells. In particular, subcultured ERM did not show expression of amelogenin 
as well as the histological observation of the root surface of deciduous teeth. These results 
suggest ERM would not have the potential to grow enamel. 
The possibility that ERM cells can differentiate into ameloblasts was examined in vitro using 
a co-culture model with dental pulp cells. Presumably, dental pulp has the potential to 
induce dental epithelial cells into ameloblasts (40). Surprisingly, although no 
immunoreactivity for amelogenin was observed in the ERM cells alone over a 4-week 
culture period (Fig. 7a-c), when ERM cells were co-cultured with dental pulp cells, both 
cytokeratin-14 and amelogenin were clearly positive (Fig. 7d-f). Since there was now a 
possibility of ERM differentiating into ameloblasts, the capacity of subcultured ERM cells to 
produce enamel was examined by transplanting subcultured ERM cells, seeded onto 
scaffolds, into the omentum of athymic rats. Histological analysis showed that all implants 
displayed the appropriate stages of amelogenesis from initiation to maturation. At 8 weeks 
post-transplantation, enamel-dentin complex structures were recognized in the implants 
(Fig. 8a). At high magnification, the width of the enamel was approximately 100 µm (Fig. 8b). 
Amelogenin expression was also detected in the region of the tall columnar cells. These 
results demonstrate that subcultured ERM have the potential to differentiate into 
ameloblasts and generate enamel in vivo, suggesting that ERM could be a new cell source 
for tissue engineering techniques investigating enamel replacement in the future (53).  
Generally, tissue-specific stem cells are thought to be activated by a repair and regeneration 
process and they are maintained in a quiescent state until they are required to act on behalf 
of the tissue. The normal behavior of stem cells is strictly governed by the cellular 
microenvironment. ERM are able to grow in vitro and become free of the influence of the 
PDL cells. It could be that ERM have the characteristics of epithelial stem/progenitor cells. 
 
8.2 Bone marrow stroma cells 
It has been known that bone marrow contains stem cells that can give rise to various types 
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of epithelial cells. One experimental study was designed to determine whether bone 
marrow cells could differentiate into ameloblasts (55) and the success of this study provides 
a new cell source for enamel tissue engineering. Basically, bone marrow contains two types 
of stem cell - hematopoietic and mesenchymal. The ability of hematopoietic stem cells to 
give rise to epithelial cells has already been shown for tissues such as skin, lung, and liver. 
However, although bone marrow cells have the potential to differentiate into dental 
mesenchymal cells (56), their ability to differentiate into ameloblasts has never been 
examined. Bone marrow cells were collected from tibias and femurs of CD1 mice and 
isolated using c-kit, a cytokine tyrosine kinase receptor expressed by hematopoietic 
progenitor cells. Dental epithelium was dissociated into single cells and the single cell 
suspension was mixed with the bone marrow cell suspension to form a pellet. The pellet 
was re-associated with dental mesenchyme obtained from the tooth germ at embryonic day 
14. After 20 days of culture, a tooth crown was generated from the constructs. The 
c-kit-positive bone marrow cells were present in the inner dental epithelium and expressed 
both amelogenin and ameloblastin, as shown by in situ hybridization (53). This was the first 
report to show that bone marrow cells can differentiate into ameloblasts. However, so far, 
no studies have shown that bone marrow cells alone, without dental epithelial cells, can 
differentiate into ameloblasts.  
 
8.3 Oral keratinocytes 
At an early stage the embryonic oral epithelium provides the instructive signals for tooth 
initiation and development. These signals are received by the mesenchymal cells, which are 
then primed to become odontogenic and in turn act as a source of reciprocal signals back to 
the epithelium. In mice, dental epithelium prior to embryonic day 12.5 has these instructions, 
and then at this stage, the ability shifts to the dental mesenchyme from the epithelium. Of 
note, non-dental embryonic epithelium can differentiate into dental epithelium when there 
is interaction with odontogenic mesenchyme (55). Thus it is possible that non-dental 
epithelial cells may be a new cell source for enamel tissue engineering technology.  
Of particular interest is whether post-natal non-dental oral epithelium can differentiate into 
ameloblasts to generate enamel. A recent study (57) designed to investigate this question 
obtained oral epithelium from the palatal epithelium of ICR mice at post-natal day 1 and the 
palatal epithelial cells were separated from the mesenchyme. Mandibular molar teeth from 
embryonic day 12.5-16.5 were isolated and dental mesenchyme was separated from the 
dental epithelium. The dissociated epithelial cells were combined with the mandibular 
molar mesenchyme for re-association. The epithelium covered the entire surface of the 
molar mesenchyme. After 2 days of culture, the re-associations were transplanted under the 
kidney capsule of an adult mouse as the host. Samples were obtained 14 days after 
transplantation and analyzed by histology. The re-association of palatal epithelium with 
dental mesenchyme formed tooth germs associated with enamel-dentin complexes (58). 
Therefore palatal mucosal epithelium, not only from embryos but also from newborn mice, 
has the potential to differentiate into ameloblasts and then generate enamel. However, the 
palatal epithelia of mice more than 2 days of age could not differentiate into ameloblasts. As 
we prefer to use older cells for enamel tissue engineering, clearly further studies are needed 
to resolve this problem for the clinical setting.  
 
9. Conclusions and future directions 
For a long time metal and resin have been investigated as potential sources to replace 
enamel. In our laboratory, we are focusing on producing enamel by tissue engineering 
methods as these techniques are believed to be an extremely powerful approach to replacing 
enamel. This goal has remained elusive until recently when we finally identified a new 
tissue engineering method to generate enamel using a specialized enamel organ culture 
technique and transplantation system. However, two problems still remain to be solved 
before this technique can be used for clinical applications. Firstly, there is still no method to 
combine the tissue-engineered enamel with the injured enamel of the original teeth. 
Secondly, we still cannot control the shape and size of the tissue-engineered enamel. If these 
two above issues could be addressed then a method to reform the injured enamel on teeth 
could be developed. The authors thank Dr. Haward Green (Harvard Medical School) for 
critical reading of the manuscript. 
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Figure legends 
 
Fig. 1. A strategy for tissue-engineered enamel. 
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formation is partly achieved. Enamel organ epithelium is connected with the dental follicle. 
 
 
Fig. 3. a: Phase contrast micrograph of 3T3-J2 feeder layer cells. 
b: The isolated enamel organ epithelial (EOE) cells were seeded onto the 3T3-J2 feeder layer 
and the EOE cell colonies grew with time in culture. 
 
 
 
 
Fig. 4. a: The subcultured enamel organ epithelial (EOE) cells from both the primary culture 
and after 4 passages expressed amelogenin, ameloblastin, MMP-20, kallikrein-4 (KLK4), and 
enamelin, but not alkaline phosphatase. 
b: Fluorescence immunocytochemistry showing the expression of amelogenin in 
subcultured EOE cells at passage 2. 
 
 
Fig. 5. a: Four weeks after transplantation, enamel was readily found in the implants. 
b: Amelogenin immunoreactivity was detected in tall columnar epithelial cells on the 
surface of the dentin or enamel. 
 
Fig. 6. a-c: There was no appreciable difference in cell morphology among epithelial cell 
rests of Malassez (ERM) (a), enamel organ epithelial (EOE) cells (b), and oral gingival 
epithelial cells (c). 
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Fig. 7. Cytokeratin14 (CK14) and amelogenin expressions in vitro 
a-c: When ERM were co-cultured with 3T3-J2 cells (a), immunofluorescence showed that 
ERM were positive for cytokeratin-14 (b) and were negative for amelogenin (c).  
d-f: When ERM were co-cultured with primary dental pulp cells (d), both cytokeratin-14 (e) 
and amelogenin (f) were clearly positive.  
 
 
Fig. 8. a: At 8 weeks post-transplantation, enamel-dentin complex structures were 
recognized in the implants. 
b: At high magnification view, the width of the enamel was approximately 100 µm. 
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1. Introduction 
Autologous bone is generally considered the gold-standard graft material. The advantage of 
an autograft is that it contains viable osteoblasts and osteogenic precursor cells that can 
contribute to the formation of new bone (Arrington et al, 1996). In addition, the autograft 
possesses the three essential elements of bone regeneration -osteogenesis, osteoinduction, 
and osteoconduction- that are required for bone regeneration. However, only a minimal 
amount of bone tissue can be harvested for autografts, the harvesting procedure may lead to 
donor site discomfort and morbidity, and it may be difficult to form this tissue into the 
desired shape (Goldberg & Stevenson, 1987; Damien & Parsons, 1991), a problem that is 
particularly important in the craniofacial region.  
Therefore, bone graft substitutes have been used to reconstruct bone defects. A bone graft 
substitute should be osteoconductive, osteoinductive, biocompatible, biodegradable, 
structurally similar to bone, easy to use, and cost-effective (Giannoudis et al, 2005). 
Hydroxyapatite (HA) and β-tricalcium phosphate (β-TCP) are both well-known ceramics 
that possess high tissue compatibility and osteoconductivity. However, neither HA nor β-
TCP has osteoinductive or osteogenic abilities, and HA usually shows minimal 
biodegradation (Spector, 1994;  Schmitz et al, 1999). 
To overcome these limitations, bone tissue engineering has been promoted as a new way to 
regenerate bone tissue. This approach combines cells capable of osteogenic activity and 
osteoinductive signal molecules with an appropriate material (Livingston et al, 2005). For 
bone tissue engineering to succeed, osteoconductive scaffolding biomaterials must provide a 
suitable environment for the cells. Furthermore, it is desirable that the scaffolds can control 
the release of growth factors. Accordingly, functional composite scaffolds for bone tissue 
engineering have been developed in combination with synthetic ceramics and natural 
polymers. 
Recently, minimally invasive treatments have been developed using an injectable system for 
bone tissue engineering. Several injectable gels have been used to carry cells in order to 
engineer bone. Amongst which are collagen (Tsuchida et al, 2003), alginate (Shang et al, 
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2001; Wang et al 2003), and fibrin (Perka et al 2001) gels, but these substances cannot be 
molded to the shapes of the bone defects when injected in situ or that they cannot follow the 
shapes of 3D cell culture molds in vitro.  
In this chapter, I introduce the design of injectable composite scaffold fabricated from β-TCP 
beads and alginate for bone tissue engineering (Matsuno, 2008). The β-TCP bead/alginate 
composite is not only injectable, but also instantaneously formed from β-TCP beads and 
alginate. Therefore, the composite is sufficiently adaptable to the irregularities of bone 
defects and which possessed adequate mechanical strength. Additionally, the composite act 
as an appropriate 3D scaffold for osteogenic cells, and function as drug delivery carrier of 
growth factors. 
 
2. Preparation of injectable composite scaffold 
2.1 β-TCP beads 
β-tricalcium phosphateis a synthetic calcium phosphate ceramic used as an alternative 
autologous bone graft. It has been reported that β-TCP has good biodegradability and 
osteoconductivity as a scaffold material for bone tissue engineering (Le geros, 2002; 
Matsuno et al, 2006).  With regard to shape availability, both block and granular forms are 
available. However, both shapes pose an injectability problem and are difficult to be molded 
into a 3D structure. 
Thus, we used the β-TCP beads for injectable bone substitute. β-TCP beads were prepared in 
a manner similar to a previously described method (Ushida et al, 2001; Furukawa et al , 
2004; Miyauchi et al , 2004). An aqueous slurry of β-TCP powder (Advance Ltd., Saitama, 
Japan) and polyvinyl alcohol (Shin-Etsu Chemical Co. Ltd., Tokyo, Japan) aqueous solution 
as a binder reagent were mixed using an ultrasonic homogenizer. The resultant slurry was 
added drop-by-drop to liquid nitrogen, whereby slurry drops were frozen, and the frozen 
beads were freeze-dried. The beads were then sintered at 1100°C for 10 hours. Diameter of 
the beads was controlled at 100－1,000 μm by regulating the opening and shutting times of 
an electromagnetic valve.  
Figure 1 shows the SEM photographs of β-TCP bead and the surface of the bead. Diameter 
of the bead was about 500 μm, and micropores were observed on the surface.  
 
 
 
 
 
 
 
  
 
 
 
 
 
Fig. 1.  SEM photographs of a β-TCP bead (A) and the surface of the bead (B). 
 
 
Figure 2 shows the XRD patterns of the synthesized β-TCP beads and commercially 
available β-TCP (OSferion®; Olympus, Tokyo, Japan). There were no significant differences 
in the intensity of β-TCP peaks between β-TCP beads and commercially available β-TCP. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.  X-ray diffraction patterns of β-TCP beads and  commercially available β-TCP 
 
2.2 Alginate hydrogel 
Alginate has many uses in bioengineering, such as in polymer films, cell encapsulation, 
wound dressings, and surgical sponges (De Vos et al, 1997; Matthew et al, 1997). Alginic 
acid is soluble in water and can be ionically crosslinked with a non-toxic divalent cation 
solution, such as calcium chloride (De Vos et al, 1997). The calcium ions bind the guluronic 
acid sites of alginate strands together to form a stable alginate gel (Becker et al, 2001). 
However, alginate lacks the initial mechanical strength needed for bone tissue engineering.  
Alginate hydrogel was made by dissolving alginic acid sodium (Protanal LF 10/60, FMC 
BioPolymer, PA, USA) in phosphate-buffer saline (PBS) to give two final concentrations of 
1.0 and 2.0 wt％. 
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2.3 Injectable 3D-formed composite scaffold 
The β-TCP beads, with a diameter of 710－850 μm, were dipped in 1.0％ CaCl2 solution 
(Sigma-Aldrich Co.) and then dried. β-TCP beads in the syringe were sterilized with 
ethylenoxide gas and alginate hydrogel with Stericup® (0.22 μm; Millipore Co., MA, USA). 
As alginate hydrogel was pushed out from the tip of the syringe, it passed through the 
CaCl2- treated β-TCP beads. As soon as a 3D-formed composite of β-TCP beads and alginate 
was obtained due to the instantaneous crosslinking that occurred in the syringe. 
Figure 3 shows a photograph of injectable 3Dformed composite of β-TCP beads and alginate 
and a light microscope photograph of the composite. Each bead was wrapped in the 
anastomosing network of the alginate gel, and the beads were bonded tightly to form a 3D 
structure. Minute crystal projections were observed on the cross-sectional surface of the β-
TCP beads treated with CaCl2 (Fig. 4). 
 
 
Fig. 3.  Injectable 3D-formed composite          Figure. 4  SEM of the surface of the 
composite.         β-TCP beads (#), alginate (+) 
 
3. Evaluation of β-TCP bead/alginate composite  
3.1 Mechanical strength of the composite 
The compression tests were performed in the two types of composites (1.0 and 2.0 wt％ 
alginate hydrogels; 5.0 mm in diameter and 10.0 mm in length). The compressive strength 
increased with increased alginate concentration. The composite of 2.0 wt％  alginate 
concentration exhibited a compressive strength of 69.0±4.6 kPa, which was significantly 
greater (P<0.05) than the strength seen with 1.0 wt％ (6.11±2.28 kPa). 
 
3.2 In vitro evaluation of 3D mesenchymal stem cell culture  
Human mesenchymal stem cells (MSCs) were dispersed into the alginate hydrogel. 
Following which, MSC loaded alginate hydrogel was added into the syringe which was 
packed with CaCl2-treated beads. Consequently, MSC-loaded alginate was crosslinked and 
MSCs were loaded into the 3D scaffold at about 2×105 cells/scaffold. They were cultured in 
an osteogenic differentiation medium (10mM β-glycerophosphate, 100 nM dexamethasone, 
and 50 μg/ml ascorbic acid) for 1, 7, and 14 days. 
 
Figure 5 shows the SEM photographs of MSC-loaded composite after 1 day and 14 days in 
the osteogenic differentiation culture. MSCs were observed in the composite at day 1 (Fig. 
5A). After 14 days, many calcified nodules appeared on the surface of β-TCP beads and 
alginate (Fig. 5B). 
Fig. 5. SEM of MSC-loaded composite at day 1 (A) and day 14 (B) in osteogenic 
differentiation culture. MSCs (arrow), calcified nodules (>) 
 
Figure 6 shows that the ALP activity of MSCs grown within the composite of osteogenic 
differentiation culture increased from day 1 to day 7, but decreased from day 7 to day 14. 
There was a significant increase between day 1 and day 7(*P<0.05), and similarly a 
significant decrease between day 7 and day 14 (**P<0.05). 
No OCN mRNA expression was detected at day 1. However, OCN mRNA expression 
increased from day 1 to day 7, and increase between day 7 and day 14 was statistically 
significant (*P<0.05) (Fig. 7). 
 
 
Fig. 6. ALP activity of MSCs grown within the composite in osteogenic differentiation 
culture. 
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Fig. 7. OCN mRNA expression levels of MSCs grown within the composite in osteogenetic 
differentiation culture.  
 
3.3 In vivo evaluation of MSCs loaded composite scaffold 
Non-osteogenic-differentiated MSCs loaded into the 3D composite scaffold (5×106 
cells/scaffold) and MSC-free composite as control were subcutaneously implanted into the 
backs of 6-week-old KSN nude mice. The mice were killed at 8 weeks after implantation.  
Figure 8 shows the histological sections of the 3D composite scaffold loaded with non-
osteogenicdifferentiated MSCs at 8 weeks after implantation. Newly formed, bone-like 
calcified tissue was directly deposited on the surface of the β-TCP beads. Interconnected 
alginate was completely degraded, and bone-like calcified tissue was observed in the 
connective tissue. The surface of the β-TCP beads was slightly degraded and vacuolization 
was observed in the beads. On the other hand, cell-free composite contained only 
fibrovascular tissue around nondegraded β-TCP beads (data was not shown). 
 
Fig. 8.  HE-stained histological sections of  the composite scaffold loaded with MSCs at 8 
weeks after implantation. 
Newly formed, bone-like calcified tissue (‡), β-TCP beads (#)  
 
 
3.4 In vitro release of growth factor from composite 
A solution of basic fibroblast growth factor (bFGF) was dispersed into the alginate hydrogel. 
Following which, bFGF incorporated alginate hydrogel was added into the syringe which 
was packed with CaCl2-treated beads. Consequently, bFGF-incorporated composite scaffold 
was obtained. In vitro release tests were performed as follows. The composite scaffolds 
completely sank in the Hank’s balanced solution, and incubated at 37°CbFGF 
concentration was determined using ELISA.   
Figure 9 shows that the release of bFGF from the composite. There was a significant increase 
between day 1 and day 4 (*P<0.05). 
 
Fig. 9. The release of bFGF from the composite. 
 
4. Conclusion 
Both ceramics and polymers have their own merits and drawbacks, and a better solution 
may be to synergize the advantageous properties of both materials for composite scaffolds. 
Therefore, many different composite forms such as sponges, gels, films, and blocks have 
been developed using different methods (Wahl & Czernuszka, 2006). However, multi 
functional composite such as our developed composite are little or no. 
Recently, the increasing popularity of minimally invasive techniques has led to the 
development of an injectable system that can be molded to the shape of the bone defect and 
which polymerizes when injected into the site (Niemeyer et al, 2004). Such devices should be 
easy to implant, thereby shortening the surgical time and minimizing the damage to healthy 
tissue. β-TCP has been used for bone tissue engineering. However, it is difficult to fit into 
the surgical sites around implants or to be shaped to the desired forms using β-TCP blocks 
or granules. The composites consisting of β-TCP beads and alginate can be injects into bone 
defect site. On the other hand, the composite can simply be cut with scissors or a sharp 
knife, and can therefore be easily molded for use for various tissue disorders.  
Bone tissue engineering approach is to combine osteogenetic cells with an appropriate 
composite scaffold. In keeping with the tissue engineering concept, cells are cultivated on an 
appropriate 3D scaffolds to replace 3D tissue defects (Liu et al, 2006). However, elaborate 
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seeding and culture conditions are needed to achieve uniform cellular distribution, sustain 
cell viability, and provide nutrients for tissue formation in scaffolds (Weinand et al, 2006). 
In this study, alginate hydrogel was used to facilitate the delivery and distribution of MSCs. 
It has been previously demonstrated that alginate hydrogels induce bone formation in vitro 
(Weinand et al, 2006; Alsberg et al, 2001). However, the lack of adequate initial strength of 
hydrogel/cell constructs requires additional mechanical support for implantation 
(Niemeyer et al, 2004). Therefore, a uniform size of CaCl2-coated β-TCP beads was selected 
to reinforce the initial strength. Calcium ions can be crosslinked with the guluronic acid sites 
of alginate strands to form a stable alginate gel (Becker et al, 2001). Leveraging on all these 
properties in this study, an instantaneously formed, injectable 3D scaffold was obtained 
after alginate hydrogel reacted with CaCl2-coated β-TCP beads and then loaded with MSCs. 
In vitro evaluation, ALP activity at 7 days was significantly increased as compared to day 1, 
but decreased from day 7 to day 14. As a marker of early osteogenic differentiation, the ALP 
activity of the construct was measured on days 1, 7, and 14 of the culture period. The typical 
rise and fall of ALP activity was characteristic of osteogenic differentiation and common to 
all culture systems (Shin et al, 2004). Furthermore, OCN mRNA expression, another marker 
of osteogenic differentiation, was significantly increased at day 14 as compared to day 7. 
Therefore, it is conceivable that calcification progressed in the composite. 
In vivo experiment demonstrated that the β-TCP bead/alginate composite had an 
osteoinductive effect in soft tissue ― without an osteogenic differentiation medium for 
MSCs. Similarly, Livingston et al. (2005) demonstrated that hydroxyapatite/β-TCP ceramic 
scaffold promoted bone formation in soft tissue, which was induced by non-osteogenic-
differentiated MSCs. Furthermore, this study demonstrated that β-TCP bead/alginate 
composite induced the formation of bone-like calcified tissue. Taken together, these results 
suggested that a 3D structure consisting of β-TCP beads and alginate allowed an 
appropriate spatial arrangement of osteogenic cells as well as vascular invasion. These 
findings also indicated that injectable β-TCP bead/alginate composites supported bone 
regeneration with a minimally invasive technique. 
In addition, the β-TCP bead/alginate composite can locally release growth factors from the 
composite, used as drug delivery carriers. It will be enhance bone formation to treat bone 
defects.
In light of the encouraging results obtained for osteogenesis, the novel composite developed 
in this study may be useful as an injectable scaffold for bone tissue engineering.  
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to reinforce the initial strength. Calcium ions can be crosslinked with the guluronic acid sites 
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of osteogenic differentiation, was significantly increased at day 14 as compared to day 7. 
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findings also indicated that injectable β-TCP bead/alginate composites supported bone 
regeneration with a minimally invasive technique. 
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In light of the encouraging results obtained for osteogenesis, the novel composite developed 
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This chapter will focus on the current and future applications of low intensity pulsed 
ultrasound (LIPUS) in tissue engineering at laboratory and clinical levels. Also, this chapter 
will explain the molecular basis of LIPUS stimulatory effects on cell expansion, 
differentiation and matrix production of different tissues. In addition, this chapter will 
provide information about the differences between LIPUS application in the laboratory 
settings and in the clinical applications with emphasis on tissue engineering applications. 
Moreover, this chapter will discuss why variability in outcome might occur when applying 
LIPUS in laboratory or clinical settings. Also, we will provide some tips on how to prevent 
potential inconsistency in treatment results with emphasis on the technique sensitivity and 
how a scientist or a clinician should be aware of this sensitivity of the application technique 
in order to optimize the utilization of LIPUS in different settings. This chapter will set a few 
hypotheses and potential new applications of utilizing LIPUS in other tissue engineering 
applications. The outcome of this chapter will be an understanding of the advantages and 
limitations of using LIPUS in tissue engineering applications either at the laboratory or in 
clinical settings. 
 
1. Introduction 
Tissue engineering utilizes cells, scaffold or housing and growth factors to maintain the 
specific characteristics of the tissue to be engineered. Tissue engineering efforts are faced 
with challenges including the availability of cells to be used for engineering specific tissue 
(Chu et al., 2002). Another challenge in tissue engineering is the availability of 
biocompatible, biodegradable scaffolds that enhance cell adhesion as well as cell 
proliferation and matrix production.  The degradation rate of the scaffolds is optimum when 
it occurs in a timely pattern with matrix production and maturation of the cell seeded within 
the scaffold. For some tissues, like bone, cartilage, skin and nerve tissue engineering, 
differentiation growth factors are readily available. However the key growth factors that are 
important in differentiating specialized tissues, like dentine in teeth tissue engineering, for 
example, are still not available. This again puts another roadblock in engineering these 
specialized tissues. Ultrasound is a form of mechanical acoustic pressure wave at 
frequencies above the limit of human hearing that when transmitted through biological 
tissues can produce different biological effects. The most widely used applications in 
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medicine are operative (usually has a frequency that ranges between 2 - 8 K Hz), therapeutic 
(usually has a of frequency that ranges  between 20 K Hz 3M Hz either in continuous or 
pulsed modes), and diagnostic (usually has a frequency that ranges between 1.6-12 M Hz) 
(Ziskin, 1987; Maylia & Nokes, 1999; Harris, 2005). The most commonly used type of 
therapeutic ultrasound is US that utilizes intensities between 30 mW to as high as 1-3 
W/cm2 and hence it may cause considerable heating in living tissues. The low intensity 
pulsed ultrasound (LIPUS) is widely accepted in cell and tissue repair due to the 
nonthermal effects of this type of ultrasound.  
 
2. LIPUS utilization in cell expansion 
The availability of optimized cell density (CD) is a major challenge in tissue engineering, 
either due to donor site morbidity (if to be harvested from another organ within the same 
individual) or precursor cells, sometimes also called undifferentiated mesenchymal stromal 
cells or (mesenchymal stem cells) (Puelacher et al., 1994; Carrier et al., 1999; Holy et al., 2000; 
Goldstein, 2001; Panossian et al., 2001). It has been reported that one of the important 
parameters impacting tissue engineering is the cell seeding density. Seeding densities more 
than 8 × 106 cells cm3 of tissue engineering scaffold promotes extracellular matrix 
production, cell distribution and/or cell alignment when compared to low cell seeding 
densities (<4 × 106 cells cm3 of scaffold). Low cell seeding densities is reported to be 
associated with decreased cell proliferation and minimal or no mechanical integrity (Freed 
et al., 1998; Carrier et al., 1999; Li et al., 2001; Saini & Wick, 2003; Leddy et al., 2004, Hsieh-
Bonassera et al., 2009). 
In this context, several studies have attempted to expand mesenchymal stem cells (MSCs) 
before differentiating them for engineering different tissues. These reports include, but are 
not limited to using different growth factors and /or mechanical stresses to enhance stem 
cell expansion. It has been reported that chondrocytes increased in number by 100-fold 
within 17 days when a special growth factor cocktail was used in the culture medium (Chen, 
et al., 2009). Also, ultra-nanocrystalline diamond films have been shown to enhance neural 
stem cell expansion for tissue engineering (Wang et al., 2006). 
Moreover other growth factors that have been used to enhance stem cell expansion include 
ascorbic acid-functionalized poly (methyl methacrylate) (AA-PMMA) (Tamama et al., 2005); 
epidermal growth factor receptor (EGFR) (Hsieh-Bonassera et al., 2009) ;  and Flt3 ligand 
(FL) was used in addition to IL-11 or G-SCF (Granulocyte-Colony Stimulating factor) to 
stimulate the growth of rat MSCs (Jacobsen et al., 1995).  These (conjugated FL) factors 
expanded the progenitors more than 40 times after 2 weeks incubation. On the other hand, 
prolactin-like protein E (PLP-E) + human thrombopoietin (TPO) showed no effect on the 
expansion of human MSCs (Lefebvre et al., 2001).  Glucocorticoids were found to be effective 
in recruiting cells rather than stimulating their proliferation (Purpura et al., 2004). It was 
reported that Dkk-1 stimulates MSCs expansion (Horwitz, 2004). Culture flasks coated with 
heparin and N-(O-beta-(6-O-sulfogalactopyranosyl)-6-oxyhexyl)-3,5-bis(dodecyloxy)-
benzamide have been shown to expand MSCs (Takagi, 2005). A similar study has shown 
that Angiopoietin-like proteins expanded HSCs 24-30 fold in ten days (Zhang et al., 2006). 
However, more studies are needed to evaluate the effect of these factors on MSCs behavior 
(especially differentiation potential) after expansion. Other attempts using pulsed 
electromagnetic fields (PEMF) showed that chondrocytes- and osteoblast-like cell 
proliferation increased (De Mattei et al., 2001; Hartig et al., 2000).  However, no studies 
tested the effect of PEMF on MSCs expansion. Others used LIPUS to enhance periosteal cell 
expansion for 5, 10, and 20 minutes for 2 and 4 days. No cell proliferation was noted (Leung 
et al., 2004).  This may be due to the small doses of ultrasound that were used. It has been 
shown that ultrasound effect on tissue is evident after three weeks of application (Tsai et al., 
1992). Also, LIPUS was used for 20 minutes for one day to stimulate MSCs expansion and 
differentiation into chondrocytes. Matrix production was enhanced; however, cell 
proliferation was not enhanced (Ebisawa et al., 2004). This may also be due to using LIPUS 
in pellet culture. MSCs are known to have cell-cell growth inhibition when they are in close 
proximity to each other.  
On the other hand, another report using LIPUS showed that LIPUS increases matrix 
production and proliferation of the intervertebral disc cell culture (Iwashina et al., 2006). The 
effect of LIPUS was different depending on the type of cells from different origins (nucleus 
pulposus [NP] or from annulus fibrosus [AF]). More recently, LIPUS has been shown to 
enhance chondrocyte proliferation in three-dimensional collagen scaffolds (Kobayashi et al., 
2009).  
Another precursor cell proliferation and differentiation that has been recently reported to be 
stimulated by LIPUS are human periodontal ligament cells that have been differentiated 
into cementoblasts (teeth root outer layer cells) (Inubushi et al., 2008). This is an important 
report on the potential use of LIPUS in dental tissue engineering. The scantiness of 
cementoblasts for teeth tissue engineering made it almost impossible in the past to tissue 
engineer teeth. However, with this recent report, it could be possible to tissue engineer teeth 
in the near future using LIPUS as a cell expansion and differentiation enhancer. Also, it has 
been reported that LIPUS enhanced cell proliferation in human fibroblasts, osteoblasts, and 
monocytes (Doan et al., 1999). 
In a pilot study in our lab, we have shown that LIPUS enhances the expansion of bone 
marrow stem cells in vitro (Figure 1). This stimulatory effect is dose dependent. 
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cementoblasts for teeth tissue engineering made it almost impossible in the past to tissue 
engineer teeth. However, with this recent report, it could be possible to tissue engineer teeth 
in the near future using LIPUS as a cell expansion and differentiation enhancer. Also, it has 
been reported that LIPUS enhanced cell proliferation in human fibroblasts, osteoblasts, and 
monocytes (Doan et al., 1999). 
In a pilot study in our lab, we have shown that LIPUS enhances the expansion of bone 
marrow stem cells in vitro (Figure 1). This stimulatory effect is dose dependent. 
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Fig. 1. Bone marrow stem cell (BMSC) expansion by LIPUS. IT can be seen that the increased 
LIPUS treatment time (20, 40, 60 minutes per day) or 2 and 3 weeks application led to 
increased  BMSC expansion as measured by cell count. 
 
3. Effect of LIPUS on in-vitro matrix formation for tissue engineering 
 Recent studies showed consistent agreement that LIPUS enhances different tissue matrix 
production by different cells in vitro. These cells include chondrocytes from different tissue 
origins (Wu et al., 1996; Doan et al., 1999; Iwabuchi et al., 2005; Mukai et al., 2005; Hsu et al., 
2006; Iwashina, et al., 2006; Schumann et al., 2006a; Inubushi et al., 2008; Korstjens et al., 
2008; Takeuchi et al., 2008; Tien et al., 2008; Kobayashi et al., 2009).  It is to be noted that the 
stimulatory effect on chondrocyte matrix production has been recently shown to be dose 
dependent (Schumann et al., 2006a; Tien et al., 2008). A more interesting in-vitro study 
showed that herniated disc resorption (HDR) treatment is accelerated by LIPUS. This effect 
was mediated by activation of matrix metalloproteinase-3 (MMP-3) maturation through 
tumor necrosis factor-alpha (TNF-alpha) and macrophage chemoattractant protein-1 (MCP-
1) pathways (Iwabuchi et al; 2005). When compared to Bioreactors, LIPUS produced more 
matrix at 28 days in tissue engineered cartilage, while bioreactors continued matrix 
production until day 42 in-vitro (Hsu et al., 2006). It is to be noted that bioreactors cannot be 
applied clinically to engineered tissues while LIPUS can be applied. Moreover, the longer 
tissue culture periods could be questionable regarding possible errors or potential culture 
infection. The in-vitro conditioning of chondrogenic differentiated mesenchymal stem cells 
by LIPUS for cartilage tissue engineering in vivo has been recently tested.  It has been 
concluded that type I and type X collagens and matrix metalloproteinase-13 are stimulated 
by LIPUS which indicate that LIPUS preconditioning in-vitro can be an effective treatment 
to upregulate chondrogenic differentiation of MSCs in vivo (Cui et al., 2007). 
Studies also reported that LIPUS stimulated matrix formation and maturation by osteoblasts 
from different bone origins (Tsai et al., 1992; Saito et al., 2004; Sena et al., 2005; Tam et al., 
2008; Suzuki et al., 2009).  The foundation for the applications of LIPUS to enhance bone 
fracture healing in clinical situations was based on the detailed  in-vitro study by Tsai et al. 
(Tsai et al., 1992)  Since then, many in-vitro and in-vivo studies were conducted and 
reported on the molecular basis of LIPUS stimulation of bone cell matrix production and 
hence its clinical applications. The most recent studies showed that LIPUS enhances 
different early and late osteoblastic differentiation gene expressions. In most of these 
reports, alkaline phosphates were markedly increased by LIPUS in different bone cell lines. 
The enhanced osteogenic differentiation by LIPUS is suggested to be due to activation of 
early differentiation genes (c-jun, c-myc, COX-2, Egr-1, TSC-22) as well as the bone 
differentiation marker genes, osteonectin and osteopontin, phosphorylation (Tam et al., 
2008)  as well as activation of ERK1/2 and p38 MAPK pathways (Sena et al., 2005). Most 
importantly, LIPUS enhances bone morphogenetic proteins expression in bone cells (Suzuki 
et al., 2009).   The importance of this report that LIPUS enhances BMPs expression is that 
LIPUS might be a future substitute of many BMPs-based therapies. 
Another cell type that has been reported to be stimulated by LIPUS to enhance matrix 
production is macrophages. It has been shown that LIPUS up-regulated the phagocytosis of 
human primary macrophages through the activation of Src and ERKs and promoted the 
protein expression of CD147 and MMPs, as well as increased the level of protein tyrosine 
phosphorylation (Ikeda et al., 2006; Li et al., 2007a).  Also, it has been reported that the effect 
of LIPUS on macrophages depends on cell adhesion, and relates to the integrin-MEK-ERK 
pathway (Li et al., 2007b).  The stimulatory effect of LIPUS on the phagocytosis of 
macrophages may be important in tissue engineering, especially during tissue replacement 
and scaffold degradation for optimum integration between the engineered and original 
tissues. Another effect of LIPUS on macrophages is the ability of LIPUS to liberate fibroblast 
mitogenic factors from macrophages which are known to be a source of many important 
growth factors which can act as wound mediators during tissue repair. This stimulatory 
effect of ultrasound appeared to be mediated by producing permeability changes in these 
cells as well as to stimulate the cell's ability to synthesize and secrete fibroblast mitogenic 
factors (Young & Dyson, 1990a). 
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Also, LIPUS has been shown to enhance epithelial cell repair (Hill et al, 2005) as well as to 
accelerate tendon healing via regulation of vascular endothelial growth factor (VEGF) 
expression (Hill et al., 2005; Lu et al., 2008).  Other reports showed that LIPUS enhances 
VEGF expression by fibroblasts, osteoblasts and monocytes (Doan et al., 1999).   Moreover, 
other angiogenesis-related cytokines, IL-8 and bFGF, were significantly stimulated in 
osteoblasts by LIPUS (Reher et al., 1999). Earlier reports also supported the importance of 
LIPUS in supporting angiogenesis (Young & Dyson, 1990b; Young & Dyson, 1990c).  The 
importance of VEGF and angiogenic factors expression by LIPUS in different tissues is very 
important in tissue engineering, especially bone tissue engineering. Angiogenesis is 
reported to be a key factor in bone maturation and bone fracture healing (Rabie et al., 2002; 
Rabie et al., 2001;  El-Bialy et al., 2003). 
Very recently, it has been reported that dental tissue matrices can be formed by LIPUS in 
vitro and in vivo. The first report about new dental tissue formation was reported while 
LIPUS was applied to osteodistracted rabbit mandibles (El-Bialy, 2003). A follow up pilot 
clinical study in human patients showed for the first time that human dental tissue matrices 
(dentine and cementum) are formed by LIPUS in 28 days (El-Bialy et al., 2004). These two 
studies triggered several in-vitro studies and potential tissue engineering teeth using LIPUS 
(Dalla-Bona et al., 2006; Scheven et al., 2007; Dalla-Bona et al., 2008; Inubushi et al., 2008; 
Scheven et al., 2009a; Scheven et al., 2009b).  Moreover, recently, we have shown that LIPUS 
has an anabolic effect on human gingival fibroblasts, which in turn may help to use these 
cells in craniofacial tissue engineering (Mostafa et al., 2009). The preliminary conclusion of 
these studies may suggest that LIPUS can play an important role in dental and craniofacial 
tissue engineering. 
Another potential application of LIPUS in enhancing tissue matrix formation for tissue 
engineering is via enhancing gene delivery to promote dentine, bone and other tissue 
engineering. Recent appreciable number of studies reported that LIPUS can provide a 
synergistic tool to enhance gene delivery to different cell types for tissue engineering 
(Inagaki et al., 2006; Kaigler et al., 2006; Kimelman et al., 2006; Nozaki et al., 2006; Tachibana 
et al., 2006; Saito et al., 2007; Shen et al., 2008; Sheyn et al., 2008; Kamimura & Liu, 2009; 
Osawa et al., 2009; Sakai et al., 2009;).  The sonoporation technique, which utilizes 
ultrasound to facilitate drug delivery or gene transfection into cells has been accepted both 
in vitro and in vivo, however clinical application of this technique for tissue engineering still 
needs further optimization in-vitro experiments before it might be applicable clinically. The 
ultrasound used in sonoporation is quite different from LIPUS, however an optimization 
experiment for utilizing LIPUS in sonoporation might be justified. 
 
4. Therapeutic ultrasound and its role in enhancing tissue engineering in vivo 
It has been widely accepted that LIPUS can enhance cartilage repair based on the previously 
mentioned in-vitro studies. Moreover, it has been suggested that LIPUS can precondition 
chondrogenic derived stem cells for in-vivo cartilage tissue engineering (Schumann et al., 
2006b; Cui et al., 2007).  In an in-vivo pilot study, we have shown that LIPUS can enhance 
tissue engineered articular condyles in rabbits (El-Bialy et al., 2009). The optimum LIPUS 
treatment for maximum tissue engineered cartilage/or articular joints is still yet to be 
established.  
On the other hand, there are controversial reports about the clinical efficacy of LIPUS in 
enhancing repair of fractured bone in human patients. While earlier reports showed that 
LIPUS enhances and accelerates repair of fractured bones (Heckman et al., 1994; Cook et al., 
1997; Kristiansen et al., 1997; Hadjiargyrou et al., 1998; Mayr et al., 2000; Warden et al., 2000; 
Nolte et al., 2001; Jingushi et al., 2007; Walker et al., 2007; Griffin et al., 2008; Busse et al., 
2009; El-Bialy et al., 2009),   recent reports showed no difference in the healing of the LIPUS 
treated and nontreated fractured bones (Emami et al., 1999; Rue et al., 2004; Handolin et al., 
2005; Lubbert et al., 2008).  
The controversial reports about the clinical success of using LIPUS in repairing bone 
fractures could be due to the difference in the proximity of the fractured bone to the LIPUS 
transducer. It can be noted that most published reports with successful LIPUS treatment 
were performed on clinically accessible bones for LIPUS application, while deep bones or 
bones with thick muscle covering showed less success in accelerating bone fracture healing 
by LIPUS.  A simple explanation of this is that the LIPUS power attenuates exponentially as 
a function of distance. In a rough estimate of LIPUS power attenuation, we have presented a 
simplified mathematical calculation as follows based on our experience in LIPUS 
attenuation of rabbit mandibles. An order-of magnitude estimate of the degree of 
attenuation and relative dose strengths between the direct and indirect sides can be made 
based on the following assumptions: 1) plane wave propagation through one side of the jaw 
and mandible, through the tongue and into the other side of the jaw and mandible (in 
reality, there will be additional loss due to scattering, especially with the presence of air 
regions); and 2) the pressure attenuation coefficient for teeth/mandible is α bone= 1.5 
Np/cm and for the tongue is α tongue = 0.15 Np/cm at 1.5 MHz (Goss et al., 1978; Goss et 
al., 1980)  assuming the bone thickness is 0.5 cm and the tongue thickness is 2 cm. With these 
assumptions the fraction of the intensity reaching the other side of the jaw would be: 
 
                 I/I0 = Exp [-2 α bone d bone] Exp [-2 α tongue d tongue]                            (1) 
 
= Exp [-2(1.5)(0.5)] Exp [-2(0.15)(2)] 
 
= 0.122. 
 
Where I is the intensity at the other side and I0 is the intensity incident on the first (treated) 
side. This is a very rough estimate that may be taken as an upper bound; but, it predicts that 
12.2% of the energy gets to the far (indirect) side relative to the near (direct) side. It has to be 
noted as previously mentioned that the stimulatory effect of LIPUS in enhancing tissue 
matrix production and bone fracture healing is dose dependent (El-Bialy et al., 2002; 
Schumann et al., 2006a).  This could explain in part the differences in clinical outcomes 
between studies when considering differences in bone sizes. 
Another consideration that needs to be taken into account while using LIPUS for tissue 
repair and/or tissue engineering is that the differences in LIPUS power could be different 
with different applications. In another words, when using LIPUS to enhance cell 
proliferation and/or matrix production in vitro, lower power is needed as there is no 
intervening tissues between the transducer and the cells. While in animal or clinical 
applications, many tissues can be intervening between the point of LIPUS application and 
the target bone or tooth, which needs further experimentation to reach the optimum LIPUS 
needed to reach each target for optimum results.  
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It is to be noted that different cell types might respond differently to LIPUS treatment time. 
While stem cells are stimulated by LIPUS in a dose dependent response (Schumann et al., 
2006a); the optimum LIPUS treatment for skin fibroblasts is 10 minutes per day (Zhou et al., 
2004). Moreover, clinical applications using LIPUS has been accepted to be 20 minutes per 
day for 3-4 weeks (Heckman et al., 1994; Cook et al., 1997; Kristiansen et al., 1997; 
Hadjiargyrou et al., 1998; Mayr et al., 2000; Warden et al., 2000; Nolte et al., 2001; Jingushi et 
al., 2007; Walker et al., 2007; Griffin et al., 2008; Busse et al., 2009), in-vitro responses vary 
from one day to 21 days. It is to be remembered that in-vitro experiments allow direct effect 
of LIPUS to the cells, while in-vivo application suffers from LIPUS power attenuation as 
explained above. In this context, in-vitro results might not be completely applicable to in-
vivo applications. 
Conclusion and future directions: 
We can conclude that there is ample literature that supports that LIPUS can be utilized to 
enhance cell proliferation and differentiation, matrix production with the differentiated 
cells, gene transfection for cell differentiation as well as tissue repair both in vitro and in 
vivo. The optimum LIPUS treatment time and dose is still yet to be studied. The potential 
applications of LIPUS in tissue engineering could be used for bone, cartilage, skin, nerve, 
and possibly teeth tissue engineering. A final remark is that the daily use of LIPUS for an 
extended period of time should not be of concern as the safety of this type of low level 
power ultrasound has been addressed before and proven to be safe (Mende et al., 1996; Hata 
et al., 1997; Blaas & Eik-Nes, 1998; Turnbull & Foster, 2002).  
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It is to be noted that different cell types might respond differently to LIPUS treatment time. 
While stem cells are stimulated by LIPUS in a dose dependent response (Schumann et al., 
2006a); the optimum LIPUS treatment for skin fibroblasts is 10 minutes per day (Zhou et al., 
2004). Moreover, clinical applications using LIPUS has been accepted to be 20 minutes per 
day for 3-4 weeks (Heckman et al., 1994; Cook et al., 1997; Kristiansen et al., 1997; 
Hadjiargyrou et al., 1998; Mayr et al., 2000; Warden et al., 2000; Nolte et al., 2001; Jingushi et 
al., 2007; Walker et al., 2007; Griffin et al., 2008; Busse et al., 2009), in-vitro responses vary 
from one day to 21 days. It is to be remembered that in-vitro experiments allow direct effect 
of LIPUS to the cells, while in-vivo application suffers from LIPUS power attenuation as 
explained above. In this context, in-vitro results might not be completely applicable to in-
vivo applications. 
Conclusion and future directions: 
We can conclude that there is ample literature that supports that LIPUS can be utilized to 
enhance cell proliferation and differentiation, matrix production with the differentiated 
cells, gene transfection for cell differentiation as well as tissue repair both in vitro and in 
vivo. The optimum LIPUS treatment time and dose is still yet to be studied. The potential 
applications of LIPUS in tissue engineering could be used for bone, cartilage, skin, nerve, 
and possibly teeth tissue engineering. A final remark is that the daily use of LIPUS for an 
extended period of time should not be of concern as the safety of this type of low level 
power ultrasound has been addressed before and proven to be safe (Mende et al., 1996; Hata 
et al., 1997; Blaas & Eik-Nes, 1998; Turnbull & Foster, 2002).  
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1. Introduction 
1.1 Tissue Engineering 
The field of tissue engineering (regenerative medicine) aims to repair and regenerate 
damaged tissues by developing biological substitutes that mimic the natural extracellular 
matrix to help guide the growth of new functional tissue in vitro or in vivo to restore, 
maintain or improve tissue function. Tissue engineering technologies are based on a 
biological triad and involve the successful interaction between three components: (1) the 
scaffold that holds the cells together to create the tissue’s physical form, (2) the cells that 
synthesise the tissue and (3) signalling mechanisms (i.e. mechanical and chemical signals) 
that direct the cells to express the desired tissue phenotype (Langer & Vacanti, 1993). 
Bioreactors can be used to provide the signals in this latter area in order to influence 
biological processes by the application of a mechanical stimulus, and may also be used as an 
alternative to, or in conjunction with growth factors.  
 
Fig. 1. The tissue engineering triad; factors that need to be considered when designing a 
suitable structure for tissue engineering applications (Lyons, et al., 2008). 
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1.2 Use of Bioreactors in Tissue Engineering  
A tissue engineering bioreactor can be defined as a device that uses mechanical means to 
influence biological processes (Darling & Athanasiou, 2003). Bioreactors can be used to aid 
in the in vitro development of new tissue by providing biochemical and physical regulatory 
signals to cells and encouraging them to undergo differentiation and/or to produce 
extracellular matrix prior to in vivo implantation. Bioreactors are devices in which biological 
or biochemical processes develop under a closely monitored and tightly controlled 
environment.  
Cells respond to mechanical stimulation and bioreactors can be used to apply mechanical 
stimulation to cells. This can encourage cells to produce extracellular matrix (ECM) in a 
shorter time period and in a more homogeneous manner than would be the case with static 
culture. For example, in comparisons between ECM protein levels of equine articluar 
chondrocytes cultured on polyglycolic acid scaffolds after 5 weeks in culture, constructs 
cultured under hydrostatic pressure showed significant improvements over constructs 
cultured in static medium (Carver & Heath, 1999). A benefit of ECM production is the 
increase in mechanical stiffness that it provides to the construct. A six-fold increase in 
equilibrium aggregate modulus (an intrinsic property of cartilage which is a measure of 
stiffness) was found after 28 days of culture in a compression bioreactor compared to free 
swelling controls (Mauck, et al., 2000). Another important application of bioreactors is in 
cellular differentiation. Mechanical stimulation can be used to encourage stem cells down a 
particular path and hence provide the cell phenotype required. Bioreactors can provide 
biochemical and physical regulatory signals that guide differentiation (Altman, et al., 2002). 
There is great potential for using mesenchymal stem cells and other multipotent cells to 
generate different cell types and bioreactors can play an important role in this process. 
As well as providing mechanical stimulation, bioreactors can also be used to improve 
cellular spatial distribution. A heterogeneous cell distribution is a major obstacle to 
developing any three-dimensional tissue or organ in vitro. Defects requiring tissue 
engineering solutions are typically many millimetres in size (Goldstein, et al., 2001). 
Scaffolds in such a size range are easily fabricated, however, problems arise when culturing 
cells on these scaffolds. As the size of the scaffold increases, diffusion of nutrients to the 
centre of the construct becomes more difficult. Static culture conditions result in scaffolds 
with few cells in the centre of the construct (Cartmell, et al., 2003). It is hypothesised that this 
is due to limited cell penetration during seeding, cell migration to the scaffold periphery 
during culture, or cell death in the centre of the scaffold (Glowacki, et al., 1998, Ishaug-Riley, 
et al., 1998, Goldstein, et al., 2001, Yu, et al., 2004, Gomes, et al., 2005). The only mechanism by 
which nutrients and waste can move when a scaffold is in static culture is by diffusion. It 
has been shown that despite homogeneous cell seeding, after long periods in culture, more 
cells are found on the periphery of constructs (Cartmell, et al., 2003) leading to peripheral 
encapsulation which hinders nutrient and waste exchange from the centre, resulting in core 
degradation of tissue engineered constructs. This is of major concern in the field of tissue 
engineering, and is a major obstacle in the formation of a viable tissue in vitro. For this 
reason, for a number of tissue types, the move towards clinical trials has been slow and 
progress to date in engineering significant quantities of functional tissue in vitro for 
implantation in humans in vivo has been somewhat disappointing.  
Thus, bioreactors can be used in tissue engineering applications to overcome problems 
associated with traditional static culture conditions, improve cellular distribution and 
 
accelerate construct maturation (Freed, et al., 2006) whilst applying biophysical signals to 
constructs to improve tissue formation in vitro prior to in vivo implantation. In general, 
bioreactors are designed to perform at least one of the following five functions, to (1) 
provide a spatially uniform cell distribution, (2) maintain the desired concentration of gases 
and nutrients in culture medium, (3) facilitate mass transport to the tissue, (4) expose the 
construct to physical stimuli and/or (5) provide information about the formation of 3D 
tissue (Vunjak-Novakovic, et al., 1998, Bancroft, et al., 2003)  
 
1.3 Bioreactor Design Requirements  
The design of the bioreactor should be as simple as possible e.g. avoiding the introduction of 
machined recesses which could become breeding grounds for micro-organisms. Simplicity 
in design should also mean that the bioreactor is quick to assemble and disassemble. Apart 
from being more efficient, this ensures that cell-seeded constructs inserted into the 
bioreactor are out of the incubator for the minimum amount of time possible. This 
minimises the risk to the cells and the experiment being undertaken. 
The detailed requirements for bioreactor design are tissue- and/or application- specific, 
however, there are a few general principles which have to be adhered to when developing a 
bioreactor. The material selection is very important as it is vital to ensure that the materials 
used to create the bioreactor do not elicit any adverse reaction from the cultured tissue. Any 
material which is in contact with media must be biocompatible or bioinert. This eliminates 
the use of most metals, although stainless steel can be used if it is treated so that chromium 
ions do not leach out into the medium. Numerous plastics comply with this constraint but 
there are further limitations on material selection that must also be kept in mind. Materials 
must be usable at 37°C in a humid atmosphere. They must be able to be sterilised if they are 
to be re-used. Bioreactor parts can be sterilised by autoclaving or disinfected by submersion 
in alcohol. If they are to be autoclaved, materials that can withstand numerous cycles of high 
temperature and pressure must be used in bioreactor manufacture. Alternatively, some non-
sterilisable disposable bioreactor parts may be used which can be replaced after each use of 
the bioreactor. Other material choices are between transparent or opaque and flexible or 
inflexible materials. Materials with different properties are needed for various components 
in the bioreactor. For example, transparent materials can be of benefit in allowing the 
construct to be monitored in the bioreactor during culture while flexible tubing can help 
with assembly of the bioreactor. 
The specific application of the bioreactor must be kept in mind during the design process to 
ensure that all the design constraints are met. If various parameters such as pH, nutrient 
concentration or oxygen levels are to be monitored, these sensors should be incorporated 
into the design. If a pump or motor is to be used, it must be small enough to fit into an 
incubator and also be usable at 37°C and in a humid environment. The forces needed for 
cellular stimulation are very small so it is important to ensure that the pump/motor has the 
capability to apply small forces accurately. In any design involving fluids, problems can 
arise with leaking fluid seals and, if possible, the need for seals should be reduced. 
However, in most cases, fluid seals are necessary and good design should decrease the 
problems with them. If a prototype bioreactor is being designed, it is worthwhile thinking 
about scale up opportunities for the bioreactor from the outset. This may mean designing a 
device that is relatively easy to enlarge without changing its characteristics or designing a 
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simple device of which many more can be made so that numerous scaffolds can be cultured 
at one time. 
 
2. Types of Bioreactors in Tissue Engineering 
Bioreactors are laboratory tissue culture devices that provide a controllable, mechanically 
active environment that can be used to study and potentially improve engineered tissue 
structure, properties and integration. Many tissue engineering studies employ conventional 
methods (static seeding) that result in constructs comprising a thin tissue like layer at the 
base of the scaffold due to gravitiational settling of the cells. In contrast convective mixing 
(spinner flasks) and convective flow (flow perfusion) can improve initial cell seeding and 
homogeneity, and thereby improve tissue architecture (Freed, et al., 2006). Numerous types 
of bioreactors including spinner flasks, rotating wall, compression, strain and flow perfusion 
bioreactors are used in various tissue engineering applications, which will all be discussed 
below. All of these bioreactors rely on forced media flow through and/or around the 
scaffold to provide nutrient and waste exchange within the scaffold.  
 
2.1 Spinner Flask Bioreactors 
One of the most basic bioreactors, a spinner flask induces mixing of oxygen and nutrients 
throughout the medium and reduces the concentration boundary layer at the construct 
surface. In a spinner flask, scaffolds are suspended at the end of needles in a flask of culture 
media. A magnetic stirrer mixes the media and the scaffolds are fixed in place with respect 
to the moving fluid (figure 2). Flow across the surface of the scaffolds results in eddies 
which are turbulent instabilities consisting of clumps of fluid particles that have a rotational 
structure superimposed on the mean linear motion of the fluid particles. They are associated 
with transitional and turbulent flow. It is via these eddies that fluid transport to the centre of 
the scaffold is thought to be enhanced (Goldstein, et al., 2001). Typically, spinner flasks are 
around 120 mL in volume (although much larger flasks of up to 8 litres have been used), are 
run at 50-80 rpm and 50% of the medium used in them is changed every two days 
(Freshney, 2000). Cartilage constructs have been grown in spinner flasks to thicknesses of 0.5 
mm (Freed & Vunjak-Novakovic, 2000). While this is an improvement on cartilage grown in 
static culture, it is still too thin for clinical use. Mass transfer in the flasks is not good enough 
to deliver homogeneous cell distribution throughout scaffolds and cells predominantly 
reside on the construct periphery.  
 
 
Fig. 2. A spinner flask bioreactor. Scaffolds are suspended in medium and the medium is 
stirred using a magnetic stirrer to improve nutrient delivery to the scaffold  
 
2.2 Rotating Wall Bioreactors 
The rotating wall bioreactor was developed by NASA (Schwarz, et al., 1992). It was 
originally designed with a view to protecting cell culture experiments from high forces 
during space shuttle take off and landing. However, the device has proved useful in tissue 
engineering here on Earth. In a rotating wall bioreactor, scaffolds are free to move in media 
in a vessel. A rotating wall vessel bioreactor consists of a cylindrical chamber in which the 
outer wall, inner wall, or both are capable of rotating at a constant angular speed (figure 3). 
The vessel wall is then rotated at a speed such that a balance is reached between the 
downward gravitational force and the upward hydrodynamic drag force acting on each 
scaffold. The wall of the vessel rotates, providing an upward hydrodynamic drag force that 
balances with the downward gravitational force, resulting in the scaffold remaining 
suspended in the media. Dynamic laminar flow generated by a rotating fluid environment is 
an alternative and efficient way to reduce diffusional limitations of nutrients and wastes 
while producing low levels of shear. Media can be exchanged by stopping the rotation 
temporarily or by adding a fluid pump whereby media is constantly pumped through the 
vessel. Fluid transport is enhanced in a similar fashion to the mechanism in spinner flasks 
and the devices also provide a more homogeneous cell distribution than static culture. Gas 
exchange occurs through a gas exchange membrane and the bioreactor is rotated at speeds 
of 15-30 rpm. Cartilage tissue of 5 mm thickness has been grown in this type of bioreactor 
after seven months of culture (Freed, et al., 1997). As tissue grows in the bioreactor, the 
rotational speed must be increased in order to balance the gravitational force and ensure the 
scaffold remains in suspension.  
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while producing low levels of shear. Media can be exchanged by stopping the rotation 
temporarily or by adding a fluid pump whereby media is constantly pumped through the 
vessel. Fluid transport is enhanced in a similar fashion to the mechanism in spinner flasks 
and the devices also provide a more homogeneous cell distribution than static culture. Gas 
exchange occurs through a gas exchange membrane and the bioreactor is rotated at speeds 
of 15-30 rpm. Cartilage tissue of 5 mm thickness has been grown in this type of bioreactor 
after seven months of culture (Freed, et al., 1997). As tissue grows in the bioreactor, the 
rotational speed must be increased in order to balance the gravitational force and ensure the 
scaffold remains in suspension.  
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Fig. 3. A rotating wall vessel bioreactor. Scaffolds are suspended in medium due to 
opposing gravitational and drag forces 
 
2.3 Compression Bioreactors 
Another widely used type of bioreactor is the compression bioreactor. This class of 
bioreactor is generally used in cartilage engineering and can be designed so that both static 
and dynamic loading can be applied. This is because static loading has been found to have a 
negative effect on cartilage formation in comparison to dynamic loading, which is more 
representative of physiological loading (Darling & Athanasiou, 2003). In general, 
compression bioreactors consist of a motor, a system providing linear motion and a 
controlling mechanism used to provide displacements of different magnitudes and 
frequencies. A signal generator can be used to control the system including load cells while 
transformers can be used to measure the load response and imposed displacement (Huang, 
et al., 2004). The load can be transferred to the cell-seeded constructs via flat platens which 
distribute the load evenly (Thorpe, et al., 2008), however in a device for stimulating multiple 
scaffolds simultaneously, care must be taken that the constructs are of similar height or the 
compressive strain applied will vary as the scaffold height does. Mass transfer is improved 
in dynamic compression bioreactors over static culture (as compression causes fluid flow in 
the scaffold) which results in the improvement of the aggregate modulus of the resulting 
cartilage tissue to levels approaching those of native articular cartilage (Mauck, et al., 2000).  
 
2.4 Strain Bioreactors 
Tensile strain bioreactors have been used in an attempt to engineer a number of different 
types of tissue including tendon, ligament, bone, cartilage and cardiovascular tissue. Some 
designs are very similar to compression bioreactors, only differing in the way the force is 
transferred to the construct. Instead of flat platens as in a compression bioreactor, a way of 
clamping the scaffold into the device is needed so that a tensile force can be applied. Tensile 
strain has been used to differentiate mesechymal stem cells along the chondrogenic lineage. 
A multistation bioreactor was used in which cell-seeded collagen-glycosaminoglycan 
scaffolds were clamped and loaded in uniaxial tension (McMahon, et al., 2008). 
Alternatively, tensile strain can also be applied to a construct by attaching the construct to 
anchors on a rubber membrane and then deforming the membrane. This system has been 
used in the culture of bioartificial tendons with a resulting increase in Young’s modulus 
over non-loaded controls (Garvin, et al., 2003).  
 
 
2.5 Hydrostatic Pressure Bioreactors 
In cartilage tissue engineering, hydrostatic pressure bioreactors can be used to apply 
mechanical stimulus to cell-seeded constructs. Scaffolds are usually cultured statically and 
then moved to a hydrostatic chamber for a specified time for loading. Hydrostatic pressure 
bioreactors consist of a chamber which can withstand the pressures applied and a means of 
applying that pressure. For example, a media-filled pressure chamber can be pressurised 
using a piston controlled by an actuator (Darling & Athanasiou, 2003). For sterility, the 
piston can apply pressure via an impermeable membrane so that the piston itself does not 
come into contact with the culture media. Variations on this design include a water-filled 
pressure chamber which pressurises a media-filled chamber via an impermeable film and is 
controlled using a variable backpressure valve and an actuator (Watanabe, et al., 2005).  
 
2.6 Flow Perfusion Bioreactors 
Culture using flow perfusion bioreactors has been shown to provide more homogeneous 
cell distribution throughout scaffolds. Collagen sponges have been seeded with bone 
marrow stromal cells and perfused with flow. This has resulted in greater cellularity 
throughout the scaffold in comparison to static controls, implying that better nutrient 
exchange occurs due to flow (Glowacki, et al., 1998). Using a calcium phosphate scaffold, 
abundant extracellular matrix (ECM) with nodules of calcium phosphate was noted after 19 
days in steady flow culture (Janssen, et al., 2006). In comparisons between flow perfusion, 
spinner flask and rotating wall bioreactors, flow perfusion bioreactors have proved to be the 
best for fluid transport. Using the same flow rate and the same scaffold type, while cell 
densities remained the same using all three bioreactors, the distribution of the cells changed 
dramatically depending on which bioreactor was used. Histological analysis showed that 
spinner flask and static culture resulted in the majority of viable cells being on the periphery 
of the scaffold. In contrast, the rotating wall vessel and flow perfusion bioreactor culture 
resulted in uniform cell distribution throughout the scaffolds (Goldstein, et al., 2001, Yu, et 
al., 2004).  
Flow perfusion bioreactors generally consist of a pump and a scaffold chamber joined 
together by tubing. A fluid pump is used to force media flow through the cell-seeded 
scaffold. The scaffold is placed in a chamber that is designed to direct flow through the 
interior of the scaffold. The scaffold is kept in position across the flow path of the device and 
media is perfused through the scaffold, thus enhancing fluid transport. Media can easily be 
replaced in the media reservoir (figure 4). However, the effects of direct perfusion can be 
highly dependent on the medium flow rate. Therefore optimising a perfusion bioreactor for 
the engineering of a 3D tissue must address the careful balance between the mass transfer of 
nutrients and waste products to and from cells, the retention of newly synthesised ECM 
components within the construct and the fluid induced shear stresses within the scaffold 
pores. 
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Fig. 3. A rotating wall vessel bioreactor. Scaffolds are suspended in medium due to 
opposing gravitational and drag forces 
 
2.3 Compression Bioreactors 
Another widely used type of bioreactor is the compression bioreactor. This class of 
bioreactor is generally used in cartilage engineering and can be designed so that both static 
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used in the culture of bioartificial tendons with a resulting increase in Young’s modulus 
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then moved to a hydrostatic chamber for a specified time for loading. Hydrostatic pressure 
bioreactors consist of a chamber which can withstand the pressures applied and a means of 
applying that pressure. For example, a media-filled pressure chamber can be pressurised 
using a piston controlled by an actuator (Darling & Athanasiou, 2003). For sterility, the 
piston can apply pressure via an impermeable membrane so that the piston itself does not 
come into contact with the culture media. Variations on this design include a water-filled 
pressure chamber which pressurises a media-filled chamber via an impermeable film and is 
controlled using a variable backpressure valve and an actuator (Watanabe, et al., 2005).  
 
2.6 Flow Perfusion Bioreactors 
Culture using flow perfusion bioreactors has been shown to provide more homogeneous 
cell distribution throughout scaffolds. Collagen sponges have been seeded with bone 
marrow stromal cells and perfused with flow. This has resulted in greater cellularity 
throughout the scaffold in comparison to static controls, implying that better nutrient 
exchange occurs due to flow (Glowacki, et al., 1998). Using a calcium phosphate scaffold, 
abundant extracellular matrix (ECM) with nodules of calcium phosphate was noted after 19 
days in steady flow culture (Janssen, et al., 2006). In comparisons between flow perfusion, 
spinner flask and rotating wall bioreactors, flow perfusion bioreactors have proved to be the 
best for fluid transport. Using the same flow rate and the same scaffold type, while cell 
densities remained the same using all three bioreactors, the distribution of the cells changed 
dramatically depending on which bioreactor was used. Histological analysis showed that 
spinner flask and static culture resulted in the majority of viable cells being on the periphery 
of the scaffold. In contrast, the rotating wall vessel and flow perfusion bioreactor culture 
resulted in uniform cell distribution throughout the scaffolds (Goldstein, et al., 2001, Yu, et 
al., 2004).  
Flow perfusion bioreactors generally consist of a pump and a scaffold chamber joined 
together by tubing. A fluid pump is used to force media flow through the cell-seeded 
scaffold. The scaffold is placed in a chamber that is designed to direct flow through the 
interior of the scaffold. The scaffold is kept in position across the flow path of the device and 
media is perfused through the scaffold, thus enhancing fluid transport. Media can easily be 
replaced in the media reservoir (figure 4). However, the effects of direct perfusion can be 
highly dependent on the medium flow rate. Therefore optimising a perfusion bioreactor for 
the engineering of a 3D tissue must address the careful balance between the mass transfer of 
nutrients and waste products to and from cells, the retention of newly synthesised ECM 
components within the construct and the fluid induced shear stresses within the scaffold 
pores. 
 
Tissue	Engineering330
 
 
Fig. 4. A flow perfusion bioreactor, media is forced through the scaffold in the scaffold 
chamber by the syringe pump (Jaasma, et al., 2008) 
 
3. Tissue Formation in Bioreactor Systems 
3.1 Flow Perfusion Bioreactors for Bone Tissue Engineering 
Bone grafts are required to aid bone defect and non-union healing, and restore function to 
the damaged area as quickly and completely as possible (Perry, 1999). They are required in a 
number of procedures e.g. replacing diseased bone, filling bone voids, reconstructive 
surgery and in spinal fusion operations. The use of bone grafts substitutes (autografts, 
allografts and xenografts) are associated with donor site morbidity, small volume of donor 
tissue harvested, disease transmission, infection and chronic pain (Perry, 1999, Langer, 
2000). Therefore, attention has turned to bone tissue engineering.  
It has been shown that fluid flow can stimulate bone cells to increase levels of bone 
formation markers (Reich & Frangos, 1991, Klein-Nulend, et al., 1997, You, et al., 2001, 
Cartmell, et al., 2003, Li, et al., 2004, Batra, et al., 2005, Kreke, et al., 2005, Jaasma & O'Brien, 
2008) and its use could improve mineralisation of the scaffold on which cells are seeded. 
Flow perfusion bioreactors increased alkaline phosphatase (ALP) expression after 7 and 14 
days of culture compared to constructs cultured in spinner flasks or rotating wall vessels 
(Goldstein, et al., 2001), and are more commonly used than any other bioreactor for use in 3-
D stimulation studies. In one study, pre-osteoblastic MC3T3-E1 cells were seeded on 
decalcified human trabecular bone, the flow rate of perfusion altered and the mRNA 
expression of Runx2, Osteocalcin (OC) and ALP measured (Cartmell, et al., 2003). It was 
found that using a steady flow rate of 1 mL/min killed a majority of the cells on the scaffold 
after 7 days in culture. However, a flow rate of 0.01 mL/min led to a high proportion of 
viable cells both on the surface and inside the scaffold. This compared favourably to static 
culture, where cells were predominantly on the periphery (Cartmell, et al., 2003).  
During locomotion, bone cells are primarily subjected to oscillatory and pulsatile flow in 
vivo (Jacobs, et al., 1998). Results from 2D cultures show that osteoblasts are more responsive 
to pulsatile than steady and oscillatory flow (Jacobs, et al., 1998). In our laboratory, a flow 
perfusion bioreactor has been developed to examine the effects of different flow profiles on 
 
cell-seeded collagen-glycosaminoglycan scaffolds (Jaasma, et al., 2008). The scaffold chamber 
was specifically designed to ensure that the compliant scaffold was under perfusive flow. 
This involved using a scaffold of larger diameter than the flow path and using spacers to 
ensure the scaffold was under 10% compression during culture. A programmable syringe 
pump was used in order to stimulate the cell-seeded constructs using different flow profiles. 
This device demonstrated that intermittent flow perfusion is advantageous for mechanically 
stimulating osteoblasts while maintaining cell viability. It was found that intermittent 
dynamic flow caused greater stimulation than a continuous low flow rate (Jaasma & 
O'Brien, 2008). Cyclyoxygenase-2 (COX-2) and osteopontin (OPN) expression increased due 
to culture in the bioreactor, as did prostaglandin E2 (PGE2) production. Whilst, in a more 
recent study in our lab, it was found that the insertion of short term rest periods (5, 10 and 
15 seconds) combined with long term rests (7 hours) provided an enhanced osteogenic 
response compared to constructs cultured in static culture, whilst simultaneously improving 
cellular spatial distribution. The use of short term rests upregulated COX-2, PGE2 and OPN 
(Partap, et al., 2009, Plunkett, et al., 2009). PGE2 levels were also found to increase over static 
controls when a calcium phosphate scaffold was cultured in a flow perfusion bioreactor 
with a flow rate of 0.025 mL/min. A stimulus of 30 minutes of oscillatory flow at 1 Hz with 
a 40 mL/min peak superimposed on steady flow increased levels of PGE2. The number of 
cells left residing on the scaffolds decreased due to this large dynamic stimulus but this 
decrease was not found to be statistically significant to static culture (Vance, et al., 2005).  
Results suggest that the increased cell proliferation and matrix mineralisation in the centre 
of the scaffold resulting from culture in a flow perfusion bioreactor are primarily due to 
better nutrient and waste exchange. However, the increased mineral deposition with an 
increase in flow rate and numerous 2D experiments indicate that cells are also stimulated by 
the flow-induced shear stress. Sikavitsas et al. (2003) added various amounts of dextran to 
the media to increase its viscosity. This allowed for the shear stress magnitude experienced 
by the cells on the scaffold to be varied independently while keeping the flow rate constant. 
Mineral deposition on the scaffold was found to be proportional to the magnitude of the 
shear stress imposed on the cells. Thus, while flow perfusion does appear to increase the 
ability of cells to remain viable at the centre of the scaffold, it also serves as a means of 
increasing matrix production and mineralisation on the scaffold (Sikavitsas, et al., 2003).  
 
3.2 Compression Bioreactor for Cartilage Tissue Engineering 
Cartilage is a supporting tissue containing chondroitin sulphates, collagen and elastic fibres 
and cells. The cells present in cartilage are known as chondrocytes and they are situated in 
lacunae in the cartilage matrix. Nutrient and waste product exchange occurs purely by 
diffusion through the cartilage matrix. It is an avascular, aneural and alymphatic tissue. The 
healing response of damaged cartilage is dependent upon the depth of the lesion. When 
minor damage occurs to cartilage, it can be repaired by appositional growth, but when 
severe damage occurs, it is repaired without complete restoration. This is thought to be due 
to the low metabolic activity of chondrocytes and its avascular nature (Martini, 2002). 
Currently, autologous chonrdocyte implantation (ACI), osteochondral grafting and bone 
marrow stimulation techniques are used to stimulate the regeneration of native cartilage. 
However, these techniques generally result in the formation of fibrocartilage which has poor 
mechanical properties and does not perform as well as native cartilage. Cartilage tissue 
engineering may offer a solution to this problem. There are three types of cartilage: hyaline, 
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Fig. 4. A flow perfusion bioreactor, media is forced through the scaffold in the scaffold 
chamber by the syringe pump (Jaasma, et al., 2008) 
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the damaged area as quickly and completely as possible (Perry, 1999). They are required in a 
number of procedures e.g. replacing diseased bone, filling bone voids, reconstructive 
surgery and in spinal fusion operations. The use of bone grafts substitutes (autografts, 
allografts and xenografts) are associated with donor site morbidity, small volume of donor 
tissue harvested, disease transmission, infection and chronic pain (Perry, 1999, Langer, 
2000). Therefore, attention has turned to bone tissue engineering.  
It has been shown that fluid flow can stimulate bone cells to increase levels of bone 
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2008) and its use could improve mineralisation of the scaffold on which cells are seeded. 
Flow perfusion bioreactors increased alkaline phosphatase (ALP) expression after 7 and 14 
days of culture compared to constructs cultured in spinner flasks or rotating wall vessels 
(Goldstein, et al., 2001), and are more commonly used than any other bioreactor for use in 3-
D stimulation studies. In one study, pre-osteoblastic MC3T3-E1 cells were seeded on 
decalcified human trabecular bone, the flow rate of perfusion altered and the mRNA 
expression of Runx2, Osteocalcin (OC) and ALP measured (Cartmell, et al., 2003). It was 
found that using a steady flow rate of 1 mL/min killed a majority of the cells on the scaffold 
after 7 days in culture. However, a flow rate of 0.01 mL/min led to a high proportion of 
viable cells both on the surface and inside the scaffold. This compared favourably to static 
culture, where cells were predominantly on the periphery (Cartmell, et al., 2003).  
During locomotion, bone cells are primarily subjected to oscillatory and pulsatile flow in 
vivo (Jacobs, et al., 1998). Results from 2D cultures show that osteoblasts are more responsive 
to pulsatile than steady and oscillatory flow (Jacobs, et al., 1998). In our laboratory, a flow 
perfusion bioreactor has been developed to examine the effects of different flow profiles on 
 
cell-seeded collagen-glycosaminoglycan scaffolds (Jaasma, et al., 2008). The scaffold chamber 
was specifically designed to ensure that the compliant scaffold was under perfusive flow. 
This involved using a scaffold of larger diameter than the flow path and using spacers to 
ensure the scaffold was under 10% compression during culture. A programmable syringe 
pump was used in order to stimulate the cell-seeded constructs using different flow profiles. 
This device demonstrated that intermittent flow perfusion is advantageous for mechanically 
stimulating osteoblasts while maintaining cell viability. It was found that intermittent 
dynamic flow caused greater stimulation than a continuous low flow rate (Jaasma & 
O'Brien, 2008). Cyclyoxygenase-2 (COX-2) and osteopontin (OPN) expression increased due 
to culture in the bioreactor, as did prostaglandin E2 (PGE2) production. Whilst, in a more 
recent study in our lab, it was found that the insertion of short term rest periods (5, 10 and 
15 seconds) combined with long term rests (7 hours) provided an enhanced osteogenic 
response compared to constructs cultured in static culture, whilst simultaneously improving 
cellular spatial distribution. The use of short term rests upregulated COX-2, PGE2 and OPN 
(Partap, et al., 2009, Plunkett, et al., 2009). PGE2 levels were also found to increase over static 
controls when a calcium phosphate scaffold was cultured in a flow perfusion bioreactor 
with a flow rate of 0.025 mL/min. A stimulus of 30 minutes of oscillatory flow at 1 Hz with 
a 40 mL/min peak superimposed on steady flow increased levels of PGE2. The number of 
cells left residing on the scaffolds decreased due to this large dynamic stimulus but this 
decrease was not found to be statistically significant to static culture (Vance, et al., 2005).  
Results suggest that the increased cell proliferation and matrix mineralisation in the centre 
of the scaffold resulting from culture in a flow perfusion bioreactor are primarily due to 
better nutrient and waste exchange. However, the increased mineral deposition with an 
increase in flow rate and numerous 2D experiments indicate that cells are also stimulated by 
the flow-induced shear stress. Sikavitsas et al. (2003) added various amounts of dextran to 
the media to increase its viscosity. This allowed for the shear stress magnitude experienced 
by the cells on the scaffold to be varied independently while keeping the flow rate constant. 
Mineral deposition on the scaffold was found to be proportional to the magnitude of the 
shear stress imposed on the cells. Thus, while flow perfusion does appear to increase the 
ability of cells to remain viable at the centre of the scaffold, it also serves as a means of 
increasing matrix production and mineralisation on the scaffold (Sikavitsas, et al., 2003).  
 
3.2 Compression Bioreactor for Cartilage Tissue Engineering 
Cartilage is a supporting tissue containing chondroitin sulphates, collagen and elastic fibres 
and cells. The cells present in cartilage are known as chondrocytes and they are situated in 
lacunae in the cartilage matrix. Nutrient and waste product exchange occurs purely by 
diffusion through the cartilage matrix. It is an avascular, aneural and alymphatic tissue. The 
healing response of damaged cartilage is dependent upon the depth of the lesion. When 
minor damage occurs to cartilage, it can be repaired by appositional growth, but when 
severe damage occurs, it is repaired without complete restoration. This is thought to be due 
to the low metabolic activity of chondrocytes and its avascular nature (Martini, 2002). 
Currently, autologous chonrdocyte implantation (ACI), osteochondral grafting and bone 
marrow stimulation techniques are used to stimulate the regeneration of native cartilage. 
However, these techniques generally result in the formation of fibrocartilage which has poor 
mechanical properties and does not perform as well as native cartilage. Cartilage tissue 
engineering may offer a solution to this problem. There are three types of cartilage: hyaline, 
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elastic and fibrocartilage. Joints can contain both hyaline cartilage and fibrocartilage, with 
the more flexible hyaline cartilage covering the bone and the more durable fibrocartilage 
acting as a shock-absorber between bones. As a joint moves, there is motion between two 
articulating layers of cartilage. This deforms the cartilage, causes fluid flow within it and 
induces a hydrostatic pressure load on it. These mechanical forces affect the chondrocytes in 
the cartilage. The force applied, along with the length of time it is applied for and the 
frequency of application modifies the response of chondrocytes (Mauck, et al., 2007). This is 
useful in bioreactor design and for use in cartilage tissue engineering; if the correct 
stimulation pattern is used, chondrocytes can be induced to produce more extracellular 
matrix and this can result in more cartilage-like tissue being formed.    
After twenty weeks in static culture, the aggregate modulus of tissue-engineered cartilage 
was 179±9 kPa. This is 40% of the value reported for native cartilage (Ma & Langer, 1999). At 
twenty five weeks, the modulus had not increased further so this may be the closest 
approximation to cartilage that can be cultured without the aid of a bioreactor. The most 
commonly used bioreactors in cartilage tissue engineering are compression bioreactors. 
When free swelling controls were compared to dynamically loaded agarose gels, after 28 
days in culture, there was a six-fold increase in the equilibrium aggregate modulus for the 
loaded gels (Mauck, et al., 2000). A sinusoidal strain of 10% at 1 Hz was applied to the gels 
for five days per week for a total of three hours per day with a rest period of one hour 
between each hour of loading. This complex loading pattern was deemed to be 
physiological and it resulted in increased glycosaminoglycan content over free swelling 
controls after 21 days in culture. The combination of increased modulus and increased 
glycosaminoglycan formation over free swelling controls after only four weeks in culture 
demonstrates the benefits of bioreactor culture in cartilage tissue engineering. Compression 
bioreactors have also been used to examine the effect of loading on the differentiation of 
bone marrow mesenchymal stem cells down the chondrocytic lineage. Growth factors such 
as transforming growth factor (TGF-) can also be used to encourage differentiation. In a 
study comparing the use of compressive loading, the use of TGF- and the use of a 
combination of loading and TGF-, it was found that compressive loading alone was just as 
effective at inducing chondrogenic differentiation as TGF- or TGF- plus loading (Huang, 
et al., 2004).  
 
4. Bioreactors: State of the Art and Future Directions 
The use of bioreactors has brought us a step closer to engineering numerous tissue types. 
Recently, a bioreactor was used to culture a tissue engineered trachea that was successfully 
implanted into a patient. A donor trachea was decellularized and subsequently seeded with 
the patients own cells. The bioreactor was specifically designed to seed and culture different 
cell types on either side of the donor tissue to allow for nutrient supply and waste removal, 
to provide biomechanical cues in the form of a hydrodynamic shear stress, as well as being 
designed to be autoclaved and handled in a sterile manner. The bioreactor rotated the 
trachea around its longitudinal axis so that a shear stress was applied to the cells to 
stimulate them and to ensure the even distribution of nutrients and waste. In addition to the 
rotation of the graft, the culture medium was continuously mixed to increase oxygenation 
and the exchange of waste and nutrients in the bioreactor chamber (Macchiarini, et al., 2008). 
 
 
However, most bioreactors at present are specialised devices with a low volume output. 
Their assembly is often time consuming and labour intensive. Many also exhibit operator 
dependent variability. Ways of minimizing the time and effort needed to form tissue must 
be sought if costs are to be reduced so that engineered tissues can be routinely used in 
clinical environments. In the future, scaled up versions of some devices (which may be 
automated) could potentially supply larger amounts of tissue. The ideal bioreactor would 
generate the required amount of tissue after a defined culture period. In addition, 
development of tissue could be monitored throughout the culture period through the 
incorporation of for example video microscopy and microcomputed tomography (CT) for 
observing the structural properties of the growing tissue. A better understanding of the 
different effects of mechanical stimulation on cell signalling and mechanotransduction is 
also needed. This can be achieved through the use of existing simple bioreactors in 
conjunction with numerical simulation of culture conditions to minimise the number of 
experiments needed. This may be the future for bioreactors in tissue engineering. 
 
5. Acknowledgements 
Funding for the salaries of Sonia Partap and Niamh Plunkett was provided by Science 
Foundation Ireland (President of Ireland Young Researcher Award, 04/Yl1/B531) and the 
Irish Research Council for Science, Engineering and Technology (RS/2005/173) respectively. 
 
6. References 
Altman, G.H.; Horan, R.L.; Martin, I.; Farhadi, J.; Stark, P.R.; Volloch, V.; Richmond, J.C.; 
Vunjak-Novakovic, G. & Kaplan, D.L. (2002). Cell Differentiation by Mechanical 
Stress. Faseb J, 16, 270-272. 
Bancroft, G.N.; Sikavitsas, V.I. & Mikos, A.G. (2003). Design of a Flow Perfusion Bioreactor 
System for Bone Tissue-Engineering Applications. Tissue Eng, 9, 549-554. 
Batra, N.N.; Li, Y.J.; Yellowley, C.E.; You, L.; Malone, A.M.; Kim, C.H. & Jacobs, C.R. (2005). 
Effects of Short-Term Recovery Periods on Fluid-Induced Signaling in Osteoblastic 
Cells. J Biomech, 38, 1909-1917. 
Cartmell, S.H.; Porter, B.D.; Garcia, A.J. & Guldberg, R.E. (2003). Effects of Medium 
Perfusion Rate on Cell-Seeded Three-Dimensional Bone Constructs in Vitro. Tissue 
Eng, 9, 1197-1203. 
Carver, S.E. & Heath, C.A. (1999). Semi-Continuous Perfusion System for Delivering 
Intermittent Physiological Pressure to Regenerating Cartilage. Tissue Eng, 5, 1-11. 
Darling, E.M. & Athanasiou, K.A. (2003). Biomechanical Strategies for Articular Cartilage 
Regeneration. Ann Biomed Eng, 31, 1114-1124. 
Darling, E.M. & Athanasiou, K.A. (2003). Articular Cartilage Bioreactors and Bioprocesses. 
Tissue Eng, 9, 9-26. 
Freed, L.E.; Guilak, F.; Guo, X.E.; Gray, M.L.; Tranquillo, R.; Holmes, J.W.; Radisic, M.; 
Sefton, M.V.; Kaplan, D. & Vunjak-Novakovic, G. (2006). Advanced Tools for 
Tissue Engineering: Scaffolds, Bioreactors, and Signaling. Tissue Eng, 12, 3285-3305. 
Freed, L.E.; Langer, R.; Martin, I.; Pellis, N.R. & Vunjak-Novakovic, G. (1997). Tissue 
Engineering of Cartilage in Space. Proceedings of the National Academy of Sciences of 
the United States of America, 94, 13885-13890. 
	Bioreactors	in	Tissue	Engineering 333
 
elastic and fibrocartilage. Joints can contain both hyaline cartilage and fibrocartilage, with 
the more flexible hyaline cartilage covering the bone and the more durable fibrocartilage 
acting as a shock-absorber between bones. As a joint moves, there is motion between two 
articulating layers of cartilage. This deforms the cartilage, causes fluid flow within it and 
induces a hydrostatic pressure load on it. These mechanical forces affect the chondrocytes in 
the cartilage. The force applied, along with the length of time it is applied for and the 
frequency of application modifies the response of chondrocytes (Mauck, et al., 2007). This is 
useful in bioreactor design and for use in cartilage tissue engineering; if the correct 
stimulation pattern is used, chondrocytes can be induced to produce more extracellular 
matrix and this can result in more cartilage-like tissue being formed.    
After twenty weeks in static culture, the aggregate modulus of tissue-engineered cartilage 
was 179±9 kPa. This is 40% of the value reported for native cartilage (Ma & Langer, 1999). At 
twenty five weeks, the modulus had not increased further so this may be the closest 
approximation to cartilage that can be cultured without the aid of a bioreactor. The most 
commonly used bioreactors in cartilage tissue engineering are compression bioreactors. 
When free swelling controls were compared to dynamically loaded agarose gels, after 28 
days in culture, there was a six-fold increase in the equilibrium aggregate modulus for the 
loaded gels (Mauck, et al., 2000). A sinusoidal strain of 10% at 1 Hz was applied to the gels 
for five days per week for a total of three hours per day with a rest period of one hour 
between each hour of loading. This complex loading pattern was deemed to be 
physiological and it resulted in increased glycosaminoglycan content over free swelling 
controls after 21 days in culture. The combination of increased modulus and increased 
glycosaminoglycan formation over free swelling controls after only four weeks in culture 
demonstrates the benefits of bioreactor culture in cartilage tissue engineering. Compression 
bioreactors have also been used to examine the effect of loading on the differentiation of 
bone marrow mesenchymal stem cells down the chondrocytic lineage. Growth factors such 
as transforming growth factor (TGF-) can also be used to encourage differentiation. In a 
study comparing the use of compressive loading, the use of TGF- and the use of a 
combination of loading and TGF-, it was found that compressive loading alone was just as 
effective at inducing chondrogenic differentiation as TGF- or TGF- plus loading (Huang, 
et al., 2004).  
 
4. Bioreactors: State of the Art and Future Directions 
The use of bioreactors has brought us a step closer to engineering numerous tissue types. 
Recently, a bioreactor was used to culture a tissue engineered trachea that was successfully 
implanted into a patient. A donor trachea was decellularized and subsequently seeded with 
the patients own cells. The bioreactor was specifically designed to seed and culture different 
cell types on either side of the donor tissue to allow for nutrient supply and waste removal, 
to provide biomechanical cues in the form of a hydrodynamic shear stress, as well as being 
designed to be autoclaved and handled in a sterile manner. The bioreactor rotated the 
trachea around its longitudinal axis so that a shear stress was applied to the cells to 
stimulate them and to ensure the even distribution of nutrients and waste. In addition to the 
rotation of the graft, the culture medium was continuously mixed to increase oxygenation 
and the exchange of waste and nutrients in the bioreactor chamber (Macchiarini, et al., 2008). 
 
 
However, most bioreactors at present are specialised devices with a low volume output. 
Their assembly is often time consuming and labour intensive. Many also exhibit operator 
dependent variability. Ways of minimizing the time and effort needed to form tissue must 
be sought if costs are to be reduced so that engineered tissues can be routinely used in 
clinical environments. In the future, scaled up versions of some devices (which may be 
automated) could potentially supply larger amounts of tissue. The ideal bioreactor would 
generate the required amount of tissue after a defined culture period. In addition, 
development of tissue could be monitored throughout the culture period through the 
incorporation of for example video microscopy and microcomputed tomography (CT) for 
observing the structural properties of the growing tissue. A better understanding of the 
different effects of mechanical stimulation on cell signalling and mechanotransduction is 
also needed. This can be achieved through the use of existing simple bioreactors in 
conjunction with numerical simulation of culture conditions to minimise the number of 
experiments needed. This may be the future for bioreactors in tissue engineering. 
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1. Introduction    
Synchrotron radiation-based micro computed tomography (SR-µCT) has become a valuable 
tool for the structural analyzes of different types of biomaterials in tissue engineering 
research. This methodology allows to investigate millimetre sized specimens in their three 
dimensional context - even on a cellular level without destroying the material. 
In this chapter we elucidate the use of SR-µCT to analyze several biomaterials for tissue 
engineering research, which are targeted at different applications in the life sciences and 
which feature completely different properties. Among the investigated materials are 
biopolymeric scaffolds for cartilage tissue engineering, a commercial fibre based scaffold, 
biodegradable microspheres as drug release system and two multi-layered materials for 
possible applications in guided nerve growth. Further, as the used SR-µCT beam line allows 
the generation of coherent and monochromatic X-rays, limitations due to low differences in 
absorption contrast can be solved by using the enhanced phase contrast imaging capabilities 
of the beam line station. The three-dimensional data acquired for each investigated sample 
allowed for qualitative and quantitative results unprecedented by light microscopy or 
electron microscopy. While the main focus has been set on imaging aspects, the results 
obtained are discussed in view of the respective literature indicating trends in future 
research. 
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2. Fundamentals of X-Ray Imaging and Tomography 
In 1895 Wilhelm Conrad Röntgen discovered a new type of radiation being emitted from a 
vacuum tube while investigating cathode rays (Röntgen, 1895). Röntgen named this type of 
radiation X-rays and produced the first medical X-ray image showing his wife’s hand. X-
rays are part of the electromagnetic spectrum, although with a much shorter wavelength 
than visible light and with the ability to penetrate matter depending on atomic mass (µ) and 
density (respectively the thickness d) according to the Lambert-Beer’s law (1). 
Especially biological matter, being of low density and being mostly composed of elements 
with a low atomic mass, is penetrated rather well. Consequently, the application of X-rays to 
medical sciences was established from the very beginning, but soon extended to 
applications in chemistry, physics and materials sciences. 
 
0
µdI I e  (1) 
 
Just over twenty years later in 1917 Johann Radon (Radon, 1917) developed the 
mathematical base to calculate cross-sectional views from series of rotational projection 
images - an approach which ultimately laid the basis for X-ray tomography and which is 
known as the projection-slice theorem. Simplified, the projection image of an object at a 
certain rotation angle θ can be described as a set of line integrals, which themselves 
represent the attenuation of the X-ray after traversal through the object. This intensity 
information is, like the first X-ray image of Röntgen’s wife, a two-dimensional image. 
Following, the mathematical fundamentals to derive three-dimensional data from these sets 
of projection images in parallel beam geometry are briefly summarized. Although, other 
beam geometries, like conical or fan beams exist, the simplest mathematical approach is 
given considering a parallel beam of X-rays. This setup was furthermore exclusively used in 
all experiments described in this chapter. For a more in depth description, the reader is 
referred to the work of Kak and Slaney (Kak & Slaney, 1988). Briefly, the total attenuation p 
of a ray at an angle θ and a position r relative to the rotation centre as displayed for a 
phantom object in Figure 1a is given by equation (2), where I is the intensity and µ is the 
attenuation coefficient corresponding to the Lambert-Beer’s law. 
 
0( , ) ln( / ) ( , )p r I I x y ds     (2) 
 
Consequently, a point (x,y) is projected onto r(θ) according to equation (3).  
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Using above formula, equation (2) can be rewritten in its transformed form (4), which is 
called the radon transform or sinogram (Figure 1b). 
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In tomography, the sinogram is used to reconstruct the sliced data from the projection data 
via the inverse of equation (4). The exact reconstruction of a given object in its sliced form 
requires an infinite amount of projections due to the projection-slice theorem. 
Practically, a finite amount of projections in the range of 103 is used to optimize between 
data size/ processing time and reconstructed details. 
Figure 1c displays the back projection obtained from the sinogram, which appears blurred 
and features a distinct halo. Applying a filter significantly reduces this effect and is 
consequently termed filtered back projection (Figure 1d, some artefacts can be observed as 
displayed in the cut-out). A parallel beam geometry has another favourable impact on the 
reconstruction of tomographic data as projections from 0°-180° are identical to projections 
from 180°-360°, which is, for example, not the case for a conical or fan beam geometry. This 
reduced amount of needed measurements directly impacts computing time and data size. 
 
 
Fig. 1. a) Geometrical representation for obtaining the sinogram as demonstrated in b) and 
which is back projected as shown in c) without applying filtering and d) applying a ramp 
filter (the cut-out has been enhanced in contrast to display artefacts due to reconstruction). 
 
3. Synchrotrons as Source for Superior X-Rays 
X-rays can be produced in two different ways. The first approach dates back to Röntgen and 
uses X-ray tubes, essentially evacuated glass tubes with an electrically heated cathode, 
High	Resolution	X-Ray	Tomography	-	3D	Imaging	for	Tissue	Engineering	Applications 339
 
2. Fundamentals of X-Ray Imaging and Tomography 
In 1895 Wilhelm Conrad Röntgen discovered a new type of radiation being emitted from a 
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radiation X-rays and produced the first medical X-ray image showing his wife’s hand. X-
rays are part of the electromagnetic spectrum, although with a much shorter wavelength 
than visible light and with the ability to penetrate matter depending on atomic mass (µ) and 
density (respectively the thickness d) according to the Lambert-Beer’s law (1). 
Especially biological matter, being of low density and being mostly composed of elements 
with a low atomic mass, is penetrated rather well. Consequently, the application of X-rays to 
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X-rays can be produced in two different ways. The first approach dates back to Röntgen and 
uses X-ray tubes, essentially evacuated glass tubes with an electrically heated cathode, 
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which emits electrons by thermionic emission from e.g. a tungsten filament. These electrons 
are accelerated towards the anode (e.g. copper) by applying a high voltage in the range of 
some kilovolts to hundred kilovolts. Furthermore, the anode’s plain surface is positioned at 
an angle relative to the incident electrons at around 5° to 20° and it is made of a heat 
resistant material like tungsten or molybdenum as most of the energy is dissipated as heat 
upon deceleration of the electrons in the anode material. Only a few percent of the energy is 
converted into X-rays which are emitted as a fan or cone beam. 
Although, current X-ray tube-based experimental setups can achieve high quality scientific 
data, some beam related limitations cannot be resolved. Here, synchrotrons offer a more 
advanced source for X-rays by accelerating charged particles (e.g. electrons) in storage rings 
up to relativistic speeds. Although electromagnetic radiation (or synchrotron radiation) is 
already emitted tangentially solely due to the particles being accelerated on a circular 
pathway, the efficacy can be raised significantly using undulators or wigglers. These so 
called insertion devices produce forward directed synchrotron radiation by using a series of 
alternating magnets, forcing the particles into oscillations and to loose energy in the form of 
synchrotron radiation. This radiation offers a high photon flux over a large range of 
energies, a high brilliance, a high level of polarization and coherency. Due to the high 
photon flux, wavelength monochromatization is a feasible approach (Dilmanian, 1992; 
Bonse & Bush, 1996). In this context, methods based on synchrotron radiation, allow for 
faster measurements and a broader spectrum of applications. For a more detailed 
comparison between synchrotron generated and tube-generated X-rays, the reader is 
referred to Bernhard et al. (Bernhard et al., 2004). 
 
 
Fig. 2. Basic SR-µCT experimental setup, allowing measurement in both absorption contrast 
and phase contrast. Top: real world projection images of a thin sectioned articular cartilage 
specimen showing the impact of the distance between scintillator and sample on absorption 
contrast/ phase contrast (adapted from Zehbe1 et al., 2009). 
 
A promising methodology for certain imaging applications, where it is impossible to rely 
solely on absorption contrast, was introduced at third generation synchrotron sources (e.g. 
 
ESRF, BESSY II or in the future PETRA III). This methodology requires a partially coherent 
beam and allows applying phase contrast to X-ray imaging techniques. While imaging in 
absorption contrast is well adapted to samples featuring a prominent difference in density 
or atomic mass, phase contrast imaging allows detection of structural details which are not 
well visible in absorption. Here, the contrast is achieved by retardation or refraction of 
coherent X-rays at phase boundaries inside the sample (Cloetens et al., 2006; Rack et al., 
2008; Zehbe1 et al., 2009). Fig. 2 illustrates the basic experimental setup which was used 
throughout this chapter and details the impact of the sample position relative to the 
scintillator on the resulting image contrast. The top left of Fig. 2 displays the projection 
images of a sliced bovine cartilage specimen mounted on a microscope slide being imaged at 
the same X-ray energy of 10 keV but different distances to the scintillator. Well visible is the 
increasing edge retrieval for the elliptical object with greater distance to the scintillator. 
 
4. X-Ray Tomography and the Life Sciences 
X-ray based tomography was first established by Hounsfield and Cormack (Hounsfield, 
1973, Cormack, 1973) using an X-ray tube based setup. This work cumulated in the 
introduction of the first clinical X-ray tomography system in 1975. With the advancement of 
superior experimental setups new scientific applications became possible, allowing adapting 
tomographic experiments to much smaller samples while obtaining an unprecedented 
resolution on the micrometer scale. This methodology was consequently termed micro 
computed tomography (µCT). 
One of the first medical related research fields in µCT was the analysis of trabecular bone 
samples by Feldkamp et al. (Feldkamp  et al., 1989) but was soon extended to other areas 
including tissue engineering (Ho & Hutmacher, 2006). The superior properties of 
synchrotron generated X-rays further benefitted the tomographic analyses in the life 
sciences and became known as SR-µCT (Bonse & Bush, 1996). Finally, µCT (regardless of the 
origin of the X-ray) is heavily dependent on advanced computer technology benefiting 
significantly from the improvements in this field over the last 20 years. In this context, it 
should be noted that current tomographic data sets can easily amount to several hundred 
gigabytes in uncompressed size (e.g. approximately 280 Gigabytes for a data set of 4096 
pixel x 4096 pixel x 4096 pixel in 32 bit grey values). Even nowadays the processing of such 
data can take a very long time or might even be impossible for single workstation computer 
systems. Concerning the experimental conditions, enhancements in scintillators (which are 
needed for the conversion of X-rays into visible light) and of course the high mechanical 
precision of modern rotational stages are prerequisites for acquiring high resolution 
tomographic data. In experiments which rely mainly on absorption contrast to image 
biological specimen, it is usually mandatory to significantly enhance this contrast. In this 
regard, metal staining commonly used in electron microscopy is a well adapted 
methodology especially if a discrimination of soft tissue structures is to be considered. One 
of the principal metal stains is osmiumtetroxide (OsO4) which is a potent lipid stain and 
allows detection of cells or other lipid tissue structures. Using SR-µCT, OsO4 has been used 
among many others by Ginty et al. to investigate cell seeded scaffolds (Ginty et al., 2006), by 
Lareida et al. to investigate the microstructure of the inner ear (Lareida et al., 2009) and by 
ourselves to detect cells inside a multilayered sheet scaffold as will be described later in 
section 7.4. A more specific staining can be achieved using immunhistochemical methods or 
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1973, Cormack, 1973) using an X-ray tube based setup. This work cumulated in the 
introduction of the first clinical X-ray tomography system in 1975. With the advancement of 
superior experimental setups new scientific applications became possible, allowing adapting 
tomographic experiments to much smaller samples while obtaining an unprecedented 
resolution on the micrometer scale. This methodology was consequently termed micro 
computed tomography (µCT). 
One of the first medical related research fields in µCT was the analysis of trabecular bone 
samples by Feldkamp et al. (Feldkamp  et al., 1989) but was soon extended to other areas 
including tissue engineering (Ho & Hutmacher, 2006). The superior properties of 
synchrotron generated X-rays further benefitted the tomographic analyses in the life 
sciences and became known as SR-µCT (Bonse & Bush, 1996). Finally, µCT (regardless of the 
origin of the X-ray) is heavily dependent on advanced computer technology benefiting 
significantly from the improvements in this field over the last 20 years. In this context, it 
should be noted that current tomographic data sets can easily amount to several hundred 
gigabytes in uncompressed size (e.g. approximately 280 Gigabytes for a data set of 4096 
pixel x 4096 pixel x 4096 pixel in 32 bit grey values). Even nowadays the processing of such 
data can take a very long time or might even be impossible for single workstation computer 
systems. Concerning the experimental conditions, enhancements in scintillators (which are 
needed for the conversion of X-rays into visible light) and of course the high mechanical 
precision of modern rotational stages are prerequisites for acquiring high resolution 
tomographic data. In experiments which rely mainly on absorption contrast to image 
biological specimen, it is usually mandatory to significantly enhance this contrast. In this 
regard, metal staining commonly used in electron microscopy is a well adapted 
methodology especially if a discrimination of soft tissue structures is to be considered. One 
of the principal metal stains is osmiumtetroxide (OsO4) which is a potent lipid stain and 
allows detection of cells or other lipid tissue structures. Using SR-µCT, OsO4 has been used 
among many others by Ginty et al. to investigate cell seeded scaffolds (Ginty et al., 2006), by 
Lareida et al. to investigate the microstructure of the inner ear (Lareida et al., 2009) and by 
ourselves to detect cells inside a multilayered sheet scaffold as will be described later in 
section 7.4. A more specific staining can be achieved using immunhistochemical methods or 
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probes. In our own research (see section 7.1) we have established Au-lysine as a potent 
marker for anionic sites at the cell surface (Zehbe2 et al., 2009). 
To circumvent the usage of staining agents, which possibly introduce artefacts or which 
might occlude certain structural details from view, the application of phase contrast imaging 
is a valuable alternative. While a measurement in absorption contrast relies on the 
adaptation of the beam energy to the sample, phase contrast imaging relies solely on a 
coherent beam and therefore can be adjusted by varying the distance between sample and 
scintillator. In this measurement mode it is further possible to significantly reduce the dose 
applied to the sample by increasing the beam energy. In principle, this mode of operation 
allows imaging both strongly and weakly absorbing structures simultaneously. The reader 
is referred to the work of Cloetens et al. (Cloetens et al., 2006) and our own work (Zehbe1 et 
al., 2009) for a more detailed discussion. 
 
5. Tissue Engineering 
In regenerative medicine, tissue engineering can be described as a tool to re-establish lost 
functionality and morphology to a previously damaged tissue. Over the years, several 
strategies were developed with combinations of cells and biomaterials playing a crucial role. 
These constructs are designed to be transplanted into the defect site and are already in 
clinical application. In orthopaedic surgery this methodology is usually termed matrix based 
autologeous chondrocyte transplantation. In this context, artificial scaffolds were 
introduced, allowing predefining a structure, into which cells can be expanded and 
immobilized in vitro or which serve as filler for migrating cells in vivo. Current tissue 
engineering strategies further adapt biochemical targeting to specifically stimulate 
proliferation, matrix synthesis or to control cell differentiation or cell migration. This last 
approach usually involves drug release concepts. 
The archetype for all these tissue engineering strategies is the native and healthy tissue 
which should be regenerated and remodelled. From an investigational viewpoint, the gold 
standard defining this native structure is given by the analysis of histolochemically stained 
slices of the specimen. Unfortunately, this approach results in the complete loss of all 
volumetric morphological information, and requires complex procedures if it is to be 
recovered, usually involving alignment and registration of subsequent serial sections 
(Braverman et al., 1986). Due to its non destructive nature and its ability to resolve the true 
volumetric representation of a given specimen, µCT and especially SR-µCT have become 
important methods in the life sciences. 
The following research details some possible applications in tissue engineering, putting a 
focus on cartilage tissue engineering. Later on, this chapter deals with approaches using 
stacks of polymer sheets for possible applications in neuronal tissue engineering. 
 
6. Experimental Setup 
Computed tomography (CT) requires a setup where either the sample or the beam source/ 
detector system (e.g. clinical CTs) are rotated relative to each other. For synchrotron 
radiation based experimental setups, a rotation of the beam source/ detector system is 
impossible. In this case, the sample is positioned on a multiaxial high precision rotational 
stage, allowing adjustment of translation, rotation and tilting. The experimental setup as 
 
displayed in Fig.2 has been used predominantly in this chapter and is described in several 
studies (Zehbe1 et al., 2007; Zehbe1 et al., 2009; Rack et al., 2008). Although the photon flux 
density is several orders of magnitude higher than in X-ray tubes, it is not constant over the 
X-ray energy. Fig. 3 displays the dependency of the photon flux density from the X-ray 
energy as was calculated according to Schäffers et al. for the BAMline experimental station 
at BESSY II (Schäffers et al., 1996). Here, at around 10 keV, the photon flux density is 
dramatically reduced due to the used monochromator (DMM, see inset) being coated with 
tungsten (L3ab absorption edge at 10.198 keV). Accordingly, measurements in this energy 
range usually require longer exposure times due to the reduced photon flux when 
compared to for example measurements at around 22 keV. In the research detailed in this 
chapter, the energy was set to different values ranging from 7 keV to 30 keV, while further 
using different sample to scintillator distances as to achieving the desired contrast mode. 
The scintillator consisted of a thin, single CdWO4 crystal and was coupled to light optics (up 
to 10x magnification) and a CCD camera (2048x2048, peltier cooled to -30 °C). The acquired 
projection images were recorded in multi-image file formats. 
 
 
Fig. 3. Photon flux density behind the double multilayer monochromator (DMM) at the 
BAMline according to Schäffers et al. and Rack et al. (Schäffers et al., 1996, Rack et al., 2008). 
Around 10 keV the flux is reduced; data from BAMline description (Riesemeier et al. 2007). 
 
7. Research 
For an in-depth description of the experimental methodology and the results obtained, the 
reader is kindly referred to Table 2 at the end of this chapter and the cited references. 
Rendered data has been re-coloured for visualization purposes. 
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7.1 Cartilage Tissue Engineering 
Degenerative, rheumatic or traumatic processes are the predominant causes for articular 
cartilage damage. The tissue itself has only a very limited regenerative potential and 
consequently, cartilage tissue engineering aims at either repopulating a defect with an 
excess amount of autologeous cells, stabilizing the defect area by supporting cell-scaffold 
constructs or enhancing the regeneration by biochemical targeting mechanisms. To better 
understand these different tissue engineering approaches it is mandatory to comprehend 
structure and function of the native tissue. Articular cartilage covers the ends of the long 
bones and is well known for its mechanical and tribological properties featuring a specific 
zonal structure of the extracellular matrix (primarily collagen II and proteoglycans) and the 
integrated cartilage cells, the chondrocytes. The following regions can be identified as 
follows: the surface zone, the middle zone, the deep zone and the subchondral bone 
(Buckwalter & Mankin, 1997). Depending on the zonal localisation, the chondrocytes appear 
in different morphologies. They are stretched along the surface as are the collagen fibres, 
while being mostly elliptical or rounded in the middle zone, where some cells form 
isogeneous cell groups. Towards the deep zone, the collagen fibres become more 
perpendicularly oriented to the surface resulting in a rise in stiffness. This zone further 
becomes increasingly calcified and connects to the subchondral bone. 
In a previous study (Zehbe1 et al., 2009) we have elucidated the use of SR-µCT to image the 
volumetric tissue morphology. Although the original data showed strong ring artefacts due 
to scintillator errors, as displayed in Fig. 4a, these artefacts were well compensated by 
sinogram correction as shown in Fig. 4b. 
 
 
 
Fig. 4. Morphology of bovine articular cartilage and data enhancement through sinogram 
correction (a-c) resulting in the rendered data (d). 
 
In the sinogram data (Fig. 4c), ring artefacts appear as parallel streaks or lines and can be 
easily filtered with a median filter. The data was rendered in a user defined colour scheme 
as displayed in Fig. 4d, showing the three-dimensional distribution and orientation of the 
chondrocytes depending on their zonal localisation. 
Consequently, a tissue engineering approach should adapt as many of these properties as 
possible. As pure cell based tissue engineering can only partly re-establish the cellularity, 
usage of scaffold systems offers a methodology not only to restore the cellularity but also 
structure and function. These scaffolds are usually made of synthetic or natural polymers by 
techniques like fibre bonding, solvent casting, gas foaming or phase separation (Mikos & 
Temenoff, 2000). In our own research on scaffolds for cartilage tissue engineering, we 
developed a technique, which uses a directional freezing process to structure water based 
solutions of gelatine. This process was further designed to allow for the electrolysis of water 
prior to freezing and consequently results in the introduction of gas bubbles inside the 
gelatine solution before it is directionally frozen. Addition of other components like salts, 
acids, ceramics or polymer particles allows synthesising composite scaffolds or achieving 
different pore morphologies (Zehbe et al., 2005; Zehbe1 et al., 2007; Zehbe2 et al., 2009). 
Fig. 5 displays some rendered representations of scaffolds made by ourselves and which are 
designed to degrade biologically. 
 
High	Resolution	X-Ray	Tomography	-	3D	Imaging	for	Tissue	Engineering	Applications 345
 
7.1 Cartilage Tissue Engineering 
Degenerative, rheumatic or traumatic processes are the predominant causes for articular 
cartilage damage. The tissue itself has only a very limited regenerative potential and 
consequently, cartilage tissue engineering aims at either repopulating a defect with an 
excess amount of autologeous cells, stabilizing the defect area by supporting cell-scaffold 
constructs or enhancing the regeneration by biochemical targeting mechanisms. To better 
understand these different tissue engineering approaches it is mandatory to comprehend 
structure and function of the native tissue. Articular cartilage covers the ends of the long 
bones and is well known for its mechanical and tribological properties featuring a specific 
zonal structure of the extracellular matrix (primarily collagen II and proteoglycans) and the 
integrated cartilage cells, the chondrocytes. The following regions can be identified as 
follows: the surface zone, the middle zone, the deep zone and the subchondral bone 
(Buckwalter & Mankin, 1997). Depending on the zonal localisation, the chondrocytes appear 
in different morphologies. They are stretched along the surface as are the collagen fibres, 
while being mostly elliptical or rounded in the middle zone, where some cells form 
isogeneous cell groups. Towards the deep zone, the collagen fibres become more 
perpendicularly oriented to the surface resulting in a rise in stiffness. This zone further 
becomes increasingly calcified and connects to the subchondral bone. 
In a previous study (Zehbe1 et al., 2009) we have elucidated the use of SR-µCT to image the 
volumetric tissue morphology. Although the original data showed strong ring artefacts due 
to scintillator errors, as displayed in Fig. 4a, these artefacts were well compensated by 
sinogram correction as shown in Fig. 4b. 
 
 
 
Fig. 4. Morphology of bovine articular cartilage and data enhancement through sinogram 
correction (a-c) resulting in the rendered data (d). 
 
In the sinogram data (Fig. 4c), ring artefacts appear as parallel streaks or lines and can be 
easily filtered with a median filter. The data was rendered in a user defined colour scheme 
as displayed in Fig. 4d, showing the three-dimensional distribution and orientation of the 
chondrocytes depending on their zonal localisation. 
Consequently, a tissue engineering approach should adapt as many of these properties as 
possible. As pure cell based tissue engineering can only partly re-establish the cellularity, 
usage of scaffold systems offers a methodology not only to restore the cellularity but also 
structure and function. These scaffolds are usually made of synthetic or natural polymers by 
techniques like fibre bonding, solvent casting, gas foaming or phase separation (Mikos & 
Temenoff, 2000). In our own research on scaffolds for cartilage tissue engineering, we 
developed a technique, which uses a directional freezing process to structure water based 
solutions of gelatine. This process was further designed to allow for the electrolysis of water 
prior to freezing and consequently results in the introduction of gas bubbles inside the 
gelatine solution before it is directionally frozen. Addition of other components like salts, 
acids, ceramics or polymer particles allows synthesising composite scaffolds or achieving 
different pore morphologies (Zehbe et al., 2005; Zehbe1 et al., 2007; Zehbe2 et al., 2009). 
Fig. 5 displays some rendered representations of scaffolds made by ourselves and which are 
designed to degrade biologically. 
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Fig. 5. Scaffolds for cartilage tissue engineering. a) Ethisorb ®, b) – f) gelatine scaffolds with 
increasing pore diameter, g) gelatine scaffolds with cells in fibrin matrix, h) gelatine-
hydroxyapatite-composite scaffolds, i) PLGA-microsphere modified gelatine scaffold, 
j) scaffold with manual separated cells (red) and Au/ Ag stained cells (white) and 
k) scaffold with Au/ Ag stained cells (white) at the surface only. 
 
Fig. 5a shows a competing commercial type scaffold (Ethisorb ®) which is made of PLGA-
fibres being connected by poly-p-dioxanone and which was cultivated with porcine 
chondrocytes (2 * 106 cells) for 1 week, although the SR-µCT data did not reveal cells, the 
scaffold morphology was well imaged. 
Figs. 5b to 5f demonstrate the effects of different freezing temperatures and differing ion 
contents (here, addition of hydrochloric acid) on the pore morphology as outlined in 
Table 1. The Feret’s diameter of the pores was calculated as mean value from each slice of 
the respective tomographic data (Zehbe2 et al., 2009). All these gelatine scaffolds were 
cultivated with porcine chondrocytes similar to the commercial Ethisorb® scaffold as 
described above. Further, the cultivated cells were labelled with a cell surface specific metal 
stain (Au-lysine in combination with a silver enhancer) to better visualize individual cells in 
the tomographic data. 
 
Scaffold 
(as labelled in Fig. 5) 
b) c) d) e) f) j) k) 
Freezing temperature 
(°C) 
 
-10 
 
-10 
 
-10 
 
-20 
 
-30 
 
-10 
 
-20 
HCl content (1 molar) 
(ml/ml) 
 
0.08 
 
0.04 
 
0.00 
 
0.00 
 
0.00 
 
0.08 
 
0.00 
Pore diameter (Feret) 
(µm) 
 
606 
 
374 
 
240 
 
131 
 
67 
 
606 
 
131 
Table 1. Parameters influencing the pore morphology of gelatine scaffolds (scaffold b) and j) 
and scaffold e) and k) are identical). 
 
Interestingly, this staining did not label all cells as intensely as desired (Fig. 5j). 
Consequently, cells were individually separated using a software-based volumetric mark-up 
tool. As a result, it was only possible to demonstrate a homogeneous and dense population 
of cells inside the larger pored scaffolds (Fig. 5b/ 5j), while the denser scaffolds appeared to 
show intensely stained cell-clusters at the surface only (Fig. 5e/ 5k). 
In a different approach we infiltrated scaffolds with a cell-suspension containing fibrin to 
immobilize the cells immediately after seeding inside the scaffold. This approach was partly 
successful, as it allowed for a better seeding efficacy but resulted in a layer of fibrin and cells 
at the surface of the scaffold only (Fig. 5g). Due to the increased phase contrast in this SR-
µCT experiment, it was possible to identify individual cells rather easily (cells can be seen as 
grainy structure on top of the scaffold). 
Another two completely different gelatine scaffolds were made by incorporating 
hydroxyapatite (HAp) as a bottom layer being designed to seal against the subchondral 
bone in vivo (Fig. 5h) and by distributing polymeric poly-lactide-co-glycolide (PLGA) 
microspheres inside the gelatine suspension (Fig. 5i). These microspheres were intended as 
possible carriers for targeting molecules (here: prostaglandine E2, PGE2) in a drug-release 
setup. The morphology and the design of the drug-loaded PLGA-microspheres are further 
detailed in section 7.3. From a tomographic viewpoint these different components were 
easily separated from the gelatine network, revealing their respective structures rather well. 
Due to all components having differing elemental compositions or densities, imaging was 
performed in absorption contrast (Zehbe1 et al., 2007). 
On the other hand absorption contrast cannot be well utilized for scaffolds in a watery or 
swollen state. Consequently, further experiments were conducted using phase contrast 
imaging to elucidate the resistance of the scaffolds against compression in a wet 
environment as detailed in the following section. 
 
7.2 Mechanics and Morphology of Scaffolds for Cartilage Tissue Engineering 
Articular cartilage demonstrates mechanical and tribological properties allowing lifelong 
relative movement of adjacent bones. Tissue engineering concepts, especially those dealing 
with artificial scaffolds, should, if possible, adapt these properties to some extend. 
In this regard, an early study of us (Zehbe et al., 2004) proved near native mechanical 
properties for gelatine scaffolds with a highly directional pore structure as discussed in the 
previous section. Mechanical testing of the water soaked scaffolds in confined and 
unconfined conditions showed a strain increase caused by fluid efflux, typical for biphasic 
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materials. Young’s moduli were determined to Es = 0.67 ± 0.02 MPa in unconfined 
compression, aggregate moduli to HA = 0.84 ± 0.03 MPa in confined compression and the 
Poisson’s ratio to εs = 0.27. The obtained values correspond well with bovine cartilage tissue 
measured by Korhonen et al. (Korhonen et al., 2002). 
Until now, we were not able to determine the three-dimensional structural changes of these 
scaffolds under mechanical load. Therefore, we adapted SR-µCT in phase contrast imaging 
mode to determine structural changes, while completely immersing the scaffolds in water. 
 
 
Fig. 6. a) Experimental setup for combined tomographical and mechanical investigations, 
b) acquired sliced data of subsequent mechanical displacements and c) rendered data 
comparing two different compression levels. 
 
Although the absorption coefficients for water and gelatine are almost similar and would 
make it extremely difficult to achieve any tomographic details in absorption, phase contrast 
imaging in this case allows for an excellent contrast. Consequently, we have established an 
experimental setup (Fig. 6a) allowing simultaneous mechanical loading and tomographic 
measurement of water soaked gelatine scaffolds. The loading setup consisting of a 
micrometer screw, a plexiglas rod and a simple force sensor is described in more detail in 
Thiem et al. (Thiem et al., 2009). Briefly, a water soaked and air bubble free scaffold was 
placed inside the plexiglas rod while carefully adjusting the on top stamp and calibrating 
the force sensor. This whole setup was placed on the sample stage and was adjusted in the 
beam. The maximum possible distance of 109 cm between sample and scintillator and a 
beam energy of 30 keV ensured sufficient phase contrast to detect the scaffold structure in 
the watery environment as seen in the sliced data (Fig. 6b) and in the rendered data (Fig. 6c). 
The parallel pore network appears to bulge at specific sites (Fig. 6b – 1.0 mm displacement) 
upon increasing the load. As a result most of the mechanical energy is dissipated at these 
sites, while leaving the overall scaffold structure mostly intact. Upon further loading, the 
 
pore network cannot withstand and the pore channels collapse (Fig. 6b – 1.5 mm 
displacement). Summarizing the previously measured biphasic material properties and the 
newly acquired three-dimensional morphological data, we expect good mechanical 
properties in vivo as well. 
 
7.3 Polymeric Drug Release System for Cartilage Tissue Engineering 
Current tissue engineering concepts consider biomolecular targeting mechanisms aimed at 
specific cells the most feasible approach towards successful tissue regeneration. 
Consequently, the integration of targeting molecules into scaffold materials might 
significantly improve the quality and long-term performance of the regenerating tissue by 
maintaining cellular differentiation and optimal tissue functions. In this context, numerous 
substances are known to promote tissue regeneration by stimulation of specific cellular 
pathways. Well established in bone and cartilage tissue engineering are the members of the 
TGF-β superfamily, including the bone morphogenic proteins (BMP) and other related 
substances (Nicoll et al.,  1998). 
From the viewpoint of cartilage tissue engineering another promising class of targeting 
molecules has been found in the metabolites of the arachidonic acid – namely 
prostaglandine E2, which has been demonstrated being important in both developmental 
processes and in tissue regeneration (Sandulache et al., 2006) including bone repair and 
cartilage regeneration. One limiting factor which applies to many targeting molecules is 
their short half-life in vivo. One possibility to prolong the availability in vitro or in vivo is to 
encapsulate the targeting molecule directly inside the scaffold material or indirectly by 
using a more defined carrier system like polymeric microspheres. 
In previous studies we have adapted this later approach and were able to successfully 
encapsulate PGE2 into polymeric polylactide-co-glycolide microspheres (Watzer et al., 2009). 
For more detailed information, the reader is referred to the chapter by Brochhausen et al. in 
this same book. The integration of these microspheres into a gelatine scaffold was briefly 
described in section 7.1. Unfortunately, the data obtained by SR-µCT did not reveal 
ultrastructural details, probably due to a too low difference in absorption contrast, which 
was the dominant image contrast. A reinvestigation (Zehbe3 et al., 2009) of single 
microspheres at a slightly higher resolution but in phase contrast imaging mode revealed 
the data presented in Fig. 7. Apparently, the PGE2-loaded PLGA-microspheres feature a 
porous shell with a compact core (Fig. 7a and Fig. 7c). It is currently unknown if this 
porosity is due to local solvent-entrapment and accumulation, while the PLGA continuously 
hardens, forming hollow structures or, some other mechanism. 
This structural data might explain the release profile (Brochhausen et al., 2008), which is 
shown in Fig. 7b, showing a burst release early on with a plateau after 24 h and decreasing 
release afterwards. The more porous shell can probably release the PGE2 much faster than 
the compact core which functions as diffusion barrier limiting the progress of the target 
molecule from the inside to the outside. 
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Fig. 7. PGE2-loaded PLGA microsphere: a) rendered SR-µCT data, b) release profile and c) 
sliced SR-µCT data. 
 
7.4 A Different Type of Cell Sheet Engineering investigated by SR-µCT 
A few years ago a novel cell culture technology was developed and termed cell sheet 
engineering (Shimizu et al., 2003). This technology uses a thermoresponsive polymer 
(poly(N-isopropylacrylamide, PIPAAm) to detach cultivated monolayer cells from tissue 
culture ware by changing the PIPAAm from a hydrophilic state to a hydrophobic state by 
decreasing the temperature below 32 °C. The main advantage of this technology is that a 
pure (autologeous) cell sheet can be harvested without any supporting biomaterial which 
can be beneficial in applications, where an artificial material is not desired. Further, these 
cell sheets can be stacked. Due to the monolayer nature of this tissue engineering technique, 
only relatively thin cell layer aggregates can be achieved. To achieve a thicker more scaffold 
like structure, we have developed a different approach by cultivating cells on thin 
composite coatings of PLGA and gelatine on cell culture ware. As the gelatine gradually 
swells in cell culture and partly dissolves, the resulting porous PLGA-gelatine sheet and the 
cells on top can be easily detached from the cell culture ware either for further in vitro 
experimentation or by stacking these sheets obtaining a layered structure of cells and 
supporting biomaterial. 
Fig. 8 displays a stack of 13 PLGA-gelatine sheets which were cultivated with a chondrocyte 
cell line (CHON-001) and which were afterwards fixated using glutaraldehyde and stained 
 
with OsO4. Due to the enhanced absorption contrast resulting from using OsO4 a 
morphological differentiation between cells and supporting PLGA-gelatine-sheets can be 
achieved via SR-µCT. 
 
 
Fig. 8. Stack of thirteen PLGA-gelatine sheets pre-cultivated with a cell line, glutaraldehyde 
fixated and OsO4 stained. a) rendered data, b) and c) sliced data (frontal and horizontal). 
 
While Fig. 8a displays the rendered SR-µCT data, Figure 8b and 8c display the 
corresponding frontal and horizontal sliced data. Arrows indicate exemplarily locations of 
OsO4 stained cells, which exhibit a strong absorption contrast sometimes resulting in 
artefacts due to shading effects. Overall, the structural data obtained indicates possible 
applications in the area of the tissue engineering of articular cartilage, skin or nerve tissue. 
Further, nerve tissue engineering is the topic of the following section describing yet another 
approach using stacked polymer sheets. 
 
7.5 Neuronal Tissue Engineering 
Restoring peripheral nerve damage is an important research field in tissue engineering 
sciences. One promising approach uses so called nerve conduits consisting of biodegradable 
polymers. The intention for using these conduits is to establish a preformed structure 
serving as guidance for axonal growth in vivo. 
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In this context, it can be beneficial to prearrange autologeous neuronal cells inside these 
conduits to achieve a better control over axonal growth e.g. by structural, biochemical or 
physical means. Biochemical stimulation can be achieved by integrating certain targeting 
molecules into the conduits similar to the methodology described in section 7.3. Here, the 
nerve growth factor protein (NGF) is probably the most relevant biochemical substance in 
neuronal tissue engineering (Bhang et al., 2007). Its usage is one of several other biochemical 
and physical mechanisms that can be applied to control neuronal regeneration (Schmidt1 et 
al., 2009). Concerning physical stimulation, it is well known, that neuronal cells are 
especially susceptible to electrical potentials. Therefore, in the following research, we 
present a rather simple methodology to control cell growth by applying an electrical 
potential and we demonstrate that SR-µCT can be used to confirm the efficacy from a three-
dimensional morphological viewpoint (Schmidt2 et al., 2009). 
One major problem occurring in tissue engineering can be attributed to the fact that cells 
usually grow in a non ordered fashion in vitro. Consequently, we have developed a 
technique to print microelectrodes on polymer sheets via a method named inverse ink-jet 
printing (using a sputter coater to establish a gold metallization) allowing for vital co-
deposition of cells and the protein fibrin on the anode part of the electrodes (Zehbe2 et al. 
2007). While the structural resolution of the electrodes is limited by the used printer, a 
minimal line width of 35 µm was achievable with a HP deskjet 3520. At first, this method 
was designed for two-dimensional cell cultivation purposes, but was later extended into the 
third dimension by stacking - similar to section 7.4. 
The electrodes being designed for an intended use in neuronal tissue engineering feature 
parallel aligned rows of thin gold made by the sputter coating process. All rows were 
contacted anodically allowing for deposition of cells and fibrin. Afterwards, several 
microelectrodes with the on top cells were stacked, fixated using glutaraldehyde, rinsed in 
distilled water and freeze-dried for further SR-µCT investigations. One microelectrode was 
used for separate vital staining using fluoresceindiacetate/ ethidiumbromide and displays 
nearly 100% vitality (see Fig. 9c). Moreover, the cells were found to adhere solely on the 
anode parts of the electrodes – an effect which we think results from the co-deposited fibrin 
network, serving as artificial extracellular matrix immobilizing the deposited cells. 
Concerning the following SR-µCT imaging experiments, the final imaging results were 
rather interesting and unexpected. As the experiments were conducted in absorption 
contrast only, the expected result would have been to observe strongly absorbing deposited 
gold structures and a weekly absorbing polymer substrate. Further, as the deposited cells 
were not stained with any metal stain (like OsO4), we did not expect to observe the cells 
themselves, as they have a low density and are thin compared to the polymer substrate. 
But interestingly, cells were imaged well (Fig. 9a and 9b) and in good accordance with the 
fluorescence microscopic images acquired previously. This effect is even more 
astonishingly, as the cells appear as even stronger absorbing structures than the deposited 
gold layer. Currently, we do not have a valid explanation for this imaging result. 
 
 
 
Fig. 9. a) rendered SR-µCT data of a design study for a possible 3D-nerve conduit consisting 
of stacked micro electrodes, b) magnified SR-µCT data showing single cells and c) 
corresponding fluorescence microscopic image of a vital stain showing 100 % vital cells. 
 
8. Discussion and Conclusion 
In this chapter we have given a brief overview of some tissue engineering strategies and 
biomaterials concepts while focussing on high resolution SR-µCT imaging. 
As was stated previously the presented research should be viewed in the light of the 
respective references, which give more detailed information. Among the described tissue 
engineering solutions, the most extensive research has been conducted on gelatine scaffolds 
with an adjustable pore network for articular cartilage tissue engineering. These scaffolds 
were designed to allow for further optimizations by introducing other substances like 
hydroxyapatite as filler for subchondral bone defects or by addition of biochemical targeting 
molecules to stimulate tissue regeneration. Here, prostaglandine E2 was immobilized 
exemplarily in polylactide-co-glycolide microspheres for extended release, while 
distributing the microspheres in the pore structure of the gelatine scaffolds. 
The presented tomographic data for this tissue engineering solution detailed both cells and 
scaffold materials down to a voxel resolution of 1.6 µm. 
One major advantage of synchrotron radiation based µCT in combination with a highly 
coherent beam was found in the enhanced phase contrast imaging capabilities of the used 
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In this context, it can be beneficial to prearrange autologeous neuronal cells inside these 
conduits to achieve a better control over axonal growth e.g. by structural, biochemical or 
physical means. Biochemical stimulation can be achieved by integrating certain targeting 
molecules into the conduits similar to the methodology described in section 7.3. Here, the 
nerve growth factor protein (NGF) is probably the most relevant biochemical substance in 
neuronal tissue engineering (Bhang et al., 2007). Its usage is one of several other biochemical 
and physical mechanisms that can be applied to control neuronal regeneration (Schmidt1 et 
al., 2009). Concerning physical stimulation, it is well known, that neuronal cells are 
especially susceptible to electrical potentials. Therefore, in the following research, we 
present a rather simple methodology to control cell growth by applying an electrical 
potential and we demonstrate that SR-µCT can be used to confirm the efficacy from a three-
dimensional morphological viewpoint (Schmidt2 et al., 2009). 
One major problem occurring in tissue engineering can be attributed to the fact that cells 
usually grow in a non ordered fashion in vitro. Consequently, we have developed a 
technique to print microelectrodes on polymer sheets via a method named inverse ink-jet 
printing (using a sputter coater to establish a gold metallization) allowing for vital co-
deposition of cells and the protein fibrin on the anode part of the electrodes (Zehbe2 et al. 
2007). While the structural resolution of the electrodes is limited by the used printer, a 
minimal line width of 35 µm was achievable with a HP deskjet 3520. At first, this method 
was designed for two-dimensional cell cultivation purposes, but was later extended into the 
third dimension by stacking - similar to section 7.4. 
The electrodes being designed for an intended use in neuronal tissue engineering feature 
parallel aligned rows of thin gold made by the sputter coating process. All rows were 
contacted anodically allowing for deposition of cells and fibrin. Afterwards, several 
microelectrodes with the on top cells were stacked, fixated using glutaraldehyde, rinsed in 
distilled water and freeze-dried for further SR-µCT investigations. One microelectrode was 
used for separate vital staining using fluoresceindiacetate/ ethidiumbromide and displays 
nearly 100% vitality (see Fig. 9c). Moreover, the cells were found to adhere solely on the 
anode parts of the electrodes – an effect which we think results from the co-deposited fibrin 
network, serving as artificial extracellular matrix immobilizing the deposited cells. 
Concerning the following SR-µCT imaging experiments, the final imaging results were 
rather interesting and unexpected. As the experiments were conducted in absorption 
contrast only, the expected result would have been to observe strongly absorbing deposited 
gold structures and a weekly absorbing polymer substrate. Further, as the deposited cells 
were not stained with any metal stain (like OsO4), we did not expect to observe the cells 
themselves, as they have a low density and are thin compared to the polymer substrate. 
But interestingly, cells were imaged well (Fig. 9a and 9b) and in good accordance with the 
fluorescence microscopic images acquired previously. This effect is even more 
astonishingly, as the cells appear as even stronger absorbing structures than the deposited 
gold layer. Currently, we do not have a valid explanation for this imaging result. 
 
 
 
Fig. 9. a) rendered SR-µCT data of a design study for a possible 3D-nerve conduit consisting 
of stacked micro electrodes, b) magnified SR-µCT data showing single cells and c) 
corresponding fluorescence microscopic image of a vital stain showing 100 % vital cells. 
 
8. Discussion and Conclusion 
In this chapter we have given a brief overview of some tissue engineering strategies and 
biomaterials concepts while focussing on high resolution SR-µCT imaging. 
As was stated previously the presented research should be viewed in the light of the 
respective references, which give more detailed information. Among the described tissue 
engineering solutions, the most extensive research has been conducted on gelatine scaffolds 
with an adjustable pore network for articular cartilage tissue engineering. These scaffolds 
were designed to allow for further optimizations by introducing other substances like 
hydroxyapatite as filler for subchondral bone defects or by addition of biochemical targeting 
molecules to stimulate tissue regeneration. Here, prostaglandine E2 was immobilized 
exemplarily in polylactide-co-glycolide microspheres for extended release, while 
distributing the microspheres in the pore structure of the gelatine scaffolds. 
The presented tomographic data for this tissue engineering solution detailed both cells and 
scaffold materials down to a voxel resolution of 1.6 µm. 
One major advantage of synchrotron radiation based µCT in combination with a highly 
coherent beam was found in the enhanced phase contrast imaging capabilities of the used 
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beamline in some experiments. Here, the demonstration of the pore channel collapse under 
mechanical loading resolved structures otherwise not visible in absorption contrast. 
A resolution up to single biological cells was demonstrated in different imaging conditions. 
While OsO4 and a combination of Au-lysine with a silver enhancer were used to increase the 
imaging results in absorption contrast, phase contrast imaging was adapted to image 
individual cells in both native cartilage tissue and inside gelatine scaffolds as well. A rather 
interesting result was found for a stack of microelectrodes, where exceptionally well 
resolved single cells were found in absorption contrast. 
In conclusion, SR-µCT is a promising methodology to investigate tissues or tissue 
engineered biomaterial-cell constructs. Due to the superior photon quality generated in 
modern synchrotron facilities a far more adaptable setup is established to solve specific 
scientific problems, otherwise not possible in X-ray tube µCT experimental setups. For 
example, this technique opens up the possibilities for in situ measurements of living tissues 
e.g. mechanical loading experiments, acquiring time-lapse tomographic data. 
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beamline in some experiments. Here, the demonstration of the pore channel collapse under 
mechanical loading resolved structures otherwise not visible in absorption contrast. 
A resolution up to single biological cells was demonstrated in different imaging conditions. 
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imaging results in absorption contrast, phase contrast imaging was adapted to image 
individual cells in both native cartilage tissue and inside gelatine scaffolds as well. A rather 
interesting result was found for a stack of microelectrodes, where exceptionally well 
resolved single cells were found in absorption contrast. 
In conclusion, SR-µCT is a promising methodology to investigate tissues or tissue 
engineered biomaterial-cell constructs. Due to the superior photon quality generated in 
modern synchrotron facilities a far more adaptable setup is established to solve specific 
scientific problems, otherwise not possible in X-ray tube µCT experimental setups. For 
example, this technique opens up the possibilities for in situ measurements of living tissues 
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1. Introduction 
1.1 Skin  
The evolution of life in the terrestrial environment required the development of a 
waterproof integument: the skin (Loden and Maibach, 2006). Skin is an extensive organ 
covering the entire exterior of the body (Stevens and Lowe, 2005). It provides the primary 
barrier against chemical and biological external agents and water loss (Hadgraft, 2001). The 
skin also plays an important role in thermoregulation, sensory perception and vitamin D 
metabolism (McKay and Leigh, 1995).  
The skin is composed of three main layers: the epidermis, the dermis and the hypodermis. 
The epidermis is the protective skin layer in contact with the external environment (Stevens 
and Lowe, 2005). This skin layer consists mainly of a stratified squamous keratinized 
epithelium (Junqueira and Carneiro, 2005). The epidermis cells, the keratinocytes, divide in 
the basal layer and differentiate throughout their migration to the surface. The epidermis is 
divided in 5 different layers (stratum basale, stratum spinosum, stratum granulosum, 
stratum lucidum and stratum corneum). The dermis is the feeder layer of the epidermis and 
provides most of the skin's mechanical resistance and elasticity. It is mainly composed of 
fibroblasts, epidermal appendages, blood vessels, nerves and nerve endings (Stevens and 
Lowe, 2005). Finally, the hypodermis is the deepest layer of the skin. It varies in size and 
content, but is usually composed of adipocytes which form the adipose tissue (Stevens and 
Lowe, 2005). Many severe skin diseases can be observed in human beings such as psoriasis. 
 
1.2 Psoriasis 
Epidemiology 
Psoriasis is an ancient chronic skin disease (Nickoloff and Nestle, 2004). Uncommon under 
the age of 10 years, it appears between the ages of 15 and 30 years affecting men and women 
(Fitzpatrick and Wolff, 2008). Psoriasis is universal in occurrence, but its prevalence in 
different populations varies from 0.1% to 11.8% (Raychaudhuri and Farber, 2001). In fact, 
this pathology shows a significant geographical variability with the lowest incidence seen at 
the equator and increasing frequency towards the poles (Kormeili et al., 2004). Psoriasis 
affects about 25 million people in North America and Europe (Lowes et al., 2007). 
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Characteristics 
Psoriasis is characterized by red and scaly plaques on the skin with a predilection for certain 
areas (elbows, knees and scalp) (Chapman et al., 1990; Lowes, et al., 2007). There are five 
clinical variants of psoriasis: guttate, erythrodermic, pustular, inverse and psoriasis vulgaris, 
the last of wich is the most common type seen in approximately 90% of patients (Fitzpatrick 
and Wolff, 2008). The severity can be divided into benign, moderate and severe psoriasis. 
Histological appearance of lesions shows elongation of the rete ridges, disappearance of the 
granular layer and persistence of the keratinocytes nuclei in the stratum corneum of the 
epidermis (Danilenko, 2008). In psoriasis, epidermal hyperproliferation, abnormal keratinocyte 
differentiation, angiogenesis with blood vessel dilatation and excess Th-1 and Th-17 
inflammation can be observed (Azfar and Gelfand, 2008). However, although genetic, 
immunological and environmental factors seem implied, the exact cause is not yet known and 
even today, psoriasis is not well understood (Bowcock, 2005).  
Treatments 
A broad spectrum of anti-psoriatic treatments, both topical and systemic, is available for the 
management of psoriasis (Fitzpatrick and Wolff, 2008). However, it is often resistant to 
treatment or, else, frequently relapses upon cessation of medication after partial or 
acceptable clearance is obtained (Kormeili, et al., 2004). The severity of the disease usually 
determines the therapeutic approach. Among the treatments, there are topical, 
phototherapy, biologic and systemic treatments (Table 1). Approximately, 70 to 80% of all 
patients with psoriasis can be treated adequately with topical therapy (Schon and Boehncke, 
2005). For others, phototherapy and systemic treatments are effective; however, the duration 
of a treatment is restricted because of the cumulative toxicity potential of an individual 
therapy (Kormeili, et al., 2004). For example, some treatments may increase the risk of 
cancer (phototherapy) while others can induce disorders in the liver (methotrexate) 
(Dubertret, 2004).  Sometimes, treatment efficacy may diminish with time and it must be 
replaced by another therapy (Fitzpatrick and Wolff, 2008). At the present time, there is still 
no curative treatment for psoriasis. 
 
Topical Phototherapy Biologic Systemic 
Corticosteroids Narrowband UVB Alefacept Cyclosporine A 
Vitamin D analogues Broadband UVB Efalizumab Methotrexate 
Tazarotene Psoralen-UVA Etanercept Acitretin 
Calcineurin inhibitors Excimer laser Infliximab Fumaric acid esters 
  Adalimumab Sulfasalazine 
   Mycophenolate mofetil 
   6-Thioguanine 
   Hydroxyurea 
Table 1. Anti-psoriatic treatments 
 
2. Tissue engineering  
Although conventional approaches for organ replacement, such as transplantation, 
autografts and implantation of engineered prostheses, are extensively used, the process by 
which a patient can regenerate a lost organ is more attractive (Yannas, 2004). Recent 
biotechnological progress in the tissue engineering field allows us to conceive, develop and 
produce biomaterials which can replace tissues or organs (Bernard et al., 2007). It has been 
demonstrated that tissue reconstruction can be applied to several different tissues such as 
skin, blood vessels, cartilage, bones and corneas (Arosarena, 2005). Tissue engineering can 
be used in experimental and clinical applications (Auger et al., 2004). 
 
3. In vivo and in vitro models versus pharmaceutical researches 
3.1 Development of drugs 
The development of a new drug takes approximately 20 years. During this period of time, 
pharmaceutical industries spend millions of dollars on the research for new, more effective 
drugs. The cost of bringing new drugs to the market has recently increased and today, it 
costs approximately 1 billion US dollars to bring a new medicine to the market. A large 
amount of research is devoted every year to the discovery of new pharmacologically 
effective substances and many molecules reach the level of pre-clinical and clinical phase 
trials. However, attrition rates in clinical development are still very high and up to 90 % of 
new compounds fail in clinical phases I-III (Zollner et al., 2004). Late-stage clinical failure 
can be, to a great extent, attributed to a lack of clinical efficacy, indicating a strong need for 
highly predictive in vivo and in vitro models. Consequently, the pharmaceutical industry 
stays alert for the development of more relevant pathological in vivo and in vitro models to 
improve the success rate of new drugs (Zollner, et al., 2004). Highly predictive models can 
easily translate into significant savings of time and money for the pharmacological industry. 
 
3.2 Experiments on psoriatic models  
Some models have already been used to evaluate the effect of various molecules on 
psoriasis. For example, a team tested an antibody directed against interleukin 15 that was 
known to inhibit the production of T lymphocytes as well as the liberation of TNF-α in vitro 
(Krueger and Bowcock, 2005). Application of this antibody on severe combined 
immunodeficient mice (SCID) led to the disappearance of psoriatic characteristics. This 
suggested that the molecule could be targeted for future studies to develop a new anti-
psoriatic treatment. 
 
4. In vivo models 
Animal models are very popular for the study of psoriasis. Many approaches are currently 
followed in order to obtain a representative animal model of the disease with all the 
characteristics of the human pathology. Many immunological and genetic models have been 
developed to date. However none of these models show all the characteristics of psoriasis. 
Researchers look for a perfect animal model which would have many genetic, histological 
and morphological similitudes with human beings and react to treatments in a similar way 
(Zollner, et al., 2004). Furthermore, the models must be easily reproducible, inexpensive and 
ethical.  
 
4.1 Spontaneous mutations  
Over the years, many mutations were described as being responsible for abnormal changes 
in the skin or hair of mice (Sundberg et al., 1990). Among these mutations, some were 
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studied for their psoriasis-like characteristics such as thickening of the skin and the 
formation of scales (Mizutani et al., 2003). However, the resulting mutants do not closely 
mimic the disease enough to be considered as good models of psoriasis. They must rather be 
used to compare local pathogenic events such hyperkeratosis, regulation of neutrophil 
infiltration and microabscess formation or dermal angiogenesis (Schon, 2008). Nearly a 
hundred mouse mutations that lead to psoriasiform phenotypes have been documented 
(Sundberg, et al., 1990).   
Homozygous asebia (Scd1ab/Scd1ab) 
The asebia mouse mutation was one of the first in vivo models used to study therapies 
directed at hyperkeratotic disorders (Schon, 2008). These homozygous asebia mutant mice 
are characterized by a hypoplasia of the sebaceous glands resulting from a defect in the 
stearoyl coenzyme A desaturase-1 (Scd1) gene (Zheng et al., 1999). This model exhibits 
moderate epidermal acanthosis, increased dermal vascularization, a dermal infiltrate 
composed of macrophages and mast cells, but neither T cells nor neutrophils (Schon, 2008). 
This lack of T cells and neutrophils do not mirror psoriatic lesions. Moreover, alterations of 
the cutaneous lipid metabolism seem different from psoriasis.  
Flaky skin mice (Ttcfsn/Ttcfsn) 
The spontaneous chronic proliferative dermatitis mutation (Sharpincpdm/Sharpincpdm) 
(HogenEsch et al., 1993) and the flaky skin (Sundberg, et al., 1990) mice show a more 
interesting psoriatic phenotype than homozygous asebia mice. The flaky skin mice are 
probably the best spontaneous model of psoriasis described (Danilenko, 2008). Its 
spontaneous mutation induces proliferation and hyperkeratosis of stratified squamous 
epithelia including the nonglandular forestomach (Stratis et al., 2006). Previous studies have 
shown a positive Koebner reaction after tape-stripping, which resolves after 6 weeks of 
treatment with oral, but not topical, cyclosporine A, topical EGF, or UVB exposure 
(Sundberg et al., 1994). The flaky skin phenotype is very complex and comprises aspects not 
present in psoriasis. To verify if plaques had an inflammatory origin, the mice were treated 
with cyclosporine. The results showed that immunosuppressive treatment had no effect on 
the psoriatic lesions of those mice. This observation demonstrated that such models are not 
complete because they lack the immunological side of the pathology (Schon, 1999).   
Spontaneous chronic proliferative dermatitis mutation 
The spontaneous chronic proliferative dermatitis mutation shows various characteristics 
found in psoriasis such as hyperproliferative skin, infiltration of inflammatory cells in the 
skin and dilation of blood vessels in the dermis (Schon, 1999). However, as with the flaky 
skin mice, the value of the spontaneous chronic proliferative dermatitis mutation for 
psoriasis research is limited by the lack of a T cell based immunopathogenesis. Moreover, as 
immunosuppressive therapeutic regimens used to treat psoriasis fail to improve skin lesions 
with these mutations, it appears uncertain whether they can be used to test potential 
therapeutic compounds (Schon, 1999).  
 
4.2 Genetically engineered models  
Genetically engineered mice represent the largest category of psoriasis models. These 
include the transgenic and knockout models. In this section, some of these models will be 
discussed. The complete list of in vivo psoriatic skin models can be seen in table 2. 
 
 
HLA-B27 rat 
The human leukocyte antigen B27 (HLA-B27) transgenic rats are normal at birth but develop 
chronic inflammation of multiple organ systems as they age (Keith et al., 2005). In this 
model, the human HLA-B27 and β2-microglobulin proteins are overexpressed and an 
epidermal acanthosis with epidermal infiltration of both CD4+ and CD8+ T cells, as well as 
immune-mediated arthritis and inflammatory bowel disease, which seem similar to the 
spondyloarthropathies in humans that have been associated with the HLA-B27 and β2-
microglobulin genes, such as acanthosis can be observed (Breban et al., 1996; Keith, et al., 
2005; Taurog et al., 1993; Yanagisawa et al., 1995). The HLA-B27 transgenic rat model has 
been used for several years to evaluate the activity and mechanisms of action of anti-
inflammatory molecules (Chadwick et al., 2005; Harnish et al., 2004; Peterson et al., 2002). 
Results show that broad-spectrum antibiotic therapy can produce significant remissions of 
inflammatory lesions, but relapse occurs when antibiotic therapy stops (Keith, et al., 2005). 
In this model, the occurrence of psoriatic skin lesions is less consistent than is the occurrence 
of the other immune-mediated disorders and there are no published reports of therapeutic 
efficacy testing for the psoriatic lesions (Danilenko, 2008; Taurog, et al., 1993; Yanagisawa, et 
al., 1995).  
CD18 hypomorphic 
The CD18 hypomorphic mice model targets leukocytes (Bullard et al., 1996). This model 
shows a decreased expression of the common β2 chain of the leukointegrin adhesion 
molecule complex (Danilenko, 2008). Beta2 integrins are leukocyte adhesion molecules 
exclusively expressed on hematopoietic cells  and are responsible for cell-cell contacts in a 
variety of inflammatory interactions (Kess et al., 2003). When the CD18 mutation was 
crossed onto the PL/J strain of mice, it developed a psoriasiform inflammatory skin 
condition with a predominantly lymphocyte infiltration (Bullard, et al., 1996). However, 
these mice exhibit nonpsoriasiform characteristics such as the absence of hyperproliferation 
markers.  
K14/VEGF and Tie2 
Mice overexpressing VEGF in epidermis via a keratin 14 promoter develop a phenotype 
very similar to psoriasis with an epidermal acanthosis, abnormal differentiation, 
inflammatory infiltrate and inflamed dermal blood vessels (Kunstfeld et al., 2004; Xia et al., 
2003). Even if this model has many immunological, vascular and epidermal resemblances 
with psoriasis, the lesions appear to be vascular-based and there is the presence of a major 
dermal infiltration of mast cells (Danilenko, 2008). Similar elements were observed in the 
Tie2 transgenic mice. With the activation of the transgene, the mice develop erythema with 
silver-white scaling, acanthosis, elongation of the rete ridges, hyperkeratosis, parakeratosis, 
increase in blood capillaries, infiltration of inflammatory cells and neutrophilic microabscess 
(Gudjonsson et al., 2007; Voskas et al., 2005). This model also reacts to cyclosporine A when 
used as a psoriatic therapy. 
K14/TGF-α, K5/TGF-β1, K14/KGF and K14/IL-20 
Many transgenic mice models were produced to target, via the keratin 5 or keratin 14 
promoter, the expression of epithelial growth factors such as TGF-α (Vassar and Fuchs, 
1991), TGF-β1 (Li et al., 2004) and KGF (Guo et al., 1993) into the basal layer. In each model, 
psoriasiform phenotype can be observed such as acanthosis, but no cutaneous inflammation 
is displayed into any of them. In the K14/IL-20 model, the expression of IL-20 was targeted 
to the basal layer under the control of a keratin 14 promoter (Blumberg et al., 2001). In this 
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model, some psoriatic characteristics can be observed such as abnormal keratinocyte 
differentiation and an expression of the keratin 6, a hyperproliferation marker (Blumberg, et 
al., 2001). However, the lack of inflammatory components is a severe drawback of this 
model, as it is for K14/TGF-α, K5/TGF-β1, K14/KGF models.  
IKK2 and JunB/c-Jun 
The immunological theory of psoriasis was challenged by more recent studies using animal 
models, including the IKK2 (Pasparakis et al., 2002) and JunB/c-Jun transgenic mice (Zenz 
et al., 2005). Results obtained with these two models have suggested revisiting the primary 
pathogenic role for epidermal keratinocytes. In the IKK2 knockout mice model, the deletion 
of the IKK2 catalytic subunit of the IκB kinase complex caused mice to develop a 
psoriasiform cutaneous inflammation (Pasparakis, et al., 2002). This model displays many 
features of psoriasis, including dependence on the dermal expression of TNF-α, acanthosis 
and abnormal differentiation. However, some characteristics of this model, such as T-cell-
independent inflammation, keratinocyte apoptosis and early death are not found in 
psoriasis (Pasparakis, et al., 2002; Stratis, et al., 2006). In the JunB/c-Jun mice model, JunB 
and c-Jun are knocked out in the epidermis of postnatal mice with Junbtm3Wag or Juntm4Wag, or 
both (Zenz, et al., 2005). In this model, affected skin areas showed infiltration of neutrophils 
and lymphocytes with upregulation of several cytokines and chemokines typical of 
psoriasis. However, other factors such as INF-γ were only slightly upregulated while IL-12 
or IL-18 were absent (Gudjonsson, et al., 2007). In this model, cutanous inflammation is not 
dependant on T cells nor is it independent of TNF signalling (Zenz, et al., 2005).     
K5.Stat3C 
The K5.Stat3C mice model is characterized by the activation of the signal transducer and 
activator of transcription 3 (Stat3) in basal keratinocytes under the control of the keratin 5 
promoter (Sano et al., 2005). Stat3 plays an important role in various biological activities 
including cell proliferation, survival and migration (Hirano et al., 2000). These mice 
developed psoriatic-like skin lesions characterized by a keratinocyte hyperplasia, a loss of 
the granular layer and parakeratosis. The presence of many dilated blood vessels and a 
leukocytic infiltration of lymphocytes and neutrophils were observed (Sano, et al., 2005). To 
generate a psoriatic phenotype in transplanted SCID mice, the injection of activated 
lymphocytes and the Stat3 transgenic skin are necessary. These results allow to establish a 
link between keratinocytes and CD4+ T lymphocytes in psoriasis (Danilenko, 2008). 
K14/IL-6 and K14/IL-1α 
A human keratin 14 promoter was used to express IL-6 in the basal cells of epidermal mice 
(Turksen et al., 1992). IL-6 expression did not lead to enhanced epidermal proliferation, but 
it did result in a thicker stratum corneum with an otherwise seemingly normal 
differentiation program. However, IL-6 expression did not lead to leukocytic infiltration 
(Turksen, et al., 1992). In 1995, Groves et al., observed characteristics of psoriasis in a 
transgenic mouse model that expresses high levels of interleukin 1α in basal epidermis. This 
model displayed many characteristics of psoriasis. Uninvolved skin of these animals was 
characterized by hyperkeratosis and dermal mononuclear cell infiltrate of  
macrophage/monocyte lineage (Groves et al., 1995). Inflammatory lesions were marked by 
a mixed cellular infiltrate, acanthosis and parakeratosis in some cases. These results strongly 
indicate that IL-1 is a cytokine which plays an important role in psoriasis and that it is 
capable of inducing an inflammatory reaction (Groves, et al., 1995). Murine transgenic 
models can provide representative models of the disease, but they can also target or confirm 
if a cytokine such as interleukin 1 or 6 has a role to play in psoriasis. 
Chymotryptic enzyme 
In 2002, Hansson et al., developed a transgenic mouse strain that overexpresses the 
chymotryptic enzyme, which is also overexpressed in the stratum corneum of psoriatic skin. 
This model allows to observe pathological characteristics of psoriasis such as an increase of 
epidermal thickness, hyperkeratosis, severe pruritus and an inflammation of the dermis 
(Hansson et al., 2002).  
 
4.3 Xenotransplantation  
Animal models based on transgenic technology have been used extensively to study the 
pathogenesis of various diseases, including psoriasis (Raychaudhuri et al., 2001). 
Xenotransplantation experiments were performed in which a skin biopsy from a patient or a 
skin equivalent produced in vitro was transplanted on mice from spontaneously mutated or 
genetically modified strains. 
Athymic nude mouse 
Athymic nude mouse have no thymus and therefore no T cells (Raychaudhuri, et al., 2001). 
This model has been used in laboratory to gain insights into the immune system and 
autoimmune diseases. The absence of a functional humoral immune system allows 
transplantation from another species without graft rejection. However, psoriatic skin 
transplanted on athymic mice develops certain histological changes that are not typical of 
psoriasis, such as the absence of parakeratosis and the presence of a granular layer 
(Raychaudhuri, et al., 2001). In past years, athymic nude mice were mainly used to verify if 
there was a difference between involved and uninvolved psoriatic skin (Fraki et al., 1983; 
Krueger et al., 1981). The results showed that involved psoriatic skin maintains its 
psoriasiform histology when transplanted onto nude athymic mice such as epidermal 
thickness and papillomatosis (Fraki, et al., 1983). However, not all the characteristics of the 
pathology were preserved. In fact, psoriatic epidermis did not contain polymorphonuclear 
leucocytes after grafting on athymic nude mice. In this study, uninvolved psoriatic 
epidermis from psoriatic patients seemed to be able to display markers of involved psoriatic 
epidermis independently from the psoriatic host. The authors suggested that the skin itself 
could be the primary cause of psoriasis.  However, some years later, other results obtained 
in a new mouse model, the severe combined immunodeficient mice, suggested that psoriasis 
is a T-cell-mediated disease (Fraki, et al., 1983). 
Severe combined immunodeficient mice (SCID)  
The severe combined immunodeficient mouse model shows a lack of T and B cells, but it 
contains functional neutrophil and mature natural killer (NK) cells with normal cell activity 
(Gudjonsson, et al., 2007). This model has a mutation in the DNA-dependant protein kinase 
gene that is required for successful T-cell and B-cell development (Gudjonsson, et al., 2007). 
It is probably the most widely used relevant model for psoriasis, but the presence of NK 
which are involved in rejection of xenogeneic tissue is a severe inconvenience (Gourlay et 
al., 1998). In fact, single-cell suspensions are rapidly recognized and lysed by mice NK cells 
(Meyerrose et al., 2003). However, in SCID mice, grafts of solid tissues are well tolerated and 
psoriatic characteristics are maintained for several months in the transplantations involving 
psoriatic skin (Raychaudhuri, et al., 2001; Takizawa et al., 1995). Raychaudhuri et al., noticed 
that clinical, histological and immunological features of psoriasis could be maintained for 
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model, some psoriatic characteristics can be observed such as abnormal keratinocyte 
differentiation and an expression of the keratin 6, a hyperproliferation marker (Blumberg, et 
al., 2001). However, the lack of inflammatory components is a severe drawback of this 
model, as it is for K14/TGF-α, K5/TGF-β1, K14/KGF models.  
IKK2 and JunB/c-Jun 
The immunological theory of psoriasis was challenged by more recent studies using animal 
models, including the IKK2 (Pasparakis et al., 2002) and JunB/c-Jun transgenic mice (Zenz 
et al., 2005). Results obtained with these two models have suggested revisiting the primary 
pathogenic role for epidermal keratinocytes. In the IKK2 knockout mice model, the deletion 
of the IKK2 catalytic subunit of the IκB kinase complex caused mice to develop a 
psoriasiform cutaneous inflammation (Pasparakis, et al., 2002). This model displays many 
features of psoriasis, including dependence on the dermal expression of TNF-α, acanthosis 
and abnormal differentiation. However, some characteristics of this model, such as T-cell-
independent inflammation, keratinocyte apoptosis and early death are not found in 
psoriasis (Pasparakis, et al., 2002; Stratis, et al., 2006). In the JunB/c-Jun mice model, JunB 
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both (Zenz, et al., 2005). In this model, affected skin areas showed infiltration of neutrophils 
and lymphocytes with upregulation of several cytokines and chemokines typical of 
psoriasis. However, other factors such as INF-γ were only slightly upregulated while IL-12 
or IL-18 were absent (Gudjonsson, et al., 2007). In this model, cutanous inflammation is not 
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the granular layer and parakeratosis. The presence of many dilated blood vessels and a 
leukocytic infiltration of lymphocytes and neutrophils were observed (Sano, et al., 2005). To 
generate a psoriatic phenotype in transplanted SCID mice, the injection of activated 
lymphocytes and the Stat3 transgenic skin are necessary. These results allow to establish a 
link between keratinocytes and CD4+ T lymphocytes in psoriasis (Danilenko, 2008). 
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characterized by hyperkeratosis and dermal mononuclear cell infiltrate of  
macrophage/monocyte lineage (Groves et al., 1995). Inflammatory lesions were marked by 
a mixed cellular infiltrate, acanthosis and parakeratosis in some cases. These results strongly 
indicate that IL-1 is a cytokine which plays an important role in psoriasis and that it is 
capable of inducing an inflammatory reaction (Groves, et al., 1995). Murine transgenic 
models can provide representative models of the disease, but they can also target or confirm 
if a cytokine such as interleukin 1 or 6 has a role to play in psoriasis. 
Chymotryptic enzyme 
In 2002, Hansson et al., developed a transgenic mouse strain that overexpresses the 
chymotryptic enzyme, which is also overexpressed in the stratum corneum of psoriatic skin. 
This model allows to observe pathological characteristics of psoriasis such as an increase of 
epidermal thickness, hyperkeratosis, severe pruritus and an inflammation of the dermis 
(Hansson et al., 2002).  
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Athymic nude mouse 
Athymic nude mouse have no thymus and therefore no T cells (Raychaudhuri, et al., 2001). 
This model has been used in laboratory to gain insights into the immune system and 
autoimmune diseases. The absence of a functional humoral immune system allows 
transplantation from another species without graft rejection. However, psoriatic skin 
transplanted on athymic mice develops certain histological changes that are not typical of 
psoriasis, such as the absence of parakeratosis and the presence of a granular layer 
(Raychaudhuri, et al., 2001). In past years, athymic nude mice were mainly used to verify if 
there was a difference between involved and uninvolved psoriatic skin (Fraki et al., 1983; 
Krueger et al., 1981). The results showed that involved psoriatic skin maintains its 
psoriasiform histology when transplanted onto nude athymic mice such as epidermal 
thickness and papillomatosis (Fraki, et al., 1983). However, not all the characteristics of the 
pathology were preserved. In fact, psoriatic epidermis did not contain polymorphonuclear 
leucocytes after grafting on athymic nude mice. In this study, uninvolved psoriatic 
epidermis from psoriatic patients seemed to be able to display markers of involved psoriatic 
epidermis independently from the psoriatic host. The authors suggested that the skin itself 
could be the primary cause of psoriasis.  However, some years later, other results obtained 
in a new mouse model, the severe combined immunodeficient mice, suggested that psoriasis 
is a T-cell-mediated disease (Fraki, et al., 1983). 
Severe combined immunodeficient mice (SCID)  
The severe combined immunodeficient mouse model shows a lack of T and B cells, but it 
contains functional neutrophil and mature natural killer (NK) cells with normal cell activity 
(Gudjonsson, et al., 2007). This model has a mutation in the DNA-dependant protein kinase 
gene that is required for successful T-cell and B-cell development (Gudjonsson, et al., 2007). 
It is probably the most widely used relevant model for psoriasis, but the presence of NK 
which are involved in rejection of xenogeneic tissue is a severe inconvenience (Gourlay et 
al., 1998). In fact, single-cell suspensions are rapidly recognized and lysed by mice NK cells 
(Meyerrose et al., 2003). However, in SCID mice, grafts of solid tissues are well tolerated and 
psoriatic characteristics are maintained for several months in the transplantations involving 
psoriatic skin (Raychaudhuri, et al., 2001; Takizawa et al., 1995). Raychaudhuri et al., noticed 
that clinical, histological and immunological features of psoriasis could be maintained for 
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durations of 12-16 weeks, while Sugai et al. conserved the human psoriatic skin transplant 
for up to 22 weeks (Sugai et al., 1998). In this latter study, the psoriatic phenotype was well 
maintained but the histological and immunohistochemical characteristics gradually 
disappeared as lymphocytic infiltration of the psoriatic lesion declined. However, Ghilhar et 
al. showed that injection of T cells from psoriatic plaques in SCID mouse could maintain the 
pathological characteristics longer than in the absence of T cells (Gilhar et al., 1997). These 
results show that the presence of inflammatory cells is necessary to maintain the psoriatic 
phenotype in the SCID model and suggest a role of inflammatory cells in the appearance of 
psoriasis (Gilhar, et al., 1997). 
Spontaneous AGR129 model  
A new model, the AGR129 mice, shows a lack of T and B cells but, contrary to the severe 
combined immunodeficient mice, it has immature NK (Boyman et al., 2004). While the 
natural killer cells are recognized to have a role in transplant rejection (Gourlay, et al., 1998), 
the AGR129 model tolerates xenogenic grafts better than the SCID model. The AGR129 mice 
are deficient in type I(A) and type II(G) IFN receptors in addition to being RAG-2-/-. 
Disruption of both IFN receptors has been previously shown to lead to decreased NK 
cytotoxic activity in vitro and in vivo (Lee et al., 2000). Such deficiencies imply that these 
mice possess immature NK cells which are much less cytotoxic than mature ones (Boyman, 
et al., 2004). Thus, transplant rejection is reduced in this type of mice. Boyman et al. 
demonstrated that human uninvolved psoriatic skin grafted onto AGR129 mice 
spontaneously developed psoriatic plaques without injection of activated immune cells or 
any other exogenous factor. In fact, skin grafts developed a psoriatic phenotype in 28 of 31 
(90 %) grafted mice (Gudjonsson, et al., 2007). Histology of developed plaques was 
comparable to psoriatic lesion biopsies from the same patient. Boyman's team also noticed 
that when they injected an inhibitor of T cells (monoclonal anti-CD3), the psoriatic 
phenotype disappeared. The same phenomenon occurred when they injected an inhibitor of 
TNF-α. Furthermore, in this model, the normal control skin did not develop a psoriasis-like 
phenotype. These observations indicate that activation and proliferation of resident T cells 
are necessary and sufficient to drive psoriasis formation, underlining an essential role for 
immune cells residing within symptomless pre-psoriatic skin (Conrad and Nestle, 2006). 
Model 
E
p
id
er
m
al
 
th
ic
kn
es
s 
A
bn
or
m
al
 
d
if
fe
re
n
ti
at
io
n
 
In
cr
ea
se
d
 
va
sc
u
la
ri
za
ti
on
 
E
p
id
er
m
al
 
T
-
ce
ll
 in
fi
lt
ra
ti
on
 
R
ef
er
en
ce
s 
Spontaneous mutation      
Homozygous asebia 
+ - + - 
(Brown and 
Hardy, 1988; 
Brown and Hardy, 
1989) 
Flaky skin  
+ + + - 
(Sundberg, et al., 
1994; Sundberg et 
al., 1997) 
Chronic proliferative dermatitis + + + - (HogenEsch, et al., 1993) 
      
Genetically engineered models      
Targeting the immune system      
HLA-B27/β2 microglobulin rat 
+ + + + 
(Breban, et al., 
1996; Keith, et al., 
2005) 
Hypomorphic CD18 
+ + + + 
(Bullard, et al., 
1996; Kess, et al., 
2003) 
E (CD103) + + ? + (Schon et al., 2000) 
K14/p40 + ? ? + (Kopp et al., 2001) 
Targeting vascular endothelium      
pTek-tTA/Tie2 + + + + (Voskas, et al., 2005) 
K14/VEGF + + + + (Xia, et al., 2003) 
Targeting epidermal proteins      
K5/Stat3C + + + + (Sano, et al., 2005) 
IKK2 + + ? - (Pasparakis, et al., 2002) 
c-Jun/JunB + + + + (Zenz, et al., 2005) 
K14/KGF + + + - (Guo, et al., 1993) 
K14/TGF- + + ? Some animals (Vassar and Fuchs, 1991) 
K14/IL-20 + + - - (Blumberg, et al., 2001) 
K14/amphiregulin + + + + (Cook et al., 1997) 
K14/IL-1 + + - ? (Groves, et al., 1995) 
K14/IL-6 + - - - (Turksen, et al., 1992) 
K10/BMP-6 + + + + (Blessing et al., 1996) 
Involucrin/integrins + + + + (Carroll et al., 1995) 
Involucrin/MEK1 + + ? + (Hobbs et al., 2004) 
Involucrin/amphiregulin + + + + (Cook et al., 2004) 
Involucrin/IFN- + + + - (Carroll et al., 1997) 
Chymotryptic enzyme + + ? + (Hansson, et al., 2002) 
      
Xenotransplantation      
Athymic nude mouse 
+ + ? - 
(Fraki, et al., 1983; 
Krueger, et al., 
1981) 
SCID 
+ + + + 
(Boehncke et al., 
1994; Gilhar, et al., 
1997; Nickoloff et 
al., 1995; 
Raychaudhuri, et 
al., 2001; Sugai, et 
al., 1998; Takizawa, 
et al., 1995) 
AGR129 + + + + (Boyman, et al., 2004) 
Table 2. In vivo models of psoriasis 
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durations of 12-16 weeks, while Sugai et al. conserved the human psoriatic skin transplant 
for up to 22 weeks (Sugai et al., 1998). In this latter study, the psoriatic phenotype was well 
maintained but the histological and immunohistochemical characteristics gradually 
disappeared as lymphocytic infiltration of the psoriatic lesion declined. However, Ghilhar et 
al. showed that injection of T cells from psoriatic plaques in SCID mouse could maintain the 
pathological characteristics longer than in the absence of T cells (Gilhar et al., 1997). These 
results show that the presence of inflammatory cells is necessary to maintain the psoriatic 
phenotype in the SCID model and suggest a role of inflammatory cells in the appearance of 
psoriasis (Gilhar, et al., 1997). 
Spontaneous AGR129 model  
A new model, the AGR129 mice, shows a lack of T and B cells but, contrary to the severe 
combined immunodeficient mice, it has immature NK (Boyman et al., 2004). While the 
natural killer cells are recognized to have a role in transplant rejection (Gourlay, et al., 1998), 
the AGR129 model tolerates xenogenic grafts better than the SCID model. The AGR129 mice 
are deficient in type I(A) and type II(G) IFN receptors in addition to being RAG-2-/-. 
Disruption of both IFN receptors has been previously shown to lead to decreased NK 
cytotoxic activity in vitro and in vivo (Lee et al., 2000). Such deficiencies imply that these 
mice possess immature NK cells which are much less cytotoxic than mature ones (Boyman, 
et al., 2004). Thus, transplant rejection is reduced in this type of mice. Boyman et al. 
demonstrated that human uninvolved psoriatic skin grafted onto AGR129 mice 
spontaneously developed psoriatic plaques without injection of activated immune cells or 
any other exogenous factor. In fact, skin grafts developed a psoriatic phenotype in 28 of 31 
(90 %) grafted mice (Gudjonsson, et al., 2007). Histology of developed plaques was 
comparable to psoriatic lesion biopsies from the same patient. Boyman's team also noticed 
that when they injected an inhibitor of T cells (monoclonal anti-CD3), the psoriatic 
phenotype disappeared. The same phenomenon occurred when they injected an inhibitor of 
TNF-α. Furthermore, in this model, the normal control skin did not develop a psoriasis-like 
phenotype. These observations indicate that activation and proliferation of resident T cells 
are necessary and sufficient to drive psoriasis formation, underlining an essential role for 
immune cells residing within symptomless pre-psoriatic skin (Conrad and Nestle, 2006). 
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Targeting epidermal proteins      
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K14/KGF + + + - (Guo, et al., 1993) 
K14/TGF- + + ? Some animals (Vassar and Fuchs, 1991) 
K14/IL-20 + + - - (Blumberg, et al., 2001) 
K14/amphiregulin + + + + (Cook et al., 1997) 
K14/IL-1 + + - ? (Groves, et al., 1995) 
K14/IL-6 + - - - (Turksen, et al., 1992) 
K10/BMP-6 + + + + (Blessing et al., 1996) 
Involucrin/integrins + + + + (Carroll et al., 1995) 
Involucrin/MEK1 + + ? + (Hobbs et al., 2004) 
Involucrin/amphiregulin + + + + (Cook et al., 2004) 
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+ + ? - 
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1981) 
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+ + + + 
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et al., 1995) 
AGR129 + + + + (Boyman, et al., 2004) 
Table 2. In vivo models of psoriasis 
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5. In vitro Models 
Contrary to in vivo models, in vitro models are generally characterized by a lack of 
inflammatory cells. Since psoriasis has been described to be an autoimmune disease 
(Bowcock, 2005; Krueger and Bowcock, 2005; Lowes, et al., 2007; Schon and Boehncke, 2005), 
the pertinence of these models has been discussed. It is important to note that (1) 
inflammatory cells can be included in most of the in vitro models, (2) these models allow to 
dissect step by step the mechanisms of psoriasis by isolating or combining the cell types and 
(3) recent studies using animal models, including the IKK2 (Pasparakis, et al., 2002) and 
JunB/c-Jun transgenic mice (Zenz, et al., 2005) are challenging the immunological theory of 
psoriasis. 
 
5.1 Monolayer  
Monolayer models allow, from a small biopsy of pathological skin, the generation of a large 
number of cells sufficient for multiple experiments. In monolayer models, only one cell type 
is considered at a time. Thus, either keratinocytes or fibroblasts will be used to test different 
conditions or observe various characteristics of the disease, such as cell proliferation or 
differentiation. These models allow the isolation of a normal or pathological cell type to 
better understand its specific role. However, they preclude the study of interactions among 
many cellular types (e.g. interactions between the dermis and the epidermis).  
Despite the absence of interaction between the different cell types, monolayer models have 
helped in the discovery of several interesting facts about psoriasis and a better 
understanding of the disease. For example, monolayer cell cultures have helped to realize 
that TGF-α regulates VEGF expression in psoriasis through an autocrine mechanism, 
leading to vascular hyperpermeability and angiogenesis (Detmar et al., 1994). In other 
experiments, van Ruissen et al. found that psoriatic keratinocytes display a lower number of 
cells in S-phase and a shorter duration of G1 compared to normal keratinocytes (van 
Ruissen et al., 1996). Monolayer cultures are widely used and have led to many critical 
observations (Table 3).  
 
5.2 De-epidermized dermis 
Organ culture on de-epidermized dermis 
Mils et al. developed a reconstructed epidermal model with a de-epidermized dermis. A 
psoriatic or normal biopsy was placed dermal side down on the epidermal surface of non 
viable de-epidermized dermis, thus in contact with the remnant basement membrane 
component (Mils et al., 1994). The dead de-epidermized dermis was maintained at the air-
liquid interface on a metallic support. In approximately 15 days, the epidermal layer grew 
out from the punch biopsy to cover the entire de-epidermized dermis. In this model, the 
psoriatic substitutes did not differ significantly from normal substitutes. The only observed 
difference was in LH8 labelling between normal and psoriatic substitutes (Mils, et al., 1994). 
No distinguishing histological or biochemical criteria could be established between normal 
and psoriatic equivalents. 
Keratinocytes on de-epidermized dermis 
Another reconstructed epidermal model was developed with normal adult human 
keratinocytes seeded on de-epidermized dermis (Tjabringa et al., 2008). This model allowed 
controlled induction of psoriasis-associated features and gene expression by the addition of 
relevant pro-inflammatory cytokines (TNF-α, IL-1α, IL-6 and IL-22) and primary 
keratinocytes obtained from donors without history of psoriasis. To produce this model, a 
hollow metal ring was placed on de-epidermized dermis and keratinocytes were seeded 
within the ring (Tjabringa, et al., 2008). Results showed that after the addition of a pro-
inflammatory cytokine mixture, the expression of psoriasis-associated proteins hBD-2 and 
SKALP/elafin for the pro-inflammatory cytokines IL-8 and of TNF-α were increased in the 
skin equivalent, as well as keratinocyte hyperproliferation cells. Tjabringa et al. also showed 
that the addition of all-trans retinoic acid inhibits the expression of psoriasis-associated 
proteins hBD-2 and SKALP/elafin in cytokine-stimulated skin equivalents and reduces 
expression of the normal differentiation marker: keratin 10, as such as acanthosis can be 
observed in psoriatic skin in vivo (Tjabringa, et al., 2008).    
 
5.3 Collagen gels  
Organ culture 
To observe cell proliferation, some studies were done by making a small full-thickness 
punch biopsy into a dermal equivalent, which itself originated from the contraction of a 
collagen gel by dermal fibroblasts (Saiag et al., 1985). The total surface area covered by the 
keratinocytes was used to calculate the cell proliferation percentage. Higher keratinocyte 
proliferation values were obtained in the presence of psoriatic fibroblasts (Saiag, et al., 1985). 
Furthermore, this model led to the conclusion that normal fibroblasts are unable to suppress 
the hyperproliferative growth of psoriatic keratinocytes and that hyperproliferation of 
normal epidermis can be induced both by uninvolved and involved psoriatic fibroblasts 
(Saiag, et al., 1985). 
Models using many cellular types  
Other teams developed skin equivalents composed of two or more cell types to better 
understand cell interactions such as those between keratinocytes and fibroblasts. In general, 
these models imply the isolation of cells from biopsies of normal or affected persons. 
Fibroblasts are extracted from the dermis, expanded and embedded in a collagen gel. 
Keratinocytes are extracted from the epidermis, expanded and plated on top of a collagen 
gel containing fibroblasts. 
Konstantinova et al. have presented a psoriatic collagen gel model which showed a 
psoriasiform phenotype. In fact, in this model, the psoriatic skin equivalent showed a 
thicker epidermis and a loss of filaggrin (Konstantinova et al., 1996). These models enabled 
to examine the effects of normal and psoriatic (involved and uninvolved) fibroblasts on 
epidermal differentiation and cytokine expression. This model led to a number of interesting 
conclusions, such as the confirmation that involved and uninvolved fibroblasts induce 
higher amounts of IL-8 than normal fibroblasts (Konstantinova, et al., 1996). This model 
allowed the observation of interactions between fibroblasts and keratinocytes, but contained 
exogenous material. As previously described, the collagen gel can be very useful for rapid 
production of skin substitutes (Bell et al., 1981a; Bell et al., 1981b; Bell et al., 1979) but, the 
presence of an exogenous scaffold can be disadvantageous for mechanical studies of the 
extracellular matrix and a severe surface reduction of dermal substitutes can be observed 
(Auger et al., 1998; Germain and Auger, 1995). Contraction can be prevented using 
anchorage methods in vitro (Eckes et al., 1995; Germain and Auger, 1995; Grinnell and 
Lamke, 1984; Parenteau et al., 1991; Xu et al., 1996). However, these anchoraged models are 
often fragile and difficult to handle. 
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5. In vitro Models 
Contrary to in vivo models, in vitro models are generally characterized by a lack of 
inflammatory cells. Since psoriasis has been described to be an autoimmune disease 
(Bowcock, 2005; Krueger and Bowcock, 2005; Lowes, et al., 2007; Schon and Boehncke, 2005), 
the pertinence of these models has been discussed. It is important to note that (1) 
inflammatory cells can be included in most of the in vitro models, (2) these models allow to 
dissect step by step the mechanisms of psoriasis by isolating or combining the cell types and 
(3) recent studies using animal models, including the IKK2 (Pasparakis, et al., 2002) and 
JunB/c-Jun transgenic mice (Zenz, et al., 2005) are challenging the immunological theory of 
psoriasis. 
 
5.1 Monolayer  
Monolayer models allow, from a small biopsy of pathological skin, the generation of a large 
number of cells sufficient for multiple experiments. In monolayer models, only one cell type 
is considered at a time. Thus, either keratinocytes or fibroblasts will be used to test different 
conditions or observe various characteristics of the disease, such as cell proliferation or 
differentiation. These models allow the isolation of a normal or pathological cell type to 
better understand its specific role. However, they preclude the study of interactions among 
many cellular types (e.g. interactions between the dermis and the epidermis).  
Despite the absence of interaction between the different cell types, monolayer models have 
helped in the discovery of several interesting facts about psoriasis and a better 
understanding of the disease. For example, monolayer cell cultures have helped to realize 
that TGF-α regulates VEGF expression in psoriasis through an autocrine mechanism, 
leading to vascular hyperpermeability and angiogenesis (Detmar et al., 1994). In other 
experiments, van Ruissen et al. found that psoriatic keratinocytes display a lower number of 
cells in S-phase and a shorter duration of G1 compared to normal keratinocytes (van 
Ruissen et al., 1996). Monolayer cultures are widely used and have led to many critical 
observations (Table 3).  
 
5.2 De-epidermized dermis 
Organ culture on de-epidermized dermis 
Mils et al. developed a reconstructed epidermal model with a de-epidermized dermis. A 
psoriatic or normal biopsy was placed dermal side down on the epidermal surface of non 
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out from the punch biopsy to cover the entire de-epidermized dermis. In this model, the 
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Keratinocytes on de-epidermized dermis 
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keratinocytes seeded on de-epidermized dermis (Tjabringa et al., 2008). This model allowed 
controlled induction of psoriasis-associated features and gene expression by the addition of 
relevant pro-inflammatory cytokines (TNF-α, IL-1α, IL-6 and IL-22) and primary 
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that the addition of all-trans retinoic acid inhibits the expression of psoriasis-associated 
proteins hBD-2 and SKALP/elafin in cytokine-stimulated skin equivalents and reduces 
expression of the normal differentiation marker: keratin 10, as such as acanthosis can be 
observed in psoriatic skin in vivo (Tjabringa, et al., 2008).    
 
5.3 Collagen gels  
Organ culture 
To observe cell proliferation, some studies were done by making a small full-thickness 
punch biopsy into a dermal equivalent, which itself originated from the contraction of a 
collagen gel by dermal fibroblasts (Saiag et al., 1985). The total surface area covered by the 
keratinocytes was used to calculate the cell proliferation percentage. Higher keratinocyte 
proliferation values were obtained in the presence of psoriatic fibroblasts (Saiag, et al., 1985). 
Furthermore, this model led to the conclusion that normal fibroblasts are unable to suppress 
the hyperproliferative growth of psoriatic keratinocytes and that hyperproliferation of 
normal epidermis can be induced both by uninvolved and involved psoriatic fibroblasts 
(Saiag, et al., 1985). 
Models using many cellular types  
Other teams developed skin equivalents composed of two or more cell types to better 
understand cell interactions such as those between keratinocytes and fibroblasts. In general, 
these models imply the isolation of cells from biopsies of normal or affected persons. 
Fibroblasts are extracted from the dermis, expanded and embedded in a collagen gel. 
Keratinocytes are extracted from the epidermis, expanded and plated on top of a collagen 
gel containing fibroblasts. 
Konstantinova et al. have presented a psoriatic collagen gel model which showed a 
psoriasiform phenotype. In fact, in this model, the psoriatic skin equivalent showed a 
thicker epidermis and a loss of filaggrin (Konstantinova et al., 1996). These models enabled 
to examine the effects of normal and psoriatic (involved and uninvolved) fibroblasts on 
epidermal differentiation and cytokine expression. This model led to a number of interesting 
conclusions, such as the confirmation that involved and uninvolved fibroblasts induce 
higher amounts of IL-8 than normal fibroblasts (Konstantinova, et al., 1996). This model 
allowed the observation of interactions between fibroblasts and keratinocytes, but contained 
exogenous material. As previously described, the collagen gel can be very useful for rapid 
production of skin substitutes (Bell et al., 1981a; Bell et al., 1981b; Bell et al., 1979) but, the 
presence of an exogenous scaffold can be disadvantageous for mechanical studies of the 
extracellular matrix and a severe surface reduction of dermal substitutes can be observed 
(Auger et al., 1998; Germain and Auger, 1995). Contraction can be prevented using 
anchorage methods in vitro (Eckes et al., 1995; Germain and Auger, 1995; Grinnell and 
Lamke, 1984; Parenteau et al., 1991; Xu et al., 1996). However, these anchoraged models are 
often fragile and difficult to handle. 
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Other studies have used similar in vitro models. In 2004, Barker et al. developed and 
characterized a new psoriatic skin model in vitro using collagen gels. In this model, psoriatic 
skin substitutes maintained many characteristics of psoriasis such as hyperproliferation, 
overexpression of chemokine receptor CXCR2 and pro-inflammatory genes (TNF-α, INF-γ 
and IL-8) and also increased levels of pro-inflammatory cytokines IL-6 and IL-8 (Barker et 
al., 2004). The substitutes derived from uninvolved psoriatic skin showed the same gene 
expression profile as those derived from involved skin substitutes with an increased 
proliferation rate when compared to normal substitutes. This model suggests that psoriatic 
individuals possess an inherent predisposition to develop the disease phenotype even in the 
absence of T cells (Barker, et al., 2004). As with the model proposed by Konstantinova et al., 
this model contains exogenous material. 
 
Models 
E
p
id
er
m
al
 
th
ic
kn
es
s 
A
bn
or
m
al
 
d
if
fe
re
n
ti
at
io
n
 
In
cr
ea
se
d
 
va
sc
u
la
ri
za
ti
on
 
E
p
id
er
m
al
 T
-c
el
l 
in
fi
lt
ra
ti
on
 
R
ef
er
en
ce
s 
Monolayer      
IL-15 ? ? ? ? (Krueger and Bowcock, 2005) 
TGF-α regulates VEGF ? ? ? ? (Detmar, et al., 1994) 
S-phase ? ? ? ? (van Ruissen, et al., 1996) 
      
De-epidermized dermis      
Organ culture - - ? - (Mils, et al., 1994) 
Keratinocytes + + ? - (Tjabringa, et al., 2008) 
      
Collagen gel      
Organ culture ? + ? ? (Saiag, et al., 1985) 
Skin substitutes + + ? - (Barker, et al., 2004; Konstantinova, et al., 1996) 
      
Self-assembly      
Skin substitutes + + - - (Bernard, et al., 2007; Jean et al., 2009) 
Table 3. In vitro models of psoriasis 
 
6. A new in vitro psoriatic skin model 
In pharmaceutical sciences, pathological skin substitutes can be very useful for toxicity or 
for cutaneous cellular and molecular biology studies. To be effective, a pathological 
substitute must mimic as closely as possible, morphological and ultrastructural 
characteristics of the pathology. At the present time, although some in vitro and in vivo 
models of psoriasis have been reported to replicate some aspects of the disease, research into 
psoriasis and the subsequent development of therapeutic strategies have been hindered by 
the absence of more relevant models (Jean, et al., 2009).  
As previously shown, a number of teams have carried out in vitro monolayer and stratified 
keratinocyte culture studies to better understand the behaviour of cell types both in an 
individual way, but also to study the interactions between cells with co-culture and 
conditioned media techniques (Mils, et al., 1994; Saiag, et al., 1985; van Ruissen, et al., 1996). 
Some of these studies have shown the importance of the interaction between fibroblasts and 
keratinocytes in psoriatic models. Amongst in vivo models (Gudjonsson et al., 2004), there 
are animal models primarily consisting of grafting a psoriatic skin athymic (Fraki, et al., 
1983) or on severe combined immunodeficient mice (Raychaudhuri, et al., 2001). While the 
clinical and histological characteristics of psoriasis can be maintained for a sufficient period 
of time to test pharmacological drugs, mouse skin is not like human skin. The graft of 
human psoriatic plaques on mice might cause in those animal models an immune response 
that differs from that in humans. Mice used for xenografts are immunocompromised to 
prevent rejection or graft shrinkage; there is no organized lymphatic system to drain the 
grafted skin and a lack of lymphocyte recirculation.  
 
7. Self-assembly method 
7.1 Introduction 
Our team has developed a new psoriatic skin model produced by the self-assembly method. 
This tissue engineered approach is based on the capacity of fibroblasts to create their own 
extracellular matrix in vitro, which makes it possible to obtain cell sheets which are easy to 
handle. A cohesive dermal tissue is obtained by stacking two of these sheets together upon 
which keratinocytes are seeded. This leads to a complete bilayered skin substitute devoid of 
exogenous extracellular matrix proteins and synthetic material. This substitute has many 
histological characteristics close to those of normal human skin (Michel et al., 1999; Pouliot 
et al., 2002). While previous studies using the self-assembly model only used healthy cells, 
the present study creates pathological substitutes with cells isolated from psoriatic biopsies. 
This work strives to develop and characterize a novel in vitro psoriatic skin model produced 
by tissue engineering, which could be used to investigate the mechanisms of abnormal 
keratinocyted growth and to study cell-cell interactions. In this section, previously 
published results will be discussed (Jean, et al., 2009). 
 
7.2 Methods 
The psoriatic substitutes were produced using our modified version of the self-assembly 
method (Fig. 1). The method is, briefly, as follows: human fibroblasts were cultured in the 
presence of ascorbic acid, thus forming manipulatable sheets, which were superimposed 
and incubated for 7 days to form the dermal component. After 7 days of culture, 
keratinocytes were seeded upon this tissue to form the epidermal layer. After another 7 days 
of culture, the substitutes were raised to the air–liquid interface (Michel, et al., 1999; Pouliot, 
et al., 2002). Biopsies were taken after 7, 14 and 21 days of culture at the air–liquid interface 
and analyzed using histological and immunohistochemical techniques. Four different 
combinations of healthy and/or psoriatic cells were used to produce skin substitutes: 
A. Healthy fibroblast/healthy keratinocyte (controls) 
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Other studies have used similar in vitro models. In 2004, Barker et al. developed and 
characterized a new psoriatic skin model in vitro using collagen gels. In this model, psoriatic 
skin substitutes maintained many characteristics of psoriasis such as hyperproliferation, 
overexpression of chemokine receptor CXCR2 and pro-inflammatory genes (TNF-α, INF-γ 
and IL-8) and also increased levels of pro-inflammatory cytokines IL-6 and IL-8 (Barker et 
al., 2004). The substitutes derived from uninvolved psoriatic skin showed the same gene 
expression profile as those derived from involved skin substitutes with an increased 
proliferation rate when compared to normal substitutes. This model suggests that psoriatic 
individuals possess an inherent predisposition to develop the disease phenotype even in the 
absence of T cells (Barker, et al., 2004). As with the model proposed by Konstantinova et al., 
this model contains exogenous material. 
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1983) or on severe combined immunodeficient mice (Raychaudhuri, et al., 2001). While the 
clinical and histological characteristics of psoriasis can be maintained for a sufficient period 
of time to test pharmacological drugs, mouse skin is not like human skin. The graft of 
human psoriatic plaques on mice might cause in those animal models an immune response 
that differs from that in humans. Mice used for xenografts are immunocompromised to 
prevent rejection or graft shrinkage; there is no organized lymphatic system to drain the 
grafted skin and a lack of lymphocyte recirculation.  
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extracellular matrix in vitro, which makes it possible to obtain cell sheets which are easy to 
handle. A cohesive dermal tissue is obtained by stacking two of these sheets together upon 
which keratinocytes are seeded. This leads to a complete bilayered skin substitute devoid of 
exogenous extracellular matrix proteins and synthetic material. This substitute has many 
histological characteristics close to those of normal human skin (Michel et al., 1999; Pouliot 
et al., 2002). While previous studies using the self-assembly model only used healthy cells, 
the present study creates pathological substitutes with cells isolated from psoriatic biopsies. 
This work strives to develop and characterize a novel in vitro psoriatic skin model produced 
by tissue engineering, which could be used to investigate the mechanisms of abnormal 
keratinocyted growth and to study cell-cell interactions. In this section, previously 
published results will be discussed (Jean, et al., 2009). 
 
7.2 Methods 
The psoriatic substitutes were produced using our modified version of the self-assembly 
method (Fig. 1). The method is, briefly, as follows: human fibroblasts were cultured in the 
presence of ascorbic acid, thus forming manipulatable sheets, which were superimposed 
and incubated for 7 days to form the dermal component. After 7 days of culture, 
keratinocytes were seeded upon this tissue to form the epidermal layer. After another 7 days 
of culture, the substitutes were raised to the air–liquid interface (Michel, et al., 1999; Pouliot, 
et al., 2002). Biopsies were taken after 7, 14 and 21 days of culture at the air–liquid interface 
and analyzed using histological and immunohistochemical techniques. Four different 
combinations of healthy and/or psoriatic cells were used to produce skin substitutes: 
A. Healthy fibroblast/healthy keratinocyte (controls) 
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B.  Psoriatic fibroblast/psoriatic keratinocyte 
C. Psoriatic fibroblast/healthy keratinocyte 
D. Healthy fibroblast/psoriatic keratinocyte 
 
Fig. 1. Self-assembly method 
 
7.3 Results 
In the presence of healthy fibroblasts and healthy keratinocytes (controls), the substitutes 
showed a uniform, smooth and white surface (Fig. 2A). When psoriatic fibroblasts and 
keratinocytes were used to produce the substitutes, the aspect of the substitutes was less 
uniform showing a surface that was thick and whitish in some regions and thinner in others 
(Fig. 2B). The same characteristics were observed with a combination of healthy fibroblasts 
and psoriatic keratinocytes (Fig. 2D). Skin substitutes produced with psoriatic fibroblasts 
and healthy keratinocytes showed the presence of some protuberances (Fig. 2C). 
 
 
Fig. 2. Macroscopic analysis of skin substitutes produced with healthy fibroblasts and 
healthy keratinocytes (A), psoriatic fibroblasts and psoriatic keratinocytes (B), psoriatic 
fibroblasts and healthy keratinocytes (C), and healthy fibroblasts and psoriatic keratinocytes 
(D). Pictures were taken after 21 days of culture at the air–liquid interface (scale bar = 2.2 
cm). Reproduced from Jean et al., 2009 © Journal of Dermatological Science. 
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dermal sheets Air-liquid interface Reconstructed 
dermis 
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Masson’s trichrome staining of 5-µm thick biopsies from skin substitutes showed that those 
produced with psoriatic keratinocytes (Fig. 3B and D) had a significantly thicker epidermis 
than the controls (Fig. 3A). The basal layer of the epidermis was less organized in psoriatic 
substitutes (Fig. 3B–D). A compact cornified layer, partly removed during the sectioning 
process of some constructs (ex; Fig. 3D), was observed in combinations containing psoriatic 
keratinocytes. No significant histological difference was noticed between the control and the 
psoriatic fibroblast/healthy keratinocyte combination (Fig. 3A and C), even if the 
macroscopic appearance of this combination showed some protuberances (Fig. 2C), which 
could suggest differences in the thickness of the epidermis. 
 
 
Fig. 3. Histological analysis of skin substitutes produced with healthy fibroblasts and 
healthy keratinocytes (A), psoriatic fibroblasts and psoriatic keratinocytes (B), psoriatic 
fibroblasts and healthy keratinocytes (C), and healthy fibroblasts and psoriatic keratinocytes 
(D) (scale bar = 5 µm). Note: the brackets indicate the measured epidermis. Reproduced 
from Jean et al., 2009 © Journal of Dermatological Science. 
 
Epidermal differentiation markers, such as involucrin, appeared in deeper epidermal layers 
of substitutes produced with psoriatic fibroblasts and psoriatic keratinocytes, compared to 
those produced with healthy fibroblasts and healthy keratinocytes (controls) (Fig. 4). An 
overexpression of involucrin, relative to the controls was observed in substitutes produced 
with psoriatic keratinocytes (both combinations). Filaggrin staining showed a diminution or 
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Epidermal differentiation markers, such as involucrin, appeared in deeper epidermal layers 
of substitutes produced with psoriatic fibroblasts and psoriatic keratinocytes, compared to 
those produced with healthy fibroblasts and healthy keratinocytes (controls) (Fig. 4). An 
overexpression of involucrin, relative to the controls was observed in substitutes produced 
with psoriatic keratinocytes (both combinations). Filaggrin staining showed a diminution or 
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absence of filaggrin expression in substitutes with psoriatic cells compared to those 
produced with healthy fibroblasts and healthy keratinocytes (controls), in which filaggrin 
expression was present from the granular layer (Fig. 4). In the combination of psoriatic 
fibroblasts and healthy keratinocytes, the expression of loricrin was similar to levels seen in 
controls but in the presence of psoriatic keratinocytes (both combinations) its expression 
was partially or completely absent (Fig. 4). In substitutes produced with psoriatic 
keratinocytes, keratin 10 expression was less intense and appeared in the upper layers of the 
epidermis compared to those produced with healthy keratinocytes (both combinations) (Fig. 
4). Some of our immunohistological results, such as loricrin and filaggrin stainings, showed 
the presence of blue nuclei stained with Hoechst in the upper layers of the stratum corneum, 
which is characteristic of parakeratosis. 
 
 
Fig. 4. Markers of keratinocyte differentiation in skin substitutes. Samples were prepared 
after 21 days of culture at the air–liquid interface (scale bar = 5 µm). The dotted line 
indicates the dermo-epidermal junction. Reproduced from Jean et al., 2009 © Journal of 
Dermatological Science.  
 
In previous studies, the organization of the stratum corneum lipids was analyzed by 
attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FITR) (Bernard, et 
al., 2007). Results suggested that the stratum corneum of involved psoriatic skin substitutes 
is less organized than that of normal skin substitutes. Bernard et al., also showed that the 
properties of uninvolved psoriatic skin may vary with the severity of the disease. In fact, in 
substitutes made with cells from a patient with 20% of affected body area, the ATR-FITR 
results are similar to controls and uninvolved psoriatic substitutes. However,  in substitutes 
made with cells from a patient with an affected body area 40%, the ATR-FITR results of 
uninvolved psoriatic substitutes are different from those of the control (Bernard, et al., 2007). 
To summarize, this study showed that psoriatic skin substitutes produced by the self-
assembly method have a higher level of lipid disorder and a modification of protein 
conformation in involved psoriatic stratum corneum layer compared to the stratum 
corneum of healthy substitutes (Bernard, et al., 2007). 
 
7.4 Discussion 
The psoriatic substitutes produced by the self-assembly method maintained many psoriasis-
like characteristics such as thicker epidermis, abnormal differentiation, increased 
proliferation and higher levels of lipid disorganization of the stratum corneum. The four 
different keratinocyte/fibroblast combinations show different intensities in the expression of 
the psoriatic phenotype. These combinations allow the observation of interactions between 
healthy/psoriatic cells and fibroblast/keratinocyte cells. This model could become the basis 
of a robust technique to better understand the mechanisms involved in psoriasis and an 
excellent tool for the study of accelerated cellular differentiation of psoriatic keratinocytes. 
In an effort to resolve this complex skin disease, our research first endeavoured to develop a 
psoriatic model devoid of complicating elements such as immunocytes, in order to dissect 
step by step the mechanisms of this pathology. However, this model will be further refined 
to include elements of the immune system which may help establish the roles of different T 
cell subsets and cytokines in psoriasis.  
 
8. Future research 
A large number of psoriatic models have been developed. However, although many 
characteristics of the disease are preserved, no model shows all of them. Experts agreed that 
there was no available model that served all their needs (Zollner, et al., 2004). The choice of 
the most suitable model must always depend on the particular scientific question. The 
ultimate purpose of future research is to find the exact causes of psoriasis in order to find 
specific and effective treatments that will provide a definitive cure for psoriasis with a 
minimum of side effects. In vitro or in vivo pathological models that faithfully mimic this 
disease would be of significant help in the research and development of new treatments. For 
that reason, the development of a more relevant model of psoriasis is a priority for the 
various research efforts that are targeting this disease and would be an important step 
towards its cure. 
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1. Introduction     
Modern Tissue Engineering represents a highly complex interdisciplinary branch of science 
which brings the life sciences and engineering together to design innovative solutions for 
the treatment of critical tissue defects after traumatic or degenerative damage. In this area an 
interesting evolution can be observed in the approach to achieve this goal: Originally 
understood as a principally biomaterial-based strategy using natural and synthetic materials 
as implants to be integrated into the neighbouring tissue, during the last two decades a 
change of paradigm has taken place which involves a movement away from the structural 
replacement of damaged tissue towards strategies to regenerate functional tissue 
(Kirkpatrick et al., 2006). In this approach cells play an important role, for example in 
seeding scaffold materials, which give a preformed structure for the regenerating tissue. A 
major aim is the synthesis of so-called tissue-like structures in vitro which can be implanted 
in the damaged tissue site and should be integrated into the body’s own tissue. Relevant 
obstacles to this strategy are the proper morphological integration of the cell-material 
construct in the structural context of the damaged tissue site as well as the maintenance of 
its function. The use of cells in combination with different biomaterials gives an important 
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input for the further development of innovative materials with the important aims of 
preserving cell viability, improving the cell seeding efficiency of a scaffold material and by 
this to enhance their functionality.  
Due to the limited regenerative potential of cartilage, traumatic damage to articular cartilage 
is a unique example for the clinical relevance of tissue engineering strategies to treat 
damaged tissue. In this context, the establishment of the autologous chondrocyte 
transplantation by Brittberg et al. (1994) represents the first innovative step to treat articular 
cartilage damage via tissue engineering. With the help of a syringe a suspension of ex vivo 
expanded chondrocytes was injected into the defect which had been covered with a 
periosteal flap. The current approach involves the expansion and transplantation of the 
autologous chondrocytes with the help of a matrix. For this pupose different material-based 
matrices are already on the market and have been developed to provide the seeded cells 
with a suitable biomimetic microenvironment. 
Modern tissue engineering approaches integrate the combined use of cells, scaffolds, and 
growth factors or signalling molecules respectively. There is the hope that such molecules 
will stimulate the controled proliferation and proper differentiation of the seeded cells in the 
scaffold. Furthermore, growth factors should also enhance the migration, proliferation, and 
differentiation of cells from the edges of the treated defect. Thus, such factors can serve first 
to optimize tissue engineered cell-scaffold constructs in vitro, and second to improve their 
performance and integration in vivo. For the targeting of potential signalling molecules and 
growth factors it is important to realize that regeneration in part recapitulates 
developmental processes. Therefore, it can be postulated that for the improvement of 
regeneration in the context of tissue engineering it is essential to understand the regulation 
of developmental processes (Reddi, 2003). With this porpose in mind our group has 
demonstrad that the growth plate of the long bones represents a suitable developmental 
model to target interesting molecules for tissue engineering application of cartilage and 
bone (Brochhausen et al., 2009). 
In this contribution we firstly focused on the structural organization and regulation of the 
growth plate. Based on this we present the development of an integrated release-system in 
an oriented gelatine-based scaffold material for cartilage tissue engineering. 
 
2. Long bone development and endochondral ossification 
Two different steps in bone development are distinguishable, both being important for 
potential tissue engineering strategies: first, the condensation of mesenchymal cells as a 
morphological template and its development to a cartilaginous template during fetal 
development, and second, the longitudinal growth of the long bones within the area of 
endochondral ossification (fig. 1). In the present report we very briefly present the process of 
foetal bone development and then concentrate on endochondral ossification and its 
regulation. 
 
 
 
Fig. 1. Schematic depiction of bone development from the hyaline cartilage model to the 
ossified bone with the growth plate as the epicentre of the long bone growth. 
 
The growth plate of long bones represents the epicentre of the long bone longitudinal 
growth. In this structurally highly organized region between the epiphysis and the 
metaphysis of the bone a cartilaginous template is responsible for longitudinal growth, 
which results in terminal ossification and thus leads to the elongation of the long bone 
(fig.2). The characteristic features of this region are chondrocytes in different proliferation 
and differentiation stages integrated in a scaffold of oriented extracellular matrix 
components, mainly consisting of different types of collagen. Since proliferation and 
differentiation in this region is a well regulated process the growth plate can be divided into 
characteristic horizontal zones. In these zones not only the chondrocytes showed a specific 
phenotype, but also specific types of collagen can be found within the different zones. 
 
2.1 The resting zone  
The zone closest to the epiphyseal cartilage is the smallest zone, called the resting zone. The 
latter consists of monomorphic, small chondrocytes with large central nuclei and a narrow 
cytoplasmatic rim. Nowadays, the resting zone cells are seen as being the cell pool for the 
adjacent proliferative zone, since they contain so called “stem-like” cells to supply new 
clones of proliferative zone chondrocytes. This hypothesis could be confirmed by findings of 
Abad et al. (2002), who demonstrated that, after removing the proliferative and the 
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input for the further development of innovative materials with the important aims of 
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endochondral ossification (fig. 1). In the present report we very briefly present the process of 
foetal bone development and then concentrate on endochondral ossification and its 
regulation. 
 
 
 
Fig. 1. Schematic depiction of bone development from the hyaline cartilage model to the 
ossified bone with the growth plate as the epicentre of the long bone growth. 
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components, mainly consisting of different types of collagen. Since proliferation and 
differentiation in this region is a well regulated process the growth plate can be divided into 
characteristic horizontal zones. In these zones not only the chondrocytes showed a specific 
phenotype, but also specific types of collagen can be found within the different zones. 
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The zone closest to the epiphyseal cartilage is the smallest zone, called the resting zone. The 
latter consists of monomorphic, small chondrocytes with large central nuclei and a narrow 
cytoplasmatic rim. Nowadays, the resting zone cells are seen as being the cell pool for the 
adjacent proliferative zone, since they contain so called “stem-like” cells to supply new 
clones of proliferative zone chondrocytes. This hypothesis could be confirmed by findings of 
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hypertrophic zones of the growth plate, a complete proliferative and hypertrophic zone was 
regenerated, based on cells from the residual resting zone alone. Furthermore, the 
chondrocytes of the resting zone might produce a morphogen, so-called Growth Plate-
Orienting Factor (GPOF) that directs the alignment of proliferative clones into columns 
parallel to the long axis of the developing bone. The GPOF diffuses into the proliferative 
zone along a concentration gradient. This gradient is thought to guide the orientation of the 
proliferative chondrocytes. 
The stem-like cells in the resting zone have a defined proliferative capacity, which is 
gradually exhausted and leads to fusion of the growth plate. Thus, the epiphyseal fusion 
process seems to be the result and not the cause of growth cessation at the moment of 
skeletal maturation. Accordingly, the term “growth plate senescence” has been introduced 
by Nilsson and Baron (2004). In this context, Stevens et al. (1999) demonstrated in 
transplantation experiments the dependence of the growth rate on the age of the donor 
animal, not that of the recipient. This finding indicates that the programmed senescence is 
not caused by hormonal or other systemic mechanisms but is intrinsic to growth plate cells 
themselves. In further investigations Gafni et al. (2001) showed that senescence is a function 
of proliferation: After systemic treatment with dexamethasone, a glucocorticoid that slows 
chondrocyte proliferation, the treated growth plates showed a delay in senescent decline of 
the growth rate, and the epiphyseal fusion occurred later.  
 
2.2 The proliferative zone 
After entering the cell cycle the cells begin to proliferate. During mitosis the cells divide in 
the horizontal axis followed by a rotation and finally the arrangement in the vertical axis 
forming the characteristic columns parallel to the longitudinal axis of the bone (Aszodi et al., 
2003). These columns are separated from each other by matrices with large amounts of 
collagen Type II. Each column contains 10 to 20 cells, depending on the mitotic activity of 
the chondrocytes. In the proximal portion of each column, multiple mitotic figures can be 
observed. It is interesting that the achromatic figure spindles are arranged parallel to the 
long axis of the bone and that the chondrocytes migrate after division so that eventually the 
daughter cells are lined in the longitudinal axis (Trueta & Morgan, 1960; Stevenson et al., 
1990). The proliferating zone is the only region in the growth plate where chondrocytes have 
relevant mitotic activity. Biochemically, in this zone the high oxygen content is noteworthy, 
as well as the high glycogen content and increased mitochondrial ATP production in 
chondrocytes (Brighton & Heppenstall, 1971). 
 
2.3 The hypertrophic zone 
After 5-10 mitotic cycles the chondrocytes lose their proliferative capacity and enter the so-
called G0 phase for further differentiation. After passing a prehypertrophic stage 
chondrocyes enter a hypertrophic differentiation stage, which in the growth plate 
unidirectionally leads to terminal differentiation. During this process the chondrocytes 
increase their volume, especially in their longitudinal diameter, about 5- to 10-fold. In this 
way, hypertrophic differentiation makes an important contribution to longitudinal growth. 
Furthermore, the hypertrophic cells synthesize high amounts of extracellular matrix 
components, especially collagen Type X (Hunziker et al., 1987; Breur et al., 1991). In 
comparison to the resting zone and the proliferative zone, the hypertrophic zone is 
 
characterized by a distinctly different extracellular matrix composition: The synthesis of the 
collagens Type II, IX and XI is dramatically reduced, whereas the production of collagen 
Type X increases. In fact, collagen Type X is only expressed in this zone of the growth plate 
and hence, it is considered to be a specific marker for chondrocytic hypertrophy. 
Furthermore, hypertrophic chondrocytes show a significant increase of intracellular calcium 
concentration. Intracellular calcium is essential for the production of release vesicles (Wang 
& Kirsch, 2002), which are rich in several types of Ca2+-binding annexins which promote 
Ca2+ uptake by these vesicles (Kirsch et al., 2000; Wang et al., 2003). Calcium phosphate, 
hydroxyapatite, phosphatases such as alkaline phophatase, and metalloproteinases are 
secreted via exocytosis, thus driving proteolytic remodelling and mineralization of the 
surrounding matrix (Lewinson & Silbermann, 1992; Vu et al., 1998). Moreover, the 
hypertrophic chondrocyte is a crucial master regulatory cell with an active metabolism. It 
prepares the matrix for calcification and vascularization (Forriol & Shapiro, 2005). In this 
context the expression of Vascular Endothelial Growth Factor (VEGF) by hypertrophic 
chondrocytes is of special interest for the initiation of the terminal ossification process. 
 
2.4 The invasive zone 
The expression of VEGF attracts invading blood vessels and, concomitantly, osteoblastic 
cells (Gerber et al., 1999). After vascularization of the mineralized cartilaginous matrix, the 
matrix is degraded by immigrant chondroclasts/ osteoclasts (Lewinson & Silbermann, 1992; 
Vu et al., 1998). The main part of the longitudinal septa (up to 80%) within the hypertrophic 
cartilage is rapidly resorbed behind the invading blood vessels, whereas the remaining septa 
serve as scaffolds on which osteoblasts deposit bone matrix (Salle et al., 2002). Finally, 
triggered by caspases, the hypertrophic chondrocytes undergo apoptosis or are resorbed 
(Gibson, 1998; Salvesen & Dixit, 1997). 
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& Kirsch, 2002), which are rich in several types of Ca2+-binding annexins which promote 
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Fig. 2. The growth palte is a well organized structure between the epihysis and the 
diaphysis of the long bones. The chondrocytes are arranged according to there proliferation 
and differentiation stage with small round shaped cells in the resting zone, flat, proliferating 
cells in the proliferatve zoe and great cells in the hypertrophic zone. In the invasive zone 
vessels grow in and give rout for the final ossification (HE and transmission electron 
microscopical images). 
 
3. Molecular Regulation of Endochondral Ossification 
The complex interplay between chondrocyte proliferation and differentiation, which is 
responsible for the characteristic morphological features of the growth plate, is highly 
orchestrated by the interaction of multiple systemic hormones and paracrine factors, which 
finally lead to changes in gene expression of the chondrocytes in the growth plate. The 
fundamental importance of endochondral ossification in long bone growth and 
development as well as in repair mechanisms of the skeleton is one reason for the increasing 
interest in the molecular factors that regulate this critical pathway. This section describes the 
latest insights into the regulation of chondrocyte proliferation and differentiation within the 
growth plate and focusses on molecules that play key roles in embryology and 
development. The description represents a choice of some important molecules without any 
claim to be exhaustive. A more prescise review of the different pathways involved in growth 
plate with respect to its potential relevance for tissue engineering is given elsewhere 
 
(Brochhausen et al. 2009). Table 1 summarizes the most important characteristics and effects 
of the signalling molecules and growth factors, which are described in detail below. 
 
3.1 Bone Morphogenetic Proteins 
Bone Morphogenetic Proteins (BMPs) represent a group of well known growth factors of the 
Transforming Growth Factor superfamily (TGF-beta). They were first identified and 
described by their capacity to stimulate ectopic cartilage and bone formation (Wozney, 
1989). On this basis, BMP’s represent a prime example of the high potential of growth 
factors for tissue engineing strategies. Today their important functional role in osteogenesis 
and chondrogenesis is well established. In early fetal development BMPs play important 
roles in the aggregation of mesenchymal cells during limb bud formation (Pizette & 
Niswander, 2000). In addition, BMPs influence the complex mechanisms in developing bone 
at later stages of skeletal development. The cellular effects of BMPs are mediated by two 
type I receptors, namely BMPRIA and BMPRIB, which heterodimerize with a type II 
receptor (BMPRII). The expression of BMPRIB was described by Zou et al. (1997) in early 
embryological development during mesenchymal cell condensations, which gives evidence 
that this receptor is involved in early bone and cartilage formation. The receptor BMPRIA 
could be detected in prehypertrophic chondrocytes (Zou et al., 1997). The differential 
expression of these receptors indicates the involvement of BMP-related pathways in 
different steps of bone and cartilage development. In this context it is of interest that BMPs 
have different expression patterns within bone and cartilage: BMP2, -3, -4, -5, and -7 are 
expressed in the perichondrium. BMP2 and -6 are expressed in hypertrophic chondrocytes 
and BMP7 is expressed in proliferating chondrocytes. 
BMPs are integrated in the Ihh-PTHrP (Indian hedgehog-parathyroid hormone-related 
peptide) signalling loop. They are capable of inducing the expression of Ihh and, hence, 
increase chondrocyte proliferation (Grimsrud et al., 2001). Furthermore, BMP pathways 
inhibit FGF signalling by constraining the expression of FGFR1 (fibroblast growth factor 
receptor 1) (Yoon et al., 2006). Within the growth plate a concentration gradient of BMP may 
be a key feature responsible for spatial regulation of chondrocyte proliferation and 
differentiation (Nilsson et al., 2007). 
Regarding tissue engineering strategies it is not surprising that recombinant human BMP’s 
have already found their way into clinical practice for the treatment of critical sized bone 
defects. To further optimize the use of these factors in tissue engineering the identifcation 
and synthesis of well-defined carriers with suitable BMP release profiles is necessary as 
described by Bessa et al. (2008). A detailed description of the physiological function of the 
different BMP’s during bone development is given by Kronenberg (2003), Forriol and 
Shapiro (2005). 
 
3.2 Fibroblast Growth Factor-signalling  
Fibroblast Growth Factors (FGFs) represent a superfamily of peptide growth factors 
synthesized by a variety of human and animal cells and act in a paracrine manner on their 
target cells. The cellular effects are mediated by plasma membrane tyrosine kinase receptors. 
The 22 distinct human FGFs are involved in diverse biological processes. In this context, a 
temporal selectivity in their expression is involved in the regulation of these pathways: the 
expression of FGF3, FGF4, FGF8 and FGF17 is restricted to embryonic tissue, whereas other 
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FGFs play significant roles not only in developmental processes but also in the biology of 
mature tissues (Jones, 2008). A further dicrimination of the effects in the FGF-related 
pathways is given by the mediation via four different types of FGF receptors (FGFR).  
Regarding skeletal development FGF1, 2, 17, and 19 are the predominant FGF members 
present in developing human cartilage (Krejci et al., 2007). In the early stage of 
endochondral bone formation multiple FGF’s as well as FGFR2 are expressed in condensing 
mesenchymal cells, which is thought to stimulate SOX9 expression (Murakami et al., 2000). 
FGFR3 is expressed by proliferating chondrocytes in the human growth plate, whereas 
FGFR1 is located in prehypertrophic and hypertrophic chondrocytes. Additionally, FGFR2 
can be detected on perichondral cells. Each of these receptors has distinct roles in bone 
development. At the moment FGFR3 is best understood: FGFR3 inhibits the proliferation of 
growth plate chondrocytes, especially by down-regulating Ihh expression in hypertrophic 
chondrocytes. Hence, FGF signalling shortens the proliferative columns. Furthermore, FGFs 
decelerate chondrocytic terminal differentiation. Thus, they decrease matrix synthesis and 
consequently delay hypertrophy of the growth plate chondrocytes (Kato & Iwamoto, 1990). 
FGF18 is expressed in the perichondrium and by an activation of FGFR3 this factor is 
thought to regulate skeletal vascularization (Liu et al., 2007). The crucial role of FGFR3-
mediated pathways in skeletal development is illustrated by the fact that a specific mutation 
in FGFR3 causes achondroplasia, the most common dwarfism in humans (Bellus et al., 1995; 
Shiang et al., 1994). A comprehensive overview of FGF and its functions during skeletal 
development is given by Olsen et al. (2000), Kronenberg (2003) as well as by Forriol and 
Shapiro (2005).  
 
3.3 Parathyroid Hormone-related Peptide (PTHrP) and Indian hedgehog (Ihh) 
PTHrP is a peptide which shares a receptor with the parathyroid hormone and has at its 
amino-terminus the identical 13 aminoacids as in the hormone itself. However, in contrast to 
the hormone PTHrP is detectable in many adult and developing tissues (Ingleton and 
Danks, 1996). Functionally, PTHrP is much more related to developmental growth factors 
such as FGF or TGF-beta than to a hormone. The identification of the PTHrP/Ihh feedback 
loop led to a major advancement in our understanding of growth plate regulation since it 
became clear that this pathway regulates the entry of chondrocytes into the hypertrophic 
phase of growth (Alvarez et al. 2003). The interplay between PTHrP and Ihh determines the 
moment when the chondrocytes leave the proliferative zone and enter the transition to 
hypertrophic chondrocytes. Perichondral cells and chondrocytes in the periarticular 
perichondrium synthesize PTHrP. This protein diffuses toward the prehypertrophic zone 
where cells have a high expression level of PTH/PTHrP receptors. After binding, PTHrP 
inhibits further differentiation to hypertrophic chondrocytes and keeps the chondrocytes in 
the proliferative stage (Lee et al., 1996). In the moment when the diffusion distances from 
the PTHrP-producing cells become too long, the effector cells are no longer sufficiently 
stimulated by PTHrP, which results in a delay of proliferation and the synthesis of Ihh, a 
member of the hedgehog family. Indian hedgehog is not only important in embryological 
development but also in the regulation of the growth plate. In this context Ihh is synthesized 
by prehypertrophic chondrocytes. As a consequence, the rate of chondrocyte proliferation 
increases and, by mechanisms that are still not fully understood, Ihh stimulates the 
production of PTHrP at the bone ends. Furthermore, by action of Ihh perichondral cells 
convert into osteoblasts and thus, enhance the formation of the bone collar. The essential 
 
role of Ihh in the postnatal integrity of the growth plate and endochondral ossification was 
clearly demonstrated by Maeda et al. (2007).  
 
3.4 Vascular Endothelial Growth Factor  
In the final ossification of the growth plate which leads to the formation of new bone the 
vascularisation of hypertrophic cartilage represents a crucial step. Thus, it is important that 
hypertrophic chondrocytes of the growth plate produce and secrete Vascular Endothelial 
Growth Factor (VEGF), one of the most potent angiogenetic factors (Gerber et al., 1999). 
VEGF in turn stimulates the proliferation and migration of endothelial cells. It enhances the 
formation of blood vessels in the hypertrophic zone of the growth plate and with this paves 
the way for ingrowth of osteoblasts, thus leading to ossification. Furthermore, the 
vascularization of the calcified cartilage within the invasive zone is essential for the 
resorption of chondrocytes by chondroclasts. Experimental data were able to demonstrate 
that the absence of VEGF causes profound disturbances in the architecture of the growth 
plate and affects significantly the longitudinal growth. In the absence of VEGF calcified 
cartilage persists as a result of a decrease in the recruitment and differentiation of 
osteoblasts and /or chondroclasts. As a morphological consequence a widening of the 
hypertrophic region and diminished trabecular bone formation could be observed as a 
result of the reduced elimination of terminally differentiated chondrocytes (Gerber et al., 
1999). Thus, VEGF-mediated capillary invasion is an essential signal that triggers cartilage 
remodelling and hence influences growth plate morphogenesis. Interestingly, hypertrophic 
chondrocytes also express receptors for VEGF, which leads to the hypothesis that this factor 
could have an autocrine function in these cells (Carlevaro et al., 2000). In addition to VEGF, 
ligands for the tyrosine kinase receptor Tie2 are further key regulators of angiogenesis and 
post-angiogenic blood vessel maturation (Asahara T, 1998, Suri C et al., 1996). The 
investigations of Horner et al. (2001) revealed the expression and spatial distribution of 
angiopoietin-1 and -2 (Ang-1 and Ang-2), the ligands for the endothelial receptor Tie-2 in 
the human growth plate. This group described Ang-1 and Ang-2 as an important regulator 
in the orchestration of neovascularization in the growth plate. In this context, Ang-1 and 
Ang-2, which were expressed by hypertrophic chondrocytes of the growth plate, seemed to 
modulate the effects of VEGF (Horner et al., 2001). The fundamental role of VEGF during 
long bone development is reviewed in detail by Ballock and O’Keefe (2003).  
 
3.5 Sox transcription factors 
Sox proteins are a member of the High-Mobility-Group (HMG) superfamily, which 
represents DNA-binding proteins, whose sequence is at least 50% identical with the 
sequence of the HMG domain of the sex-determining region located on the Y chromosome 
of human and other mammals (Sinclair et al., 1990). This relation is responsible for the name 
of the Sox protein family (Wegner, 1999). During long bone development Sox9 is critically 
involved in several stages during the developmental processes. In early embryological 
development Sox9 is required for the aggregation of mesenchymal cells (Bi et al., 1999). Sox5 
and Sox6, two other members of the Sox family, are coexpressed with Sox9 in 
chondroprogenitor cells and there is strong evidence that these genes are clearly needed for 
the differentiation of the chondrocytic lineage (Lefebvre et al., 1998; Akiyama et al., 2002). 
Furthermore, Sox9 is necessary for the expression of various extracellular matrix 
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FGFs play significant roles not only in developmental processes but also in the biology of 
mature tissues (Jones, 2008). A further dicrimination of the effects in the FGF-related 
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role of Ihh in the postnatal integrity of the growth plate and endochondral ossification was 
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3.4 Vascular Endothelial Growth Factor  
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post-angiogenic blood vessel maturation (Asahara T, 1998, Suri C et al., 1996). The 
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3.5 Sox transcription factors 
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sequence of the HMG domain of the sex-determining region located on the Y chromosome 
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of the Sox protein family (Wegner, 1999). During long bone development Sox9 is critically 
involved in several stages during the developmental processes. In early embryological 
development Sox9 is required for the aggregation of mesenchymal cells (Bi et al., 1999). Sox5 
and Sox6, two other members of the Sox family, are coexpressed with Sox9 in 
chondroprogenitor cells and there is strong evidence that these genes are clearly needed for 
the differentiation of the chondrocytic lineage (Lefebvre et al., 1998; Akiyama et al., 2002). 
Furthermore, Sox9 is necessary for the expression of various extracellular matrix 
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components, especially the collagen Types II, IX, XI as well as aggrecan (Bi et al., 1999; 
Lefebvre and de Crombrugghe, 1998). At later stages of development, the presence of Sox9, 
partly mediated by Sox5 and Sox6, is essential for chondrocyte proliferation and the 
alignment of proliferative clones into columns parallel to the longitudinal axis of the 
developing bone, indicating their important role in the proliferative zone of the growth plate 
(Akiyama et al., 2002). This fact is further ilustrated by the fact that the expression of the 
Sox5, Sox6, and Sox9 genes is completely turned off in hypertrophic chondrocytes (Lefebvre 
et al., 1998). Functionally, in the proliferative zone of the growth plate Sox9 prevents the 
transition of proliferating chondrocytes into hypertrophic chondrocytes, and is thus 
involved in the control of subsequent endochondral ossification (Akiyama et al., 2002). 
Furthermore, Zehentner et al. (1999) provided evidence that BMPs are also modulated by 
the expression of Sox9. With the help of transducing experiments Hardingham et al. (2006) 
demonstrated the critical role of Sox9 in chondrogenesis of isolated human articular 
chondrocytes. Regarding possibile tissue engineering strategies for cartilage, Khan et al. 
(2009) concluded that chondroprogenitors maintain SOX9 expression during extended 
monolayer culture and further retain chondrogenic potential. These findings demonstrate 
that the sox transcription factors not only play a crucial role in endochondral ossification but 
also in establishing the phenotype of articular cartilage both in vivo and in vitro, indicating 
that the regulation of the growth plate represents a suitable model to target potential 
signalling molecules and growth factors for cartilage tissue engineering. 
 
3.6 Runx2 
Runx2 (also known as Cbfa1) is another important transcription factor of the Runt-domain 
family (Ito, 1999). Runx2 is expressed during condensation of mesenchymal cells in early 
bone development and later in osteoblasts, but also in hypertrophic chondrocytes (Ducy et 
al., 1997; Inada et al., 1999; Kim et al., 1999; Otto et al., 1997). The analyses of Runx2 deficient 
mice gave evidence for the crucial functions of Runx2 during skeletal development: This 
transcription factor is firstly required for the differentiation of mesenchymal progenitor cells 
into osteoblasts. Later on in the growth plate of the long bones Runx2 enhances chondrocyte 
terminal differentiation (Inada et al., 1999; Kim et al., 1999) opening up the way for 
subsequent ossification. In Runx2-deficient mice, no endochondral and no intramembranous 
bone formation is present due to an arrest in osteoblast differentiation (Otto et al., 1997; 
Komori et al., 1997). In such mice, most bones either lack, or have reduced numbers of 
hypertrophic chondrocytes. In addition, hypertrophic chondrocytes fail to mineralize their 
matrix and have reduced or undetectable expression levels of osteotypical genes, such as 
osteopontin and MMP-13 (Takeda et al., 2001; Ueta et al., 2001). Thus, Runx2 is required for 
the differentiation of mesenchymal progenitor cells into osteoblasts. Furthermore, in the 
growth plate of long bones, this transcription factor enhances chondrocyte terminal 
differentiation (Inada et al., 1999; Kim et al., 1999) and is therefore a crucial factor for the 
definitive formation of trabecular bone. 
 
 
 
Fig. 3. Schematic depiction of the regulation of the growth plate with stimulating molecules 
(green arrows) and inhibitory molecules (red lines). 
 
3.7 Prostaglandin E2 
Prostaglandin E2 (PGE2) is a metabolite of the arachidonic acid cascade, an evolutionary 
highly conserved familiy of lipid mediators. Prostaglandins are involved in numerous 
physiological and pathophysiological mechanisms, as well as in the regulation of 
developmental processes. In the latter context, PGE2 also plays a significant role in skeletal 
development. In osteoblast-like cells, endogenous PGE2 was shown to affect proliferation 
and differentiation by stimulation of DNA synthesis and alkaline phosphatase activity 
(Igarashi et al., 1994). Furthermore, PGE2 influences the differentiation of chondrocytes as 
previously shown for the chondrocyte cell line RCJ3.1C5.18 (Lowe et al. 1996) and for rat 
growth plate chondrocytes (Schwartz et al. 1998, O’Keefe et al., 1992, Brochhausen et al., 
2006). In addition to such findings in cell culture, the physiological role of prostaglandins 
was clarified by its stimulating effect on bone formation and increase in bone mass after 
systemic administration of PGE2 to infants (Ueda et al., 1980) and animals (Suponitzki & 
Weinreb, 1998). Interestingly, also local administration of PGE2 resulted in osteogenesis in 
situ (Yang et al., 1993, Marks & Miller, 1988). The cellular effects of PGE2 are mediated by 
the binding to transmembranal G protein-coupled receptors. Four different EP receptors are 
known, which are linked to different intracellular signal transduction pathways (Narumiya 
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2006). In addition to such findings in cell culture, the physiological role of prostaglandins 
was clarified by its stimulating effect on bone formation and increase in bone mass after 
systemic administration of PGE2 to infants (Ueda et al., 1980) and animals (Suponitzki & 
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the binding to transmembranal G protein-coupled receptors. Four different EP receptors are 
known, which are linked to different intracellular signal transduction pathways (Narumiya 
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et al., 1999). The EP1 receptor is coupled to intracellular Ca2+ mobilization, while the EP2 
and EP4 receptors increase intracellular cAMP accumulation. By contrast, EP3 inhibits 
intracellular cAMP accumulation. Regarding bone formation and bone resorption the EP4 
receptor has been shown to be essential in terms of PGE2 action in bone (Yoshida et al., 
2002). In this respect the critical involvement of EP4 receptor in fracture healing was 
demonstrated very recently (Yoshida et al., 2002, Xie et al., 2009). Furthermore, EP2 and EP4 
receptors were shown to be required for PGE2-dependent chondrocyte differentiation 
(Miyamato et al., 2003).  
Despite their obvious role in bone and cartilage metabolism, prostaglandins are not in the 
main focus regarding potential tissue engineering strategies of bone and cartilage.  
 
Name Substance class Receptors Effect Reference 
BMP Protein growth 
factor 
BMPRI-A, 
BMPRI-B 
Cartilage & 
bone 
formation 
Grimsrud et al. 
(2001), Pizette & 
Niswander (2000) 
FGF peptide growth 
factor 
FGFR1, 
FGFR2, 
FGFR3 
Mesenchymal 
condensation, 
Osteogenic 
differentiation 
Kronenberg (2003), 
Hassan et al. (2007) 
Krejci et al. (2007) 
PTHr
P 
Signalling 
peptide 
G-protein GS 
and Gq 
receptors 
Chondrocyte 
proliferation 
Lee et al. (1996) 
Ihh Signalling protein Patched-1, 
Smo 
Chondrocyte 
proliferation 
Kronenberg (2003) 
VEGF Protein growth 
factor 
VEGF-R Vascularizatio
n, ingrowth of 
osteobalsts & 
chondroblasts 
Gerber et al. (1999) 
Sox Transcription 
factor 
DNA-
binding 
Chondrocyte 
differentiation 
& 
proliferation 
Lefebvre et al. (1998) 
Akiyama et al. (2002) 
Runx
2 
Transcription 
factor 
DNA-
binding 
Matrix 
mineralization
, chondrocyte 
differentiation 
Inada et al. (1999) 
Kim et al. (1999), 
Takeda et al. (2001), 
Ueta et al. (2001) 
PGE2 Lipid mediator G-protein 
receptors, 
EP1, EP2, 
EP3, EP4 
Chondrocyte 
proliferation, 
bone 
formation 
Brochhausen et al. 
(2006) 
Xie et al. (2009) 
Table 1. Summary of important growth factors and signalling molecules with relevant 
impact for the regulation of proliferation and differenzation of growth plate chondrocytes. 
 
4. Experimental Setup 
A principal aim of our research efforts was to develop an integrated release-system in an 
oriented scaffold for cartilage tissue engineering. Regarding the scaffold, one goal was to 
imitate the physiological fibre orientation of articular cartilage to achieve a topographically 
beneficial microenvironment. Articular cartilage represents a highly organized tissue not 
 
only at the cellular level, but also at the level of extracellular matrix components. Based on 
the spatial distribution, the morphological characterization and the biochemical activity of 
cells three zones are distinguishable in the articular cartilage (fig. 4): the superficial zone 
with flat aligned chondrocytes and perpendicularly arranged fibres, the middle zone with 
clusters of round shaped chondrocytes in a scaffold of parallel aligned collagen fibres and 
the deep zone with calcified cartilage.  
 
 
Fig. 4. Histomorphology of articular cartilage of the rat (HE, x200) with schematic depiction 
of the fibre arrangement.  
 
Reviewing the previously described signalling molecules, there are several reasons for the 
use of PGE2 in cartilage tissue engineering: First of all several in vitro and in situ data 
demonstrate an important role for PGE2 in cartilage development. Furthermore, this 
molecule, its metabolism, biological effects and possible side effects are already well 
understood and investigated. Finally, this substance is already on the market since decades, 
and is thus available in pharmaceutical quality and for a price less expensive than many of 
the modern developments. Since PGE2 has a short half-life, which ranges under 
physiological conditions between 30 seconds in the cardiovascular system and 35 minutes in 
amniotic fluid (Bygdeman 2003, Ghodgaonkar et al. 1979) we established a release system 
for this molecule as an important prerequisite for its potential use in tissue engineering 
strategies. As release sytem we developed poly-D,L-lactide-co-glycolide (PLGA) 
microspheres, which were originally designed for the expansion of chondrocytes (Gabler et 
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(Miyamato et al., 2003).  
Despite their obvious role in bone and cartilage metabolism, prostaglandins are not in the 
main focus regarding potential tissue engineering strategies of bone and cartilage.  
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understood and investigated. Finally, this substance is already on the market since decades, 
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for this molecule as an important prerequisite for its potential use in tissue engineering 
strategies. As release sytem we developed poly-D,L-lactide-co-glycolide (PLGA) 
microspheres, which were originally designed for the expansion of chondrocytes (Gabler et 
Tissue	Engineering396
 
a., 2007). Polylactide and its polymers are well established as drug release systems and are 
already in clinical use. Some examples for polylactide based release systems which are 
already in clinical application or hich are used in anmimal models are presented in Table 2, 
indicating that various substances can be integrated in corresponding systems. Thus, the 
polymer used in our experiments has also been shown to be could also be suitable for the 
integration and controlled release of further potential signalling moecules or growth factors. 
For the analyses of the PGE2 levels a novel sample preparation procedure was developed 
based on a previously published gas chromatography tandem mass spectrometry (GC-
MS/MS) method for prostaglandin detection (Schweer et al., 1994). The modification of this 
method wich is demonstrated in detail elswere (Watzer et al., 2009, Brochhausen et al., 2009) 
was necessary to determine the incorporated PGE2 levels. 
The combination of two different material approaches for scaffold and release sytems was 
given by the idea to create a veritable toolbox which permits the use of different factors in 
the same three-dimensional scaffold material combined with a systematic analysis of their 
effects. 
 
Active 
Agent 
Release systeme Indication Reference 
TGF-beta 1 PLGA (scaffold) Cartilage/bo
ne grwoth 
Gombotz et al. (1994) 
BMP PLGA (scaffold) Bone growth Ferguson et al. (1987), 
Johnson et al. (1988) 
VEGF PLGA-PEG 
(microspheres) 
Angiogenesis King & Patrick (2000) 
PGE1 Lipid-microspheres Vasodilatatio
n 
Kanamaru et al. 
(1998) 
Table 2. Summary of active agents integrated in a PLGA related release-system, which are 
either used in animal models or already in clinical application. 
 
5. Research 
5.1 Scaffold design 
From the biomaterial point of view the basis for the scaffold system was the development of 
a processing route for a material with similar structural, biochemical and mechanical 
properties as native articular cartilage. The basic approach and methodology for the 
synthesis route is based on a directional freezing technique which can be further combined 
with an electrolytic process (Zehbe et al., 2005). For this purpose, a gelatin solution was 
exposed to an electric field which leads to an arrangement of the fibres along the gas bubble 
formation. The container with the gelatin solution was positioned on the cold side of a 
peletier element. Thus, variation of the applied temperature was possible. A detailed 
description of the combination process which adapts an electrolytic decomposition process 
of the gelatin solution to introduce another pore fraction prior to freezing is precisely 
decribed in Zehbe et al. (2004, 2005). Freezing led to a stabilization of the fibre arrangement 
along the direction of ice crystal formation. After complete freezing, the sample was freeze 
dried to remove the ice crystals. Since a non-cross linked gelatin-based sample would 
rapidly dissolve under the fluid conditions in vitro or in vivo, the material was finally cross-
 
linked to guarantee chemical stability of the material. As a result, a porous network was 
achieved after complete removal of the formed ice crystals. 
Interestingly, the degree of directionality of the pores as well as the pore size is dependent 
on the freezing temperature, the ion content and the gelatin concentration. Thus, scaffolds 
with suitable directional pore channels could be synthesized at lower freezing temperatures 
without additional ions, while scaffolds with larger, non-directional pores could be made 
using higher freezing temperatures and elevated ion contents (fig 5a). In addition, based on 
this original scaffold processing route, we have introduced a hydroxyapatite layer to mimick 
the subchondral bone and address the potential application in tissue engineered-based 
treatment of deep cartilage defects (fig 5b). 
Furthermore, we integrated in this scaffold drug release components in the form of PLGA-
microspheres, which themselves were further enhanced by the integration of an active agent 
to meet so-called 3rd generation tissue engineering requirements. 
 
 
Fig. 5. X-ray tomographic slice representations of scaffolds with varying pore-channel 
networks (a) and sliced representation of a scaffold featuring hydroxyapatite as bone-like 
layer (b) (adapted from Zehbe et al., 2007). 
 
5.2 PLGA- release system for prolonged PGE2 release 
As already mentioned above, the possible use of PGE2 is highly limited due to its short half-
life under physiological conditions. Therefore, for tissue engineering strategies this molecule 
should be used in the form of a release-system to guarantee a prolonged bioavailability. 
With respect to the microsphere scaffold modification we adapted an emulsion-based 
synthesis pathway which is described in detail by Brochhausen et al. (2007, 2009). In these 
protocols the microspheres were synthesized using a co-solvent emulsification method. The 
PLGA (Resomer RG859SR, Boehringer Ingelheim) used in our experiments had a lactide-
glycolide-ratio of 85:15, a residual monomer content of < 2.0 % and an inherent viscosity of 
2.5 - 3.5 dl/g. In the first step, 0.1 g PLGA granules were dissolved in 1.0 CHCl3. Then, PGE2 
was dissolved in hexauoroisopropanol (HFIP) in a concentration of 1.0 mg/ml. The PLGA 
solution was mixed with the PGE2 solution giving the following composition: 0.1 g PLGA, 
3.5 µg PGE2, 1.0 ml CHCl3 and 3.5 µl HFIP. To allow the complete removal of the organic 
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a., 2007). Polylactide and its polymers are well established as drug release systems and are 
already in clinical use. Some examples for polylactide based release systems which are 
already in clinical application or hich are used in anmimal models are presented in Table 2, 
indicating that various substances can be integrated in corresponding systems. Thus, the 
polymer used in our experiments has also been shown to be could also be suitable for the 
integration and controlled release of further potential signalling moecules or growth factors. 
For the analyses of the PGE2 levels a novel sample preparation procedure was developed 
based on a previously published gas chromatography tandem mass spectrometry (GC-
MS/MS) method for prostaglandin detection (Schweer et al., 1994). The modification of this 
method wich is demonstrated in detail elswere (Watzer et al., 2009, Brochhausen et al., 2009) 
was necessary to determine the incorporated PGE2 levels. 
The combination of two different material approaches for scaffold and release sytems was 
given by the idea to create a veritable toolbox which permits the use of different factors in 
the same three-dimensional scaffold material combined with a systematic analysis of their 
effects. 
 
Active 
Agent 
Release systeme Indication Reference 
TGF-beta 1 PLGA (scaffold) Cartilage/bo
ne grwoth 
Gombotz et al. (1994) 
BMP PLGA (scaffold) Bone growth Ferguson et al. (1987), 
Johnson et al. (1988) 
VEGF PLGA-PEG 
(microspheres) 
Angiogenesis King & Patrick (2000) 
PGE1 Lipid-microspheres Vasodilatatio
n 
Kanamaru et al. 
(1998) 
Table 2. Summary of active agents integrated in a PLGA related release-system, which are 
either used in animal models or already in clinical application. 
 
5. Research 
5.1 Scaffold design 
From the biomaterial point of view the basis for the scaffold system was the development of 
a processing route for a material with similar structural, biochemical and mechanical 
properties as native articular cartilage. The basic approach and methodology for the 
synthesis route is based on a directional freezing technique which can be further combined 
with an electrolytic process (Zehbe et al., 2005). For this purpose, a gelatin solution was 
exposed to an electric field which leads to an arrangement of the fibres along the gas bubble 
formation. The container with the gelatin solution was positioned on the cold side of a 
peletier element. Thus, variation of the applied temperature was possible. A detailed 
description of the combination process which adapts an electrolytic decomposition process 
of the gelatin solution to introduce another pore fraction prior to freezing is precisely 
decribed in Zehbe et al. (2004, 2005). Freezing led to a stabilization of the fibre arrangement 
along the direction of ice crystal formation. After complete freezing, the sample was freeze 
dried to remove the ice crystals. Since a non-cross linked gelatin-based sample would 
rapidly dissolve under the fluid conditions in vitro or in vivo, the material was finally cross-
 
linked to guarantee chemical stability of the material. As a result, a porous network was 
achieved after complete removal of the formed ice crystals. 
Interestingly, the degree of directionality of the pores as well as the pore size is dependent 
on the freezing temperature, the ion content and the gelatin concentration. Thus, scaffolds 
with suitable directional pore channels could be synthesized at lower freezing temperatures 
without additional ions, while scaffolds with larger, non-directional pores could be made 
using higher freezing temperatures and elevated ion contents (fig 5a). In addition, based on 
this original scaffold processing route, we have introduced a hydroxyapatite layer to mimick 
the subchondral bone and address the potential application in tissue engineered-based 
treatment of deep cartilage defects (fig 5b). 
Furthermore, we integrated in this scaffold drug release components in the form of PLGA-
microspheres, which themselves were further enhanced by the integration of an active agent 
to meet so-called 3rd generation tissue engineering requirements. 
 
 
Fig. 5. X-ray tomographic slice representations of scaffolds with varying pore-channel 
networks (a) and sliced representation of a scaffold featuring hydroxyapatite as bone-like 
layer (b) (adapted from Zehbe et al., 2007). 
 
5.2 PLGA- release system for prolonged PGE2 release 
As already mentioned above, the possible use of PGE2 is highly limited due to its short half-
life under physiological conditions. Therefore, for tissue engineering strategies this molecule 
should be used in the form of a release-system to guarantee a prolonged bioavailability. 
With respect to the microsphere scaffold modification we adapted an emulsion-based 
synthesis pathway which is described in detail by Brochhausen et al. (2007, 2009). In these 
protocols the microspheres were synthesized using a co-solvent emulsification method. The 
PLGA (Resomer RG859SR, Boehringer Ingelheim) used in our experiments had a lactide-
glycolide-ratio of 85:15, a residual monomer content of < 2.0 % and an inherent viscosity of 
2.5 - 3.5 dl/g. In the first step, 0.1 g PLGA granules were dissolved in 1.0 CHCl3. Then, PGE2 
was dissolved in hexauoroisopropanol (HFIP) in a concentration of 1.0 mg/ml. The PLGA 
solution was mixed with the PGE2 solution giving the following composition: 0.1 g PLGA, 
3.5 µg PGE2, 1.0 ml CHCl3 and 3.5 µl HFIP. To allow the complete removal of the organic 
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solvents by evaporation, the resulting solution was stirred over night in 0.5 % polyvinyl 
alcohol at 300 rpm with the help of a multi-position magnetic stirrer (RO 15 power Ikamag, 
IKA, Germany) according to the adaption of a previously described method (Gabler et al., 
2007). Finally, the resulting microspheres were washed in sterile deionized water. 
The characterization of the microspheres especially with respect to their size distribution 
was performed according to a protocol developed in our research group: In brief, SEM-
images showing approximately 50 to 100 well dispersed microspheres were imaged top 
down and were then analyzed with the software ImageJ according to Gabler et al. (2007). In 
addition, the degradation changes regarding mass loss, pH-shift and the morphological 
changes of the microspheres in cell culture medium were documented over a timeframe of 
up to 100 days. Regarding the release profile we were able to show the kinetics of PGE2 
release over a period of 154 hours as measured by gas chromatography-mass spectroscopy 
(GC-MS/MS) and mass spectroscopy (Brochhausen et al.,2009). For this purpose the method 
of Schweer et al. (1994) was adapted. An important advantage of this method is that the 
structurally and thus functionally intact molecule could be detected even at very low 
concentrations. As a result of our analyses, we were able to determine reliably the amount of 
incorporated PGE2 in the PLGA microspheres. Interestingly, the stability of PGE2 was pH 
dependent: Strong acidic or basic environments reduced the half-life from 300 hours (pH 2.6 
- 4.0) to below 50 hours at pH 2.0 or pH 8.8. Furthermore, we showed that the half-life of 
incorporated PGE2 is highly temperature dependent (fig. 6). Thus, the half life could be 
increased from 70 days at 37 °C to 300 days at 8 °C. In our kinetic study we demonstrated a 
gradual concentration increase of PGE2 in DMEM over the first 13 h, followed by a 
concentration plateau for 35 h and a slight decline of the PGE2 concentration after the 48 h 
time point.  
 
 
Fig. 6. pH dependent (a) and temperature dependent stability of PGE2 (b), graphs adapted 
from Watzer et al., 2009. 
 
For the used PLGA-type with a lactide-glycolide-ratio of 85:15 we hypothesized that the 
PGE2 is primarily released from the outer shell of the microsphere as depicted in figure 7. 
Our image shows a microsphere after degradation for 80 days, as well as a superimposed 
graph of the kinetic experiments. After 80 days in cell culture medium the interior of the 
sphere is highly degraded, while the shell is almost intact. Further analysis with SR-µCT 
 
revealed that the microspheres consist of a porous shell and a compact core. These findings 
could be confirmed by scanning electron microscopy (SEM) and atomic force microscopy 
(AFM) which clearly showed the internal and external structure of the microspheres with a 
distinct nanostructure of the polymeric phase and both nano- and micro-porosity (Watzer et 
al., 2009). Thus, the rapid increase of PGE2 could be the result of the release out of the 
porous shell, whereas the later PGE2 values could be the result of the release out of the core. 
Regarding the degradation of the microspheres we hypothesized that the slow erosion of the 
surfaces results in a semi-permeable membrane which delays the release of degradation 
products and thus results in autocatalytic processes, amplifying the degradation inside the 
material (Heidemann et al., 2002, Maspero et al., 2002, Gabler et al., 2007). 
 
 
Fig. 7. PGE2 release profile from PLGA microspheres and proposed release mechanism 
derived from SEM investigations. Initial release from the outer shell (a) and sustained 
release from the core after more than 160 h (b). 
 
For the combined drug-release-scaffold system PGE2-loaded microspheres were added to 
the gelatin solution and stirred until the gelatin gelled. By this procedure sedimentation of 
the spheres could be prevented so that a homogeneous distribution of microspheres could 
be reached without negatively affecting the casting of the gelatin in the freezing apparatus. 
After the freezing process, the microsphere-modified frozen gelatin samples were freeze 
dried and chemically cross linked as described above. We analysed the distribution of the 
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2007). Finally, the resulting microspheres were washed in sterile deionized water. 
The characterization of the microspheres especially with respect to their size distribution 
was performed according to a protocol developed in our research group: In brief, SEM-
images showing approximately 50 to 100 well dispersed microspheres were imaged top 
down and were then analyzed with the software ImageJ according to Gabler et al. (2007). In 
addition, the degradation changes regarding mass loss, pH-shift and the morphological 
changes of the microspheres in cell culture medium were documented over a timeframe of 
up to 100 days. Regarding the release profile we were able to show the kinetics of PGE2 
release over a period of 154 hours as measured by gas chromatography-mass spectroscopy 
(GC-MS/MS) and mass spectroscopy (Brochhausen et al.,2009). For this purpose the method 
of Schweer et al. (1994) was adapted. An important advantage of this method is that the 
structurally and thus functionally intact molecule could be detected even at very low 
concentrations. As a result of our analyses, we were able to determine reliably the amount of 
incorporated PGE2 in the PLGA microspheres. Interestingly, the stability of PGE2 was pH 
dependent: Strong acidic or basic environments reduced the half-life from 300 hours (pH 2.6 
- 4.0) to below 50 hours at pH 2.0 or pH 8.8. Furthermore, we showed that the half-life of 
incorporated PGE2 is highly temperature dependent (fig. 6). Thus, the half life could be 
increased from 70 days at 37 °C to 300 days at 8 °C. In our kinetic study we demonstrated a 
gradual concentration increase of PGE2 in DMEM over the first 13 h, followed by a 
concentration plateau for 35 h and a slight decline of the PGE2 concentration after the 48 h 
time point.  
 
 
Fig. 6. pH dependent (a) and temperature dependent stability of PGE2 (b), graphs adapted 
from Watzer et al., 2009. 
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PGE2 is primarily released from the outer shell of the microsphere as depicted in figure 7. 
Our image shows a microsphere after degradation for 80 days, as well as a superimposed 
graph of the kinetic experiments. After 80 days in cell culture medium the interior of the 
sphere is highly degraded, while the shell is almost intact. Further analysis with SR-µCT 
 
revealed that the microspheres consist of a porous shell and a compact core. These findings 
could be confirmed by scanning electron microscopy (SEM) and atomic force microscopy 
(AFM) which clearly showed the internal and external structure of the microspheres with a 
distinct nanostructure of the polymeric phase and both nano- and micro-porosity (Watzer et 
al., 2009). Thus, the rapid increase of PGE2 could be the result of the release out of the 
porous shell, whereas the later PGE2 values could be the result of the release out of the core. 
Regarding the degradation of the microspheres we hypothesized that the slow erosion of the 
surfaces results in a semi-permeable membrane which delays the release of degradation 
products and thus results in autocatalytic processes, amplifying the degradation inside the 
material (Heidemann et al., 2002, Maspero et al., 2002, Gabler et al., 2007). 
 
 
Fig. 7. PGE2 release profile from PLGA microspheres and proposed release mechanism 
derived from SEM investigations. Initial release from the outer shell (a) and sustained 
release from the core after more than 160 h (b). 
 
For the combined drug-release-scaffold system PGE2-loaded microspheres were added to 
the gelatin solution and stirred until the gelatin gelled. By this procedure sedimentation of 
the spheres could be prevented so that a homogeneous distribution of microspheres could 
be reached without negatively affecting the casting of the gelatin in the freezing apparatus. 
After the freezing process, the microsphere-modified frozen gelatin samples were freeze 
dried and chemically cross linked as described above. We analysed the distribution of the 
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microspheres by high resolution X-Ray tomography as described in detail in the chapter by 
Zehbe et al. in this book. 
 
5.2 Chondocyte isolation and Cell Seeding of Scaffolds 
For the cell culture experiments with the release-scaffold system bovine chondrocytes were 
used. For this purpose, fetlock joints of 3-4 months old calves were obtained directly after 
slaughter and processed under aseptic conditions. Articular cartilage chondrocytes were 
harvested aseptically from dissected flakes of the full thickness cartilage. After harvesting 
the cartilage flakes were washed twice for 15 min with Tyrode’s balanced salt solution 
(TBSS) containing penicillin, streptomycin and amphotericin B. The cartilage flakes were 
then predigested with 1 mg/mL of pronase (Roche Diagnostics GmbH, Mannheim, G) on a 
magnetic stirrer at 37°C for 2 h, followed by washing with TBSS. Afterwards the specimens 
were digested with 600 units/mL of collagenase type II (Worthington Biochemical Corp, 
Lakewood, NJ) in DMEM by stirring at 37°C for a maximum of 15 h. The suspension was 
then filtered, and the isolated chondrocytes were washed 3 times with DMEM containing 
10% fetal bovine serum (FBS). The viability of the isolated cells was determined using the 
trypan blue exclusion method. The cells were cultured in 175 cm2 culture flasks at 5% CO2, 
95% humidity and 37°C in DMEM containing 10% FBS. Chondrocytes were cultured in 
monolayers until confluence and then seeded onto the scaffolds. Cell-seeded scaffolds were 
cultured in 12-well tissue culture plates in DMEM supplemented with 10% FCS, 
nonessential amino acids, and 40 µg/mL of l-proline. After 2 days, 50 µg/mL of ascorbic 
acid was added. The medium was changed three times per week. Cell scaffold constructs 
were analyzed after 8 days of culture.  
In these experiments the cultured cells showed a round shaped chondrocytic phenotype as 
seen by histological examination. Regarding the distribution of cells the majority of cells was 
detectable in the upper half of the scaffold. In this area cell clusters consisting of two or more 
cells could be seen, which are typical for the middle zone of articular cartilage. With the help 
of alcian blue staining, the production of extracellular matrix components was demonstrated 
especially surrounding the cell clusters (fig 8). 
In further experiments with cultured human chondrocytes from patients who underwent 
implantation of endoprothesis due to osteoarthrosis, preliminary data revealed that in the 
presence of low dose PGE2 the seeded cells showed a chondrocytic, round shaped 
phenotype with arrangement of multiple clusters, whereas cells without PGE2 showed a 
spindle shaped fibrocytic phenotype (Brochhausen et al., 2008). 
 
 
Fig. 8. Bovine chondrocytes cultivated for eight days in the combined release-scaffold 
system with round shaped chondroid phenotype (a, HE, x400), formation of chondrocyte 
clusters (b, arrow) and relevant extracellularmatrix production (b, alcian blue, x400)  
 
6. Conclusion 
In the present report we demonstrate that growth plate cartilage is a suitable model for 
strategies to target potential signalling molecules and growth factors for tissue engineering. 
Furthermore, we described the synthesis of a scaffold material with a structural design that 
gives ingrowing cells a pre-defined microenvironment similar to the cellular organization in 
native articular cartilage. Based on knowledge gained from the development of bone we 
used PGE2 as a signalling molecule for cartilage tissue engineering strategies. In this context 
we firstly immobilized this molecule in polyester-based (PLGA) microspheres and then 
incorporated these in our gelatin-based orientated scaffold. The present experiments 
confirmed the prolonged release of PGE2 from the PLGA microspheres and the beneficial 
effects of low dose PGE2 for the phenotype of bovine and human articular chondrocytes 
seeded on the three-dimensional scaffold. 
Since PLGA release systems are already used for various substances the present 
microsphere-scaffold system opens the perspective for the incorporation of further 
signalling molecules and growth factors. Furthermore, our construct facilitates the 
systematic analysis of different factors influencing the proliferation and differentiation of 
chondrocytes in an identical three-dimensional environment. For further tissue engineering 
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6. Conclusion 
In the present report we demonstrate that growth plate cartilage is a suitable model for 
strategies to target potential signalling molecules and growth factors for tissue engineering. 
Furthermore, we described the synthesis of a scaffold material with a structural design that 
gives ingrowing cells a pre-defined microenvironment similar to the cellular organization in 
native articular cartilage. Based on knowledge gained from the development of bone we 
used PGE2 as a signalling molecule for cartilage tissue engineering strategies. In this context 
we firstly immobilized this molecule in polyester-based (PLGA) microspheres and then 
incorporated these in our gelatin-based orientated scaffold. The present experiments 
confirmed the prolonged release of PGE2 from the PLGA microspheres and the beneficial 
effects of low dose PGE2 for the phenotype of bovine and human articular chondrocytes 
seeded on the three-dimensional scaffold. 
Since PLGA release systems are already used for various substances the present 
microsphere-scaffold system opens the perspective for the incorporation of further 
signalling molecules and growth factors. Furthermore, our construct facilitates the 
systematic analysis of different factors influencing the proliferation and differentiation of 
chondrocytes in an identical three-dimensional environment. For further tissue engineering 
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applications it is of interest to create gradients of signalling molecules and growth factors 
within the scaffold by establishing a graded microsphere distribution. 
In conclusion, we demonstrate in this contribution an innovative scaffold material with 
properties of a biphasic composition and the incorporation of signalling molecules with the 
perspective to improve our understanding of the triad of cells, materials and signalling 
molecules as essential elements for tissue engineering strategies.  
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1. Introduction 
Articular cartilage has a limited repair capacity due to its low mitotic activity, avascular 
nature, and sparse cell population. Osteoarthritis, a painful condition of the joints, has 
affected over 200 million people worldwide. Cell-based tissue engineering is emerging as a 
promising clinical option to address tissue and organ failure by implanting biological 
substitutes for the compromised tissue. 
Various dynamic stresses such as shear flow, hydrostatic pressure, and direct compression 
exist in living bodies and are thought to contribute to cartilage formation. A rotational 
culture can provide such a mechanical load in a simple manner. In this chapter, we 
introduce our recent scaffoldf-free cartilage tissue engineering approaches using such a 
rotational culture. 
  
2. Articular cartilage 
Articular cartilage is a form of hyaline cartilage that envelopes the surface of diarthrodial 
joints in the human body to distribute the force and allow smooth movement with minimal 
friction between two bones. Diarthroidial joints are joints where threre is a lot of motion 
between opposing bones; for example, the ankle, knee, hip, shoulder, or elbow joints. The 
joints can bear very large compressive loads and has a very low coefficient of friction (0.005 
to 0.05). Unlike other connective tissues, cartilage does not contain anyblood vessels, nerves, 
or lymphatics. Therefore, it receives nutrients though convection from the surrounding 
synovial fluid, or diffusion, which is aided by the pumping action created during 
compression of the cartilage. Cartilage is made up of chondrocytes embedded in a rich 
matrix of collagen and proteoglicans (Fig. 1). 
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Fig. 1. Cartilage composition 
 
Cells in articular cartilage , which are known as chondrocytes, account for only 5% of the 
volume of the cartilage. Approximately 70-80% of the articular cartilage is composed of 
water, whereas the solid phases in composed primarily of type II collagen and aggrecan, a 
chondroitin and keratan sulohate proteoglycan (Tablel). 
Water  66-79% 
Solid  21-34％ 
Minerals   
Residual ash  5-6％ 
Organic 
materials  
 
Collagen  48-62％ 
Glycosaminoglycan  8-15％ 
Protein  14-23％ 
Hyaluronic acid  <1％ 
Sialic acid  <1％ 
Lipid  <1％ 
Glycoprotein  <1％ 
Table 1. Biochemical composition of articular cartilage 
 
Collagen forms a network of fibrils, which resist the swelling pressure generated by the 
proteoglycans. Aggrecan, because of its tendency to non-covalemtly interact with 
hyaluronic acid, forms huge aggregates that become trapped in the collagen network. 
Because of their numerous negatively charged sulfate groups, these proteoglycan aggregates 
attract cations, which in turn bring in water to minimize differences in osmotic pressure. 
Thus, thpe II collagen and proteoglycans create a   swollen, hydrated tissue that resists 
compression. Therefore, the articular cartilage functions as load bearing, shock absorbing, 
and friction reducing material in diarthrodial joints. 
Cartilage tissue has only a small capacity for self-repair. The avascular nature, the sparse cell 
population, and the low mitotic activity of the chondrocytes severely limit the natural healing 
of these cartilage defects(Campbell et al., 1969; Mankin et al., 1982; Ushida et al., 2002). Many 
patients with damaged cartilage due to trauma or diseases such as osteoarthritis and 
osteochondrosis dissecans are existing in the world. The degradation of cartilage eventually 
leads to osteoarthritis, which is the thinning of the articular cartilage resulting in a bone-to-
bone joint, causing pain and a reduction in notion. In this disease, there is often the loss of 
proteoglycans, which leads to decreased compressive stiffness of the tissue. When 
osteoarthritis reaches the subcondral bone, an ingress of cells from the bone marrow will 
generate fibrocartilagegious repair. This leads to a tissue that has lower proteoglycan and high 
levels of type I collagen. Fibrocartilage is mechanically insufficient as it cannot withstand the 
normal physiological loads and wear stresses on the knee during work or sports. In very 
severe cases, both bones of the joint may grow into one antoher, causing them to fuse together. 
The joints most commonly affected by osteoarthritis include the hips, knees, wrists, between 
the fingers, and between the vertebrae. 
 
3. Current treatment for osteoarthritis 
Current therapies include transplantation of healthy host cartilage or implantation of 
artificial prosthetic devices. However, problems remained in these treatments. The amount 
of donor tissue for transplantation is limited, and durability of the prosthetic devices (Fig. 2) 
is not good by wear debris or adhesive breakdown at the host/prosthesis interface. For 
these reasons, there is considerable interest in developing cell therapies and tissue-
engineered cartilages to treat damaged cartilage(Brittberg et al., 1994; Freed et al., 1994a, 
Freed et al., 1994b, Freed et al., 1994c). 
 
  
Before After 
Fig. 2. Knee joint replacement prosthesis 
(http:// assets.aarp.org/external_sites/adam/html/2/9494.html) 
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Still, many problems remain in cartilage tissue engineering using cells. When grown in two-
dimensional culture, adult articular chondrocytes are capable of proliferation, promoting 
researchers to use cultured autologous chondrocytes to accelerate cartilage regeneration. 
However, the proliferating chondrocytes gradually lose their differentiated phenotype(von 
der Mark et al., 1977; Benya et al., 1982, Fig.3), as indicated by the loss of synthesis of 
aggrecan and type II collagen and the increase of synthesis of type I collagen (Fig. 4, Chen et 
al., 2003, Ushida et al., 2004). Therefore, in order to form a tissue-engineered cartilage using 
proliferated chondrocytes with a dedifferentiated phenotype, it is thought that reexpression 
of the chondrogenic phenotype should be induced before implantation. 
 
  
Fig. 3. Chondrocytes in 2-dimensional culture. Left: Primary chondrocytes, right: 
dedifferentiated chondrocytes 
 
 
Fig. 4. Northern blot analysis of the mRNA encoding type I collagen. Type II collagen, and 
aggrecan of bovine chnodrocytes cultured in monolayer for 0, 1, 2, 3 and 4 passages (Chen et 
al., 2003, Ushida et al., 2004). 
 
To date, "pellet" culture systems (Fig. 5) under static conditions have been reported as a 
method for preventing and reversing the phenotypic modulation of chondrogenesis in 
vitro(Hay et al., 2000; Johnstone et al., 1998; Lunstrum et al., 1999; Mackay et al., 1998; 
Oberlender et al., 1994; Pittenger et al., 1999; Tracy et al., 1994; Yoo et al., 1998). 
 
  
Fig. 5. Pellet culture by dedifferentiated chondrocytes (Tsuchiya et al., 2005). 
This culture system allows cell-cell interactions analogous to those that occur in 
condensation during embryonic development. Although the system facilitates chondrogenic 
differentiation from dedifferentiated chondrocytes or mesenchymal stem cells with high 
reproducibility, its clinical application to tissue engineering has not been successful thus far. 
Because the "pellet" culture system forms only one small cell-aggregate per tube by a 
centrifugator, it is difficult to yield sufficient numbers of pellets with the differentiated 
phenotype. Therefore, a cartilage tissue with a large size in which cell-cell interactions exist, 
as in a pellet culture, without using a scaffold was tried to form for tissue engineering. 
 
4. Scaffold-free cartilage model by dynamic rotational culture 
By using a high porous simple mold, scaffold-free cartilage tissue of arbitrary shapes was 
tried to fabricate (Furukawa et al., 2008). Various dynamic stresses such as shear flow, 
hydrostatic pressure, and direct compression exist in living bodies and are though to 
contribute a scaffold-free rotational culture provided such a mechanical load in a simple 
manner. Thus, it was demonstrated that a scaffold-free cartilage tissue with a large size and 
arbitrary shape for tissue engineering could be regenerated without any scaffolds, by 
making cell-cell interaction and mechanical stress loading for tissue engineering. 
When a cylindrical glass mold with a diameter of 1 cm was used, dedifferentiated 
chondrocytes of 1.5x107 cells were inoculated into the mold using a commercially available 
culture-insertion film with pores of 0.4 |_im. Oxygen and nutrition can diffuse from the 
lower and upper sides of cells. After 8 hours of cell inoculation, the mold was removed from 
the membranous surface, and cell plates were left on there with the same shape as the mold. 
After 24 hours' static culture for shape stabilization, scaffold-free tissue was moved to a 6-
well culture plate without any shape changing adding 5 ml of differentiation medium, and 
was begun on rotational culture. In this point, the scaffold-free plate was very fragile; 
therefore, displacement of the tissue to the rotational culture plate was done with great care. 
A disk-like cartilage tissue was formed by 3 weeks' culture as shown in Fig. 6. 
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Fig. 6. Appearance of the scaffold-free cartilage tissue after 3-week culture. A, B, E-H: 
Rotationcal culture, C, D: static culture. A-D, F: mold shapes were circle. E: Mold shape was 
square. G: Spade shape formed by stamping out with a metal mold. H: F-C. 
 
When the cartilage plate without any scaffold cultured under shear flow conditions 
(rotational culture condition) was grasped, the shape of the plate with a disk-like form was 
maintained (Fig. 6B). In contrast, the cartilage plates cultured under static conditions 
changed to a dogleg shape when grasped (Fig. 6D); often they could not keep their shape for 
3 weeks if we changed the medium. Therefore, it was obvious that mechanical conditions 
played an important role in the mechanical properties of a scaffold-free cartilage tissue. 
When a square mold was used, a square-shaped cartilage plate was formed under shear 
flow conditions (Fig. 6E). The formation of a comparatively large cartilage tissue was also 
possible as shown in Fig. 6F. Furthermore, it was possible to form and cut it into spade 
shapes, i.e., arbitrary shapes, by stamping out with a metal mold (Fig. 6G, 6H). 
The thickness, diameter, and volume of cartilage tissue formed by a glass mold with a 
diameter of 1 cm at the start point of culture were measured. The thickness of the cartilage 
tissue continued to increase for the 3-week rotation culture (Fig. 7A). The diameter increased 
slightly for 1 week, then remained the same (Fig. 7B). The volume continued to increase for 
the 3-weeks culture (Fig. 7C). Similar results were obtained in control static culture. To 
confirm the viability of the chondrocytes in the cartilage tissue, the scaffold-free cartilage 
with a diameter of 1 cm cultured under shear flow conditions was stained with calcein-AM 
and propium iodide. Necrosis in the center of the tissue was not observed; the majority of 
the cartilage cells in the central part of the cartilage tissue were understood to be living. 
Therefore, it was suggested that the chondrocytes included in the cartilage tissue were alive 
and maintained their growth for 3 week in vitro. 
 
 
Fig. 7. Time changes in thickness, diameter, and volume of the cartilage tissue for 3-week 
rotational culture. D: Dynamic (rotational) culture of the cartilage tissue, S: Static culture. A) 
Thickness of the cartilage plate was measured by a mechanical spectrometer (AGS-G, 
Shimazu, Kyoto, Japan), mean±SE (n=4). B) Diameter was measured by a caliper square. C) 
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Fig. 6. Appearance of the scaffold-free cartilage tissue after 3-week culture. A, B, E-H: 
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Volumes of the cartilage plate were calculated from the data of the thickness and the 
diameter of the cartilage plates, independently. 
To investigate the existence of proteoglycans, the cartilage tissue with a diameter of 1 cm 
was stained with safranin-O and toluidine blue. The cartilage tissue cultured under dynamic 
conditions (rotational culture) for 3 weeks showed strong staining properties (Fig. 8B and 
8D) compared with that of the static culture (Fig. 8A and 8C). In rotational culture, cells 
aligned horizontally to the surface were observed (Fig. 9B). In contrast, cartilage tissue 
cultured under static conditions did not have such alignment; instead, cells near the surface 
had a round shape without any orientation (Fig. 9A). 
 
  
Fig. 8. Distribution of proteoglycan was investigated. A and C) Scaffold-free cartilage tissue 
cultured under a static condition without flow was stained with safranin-O after cultivation 
of 3 weeks. B and D) Scaffold-free cartilage tissue cultured by rotational culture was stained 
with safranin-O after 3 weeks. Scales, 200|im. Magnifications of objective lens, A, B; x4, C, 
D; x20. 
 
The edge of the cartilage tissue cultured under static conditions was not smooth while that 
of rotational culture was extremely smooth. In cartilage tissue by rotational culture, there 
were parts, near the surface, not stained with safranin-O (Fig. 3B and 3D). The results by 
toluidine blue were similar to the results of safranin-O (data was not shown). The cartilage 
tissue formed by rotational culture presented metachromasia, and the color was stronger 
than those of the static cultures. The tendencies of the cell shape and tissue formation were 
also similar to those of safranin-O. 
 
 
Fig. 9. Tissue cultured by static (A), and rotational conditions (B) was stained with HE in 
order to observe cell distributions. A: Magnification of objective lens=x5, B: Objective 
lens=x20. Scales, 200|im. 
 
Irnmunohistochernical analysis showed that type II collagen protein was abundantly 
distributed in scaffold-free cartilage tissue cultured by rotational culture (Fig.lOA). On the 
other hand, cartilage tissue formed by static culture showed inhomogeneous distribution of 
type II collagen protein (Fig. 10B). 
 
  
Fig. 10. Cartilage tissue by 3-week culture was stained with type II collagen antibody. A) 
Cartilage tissue cultured by rotational conditions. B) Cartilage tissue cultured by static 
conditions. Objective lens: x5, Scales; 200|im. 
 
The cartilage tissue formed by 3 weeks' rotational culture had scarcely any type I collagen 
protein (Fig. 11A). In static culture, type I collage protein appeared at the edge of the 
cartilage tissue as shown in brown color (Fig 11B). 
The amounts of proteoglycan and total collagen protein secreted were quantitatively 
investigated. As shown in Fig. 12, rotational culture significantly increased the protein 
production. The rotational culture was effective in terms of matrix production per DNA 
contents in the cartilage tissue with a diameter of 1 cm when compared to static culture. 
There were statistical differences between dynamic and static cultures (PG/DNA; p<0.05, 
CN/DNA; p<0.01). 
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Fig. 12. Proteoglycan and total collagen protein expressed in the cartilage tissue waere 
measured by DMMB method and hydroxyproline assay. S) Static culture of the cartilage 
tissue, D) Dynamic (rotational) culture of the cartilage tissue. 
 
The expression levels of mRNA of type II collagen and proteoglycan in cartilage tissue 
cultured under shear flow conditions were higher than that of static, culture (Fig. 13). On the 
other hand, type I collagen mRNA was expressed at a lower level in the cartilage tissue 
under rotational culture than in static cultures. 
 
 
Fig. 13. Gene expression of GAPDH, aggrecan, type II collagen, and type I collagen of the 
tissue was investigated using RT-PCR methods. S) Static culture of the cartilage tissue, D) 
Rotational culture of the cartilage tissue. 
 
To obtain quantitative data of the mechanical properties of the cartilage tissue, a stress-
strain curve (Fig. 14B) was obtained using dumbbell-shaped culturing samples (Fig. 14C) 
prepared by stamping out with a metal mold (Fig. 14A). The values of calculated rupture 
strength and Young's modulus from the data of Fig. 13C significantly increased in cartilage 
tissue cultured under shear flow conditions. There were statistically significant differences 
in the values between dynamic and static cultures. The tactile impression of the cartilage 
tissue by rotational culture was like a plastic coaster. 
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Fig. 14. Mechanical properties of the cartilage tissue. A) Shape of the mold for evaluating the 
mechanical properties of cartilage tissue. B) Stress-strain curve was investigated. D1, D2 and 
D3 are data of the samples cultured by rotational culture. S1, S2 and S3 are those of samples 
cultured under static conditions. C) Dumbbell-shaped samples were prepared for the 
mechanical evaluations of the cartilage tissue. 
 
5. In vivo implantaion experiments of scaffold-free cartilage tissues cultured 
under dynamic rotational conditions 
For animal transplantations of a scaffold-free cartilage tissue cultured under shear flow 
conditions, the tissue by dedifferentiated chondrocytes derived from Japanese white rabbits 
was tried to form (Nagai, Furukawa et al, 2008; Sato et al., 2008). After 7 days weeks of 
rotational culture, the plate was cultured under dynamnic conditions, using rotational 
culture. After 2-3 weeks of rotational culture, the chondrocyte plate maintained a constant 
form and was considered stable enough to be handled with surgical pincers (Fig. 15). 
Conversely, after 3 weeks of static culture, the plate gradually changed into an arch over 
that time (data was not shown). Histological and immunohistochemical evaluations 
indicated that the plate had cartilaginous qualities in terms of cell distribution and 
organization and the production of glycosaminoglycans and type II collagen in rotational 
cultures. The chondrocyte-plates measuring about 1.1 mm in thickness after 2 weeks and 
about 1.4 mm after 3 weeks of cultivation had a regular cylindrical shape and the 
macroscopic appearance of cartilage. The chondrocytes-plate was thus able to be made 
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without losing its regular cylindrical shape regardless of the cellular passage number 
(Fig.15). 
 
 
Fig. 15. Scaffold-free cartilage tissue by dedifferentiated rabbit chondrocytes culutured 
under dynamic rotational culture conditions. Left columns were macroscopic appearances. 
Center was the scanning electron microscopic appearance. Right columns show the cros-
sections stained with safranin-O (S.O.), collagen type II (COL II) and collagen type I (COL I) 
antibodies. 
 
As a preliminary in vivo implantation experiment of the scaffold-free cartilage tissue 
cultured under dynamic rotational culture conditions, one-week and 2-week plates were 
transplated to the total thickness-defect model in patellar grooves of rabbits. At 4 weeks 
after implantation, fibrous tissue ad replaced most of te 1-week plates, and many 
inflammatory cells were seen in the subchondral bone. Alternatively, 2-week plates 
maintained their shape and integrated with the host cartilage(Fig. 16). 
 
Fig. 16. Preliminary in vivo implantation experiments. Histological analysis with safranin O 
and Masson's trichrome at 4 weeks. Left picture in the 1 week chondrocyte plate insertion 
group and right in the 2 week chondrocyte plate insertion group (scale bars=1mm). 
 
At 4 weeks after implantation, according to macroscopic observation, the chondrocyte plate 
insertion group seemed to show better results in terms of the integration of host cartilage, 
and the defects repaired by the plate were shoother than in the noninsertion group (Fig. 17, 
Nagai et al., 2008). In the chondrocyte plate insertion group (CP), the repair site appeared to 
be filled with cartilaginous tissues, which were strongly stained with safranin O (Fig. 17), 
positive for type II collagen(Fig. 17), and negative for tupe I collagen (data was not shown). 
Lateral integration of the cnohdrocyte plate was well bounded at both sides of host cartilage. 
Basal integration of the plate was also good. Each implanted chondrocytes plate was clearly 
visible but was thinner than before implantation (650-700|_im thick). The interfacial 
adhesion between the plate and the lower portion of the repair tissue contained 
hypertrophic chondrocytes that were remodeling the subchondral bone. Structural integrity 
of the plate was shown by the begining of columnar organization of rounded chondrocytes. 
No infiltration of inflammatory cells within the subchondral bone was seen. Alternatively, 
in the noninsertion group, the defects were filled with mainly fibrous tissue concealing the 
lower portion of the repair tissue. The lower portions of the regions stained with safranin O 
were positive for type II collagen but not for type I. 
 
 
Fig. 17. Macroscopic and histological analysis of the in vivo study for safranin O and for 
type II collagen. Macroscopic observations on femoral chondyles at 4 weeks after surgery. In 
the chondrocyte plate group (CP), the defect seemed to be better regarding the integration of 
host cartilage than in the noninsertion control group (Defect). Scale bars=250 |_im 
  
6. Perspectives for the scaffold-free cartilage formation cultured under 
dynamic rotational conditions 
The scaffold-free cartilage tissue by rotational culture was proven to have better mechanical, 
biochemical, and histochemical properties than that of scaffold-free cartilage tissue under 
static conditions. During a 3-week culture, cartilage tissue composed of dedifferentiated 
chondrocytes and extracellular matrices was formed, without use of a scaffold. Based on our 
analysis of tissue growth after 3 weeks, the scaffold-free cartilage tissue by rotational culture 
was able to assume arbitrary shapes according to the mold. If shear force is never loaded 
onto the cartilage tissue, the mechanical properties become extremely week; hence, the 
rotational culture may be an essential factor in terms of shape control of scaffold-free 
cartilage tissue with an arbitrary shape. From the view point of clinical medicine, although 
we must obtain detailed data on differences for scaffold-free cartilage formation of factors 
such as cellular species, culture period, passage number, number of cells inoculated to a 
mold and so on, this work should suggest an evocative concept for future research. 
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Many papers have reported on high-cell-density cultures in which cells contact, creating 
cell-cell interactions, to promote differentiation from dedifferentiated chondrocytes(Koch, 
2002) and/or stem cells such as mesencymal stem cells(Denker, 1999). Moreover, it is also 
known that cartilage differentiation is promoted when cells condense in the stage of 
generating(Summerbell, 1972; Thorogood, 1975). Furthermore, it is also reported that the 
mechanical stresses existing under physiological conditions such as a walking(Hodge, 1986) 
regulate the differentiation of chondrocytes(Smith, 2000, Matsuda, 2003). Therefore, these 
backgrounds may support the reason why dramatic facilitatory effects in differentiation 
occurred by loading of shear flow (rotational culture) to scaffold-free cartilage tissue. 
As a mechanism of the effect of rotational culture on the differentiation of dedifferentiated 
chondrocytes and the increase in the mechanical properties, involvements of shear stress, 
oxygen and nutrition diffusion were considered. Comparing the scaffold-free cartilage 
tissue cultured under static conditions with that under dynamic conditions, the static-
culture cartilage tissue had surface irregularities and was not smooth; the exterior surface 
seemed to be open. On the other hand, a smooth tight membrane existed on the surface area 
of the scaffold-free cartilage tissue cultured under dynamic conditions (rotational culture). 
The cells in the membrane aligned horizontal to the surface. The appearance of this smooth 
layer was considered to have enabled accumulation of an extracellular matrix such as 
proteoglycan and collagen in the cartilage tissue. As a result, the method may have 
succeeded at tissue formation with abundant matrices like cartilage and improvement of 
mechanical properties. It is speculated that this smooth membrane layer appeared only in 
the dynamic culture and is due to the direct effect of shear flow. The reason why the 
membranous layer appeared only in the dynamic culture system was not clear, but it is 
obvious that cartilage cells can detect mechanical stresses such as shear stress, hydrostatic 
pressure, direct compression, etc., and that the stresses promote the production and 
deposition of a matrix similar to that in cartilage. There is no doubt that a low shear force 
exists in the rotational culture. This shear force may stimulate scaffold-free cartilage tissue to 
differentiate without cell damage. Therefore, it was suggested that a combination of 
mechanical stress and scaffold-free cartilage tissue composed solely of chondrocytes at the 
start point of culture may well become a suitable model for tissue-engineered cartilage. 
As a cartilage tissue engineering, autologous chondrocytes transplantation was tried 
(Brittberg et al., 1994). But problems in this method due to loss of viability in the 
transplanted cells and the difficulty of fixing chondrocytes into a defect remained. To 
improve the cell loss, wakitani et al. embedded allograft articular chondrocytes in collagen 
gel (Wakitani et al., 1989; 1996). However, it was difficulty that the collagen gel keeps the 
shape with cells. Currently biodegradable scaffolds either synthetic or naturally derived 
ones, are applying to control the shapes. But the phenotype control of chondrocytes in the 
scaffold was not enough. On the other hand, scaffold-free cartilage tissues formed by 
methods using alginate gel(Matsuda, 2003; Stoddart et al., 2006a), agarose gel (Kelm et al., 
2004), rotational wall vessel(Marlovits, 2003), special system(Maini-Varlet, 2001; Grogan, 
2003; Wang, 2004; Park, 2006), and a suspension culture of aggregating 
chondrocytes(Furukawa, 2003; Tsuchiya, 2005) are reported, and the phenotype of 
chondrocytes in the scaffold-free cartilage was possible to control , but these methods could 
not freely form cartilage tissues into arbitrary shapes. Furukawa et al (2008) succeeded in 
the formation of cartilage tissue into arbitrary shapes using two kinds of techniques. 
Rotational culture realized cartilage tissue formation with arbitrary shape. It was thought 
that the induction of mechanical properties by rotational culture contributed to the shape 
retention. In addition, the next point was based on a simple mold system. For oxygen and 
nutrition supply from the lower and upper sides of the cartilage tissue, a culture insertion 
with a highly porous film (pores 0.4 | m in diameter) was used as a basement support at the 
only start point of tissue formation. Chondrocytes were not able to pass through the porous 
film. When a mold was set on the porous film, cartilage tissues of arbitrary shapes were 
easily induced. Because to adhere cells each other, a large amount of oxygen and nutrition 
may be needed. If we use normal culture dish or plastic rigid plate without pores at this 
point, all cells died and did not form tissue. In order to design complicated three-
dimensional (3-D) molds for shapes such as a total knee cartilage, design of 3-D molds will 
be needed in the future, but this is a realizable technology. 
To compare the mechanical properties of tissue engineered cartilages cultured by static and 
dynamic conditions, tensile tests were carried out. It was proven that the loading of 
mechanical stress increased the mechanical properties of the tissue by using the method. 
Therefore, it was understood that improvement of the mechanical properties realized 
formation of tissue engineered cartilage tissue with arbitrary shapes from the analysis. 
When the tensile testing data of scaffold-free cartilage tissue cultured under dynamic shear 
flow conditions to bovine native cartilage of 5 month old (Williams, 2001) were compared, 
the value of rapture strength was 58%, and Young's modulus was 6.4%. On the other hand, 
the values of scaffold-free tissue cultured under static conditions compared to the native 
cartilage tissue were 11, and 1.2%, respectively. These data suggested that the scaffold-free 
cartilages formed under dynamic and static culture conditions had inferior tensile properties 
to native cartilage tissue. Shear stress, oxygen and nutrition diffusion may reinforce the 
mechanical properties of scaffold-free cartilage by rotational culture. From the study, it was 
not clear which one has most prominent effect on mechanical properties of them. On the 
other hand, many researchers had already reported that the positive effects of mechanical 
stresses such as shear flow (Freed et al., 1994a, Freed et al., 1994b, Freed et al., 1994c, Vunjak-
Novakovic et al., 1996), hydrostatic pressure with flow (Allemann et al., 2000, Mizuno et al., 
2002), hydrostatic pressure without flow (Smith et al., 1996, Smith et al., 2000, Angle et al., 
2003, Toyoda, et al., 2003, Kawanishi et al., 2007), dynamic compression(Elder et al., 2001), 
microgravity (Freed et al., 1997) on extracellular matrix production of chondrocytes. It was 
obvious that extracellular matrix production increase the mechanical properties of tissue 
engineered cartilage. Therefore, probably shear stresses by rotational culture also reinforce 
the mechanical properties of our scaffold-free cartilage tissue. 
Recently, Elder et al reported an effect of hydrostatic pressures, and Stoddart et al (2006b) 
did an effect of of compressive force, on the formation of scaffold-free cartilage tissue from 
immature primary bovine chondrocytes. According to their studies, constant hydrostatic 
pressures of 5 and 10 MPa were more effective than oscilatory ones. The cyclical load of 
compressive force increased the chondrogenic protein and mRNA productions. However 
we can not directly compare the effects of the dynamic rotation, hydrostatic pressure and 
compression on matrix production of scaffold-free cartilage tissues, because the cell 
population was different; Elder et al and Stoddart et al. used immature chondrocytes 
(differentiated chondrocytes), and Furukawa et al used dedifferentiated bovine 
chondrocytes.The hydrocstatic pressure and compressive force loading machines have 
complicated structures. Therefore, they have a higher risk of bacteria contaminations into 
their systems. In addition,the complicated structures take a great deal of time and effort to 
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tissue cultured under static conditions with that under dynamic conditions, the static-
culture cartilage tissue had surface irregularities and was not smooth; the exterior surface 
seemed to be open. On the other hand, a smooth tight membrane existed on the surface area 
of the scaffold-free cartilage tissue cultured under dynamic conditions (rotational culture). 
The cells in the membrane aligned horizontal to the surface. The appearance of this smooth 
layer was considered to have enabled accumulation of an extracellular matrix such as 
proteoglycan and collagen in the cartilage tissue. As a result, the method may have 
succeeded at tissue formation with abundant matrices like cartilage and improvement of 
mechanical properties. It is speculated that this smooth membrane layer appeared only in 
the dynamic culture and is due to the direct effect of shear flow. The reason why the 
membranous layer appeared only in the dynamic culture system was not clear, but it is 
obvious that cartilage cells can detect mechanical stresses such as shear stress, hydrostatic 
pressure, direct compression, etc., and that the stresses promote the production and 
deposition of a matrix similar to that in cartilage. There is no doubt that a low shear force 
exists in the rotational culture. This shear force may stimulate scaffold-free cartilage tissue to 
differentiate without cell damage. Therefore, it was suggested that a combination of 
mechanical stress and scaffold-free cartilage tissue composed solely of chondrocytes at the 
start point of culture may well become a suitable model for tissue-engineered cartilage. 
As a cartilage tissue engineering, autologous chondrocytes transplantation was tried 
(Brittberg et al., 1994). But problems in this method due to loss of viability in the 
transplanted cells and the difficulty of fixing chondrocytes into a defect remained. To 
improve the cell loss, wakitani et al. embedded allograft articular chondrocytes in collagen 
gel (Wakitani et al., 1989; 1996). However, it was difficulty that the collagen gel keeps the 
shape with cells. Currently biodegradable scaffolds either synthetic or naturally derived 
ones, are applying to control the shapes. But the phenotype control of chondrocytes in the 
scaffold was not enough. On the other hand, scaffold-free cartilage tissues formed by 
methods using alginate gel(Matsuda, 2003; Stoddart et al., 2006a), agarose gel (Kelm et al., 
2004), rotational wall vessel(Marlovits, 2003), special system(Maini-Varlet, 2001; Grogan, 
2003; Wang, 2004; Park, 2006), and a suspension culture of aggregating 
chondrocytes(Furukawa, 2003; Tsuchiya, 2005) are reported, and the phenotype of 
chondrocytes in the scaffold-free cartilage was possible to control , but these methods could 
not freely form cartilage tissues into arbitrary shapes. Furukawa et al (2008) succeeded in 
the formation of cartilage tissue into arbitrary shapes using two kinds of techniques. 
Rotational culture realized cartilage tissue formation with arbitrary shape. It was thought 
that the induction of mechanical properties by rotational culture contributed to the shape 
retention. In addition, the next point was based on a simple mold system. For oxygen and 
nutrition supply from the lower and upper sides of the cartilage tissue, a culture insertion 
with a highly porous film (pores 0.4 | m in diameter) was used as a basement support at the 
only start point of tissue formation. Chondrocytes were not able to pass through the porous 
film. When a mold was set on the porous film, cartilage tissues of arbitrary shapes were 
easily induced. Because to adhere cells each other, a large amount of oxygen and nutrition 
may be needed. If we use normal culture dish or plastic rigid plate without pores at this 
point, all cells died and did not form tissue. In order to design complicated three-
dimensional (3-D) molds for shapes such as a total knee cartilage, design of 3-D molds will 
be needed in the future, but this is a realizable technology. 
To compare the mechanical properties of tissue engineered cartilages cultured by static and 
dynamic conditions, tensile tests were carried out. It was proven that the loading of 
mechanical stress increased the mechanical properties of the tissue by using the method. 
Therefore, it was understood that improvement of the mechanical properties realized 
formation of tissue engineered cartilage tissue with arbitrary shapes from the analysis. 
When the tensile testing data of scaffold-free cartilage tissue cultured under dynamic shear 
flow conditions to bovine native cartilage of 5 month old (Williams, 2001) were compared, 
the value of rapture strength was 58%, and Young's modulus was 6.4%. On the other hand, 
the values of scaffold-free tissue cultured under static conditions compared to the native 
cartilage tissue were 11, and 1.2%, respectively. These data suggested that the scaffold-free 
cartilages formed under dynamic and static culture conditions had inferior tensile properties 
to native cartilage tissue. Shear stress, oxygen and nutrition diffusion may reinforce the 
mechanical properties of scaffold-free cartilage by rotational culture. From the study, it was 
not clear which one has most prominent effect on mechanical properties of them. On the 
other hand, many researchers had already reported that the positive effects of mechanical 
stresses such as shear flow (Freed et al., 1994a, Freed et al., 1994b, Freed et al., 1994c, Vunjak-
Novakovic et al., 1996), hydrostatic pressure with flow (Allemann et al., 2000, Mizuno et al., 
2002), hydrostatic pressure without flow (Smith et al., 1996, Smith et al., 2000, Angle et al., 
2003, Toyoda, et al., 2003, Kawanishi et al., 2007), dynamic compression(Elder et al., 2001), 
microgravity (Freed et al., 1997) on extracellular matrix production of chondrocytes. It was 
obvious that extracellular matrix production increase the mechanical properties of tissue 
engineered cartilage. Therefore, probably shear stresses by rotational culture also reinforce 
the mechanical properties of our scaffold-free cartilage tissue. 
Recently, Elder et al reported an effect of hydrostatic pressures, and Stoddart et al (2006b) 
did an effect of of compressive force, on the formation of scaffold-free cartilage tissue from 
immature primary bovine chondrocytes. According to their studies, constant hydrostatic 
pressures of 5 and 10 MPa were more effective than oscilatory ones. The cyclical load of 
compressive force increased the chondrogenic protein and mRNA productions. However 
we can not directly compare the effects of the dynamic rotation, hydrostatic pressure and 
compression on matrix production of scaffold-free cartilage tissues, because the cell 
population was different; Elder et al and Stoddart et al. used immature chondrocytes 
(differentiated chondrocytes), and Furukawa et al used dedifferentiated bovine 
chondrocytes.The hydrocstatic pressure and compressive force loading machines have 
complicated structures. Therefore, they have a higher risk of bacteria contaminations into 
their systems. In addition,the complicated structures take a great deal of time and effort to 
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load the mechanical stresses on tissue-engineered consructs. In contrast, in dynamic 
rotational culture, a simple and straightforward procedure is enough to load a mechanical 
stress on scaffold-free cartilage tissues. For clinical treatment of cartilage diseases, usages of 
a simple stractured machine and protocol are important point for the success, therefore, the 
dynamic rotational culture will facilitate future clinical trials. 
According to conventional tissue engineering, the mass balance between the disappearance 
(hydrolysis) of a biodegradable scaffold and the production/deposition of extracellular 
matrix from cells inoculated to the scaffold has been thought to be important for regulation 
of shape(Freed, 1997; Furukawa, 2002). The cartilage tissue which constituted of 
chondrocytes and ECM produced by inoculated dedifferentiated chondrocytes has arbitrary 
shapes, and did not need any scaffold to control the shape.In scaffold-free cartilage tissue 
examined by this study, although the thickness of the cartilage tissue increased linearly with 
time, a change in a transverse direction was not observed (constant). As a result, it turned 
out that the volume of the cartilage tissue also increased linearly with time. Therefore, a 
quantitative prediction of the tissue growth and shape change by a calculation may be 
possible. So, the model may point out the possibility for a new tissue design by shape 
control not only by using a biodegradable scaffold, but also by using a mold with an 
arbitrary shape and calculation of the cartilage growth. 
From the view point of the clinical medicine, our scaffold-free cartilage tissue cultured by 
shear flow conditions was thought as a suitable model, because the scaffold-free cartilage 
tissue had promising biochemical, mechanical properties as a tissue-engineered cartilage 
tissue. In addition, it was cultured by medium without special expensive factors such as 
transforming growth factor and bone morphologic growth factor etc. The useless of special 
growth factors not only will prevent the tissue-engineered cartilage tissue from a risk of 
carcinogenesis, but also realize cost-cutting of medical expenses. Then, transplantation of 
biomaterial , a kind of foreign body, to our body was not needed in our approach. Therefore, 
it was though that the barrier to the promotion of clinical trial is lower. 
  
7. Conclusion 
In conclusion, a scaffold-free cartilage tissue with arbitrary shapes and a large size with 
promising biological, mechanical properties was formed. The scaffold-free cartilage loaded 
mechanical stress based on a high porous simple mold system may become tools of not only 
therapies for diseases such as osteoarthritis and osteochondrosis dissecans as a tissue-
engineered cartilage, but also clarification of the mechanisms of cartilage formation and 
therapeutic treatment instead of conventional pellet culture system. 
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load the mechanical stresses on tissue-engineered consructs. In contrast, in dynamic 
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stress on scaffold-free cartilage tissues. For clinical treatment of cartilage diseases, usages of 
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According to conventional tissue engineering, the mass balance between the disappearance 
(hydrolysis) of a biodegradable scaffold and the production/deposition of extracellular 
matrix from cells inoculated to the scaffold has been thought to be important for regulation 
of shape(Freed, 1997; Furukawa, 2002). The cartilage tissue which constituted of 
chondrocytes and ECM produced by inoculated dedifferentiated chondrocytes has arbitrary 
shapes, and did not need any scaffold to control the shape.In scaffold-free cartilage tissue 
examined by this study, although the thickness of the cartilage tissue increased linearly with 
time, a change in a transverse direction was not observed (constant). As a result, it turned 
out that the volume of the cartilage tissue also increased linearly with time. Therefore, a 
quantitative prediction of the tissue growth and shape change by a calculation may be 
possible. So, the model may point out the possibility for a new tissue design by shape 
control not only by using a biodegradable scaffold, but also by using a mold with an 
arbitrary shape and calculation of the cartilage growth. 
From the view point of the clinical medicine, our scaffold-free cartilage tissue cultured by 
shear flow conditions was thought as a suitable model, because the scaffold-free cartilage 
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carcinogenesis, but also realize cost-cutting of medical expenses. Then, transplantation of 
biomaterial , a kind of foreign body, to our body was not needed in our approach. Therefore, 
it was though that the barrier to the promotion of clinical trial is lower. 
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mechanical stress based on a high porous simple mold system may become tools of not only 
therapies for diseases such as osteoarthritis and osteochondrosis dissecans as a tissue-
engineered cartilage, but also clarification of the mechanisms of cartilage formation and 
therapeutic treatment instead of conventional pellet culture system. 
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1. Introduction 
Menisci represent fundamental structures for the maintenance of knee homeostasis, playing a 
key role in knee biomechanics. Lesions of the meniscus are frequently observed in orthopedic 
practice. Injury to the meniscus is one of the most common problems in the knee joint, with a 
mean annual incidence of 60 to 70 per 100 000 knee injuries  (Erkman et al. 1975; Hede et al 
1990; Neilson et al 1991; Renstrom P 1990; Weinand et al 2006). Injury or loss of meniscal tissue 
leads to pain, knee dysfunction and osteoarthritis at long term (Cook et al 2005; Wyland 2002). 
Studies have demonstrated that knee degeneration is inversely related to the amount of 
meniscal tissue resected (McDermott and Amis 2006; Rijk 2004). Unfortunately, their intrinsic 
regenerative potential is poor. Healing is usually limited to the vascularized areas in the outer 
one third of the meniscus (Arnoczky and Warren 1983; Miller 1994). When a lesion involves 
the avascular portion of the meniscus, the reparative process cannot occur, since it emanates 
from bleeding and subsequent inflammation. As a result, the standard biological healing 
process produces limited results. Thus, a large proportion of meniscal tears observed at 
arthroscopy remain irreparable, and partial, subtotal or even total meniscectomy is often 
necessary, regardless of the recognized consequence. Even after an only partial meniscectomy, 
knee mechanics are subject to dramatic changes, leading often to the development of early 
osteoarthritis. Therefore, menisci should be repaired whenever possible. 
In the last decades, tissue engineering approaches have been advocated to improve the 
reparative processes of joint tissues. The possibility to entirely reproduce the meniscus 
structure and function is highly attractive, and some new biomaterials have been studied 
and applied in preclinical and clinical studies. 
 
2. Preclinical studies 
In the last decade, replacement strategies have been applied to the menisci tissue in order to 
enhance their intrinsic reparative properties (Peretti et al. 1999; Peretti et al. 2004; Weinand 
et al. 2006) or even to replace them with an engineered tissue. Several materials have been 
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tested as partial meniscus substitutes in preclinical studies. Veth et al  (Veth et al. 1986) used 
carbon fiber for meniscus repair in dogs, with poor results. Small intestine submucosa (SIS) 
was successfully used to repair posterior vascular meniscal defects (Cook et al. 2006), but 
not for complete substitution. Total meniscus substitution remains difficult and has been 
poorly described in the literature. A polyvinyl alcohol-hydrogel meniscus in rabbits showed 
interesting results in terms of chondroprotection, but certain unresolved problems persisted: 
durability of the polymer, fixation method, complete tissue regeneration in a material that 
does not adhere to tissue (De Groot et al. 1997; Kobayashi et al.2003). Van Tienen et al (Van 
Tienen et al 2006) studied two different porous polyester urethane polymers as meniscus 
substitutes in dogs. Despite the promising results in tissue formation, one of the materials 
(aromatic 4,4,-diphenylmethanediisocynate) is thought to degrade into toxic products. Other 
polymer implants did not show to prevent cartilage degeneration or were not suitable as 
meniscal substitute because of poor tissue ingrowth related to polymer degradation rate and 
poor mechanical properties (Van Tienen et al. 2002; Van Tienen et al 2003). Tissue 
engineering has recently been proposed as a possible solution for meniscal regeneration. A 
few animal studies investigated the possibility of using cells in combination with different 
scaffold biomaterials for a partial or total meniscal substitution (Van Tienen et al. 2002; Van 
Tienen et al 2003; Van Tienen et al 2006; Weinand et al 2006; Chiari et al. 2006; Kon et al 
2008).  
Several polymers, both natural and synthetic, have been tested for engineering meniscal and 
cartilage tissue in vitro or in vivo. Among the synthetic scaffolds, favorable polymers are open 
lattice structures with large pores into which cartilage matrix is permitted to form and new 
synthetic hydrogels are also good candidate scaffolds for generating meniscal tissue. 
Collagen sponges have many desirable properties as a biological scaffold, including 
porosity, biodegradability, and biocompatibility. Multiple methods for preparing collagen 
and collagen-GAG scaffolds have been reported.  Generally, collagen scaffolds are made 
from animal tissues such as type I collagen from bovine tendon. It is also possible to 
chemically modify the biomechanical and biological properties of the collagen scaffolds to 
enhance certain characteristics that promote tissue formation (Speer et al. 1979). Open lattice 
collagen scaffolds, some of which also include glycosaminoglycans, have been synthesized 
and used for generating new matrix. Following the list of the potential biological scaffolds 
for meniscus repair, hyaluronan could play an important role. A resorbable biomaterial 
consisting of hyaluronic acid and polycaprolactone was also tested for total meniscal 
substitution (Kon et al; 2008). 
The other critical element for engineering meniscal tissue is finding the most suitable cell 
source. Various cell-sources have been evaluated in vitro to find the most suitable source for 
cell augmentation of tissue engineered meniscus. Meniscal cells can be isolated by enzymatic 
digestion of the tissue. Histological evidence suggests that the meniscal cells are capable of 
generating fibrocartilagenous tissue resembling meniscus. It is unlikely, however, that 
autologous meniscal fibrochondrocytes will be used to engineer one’s own meniscus because 
of the lack of expendable donor sites. It is conceivable that allogeneic meniscal cells could be 
used as an option for overcoming the donor site related problems. The central issue involving 
the use of allogeneic chondrocytes is their potential for eliciting an immune response once the 
extracellular matrix is removed and MHC antigens are exposed (Tiku et al. 1985). 
Different cell lines have been proposed as alternative solution for meniscal tissue 
engineering. Chondrocytes could be used to generate meniscal tissue or used to induce 
meniscal repair. Articular chondrocytes showed the highest tissue regeneration capacity, 
with cellular and matrix phenotypes similar to those of both the inner and outer meniscus 
regions (Ibarra et al. 2000; Marsano et al. 2007). 
Moreover, cartilage harvesting from a less loaded joint area would be less damaging to the 
knee biomechanics as compared to healthy meniscal tissue harvesting. Peretti et al (Peretti et 
al; 2004) have shown that articular chondrocytes seeded onto a devitalized allogenic 
meniscal slices or on a Vicryl mesh scaffold are capable of inducing a healing process in 
swine meniscus. Other alternative cartilage sources for obtaining cells include the cartilage 
portion of ribs or ear cartilage (Johonson et al 2004). MSCs are another valid candidate for 
meniscal bioengineering. Multiple experiments using human, chicken, dog, and rabbit 
MSCs have shown that, under controlled in vitro conditions, these cells can differentiate into 
bone, fat, tendon, muscle and cartilage-like tissues (Caplan et al. 2001; Pittenger et al. 1999; 
Conget et al. 1999). 
All these cell sources could be used to engineer reparative meniscal tissue. 
Walsh et al. (Wlash et al. 1999) used a collagenous sponge loaded with mesenchymal stem 
cells to treat a partial meniscus defect in rabbits. They reported that the presence of cells 
augmented the repair process but did not prevent knee degeneration. Martinek et al. 
(Martinek et al. 2006) documented better macroscopic and histological results in CMI 
implants seeded with meniscal fibrochondrocytes in comparison to cell-free implants in 
sheep. However, the tissue-engineered meniscus was biomechanically unstable and the 
implant size reduced during the three-month observation period. Therefore, the authors 
suggested that an improvement in scaffold and cell seeding procedure is required before 
human application.  
Ibarra et al. also reported on a pilot study in sheep where they used autologous meniscal 
fibrochondrocytes and PGA polymer (Ibarra et al. 2000). The authors report that the 
constructs produced a new tissue with fibroblasts and chondrocytes. The presence of 
collagen fibers was observed histologically and the cells produced proteoglycans. The 
number of animals was small, but the authors demonstrated proof-of-principle for the 
technique. Polyurethane was initially developed and tested in animal studies for total 
meniscal replacement but is now being assessed as a scaffold for partial meniscal 
replacement as an alternative for the CMI (Van Tienen et al. 2003). Brophy and colleagues 
(Brophy et al. 2008) showed in sheep cadavers that the contact pressures after partial 
meniscectomy and replacement with a polyurethane scaffold were less than the contact 
pressures after partial meniscectomy only. 
We have investigated the feasibility of using a new resorbable biomaterial consisting of 
hyaluronic acid and polycaprolactone for total meniscal substitution in a sheep model 
(Chiari et al. 2006; Kon et al. 2008). Twenty-four skeletally mature sheep were treated with 
total medial meniscus replacements while 2 meniscectomies served as empty controls. The 
animals were divided in two groups: cell free scaffold or scaffold seeded with autologous 
chondrocytes. Autologous chondrocytes were used as we have previously demonstrated 
that, both in vitro and following ectopic implantation, expanded articular chondrocytes 
were superior to meniscal cells, synovial or fat pad cells in their capacity to reach 
phenotypes typical of the inner and outer meniscus regions (Marsano et al. 2007). Two 
different surgical techniques were compared: in 12 animals the implant was sutured to the 
capsule and to the meniscal ligament and in the other 12 animals also a transtibial fixation of 
the horns was used. The animals were euthanized after 4 months. The specimens were 
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tested as partial meniscus substitutes in preclinical studies. Veth et al  (Veth et al. 1986) used 
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not for complete substitution. Total meniscus substitution remains difficult and has been 
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meniscal substitute because of poor tissue ingrowth related to polymer degradation rate and 
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lattice structures with large pores into which cartilage matrix is permitted to form and new 
synthetic hydrogels are also good candidate scaffolds for generating meniscal tissue. 
Collagen sponges have many desirable properties as a biological scaffold, including 
porosity, biodegradability, and biocompatibility. Multiple methods for preparing collagen 
and collagen-GAG scaffolds have been reported.  Generally, collagen scaffolds are made 
from animal tissues such as type I collagen from bovine tendon. It is also possible to 
chemically modify the biomechanical and biological properties of the collagen scaffolds to 
enhance certain characteristics that promote tissue formation (Speer et al. 1979). Open lattice 
collagen scaffolds, some of which also include glycosaminoglycans, have been synthesized 
and used for generating new matrix. Following the list of the potential biological scaffolds 
for meniscus repair, hyaluronan could play an important role. A resorbable biomaterial 
consisting of hyaluronic acid and polycaprolactone was also tested for total meniscal 
substitution (Kon et al; 2008). 
The other critical element for engineering meniscal tissue is finding the most suitable cell 
source. Various cell-sources have been evaluated in vitro to find the most suitable source for 
cell augmentation of tissue engineered meniscus. Meniscal cells can be isolated by enzymatic 
digestion of the tissue. Histological evidence suggests that the meniscal cells are capable of 
generating fibrocartilagenous tissue resembling meniscus. It is unlikely, however, that 
autologous meniscal fibrochondrocytes will be used to engineer one’s own meniscus because 
of the lack of expendable donor sites. It is conceivable that allogeneic meniscal cells could be 
used as an option for overcoming the donor site related problems. The central issue involving 
the use of allogeneic chondrocytes is their potential for eliciting an immune response once the 
extracellular matrix is removed and MHC antigens are exposed (Tiku et al. 1985). 
Different cell lines have been proposed as alternative solution for meniscal tissue 
engineering. Chondrocytes could be used to generate meniscal tissue or used to induce 
meniscal repair. Articular chondrocytes showed the highest tissue regeneration capacity, 
with cellular and matrix phenotypes similar to those of both the inner and outer meniscus 
regions (Ibarra et al. 2000; Marsano et al. 2007). 
Moreover, cartilage harvesting from a less loaded joint area would be less damaging to the 
knee biomechanics as compared to healthy meniscal tissue harvesting. Peretti et al (Peretti et 
al; 2004) have shown that articular chondrocytes seeded onto a devitalized allogenic 
meniscal slices or on a Vicryl mesh scaffold are capable of inducing a healing process in 
swine meniscus. Other alternative cartilage sources for obtaining cells include the cartilage 
portion of ribs or ear cartilage (Johonson et al 2004). MSCs are another valid candidate for 
meniscal bioengineering. Multiple experiments using human, chicken, dog, and rabbit 
MSCs have shown that, under controlled in vitro conditions, these cells can differentiate into 
bone, fat, tendon, muscle and cartilage-like tissues (Caplan et al. 2001; Pittenger et al. 1999; 
Conget et al. 1999). 
All these cell sources could be used to engineer reparative meniscal tissue. 
Walsh et al. (Wlash et al. 1999) used a collagenous sponge loaded with mesenchymal stem 
cells to treat a partial meniscus defect in rabbits. They reported that the presence of cells 
augmented the repair process but did not prevent knee degeneration. Martinek et al. 
(Martinek et al. 2006) documented better macroscopic and histological results in CMI 
implants seeded with meniscal fibrochondrocytes in comparison to cell-free implants in 
sheep. However, the tissue-engineered meniscus was biomechanically unstable and the 
implant size reduced during the three-month observation period. Therefore, the authors 
suggested that an improvement in scaffold and cell seeding procedure is required before 
human application.  
Ibarra et al. also reported on a pilot study in sheep where they used autologous meniscal 
fibrochondrocytes and PGA polymer (Ibarra et al. 2000). The authors report that the 
constructs produced a new tissue with fibroblasts and chondrocytes. The presence of 
collagen fibers was observed histologically and the cells produced proteoglycans. The 
number of animals was small, but the authors demonstrated proof-of-principle for the 
technique. Polyurethane was initially developed and tested in animal studies for total 
meniscal replacement but is now being assessed as a scaffold for partial meniscal 
replacement as an alternative for the CMI (Van Tienen et al. 2003). Brophy and colleagues 
(Brophy et al. 2008) showed in sheep cadavers that the contact pressures after partial 
meniscectomy and replacement with a polyurethane scaffold were less than the contact 
pressures after partial meniscectomy only. 
We have investigated the feasibility of using a new resorbable biomaterial consisting of 
hyaluronic acid and polycaprolactone for total meniscal substitution in a sheep model 
(Chiari et al. 2006; Kon et al. 2008). Twenty-four skeletally mature sheep were treated with 
total medial meniscus replacements while 2 meniscectomies served as empty controls. The 
animals were divided in two groups: cell free scaffold or scaffold seeded with autologous 
chondrocytes. Autologous chondrocytes were used as we have previously demonstrated 
that, both in vitro and following ectopic implantation, expanded articular chondrocytes 
were superior to meniscal cells, synovial or fat pad cells in their capacity to reach 
phenotypes typical of the inner and outer meniscus regions (Marsano et al. 2007). Two 
different surgical techniques were compared: in 12 animals the implant was sutured to the 
capsule and to the meniscal ligament and in the other 12 animals also a transtibial fixation of 
the horns was used. The animals were euthanized after 4 months. The specimens were 
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assessed by gross inspection and histology. All implants showed excellent capsular 
ingrowth at the periphery. Marcoscopically, no difference was observed between Cell 
Seeded and Cell Free group. Better implant appearance and integrity was observed in the 
group without trans-osseous horn fixation. Using the latter implantation technique, lower 
joint degeneration was observed in the cell-seeded group with respect to cell-free implants. 
The histological analysis indicated cellular infiltration and vascularisation throughout the 
implanted constructs. Cartilaginous tissue formation was significantly more frequent in the 
cell-seeded constructs. Our study supports the potential of the Hyaff/PCL scaffold for total 
meniscal substitution and seeding of the scaffolds with autologous chondrocytes provides 
some benefit in the extent of fibrocartilaginous tissue repair. 
  
Fig. 1. Four month results after medial meniscus (left) replacement, (A) cell-seeded implants, 
(B) cell-free implants (left).  
 
3. Clinical studies 
Although the literature addresses merely the total replacement of the meniscus in animal 
studies, with or without cells, the current clinical studies only concern partial replacement of 
the resected meniscus with cell-free scaffolds. To the authors’ knowledge, no clinical studies 
have been published in which the meniscus was replaced by a bioengineered meniscus. 
Stone et al. (Stone et al. 1997) have developed a bioreadsorbable collagen matrix (CMI) 
which acts as a scaffold to restore the original medial meniscal. We studied (Zaffagnini et al. 
2007) and prospectively evaluated the results of CMI implantation at a follow-up from a 
minimum of 6 to a maximum of 8 years. Eight patients (mean age 25) were evaluated at a 
final observation point from 6 to 8 years after CMI implantation. Inclusion criteria were an 
irreparable meniscal tear or a previous meniscectomy involving the medial meniscus. There 
were no complications related to the device. All patients were able to return to daily 
activities without limitations 3 months after surgery. Both subjective CKRS score and 
objective IKDC score showed improvement in all cases except one patient with an ACL re-
injury. In two cases scores were slightly worse from 2 years after surgery to the final 
observation point. The other five cases obtained maximum score at final follow-up. In four 
cases the absence of pain remained until the final observation point, while in four cases a 
low entity of pain was described at long term follow-up. MRI showed in five cases mixoid 
degeneration signal, two had normal signal with reduced size, while one patient had no 
recognizable implant. Six patients had preserved cartilage and articular space, with no 
changes compared to pre-op control. Arthroscopic second look evaluation has been 
performed in three cases, revealing in two cases the presence of the implant, although with a 
reduced size compared to the original one, while in one case the CMI was almost 
disappeared. Our small series of eight patients prospectively followed from 6 to 8 years of 
follow-up has shown highly satisfactory results. Although the aspect of the implant was 
mostly abnormal, the implant may have helped reduce the deterioration of the knee joint at 
final observation time. 
Recently, a new polyurethane scaffold, presented by Brophy and colleagues (Brophy et al. 
2008), has been introduced in clinical practice. The polyurethanes are believed to have better 
material properties For fixation to the remaining native meniscus tissue and to resist the 
extreme forces within the knee joint. A prospective clinical trial, which is being performed at 
this moment, should reveal if this hypothesis would hold. The preliminary results seem 
promising. 
 
Fig. 2. New polyurethane scaffold. (Courtesy of Orteq Bioengineering) 
 
 
Fig. 3. At 24 months increased tissue can be seen anterior to the residual rim of the native 
meniscus when compared to the month 12 findings. 
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meniscal substitution and seeding of the scaffolds with autologous chondrocytes provides 
some benefit in the extent of fibrocartilaginous tissue repair. 
  
Fig. 1. Four month results after medial meniscus (left) replacement, (A) cell-seeded implants, 
(B) cell-free implants (left).  
 
3. Clinical studies 
Although the literature addresses merely the total replacement of the meniscus in animal 
studies, with or without cells, the current clinical studies only concern partial replacement of 
the resected meniscus with cell-free scaffolds. To the authors’ knowledge, no clinical studies 
have been published in which the meniscus was replaced by a bioengineered meniscus. 
Stone et al. (Stone et al. 1997) have developed a bioreadsorbable collagen matrix (CMI) 
which acts as a scaffold to restore the original medial meniscal. We studied (Zaffagnini et al. 
2007) and prospectively evaluated the results of CMI implantation at a follow-up from a 
minimum of 6 to a maximum of 8 years. Eight patients (mean age 25) were evaluated at a 
final observation point from 6 to 8 years after CMI implantation. Inclusion criteria were an 
irreparable meniscal tear or a previous meniscectomy involving the medial meniscus. There 
were no complications related to the device. All patients were able to return to daily 
activities without limitations 3 months after surgery. Both subjective CKRS score and 
objective IKDC score showed improvement in all cases except one patient with an ACL re-
injury. In two cases scores were slightly worse from 2 years after surgery to the final 
observation point. The other five cases obtained maximum score at final follow-up. In four 
cases the absence of pain remained until the final observation point, while in four cases a 
low entity of pain was described at long term follow-up. MRI showed in five cases mixoid 
degeneration signal, two had normal signal with reduced size, while one patient had no 
recognizable implant. Six patients had preserved cartilage and articular space, with no 
changes compared to pre-op control. Arthroscopic second look evaluation has been 
performed in three cases, revealing in two cases the presence of the implant, although with a 
reduced size compared to the original one, while in one case the CMI was almost 
disappeared. Our small series of eight patients prospectively followed from 6 to 8 years of 
follow-up has shown highly satisfactory results. Although the aspect of the implant was 
mostly abnormal, the implant may have helped reduce the deterioration of the knee joint at 
final observation time. 
Recently, a new polyurethane scaffold, presented by Brophy and colleagues (Brophy et al. 
2008), has been introduced in clinical practice. The polyurethanes are believed to have better 
material properties For fixation to the remaining native meniscus tissue and to resist the 
extreme forces within the knee joint. A prospective clinical trial, which is being performed at 
this moment, should reveal if this hypothesis would hold. The preliminary results seem 
promising. 
 
Fig. 2. New polyurethane scaffold. (Courtesy of Orteq Bioengineering) 
 
 
Fig. 3. At 24 months increased tissue can be seen anterior to the residual rim of the native 
meniscus when compared to the month 12 findings. 
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4. Conclusion 
Subtotal or total meniscectomy is no longer considered a valid option for the treatment of 
meniscal tears, while preservation or regeneration of this tissue is now recommended, when 
possible, for the maintenance of a healthy knee. Menisci have poor intrinsic healing 
potential so that techniques based on fixation of the avascular regions of torn menisci often  
fail to allow for biological repair of the tissue. Until now, the properties of this tissue seemed 
hard to mimic. Tissue engineering for meniscal replacement represents an innovative and 
promising solution. Many materials have been proposed and tested in preclinical studies, 
but for the time being meniscus regeneration is still in its infancy, and further studies need 
to confirm the potential of the tissue engineering approach. 
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Abstract 
Injuries to the anterior cruciate ligament (ACL) and the meniscus are very common. Both the 
ACL and the meniscus play a crucial role in the complex biomechanics of the knee and 
operative treatment is often necessary. For example, in the US approximately 200,000 ACL 
reconstructions are performed annually. Usually, autogenous tendons like the mid- third of 
the patellar tendon or the hamstring tendons (semitendinosus/gracilis) are used. 
Nevertheless, the availability of autogenous tendons for ACL reconstruction is limited as 
well as the possibilities of meniscus repair. Ligament and meniscus allografts often show 
problems regarding long-term stability, immunological reactions and possible transmission 
of infectious diseases, whereas synthetic materials can cause foreign body reactions and 
often lack good initial biomechanical stability or fail to maintain long-term stability.  
The idea of acellularizing ligaments and meniscus cartilage has arisen to remove the 
immunogenic cells to reduce the adverse immunological reactions. By preserving the 
extracellular matrix (e. g. collagen, glycosaminoglycans, proteoglycans), the main 
biomechanical properties are preserved and the so obtained scaffolds provide a natural 
environment for the ingrowing cells. The acellular scaffolds can be used as a scaffold for in 
vivo repopulation or can be seeded with autologous cells in vitro before implantation using 
different cell sources. By this, further improvement of the biochemical and biomechanical 
properties as well as the remodelling of the graft could be improved. 
In the meantime, a variety of different methods has been described to acellularize tissues 
reaching from repetitive freezing/ thawing over the use of hydrostatic high pressure to 
different chemical methods. Only by chemical means are the cells actually removed. In 
terms of chemical acellularization, SDS (sodium dodecyl sulphate), Triton-X or TnbP (tri-
nitro-butyl-phosphate) are the most popular substances, with SDS being the strongest cell 
removal agent for tendon and meniscus tissue. As in vitro tests have shown, tissue 
processing using SDS does not influence the biomechanical properties, while all cells - being 
responsible for the immunological effects - are removed. However, more research using in 
vivo animal experiments has to be performed before application in humans is possible. 
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This tissue engineering strategy might be suitable to satisfy the increasing demand for tissue 
engineered tissue coming along with the increased patients´ demands in the future. 
 
1. Introduction 
Injuries to the ACL and the meniscus are very common and negatively influence the 
complex biomechanics of the knee joint. Due to the poor vascularity, both structures show 
limited healing capacity and surgical repair is often necessary (Arnozcky 1983, Arnozcky 
1983). In the US approximately 200,000 ACL reconstructions are performed per year and the 
number is still growing. The golden standard is the reconstruction of the injured ACL by 
using autogenous tendons like the hamstring tendons (semitendinosus/gracilis) or the 
middle- third of the patellar or quadriceps tendon. These methods have been used for 
several years now and show reliable results in the long- term. However, the problem of 
development of osteoarthrosis in the long term is not solved yet (Lohmander 2007, Messmer 
1999). So far no study exists proving a chondro-protective effect after ACL reconstruction. 
The reported outcome 32 years after ACL replacement is unacceptable in about 50% of cases. 
In accompanying meniscus lesions the outcome is even worse (Taylor 2009). Whether this is 
mainly due to cartilage injury at the time of accident or due to altered joint biomechanics is 
not known yet. So far, there exists no clear consensus, which patients benefit from ACL 
replacement in the long run. New techniques of ACL reconstruction like the anatomic 
double-bundle reconstruction (anteromedial and posterolateral bundle) and new methods of 
fixation might improve the outcome in the future (Kondo 2008, Zantop 2008, Brucker 2006).  
Though the ACL reconstruction using autogenous tendons is currently the gold standard, 
some problems still remain. There is on the one hand the problem of donor site morbidity 
with persisting anterior knee pain and the inability to kneel, especially after the use of 
patellar tendon transplants (Kartus 2001). Muscle strength deficits have been found after 
ACL reconstruction with patellar and hamstring grafts (Aune et al. 2001; Beard et al. 2001), 
especially the harvesting of hamstring grafts has been found to cause muscular weakness at 
high knee flexion angles (Makihara et al., 2006; Nakamura et al., 2002; Tashiro et al., 2003). 
Furthermore the availability of autogenous tendons is limited. In multi-ligamentous knee 
injuries the use of allografts is often required. Different allograft ligaments may be used: 
bone-patella-tendon-bone, hamstring, achilles or tibialis anterior/posterior tendons. 
However, no differences between the used allograft tissue have been reported, whereas 
significant differences exist, which sterilization processes were used (Carey et al. 2009; 
Krych et al. 2007). In a recent systematic review comparing ACL replacement using 
autografts with allografts, similar medium term results were reported in non-randomized 
studies (Carey et al., 2009). Still, immunogenic reactions may cause degenerative alterations 
and the potential risk of disease transmission remains. Using standard sterilization 
procedures like lyophilisation (Crawford et. al, 2004) or gamma irradiation (Fideler et al. 
1995; Gibbons et al. 1991) retroviruses (i.e. HIV) can hardly be destroyed.  
Apart from the ligaments, the meniscus plays a crucial role in the complex biomechanics of 
the knee, as it works as a shock absorber and transforms joint pressure in circular meniscus 
tension. This is mediated by the complex structure (mainly its circular collagen network) of 
the meniscus. Unfortunately its healing capacities are very poor. As soon as a radial tear 
destroys the circular collagen network or the horns are ruptured, the meniscus looses all 
biomechanical function. This leads to joint overload and might end in an overuse of the 
cartilage and an early onset of osteoarthritis (Lohmander et al. 2007; Allaire et al. 2008). 
Many improvements have been made to reconstruct the injured meniscus, but due to its 
biomechanical and anatomical specialities this is still impossible in many cases.  
The transplantation of meniscus allografts is a viable option but has its own problems as 
well (Packer et al. 2009). On the one hand there is the problem that there are too little donor 
organs as the meniscus of elderly people has usually degenerative alterations and can 
thereby not be used. Apart from the lack of organs it is difficult to get a suitable transplant 
fitting in size. In a recent work Van Thiel et al. 2009 could show that the fitting size of the 
meniscus is mainly correlated with height, weight and gender of the donor and recipient. 
Apart from that, the fixation is technically demanding. Because of this, the transplantation of 
meniscus is reserved to specialized centers. Unfortunately, long-term results still show 
problems due to immunogenic and degenerative alterations. Verdonk et al. (2006) examined 
the long- term results of meniscus transplantation clinically and radiologically and they 
could show, that the meniscus transplantation lead to an improvement of function and relief 
of pain. Nevertheless, substantial disability and knee pain were present at the follow up 
after 10 years. On MRI the meniscus transplants had signs of graft extrusion and an 
increased signal intensity indicating degeneration. The failure rate was 18% with conversion 
to a total arthroplasty (Verdonk 2006). Wirth et al. (2002) found  similar results but could 
show, that deep frozen meniscal grafts were superior compared to lyophilized meniscal 
grafts at a follow up of 3 and 14 years. The latter even showed similar results to the control 
group after meniscectomy. If those problems could be solved in the future, the meniscus 
transplantation might gain much popularity over time.  
As an alternative to allografts the use of synthetic tendon constructs (e.g. silk, Gore Tex, 
LAD) or meniscus prostheses (CMI, Actifit etc.) have emerged (Martinek 2006; van 
Tienen et. al 2009; Zaffagnini et al., 2008). Most of the prostheses used for ACL 
reconstruction have failed as they showed an adverse effect on the cartilage and caused in 
some cases a marked synovialitis. Though their biomechanical Properties were excellent 
initially, most of the prostheses had the problem of degradation, tunnel widening and high 
failure rates after several years (Muren et al., 2005; Roolker et al., 2000). Compared to the 
biomechanical properties of ligaments, meniscus tissue is even more complex and not 
surprising, the middle to long term results of the artificial meniscus constructs show 
different results from one study to the other, but in general do not reach the anatomic, 
biomechanical results (Buma et al., 2007). So far, artificial constructs (neither ACL nor 
meniscus) do not reach the biomechanical properties of autologous tissue and are therefore 
not an ideal long- term alternative.  
To improve the long-term outcome of ligament and meniscus allografts, new strategies are 
needed. Recently the use of extracellular matrix (ECM) scaffolds by means of 
acellularization of allograft tissue has become popular (Badylak et al., 2007, Badylak et al., 
2009). In the following we will depict the different means of acellularization, describe our 
used method and give future prospects in the field of tissue engineering concerning 
ligament and meniscus tissue. 
 
2. Acellularization methods 
Recently, biologic scaffold materials composed of extracellular matrix are widely used in 
surgical procedures for the reconstruction of numerous tissues and organs and their use in 
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several years now and show reliable results in the long- term. However, the problem of 
development of osteoarthrosis in the long term is not solved yet (Lohmander 2007, Messmer 
1999). So far no study exists proving a chondro-protective effect after ACL reconstruction. 
The reported outcome 32 years after ACL replacement is unacceptable in about 50% of cases. 
In accompanying meniscus lesions the outcome is even worse (Taylor 2009). Whether this is 
mainly due to cartilage injury at the time of accident or due to altered joint biomechanics is 
not known yet. So far, there exists no clear consensus, which patients benefit from ACL 
replacement in the long run. New techniques of ACL reconstruction like the anatomic 
double-bundle reconstruction (anteromedial and posterolateral bundle) and new methods of 
fixation might improve the outcome in the future (Kondo 2008, Zantop 2008, Brucker 2006).  
Though the ACL reconstruction using autogenous tendons is currently the gold standard, 
some problems still remain. There is on the one hand the problem of donor site morbidity 
with persisting anterior knee pain and the inability to kneel, especially after the use of 
patellar tendon transplants (Kartus 2001). Muscle strength deficits have been found after 
ACL reconstruction with patellar and hamstring grafts (Aune et al. 2001; Beard et al. 2001), 
especially the harvesting of hamstring grafts has been found to cause muscular weakness at 
high knee flexion angles (Makihara et al., 2006; Nakamura et al., 2002; Tashiro et al., 2003). 
Furthermore the availability of autogenous tendons is limited. In multi-ligamentous knee 
injuries the use of allografts is often required. Different allograft ligaments may be used: 
bone-patella-tendon-bone, hamstring, achilles or tibialis anterior/posterior tendons. 
However, no differences between the used allograft tissue have been reported, whereas 
significant differences exist, which sterilization processes were used (Carey et al. 2009; 
Krych et al. 2007). In a recent systematic review comparing ACL replacement using 
autografts with allografts, similar medium term results were reported in non-randomized 
studies (Carey et al., 2009). Still, immunogenic reactions may cause degenerative alterations 
and the potential risk of disease transmission remains. Using standard sterilization 
procedures like lyophilisation (Crawford et. al, 2004) or gamma irradiation (Fideler et al. 
1995; Gibbons et al. 1991) retroviruses (i.e. HIV) can hardly be destroyed.  
Apart from the ligaments, the meniscus plays a crucial role in the complex biomechanics of 
the knee, as it works as a shock absorber and transforms joint pressure in circular meniscus 
tension. This is mediated by the complex structure (mainly its circular collagen network) of 
the meniscus. Unfortunately its healing capacities are very poor. As soon as a radial tear 
destroys the circular collagen network or the horns are ruptured, the meniscus looses all 
biomechanical function. This leads to joint overload and might end in an overuse of the 
cartilage and an early onset of osteoarthritis (Lohmander et al. 2007; Allaire et al. 2008). 
Many improvements have been made to reconstruct the injured meniscus, but due to its 
biomechanical and anatomical specialities this is still impossible in many cases.  
The transplantation of meniscus allografts is a viable option but has its own problems as 
well (Packer et al. 2009). On the one hand there is the problem that there are too little donor 
organs as the meniscus of elderly people has usually degenerative alterations and can 
thereby not be used. Apart from the lack of organs it is difficult to get a suitable transplant 
fitting in size. In a recent work Van Thiel et al. 2009 could show that the fitting size of the 
meniscus is mainly correlated with height, weight and gender of the donor and recipient. 
Apart from that, the fixation is technically demanding. Because of this, the transplantation of 
meniscus is reserved to specialized centers. Unfortunately, long-term results still show 
problems due to immunogenic and degenerative alterations. Verdonk et al. (2006) examined 
the long- term results of meniscus transplantation clinically and radiologically and they 
could show, that the meniscus transplantation lead to an improvement of function and relief 
of pain. Nevertheless, substantial disability and knee pain were present at the follow up 
after 10 years. On MRI the meniscus transplants had signs of graft extrusion and an 
increased signal intensity indicating degeneration. The failure rate was 18% with conversion 
to a total arthroplasty (Verdonk 2006). Wirth et al. (2002) found  similar results but could 
show, that deep frozen meniscal grafts were superior compared to lyophilized meniscal 
grafts at a follow up of 3 and 14 years. The latter even showed similar results to the control 
group after meniscectomy. If those problems could be solved in the future, the meniscus 
transplantation might gain much popularity over time.  
As an alternative to allografts the use of synthetic tendon constructs (e.g. silk, Gore Tex, 
LAD) or meniscus prostheses (CMI, Actifit etc.) have emerged (Martinek 2006; van 
Tienen et. al 2009; Zaffagnini et al., 2008). Most of the prostheses used for ACL 
reconstruction have failed as they showed an adverse effect on the cartilage and caused in 
some cases a marked synovialitis. Though their biomechanical Properties were excellent 
initially, most of the prostheses had the problem of degradation, tunnel widening and high 
failure rates after several years (Muren et al., 2005; Roolker et al., 2000). Compared to the 
biomechanical properties of ligaments, meniscus tissue is even more complex and not 
surprising, the middle to long term results of the artificial meniscus constructs show 
different results from one study to the other, but in general do not reach the anatomic, 
biomechanical results (Buma et al., 2007). So far, artificial constructs (neither ACL nor 
meniscus) do not reach the biomechanical properties of autologous tissue and are therefore 
not an ideal long- term alternative.  
To improve the long-term outcome of ligament and meniscus allografts, new strategies are 
needed. Recently the use of extracellular matrix (ECM) scaffolds by means of 
acellularization of allograft tissue has become popular (Badylak et al., 2007, Badylak et al., 
2009). In the following we will depict the different means of acellularization, describe our 
used method and give future prospects in the field of tissue engineering concerning 
ligament and meniscus tissue. 
 
2. Acellularization methods 
Recently, biologic scaffold materials composed of extracellular matrix are widely used in 
surgical procedures for the reconstruction of numerous tissues and organs and their use in 
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orthopaedic research surgery has emerged over the last years. As scaffolds allograft or 
possibly xenograft tendons/meniscus are used, which are acellularized by different 
methods.  
 
The basic requirements for optimal acellularization methods are:  
1. removal of all cellular components as the cells (especially fibroblasts) and  
macrophages seem to play a crucial role in the cell- mediated immunogenic 
reactions, i.e. host versus graft reaction (Badylak 2008). 
 
2. preserving the extracellular matrix which is responsible for biomechanical 
stability and preserving chemoatractants and providing cell attachment sites for 
ingrowing cells (Reing 2009).  
 
The ECM has chemotactic factors that attract cells (Beattie et al., 2009) and supportive 
function for the diffusion of nutrients from the blood to the cells. Most important, the 
biomechanical properties are mediated by the extracellular matrix. For example, the tensile 
strength of tendons is mediated by its collagen I fibrils, whereas the hyaline cartilage 
properties are maintained by the interplay of a collagen II network with large proteoglycans 
(aggrecan) and negatively charged glycosaminoglycans (Tischer et al., 2002). Finally, the 
process of repopulation is dependent on an intact matrix and the used method should not be 
cytotoxic to allow cellular ingrowth. The repopulation can then happen in vitro before 
implantation or in vivo. 
Therefore different methods have been described for the acellularization of tissues and 
every method has its own advantages and disadvantages. Generally, two methods can be 
distuingished: first methods which destroy all cells, but leave cellular components and 
debris and second methods which remove all the cellular components from the tissue by 
chemical means. In the following section, the most common methods are now discussed in 
more detail. 
 
2.1. The Gamma irradiation 
The gamma irradiation is widely used and one of the methods with the longest experience. 
It is very effective in destroying cells and most of the pathogenic germs. Still the gamma 
irradiation faces a dilemma, as doses of 3.5 Mrad (35kGy) are needed to destroy the DNA of 
the HIV. However, using this amount of energy weakens the transplant, leading to loss of 
biomechanical stability, making it unsuitable for implantation (Fideler BM et al., 1995). In 
most cases irradiation doses of 1 to 2.5 Mrad (10- 25kGy) are used with a slight remaining 
risk of disease transmission (Buck et al., 1989). In a study by Curran it could be shown that 
irradiation of allografts with a dose of 20kGy lead to minor biomechanical properties 
compared to the untreated control group. Elongation was more than 27% higher and the 
load to failure was diminished as well (Curran et al., 2009). In a prospective randomized 
trial by Sun (Sun et al., 2009) the clinical outcome after ACL replacement with autograft 
patellar-tendon-bone and irradiated as well as non-irradiated allograft (all used allografts 
had been frozen) was examined. Whereas the non-irradiated allografts showed similar 
results to the autografts, the clinical outcome of the irradiated allografts was inferior in the 
clinical scores and the subjective instability was much more common in this group of 
patients. Taking that into account the irradiation can no longer be recommended as a 
sterilization procedure as it weakens the tissue and thereby negatively influences the 
biomechanical properties without reliably destroying retroviruses like HIV.  
 
2.2. Lyophilization/cryopreservation 
Lyophilization means the preparation of tissue by repetitive freezing and thawing. This 
leads to the destruction of cells, but as with irradiation the cellular components mainly 
remain within the extracellular matrix. The lyophiliation process has been widely used and 
has been proven as a simple and cheap method and is therefore most commonly used (Sass 
et al., 2009; Busam et. al, 2007; Lewis et al., 2008). Much work has been performed on the 
effects of cryopreservation on tendon allografts, but the potential adverse effects on 
mechanical properties and histological changes by ice crystal formation (Mahirogullari 
2007). In a work by Park 2008 the effects of cryopreservation or heating on the mechanical 
properties and histomorphology of rat bone-patellar tendon-bones (BTBs) were 
investigated. BTBs were processed by cryopreservation at -80°C for 3 weeks, or heating at 
+80°C for 10 min. Tensile testing and histomorphological examinations were performed. 
The cryopreservation of tendons showed less influences on their mechanical properties. 
When cryopreserved BTBs were fixed in frozen state by the freeze-substitution method, 
many widened interfibrillar spaces were observed. These results suggest that the collagen 
fibres of cryopreserved tendons were histomorphologically affected by ice crystals. The 
cryopreservation does not only affect the cellular components, but also the collagen matrix, 
which might have effects on the biomechanical properties as well.  
However, a new work by Gelber et al. (2009) showed that the ultra structure of the meniscus 
is not affected by cryopreservation. Therefore, an allograft stored in that way would not 
alter its biomechanical properties, although its cellular viability is highly unpredictable. As 
the immunogenicity is cell-mediated, this imponderability makes the cryopreservation not 
the method of choice for tissue engineering applications, especially as the fibril diameters in 
frozen menisci show a thinner diameter and had a higher degree of disarray. These 
alterations of the collagen network can partially explain the pathological changes found in 
shrunken menisci after transplantation (Gelber et al., 2008). 
 
2.3. High pressure treatment 
The treatment of tissue with hydrostatic high pressure has emerged over the last years. By 
this method tissue is exposed to hydrostatic high pressure of up to 600MPa for 10 minutes.  
Diehl et al. (2006) could show that this treatment had no adverse effect on the biomechanical 
properties of the treated tissue. The cells were destroyed by this treatment and similar to the 
lyophilization the cellular components remain in the extracellular matrix and might thereby 
still be immunogenic. Apart from the use in tissues, high hydrostatic pressure (HHP) is 
widely used in the food processing industry, for example to inactivate vegetative 
microorganisms in meat products, milk and juice, thereby avoiding the addition of any 
chemical preservatives. Besides this HHP is also an attractive novel approach to effectively 
kill tumor cells in bone, cartilage or tendon ex vivo while leaving the tissues' mechanical 
properties unimpaired, thus allowing possible reimplantation of the resected tissue explants 
(Diehl et al., 2006, Diehl et al., 2008). However, human studies on this topic are still missing. 
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orthopaedic research surgery has emerged over the last years. As scaffolds allograft or 
possibly xenograft tendons/meniscus are used, which are acellularized by different 
methods.  
 
The basic requirements for optimal acellularization methods are:  
1. removal of all cellular components as the cells (especially fibroblasts) and  
macrophages seem to play a crucial role in the cell- mediated immunogenic 
reactions, i.e. host versus graft reaction (Badylak 2008). 
 
2. preserving the extracellular matrix which is responsible for biomechanical 
stability and preserving chemoatractants and providing cell attachment sites for 
ingrowing cells (Reing 2009).  
 
The ECM has chemotactic factors that attract cells (Beattie et al., 2009) and supportive 
function for the diffusion of nutrients from the blood to the cells. Most important, the 
biomechanical properties are mediated by the extracellular matrix. For example, the tensile 
strength of tendons is mediated by its collagen I fibrils, whereas the hyaline cartilage 
properties are maintained by the interplay of a collagen II network with large proteoglycans 
(aggrecan) and negatively charged glycosaminoglycans (Tischer et al., 2002). Finally, the 
process of repopulation is dependent on an intact matrix and the used method should not be 
cytotoxic to allow cellular ingrowth. The repopulation can then happen in vitro before 
implantation or in vivo. 
Therefore different methods have been described for the acellularization of tissues and 
every method has its own advantages and disadvantages. Generally, two methods can be 
distuingished: first methods which destroy all cells, but leave cellular components and 
debris and second methods which remove all the cellular components from the tissue by 
chemical means. In the following section, the most common methods are now discussed in 
more detail. 
 
2.1. The Gamma irradiation 
The gamma irradiation is widely used and one of the methods with the longest experience. 
It is very effective in destroying cells and most of the pathogenic germs. Still the gamma 
irradiation faces a dilemma, as doses of 3.5 Mrad (35kGy) are needed to destroy the DNA of 
the HIV. However, using this amount of energy weakens the transplant, leading to loss of 
biomechanical stability, making it unsuitable for implantation (Fideler BM et al., 1995). In 
most cases irradiation doses of 1 to 2.5 Mrad (10- 25kGy) are used with a slight remaining 
risk of disease transmission (Buck et al., 1989). In a study by Curran it could be shown that 
irradiation of allografts with a dose of 20kGy lead to minor biomechanical properties 
compared to the untreated control group. Elongation was more than 27% higher and the 
load to failure was diminished as well (Curran et al., 2009). In a prospective randomized 
trial by Sun (Sun et al., 2009) the clinical outcome after ACL replacement with autograft 
patellar-tendon-bone and irradiated as well as non-irradiated allograft (all used allografts 
had been frozen) was examined. Whereas the non-irradiated allografts showed similar 
results to the autografts, the clinical outcome of the irradiated allografts was inferior in the 
clinical scores and the subjective instability was much more common in this group of 
patients. Taking that into account the irradiation can no longer be recommended as a 
sterilization procedure as it weakens the tissue and thereby negatively influences the 
biomechanical properties without reliably destroying retroviruses like HIV.  
 
2.2. Lyophilization/cryopreservation 
Lyophilization means the preparation of tissue by repetitive freezing and thawing. This 
leads to the destruction of cells, but as with irradiation the cellular components mainly 
remain within the extracellular matrix. The lyophiliation process has been widely used and 
has been proven as a simple and cheap method and is therefore most commonly used (Sass 
et al., 2009; Busam et. al, 2007; Lewis et al., 2008). Much work has been performed on the 
effects of cryopreservation on tendon allografts, but the potential adverse effects on 
mechanical properties and histological changes by ice crystal formation (Mahirogullari 
2007). In a work by Park 2008 the effects of cryopreservation or heating on the mechanical 
properties and histomorphology of rat bone-patellar tendon-bones (BTBs) were 
investigated. BTBs were processed by cryopreservation at -80°C for 3 weeks, or heating at 
+80°C for 10 min. Tensile testing and histomorphological examinations were performed. 
The cryopreservation of tendons showed less influences on their mechanical properties. 
When cryopreserved BTBs were fixed in frozen state by the freeze-substitution method, 
many widened interfibrillar spaces were observed. These results suggest that the collagen 
fibres of cryopreserved tendons were histomorphologically affected by ice crystals. The 
cryopreservation does not only affect the cellular components, but also the collagen matrix, 
which might have effects on the biomechanical properties as well.  
However, a new work by Gelber et al. (2009) showed that the ultra structure of the meniscus 
is not affected by cryopreservation. Therefore, an allograft stored in that way would not 
alter its biomechanical properties, although its cellular viability is highly unpredictable. As 
the immunogenicity is cell-mediated, this imponderability makes the cryopreservation not 
the method of choice for tissue engineering applications, especially as the fibril diameters in 
frozen menisci show a thinner diameter and had a higher degree of disarray. These 
alterations of the collagen network can partially explain the pathological changes found in 
shrunken menisci after transplantation (Gelber et al., 2008). 
 
2.3. High pressure treatment 
The treatment of tissue with hydrostatic high pressure has emerged over the last years. By 
this method tissue is exposed to hydrostatic high pressure of up to 600MPa for 10 minutes.  
Diehl et al. (2006) could show that this treatment had no adverse effect on the biomechanical 
properties of the treated tissue. The cells were destroyed by this treatment and similar to the 
lyophilization the cellular components remain in the extracellular matrix and might thereby 
still be immunogenic. Apart from the use in tissues, high hydrostatic pressure (HHP) is 
widely used in the food processing industry, for example to inactivate vegetative 
microorganisms in meat products, milk and juice, thereby avoiding the addition of any 
chemical preservatives. Besides this HHP is also an attractive novel approach to effectively 
kill tumor cells in bone, cartilage or tendon ex vivo while leaving the tissues' mechanical 
properties unimpaired, thus allowing possible reimplantation of the resected tissue explants 
(Diehl et al., 2006, Diehl et al., 2008). However, human studies on this topic are still missing. 
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2.4. Enzymatic treatment 
Acellularization using enzymatic treatment uses various enzymes like trypsin, collagenase 
and others to open up the ECM and remove cellular components. For example Maier et al. 
described an enzymatic way of acellularization of ovine meniscus tissue (Maier et al. 2007). 
Forty-one menisci were used to establish their own protocol. They used distilled water, 
trypsin and collagenase A to acellularize meniscus samples and could show that the 
biomechanical and the biochemical properties were left almost unaffected. In a recently 
published work by Vavken et al. 2009, they could demonstrate the effectiveness of 
enzymatic acellularization of the ACL. Therefore, they used a combination of Trypsin, 
EDTA and PBS and could show that the samples could be acellularized by this enzymatic 
treatment. The glycosaminoglycan content was negatively affected as well.  
Taking everything into account, we believe that  enzymatic treatment and especially the 
combination of collagenase and trypsin has adverse effects on the extracellular  matrix and 
the collagen network. These enzymes can actually destroy the ECM and this could cause 
problems in reseeding the acellularized samples or even the biomechanical results. Future 
research would be needed to prove the safety of these methods.  
 
2.5. Chemical acellularisation by solvents/detergents 
A newer promising approach is the extraction of cells by chemical solvents/detergents. The 
most widely used chemicals are sodium dodecyl sulphate (SDS, an ionic detergent), Triton-
X (a non-ionic detergent) and tri-nitro-butyl phosphate (TnBP). They have been described to 
acellularize tissue and successful application was performed on small intestine (Badylak et 
al., 1995), the urinary bladder (Chen et al.,  1999), the liver (Brown et al., 2006), arterial 
vasculature (Walles et al.,  2003), dermis (Armour et al., 2006), heart valves (Cebotari et al., 
2006) and oesophagus transplants (Bhrany et al. 2006; Gilbert et al., 2006) among others. In 
orthopaedic surgery there have been experiments using Graft jacket®  in irreparable rotator 
cuff defects for tendon augmentation (Barber et al., 2006; Coons et al., 2006). Acellularization 
of tendons (Tischer et al., 2007; Gilbert et al., 2006) and meniscal samples (Sandmann et al. 
2008; Stapleton et al., 2008) has caused further interest in this technique. 
Bolland et al. aimed to produce a natural, acellular matrix from porcine bladder tissue for 
use as a scaffold in developing a tissue-engineered bladder replacement. They used full-
thickness, intact porcine bladders, which were acellularised by distention and immersion in 
hypotonic buffer containing 0.1% (w/v) SDS and nuclease enzymes. Histological analysis of 
the resultant matrices showed that they were completely acellular whereas the major 
structural proteins had been retained. Intracellularly, some poorly soluble proteins 
remained. The amount of DNA per mg dry weight of fresh porcine bladder was 2.8 (+/-0.1) 
g/mg compared to 0.1 (+/-0.1) g/mg in acellularised bladder. In biomechanical testing 
the tensile testing indicated that acellularisation did not significantly compromise the tensile 
strength of the tissue. Cytotoxicity assays using porcine smooth muscle cell cultures 
excluded the presence of soluble toxins in the biomaterial (Bolland et al., 2007). A newer 
work by Gilbert et al. has shown that the presence of remaining intracellular DNA might not 
have as adverse effects as at first suspected. They examined the DNA content of 
commercially available ECM scaffold materials and compared their DNA content with 
scaffolds prepared in the laboratory using different acellularisation protocols. Most of the 
examined scaffolds still contained some amounts of DNA (4 out of 6 from the commercially 
available scaffolds and 2 out of 3 from the produced ECM scaffolds). Interestingly, scaffolds 
which retained higher amounts of DNA did not show worse results than the scaffolds with 
less DNA (Gilbert et al., 2008). In a work by Brown et al., it could be shown in an animal 
model that the presence of cellular components within the extracellular matrix scaffold 
modulates the phenotype of the macrophages participating in the host response following 
implantation. Scaffolds containing cellular components (even autologous cellular 
components), elicited a predominantly M1 type macrophage response, resulting in a more 
dense connective tissue and/or scarring. Acellular scaffolds, however, were observed to 
elicit a predominantly M2 type macrophage response, which results in a more constructive 
type of remodelling response (Brown et al., 2009). 
In the same animal model (abdominal wall defect in rats covered with several ECM 
scaffolds, i.e. porcine small intestinal submucosa (SIS), noncrosslinked SIS, and autologous 
body wall ) the effect of macrophages that derive from peripheral blood in the degradation 
of ECM scaffolds was examined and Valentine et al. could show, that peripheral blood 
monocytes are required for the early and rapid degradation of both SIS scaffolds and 
autologous body wall, and that carbodiimide crosslinked SIS’s are resistant to macrophage-
mediated degradation (Valentin et al., 2009). Apart from the macrophages the T 
lymphocytes play a crucial role in organ rejection, especially in cell-mediated immune 
responses to xenografts (Strom et al., 1996). Th1 lymphocytes produce cytokines such as 
interleukin (IL)-2, interferon (IFN)-, and tumor necrosis factor (TNF)-, leading to 
macrophage activation, stimulation of complement and differentiation of CD8+ cells to a 
cytotoxic phenotype, which leads to transplant rejection (Chen et al., 1996). In contrast, Th2 
lymphocytes produce IL-4, IL-5, IL-6, and IL-10, cytokines that do not activate macrophages. 
Resulting from this, the activation of the Th2 pathway is associated with transplant 
acceptance (Chen et al., 1995). The only ECM scaffold material for which the Th1/Th2 
response has been characterized so far is small intestine ECM (Allman et al., 2001). Allman 
implanted SIS-ECM subcutaneously in mice and could show that the expression of IL-4 
(Th2) was increased, while the expression of IFN- (Th1) was markedly decreased by 100-
fold compared to the response elicited by the xenogeneic muscle group. Although there was 
an immune response to the SIS-ECM after implantation, this response was dominated by the 
Th2 pathway mediators, lacking an acute rejection.  
Since similar studies have not been conducted for other forms of ECM scaffold materials, it 
is not possible to determine whether they would elicit the same type of host response. 
Thinking of the diversity of different tissues and scaffolds, it seems likely that the host 
response to biologic scaffolds will vary to a large degree following implantation. Further 
research is needed to understand the immunogenic reactions to the implanted scaffolds and 
the effects of acellularisation on the repopulation of these scaffolds. One step in this 
direction are two recent publications by Beattie et al. and Reing et al. who could show that 
the acellularisation process and the produced degradation products are important 
modulators for the recruitment and proliferation of appropriate cell types during the 
remodelling process (Beattie et al., 2009; Reing et al., 2009).  
The first study using acellularized tissue in orthopaedic research was performed by 
Cartmell et al. (Cartmell et al., 2000). Therein, they investigated the effectiveness of 
treatment of rat tail tendons with SDS, Tri (n-butyl) phosphate and Triton-X and found that 
both the treatment with SDS (1% for 24h) or TnBP (1%for 48h) resulted in an acellular matrix 
with retention of almost normal histological structure. The biomechanical properties were 
similar to native tendons. In contrast, Triton-X (1% for 24h) disrupted the collagen fibers and 
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2.4. Enzymatic treatment 
Acellularization using enzymatic treatment uses various enzymes like trypsin, collagenase 
and others to open up the ECM and remove cellular components. For example Maier et al. 
described an enzymatic way of acellularization of ovine meniscus tissue (Maier et al. 2007). 
Forty-one menisci were used to establish their own protocol. They used distilled water, 
trypsin and collagenase A to acellularize meniscus samples and could show that the 
biomechanical and the biochemical properties were left almost unaffected. In a recently 
published work by Vavken et al. 2009, they could demonstrate the effectiveness of 
enzymatic acellularization of the ACL. Therefore, they used a combination of Trypsin, 
EDTA and PBS and could show that the samples could be acellularized by this enzymatic 
treatment. The glycosaminoglycan content was negatively affected as well.  
Taking everything into account, we believe that  enzymatic treatment and especially the 
combination of collagenase and trypsin has adverse effects on the extracellular  matrix and 
the collagen network. These enzymes can actually destroy the ECM and this could cause 
problems in reseeding the acellularized samples or even the biomechanical results. Future 
research would be needed to prove the safety of these methods.  
 
2.5. Chemical acellularisation by solvents/detergents 
A newer promising approach is the extraction of cells by chemical solvents/detergents. The 
most widely used chemicals are sodium dodecyl sulphate (SDS, an ionic detergent), Triton-
X (a non-ionic detergent) and tri-nitro-butyl phosphate (TnBP). They have been described to 
acellularize tissue and successful application was performed on small intestine (Badylak et 
al., 1995), the urinary bladder (Chen et al.,  1999), the liver (Brown et al., 2006), arterial 
vasculature (Walles et al.,  2003), dermis (Armour et al., 2006), heart valves (Cebotari et al., 
2006) and oesophagus transplants (Bhrany et al. 2006; Gilbert et al., 2006) among others. In 
orthopaedic surgery there have been experiments using Graft jacket®  in irreparable rotator 
cuff defects for tendon augmentation (Barber et al., 2006; Coons et al., 2006). Acellularization 
of tendons (Tischer et al., 2007; Gilbert et al., 2006) and meniscal samples (Sandmann et al. 
2008; Stapleton et al., 2008) has caused further interest in this technique. 
Bolland et al. aimed to produce a natural, acellular matrix from porcine bladder tissue for 
use as a scaffold in developing a tissue-engineered bladder replacement. They used full-
thickness, intact porcine bladders, which were acellularised by distention and immersion in 
hypotonic buffer containing 0.1% (w/v) SDS and nuclease enzymes. Histological analysis of 
the resultant matrices showed that they were completely acellular whereas the major 
structural proteins had been retained. Intracellularly, some poorly soluble proteins 
remained. The amount of DNA per mg dry weight of fresh porcine bladder was 2.8 (+/-0.1) 
g/mg compared to 0.1 (+/-0.1) g/mg in acellularised bladder. In biomechanical testing 
the tensile testing indicated that acellularisation did not significantly compromise the tensile 
strength of the tissue. Cytotoxicity assays using porcine smooth muscle cell cultures 
excluded the presence of soluble toxins in the biomaterial (Bolland et al., 2007). A newer 
work by Gilbert et al. has shown that the presence of remaining intracellular DNA might not 
have as adverse effects as at first suspected. They examined the DNA content of 
commercially available ECM scaffold materials and compared their DNA content with 
scaffolds prepared in the laboratory using different acellularisation protocols. Most of the 
examined scaffolds still contained some amounts of DNA (4 out of 6 from the commercially 
available scaffolds and 2 out of 3 from the produced ECM scaffolds). Interestingly, scaffolds 
which retained higher amounts of DNA did not show worse results than the scaffolds with 
less DNA (Gilbert et al., 2008). In a work by Brown et al., it could be shown in an animal 
model that the presence of cellular components within the extracellular matrix scaffold 
modulates the phenotype of the macrophages participating in the host response following 
implantation. Scaffolds containing cellular components (even autologous cellular 
components), elicited a predominantly M1 type macrophage response, resulting in a more 
dense connective tissue and/or scarring. Acellular scaffolds, however, were observed to 
elicit a predominantly M2 type macrophage response, which results in a more constructive 
type of remodelling response (Brown et al., 2009). 
In the same animal model (abdominal wall defect in rats covered with several ECM 
scaffolds, i.e. porcine small intestinal submucosa (SIS), noncrosslinked SIS, and autologous 
body wall ) the effect of macrophages that derive from peripheral blood in the degradation 
of ECM scaffolds was examined and Valentine et al. could show, that peripheral blood 
monocytes are required for the early and rapid degradation of both SIS scaffolds and 
autologous body wall, and that carbodiimide crosslinked SIS’s are resistant to macrophage-
mediated degradation (Valentin et al., 2009). Apart from the macrophages the T 
lymphocytes play a crucial role in organ rejection, especially in cell-mediated immune 
responses to xenografts (Strom et al., 1996). Th1 lymphocytes produce cytokines such as 
interleukin (IL)-2, interferon (IFN)-, and tumor necrosis factor (TNF)-, leading to 
macrophage activation, stimulation of complement and differentiation of CD8+ cells to a 
cytotoxic phenotype, which leads to transplant rejection (Chen et al., 1996). In contrast, Th2 
lymphocytes produce IL-4, IL-5, IL-6, and IL-10, cytokines that do not activate macrophages. 
Resulting from this, the activation of the Th2 pathway is associated with transplant 
acceptance (Chen et al., 1995). The only ECM scaffold material for which the Th1/Th2 
response has been characterized so far is small intestine ECM (Allman et al., 2001). Allman 
implanted SIS-ECM subcutaneously in mice and could show that the expression of IL-4 
(Th2) was increased, while the expression of IFN- (Th1) was markedly decreased by 100-
fold compared to the response elicited by the xenogeneic muscle group. Although there was 
an immune response to the SIS-ECM after implantation, this response was dominated by the 
Th2 pathway mediators, lacking an acute rejection.  
Since similar studies have not been conducted for other forms of ECM scaffold materials, it 
is not possible to determine whether they would elicit the same type of host response. 
Thinking of the diversity of different tissues and scaffolds, it seems likely that the host 
response to biologic scaffolds will vary to a large degree following implantation. Further 
research is needed to understand the immunogenic reactions to the implanted scaffolds and 
the effects of acellularisation on the repopulation of these scaffolds. One step in this 
direction are two recent publications by Beattie et al. and Reing et al. who could show that 
the acellularisation process and the produced degradation products are important 
modulators for the recruitment and proliferation of appropriate cell types during the 
remodelling process (Beattie et al., 2009; Reing et al., 2009).  
The first study using acellularized tissue in orthopaedic research was performed by 
Cartmell et al. (Cartmell et al., 2000). Therein, they investigated the effectiveness of 
treatment of rat tail tendons with SDS, Tri (n-butyl) phosphate and Triton-X and found that 
both the treatment with SDS (1% for 24h) or TnBP (1%for 48h) resulted in an acellular matrix 
with retention of almost normal histological structure. The biomechanical properties were 
similar to native tendons. In contrast, Triton-X (1% for 24h) disrupted the collagen fibers and 
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was not as effective in acellularization as the two other methods, causing a disruption of the 
normal D-period of reconstituted rat tail tendon collagen fibers and an approximate 50% 
decrease in wet tensile strength and stiffness values. Following this, in 2004 Cartmell and 
Dunn could show that bone-patella-tendon-bone ligaments from rabbits could be 
successfully acellularized and reseeded with fibroblasts. Fibroblast proliferation rate was 
thereby slightly retarded on SDS- treated patellar tendons, whereas the repopulation in the 
TnBP- treated group was successful. Ingram et al. examined the additional effects of 
ultrasound on the repopulation process of natural tendon scaffolds acellularized with 0.1% 
SDS and found that repopulation with tenocytes was improved (Ingram et al., 2007). The 
work of Woods et al. compared the effectiveness of three extraction protocols in the 
development of an acellularized porcine bone-anterior cruciate ligament- bone graft (Woods 
et al. 2005). Therefore, they combined Triton-X (1% for 24 hours) either with SDS (1% for 24 
hours) or TnBP (1% for 24 hours). The combination of Triton-X with SDS was most effective 
at removing cell nuclei and intracellular protein (vimentin) from the ACL but affected both 
the collagen and glycosaminoglycan (GAG) components of the extracellular matrix while 
increasing the tensile stiffness of the ligament. In contrast, the combination of Triton-X with 
Triton-X was least effective of the three treatments in terms of cellular extraction, anyway its 
use did not alter the mechanical (stiffness and failure load) and biochemical (collagen and 
GAG content) properties of the ACL compared to the control group significantly. Triton-
TnBP matched the level of decellularization achieved by Triton-SDS in terms of visible cell 
nuclei. It had lower effects on the extraction of the intracellular vimentin. Though Triton-
TnBP did change the collagen content of the ACL (significant reduction of collagen content), 
the mechanical properties (tensile stiffness, failure load) were left unaffected. Overall, all 
three decellularization treatments maintained adequate mechanical and biochemical 
properties of B-ACL-B grafts. In a study by Vavken et al. 2009 the effectiveness of the 
acellularization of porcine ACL with Triton-X (0.25% for 24 hours), SDS (0.1% for 24 hours) 
and trypsin (0.1% for 24 hours) was examined. All acellularization protocols reduced DNA 
content, with triton-X treatment having the greatest effect. Concurrently, acellularization did 
not affect tissue collagen or total protein content, but did decrease glycosaminoglycan 
content. In this work Triton-X had the lowest effect on glycosaminoglycan depletion, so that 
the author favoured the acellularization with Triton-X. These different results show that 
future research is needed to find the most effective and most gentle way of acellularization 
to prepare the scaffold for repopulation. 
For the acellularization of meniscal samples there is even more research needed. We could 
show (Sandmann et al., 2009) that the treatment of human meniscal samples with SDS 2% 
for 2 weeks is highly effective in acellularization (see chapter 5). In another work published 
by Stapleton et al. 2008 a different protocol was used for the acellularization of porcine 
meniscal samples. The menisci were acellularized by exposing the tissue to repetitive freeze-
thaw cycles, incubation in hypotonic tris buffer, 0.1% (w/v) sodium dodecyl sulfate in 
hypotonic buffer plus protease inhibitors, nucleases and hypertonic buffer followed by 
desinfection using 0.1% (v/v) peracetic acid and final washing in phosphate-buffered saline. 
Histological, immunohistochemical, and biochemical analyses of the acellularized tissue 
confirmed the retention of the major structural proteins. However, a 59.4% loss of 
glycosaminoglycan content was noticed but with no significant alteration of the 
biomechanical characteristics. Furthermore, acellularized tissue and extracts were not 
cytotoxic to cells.  
Up to now, there are many unanswered questions regarding acelluarized scaffolds. The 
method of acellularization seems to be very promising of creating a collagen scaffold for 
tissue engineering of ligaments and meniscus, as the extracellular matrix and thereby the 
biomechanical properties are mainly preserved. However, in vivo animal studies are still 
missing. In the future acellularized tendons or meniscus samples might play a crucial role in 
orthopaedic surgery as do several extracellular matrix materials, which have been 
commercialized so far and are applied in a variety of indications reaching from the 
reconstruction of soft tissue defects (Ueno et al., 2004) to grafts in vascular surgery (Hiles et 
al., 1993) or neurosurgery (LeVisage et al., 2005).  
 
3. Repopulation of acellularized scaffolds 
The repopulation of acellularized tissue using detergents/solvents might improve and 
fasten incorporation and remodelling processes and thereby improve the long- term results. 
Cell proliferation on acellularized tissue is dependent on the used chemical treatment, with 
SDS showing the best acellularization rate but slightly diminished cell proliferation 
compared to Triton-X or TnbP (Gratzer et al., 2006, also see previous section). 
In a study published by Cartmell in 2004 the seeding of acellularized tendons was most 
effective in TnBP treated tendons. They were seeded with fibroblasts and viable tissue-
engineered grafts could be created. These modified allografts could be developed into 
mechanically functional delivery vehicles for cells, gene therapy vectors, or other biological 
agents. Whereas multiple in vitro studies have been performed to repopulate acellular tissue 
(Cartmell et al., 2004; Gratzer et al., 2006), in vivo animal studies are sparse. In a study by 
Vavken et al. 2009 it could be shown that acellularized tendons treated with Triton-X could 
best be repopulated as the extracellular matrix was mainly unaffected. SDS treated tissue 
seems more difficult to repopulate, whereas it shows the best acellularization properties. 
Harrison et al., 2005 compared the effect of different culture condition variables (i.e. (1) the 
number of cells used for seeding, (2) the addition of epidermal growth factor (EGF), and (3) 
culture duration) on the repopulation of porcine ACL with fibroblasts. They found that 
Triton-X and TnBP acellularized ACL’s were suitable for repopulation. Cellular ingrowth in 
the SDS group was successful, but less effective. At first it was supposed that this might be 
due to cytotoxic effects of SDS, but Gratzer et al., 2006 showed that not the cytotoxicity but 
probably matrix alterations were responsible for that.  
Nevertheless, little is known about the optimal cell source for tissue engineering of 
ligaments. Van Eijk et al. 2004 searched for the optimal cell source for tissue engineering of 
the anterior cruciate ligament. They compared the use of bone marrow stromal cells 
(BMSCs), ACL fibroblasts and skin fibroblasts and seeded them onto a resorbable suture 
material [poly(L-lactide/glycolide) multifilaments] at five different seeding densities, and 
cultured them for up to 12 days. All cell types tested attached to the suture material, 
proliferated, and synthesized extracellular matrix rich in collagen type I. On day 12 the 
scaffolds seeded with BMSCs showed the highest DNA content (p < 0.01) and the highest 
collagen production (p < 0.05 for the two highest seeding densities). Scaffolds seeded with 
ACL fibroblasts showed the lowest DNA content and collagen production. Another 
interesting study examined the proliferation and survival of different cell types (ACL 
fibroblasts vs. skin fibroblasts) on ligament analogues in the harsh environment of the rabbit 
knee joint (Belincampini 1998). Liu et al 2008 concluded in their study, that BMSC are a 
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and trypsin (0.1% for 24 hours) was examined. All acellularization protocols reduced DNA 
content, with triton-X treatment having the greatest effect. Concurrently, acellularization did 
not affect tissue collagen or total protein content, but did decrease glycosaminoglycan 
content. In this work Triton-X had the lowest effect on glycosaminoglycan depletion, so that 
the author favoured the acellularization with Triton-X. These different results show that 
future research is needed to find the most effective and most gentle way of acellularization 
to prepare the scaffold for repopulation. 
For the acellularization of meniscal samples there is even more research needed. We could 
show (Sandmann et al., 2009) that the treatment of human meniscal samples with SDS 2% 
for 2 weeks is highly effective in acellularization (see chapter 5). In another work published 
by Stapleton et al. 2008 a different protocol was used for the acellularization of porcine 
meniscal samples. The menisci were acellularized by exposing the tissue to repetitive freeze-
thaw cycles, incubation in hypotonic tris buffer, 0.1% (w/v) sodium dodecyl sulfate in 
hypotonic buffer plus protease inhibitors, nucleases and hypertonic buffer followed by 
desinfection using 0.1% (v/v) peracetic acid and final washing in phosphate-buffered saline. 
Histological, immunohistochemical, and biochemical analyses of the acellularized tissue 
confirmed the retention of the major structural proteins. However, a 59.4% loss of 
glycosaminoglycan content was noticed but with no significant alteration of the 
biomechanical characteristics. Furthermore, acellularized tissue and extracts were not 
cytotoxic to cells.  
Up to now, there are many unanswered questions regarding acelluarized scaffolds. The 
method of acellularization seems to be very promising of creating a collagen scaffold for 
tissue engineering of ligaments and meniscus, as the extracellular matrix and thereby the 
biomechanical properties are mainly preserved. However, in vivo animal studies are still 
missing. In the future acellularized tendons or meniscus samples might play a crucial role in 
orthopaedic surgery as do several extracellular matrix materials, which have been 
commercialized so far and are applied in a variety of indications reaching from the 
reconstruction of soft tissue defects (Ueno et al., 2004) to grafts in vascular surgery (Hiles et 
al., 1993) or neurosurgery (LeVisage et al., 2005).  
 
3. Repopulation of acellularized scaffolds 
The repopulation of acellularized tissue using detergents/solvents might improve and 
fasten incorporation and remodelling processes and thereby improve the long- term results. 
Cell proliferation on acellularized tissue is dependent on the used chemical treatment, with 
SDS showing the best acellularization rate but slightly diminished cell proliferation 
compared to Triton-X or TnbP (Gratzer et al., 2006, also see previous section). 
In a study published by Cartmell in 2004 the seeding of acellularized tendons was most 
effective in TnBP treated tendons. They were seeded with fibroblasts and viable tissue-
engineered grafts could be created. These modified allografts could be developed into 
mechanically functional delivery vehicles for cells, gene therapy vectors, or other biological 
agents. Whereas multiple in vitro studies have been performed to repopulate acellular tissue 
(Cartmell et al., 2004; Gratzer et al., 2006), in vivo animal studies are sparse. In a study by 
Vavken et al. 2009 it could be shown that acellularized tendons treated with Triton-X could 
best be repopulated as the extracellular matrix was mainly unaffected. SDS treated tissue 
seems more difficult to repopulate, whereas it shows the best acellularization properties. 
Harrison et al., 2005 compared the effect of different culture condition variables (i.e. (1) the 
number of cells used for seeding, (2) the addition of epidermal growth factor (EGF), and (3) 
culture duration) on the repopulation of porcine ACL with fibroblasts. They found that 
Triton-X and TnBP acellularized ACL’s were suitable for repopulation. Cellular ingrowth in 
the SDS group was successful, but less effective. At first it was supposed that this might be 
due to cytotoxic effects of SDS, but Gratzer et al., 2006 showed that not the cytotoxicity but 
probably matrix alterations were responsible for that.  
Nevertheless, little is known about the optimal cell source for tissue engineering of 
ligaments. Van Eijk et al. 2004 searched for the optimal cell source for tissue engineering of 
the anterior cruciate ligament. They compared the use of bone marrow stromal cells 
(BMSCs), ACL fibroblasts and skin fibroblasts and seeded them onto a resorbable suture 
material [poly(L-lactide/glycolide) multifilaments] at five different seeding densities, and 
cultured them for up to 12 days. All cell types tested attached to the suture material, 
proliferated, and synthesized extracellular matrix rich in collagen type I. On day 12 the 
scaffolds seeded with BMSCs showed the highest DNA content (p < 0.01) and the highest 
collagen production (p < 0.05 for the two highest seeding densities). Scaffolds seeded with 
ACL fibroblasts showed the lowest DNA content and collagen production. Another 
interesting study examined the proliferation and survival of different cell types (ACL 
fibroblasts vs. skin fibroblasts) on ligament analogues in the harsh environment of the rabbit 
knee joint (Belincampini 1998). Liu et al 2008 concluded in their study, that BMSC are a 
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better cell source than ACL fibroblasts when using silk scaffolds for ACL tissue engineering. 
The same conclusion was reached in the study be Ge et al. in 2005. 
 
4. Tissue engineering of the ACL - own work 
The aim of our study (Tischer et al. 2007) was to investigate investigate whether the treatment 
of rabbit  semitendinosus tendons with SDS leads to cell free constructs and whether these 
could serve as a scaffold for tissue engineering of the ACL.  Therefore allograft semitendinosus 
tendons were treated with SDS using a special protocol (see table 1).  
 
Day 1 Deionized water 24h 
Day 2 1% SDS 24h 
Day 3 Deionized water 24h 
Day 4 70% ethanol 24h 
Day 5 Phosphate buffered saline (PBS) Several times 
Table 1. Acellularization protocol for rabbit semitendinosus tendons 
 
Following the acellularization process, the tendons were seeded with autologous dermal 
fibroblasts. Therefore dermal fibroblasts were taken from a small skin biopsy, extracted and 
cultured for approximately 10 days until the cells were confluent. The cells were split and 
after confluence solutions were made with a cell number of 1.0x106 cells/ 0.5ml medium. 
This suspension was injected into the acellular tendons in line with the collagen fibres. 
Additionally, cell suspension was applied for 4 days to the tendon surface for outer 
settlement of the cells. 
Following, the tendons were tested biomechanically and histologically. For biomechanical 
testing three groups were examined, being nine native tendons, nine acellular tendons and 
nine tendons seeded with autologous dermal fibroblasts for 4 days of culture. The load to 
failure test was performed on a universal material test machine (Modell Zwicki 1120, Fa. 
Zwick, Germany) with a preload of 2N. The load- to failure test was performed by 
increasing the tensile loading continuously with a speed of 10mm/min. Apart from the load 
to failure the biomechanical properties elongation of tendon until rupture and the stiffness 
were recorded.  
For histological examination six tendons were used in each group. As standard all 
longitudinal sections were stained with hematoxylin-eosin. For analysis of changes in the 
extracellular matrix, tendons from each group were stained with a panel of monoclonal 
antibodies directed against collagen 1, 3, 4, 6, Pro-collagen 1, versican and vimentin. 
Histological staining with a standard Hematoxylin/Eosin staining revealed that all cells 
could be removed from the tendons and the constructs were cell-free (see figure 1). No more 
cell nuclei could be seen. The acellularization process lead to more interfascicular spaces in 
the SDS group. The group with the seeded tendon constructs lead to increased irregularities 
in the tendons. The cells were viable, but most of them did not show the typical spindle 
shape appearance. Survival of the cells was proven by immunohistochemical staining for 
pro-collagen I, the precursor molecule of collagen I, which was absent after acellularization 
but was found around the seeded cells after seeding.  
 
Fig. 1. Histological appearance of native (a) and acellular (b) rabbit semitendinosus tendon. 
No more cell nuclei can be found after acellularization (b). (HE staining, 100x 
magnification). 
 
The treatment of the tendon constructs did not show any staining irregularities in the 
composition of the extracellular matrix. Staining for the collagens I, III, IV and VI did not 
show significant differences between the groups.  Furthermore the distribution of 
macromolecules like versican was equally distributed in all three tested groups. Vimentin, 
an intermediary filament especially characteristic for fibroblasts was decreased, but clearly 
detectable. 
 
Biomechanical results 
For biomechanical testing nine native tendons, nine acellular tendons and nine cells seeded 
for 4 days were tested. The tests were done using a universal material test machine and with 
load- to failure testing. The maximum load to failure, the elongation of the tendon until 
rupture and the stiffness could be recorded (see table 2). The load to failure between the 
three groups was statistically not significant as is shown in the following table. 
 Load to failure Stiffness Elongation 
Native tendons 134.5  12.9N 58.9  6.57N/mm 2.47  0.33% 
Acellular tendons 118.5  7.3N 48.5  3.05N/mm 2.46  0.06% 
Seeded tendons 132.3  5.6N 18.5  1.73N/mm 7.50  0.5% 
 
Table 2. Results of load to failure testing of rabbit semitendinosus tendons 
 
The elongation of the seeded tendons as well as the stiffness were significantly elevated 
compared to the acellular or the native control group. The most evident explanation might 
be that the seeded tendons underwent a swelling process during cell culture, which was not 
compensated for by our only short pretensioning before testing. However, for comparability 
between the other groups, pretensioning was not changed.  
 
Animal model 
While the in vitro results of repopulated acellular scaffold were very promising, in vivo 
results are missing. Therefore the above described scaffold was tested in an in vivo rabbit 
model of ACL replacement (see figure 2). Therein we could show that SDS acellularized, 
allogenic constructs colonized with autologous fibroblasts (Tischer et al. 2009) had 
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better cell source than ACL fibroblasts when using silk scaffolds for ACL tissue engineering. 
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of rabbit  semitendinosus tendons with SDS leads to cell free constructs and whether these 
could serve as a scaffold for tissue engineering of the ACL.  Therefore allograft semitendinosus 
tendons were treated with SDS using a special protocol (see table 1).  
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Table 1. Acellularization protocol for rabbit semitendinosus tendons 
 
Following the acellularization process, the tendons were seeded with autologous dermal 
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cultured for approximately 10 days until the cells were confluent. The cells were split and 
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This suspension was injected into the acellular tendons in line with the collagen fibres. 
Additionally, cell suspension was applied for 4 days to the tendon surface for outer 
settlement of the cells. 
Following, the tendons were tested biomechanically and histologically. For biomechanical 
testing three groups were examined, being nine native tendons, nine acellular tendons and 
nine tendons seeded with autologous dermal fibroblasts for 4 days of culture. The load to 
failure test was performed on a universal material test machine (Modell Zwicki 1120, Fa. 
Zwick, Germany) with a preload of 2N. The load- to failure test was performed by 
increasing the tensile loading continuously with a speed of 10mm/min. Apart from the load 
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For histological examination six tendons were used in each group. As standard all 
longitudinal sections were stained with hematoxylin-eosin. For analysis of changes in the 
extracellular matrix, tendons from each group were stained with a panel of monoclonal 
antibodies directed against collagen 1, 3, 4, 6, Pro-collagen 1, versican and vimentin. 
Histological staining with a standard Hematoxylin/Eosin staining revealed that all cells 
could be removed from the tendons and the constructs were cell-free (see figure 1). No more 
cell nuclei could be seen. The acellularization process lead to more interfascicular spaces in 
the SDS group. The group with the seeded tendon constructs lead to increased irregularities 
in the tendons. The cells were viable, but most of them did not show the typical spindle 
shape appearance. Survival of the cells was proven by immunohistochemical staining for 
pro-collagen I, the precursor molecule of collagen I, which was absent after acellularization 
but was found around the seeded cells after seeding.  
 
Fig. 1. Histological appearance of native (a) and acellular (b) rabbit semitendinosus tendon. 
No more cell nuclei can be found after acellularization (b). (HE staining, 100x 
magnification). 
 
The treatment of the tendon constructs did not show any staining irregularities in the 
composition of the extracellular matrix. Staining for the collagens I, III, IV and VI did not 
show significant differences between the groups.  Furthermore the distribution of 
macromolecules like versican was equally distributed in all three tested groups. Vimentin, 
an intermediary filament especially characteristic for fibroblasts was decreased, but clearly 
detectable. 
 
Biomechanical results 
For biomechanical testing nine native tendons, nine acellular tendons and nine cells seeded 
for 4 days were tested. The tests were done using a universal material test machine and with 
load- to failure testing. The maximum load to failure, the elongation of the tendon until 
rupture and the stiffness could be recorded (see table 2). The load to failure between the 
three groups was statistically not significant as is shown in the following table. 
 Load to failure Stiffness Elongation 
Native tendons 134.5  12.9N 58.9  6.57N/mm 2.47  0.33% 
Acellular tendons 118.5  7.3N 48.5  3.05N/mm 2.46  0.06% 
Seeded tendons 132.3  5.6N 18.5  1.73N/mm 7.50  0.5% 
 
Table 2. Results of load to failure testing of rabbit semitendinosus tendons 
 
The elongation of the seeded tendons as well as the stiffness were significantly elevated 
compared to the acellular or the native control group. The most evident explanation might 
be that the seeded tendons underwent a swelling process during cell culture, which was not 
compensated for by our only short pretensioning before testing. However, for comparability 
between the other groups, pretensioning was not changed.  
 
Animal model 
While the in vitro results of repopulated acellular scaffold were very promising, in vivo 
results are missing. Therefore the above described scaffold was tested in an in vivo rabbit 
model of ACL replacement (see figure 2). Therein we could show that SDS acellularized, 
allogenic constructs colonized with autologous fibroblasts (Tischer et al. 2009) had 
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significantly weaker biomechanical properties than autologous tendons. In histological 
examination inflammatory reactions and acellular regions could be noticed, which might be 
due to the used acellularization method. However, since this is the first study in the field, 
more research as to be performed. 
 
 
Fig. 2. Rabbit ACL replacement model using double stranded semitendinosus tendon at 
anatomical insertion site. Fixation was performed using custom made endobuttons. 
 
A lot of ACL research has been done in the rabbit model and though it is a good animal 
model, future research in the field of double bundle research should take place in bigger 
animals, as their anatomy and the forces come closer to the forces in human knee joints. 
Questions, like the best fixation technique or the advantages of the double bundle 
reconstruction should be best addressed in bigger animals (Tischer et al., 2009). 
 
Discussion 
Solvents, like SDS or Triton- X have been shown to be effective agents in acellularizing 
tissues. In our work we focussed on SDS and our results show that with the solvent SDS it is 
possible to acellularize tendon tissue. The advantage compared to other methods is that by 
the acellularization with SDS the constructs are made cell- free and all the cell- detritus is 
washed out as well. This makes them less immunogenic as the cell-based reactions do not 
take place in the same way. The acellularization with SDS has been shown to be most 
effective.  
Secondly, SDS acellularized constructs can be reseeded again. This might be a little more 
difficult than when using other methods due to an alteration of extracellular matrix 
hindering repopulation (Gratzer et al., 2006), but it has been shown to work (Ingram et al., 
2007). Acellular and repopulated scaffolds might be very useful in the future as the 
integration of transplants can thereby be improved. A small dermal biopsy followed by cell 
culture might be enough to create a “custom-fit” transplant. Future research has to be done 
in this field to evaluate the possibilities. 
 
5. Tissue engineering of the Meniscus - own work 
Tissue engineering of the meniscus is even more complex than that of ligaments or tendons, 
as the meniscus has an even more complex collagen network and most of the methods 
described before have lead to a failure in acellularization or a deterioration of the 
biomechanical properties. Inspired by the work mentioned above, we tried to apply the 
same acellularization protocol and initially failed. After gradually improving the SDS 
concentration and time we finally succeeded in acellularization using SDS for meniscus 
samples (see table 3). Since the diffusion of chemicals is time dependent, larger tissue 
specimens are expected to take longer before acellularization is achieved. A higher 
concentration of SDS (2% compared to 1%) and a longer duration were needed to get a cell- 
free meniscus construct. 
 
Day 1 Deionized water 24h 
Day 2- 14 2% SDS  
Day 15 Deionized water 24h 
Day 16 70% ethanol 24h 
Day 17 Phosphate buffered saline (PBS) Several times 
Table 3. Extraction protocol for human meniscus constructs 
 
Histological and immunhistochemical results 
After treatment with SDS 2% for 2 weeks all meniscus samples (both medial and lateral) 
were identified as acellular by hematoxylin/eosin staining. Phase-contrast examinations 
revealed regular collagen bundle arrangement in the acellular specimens as seen in intact 
menisci. Immunohistochemically, no differences in the labelling patterns for collagen 1, 2 
and 6 were observed when compared with intact menisci. Whereas for collagen I there was 
strong labelling in the whole meniscus, collagen 2 was labelled only in the fibrocartilaginous 
section of both groups. Collagen VI staining was evenly distributed throughout the 
meniscus tissue, both in acellularized and intact menisci. 
 
 
Fig. 3. Native (a) and acellular (b) meniscus samples at 200x magnification. 
 
Biomechanical results 
After the acellularization process a total of 5 medial and 5 lateral human menisci were 
examined using a ball indention test. The undersurface of the menisci was oriented 
perpendicular to the testing device. Three cylinders with a diameter of 5.0 mm and a height 
of 4.0 mm were punched out of each meniscus. These cylinders were put into a custom-
made device and the upper part of the cylinder was shaped to create a surface parallel to the 
base. The sample was then put into a custom-designed metallic plate with a circular cavity 
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significantly weaker biomechanical properties than autologous tendons. In histological 
examination inflammatory reactions and acellular regions could be noticed, which might be 
due to the used acellularization method. However, since this is the first study in the field, 
more research as to be performed. 
 
 
Fig. 2. Rabbit ACL replacement model using double stranded semitendinosus tendon at 
anatomical insertion site. Fixation was performed using custom made endobuttons. 
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same acellularization protocol and initially failed. After gradually improving the SDS 
concentration and time we finally succeeded in acellularization using SDS for meniscus 
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free meniscus construct. 
 
Day 1 Deionized water 24h 
Day 2- 14 2% SDS  
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Day 17 Phosphate buffered saline (PBS) Several times 
Table 3. Extraction protocol for human meniscus constructs 
 
Histological and immunhistochemical results 
After treatment with SDS 2% for 2 weeks all meniscus samples (both medial and lateral) 
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menisci. Immunohistochemically, no differences in the labelling patterns for collagen 1, 2 
and 6 were observed when compared with intact menisci. Whereas for collagen I there was 
strong labelling in the whole meniscus, collagen 2 was labelled only in the fibrocartilaginous 
section of both groups. Collagen VI staining was evenly distributed throughout the 
meniscus tissue, both in acellularized and intact menisci. 
 
 
Fig. 3. Native (a) and acellular (b) meniscus samples at 200x magnification. 
 
Biomechanical results 
After the acellularization process a total of 5 medial and 5 lateral human menisci were 
examined using a ball indention test. The undersurface of the menisci was oriented 
perpendicular to the testing device. Three cylinders with a diameter of 5.0 mm and a height 
of 4.0 mm were punched out of each meniscus. These cylinders were put into a custom-
made device and the upper part of the cylinder was shaped to create a surface parallel to the 
base. The sample was then put into a custom-designed metallic plate with a circular cavity 
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(diameter 5.0 mm and depth 4.0 mm) to prevent the samples from dislocating during testing 
(see figure 4). The test was performed as a minimally constraint compression-relaxation test. 
During testing, the meniscus samples were kept moist using physiologic saline solution. A 
preload of 0.1 N was used and samples were checked intermittently during testing for 
displacement. The test cycle consisted of four phases: preloading of the sample with 0.1 N; 
dynamic compression with a constant load velocity of 5 mm/min until 7 N; static 
compression of the sample for 60 s with a load of 7 N; relaxation of the sample with a 
constant unload velocity of 1 mm/min until a load of 0.15 N. After an interval of 60 s, the 
new test cycle started until a total number of five test cycles were reached. Load, indentor 
position, and time were displayed by the test software TestXpert and the following three 
biomechanical values could be calculated: (1) Relative sample compression calculated by the 
indentor position in relation to absolute sample height at the end of the dynamic 
compression phase (Compression is an indicator for viscosity and characterizes the ability of 
the tested tissue to evade the indenter) (2) ) Stiffness determined from the linear elastic slope 
of the loading curve between 2 and 5 N. High stiffness values mean high elasticity and vice 
versa. (3) Residual force (load measured at the end of the static compression phase). The 
residual force is influenced by the ability of tissue to evade the indenter in unconstraint 
compression (viscosity) as well as by the reset forces present in the tested tissue (elasticity). 
High residual forces show more elastic than viscous properties.  
 
 
Fig. 4. Scheme of the ball indention trial (Sandmann et al., 2009). 
 
The testing showed that the acellularization did not affect the biomechanical properties of 
the tested tissue. The test was performed with cyclic loading in 5 cycles with a maximum 
load of 7N. Between the cycles 60seconds of relaxation were used. Stiffness increased 
significantly throughout testing by 162% (native meniscus) and 143% (acellular meniscus). 
During each testing cycle the differences between the two groups—intact meniscus and 
acellular scaffold—were not statistically significant. Mean compression of sample height 
was 32% (±7.2%) for intact meniscus samples after the fifth cycle compared to 35% (±8.3%) 
in the scaffolds. Scaffold compression exceeded compression of intact meniscus by 9%, 
being not statistically significant (p > 0.05). The residual force of the two groups increased 
after each cycle, but no statistically significant difference could be noticed. Biomechanical 
results were not significantly different comparing processed medial or processed lateral 
meniscus samples with the control group.  
 
 Stiffness 
(cycle 1) 
Stiffness 
(cycle 5) 
Mean 
compression 
height after 5 
cycles 
Residual force 
(cycle 1) 
Resiudal 
force 
(cycle 5) 
Native 
meniscus 
11.6 ± 3.2 
N/mm   
31.1 ± 3.3 
N/mm 
32% (±7.2%) 1.0 ± 0.41 N 3.0± 0.36 
N 
Acellular 
meniscus 
12.3 ± 2.9 
N/mm 
30 ± 3.2 
N/mm 
35% (±8.3%) 3.1 ± 0.4 N 3.2 ± 0.41 
N 
Table 4. Results of biomechanical testing 
 
Discussion 
Comparable to the tissue engineering of tendons the treatment of human meniscus samples 
with the potent solvent SDS generated cell-free meniscus scaffolds. Theses scaffolds have 
been shown to be biomechanically stable with characteristics similar to native meniscus 
samples. Special caution was given to the different biomechanical characteristics of 
meniscus tissue compared to tendon tissue. Seeding of the acellularized menisci has not 
been tested so far but future research might have to answer the question, whether 
repopulation of meniscus samples is possible and whether the repopulation rates can be 
improved by different stimulation methods like mechanical stimuli generated in bioreactors. 
 
6. Outlook 
The ACL and the meniscus are the both structures in the knee joint which are frequently 
injured and so far in most cases no restoration of the original anatomy is possible. Especially 
the development of osteoarthrosis in the long term is still an unsolved problem. Fortunately, 
many advances have been made in the surgical reconstruction of the ACL and the 
disastrous total meniscectomy has been abandoned long ago. The role of new surgical 
techniques like double bundle ACL surgery still has to be found. 
Apart from the acellularization of tissues, the use of growth factors, additionally or alone, 
seems to be a very promising option in improving the long- term results. Especially in 
meniscus transplants those factors that stimulate matrix synthesis and inhibit degradation of 
the extracellular matrix could be very useful. Future research has to point on the 
repopulation process and its improvement.  Angiogenic growth factors might contribute to 
even further improve the results. Maybe the use of bioreactors producing adequate 
mechanical stimuli, growth factors or synthetic scaffolds (e.g. silk) will help to solve the 
remaining questions.  
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the tested tissue. The test was performed with cyclic loading in 5 cycles with a maximum 
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significantly throughout testing by 162% (native meniscus) and 143% (acellular meniscus). 
During each testing cycle the differences between the two groups—intact meniscus and 
acellular scaffold—were not statistically significant. Mean compression of sample height 
was 32% (±7.2%) for intact meniscus samples after the fifth cycle compared to 35% (±8.3%) 
in the scaffolds. Scaffold compression exceeded compression of intact meniscus by 9%, 
being not statistically significant (p > 0.05). The residual force of the two groups increased 
after each cycle, but no statistically significant difference could be noticed. Biomechanical 
results were not significantly different comparing processed medial or processed lateral 
meniscus samples with the control group.  
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Discussion 
Comparable to the tissue engineering of tendons the treatment of human meniscus samples 
with the potent solvent SDS generated cell-free meniscus scaffolds. Theses scaffolds have 
been shown to be biomechanically stable with characteristics similar to native meniscus 
samples. Special caution was given to the different biomechanical characteristics of 
meniscus tissue compared to tendon tissue. Seeding of the acellularized menisci has not 
been tested so far but future research might have to answer the question, whether 
repopulation of meniscus samples is possible and whether the repopulation rates can be 
improved by different stimulation methods like mechanical stimuli generated in bioreactors. 
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The ACL and the meniscus are the both structures in the knee joint which are frequently 
injured and so far in most cases no restoration of the original anatomy is possible. Especially 
the development of osteoarthrosis in the long term is still an unsolved problem. Fortunately, 
many advances have been made in the surgical reconstruction of the ACL and the 
disastrous total meniscectomy has been abandoned long ago. The role of new surgical 
techniques like double bundle ACL surgery still has to be found. 
Apart from the acellularization of tissues, the use of growth factors, additionally or alone, 
seems to be a very promising option in improving the long- term results. Especially in 
meniscus transplants those factors that stimulate matrix synthesis and inhibit degradation of 
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repopulation process and its improvement.  Angiogenic growth factors might contribute to 
even further improve the results. Maybe the use of bioreactors producing adequate 
mechanical stimuli, growth factors or synthetic scaffolds (e.g. silk) will help to solve the 
remaining questions.  
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7. Conclusion 
Tissue engineering provides a lot of possibilities for improving tendon or meniscus 
scaffolds. Especially, the acellularization process with following cell seeding might be a very 
effective way of improving incorporation and remodelling processes as well as avoiding the 
cell-based immune reactions, which may be partially responsible for the deterioration of the 
allografts over the years. We have shown that the treatment of tendons or meniscus samples 
with the solvent SDS produces cell- free constructs. Despite acellularization, the extracellular 
matrix remains widely intact and the biomechanical properties remain unaltered. Whether 
the acellularization and the seeding will be successful in the long term has still to be shown 
in further animal models. Only then will human application be possible and improve 
operative treatment for our patients.  
Big efforts have been made during the last years in vitro and in vivo and we believe that the 
tissue engineering of tendons and menisci samples might play a crucial role in the future of 
orthopaedic surgery. 
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1. Introduction 
Injury to the peripheral nervous system (PNS) and central nervous system (CNS) may result 
in severe functional loss. Spontaneous regeneration is limited to small lesions within the 
injured PNS and is actively suppressed within the CNS. In this chapter we discuss the 
pathology and changes in the physiological environment following PNS/CNS injury. 
Several key factors such as the glial scar and inhibitory biomolecules are addressed. Neural 
tissue engineering approaches attempt to provide an alternative to nerve autografts, and 
have shown some promising regenerative outcomes. The scaffolds are designed to provide 
mechanical support for endogenous/transplanted cells at the lesion site, provide guidance 
cues to neurites and for the attachment or delivery of biomolecules that promote 
regeneration. Unfortunately many of the current scaffolds used for neural tissue engineering 
provide only limited regulation of cellular response due to insufficient control of physical 
support, topological stimulation, degradability and inflammatory/foreign body responses.  
 
Nanostructured materials are currently being investigated for a new generation of neural 
tissue engineering scaffold. Bio-nanotechnology approaches extend current scaffold 
strategies for an enhanced manipulation of the physical, biochemical and biological cues 
that can significantly enhance cell survival and nerve regeneration. Two types of 
nanofabrication are discussed in this chapter:  
 
(1) electrospinning, which produces nanofibers using a wide range of polymers with 
controlled fiber diameter, degree of alignment and pore size, and   
 
(2) self-assembled peptide hydrogels which are particularly useful to fill cavities of irregular 
shape, especially in the case of brain and spinal cord injuries. 
 
In both cases, the nanofibrillar scaffolds mimic some structural features of the extracellular 
matrix but importantly, the nano-size dimension allows for the high density presentation in 
three dimensions of peptides and growth factors important for neural repair. 
Biofunctionalisation strategies will therefore be discussed in some detail.  Finally this 
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 chapter will provide some commentary on the short to long term view on neural tissue 
engineering and identify some key biological and engineering milestones required for 
successful nerve regeneration. 
 
2. Physiological challenges for nerve repair in the PNS & CNS  
In the United States, approximately 20,000 peripheral nerve injuries required clinical 
treatment per year (Neville, Huang et al. 2009). Most of the injuries are repaired using nerve 
autografts, however, autografts are limited to the source of donor nerves and can cause 
donor site morbidity. Injuries to peripheral nerves cause several deficits including loss of 
function of the innervated tissue and neuropathic pain. Peripheral nerve injuries are largely 
induced by trauma resulting from accidents. Peripheral nerves can spontaneously recover 
from injury when they are not completely severed however in most cases complete nerve 
transection occurs. After injury, the distal portion of the completely severed nerve begins to 
degenerate, while the proximal end of the nerve stump swells but undergoes less damage 
via retrograde degradation. Concurrently, Schwann cells surrounding the axons also 
degrade. The myelin and axonal debris are phagocytozed by macrophages and Schwann 
cells followed by regeneration at the proximal end toward the distal stump (Schmidt and 
Leach 2003). The regenerative outcome depends on the distance and the alignment between 
the proximal and distal ends. For large defects and non-aligned nerves, structural and 
functional recovery may not be achieved.  
 
Unlike the PNS, CNS neurons are usually inhibited from regenerating across a lesion site. 
This inhibition results from a combination of biomechanical and biochemical factors, where 
healthy adult neurons are actively inhibited from regenerating (Tom, Steinmetz et al. 2004; 
Zhang, Uchimura et al. 2006; Busch and Silver 2007). The site-specific nature of this 
inhibition has been demonstrated in the 1980s by a series of experiments showing the failure 
of PNS axons to lengthen when encountered with CNS glia (David and Aguayo 1981). In the 
following years, many important inhibitory factors and the associated cell types have been 
identified at the site of injury following CNS damage. Of the biomechanical inhibitory 
factors, the major obstacle to regeneration after injury is the formation of a glial scar. 
Astrocytes undergo a morphological change, extending interwoven processes that lay down 
a rigid and relatively permanent collagenous scar that physically blocks axonal elongation 
and reconnection between proximal and distal ends (Fawcett 1997; Fitch and Silver 2008). 
The problem is compounded as astrocytes up-regulate glycoproteins like tenascin and a 
number of chondroitin sulphate proteoglycans which play an inhibitory role via growth 
cone repulsion and inhibition mechanisms to the regenerating neurites (Taylor, Pesheva et 
al. 1993; Fidler, Schuette et al. 1999; Chan, Roberts et al. 2008).  Oligodendrocytes continue to 
express myelin proteins after injury. Both myelin proteins and myelin debris contain 
regeneration inhibitors including Nogo-A, myelin oligodendrocyte glycoprotein (MOG) and 
myelin-associated glycoprotein (MAG), which are the major contributors to the inhibition of 
axon regeneration post injury (GrandPre, Nakamura et al. 2000; Kottis, Thibault et al. 2002; 
Filbin 2003; He and Koprivica 2004; Karnezis, Mandemakers et al. 2004).  
 
To date, much of the focus of neural tissue engineering in the CNS has been on curing spinal 
cord injuries (SCIs). This is largely due to the clearly defined role that scaffolds play in 
 
restoring neural pathways following SCI. There are about 12,000 new cases of SCI each year 
in the United States and the number of people with SCI has been estimated to be 
approximately 255,000. Statistical reports also show that the causes of traumatic SCI are 
primarily attributed to motor vehicle accidents (42%), followed by violence (15.3%), falls 
(27.1%), and recreational activities (7.4%) (National Spinal Cord Injury Statistical Center 
2009). A recent report released in Australia on behalf of the Victorian Neurotrama Initiative 
(Access Economics 2009) states that the life time costs of disease and injury to the nervous 
system is in excess of $10.5AUD billion per annum, a significant figure for a population less 
than 25 million.  Therefore such injuries are partly responsible for a major economic burden 
as well as the devastating personal consequences to the patient. 
 
During primary injury of the spinal cord, vascular damage results in microhaemorrhages, 
which happen within minutes, radiating outward from the central grey matter over several 
hours. In the case of SCIs, the cord itself can swell significantly to occupy the whole spinal 
canal at the lesion site, resulting in secondary ischaemia when swelling exceeds venous 
blood pressure. Ischaemia leads to the release of cytokines and toxic levels of otherwise 
normally secreted factors from damaged cells, triggering an acute inflammatory cascade 
that attacks intact neighbouring cells (known as the by-stander effect). Secondary injuries 
include depolarization of neurons and abnormal release of amino acids. Following ischemia, 
hypersecretion of factors such as glutamate occurs, resulting in toxic levels in both the 
injured spinal cord and brain (Dirnagl, Iadecola et al. 1999; Ao, Wang et al. 2007). Excessive 
levels of this neurotransmitter, secreted from the injured spinal neurons, axons and 
astrocytes leads to a highly disruptive over-excitation of neighbouring neurons 
(excitotoxicity). Affected neurons undergo demyelination and increased calcium signalling, 
triggering apoptotic cascades and oxidative free radical damage. In addition, the humoral 
pro-inflammatory response of cytokine secretion causes neutrophil and macrophage 
infiltration into the injury site to ingest bacteria and debris, resulting in edematous cavities 
(Fitch, Doller et al. 1999). 
 
3. Current scaffold strategies for new synaptic connections  
3.1 Nerve guidance conduits 
Gaps and cavities often appear in the injured PNS/CNS, resulting from traumaic injuries or 
macrophage infltration and post-injury inflammation (Blight 1994; Fitch, Doller et al. 1999). 
Scaffolds have been implanted or injected into cavities (lesion site) of the injured PNS/CNS 
normally in the form of conduits with impermeable/permeable walls (Heijke, Klopper et al. 
2001; Lundborg, Rosen et al. 2004; Chew, Mi et al. 2007). These materials can be either 
biologically inert (Lundborg, Dahlin et al. 1991; Zhao, Lundborg et al. 1997; Heijke, Klopper 
et al. 2001) or biodegradable with a controlled degradation rate (Borkenhagen, Stoll et al. 
1998; Xie, Li et al. 2008). Scaffolds are used to bridge or fill the gaps/cavities at the lesion site 
as well as provide support to surrounding nerve tissue and endogenous/implanted cells. 
Scaffolds provide adhesion sites to cells, allowing subsequent cell function including 
proliferation and differentation and even regulate specific cellular behavior by careful 
manipulation of the dimensional, topograpic and biochemical properties (Corey, Lin et al. 
2007; Dodla and Bellamkonda 2008; Christopherson, Song et al. 2009). 
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 The guidance conduit serves several important roles for nerve regeneration such as: 
 
a) directing axonal sprouting from the regenerating nerve (Tsai, Dalton et al. 2004; Panseri, 
Cunha et al. 2008), 
b) protecting the regenerating nerve by restricting the infiltration of fibrous tissue (Li and 
David 1996; Kitahara, Suzuki et al. 1998; Bundesen, Scheel et al. 2003; Yang, Xu et al. 2004; 
Lietz, Ullrich et al. 2006; Oh, Kim et al. 2008), and 
c) providing a pathway for diffusion of neurotropic and neurotophic factors (Moore, 
Macsween et al. 2006; Chew, Mi et al. 2007).  
 
Guidance conduites have several advantages over microsurgical autografting, the current 
gold standard for nerve repair. Suture line tension especially for long nerve gaps (>5 mm) is 
ineffective, however regeneration is improved using a guidance conduit (Terzis, Faibisoff et 
al. 1975; Schmidhammer, Zandieh et al. 2005). The use of donor nerve allografts is less 
feasible, due to the limited availability of tissue and morbidity following microsurgical 
procedures. Guidance conduits have therefore received considerable research focus over the 
past decade. 
 
Early guidance conduits were primarliy made of silicone due to its stability under 
physiological conditions, biocompatibility, flexibility as well as ease of processing into 
tubular structures (Zhao, Lundborg et al. 1997; Chen, Hsieh et al. 2000). Although silicone 
conduits have proven reasonably successful as conduits for small gap lengths in animal 
models (<5 mm) (Lundborg, Dahlin et al. 1982), the non-biodegradability of silicone 
conduits has limited its application as a strategy for long-term repair and recovery. Tubes 
also eventually become encapsulated with fibrous tissue, which leads to nerve compression, 
requiring additional surgical intevention to remove the tube (Lundborg, Dahlin et al. 1991; 
Chamberlain, Yannas et al. 1998). Another limiting factor with inert guidance conduits is 
that they provide little or no nerve regeneration for gap lengths over 10 mm in the PNS 
(Lundborg, Dahlin et al. 1982) unless exogenous growth factors are used.  In animal studies, 
biodegradable nerve guidance conduits have provided a feasible alternative, preventing 
neuroma formation and infiltration of fibrous tissue (Jansen, van der Werff et al. 2004; Oh, 
Kim et al. 2008). Biodegradable conduits have been fabricated from natural or synthetic 
materials such as collagen, chitosan and poly-L-lactic acid (Chamberlain, Yannas et al. 1998; 
Mingyu, Kai et al. 2004; Patel, Vandevord et al. 2008; Ichihara, Inada et al. 2009). 
 
Guidance conduits can be used solely to form an open lumen (Panseri, Cunha et al. 2008), or 
in combination with molecular and/or biological cues. Open lumina are hypothesized to 
provide space for linear nerve outgrowth to enable axons to selectively reinnervate the 
appropriate target. However, a pitfall of an open lumen approach is that it provides limited 
physical support and can not adequately control the cellular microenvironment. This is due 
to inadequate sites for cell adhesion and attachment of biological molecules as well as 
insufficient topological stimulation, which limits the ability of the conduits to encourage cell 
migration. Therefore, scaffolds are more wildly used in combination with molecular cues to 
improve nerve regeneration (Labrador, But et al. 1998). Various types of peptides, proteins 
and polysaccharides, which enhance cell adhesion, proliferation and provide neutrophin 
support (Lee, Yu et al. 2003), can be used to fill the open lumen (Nakamura, Inada et al. 
 
2004) or can be blended with the conduit forming material (Mingyu, Kai et al. 2004; Xie, Li et 
al. 2008). Other cellular cues can also be incorporated using such strategies (Sinis, Schaller et 
al. 2009). The reconnection of severed nerve axons in the PNS requires appropriate guidance 
of Schwann cells (Sinis, Schaller et al. 2009). In the case of large gaps between severed 
proximal and distal axons or severely damaged nerve bundles, guidance conduits with 
implanted stem/progenitor or supporting cells are essential for axon reconnection 
(Murakami, Fujimoto et al. 2003; Leaver, Harvey et al. 2006). For instance, conduits seeded 
with Schwann cells show a comparable effectiveness to autografts in sciatic nerve repair 
although control conduits with no Schwann cells contained significantly lower densities of 
nerve fibers, highlighting the importance of cellular biological cues (Neville, Huang et al. 
2009).  
 
Experimentally, cell-based therapies using stem and progenitor cell types have led to 
promising results for the treatment of both PNS and CNS injuries (Lu, Jones et al. 2005; 
Cummings, Uchida et al. 2006; Deshpande, Kim et al. 2006), with the intention of replacing 
lost and damaged cells in order to improve endogenous nerve regeneration. While 
functional recovery at the transplantation site requires cell survival in sufficient numbers, 
programmed cell death of the transplanted cells invariably occurs due a dearth of 
appropriate cell-matrix interactions. This has been a major limiting factor in the effectiveness 
of cell replacement therapies, with some reports of less than 10% of cells surviving after 
transplantation (Belle, Caldwell et al. 2004). Scaffolds which provide physical support, 
controlled degradability, controlled inflammatory/foreign body response and guidance 
cues must therefore also provide a suitable milieu for the survival and viability of 
transplanted cells. Unfortunately, current scaffolds for neural tissue engineering do not yet 
meet all these criteria. However recent progress in nanostructured and biomimetic scaffolds 
for neural tissue engineering has provided encouraging results, particularly when interfaced 
with stem cell therapies.  
 
4. Nanostructured Scaffolds for Neural Tissue Engineering: Fabrication and 
Design 
The neural architecture of the brain and spinal cord is more complex compared to the PNS, 
typically organized into discrete three-dimensional (3D) populations, depending on their 
roles in transmitting and processing signals according to the spatial body plan.  At the 
micro- and nanoscale, cells of the CNS reside within functional microenvironments 
consisting of physical structures including pores, ridges, and fibers that make up the 
extracellular matrix (ECM) and plasma membrane cell surfaces of closely apposed 
neighboring cells (Desai 2000). Cell-cell and cell-matrix interactions contribute to the 
formation and function of this architecture, dictating signaling and maintenance roles in the 
adult tissue, based on a complex synergy between biophysical (e.g. contact-mediated 
signaling, synapse control), and biochemical factors (e.g. nutrient support and inflammatory 
protection). Neural tissue engineering scaffolds are aimed toward recapitulating some of the 
3D biological signaling that is known to be involved in the maintenance of the PNS and CNS 
and to facilitate proliferation, migration and potentially differentiation during tissue repair. 
Nanostructured and biofunctional scaffolds are currently being investigated for the 
provision of microenvironments that are similar to those occurring in vivo, in the 
Tissue	Engineering462
 The guidance conduit serves several important roles for nerve regeneration such as: 
 
a) directing axonal sprouting from the regenerating nerve (Tsai, Dalton et al. 2004; Panseri, 
Cunha et al. 2008), 
b) protecting the regenerating nerve by restricting the infiltration of fibrous tissue (Li and 
David 1996; Kitahara, Suzuki et al. 1998; Bundesen, Scheel et al. 2003; Yang, Xu et al. 2004; 
Lietz, Ullrich et al. 2006; Oh, Kim et al. 2008), and 
c) providing a pathway for diffusion of neurotropic and neurotophic factors (Moore, 
Macsween et al. 2006; Chew, Mi et al. 2007).  
 
Guidance conduites have several advantages over microsurgical autografting, the current 
gold standard for nerve repair. Suture line tension especially for long nerve gaps (>5 mm) is 
ineffective, however regeneration is improved using a guidance conduit (Terzis, Faibisoff et 
al. 1975; Schmidhammer, Zandieh et al. 2005). The use of donor nerve allografts is less 
feasible, due to the limited availability of tissue and morbidity following microsurgical 
procedures. Guidance conduits have therefore received considerable research focus over the 
past decade. 
 
Early guidance conduits were primarliy made of silicone due to its stability under 
physiological conditions, biocompatibility, flexibility as well as ease of processing into 
tubular structures (Zhao, Lundborg et al. 1997; Chen, Hsieh et al. 2000). Although silicone 
conduits have proven reasonably successful as conduits for small gap lengths in animal 
models (<5 mm) (Lundborg, Dahlin et al. 1982), the non-biodegradability of silicone 
conduits has limited its application as a strategy for long-term repair and recovery. Tubes 
also eventually become encapsulated with fibrous tissue, which leads to nerve compression, 
requiring additional surgical intevention to remove the tube (Lundborg, Dahlin et al. 1991; 
Chamberlain, Yannas et al. 1998). Another limiting factor with inert guidance conduits is 
that they provide little or no nerve regeneration for gap lengths over 10 mm in the PNS 
(Lundborg, Dahlin et al. 1982) unless exogenous growth factors are used.  In animal studies, 
biodegradable nerve guidance conduits have provided a feasible alternative, preventing 
neuroma formation and infiltration of fibrous tissue (Jansen, van der Werff et al. 2004; Oh, 
Kim et al. 2008). Biodegradable conduits have been fabricated from natural or synthetic 
materials such as collagen, chitosan and poly-L-lactic acid (Chamberlain, Yannas et al. 1998; 
Mingyu, Kai et al. 2004; Patel, Vandevord et al. 2008; Ichihara, Inada et al. 2009). 
 
Guidance conduits can be used solely to form an open lumen (Panseri, Cunha et al. 2008), or 
in combination with molecular and/or biological cues. Open lumina are hypothesized to 
provide space for linear nerve outgrowth to enable axons to selectively reinnervate the 
appropriate target. However, a pitfall of an open lumen approach is that it provides limited 
physical support and can not adequately control the cellular microenvironment. This is due 
to inadequate sites for cell adhesion and attachment of biological molecules as well as 
insufficient topological stimulation, which limits the ability of the conduits to encourage cell 
migration. Therefore, scaffolds are more wildly used in combination with molecular cues to 
improve nerve regeneration (Labrador, But et al. 1998). Various types of peptides, proteins 
and polysaccharides, which enhance cell adhesion, proliferation and provide neutrophin 
support (Lee, Yu et al. 2003), can be used to fill the open lumen (Nakamura, Inada et al. 
 
2004) or can be blended with the conduit forming material (Mingyu, Kai et al. 2004; Xie, Li et 
al. 2008). Other cellular cues can also be incorporated using such strategies (Sinis, Schaller et 
al. 2009). The reconnection of severed nerve axons in the PNS requires appropriate guidance 
of Schwann cells (Sinis, Schaller et al. 2009). In the case of large gaps between severed 
proximal and distal axons or severely damaged nerve bundles, guidance conduits with 
implanted stem/progenitor or supporting cells are essential for axon reconnection 
(Murakami, Fujimoto et al. 2003; Leaver, Harvey et al. 2006). For instance, conduits seeded 
with Schwann cells show a comparable effectiveness to autografts in sciatic nerve repair 
although control conduits with no Schwann cells contained significantly lower densities of 
nerve fibers, highlighting the importance of cellular biological cues (Neville, Huang et al. 
2009).  
 
Experimentally, cell-based therapies using stem and progenitor cell types have led to 
promising results for the treatment of both PNS and CNS injuries (Lu, Jones et al. 2005; 
Cummings, Uchida et al. 2006; Deshpande, Kim et al. 2006), with the intention of replacing 
lost and damaged cells in order to improve endogenous nerve regeneration. While 
functional recovery at the transplantation site requires cell survival in sufficient numbers, 
programmed cell death of the transplanted cells invariably occurs due a dearth of 
appropriate cell-matrix interactions. This has been a major limiting factor in the effectiveness 
of cell replacement therapies, with some reports of less than 10% of cells surviving after 
transplantation (Belle, Caldwell et al. 2004). Scaffolds which provide physical support, 
controlled degradability, controlled inflammatory/foreign body response and guidance 
cues must therefore also provide a suitable milieu for the survival and viability of 
transplanted cells. Unfortunately, current scaffolds for neural tissue engineering do not yet 
meet all these criteria. However recent progress in nanostructured and biomimetic scaffolds 
for neural tissue engineering has provided encouraging results, particularly when interfaced 
with stem cell therapies.  
 
4. Nanostructured Scaffolds for Neural Tissue Engineering: Fabrication and 
Design 
The neural architecture of the brain and spinal cord is more complex compared to the PNS, 
typically organized into discrete three-dimensional (3D) populations, depending on their 
roles in transmitting and processing signals according to the spatial body plan.  At the 
micro- and nanoscale, cells of the CNS reside within functional microenvironments 
consisting of physical structures including pores, ridges, and fibers that make up the 
extracellular matrix (ECM) and plasma membrane cell surfaces of closely apposed 
neighboring cells (Desai 2000). Cell-cell and cell-matrix interactions contribute to the 
formation and function of this architecture, dictating signaling and maintenance roles in the 
adult tissue, based on a complex synergy between biophysical (e.g. contact-mediated 
signaling, synapse control), and biochemical factors (e.g. nutrient support and inflammatory 
protection). Neural tissue engineering scaffolds are aimed toward recapitulating some of the 
3D biological signaling that is known to be involved in the maintenance of the PNS and CNS 
and to facilitate proliferation, migration and potentially differentiation during tissue repair. 
Nanostructured and biofunctional scaffolds are currently being investigated for the 
provision of microenvironments that are similar to those occurring in vivo, in the 
Bio-nanotechnology	Approaches	to	Neural	Tissue	Engineering 463
 development of improved cellular function and successful regenerative outcomes (Stevens 
and George 2005). The scaffold fabrication techniques of electrospinning, self-assembly and 
phase separation are currently the mainstay of this approach, because they are capable of 
producing nanoscale (10 to 2000 nm) polymer fibers. This chapter will focus on two methods 
of fabricating nanostructured scaffolds; the “top-down” approach of electrospinning and the 
“bottom-up” of molecular self-assembly of peptides, both of which have recently received 
considerable attention in neural tissue engineering. 
 
4.1 Electrospinning 
Electrospinning was patented by Formhals in 1934 (Formhals 1934) and involves the 
production of a polymer filament using an electrostatic force. Electrospinning is a versatile 
technique that enables production of polymer fibers with diameters ranging from a few 
microns to tens of nanometers. A schematic for an experimental device for electrospinning is 
outlined in Fig. 1. 
 
 
Fig. 1. An electrospinning device with a plate-shape metallic collector. The metallic plate can 
be either stationary or rotating to achieve different orientations of electrospun nanofibers 
(Reprinted from Tissue Engineering with permission of Mary Ann Liebert) 
 
Although the electrospinning process is relatively simple in terms of its output, an 
understanding of the underlying mechanisms and several key processing conditions are 
essential for effective control of fiber properties. As the polymer solution is pumped to the 
spinneret tip, the high voltage induces charge accumulation to the solution. The droplet is 
then elongated into a conical shape, known as a Taylor cone (Taylor 1969) due to the 
electrostatic repulsive force. Electrospinning is initiated when the repulsive force of the 
solution exceeds the surface tension of the droplet. A finely charged jet is formed at the tip 
of the Taylor cone. The jet is then stretched and accelerated, accompanied by solvent 
evaporation, and eventually collected by the target. Adjustment of the applied DC voltage, 
feeding rate, polymer solution viscosity and working distance can be used to control the 
morphology of the collected fibers. Here, some key effects of these processing parameters 
 
are briefly introduced; for a more detailed review of the electrospinning process the authors 
direct you to the following reviews (see (Pham, Sharma et al. 2006) and (Boudriot and 
Wendorff 2006) ). In most cases, increasing the applied DC voltage and resultant electric 
field will cause greater stretching of the polymer solution, which consequently reduces the 
diameter of the fibers. However, too high a voltage at a given feed rate will lead to a smaller 
and less stable Taylor cone, which can cause larger diameter bead formation along the fibers 
(Zong, Kim et al. 2002; Kim, Kim et al. 2005). The feed rate will also determine the volume of 
the polymer solution available for electrospinning at the spinneret tip. At a given voltage, 
higher feed rates generally yield fibers with larger diameters, although these rates are 
accompanied by slow solvent evaporation during flight time, leading to residual solvent 
and fusion of fibers. Working distance has less of an influence on fiber morphology, but 
smaller working distances results in an increased electric field strength and reduced flight 
time, which may also cause bead formation and fiber fusion.  
 
Of physiological interest is the fabrication of scaffolds with variable fiber orientation and 
patterning, to create more sophisticated structures that can direct processes like cell 
migration and neurite outgrowth. A plate-shape metallic collector is often used to collect 
randomly orientated nanofibers, while aligned nanofibers can be collected by a rapidly 
rotating cylindrical target (mandrel) with controlled speed to give different degrees of fiber 
alignment. Alternatively, aligned nanofibers can be obtained between a parallel metallic 
collector gap, through the modified electrostatic field profile rather than mechanical 
rotation. The interfiber distance of the electrospun scaffolds can be controlled to some extent 
by means of adjusting the fiber diameter (Eichhorn and Sampson 2005), rotating speed of 
the collecting mandrel (Zhu, Cui et al. 2008), co-electrospinning a soluble or “sacrificial” 
fiber (Baker, Gee et al. 2008) or by combining with salt leaching (Nam, Huang et al. 2007). 
 
4.2 Electrospun nanofibrous scaffolds for nerve generation 
Fibers produced by thermal extrusion with diameters in the order of several hundred 
microns have been used in guidance tubes to provide structural support for cells (Wen and 
Tresco 2006). However cell orientation, directed process elongation and cell migration are 
very limited, especially for large diameter fibers of greater than 500 µm.  There is also no 
appreciable induction of guidance effects on adhered cultured cells (Wen and Tresco 2006). 
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their immediate environment, at the microscale (cells and matrix) and nanoscale 
(macromolecular structures). As the electrospinning technique is capable of providing 
nanofibers of 10-1000 nm in diameter with some degree of control over the structural 
parameters, such as fiber alignment and interfiber distance, it has become a major research 
focus in neural tissue engineering. The “porosity” of electrospun scaffolds can be up to 
70~90% (Yang, Xu et al. 2004; Gupta, Venugopal et al. 2009) which can facilitate ingrowth and 
migration of cells, as well as the transportation of nutrients (e.g. metabolites, oxygen) and 
signaling factors (e.g. growth factors, cytokines). The high surface-to-volume ratio of 
nanofibrous scaffolds, can provide many more binding sites to cell membrane receptors. This 
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 development of improved cellular function and successful regenerative outcomes (Stevens 
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 can lead to appropriate regulation of gene expression and amplify certain cellular processes. 
Although the mechanisms of how cells probe and respond to these nanofeatures is still not 
clear, different topographies of nanofibrous scaffolds have been demonstrated to induce 
diverse cellular behavior, including cell adhesion, migration (Yang, Xu et al. 2004), orientation 
(Schnell, Klinkhammer et al. 2007), infiltration and differentiation (Nisbet, Yu et al. 2008). 
 
Nanofibrous scaffolds & adhesion: 
Electrospun poly(L-lactic acid) (PLLA) nanofibrous scaffolds show significant improvement 
for neural stem cell adhesion in vitro compared with those cultured on solvent cast flat 
PLLA surfaces (Yang, Xu et al. 2004). PC12 cells cultured on either flat or nanostructured 
surfaces in close proximity, migrate from the flat region towards the nanostructured region 
of the surface (Cecchini, Bumma et al. 2007). A commonly held explanation for the enhanced 
adhesion is the increase in surface roughness and surface area, leading to an increase in non-
specific protein adsorption and availability of focal adhesion sites (Fan, Cui et al. 2002; 
Manwaring, Walsh et al. 2004; Yao, O'Brien et al. 2009). 
 
Nanofibrous scaffolds & stem/progenitor cell differentiation: 
Embryonic stem (ES) cells provide a useful model for therapeutic investigation in tissue 
engineering due to their ability to give rise to all the main types of adult somatic cells 
(pluripotency). For the purpose of PNS/CNS regeneration, neural progenitor cells derived 
from ES cells are typically derived from 4-/4+ retinoic acid induction protocol (Bain, 
Kitchens et al. 1995). The 4-/4+ induction method avoids the inappropriate differentiation of 
ES cells within the adult PNS and CNS. During the time that ES cells are cultured as 3D 
aggregates called embryonic bodies (EBs) they are exposed to retinoic acid, giving rise to the 
three major types of nerve cells: neurons, astrocytes and oligodendrocytes.  
 
Stem cells cultured in vitro on nanofibrous scaffolds can differentiate in response not only to 
the soluble differentiation factors, but to the structural features of their surrounding 
microenvironment. Nanofibrous environments often encourage the differentiation of stem 
cells and can bias their differentiation toward specific lineages providing enriched populations 
(Nisbet, Yu et al. 2008). Immunohistochemstry of EBs containing neural progenitor cells 
established by 4-/4+ induction showed preferential differentiation into neural lineages when 
cultured on electrospun PCL nanofibers with a mean fiber diameter of 250 nm (Fig. 2) (Xie, 
Willerth et al. 2009). About 60% of the cells within the EBs underwent differentiation when 
cultured on either aligned or random nanofibers (Xie, Willerth et al. 2009). Significantly lower 
numbers of glial fibrillary acidic protein (GFAP)-positive cells (astrocytes) were observed on 
aligned nanofibers compared with those on random nanofibers. Stem/progenitor cells 
normally show biased differentiation depending on substrate morphology. The majority of the 
human embryonic stem cells cultured on electrospun polyurethane scaffolds with a mean fiber 
diameter of 360±80 nm differentiate toward neuronal formation, while on 2D flat surfaces, a 
high proportion of GFAP positive cell types was evident (Carlberg, Axell et al. 2009). Fiber 
diameter also influences the differentiation of neural stem cells (NSCs) derived from mature 
CNS lineages (Christopherson, Song et al. 2009). Rat hippocampus-derived adult NSCs show 
enhanced differentiation on polyethersulfone nanofibrous substrates compared with that on 
tissue culture plastic (Fig. 3) (Christopherson, Song et al. 2009). However, an increase of 
oligodendrocytes was evident on smaller diameter fibers (283 nm), with the highest neuron 
 
cell number and lowest astrocyte numbers observed on the larger diameter (749 nm) fiber 
substrates. Cell therapy for spinal cord injuries in animal models using neural progenitors 
without a scaffold showed 10% of the transplanted cells becoming neurons, 60% 
oligodendrocytes, and about 30% astrocytes (McDonald, Becker et al. 2004). The intrinsic 
structural features of electrospun nanofibers, used as a “permanent” stimulus during nerve 
regeneration, may provide better cues to control cell differentiation compared with cell 
suspension injections.     
 
 
Fig. 2. Immunohistochemstry of ES cells, EBs (treated with by 4-/4+ induction) cultured on 
tissue culture plates without scaffolds and of EBs (treated with by 4-/4+ induction) cultured 
on aligned or random PCL nanofibrous scaffolds for 14 days. Cells were stained with SSEA-
1 for undifferentiated mouse ES cells, Nestin for neural precursor cells, Tuj1 for neuronal 
cells, O4 for oligodendrocytes, and GFAP for astrocytes. * p < 0.05 compared with ES cells. + 
p < 0.05 compared with EBs. # p < 0.05 compared with random PCL nanofibers. (Reprinted 
from Biomaterials with permission of Elsevier) (Xie, Willerth et al. 2009). 
 
 
Fig. 3. Immunohistochemstry of rat NSCs cultured on tissue culture polystyrene (TCPS), 
electrospun polyethersulfone nanofibrous scaffolds with diameters of 283 and 749 nm 
respectively in differentiation medium. Cells were stained with Nestin for neural progenitor 
cells, Tuj-1 for neurons, RIP for oligodendrocytes, GFAP for astrocytes. * p < 0.05 compared 
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 with cell staining on the other two culture substrates. (Reprinted from Biomaterials with 
permission of Elsevier) (Christopherson, Song et al. 2009) 
 
Electrospun nanofibrous scaffolds and contact guidance:  
In repairing intricate neural networks, different kinds of cell types need to be spatially 
distributed into discrete patterns, with axons precisely guided to their synaptic targets. The 
way spatial distribution mediates guidance of neurites depends on the following factors 
inherent to the nanostructured scaffold:  
 
1) physical cues e.g. scaffold fiber dimension, scaffold topography, external stress and 
stiffness.  
2) chemical cues e.g. surface-bound charged molecules and functional groups 
3) biological cues e.g. signaling and growth factors and ECM molecules 
 
The topography of the nanofibrous scaffold plays an important guidance role for neurite 
outgrowth. Primary rat dorsal root ganglia (DRG) cultured on aligned electrospun fibers of 
acrylonitrile-co-methylacrylate (PAN-MA) (diameter ranged between 400 and 600 nm) 
extend neurites parallel to the fiber direction (Fig. 4) (Kim, Valerie et al. 2008). Neurites 
extending out from EBs on electrospun poly-ε-caprolactone (PCL) also followed the aligned 
fiber direction  (Xie, Willerth et al. 2009), indicating that cells at different stages can respond 
similarly to these topographies.  
 
By comparing micro- with nanostructured scaffolds, submicron topography not only causes 
highly increased non-isotropic differentiation but also significantly influences the contact 
guidance cues for PC12 and substantia nigra cells (Manwaring, Walsh et al. 2004; Cecchini, 
Bumma et al. 2007). However, nanoscale features may only exert contact guidance cues 
within a certain window of nanodimensions (Manwaring, Walsh et al. 2004; Foley, 
Grunwald et al. 2005). Neurites on aligned fibers are significantly longer than that on 
randomly aligned fibers (Corey, Lin et al. 2007; Xie, Willerth et al. 2009; Yao, O'Brien et al. 
2009), and this increase in length is also associated with changes in the polarity of individual 
cells due to re-organization of cytoskeletal components. Similar changes in cell structure are 
responsible for the elongated morphology of the cell body and neurite outgrowth for PC12 
cells, human embryonic stem cells and neuroblastoma cells (Corey, Lin et al. 2007; Gerecht, 
Bettinger et al. 2007; Ferrari, Cecchini et al. 2009). Specifically, cytoskeletal filaments 
including vimentin, α-tubulin and calponin align in the same axis as the topographic 
nanoscale feature (Gerecht, Bettinger et al. 2007), with a reversal of filament alignment in 
response to treatment with actin polarization disrupters. However, the precise sequence of 
cytoskeletal events in association with the observed contact guidance remains unclear 
(Cecchini, Bumma et al. 2007). 
 
 
 
 
Fig. 4. Contact guidance role of aligned electrospun PAN-MA nanofibers of neurites 
extending from cultured DRG explants: (A) neurites extended parallel to aligned fibers, 
stained by NF160 for axons. (B) Schwann cell migration along aligned fibers, stained by S-
100. (C, D) Random outgrowth of DRG neurites on random fibers, stained by NF160 and S-
100 respectively. (E) Quantitative comparison of neurite outgrowth on aligned and random 
fibers, arrows indicate neurite extending direction, arrow length indicates the possibility of 
growth in that direction. (F) Quantitative comparison of neurite outgrowth length and 
Schwann cell migration on random and aligned fibers. *p < 0.05, error bar stands for 
standard error of mean (Reprinted from Biomaterials with permission of Elsevier) (Kim, 
Haftel et al. 2008).  
 
In addition to topographical cues on neurite guidance, chemical cues, in many cases, are just 
as critical for nerve regeneration. After PNS/CNS injury, the secreted growth factors are 
normally at sub-optimal levels, and aligned nanofibrous scaffolds can potentially encourage 
neuritogenesis in cooperation with growth factors, especially for fibers with diameters less 
than 400 nm (Foley, Grunwald et al. 2005). Collectively, the alignment of nanofibrous 
scaffolds could potentially provide a better approach to PNS and CNS repair when bridging 
long gaps across a lesion site.  
 
Building Biofunctionality into Electrospun Nanofibers: 
Synthetic polymeric materials are widely used due to their superior mechanical properties 
and ease of electrospinning. At present, many of these biodegradable polymers have limited 
interaction with cells, relying largely on non-specific adsorption of proteins and the 
subsequent interaction with cell membrane processes and receptors which may give mixed 
and unwanted signaling (Cecchini, Bumma et al. 2007). The challenge remains to produce 
nanofibers with more bioactive surfaces, significantly improving specific targeting of cell-
substrate interactions and consequently creating a more biomimetic microenvironment for 
implanted cells. There are several methods to improve bioactivity of nanofibrous scaffolds:  
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 1) Polymer blending 
Synthetic polymers can be blended with naturally derived biopolymers and ECM 
components such as hyaluronic acid (Ji, Ghosh et al. 2006) and collagen (Schnell, 
Klinkhammer et al. 2007; Jose, Thomas et al. 2009). Some of these polymers normally have 
specific biomolecular interactions at the cell surface to elicit specific responses and 
phenotypic changes, however the biomolecules themselves are limited in terms of 
practicality by their poor mechanical properties and formability. It is possible to fabricate 
electrospun scaffolds from blends of synthetic and natural polymers, which will then have 
improved cell-substrate interactions. Collagen for example, is the prevalent structural 
protein of the ECM, however it is relatively unstable due to the low fiber strength to 
withstand long-term support for cell adhesion and rapid enzymatic degradation (Okada, 
Hayashi et al. 1992). It should be noted that collagen denatures into gelatin when being 
electropun from fluoroalcohol solvents, therefore losing some of its ECM function (Zeugolis, 
Khew et al. 2008). However, using a mixture of phosphate-buffered saline and ethanol as 
solvent can avoid denaturing of collagen during the electrospinning process (Dong, Arnoult 
et al. 2009). Blending collagen with synthetic polymers has also assisted in overcoming these 
issues.  The orientation of neurites from chick embryonic DRG is enhanced on aligned 
blended polycaprolactone/collagen (72:25) nanofibers compared with that on aligned, pure 
PCL (Fig. 5) (Schnell, Klinkhammer et al. 2007). Meanwhile, strong fasciculation of axons 
occurred on PCL nanofibers, which may suggest stronger axon-axon interactions in 
preference to axon-substrate interactions. The migration and proliferation of Schwann cells 
is also significantly improved on aligned PCL/collagen nanofibers, indicating more specific 
biomolecular interactions between cells and the collagen polymers on the nanofiber surface 
(Geiger, Bershadsky et al. 2001). 
 
Fig. 5. Orientation of neurites extending from DRG explants on polylysine coated coverslips 
(pl), aligned PCL electrospun nanofibers (P), aligned collagen/PCL co-electrospun 
nanofibers (C/P), measured on 1, 4 and 7 days in vitro (DIV). The horizontal dotline (50% 
orientation index) indicates random alignment of neurites, 0% and 100% orientation index 
represent perpendicular and complete alignment respectively. *p<0.05, **p<0.01 compared 
with random alignment , ##p<0.01 between P and C/P at 1 day in vitro, error bars indicate 
standard error of the mean. (Reprinted from Biomaterials with permission of Elsevier) 
(Schnell, Klinkhammer et al. 2007). 
 
 
2) Surface biofunctionalization  
Although naturally derived polymers like collagen can be electrospun together with 
synthetic polymers to provide biomemitic nanofibrous scaffolds described previously, the 
concentration of the biological polymer in the blend is variable and limited in order to 
maintain desirable mechanical strength, diameter and orientated structure (Kwon and 
Matsuda 2005; Schnell, Klinkhammer et al. 2007). The bioactivity of the biological molecule 
in the blend largely depends on its degree of migration to the nanofiber surface where it is 
exposed to cells (Kwon and Matsuda 2005). Furthermore, low molecular weight molecules 
are difficult to be processed via electrospinning since a sufficient molecular weight is 
generally required to provide viscosities for stable fiber formation. However, specific 
peptide motifs derived from fibronectin and collagen VI have been identified to play an 
important role in nerve regeneration such as encouraging sprouting of hippocampal mouse 
neurons (Schense, Bloch et al. 2000), and these motifs are only short fragments of up to six 
amino acids. Therefore, immobilization of these molecules to the synthetic nanofiber surface 
provides an alternative method to render the fibers bioactive. Low molecular weight 
biological molecules can be covalently cross-linked to the surface, provided the surfaces are 
suitably functionalized for crosslinking, otherwise, pre-chemical treatment is required. The 
type and density of functional groups available for crosslinking will determine the degree of 
functionalization and subsequent bioactivity of the scaffold. Polyamine nanofibers with 
surface immobilized peptides derived from spliced fibronectin type III repeat D of human 
tenascin-C significantly enhance neuronal attachment, neurite generation and neurite 
extension in a range of cell types (Ahmed, Liu et al. 2006). Therefore, surface immobilization 
of these small molecules that are neuroactive can provide a great advantage for neural tissue 
engineering. In addition small molecules, growth factors such as brain-derived neurotrophic 
factor (Horne, Nisbet et al. 2009) and basic fibroblast growth factor (Patel, Kurpinski et al. 
2007) that are immobilized can also promote cell survival and neurite outgrowth. 
 
Although electrospun nanofibers have gained widespread use in neural tissue engineering 
and will undoubtedly continue to do so in the future, “bottom up” or self-assembly 
approaches to nanofabrication have recently been applied to produce nanofibrous scaffolds 
for nerve repair.  Although the number of studies in this area is currently not as numerous 
as that for electrospinning, this will perhaps change in the future as advances in the self-
assembly processes lead to improved features such as mechanical properties and controlled 
degradability.  The remainder of the chapter will focus on self-assembling oligopeptides and 
polypeptides, and provides a constructive counterpoint for the previous discussion on 
electrospun nanofibers. 
 
4.3 Lessons learned from nature: Self-assembling scaffolds 
Self-assembly is ubiquitous in nature and presents another approach for producing 
nanofibrous scaffolds for neural tissue engineering.  Molecular self-assembly is mediated by 
weak, non-covalent bonds, such as van der Waals forces, hydrogen bonds, ionic bonds, and 
hydrophobic interactions. Although these bonds are relatively weak, collectively they play a 
major role in the conformation of biological molecules found in nature. In particular self-
assembling peptides, under physiological conditions can give hydrogels with nanofibrous 
substructures. The self assembling peptides can be injected, potentially with replacement 
cells, at the lesion site in a minimally invasive procedure. 
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 1) Polymer blending 
Synthetic polymers can be blended with naturally derived biopolymers and ECM 
components such as hyaluronic acid (Ji, Ghosh et al. 2006) and collagen (Schnell, 
Klinkhammer et al. 2007; Jose, Thomas et al. 2009). Some of these polymers normally have 
specific biomolecular interactions at the cell surface to elicit specific responses and 
phenotypic changes, however the biomolecules themselves are limited in terms of 
practicality by their poor mechanical properties and formability. It is possible to fabricate 
electrospun scaffolds from blends of synthetic and natural polymers, which will then have 
improved cell-substrate interactions. Collagen for example, is the prevalent structural 
protein of the ECM, however it is relatively unstable due to the low fiber strength to 
withstand long-term support for cell adhesion and rapid enzymatic degradation (Okada, 
Hayashi et al. 1992). It should be noted that collagen denatures into gelatin when being 
electropun from fluoroalcohol solvents, therefore losing some of its ECM function (Zeugolis, 
Khew et al. 2008). However, using a mixture of phosphate-buffered saline and ethanol as 
solvent can avoid denaturing of collagen during the electrospinning process (Dong, Arnoult 
et al. 2009). Blending collagen with synthetic polymers has also assisted in overcoming these 
issues.  The orientation of neurites from chick embryonic DRG is enhanced on aligned 
blended polycaprolactone/collagen (72:25) nanofibers compared with that on aligned, pure 
PCL (Fig. 5) (Schnell, Klinkhammer et al. 2007). Meanwhile, strong fasciculation of axons 
occurred on PCL nanofibers, which may suggest stronger axon-axon interactions in 
preference to axon-substrate interactions. The migration and proliferation of Schwann cells 
is also significantly improved on aligned PCL/collagen nanofibers, indicating more specific 
biomolecular interactions between cells and the collagen polymers on the nanofiber surface 
(Geiger, Bershadsky et al. 2001). 
 
Fig. 5. Orientation of neurites extending from DRG explants on polylysine coated coverslips 
(pl), aligned PCL electrospun nanofibers (P), aligned collagen/PCL co-electrospun 
nanofibers (C/P), measured on 1, 4 and 7 days in vitro (DIV). The horizontal dotline (50% 
orientation index) indicates random alignment of neurites, 0% and 100% orientation index 
represent perpendicular and complete alignment respectively. *p<0.05, **p<0.01 compared 
with random alignment , ##p<0.01 between P and C/P at 1 day in vitro, error bars indicate 
standard error of the mean. (Reprinted from Biomaterials with permission of Elsevier) 
(Schnell, Klinkhammer et al. 2007). 
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engineering. In addition small molecules, growth factors such as brain-derived neurotrophic 
factor (Horne, Nisbet et al. 2009) and basic fibroblast growth factor (Patel, Kurpinski et al. 
2007) that are immobilized can also promote cell survival and neurite outgrowth. 
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and will undoubtedly continue to do so in the future, “bottom up” or self-assembly 
approaches to nanofabrication have recently been applied to produce nanofibrous scaffolds 
for nerve repair.  Although the number of studies in this area is currently not as numerous 
as that for electrospinning, this will perhaps change in the future as advances in the self-
assembly processes lead to improved features such as mechanical properties and controlled 
degradability.  The remainder of the chapter will focus on self-assembling oligopeptides and 
polypeptides, and provides a constructive counterpoint for the previous discussion on 
electrospun nanofibers. 
 
4.3 Lessons learned from nature: Self-assembling scaffolds 
Self-assembly is ubiquitous in nature and presents another approach for producing 
nanofibrous scaffolds for neural tissue engineering.  Molecular self-assembly is mediated by 
weak, non-covalent bonds, such as van der Waals forces, hydrogen bonds, ionic bonds, and 
hydrophobic interactions. Although these bonds are relatively weak, collectively they play a 
major role in the conformation of biological molecules found in nature. In particular self-
assembling peptides, under physiological conditions can give hydrogels with nanofibrous 
substructures. The self assembling peptides can be injected, potentially with replacement 
cells, at the lesion site in a minimally invasive procedure. 
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 Self-assembled amphiphilic polymers (oligopeptides & polypeptides) 
Amphiphilic peptide molecules, possessing a hydrophilic head group and a hydrophobic 
hydrocarbon tail group, can undergo micellization in aqueous environments. During this 
process, the hydrophobic interaction is the main driving force bringing closely together the 
head groups on the surface of the self-assembled aggregate. The self-assembled aggregate 
transition results from the balance between the attractive hydrophobic interactions and 
repulsive forces experienced by the head groups. Therefore, the self-assembly process can be 
triggered by the addition of cell culture medium in vitro or physiological fluids in vivo. Here 
the presence of ions in the culture medium or physiological fluids screen electrostatic 
repulsion among the molecules and promotes self-assembly (Silva, Czeisler et al. 2004; 
Tysseling-Mattiace, Sahni et al. 2008). Upon the addition of cell culture medium or 
physiological fluids, some oligopeptides form β-sheet secondary structures, followed by the 
spontaneous formation of nanofibrous structures with chain directions perpendicular to the 
fibril cross section (Zhang, Holmes et al. 1995; Holmes, de Lacalle et al. 2000; Semino, 
Kasahara et al. 2004; Gelain, Bottai et al. 2006). The self-assembly process yields a product 
with gel-like properties, while the micro-architecture of the self-assembled aggregate 
depends on the molecular structure and concentration of the amphiphiles, solvent dielectric 
constant, pH, balance of counter ions, and type and concentration of salt. (Holmes, de 
Lacalle et al. 2000). The wormlike self-assembled aggregates with branched or randomly 3D 
network structures, normally have fiber cross-sectional diameters of 2-20 nm, and the 
apparent length can be as high as several micrometers (Cates and Candau 1990; Holmes, de 
Lacalle et al. 2000; Silva, Czeisler et al. 2004). In this chapter, the importance of nanofibrous 
structures via self-assembly that provide a 3D architecture for both endogenous and 
implanted cells will be highlighted. 
 
The potential advantage of amphiphile molecular self-assembly is that the molecules can be 
injected into cavities within CNS/PNS lesion site which causes little tissue damage and 
minimal inflammation at the site of injection (Holmes, de Lacalle et al. 2000; Tysseling-
Mattiace, Sahni et al. 2008; Yang, Song et al. 2009), while larger injuries caused by 
implantation of other tissue engineering scaffolds like electrospun nanofibers may be 
difficult to avoid.  Amphiphilic oligopeptides can be prepared in isotonic glucose solutions 
(Yang, Song et al. 2009) and then injected into the lesion site, where the self-assembly 
process is triggered by ions in the aqueous physiological environment.  
 
The use of self-assembled nanofibers for nerve regeneration has provided some promising 
results, partially due to their high surface-to-volume ratio, fiber diameter and 3D 
architecture that resemble the natural ECM, but also in the spatial and high density 
presentation of small bioactive molecules to cell receptors. Self-assembled oligopeptide 
nanofibers present a promising microenvironment to cells with improved regenerative 
outcomes, including extensive neurite outgrowth, formation of functional synaptic 
connections for both cultured neuronal cell lines and primary neuronal cells, with no 
significant difference compared with cells cultured in vitro on Matrigel (Holmes, de Lacalle 
et al. 2000). Despite the simple chemistry of many of these oligopeptides (Holmes, de Lacalle 
et al. 2000; Guo, Su et al. 2007), compared with Matrigel which contains a range of ECM 
components and growth factors that are well known to promote neuronal cell adhesion and 
functional development, the structural roles of self-assembled nanofibrous scaffolds have 
 
shown a complimentary effect to chemical cues. Specific amino acid sequences such as 
arginine-glycine-aspartic acid (RGD) and isolucine-lysine-valine-alanine-valine (IKVAV) 
derived from fibronectin and laminin respectively, are involved in receptor interactions 
which play an important role in neurite outgrowth and guidance of neurite extension 
(Tashiro, Sephel et al. 1991; Schense, Bloch et al. 2000). These amino acid sequences can also 
be appended with synthetic peptides for self-assembly to create more biomimetic 
microenvironments.  
 
Potentially, low cost amphiphilic polymers can be used as a backbone appended with these 
various chemical and biological motifs, able to self-assemble into 3D nanofibrous scaffolds 
and trigger specific cellular responses (Fig. 6)  (Silva, Czeisler et al. 2004; Gelain, Bottai et al. 
2006) Moreover, nanofibrous scaffolds tailored with well defined, synthetic functional 
groups such as cell signalling motifs known to control specific gene expression or cell 
signalling processes provide research tools to investigate cellular response in a more in vivo 
like 3D environment where cells are more likely to receive more external stimuli rather than 
traditional 2D surfaces coated with these functional groups.  
 
 
Fig. 6. (a) Schematic molecular structures of Arginine–Alanine–Aspartate (RAD) 16 peptide 
and Bone Marrow Homing Peptide (BMHP) 1, 2 appended RAD16. (b) Schematic structures 
of four different appended functional motifs RAD16 (I-V) and the structure of self-
assembled peptide nanofibers. The enlarged insert shows the β-sheet with functional motifs 
extending out. (Reprinted from PLoS ONE with permission of Gelain et al.) (Gelain, Bottai et 
al. 2006). 
 
Self-assembled oligopeptide nanofibers not only present these molecules to cells but arrange 
them in a spatial order that significantly changes the cellular response (Silva, Czeisler et al. 
2004; Gelain, Bottai et al. 2006). For example, peptides coupled with IKVAV that self-
assembled into nanofibers suppressed the differentiation of neural progenitor cells into 
astrocytes in vitro, however, non-bioactive IKVAV nanofibers mixed with soluble bioactive 
ones did not provide a biased differentiation effect (Silva, Czeisler et al. 2004). Self-
assembled oligopeptides in vivo normally elicit a minimal inflammatory response (Guo, Su 
et al. 2007; Tysseling-Mattiace, Sahni et al. 2008). They can also suppress the hyperplastic 
response post CNS injury, but do not affect the early hypertrophic response, which may 
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 promote blood-brain barrier repair (Faulkner, Herrmann et al. 2004; Tysseling-Mattiace, 
Sahni et al. 2008). The reduced apoptosis of oligodendrocytes post injury within self-
assembled oligopeptides can potentially contribute to the remyelination of regenerating 
axons at the injury site (Karimi-Abdolrezaee, Eftekharpour et al. 2006). 
 
Diblock copolypeptides (about 200 amino acid residues) can also self assemble into 
nanofibrous hydrogels.  The copolypeptides contain a hydrophilic polyelectrolyte block and 
a hydrophobic α-helical domain (Nowak, Breedveld et al. 2002; Breedveld, Nowak et al. 
2004; Deming 2005) (Fig. 7). The polyelectrolyte block can be composed of a series of 
bioactive peptides like polylysine and polyglutamate with controlled degrees of 
polymerization which subsequently influences the gel point and strength of the resultant 
nanofibrous hydrogels in vitro and in vivo (Breedveld, Nowak et al. 2004; Yang, Song et al. 
2009).   The combination of hydrophobic α-helical block composed with a sufficient number 
of peptides residuals and the hydrophilic block helps the formation of a stiff gel and 
gelation at very low polypeptide concentrations (Nowak, Breedveld et al. 2002), potentially 
providing a wider range of hydrogel porosities. However, the properties of the hydrogel in 
vitro may not directly translate to hydrogels in vivo, due to the effect of different ions of 
body fluid on the self-assembly process (Beniash, Hartgerink et al. 2005). Unlike self-
assembled oligopeptides, polypeptides can be assembled in vitro with or without cell 
suspensions, then injected to the lesion site by a micro-syringe due to shear thinning, 
followed by rapid structural recovery. 
 
Fig. 7. Schematic structure of self-assembled polypeptides (a) Building block of self-
assembled polypeptides, composed of charged polyelectrolyte block and oligopeptides that 
forms an α-helical domain. (b) Schematic structure of fibril-like nanostructure formed via β-
sheet growth (no side chain shown). The enlarged insert shows the structure of β-sheet with 
polyelectrolyte side chains (Reprinted with permission from Breedveld et al. Copyright 2009 
American Chemical Society) (Breedveld, Nowak et al. 2004).  
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Self-assembled peptide nanofibers can potentially reduce the formation of a glial scar by 
means of either suppressing the astrogliosis post injury within the self-assembled scaffold 
due to the nanofiber dimension and surface chemistry (Tysseling-Mattiace, Sahni et al. 2008) 
or by preventing infiltration of glial cells into the hydogel which can last for up to 8 weeks 
(Yang, Song et al. 2009). Fig. 8 shows an example of injecting self-assembling lysine-leucine 
block co-polymer (K180L20) into the mouse forebrain, which triggered moderate astrogliosis 
comparable to saline injection controls. The astrocyte activity reduced remarkably after 8 
weeks within the host tissue with no evidence of glial cell ingrowth into the self-assembled 
scaffold. The minimal inflammatory response of the host tissue (Holmes, de Lacalle et al. 
2000; Yang, Song et al. 2009) to self-assembled peptides reveals the potential to reduce 
inflammation-induced secondary injuries as well as the level of inhibitory molecules to 
promote functional recovery for the PNS/CNS. 
 
 
Fig. 8. Astrogliosis examined 8 weeks after physiological saline (a, b) and 3% K180L20 self-
assembly polypeptide (c, d) injection into mouse forebrain. All tissue sections were 
immunochemically stained with GFAP for astrocytes. (b, d) are corresponding enlarged 
images of the box section in (a, c). Scale bar indicates 150 μm in (a, c) and 45 μm in (b, d) 
respectively. (Reprinted from Biomaterials with permission from Elsevier) (Yang, Song et al. 
2009) 
 
5. Long term view on neural tissue engineering 
Although both electrospun and self-assembled peptide fibrous scaffolds show promising 
results in nerve regeneration after PNS/CNS injuries, there is still an essential requirement 
to further investigate the cellular response in vivo with scaffolds. The importance of 
transplantation of stem/progenitor cells arises because of the complicated dynamic in vivo 
microenvironment. The presence of proteins with non-specific adsorption properties on the 
scaffold surface can possibly cause unexpected outcomes in vivo (Yang, Song et al. 2009). 
a b 
c d 
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 This may lead to differences in cellular responses such as adhesion and differentiation. 
Besides, various types of resident cells presented at the lesion site such as endogenous 
astrocytes, oligodendrocytes, and microglia together with their molecular products post 
injury may contribute to a more pernicious environment to neurons and implanted cells.  In 
the case of SCI, the state of the axons as well as the extent and chronicity of the lesions are 
an important determinant of locomotor ability, e.g. the time point at which transplanted 
oligodendrocytes remyelinate regenerating axons most effectively (Keirstead, Nistor et al. 
2005).  There is an urgent need to define at which stage of differentiation neural-committed 
progenitor cells should be transplanted, and therefore optimize the regenerative functions of 
transplanted cells. 
 
An understanding of the mechanisms of the inhibitory environment and barriers for 
regeneration post PNS/CNS injury is still limited. Although many inhibitory factors, like 
chondroitin sulphate proteoglycans and axon outgrowth inhibitors have been identified, a 
large number of molecules that are being produced by various cell types post injury, have 
not yet been characterized and their role in nerve regeneration remains to be defined (Fitch 
and Silver 2008). Moreover, the specific stimuli that trigger astrocyte and oligodendroctye 
activation remains unclear, which restricts the use of these as support cells. 
 
The current “design rules” of tissue engineering scaffolds used for nerve repair only mimic 
a small part of the structural features of natural ECM and incorporate a limited number of 
biochemical cues that are known to promote functional recovery of injured nerves. The 
inflammation and foreign body response due to the introduction of the scaffold and 
transplanted cells needs to be controlled to reduce further activation of cells like microglia, 
astrocytes and oligodendrocytes which contribute to the inhibitory environment. Studies 
using scaffolds with/without transplanted cells for nerve regeneration are largely based on 
animal models. However, in vivo studies in patients will be essential to evaluate the 
effectiveness of such neural tissue engineering approaches as therapeutic strategies. 
 
There are still numerous physical and biochemical features (and combinations thereof) 
which remain uncharacterized, and may be of great importance for cell survival and 
regulation of the cellular response. For instance in vitro studies have revealed some of the 
cellular responses to specific physical or biochemical cues presented by the scaffold. 
However a detailed understanding of the cellular response to the combination of these 
external cues within 3D architectures is limited at this stage.  
 
Many challenges lay ahead to achieve successful nerve regeneration using scaffolds. The 
current regenerative outcome obtained both in vitro and in vivo in animal models using 
nanostructured scaffolds, reveals the exciting possibility of manipulating cell behaviour that 
can promote cell survival, neurite outgrowth, appropriate reinnervation and consequently 
the functional recovery post PNS/CNS injuries. 
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 This may lead to differences in cellular responses such as adhesion and differentiation. 
Besides, various types of resident cells presented at the lesion site such as endogenous 
astrocytes, oligodendrocytes, and microglia together with their molecular products post 
injury may contribute to a more pernicious environment to neurons and implanted cells.  In 
the case of SCI, the state of the axons as well as the extent and chronicity of the lesions are 
an important determinant of locomotor ability, e.g. the time point at which transplanted 
oligodendrocytes remyelinate regenerating axons most effectively (Keirstead, Nistor et al. 
2005).  There is an urgent need to define at which stage of differentiation neural-committed 
progenitor cells should be transplanted, and therefore optimize the regenerative functions of 
transplanted cells. 
 
An understanding of the mechanisms of the inhibitory environment and barriers for 
regeneration post PNS/CNS injury is still limited. Although many inhibitory factors, like 
chondroitin sulphate proteoglycans and axon outgrowth inhibitors have been identified, a 
large number of molecules that are being produced by various cell types post injury, have 
not yet been characterized and their role in nerve regeneration remains to be defined (Fitch 
and Silver 2008). Moreover, the specific stimuli that trigger astrocyte and oligodendroctye 
activation remains unclear, which restricts the use of these as support cells. 
 
The current “design rules” of tissue engineering scaffolds used for nerve repair only mimic 
a small part of the structural features of natural ECM and incorporate a limited number of 
biochemical cues that are known to promote functional recovery of injured nerves. The 
inflammation and foreign body response due to the introduction of the scaffold and 
transplanted cells needs to be controlled to reduce further activation of cells like microglia, 
astrocytes and oligodendrocytes which contribute to the inhibitory environment. Studies 
using scaffolds with/without transplanted cells for nerve regeneration are largely based on 
animal models. However, in vivo studies in patients will be essential to evaluate the 
effectiveness of such neural tissue engineering approaches as therapeutic strategies. 
 
There are still numerous physical and biochemical features (and combinations thereof) 
which remain uncharacterized, and may be of great importance for cell survival and 
regulation of the cellular response. For instance in vitro studies have revealed some of the 
cellular responses to specific physical or biochemical cues presented by the scaffold. 
However a detailed understanding of the cellular response to the combination of these 
external cues within 3D architectures is limited at this stage.  
 
Many challenges lay ahead to achieve successful nerve regeneration using scaffolds. The 
current regenerative outcome obtained both in vitro and in vivo in animal models using 
nanostructured scaffolds, reveals the exciting possibility of manipulating cell behaviour that 
can promote cell survival, neurite outgrowth, appropriate reinnervation and consequently 
the functional recovery post PNS/CNS injuries. 
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1. Introduction 
The organism is a complex machinery, which is composed of different systems acting in 
synergy to maintain the homeostasis and the integrity of the human body. When one of 
these systems cannot provide its regulating function, the quality of life and the survival of 
the organism are imperiled. The purpose of the urinary tract is to ensure equilibrium and 
consistency of the blood components. Thus, it maintains the osmotic tension, the acido-basic 
and hydro-electrolytic balance. The urine is elaborated from the blood medium and then 
evacuated out of the body. It consists of metabolic, nitrogenous and exogenous wastes, 
which makes it a toxic biological liquid for cells and structural proteins. 
 
The human urinary system is composed of two sections; the upper urinary tract which 
includes the kidneys and the ureters; and the lower urinary tact that includes the bladder 
and the urethra. The bladder is a watertight and compliant reservoir in charge of urine 
storage before its evacuation via the urethra under sphincter control. In order to preserve 
the integrity of the upper urinary system, the maximum capacity of the bladder is 
approximately 500 mL. This eliminates possible reflux which could damage the renal 
function.  There are two main differences between the female and male urinary tracts; the 
presence of the prostate and the length of the urethra. As showed in figure 1, the length of 
the female urethra is around 3 to 4 centimeters compared to 20 centimeters for the male. 
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Fig. 1. Schematic representation of the urinary tract in woman and man. A) Kidneys. B) 
Ureters. C) Bladder. D) Urethra. E) Prostate. 
 
As shown in figure 2, for the bladder and the urethra, the bladder mucosa is underlined 
with a unique and highly specialized epithelium, known as urothelium, which rests on a 
basal lamina. Underneath, the lamina propria is made of fibroblasts, microcapillaries and 
fibers of collagen mostly of type I and III. The detrusor muscle is formed by smooth muscle 
cells with interfascicular connective tissue containing fibers of collagen I and III. Finally, the 
presence of a serosa completes the bladder wall. The presence of collagen type I, III and 
elastin largely determine the mechanical properties of the bladder wall (McCarthy et al 
2003). For the urethra, the mucosa is similar to the bladder but a smooth muscle cells layer 
replaces the detrusor and the serosa is not present. 
 
 
Fig. 2.  Histological representation of the bladder structure of the mucosa.  
 
All bladder layers have an important role, however we will focus our attention to the 
urothelium since it is the tissue which is directly in contact with the urine. In order to limit 
the passage of water and ions between urine and the bloodstream, the luminal superficial 
cell layer is composed of so called umbrella cells, which are derived from the basal 
urothelial cells precursors (Bolland & Southgate 2008). Umbrella cells are characterized by 
the presence of a specialized asymmetric apical membrane (AUM), which is an arrangement 
of uroplakin proteins by specific interactions, to form a protective barrier on the apical 
surface (Veranic et al. 2004). It is important to note that uroplakin organization is therefore a 
specific differentiation marker of the urothelium (Sun 2006). 
 
 
Fig. 3.  Schematic representation of the pseudo-stratified urothelium. A) Basal cell. B) 
Intermediate cell. C) Superficial cell also known as umbrella cell. 
 
Several conditions like congenital malformations, cancer, traumatisms and stricture can 
cause problems that will require surgical treatments to replace the injured section. To rectify 
those low urinary tract problems, partial or total reconstruction might be needed. In 
urology, the need for autologous tissues with properties similar to the native tissues is an 
important limitation. However, in organ regeneration, tissue engineering recently made 
great advances. It regroups biological, clinical and engineer disciplines that elaborate 
physiologically functional tissues similar to the native one found in vivo. Contrarily to the 
beginning of tissue engineering, cellular and molecular organizations are strongly 
considered nowadays. It is the reason why this discipline needs different matrices and host 
cells to reproduce a substitute conform to the original organ. Different types of substitutes, 
going from non-urologic tissues to different types of biomaterials, have been developed and 
used to guide in vivo regeneration on the injured site. The host cells migration from the 
extremity toward the center of the graft, consistently lead to post-surgical reorganization of 
the implanted substitute. This is why all current research studies head toward the fact that 
seeding cells in vitro on a matrix support will lead to better post-surgical results. This 
chapter will describe the tissue engineering position in urologic reconstruction and explore 
its evolution with the different types of strategies used. 
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those low urinary tract problems, partial or total reconstruction might be needed. In 
urology, the need for autologous tissues with properties similar to the native tissues is an 
important limitation. However, in organ regeneration, tissue engineering recently made 
great advances. It regroups biological, clinical and engineer disciplines that elaborate 
physiologically functional tissues similar to the native one found in vivo. Contrarily to the 
beginning of tissue engineering, cellular and molecular organizations are strongly 
considered nowadays. It is the reason why this discipline needs different matrices and host 
cells to reproduce a substitute conform to the original organ. Different types of substitutes, 
going from non-urologic tissues to different types of biomaterials, have been developed and 
used to guide in vivo regeneration on the injured site. The host cells migration from the 
extremity toward the center of the graft, consistently lead to post-surgical reorganization of 
the implanted substitute. This is why all current research studies head toward the fact that 
seeding cells in vitro on a matrix support will lead to better post-surgical results. This 
chapter will describe the tissue engineering position in urologic reconstruction and explore 
its evolution with the different types of strategies used. 
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2. Native Non-Urologic Tissues: the Beginning of Tissue Engineering 
2.1 Bladder  
In view of the necessity to maintain the compliance of pathological bladders, several types 
of tissues have been used unsuccessfully. The skin, the omentum, the stomach, the 
pericardium, representing native substitutes (Draper & Stark 1956, Goldstein et al. 1967, 
Andretto et al. 1981, Nguyen & Mitchell 1991), but also silicone, polyvinyl and Teflon, for 
the alloplastic materials (Kudish 1957, Bogash et al. 1960, Kelami et al. 1970), but they 
quickly encountered significant complications. The absence of biocompatibility, 
vascularization and the immunogenicity of some of these substitutes, as well as the direct 
contact with the toxic urine, lead mainly to the formation of fibrosis and contraction of the 
graft (Burbige & Hensle 1986, Vemulakonda et al. 2008). In parallel, the substitution of the 
bladder by the means of various intestinal segments has been practiced more successfully 
since the beginning of the eighties (Tariel et al. 2006). While taking into account the limits 
previously observed, this technique called enterocystoplasty is the clinical treatment 
currently used. 
 
Unlike the first substitutes described, the intestinal segment allows improvement in 
compliance. Moreover, it has the advantage of being richly vascularized, preventing 
necrosis, inflammation, and thus, the contraction of the graft. However, like the first native 
substitutes, the mucous membrane of the intestinal segment has absorption properties and 
electrolytic secretion which are specific to it. Thus, the incorporation of these various native 
tissues involves metabolic imbalances specific to each one, as well as the formation of mucus 
and urolithiases, which are significant morbidity factors (Mundy & Nurse 1992, McDougal 
1992). Its addition to the biochemical profiles of mucous membranes used, the bad contact 
with the toxic urine leads to risks of neoplasic transformation of the native substitutes 
(Woodhams et al. 2001, Ali-El-Dein et al. 2002), as well as structural deterioration of 
alloplastic substitutes (Cross et al. 2003). The incorporation of intestinal segments previously 
de-epithelialized was attempted to avoid mucus production and potential reabsorption 
within an animal model but it lead to fibrosis, and then, the contraction of the graft because 
of the urine being in direct contact with the underlying submucosa and extracellular matrix 
(Hafez et al. 2005). 
 
2.2 Urethra 
Several non-urologic tissues have also been tried for urethral reconstruction: ureter in 1909 
(Schmieden 1909), saphenous vein in 1910 (Tuffier 1910) and appendix in 1911 (Lexer 1911). 
The skin was first used in 1914 (Nové-Josserand 1914) as a split thickness graft rolled into a 
tube. The results were not as expected because of the contracture of the graft, so it was 
abandoned until 1941 (Humby 1941) when a full thickness skin graft from the genital region 
was reported. In 1948 (Mc Indoe 1948), a split thickness graft technique was used. The 
patient had to wear a dilator for 6 months before the intervention as a tissue expander to 
obtain the harvest skin. The same year, the skin sample was used for urethral reconstruction 
(Vyas et al 1987, Young & Benjamin 1948).  
 
The use of skin graft for urethroplasty is of two types, split or full thickness. For the full 
thickness skin graft, various donor sites like penile foreskin, supraclavicular skin, inner 
aspect of the upper arm, abdominal wall, buttock and thigh have been used for their 
different characteristics (Devine & Horton 1977, Hanna 1983, Hendren & Crooks 1980, 
Shapiro 1984). At the moment, the most commonly used remains the penile skin and 
foreskin as a flap, because they are more pliable and less thicker than the other types of 
sampling (Vyas et al 1987). Also the absence of hair in those two sites reduces the 
probabilities of complications. In general, good results have been obtained with the use of 
skin for urethroplasty. However, post-surgical complications still occurs. At the harvesting 
site, both type of skin graft can leads to poor cosmetic wound healing. Moreover, both types 
of skin grafts can lead to poor cosmetic wounds at the harvesting site.  At the reconstruction 
site, complications like recurrent strictures or fistulas are found. Also, Balanitis Xerotica 
Obliterans, a genital skin inflammatory disease, can occur. Finally, hair growth from hair 
bearing harvest site, with or without concretion and graft contracture has been observed. 
The use of split thickness skin graft has shown a reduced tendency to contract, but it comes 
with a lack of adequate resiliency and strength (Markiewicz et al 2007). Actually, penile and 
foreskin skin flaps are considered the gold standard for urethroplasty, but when they are 
not available, due to use of that skin in a prior intervention, circumcision, presence of scar 
tissues or because of a long urethral defect, other tissues are needed for urethral 
reconstruction (Theodorescu et al 1998).   
 
The first report using oral mucosa for urethroplasty was in 1941 (Humby 1941). It was not 
used again until 1992 (Burger et al 1992) where it was reintroduced as another free graft 
material for urethral reconstruction like penile skin. Two sites for oral mucosa are most 
commonly used for harvesting: the buccal and labial mucosa of the lower lip. If there is a 
lack of available genital skin, oral mucosa is a good replacement graft material because it is 
easily harvested, non-air bearing and in abundant supply even for adult cases. It has 
furthermore interesting properties like elasticity, abundant submucosal vascularity, thick 
mucosal layer and it is tolerant to air and liquid exposures (Caldamone et al 1998). Also, this 
avoids cosmetic disadvantages and consequences caused by the use of genital skin 
harvested from the penis (Barbagli & Lazzeri 2006). The morbidity associated with oral 
mucosa is pain, discomfort, limited range jaw opening, neurosensory defect and salivary 
flow modification. Those complications are temporary, going from 1 to several months 
depending on the harvesting site. The post-surgical complications found after urethral 
reconstruction are still fistula formation, stricture and meatal stenosis (Barbagli & Lazzeri 
2006, Markiewicz et al 2008, Markiewicz et al 2007). A study compared oral mucosa with 
penile skin for urethroplasty and obtained a similar overall success rate with no significant 
difference and in conclusion, they were declared both excellent materials for urethral 
reconstruction (Alsikafi NF 2005).  
 
Bladder mucosa for instance was first introduced in 1947 for urethroplasty, but significant 
complication rates delayed its clinical use until 1981 (Coleman et al 1981), where it was 
associated with good results in the case of a deficit of penile skin. It gained an immediate 
popularity with the clinicians because of its structural similarity with the urethra. However, 
due to the lower abdominal incision required to access the harvest site, the procedure is 
technically complex, it often results in poor esthetics and delay in wound healing occurs at 
the donor site. The principal complications found at the reconstructed site are mucosal 
prolapse and meatal stenosis (Markiewicz et al 2007, Vyas et al 1987). To overcome the 
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complications found with the use of bladder mucosa, a combination of preputial or penile 
skin with bladder mucosa have been used (Duffy et al 1988). A reduction of the meatal 
stenosis was observed, but no other follow-up studies on this combination were found 
afterward.        
 
For female urethral reconstruction, vaginal mucosa have been used (Brannan 1951). Urethral 
stricture or fistula in female are not as frequent and it is related to continence problems 
(McKinney 1979). The principal advantages of vaginal mucosa are the same as oral mucosa. 
It is easily available, hairless, elastic, naturally wet and it avoids any cosmetic wound 
problems. Good results have been obtained and limited complications have been reported 
post-surgically (Tsivian & Sidi 2006).  
 
Other non urologic tissues have been studied for urethroplasty for specific situations when 
the gold standard is not available. In 1967, tunica vaginalis found around the testicule was 
first reported in an experimental study for urethral reconstruction (Ariyoshi 1967). It was 
recommended because it is a readily available source, simple to harvest and use. Other 
advantages such as a lack of hair follicles, a good tensile and physical property resulting in 
better sutures holding and a very good vascularization were reported. Over the years, it has 
been used in experimental studies for surgical techniques in urethroplasty (Calado et al 
2005, Khoury et al 1989, Talja et al 1987) and in general, good results were observed. In 1998, 
a study compared an onlay flap with a tube flap performed on a New Zealand rabbit model 
with a control group. The New Zealand rabbit is the standard animal model used for 
urethral reconstruction. Their conclusion was that an onlay flap was more suitable for long 
term reconstruction, because it was further vascularized than the tube flap (Theodorescu et 
al 1998). In 2009, another study combined tunica vaginalis with preputial island flap, on a 
rabbit model for 12 weeks to overcome the complications found with the use of tunica 
vaginalis alone (Leslie et al 2009). Even with that combination, fistula and urethral 
diverticulum occurred. Clinically, the use of tunica vaginalis was evaluated in two studies 
with different conclusions. One found the use of tunica vaginalis useful mainly in difficult 
cases as long as there is no external exposure (Snow & Cartwright 1992) and the other found 
no advantage to its use as an onlay flap in proximal urethral repair due to its high stricture 
rate (Joseph & Perez 1999). The use of tunica vaginalis is now for coverage purposes, to 
protect the reconstructed area. Another tissue was used for an experimental study, the use 
of autologous vein graft on the rabbit model without strong conclusions (Kahveci et al 1995). 
More recently, colonic mucosa has been suggested for the urethral replacement in case of 
long and complex stricture. A dog model has been studied and it was also used for human 
urethral reconstruction with relatively good results. The principal complications at the 
harvest site were not described but at the reconstruction site: meatal stenosis, bulbar or 
bulbomembranous urethral stenosis and proximal anastomotic site stricture were observed 
with low complication rate (Xu et al 2004, Xu et al 2009, Xu et al 2003). 
 
3. Acellular Tissue Matrices 
The acellular matrix are obtained from native tissues, decellularized and sterilized. Thus, 
they are naturally cytocompatible and biodegradable, which represents a major asset as a 
substitution support. Various methods are used to carry out their preparation (Rosario et al. 
2008), but the general outline presents a mechanical delamination of the tissue followed by 
an enzymatic treatment, an hypotonic solution to destroy cell residues and finally, the 
sterilization with ethylene oxide or peracetic acid. This kind of substitute has the advantage 
of presenting mechanical and biochemical properties, comparable to the native tissue. 
Indeed, the processing procedure allows preserving the three-dimensional environment, 
favorable to the cell infiltration, migration and proliferation within the substitute 
(Sutherland et al. 1996). The infiltrating cells then could have the suitable organization and 
differentiation to produce their own matrix during the resorption of the support, but this 
one is not in conformity with the physiological architecture. Indeed, these models cannot be 
identical since the mechanical and chemical treatment for the acellularization and 
sterilization, inevitably deteriorate the composition and organization of the matrix proteins 
(Brown et al. 2002). Let’s remember that proteins are prone to unfolding which can be 
caused by temperature increase, other denaturing biophysical elements, like the pH, and 
biochemical agents, like urea. Thus, elasticity and mechanical resistance are decreased, 
which might not allow size variations during the bladder cycles of filling and emptying. 
Nevertheless, the aptitude to support the neovascularization is preserved (Lantz et al. 1993, 
Kajbafzadeh et al. 2007), at least the presence of endothelial cells precursors was observed 
post-graft, which is kinetically supported by the frequent use of a 100 µm thickness graft, 
instead of the full thickness. 
 
3.1 Bladder  
The small intestinal submucosa (SIS) was the first marketed model. After acellularization, a 
matrix mainly made up of collagen (I, II, VI), glycoaminoglycans, proteoglycans and 
glycoproteins like fibronectin was obtained. The combination of these various structural 
proteins allowed the storage of multiple growth factors, thus making them available to the 
surrounding cells. The heparan sulfate proteoglycans (HSPG), fibroblast growth factor 2 
(FGF2), transforming growth factor beta (TGF-), and the vascular endothelial growth factor 
(VEGF), essential to promote the graft neovascularization, were detected by 
immunofluorescence (Hurst & Bonner 2001), but in vivo regeneration showed only limited 
results in the rat and the dog models (Zhang et al. 2006). Indeed, the bladder capacity was 
improved partially even after 9 months post-operatively, however rapid deaths of one 
fourth (1/4) of the dogs due to perforation within the SIS had to be accounted for. To 
explain such results, an hypothesis was put forward by the same team at the sight of in vitro 
results, after urothelial and smooth muscle cells seeding (Zhang et al. 2000). Cells showed a 
good SIS adherence, but their organization and differentiation were not observed; which is 
however essential to preserve the graft size and to restore the functionality of the 
pathological bladder. A certain cytotoxicity was noticed concerning the SIS matrix, in 
addition to its immunogenic nature. Indeed, a series of postoperative inflammatory 
reactions (Ho et al. 2004) preceded the in vitro detection of porcine DNA residues on the 
commercially available SIS, by specific chromatin staining (Feil et al. 2006). These last 
reports made on this model, confirmed it as an unfavorable substitute for vesical 
reconstruction. 
 
Recently, it was reported that the specific use of the organ to be regenerated is the most 
appropriate for the cellular organization and functionality (Sievert & Tanagho 2000). Thus, 
the bladder acellular matrix graft (BAMG) constitutes a logical substitute for the cell 
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development. It was studied on various animal models, after being characterized in vitro. 
Under physiological conditions, the bladder matrix is made up of structure proteins, 
proteoglycans and glycoaminoglycans, able to trap and store the growth factors. 
Particularly, the matrix network constitutes a biochemical and spatial database, specific to 
the organ-source, thus informing the cells about the type of organization to be adopted. The 
bladder matrix therefore seems to be a substitute of choice, but after acellularization and 
sterilization treatments, the BAMG obtained displayed a diminished composition of elastin, 
laminin and fibronectin (Farhat et al. 2008). Collagen I and IV are preserved while the 
collagen III, one of the most abundant isoforms under the physiological conditions, seems to 
be degraded. The molecular architecture deterioration of the BAMG could potentially 
decrease its regenerating capacities. However, the dynamic culture of smooth muscle cells, 
within the BAMG, displayed encouraging results on the collagen I, III and IV synthesis 
(Farhat & Yeger 2008). 
 
Beforehand, stretching forces were applied, which generated a growing interest to 
determine the impact of mechanical stress on the cell-cell and cell-matrix interactions 
(Baskin et al. 1993, Adam et al. 2004). However, this type of stress does not correspond to 
the physiological forces applied to the bladder. Dr. Farhat’s team developed a bioreactor 
able to apply hydrostatic pressure waves, thus imitating the bladder filling and emptying 
(Wallis et al. 2008). Briefly, the seeded porcine BAMG, which is seeded with urothelial and 
smooth muscle cells, is placed between two chambers. One of which will be used to apply a 
pressure, gradually increasing on the presenting cell surface. At the end of four hours, the 
pressure reaches 10 cm H2O, intravesical pressure at the fœtal stage, to fall abruptly in a few 
seconds to zero, to act like a voiding. The mRNA expression of matrix proteins increased 
significantly under mechanical stimulation and the mRNA expression of differentiation 
markers presented encouraging results. Indeed, mRNA coding for uroplakin II seemed to 
increase, which is promising for obtaining a watertight model and avoiding deterioration by 
the urine. This mode of dynamic preconditioning constitutes a promising alternative to 
counterbalance the deterioration attributable to the acellularized tissue preparation. 
Unfortunately in this study, only the gene expression was studied, which does not 
constitute sufficient information, since the protein functionality depends on its complete 
synthesis, its good folding and its appropriate localization, among other things. This 
bioreactor design is ideal to elaborate a bladder substitute under similar physiological 
conditions, but it still needs optimization. For example, the chamber design does not allow 
uniform distribution of the pressure waves on the tissue in place, but the evolution of this 
work is followed with attention. Meanwhile, studies in static mode continue and present 
relatively favorable results after implantation in a porcine model (Merguerian et al. 2000); in 
spite of the recurring complications observed, such as calcification formation and graft 
retraction. Urothelial and smooth muscle cells infiltration was noted but their localization 
remained limited to the graft periphery, and their organization was incomplete. The already 
raised hypothesis is that acellularization treatment affects the bladder matrix architecture. 
The BAMG is then obtained with a too high porosity to retain the growth factors and to 
promote the cell propagation (Farhat et al. 2003). In static culture conditions, porosity 
reduction was observed by hyaluronic acid incorporation during rehydratation phase of 
lyophilized BAMG (Cartwright et al. 2006). Hyaluronic acid is an essential 
glycoaminoglycan, known to support cell proliferation and migration in the extracellular 
matrix. The study’s authors also claimed to make a barrier against urine with this method, 
but let us remember that urine pH and ionic forces have denaturing properties for 
nonspecific urothelium proteins. 
 
BAMG and SIS are also limited by their xenogenic source. The rejection of this type of 
substitute is a serious possibility in sight of epitope presence, specific to the organ-source. 
The Gal oligosaccharide was found in the porcine SIS extracellular matrix, and that, even 
after the various preparation treatments (Badylak & Gilbert 2008). This antigen is present on 
the cell surface of many species, except human and a category of monkeys, which poses 
problems of immunological recognition post-graft. In the same way, it is not possible to 
eliminate any risk of viral contamination. To get around these undesirable characteristics, in 
addition to the differences inherent to the acellularized matrices preparation and their 
source (Kropp et al. 2004), the idea of constructing neobladders in a reproducible way was 
made possible by the use of synthetic polymers. 
 
3.2 Urethra 
The use of acellular matrix relies on the fact that it could have an effect with its environment 
because the extracellular matrix could influence the biological behavior of the cells (Farhat 
et al 2008) and lead to a better integration of the graft. In the literature, many acellular tissue 
matrices are called collagen matrix, for example, the bladder acellular matrix graft (BAMG). 
The principal advantages of using a BAMG matrix, as the other types of acellular matrices 
for urethral reconstruction is that it is an “off the shelf “ material that eliminates all other 
surgery required for harvesting. It may also shorten the operative time, since it is easily 
prepared in large quantity in laboratory and can be stored until its use (Chen et al 1999, De 
Filippo et al 2002). Many studies have been done on the use of this type of material alone or 
with cells. A study was first done using xenogenic BAMG from a porcine source on the 
rabbit model for 6 months with an onlay fashion graft. Their goal was to evaluate if the use 
of BAMG would be suitable for a urethral reconstruction on an animal model (Chen et al 
1999). Their results have demonstrated that it was appropriate since there was no evidence 
of infection, graft rejection, fistula or stone formation. In 2003, a study was done with an 
allogenic BAMG coming from cadaveric human bladder tissue on 28 adult patients (El-
Kassaby et al 2003). A follow-up of 36 to 48 months was made and good results were 
observed, only 4 strictures occurred. Finally, another study was done with xenogenic BAMG 
in a tubular form from a porcine source, on a rabbit model for 1 month but reported 
opposite results (Dorin et al 2008). Their goal was to determine if there was a maximum 
limit for urethral defect in which an acellular matrix would be sufficient for replacement. 
The results showed that an unseeded tubularized BAMG may be successful when used for 
repair of a relatively small urethral defect of less than 0,5 centimeter. It is also well 
documented that re-anastomosis in those small urethral defects is very successful, so it 
would seem to limit the potential value of acellular tubularized matrix graft. The study 
suggested that for a urethral defect over 1 centimeter, the need to seed cells on acellular 
matrix may be necessary to allow the growth of healthy urethral tissue and avoid stricture 
formation and other complications. It also showed the discrepancy observed in the last 
decade from the literature regarding the success of acellular matrices for tissue regeneration 
on small animals and the failure on large animals and humans (Dorin et al 2008).  
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development. It was studied on various animal models, after being characterized in vitro. 
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spite of the recurring complications observed, such as calcification formation and graft 
retraction. Urothelial and smooth muscle cells infiltration was noted but their localization 
remained limited to the graft periphery, and their organization was incomplete. The already 
raised hypothesis is that acellularization treatment affects the bladder matrix architecture. 
The BAMG is then obtained with a too high porosity to retain the growth factors and to 
promote the cell propagation (Farhat et al. 2003). In static culture conditions, porosity 
reduction was observed by hyaluronic acid incorporation during rehydratation phase of 
lyophilized BAMG (Cartwright et al. 2006). Hyaluronic acid is an essential 
glycoaminoglycan, known to support cell proliferation and migration in the extracellular 
matrix. The study’s authors also claimed to make a barrier against urine with this method, 
but let us remember that urine pH and ionic forces have denaturing properties for 
nonspecific urothelium proteins. 
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substitute is a serious possibility in sight of epitope presence, specific to the organ-source. 
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problems of immunological recognition post-graft. In the same way, it is not possible to 
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addition to the differences inherent to the acellularized matrices preparation and their 
source (Kropp et al. 2004), the idea of constructing neobladders in a reproducible way was 
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The principal advantages of using a BAMG matrix, as the other types of acellular matrices 
for urethral reconstruction is that it is an “off the shelf “ material that eliminates all other 
surgery required for harvesting. It may also shorten the operative time, since it is easily 
prepared in large quantity in laboratory and can be stored until its use (Chen et al 1999, De 
Filippo et al 2002). Many studies have been done on the use of this type of material alone or 
with cells. A study was first done using xenogenic BAMG from a porcine source on the 
rabbit model for 6 months with an onlay fashion graft. Their goal was to evaluate if the use 
of BAMG would be suitable for a urethral reconstruction on an animal model (Chen et al 
1999). Their results have demonstrated that it was appropriate since there was no evidence 
of infection, graft rejection, fistula or stone formation. In 2003, a study was done with an 
allogenic BAMG coming from cadaveric human bladder tissue on 28 adult patients (El-
Kassaby et al 2003). A follow-up of 36 to 48 months was made and good results were 
observed, only 4 strictures occurred. Finally, another study was done with xenogenic BAMG 
in a tubular form from a porcine source, on a rabbit model for 1 month but reported 
opposite results (Dorin et al 2008). Their goal was to determine if there was a maximum 
limit for urethral defect in which an acellular matrix would be sufficient for replacement. 
The results showed that an unseeded tubularized BAMG may be successful when used for 
repair of a relatively small urethral defect of less than 0,5 centimeter. It is also well 
documented that re-anastomosis in those small urethral defects is very successful, so it 
would seem to limit the potential value of acellular tubularized matrix graft. The study 
suggested that for a urethral defect over 1 centimeter, the need to seed cells on acellular 
matrix may be necessary to allow the growth of healthy urethral tissue and avoid stricture 
formation and other complications. It also showed the discrepancy observed in the last 
decade from the literature regarding the success of acellular matrices for tissue regeneration 
on small animals and the failure on large animals and humans (Dorin et al 2008).  
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Due to these problems, studies began to report the importance of seeding cells on BAMG for 
urethral reconstruction. Those studies were done using xenogenic and allogenic BAMG 
seeded with cells and they were compared to unseeded BAMG as control. A first study 
using a porcine xenogenic BAMG in a tubular form was seeded with urothelial and smooth 
muscle cells extracted from New Zealand rabbit’s bladders and implanted on a rabbit model 
for 6 months. The results showed that BAMG seeded with cells from normal bladder tissue 
can be used for a tubularized replacement, whereas BAMG without cells lead to poor tissue 
formation and stricture (De Filippo et al 2002). Another study, with an allogenic model 
consisting of BAMG seeded with foreskin epithelial cells from New Zealand rabbit’s was 
performed on the same kind of animal for 6 months. The results were similar to the previous 
study, the BAMG seeded with epidermal cells obtained better outcomes than BAMG alone. 
Also, the research team claimed that the use of epidermal cells seemed adequate to replace 
urothelial cells (Fu et al 2007). The problem was that after 6 months, the epidermal cells kept 
their structural form rather than acquiring the transitional structure known to the urothelial 
cells. An additional study was done with rabbit allogenic BAMG. This time, the team seeded 
rabbit’s oral keratinocytes and the study was done on rabbit model for a duration of 6 
months. Their results showed that oral keratinocytes have a good biocompatibility with 
BAMG. It confirmed the prior results that seeded BAMG are superior to unseeded BAMG 
(Li et al 2008a, Li et al 2008b) and the oral keratinocytes kept their structure of stratified 
squamous epithelium rather than the transitional form of the urothelial cells, even after 6 
months. In conclusion, cell seeded matrices seem to allow tissue regeneration across the 
defect and the maintenance of a non-obstructive outflow from the bladder; it confirms the 
need to incorporate cells.  
 
For urethral reconstruction, other tissues were studied as acellular matrix graft. Small 
intestinal submucosa (SIS) was first suggested because it was shown to promote tissue 
specific regeneration in a variety of organs. SIS is composed of a collagen meshwork with 
various intrinsic growth factors, cytokines, structural proteins, glycoproteins and 
proteoglycans that may assist in cell migration as well as cell growth and differentiation 
during the regenerative process (Colvert et al 2002). The advantages of using this type of 
tissue are similar to BAMG matrices. A pilot study was done using xenogenic SIS, from a 
porcine source on a rabbit model for 3 months. Their goal was to evaluate the suitability of 
the SIS onlay patch in urethroplasty (Kropp et al 1998) and its feasibility, but it was a short-
term study and not further mentioned. Also, the use of homologous acellular urethra was 
suggested for urethral reconstruction. The advantage of using an acellular urethra is that the 
extracellular matrix comes from the same place, so the various intrinsic growth factors; 
cytokines, structural proteins, glycoproteins and proteoglycans are identical. It allows a 
single-stage intervention with a tissue that has the same form and dimension. A research 
team studied the use of a homologous acellular urethra matrix for urethroplasty on a rabbit 
model for 8 months (Sievert et al 2000). Their goal was to evaluate urethral replacement by a 
free homologous graft of acellular urethral matrix on a rabbit model. They made a complete 
study of the different parameters on the take of the graft. Their results demonstrated a 
functional and histological regeneration. Another team did a similar study. They also used 
an allogenic acellular urethral matrix on a rabbit model. Their goal was the same but their 
implantation was for 6 months (Hu et al 2008). The results obtained were not convincing but 
they were similar. Also, an acellular aortic matrix was used for urethral reconstruction. The 
goal of this research team was to create an experimental model of urethral defect and to 
repair it using allogenic acellular aortic grafts as urethral substitutes (Parnigotto et al 2000). 
The advantages of using an aortic acellular matrix are the initial tubular structure with 
suitable dimensions and it is directly applicable. The surgeon can decide the length of the 
defect as well as the size of the urethra to be reconstructed. In general, they obtained good 
results, however, it was not further mentioned. 
 
4. Synthetic polymers 
Synthetic polymers are thermoplastic materials made of biodegradable composites that can 
be tailored to the patient’s organ size. Mechanical and structural properties such as the size 
of the pores of these biomaterials can be controlled and their biological degradation is done 
by hydrolysis (Freed et al. 1994). It can also be produce in big quantity at a relatively low 
cost. 
 
4.1 Bladder  
The biomaterials synthesis, such as polyglycolic acid (PGA) and polylactic-co-glycolic acid 
(PLGA), offers a controlled composition after each production. They are authorized by the 
FDA and generally used for clinical drug encapsulation. This concept to isolate content from 
external space is particularly attractive for the bladder, since it can be used for the 
elaboration of a urinary storage bag. In vivo studies were performed where dogs were 
subjected to partial bladder replacement, using a PGA/PLGA scaffold, with cultured 
urothelial cells seeded on the luminal surface and smooth muscle cell on the exterior surface 
(Oberpenning et al. 1999). A functional evaluation was performed for 11 months which 
displayed an increased capacity to retain urine. This study demonstrated, most of all, that 
successful reconstitution of an organ was promoted when using cultured cells in vitro. The 
construct without cell seeding led to contraction and shrinkage already seen at the first post-
graft month. Although histological results seemed to have a normal architecture, the study 
did not specify if the in vivo cellular organization was present just at the periphery or on the 
whole synthetic graft. Indeed, the migration of surrounding cells has not been frequently 
observed in the middle of the graft, where inosculation with host’s vasculature takes more 
time in this area. Nanobiotechnology is well-positioned to influence synthetic scaffold 
optimization, but at cellular scale, the coating with a 3T3 mouse fibroblast as a feeder layer 
for urothelial cells already demonstrated an increased proliferation (Drewa et al. 2006).  
 
In the same way as for the canine model, Atala’s team continued clinical tests on candidate 
patients for cystoplasty suffering from high pressure bladders or pathological non-
compliant bladder, by using the same scaffold wrapped with omentum but using a mixed of 
collagen and PGA (Atala et al. 2006). This study provided two key elements. First, the 
culture of urothelial and smooth muscle cells in a three-dimensional environment was 
feasible. Second, a nutritional support by the highly vascularized omentum wrapped 
around the synthetic scaffold provided positive effects on success. The young age of the 
patients theoretically promotes in vivo regeneration, but after 5 years, only one of the seven 
patients seemed to have significantly increased bladder compliance. In spite of everything, 
the biopsies obtained months after implantation showed a good organization of urothelial 
and smooth muscle cells, but the authors did not explain this paradox with the post-
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using a porcine xenogenic BAMG in a tubular form was seeded with urothelial and smooth 
muscle cells extracted from New Zealand rabbit’s bladders and implanted on a rabbit model 
for 6 months. The results showed that BAMG seeded with cells from normal bladder tissue 
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consisting of BAMG seeded with foreskin epithelial cells from New Zealand rabbit’s was 
performed on the same kind of animal for 6 months. The results were similar to the previous 
study, the BAMG seeded with epidermal cells obtained better outcomes than BAMG alone. 
Also, the research team claimed that the use of epidermal cells seemed adequate to replace 
urothelial cells (Fu et al 2007). The problem was that after 6 months, the epidermal cells kept 
their structural form rather than acquiring the transitional structure known to the urothelial 
cells. An additional study was done with rabbit allogenic BAMG. This time, the team seeded 
rabbit’s oral keratinocytes and the study was done on rabbit model for a duration of 6 
months. Their results showed that oral keratinocytes have a good biocompatibility with 
BAMG. It confirmed the prior results that seeded BAMG are superior to unseeded BAMG 
(Li et al 2008a, Li et al 2008b) and the oral keratinocytes kept their structure of stratified 
squamous epithelium rather than the transitional form of the urothelial cells, even after 6 
months. In conclusion, cell seeded matrices seem to allow tissue regeneration across the 
defect and the maintenance of a non-obstructive outflow from the bladder; it confirms the 
need to incorporate cells.  
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intestinal submucosa (SIS) was first suggested because it was shown to promote tissue 
specific regeneration in a variety of organs. SIS is composed of a collagen meshwork with 
various intrinsic growth factors, cytokines, structural proteins, glycoproteins and 
proteoglycans that may assist in cell migration as well as cell growth and differentiation 
during the regenerative process (Colvert et al 2002). The advantages of using this type of 
tissue are similar to BAMG matrices. A pilot study was done using xenogenic SIS, from a 
porcine source on a rabbit model for 3 months. Their goal was to evaluate the suitability of 
the SIS onlay patch in urethroplasty (Kropp et al 1998) and its feasibility, but it was a short-
term study and not further mentioned. Also, the use of homologous acellular urethra was 
suggested for urethral reconstruction. The advantage of using an acellular urethra is that the 
extracellular matrix comes from the same place, so the various intrinsic growth factors; 
cytokines, structural proteins, glycoproteins and proteoglycans are identical. It allows a 
single-stage intervention with a tissue that has the same form and dimension. A research 
team studied the use of a homologous acellular urethra matrix for urethroplasty on a rabbit 
model for 8 months (Sievert et al 2000). Their goal was to evaluate urethral replacement by a 
free homologous graft of acellular urethral matrix on a rabbit model. They made a complete 
study of the different parameters on the take of the graft. Their results demonstrated a 
functional and histological regeneration. Another team did a similar study. They also used 
an allogenic acellular urethral matrix on a rabbit model. Their goal was the same but their 
implantation was for 6 months (Hu et al 2008). The results obtained were not convincing but 
they were similar. Also, an acellular aortic matrix was used for urethral reconstruction. The 
goal of this research team was to create an experimental model of urethral defect and to 
repair it using allogenic acellular aortic grafts as urethral substitutes (Parnigotto et al 2000). 
The advantages of using an aortic acellular matrix are the initial tubular structure with 
suitable dimensions and it is directly applicable. The surgeon can decide the length of the 
defect as well as the size of the urethra to be reconstructed. In general, they obtained good 
results, however, it was not further mentioned. 
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Synthetic polymers are thermoplastic materials made of biodegradable composites that can 
be tailored to the patient’s organ size. Mechanical and structural properties such as the size 
of the pores of these biomaterials can be controlled and their biological degradation is done 
by hydrolysis (Freed et al. 1994). It can also be produce in big quantity at a relatively low 
cost. 
 
4.1 Bladder  
The biomaterials synthesis, such as polyglycolic acid (PGA) and polylactic-co-glycolic acid 
(PLGA), offers a controlled composition after each production. They are authorized by the 
FDA and generally used for clinical drug encapsulation. This concept to isolate content from 
external space is particularly attractive for the bladder, since it can be used for the 
elaboration of a urinary storage bag. In vivo studies were performed where dogs were 
subjected to partial bladder replacement, using a PGA/PLGA scaffold, with cultured 
urothelial cells seeded on the luminal surface and smooth muscle cell on the exterior surface 
(Oberpenning et al. 1999). A functional evaluation was performed for 11 months which 
displayed an increased capacity to retain urine. This study demonstrated, most of all, that 
successful reconstitution of an organ was promoted when using cultured cells in vitro. The 
construct without cell seeding led to contraction and shrinkage already seen at the first post-
graft month. Although histological results seemed to have a normal architecture, the study 
did not specify if the in vivo cellular organization was present just at the periphery or on the 
whole synthetic graft. Indeed, the migration of surrounding cells has not been frequently 
observed in the middle of the graft, where inosculation with host’s vasculature takes more 
time in this area. Nanobiotechnology is well-positioned to influence synthetic scaffold 
optimization, but at cellular scale, the coating with a 3T3 mouse fibroblast as a feeder layer 
for urothelial cells already demonstrated an increased proliferation (Drewa et al. 2006).  
 
In the same way as for the canine model, Atala’s team continued clinical tests on candidate 
patients for cystoplasty suffering from high pressure bladders or pathological non-
compliant bladder, by using the same scaffold wrapped with omentum but using a mixed of 
collagen and PGA (Atala et al. 2006). This study provided two key elements. First, the 
culture of urothelial and smooth muscle cells in a three-dimensional environment was 
feasible. Second, a nutritional support by the highly vascularized omentum wrapped 
around the synthetic scaffold provided positive effects on success. The young age of the 
patients theoretically promotes in vivo regeneration, but after 5 years, only one of the seven 
patients seemed to have significantly increased bladder compliance. In spite of everything, 
the biopsies obtained months after implantation showed a good organization of urothelial 
and smooth muscle cells, but the authors did not explain this paradox with the post-
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operative urodynamic results.  Generally, the disadvantages of these polymers lie in the bad 
cicatrization with the host’s tissue, as well as in the absence of biological recognition. 
However, on this last point, the nanobiotechnologies have the capacity to improve them by 
integrating cellular recognition domains in their structure, such as RGD peptide (Cook et al. 
1997). 
 
Harrington’s review defines the discipline as the creation of objects or a surface whose 
unique functions are a direct result of their nanoscale dimension/organization (Harrington 
et al. 2008). The beginning of engineered synthetic matrices focused on the three-
dimensional and porosity aspect, but to imitate the cellular environment with a more 
efficient approach, composites at a lower than 100nm were used to elaborate scaffolds since 
extracellular matrix proteins are nano-dimensional. To direct the cellular phenotype, the 
nanofibers composites are designed like collagen I and III fibrils, the most abundant 
isoforms of the native bladder. The conventional methods are based on a similar concept of 
adhesive protein interactions, such as non-covalent links, to form supramolecular polymer. 
Two synthesis techniques are commonly used. The « bottom-up » synthesis consists of 
triggered nanomolecules which self-assemble into a molecular object, like the micelles 
formation from individually charged lipids. In this case, the aggregate dimension is pre-
determined through the incorporation of features with specific adhesive properties. The « 
top-down » approach is a technique in which untreated material is specifically degraded to 
result in a nanoscale patterned surface, as with lithographic techniques. Therefore, it 
appears evident that the new generation of biomaterials must manage the cells in their 
native language. Indeed, the incorporation of cytokines and the growth factor signaling 
could influence the cell behavior and promote controlled tissue regeneration. The challenge 
of this discipline is to precisely copy the extracellular matrix proteins architecture, to inform 
the cells of their physiological organization. In the bladder tissue engineering field, some 
studies of nanoscale materials were successfully completed (Baker et al. 2006, Han et al. 
2006, McManus et al. 2007). Bladder smooth muscle cells adhesion and enhancement in 
elastin and collagen deposition were measured with the application of nano-structured 
PLGA/polyether-urethane scaffold (Pattison et al. 2007). The same study showed that 
synthetic composites are not yet spared from urine degradation, which led to post-graft 
bladder leaks in a rat model. Moreover, the clinical application of this cell-seeded construct 
still remains expensive. 
 
4.2 Urethra 
Many synthetic polymers have been studied over the years, alone or with cells to add more 
support to the material. The principal advantage using synthetic polymer is that it decreases 
the inflammatory reaction and other adverse effects, it is biodegradable and it eliminates the 
risk of hair growth or stone encrustation on hairs in the urethral lumen that can be found 
with the hair baring skin. Because it is an artificial material, it eliminates complications 
related to harvesting. Furthermore, it is possible to play on the different proprieties of the 
polymer like its porosity, the length and the diameter required for urethroplasty (Olsen et al 
1992). At the end of the 70’s, some alloplastics were studied for urethral reconstruction: 
Silicone, Dracon, Gore-Tex and Teflon were used without great success on dog and human 
(Court et al 1971, Court et al 1973, Gilbaugh et al 1969, Hakky 1977). They were unsuccessful 
and these materials could bring post-surgical complications like fistula and periurethral 
haematomas (Dreikorn et al 1979). With the improvement of technology, new synthetic 
polymers appeared and were studied for urethroplasty. In 1992, a tube formed of 
polyhydroxybutyric acid (PHB) coated with polyglycolic acid (PGA) on the inside was 
tested for urethroplasty on a dog model for 12 months. After 8 months, the polymer had 
completely disappeared and the lumen of the urethra was somewhat wider than normal 
and no complications were reported (Olsen et al 1992). These results were interesting but 
they were only based on macroscopic and histological examinations, no further studies were 
made after. In 1997, a group suggested to use guide implant for short urethral gaps. They 
made a pilot study on a new biodegradable and highly biocompatible polymer, the 
hyaluronan benzyl ester (Hyaff-11) on a rabbit model for a month. The implant guide was 
compared to two control groups; one using a silicone guide and a negative control. The 
principal advantages of the Hyaff-11 resides in its inertness, its possibility of producing 
devices with variable rates of biodegradation, its favorable profile of toxicity and 
biocompatibility, its properties of protecting delicate tissues and its potential for wound 
healing. In this pilot study, no complications were observed except at the suture site where 
microfistulas appeared. On histology, the use of Hyaff-11 seemed to promote the 
proliferation of urothelial cells in cuboidal form in opposition to the silicone guide, where 
the urothelial cells were in regression and in a squamous epithelium (Italiano et al 1997). No 
further studies were made with this material for urethroplasty. 
 
More recently, a research team studied the use of a polyglycolic acid (PGA) stent coated 
with a polylactic-co-glycolic acid (PLGA) solution and seeded with bovine chondrocytes 
(Amiel et al 2001). They compared the model’s reaction in vitro, in static condition, in a 
bioreactor and in vivo. It was implanted subcutaneously in a nude-mouse, for 4 and 10 
weeks. The ability to implant chondrocytes in the genitourinary tract has been demonstrated 
in the literature for the treatment of vesicourethral reflux (Atala et al 1993, Atala et al 1994, 
Diamond & Caldamone 1999), urinary incontinence (Atala et al 1994) and penile prosthesis 
(Yoo et al 1998, Yoo et al 1999). Their final goal was to use autologous chondrocytes to 
obtain a biocompatible model. Generally, good results were obtained but further long-term 
studies have to be made on animal models. Also, the effect of toxic urine on the model has 
to be evaluated. Another team studied the use of synthetic polymer with cells on a rabbit 
model for 24 weeks (Fu et al 2009), a poly L-polylactic acid (PLLA) polymer stent seeded 
with autologous urothelial cells from the urethra. They used PLLA because it has a 
satisfactory mechanical strength in cross-section and moderate longitudinal flexibility, 
making it easy to adapt its expansion so that it can ensure support for the urethra and avoid 
collapse. The structure of the polymer also provides a good environment for cell adhesion. 
Good results were obtained. After 12 weeks, the polymer was degraded and after 24 weeks, 
the cells were implanted successfully, survived and regenerated well. However, it remains a 
short-term study. Like for other acellular tissue matrices, the use of cells in new synthetic 
polymers helped prevent complications and provided a better repair after urethroplasty. 
Even with these results, other materials are chosen before them and as one can see, not a lot 
of studies have been made to support their long-term use in urethral reconstruction. 
 
Evolution	in	Tissue	Engineering	for	the	Lower	Urinary	Tract 497
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cicatrization with the host’s tissue, as well as in the absence of biological recognition. 
However, on this last point, the nanobiotechnologies have the capacity to improve them by 
integrating cellular recognition domains in their structure, such as RGD peptide (Cook et al. 
1997). 
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the urothelial cells were in regression and in a squamous epithelium (Italiano et al 1997). No 
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More recently, a research team studied the use of a polyglycolic acid (PGA) stent coated 
with a polylactic-co-glycolic acid (PLGA) solution and seeded with bovine chondrocytes 
(Amiel et al 2001). They compared the model’s reaction in vitro, in static condition, in a 
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(Yoo et al 1998, Yoo et al 1999). Their final goal was to use autologous chondrocytes to 
obtain a biocompatible model. Generally, good results were obtained but further long-term 
studies have to be made on animal models. Also, the effect of toxic urine on the model has 
to be evaluated. Another team studied the use of synthetic polymer with cells on a rabbit 
model for 24 weeks (Fu et al 2009), a poly L-polylactic acid (PLLA) polymer stent seeded 
with autologous urothelial cells from the urethra. They used PLLA because it has a 
satisfactory mechanical strength in cross-section and moderate longitudinal flexibility, 
making it easy to adapt its expansion so that it can ensure support for the urethra and avoid 
collapse. The structure of the polymer also provides a good environment for cell adhesion. 
Good results were obtained. After 12 weeks, the polymer was degraded and after 24 weeks, 
the cells were implanted successfully, survived and regenerated well. However, it remains a 
short-term study. Like for other acellular tissue matrices, the use of cells in new synthetic 
polymers helped prevent complications and provided a better repair after urethroplasty. 
Even with these results, other materials are chosen before them and as one can see, not a lot 
of studies have been made to support their long-term use in urethral reconstruction. 
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5. Autologous approach: the self-assembly method 
To this day, the integration of previously described substitutes has caused chronic 
inflammation or graft rejection. That is explain by the degradation of biosynthetic or 
xenogenous scaffold, that release non-recognized materials. The last few years, the organ 
reconstruction field knew the emergence of the self-assembly method (Auger et al. 2002), 
based on the cell capacity to produce their own matrix support. This approach consists of a 
cell culture in well defined conditions that will construct an autologous scaffold free of 
exogenous biomaterials. At the Laboratoire d’organogénèse expérimentale (LOEX), the self-
assembly method proved its capacities in skin, blood vessel, and cornea regeneration 
(Pouliot et al. 2002, Tremblay et al. 2005, Germain et al. 1999), for graft or pharmacological 
studies. This is why our team works to elaborate autologous urological tissues. We 
investigate the feasibility to reproduce the physiological structure of bladder mucosa and 
genitourinary tubes. Dermal fibroblasts are interesting cells since, in presence of ascorbic 
acid (Chepda et al 2001, Davidson et al 1997), they have the ability to synthesize 
extracellular matrix in an increased way to form a collagen-layer. The autologous sheets 
could be then superposed or rolled to create a three-dimensional environment for the 
reorganization of additional cells specific to the reconstructed organ.  
 
5.1 Bladder  
The method starts by extracting urothelial, endothelial and smooth muscle cells, from a 
simple bladder biopsy (1cm by 5cm). This minimally invasive preoperative phase to harvest 
the three cell types of the bladder, was reported and confirmed good individual cell 
population purity (Magnan et al. 2006). The endothelialization of any substitute is necessary 
to promote the survival of the graft. Recently, LOEX laboratory obtained a rapid 
inosculation with a capillary-like network of reconstructed tissue and the host vasculature 
(Tremblay PL et al. 2005). Consequently, when cellular sheets were obtained, endothelial 
cells were added on, one day before they were superimposed, three by three. Urothelial cells 
were then seeded on top of the three-dimensional construction, and after a proliferation 
phase, the construction was elevated to the air/liquid interface as showed in figure 4. This 
technique was inspired from in vitro engineered epidermis, to induce cell maturation, 
because urothelial and epidermal cells are both epithelial in origin. However, epidermis and 
urothelium organization are not exactly the same. To generate a more physiological process, 
the replacement of the air/liquid phase by the dynamic bioreactor culture is currently being 
considered. 
 
 
Fig. 4.  Schematic representation of the bladder self-assembly approaches. 
 
In the meantime, histological analysis showed a good distribution of the extracellular matrix 
and the cellular multi-layered morphology appears to be characteristic of normal bladder 
urothelium. Collagen I and basal membrane, essential to urothelial organization, were 
identified by immunofluorescence. More interestingly, cytokeratin 8/18 staining confirmed 
the good distribution of a stratified urothelium on the whole bioengineered support, which 
is important to avoid urine infiltration. Tissue permeability was evaluated by using Franz’s 
cells, which consists of placing the vesical equivalent between the donor compartment 
containing radioactive urea and the receiver compartment, from which samples are 
obtained at different time points to determine permeation profiles. The endothelialized 
vesical equivalent displayed the same profile as the native bladder, contrarily to a 
construction of fibroblast only, which showed a fast diffusion of urea. This demonstration 
proved the necessity of having reconstructed urothelium covering substitutes, in order to 
avoid urine extravasation and secondarily, in vivo necrosis and fibrosis. Mechanical 
characteristics of the vesical equivalent seemed to have sufficient resistance to allow 
suturing. Even if the metalloproteinases released by endothelial cells reduced the vesical 
equivalent resistance, results remained satisfying because of their superiority compared to 
the minimal threshold measured from the native bladder (Dahms et al. 1998). Although this 
model still requires improvements, such as smooth muscle cells incorporation, its 
autologous origin and its efficiency as a barrier to urea, encourage further optimization in 
order to make this tissue-engineered equivalent, an ideal bladder replacement. 
 
5.2 Urethra  
Our tubular equivalent is build from the same cellular type. As showed in figure 5 and 
described previously (Magnan et al 2009), mature fibroblasts extracted from the skin are 
grown in culture medium for 28 days with ascorbic acid to stimulate the production of 
extracellular matrix. The presence of the extracellular matrix provides the formation of a 
fibroblasts sheet easy to handle, it enables us to roll it around a mandrel to obtain a tubular 
form. Then it is grown with another culture medium for 21 days with ascorbic acid, to 
increase the cohesion between the fibroblasts layers. When we obtain a uniform tube, 
urothelial cells are then seeded inside the tubular model and placed under perfusion at 15 
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ml per minute in a bioreactor with culture medium for 7 days with ascorbic acid to promote 
proliferation and maturation of the urothelial cells. 
 
Fig. 5.  Schematic representation of the urethral self-assembly approaches.  
 
Macroscopically, the model was uniformly assembled, provided suture resistance and was 
easily handled. Histologically, we obtained a thick layer of fibroblasts in an abundant 
extracellular matrix and the urothelium was similar to a native urethra. The urethral model 
characterization with cytokeratin 8/18 by immunofluorescence and western blot confirmed 
the presence of a well differentiated and pseudostratified urothelium. The viability test 
demonstrated that the cells could be reextracted from the tube and reseeded with a 2% 
mortality rate, which is normally found in cell culture. Finally, the results of the burst 
pressure tests confirmed a higher resistance when compared to native porcine urethra.  
 
Our autologous urethral equivalent is an innovative model that offers a promising 
alternative for urethral replacement or reconstruction. Like for alternative tissues, cell 
extraction will need harvesting from a skin biopsy, but in a smaller amount. To collect the 
urothelial cells, a bladder wash will be use. But the greatest advantage remains that our 
model will use the patient’s cells with no xenogenic matrix, which should decrease the 
inflammatory reaction post-surgically. 
 
6. Conclusion 
Significant complications of alternative native tissue used for reconstruction raised the need 
for other types of materials. Tissue engineering had known successes and limits, but those 
limitations have contributed to move forward the knowledge in urologic tissue 
regeneration. Naturally derived materials and acellular tissue matrices have the potential 
advantages of familiar biological architecture. On the other hand, synthetic polymers can be 
obtained reproducibly on a large scale with control properties. But the challenge to produce 
a urologic tissue replacement with a scaffold that demonstrates functional compatibility 
with the native tissue still remains relevant. With the results obtained from the different 
studies, the protection against urine toxicity by a watertight construct and the quick 
vascularization of the urologic substitute are necessary to preserve the cellular growth and 
avoid graft contraction. The self-assembly approach seems a promising option to obtain an 
autologous engineered equivalent, endotheliazed and similar to the native tissue. For the 
future, all tissue engineering disciplines will need to explore new techniques, going from 
dynamic cell culturing to nanobiotechnologies, to obtain a unique structure and the full 
functionality of the urologic tissue to replace. We will have to consider the differences 
between a healthy animal model and the implantation of the substitute into a human patient 
with an active urologic pathology. This will be a major challenge. 
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On tissue engineering field the research about skin substitutes represents historically the 
most promising approach to heal acute and chronic skin wounds, reducing requirements for 
donor skin autografts. Aim of this chapter is to made the state of art of the most important 
skin substitutes and to resume the principal tissue engineering techniques for its in vitro 
reconstruction. In the first part we will pay the attention to the description of the evolutive 
course of skin substitutes, stressing the main steps happened thanks to the important inputs 
coming from biotechnologies progresses and clinical practice. Since then the research in 
bioengineering skin, moved by clinical pressing of reconstructive and burn surgery, made 
progresses trying to develop cutaneous substitutes very similar to native skin by a morpho-
functional point of view. So it has been possible, starting from a 2X2 cm skin human biopsy, 
to realize completely autologous cutaneous substitutes not only composed of two many 
structures of skin, dermis and epidermis, but containing also other important components: 
microvascular network, micro nervous network, skin immonocompetent system and 
melanocyte system. The final goal is to develop effective and easy handling skin substitutes 
that could be reproduce human skin anatomy and physiology, introducing new advantages 
linked to successful grafting and then to satisfactory clinical results by functional and 
aesthetic point of view.  
 
1. Introduction 
Tissue Engineering (TE) is "an interdisciplinary field that applies the principles of 
engineering and life sciences toward the development of biological substitutes that restore, 
maintain, or improve tissue function or a whole organ". Tissue engineering has also been 
defined as "understanding the principles of tissue growth, and applying this to produce 
functional replacement tissue for clinical use."  
Powerful recent developments in the multidisciplinary field of tissue engineering have 
yielded a novel set of tissue replacement parts and implementation strategies. Scientific 
advances in biomaterials, stem cells, growth and differentiation factors, and biomimetic 
environments have created unique opportunities to fabricate tissues in the laboratory from 
combinations of engineered extracellular matrices ("scaffolds"), cells, and biologically active 
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molecules. Among the major challenges now facing tissue engineering there is the need for 
more complex functionality with biomechanical stability in laboratory-grown tissues 
destined for transplantation.  
Thus, the scientific and medical communities are working together to develop engineered 
tissues and regenerative approaches utilizing various combinations of stem and progenitor 
cells, biomaterials, growth factors, and gene therapy. However, after three decades, the 
potential to provide tissues and organs to millions of patients suffering from trauma, 
congenital defects, and chronic diseases has yet to be fully accomplished.  
On the whole, tissue engineering appears to be the new frontier of medicine for its impact 
on regenerative and reconstructive procedures in humans. In fact, its ultimate goal is to 
develop powerful new therapies, namely “biological substitutes”, for structural and 
functional disorders that have been proven to be difficult or impossible to tackle 
successfully with the current approaches of interventional medicine. In addition, providing 
“cell-to-tissue replacement parts” of the human body it can ultimately afford the 
irremediable shortage of transplantable organs. 
Despite the rapid advancement of state of the art medically driven technologies, numerous 
challenges still exist for translating technology to the clinic including long and often 
undefined regulatory approval pathways, high translational costs, potential safety 
appropriate risk/benefit and cost/benefit ratios, and appropriate matching of technology 
and application. The latter may be one of the most difficult tasks faced by the biomedical 
engineer. Although development of general platform technologies can lead to major 
breakthroughs across multiple disciplines, conventional wisdom suggests rapid clinical 
translation and requires a systematic approach that involves first identifying and 
understanding a problem followed by engineering a focused solution. As technology 
rapidly advances, the bioengineer have more tools at their disposal than ever before, yet 
only if they are able to select the right tools and technologies, for society benefit. 
Tissue engineered substitutes should have some essential characteristics which include: 
being easy to handle and apply to the injured site; provide vital barrier function with 
appropriate water flux; be readily adherent; have appropriate physical and mechanical 
properties; undergo controlled degradation; be sterile, non-toxic, non-antigenic; and evoke 
none or minimal inflammatory reactivity. Additionally, they should incorporate into the 
host with minimal scarring and pain and facilitate angiogenesis, while still being cost-
effective.  
The ability to create thick tissues is a major tissue engineering challenge, requiring the 
development of a suitable vascular supply. Current trends are seeing the utilization of cells 
seeded into hybrid matrix/scaffold systems to create in vitro vascular analogues. 
Approaches that aim to create vasculature in vitro include the use of biological extracellular 
matrices, co-culture of cells, incorporation of growth factors, culture in dynamic bioreactor 
environments, and combinations of these. Of particular interest are those approaches that 
aim to create bioengineered tissues in vitro that can be readily connected to the host's 
vasculature following implantation in order to maintain cell viability. A major consideration 
when developing a tissue engineering strategy for promoting repair and regeneration is to 
identify suitable sources of cells and mechanisms by which they can function and interact 
properly. These cells would also have to be abundant enough to be able to carry out the 
regeneration process completely.  
Another obstacle to the large scale clinical application of cell therapy using conventional 
procedure is the extremely high cost of the treatment. The economic limit is due to the high 
cost of the actual manual operations for ex vivo cell expansion and differentiation in respect 
of the international regulations (Good laboratory and manufacture practices, GLP, GMP or 
Food and Drug Administration, FDA) that control the trading of clinical products.  
Therefore there is a diffuse and pressing necessity to develop new methods and culture 
techniques that are able to control the cell micro-environment during both cell expansion 
and differentiation leading to repeatable clinical grade batches, operating in safety 
conditions and at low costs. This last point is often ignored but it is fundamental to make the 
clinical progresses available to everybody and not only to few people. 
 
2. Anatomy of the skin  
The skin is the largest organ of the body in vertebrates and is composed of the epidermis 
and dermis with a complex nerve and blood supply (Fig. 1). A third layer the hypodermis, is 
composed mainly of fat and a layer of loose connective tissue. These three layers play an 
important role in protecting the body from any mechanical damage such as wounding.  
I. The epidermis is thin and highly cellular, composed mainly of keratinocytes and in the 
lower epidermal layers, melanocytes, for pigmentation. It does, however, have 
sufficient thickness to provide vital barrier function. Mammalian epidermis and its 
appendages (hair, nail, sweat and sebaceous glands) maintain homeostasis by constant 
recycling of the basal cell layer.  
II. The dermis situated directly below the epidermis, constitutes the bulk of the skin and 
is composed of collagen with some elastin and glycosaminoglycans (GAG’s). 
Hemidesmosomal structure are the main components of the basement membrane that 
mechanically stabilizes the interaction between epidermis and dermis. Basement 
membrane is an extremely complex and dynamic structure, which is responsible of the 
tight junction of the upper epidermis and underlying connective tissue. The dermis is a 
thicker tissue made essentially of a loose array of fibroblasts (mesenchymal cells) and 
vasculature (endothelial cells) forming an approximately 2-5 mm thick connective 
tissue sustaining the overlaid epidermis which is separated from the dermis by a 20 
nm thick multilayered membrane: basement membrane. The dermal matrix, which 
provides considerable strength to skin by virtue of the arrangement of collagen fibers, 
has specialized components and structures. Collagenous mesh work is interwoven 
with varying contents of elastin fibers, proteoglycons (GAG being predominantly 
hyaluronic acid and dermatan sulfate with some chondroitin-6-sulphate and heparin 
sulphate), fibronectin and other components. (Metcalfe and Ferguson 2007) 
III. The hypodermis, the final layer, contains adipose tissue that is well vascularised 
and contributes to both the thermoregulatory and mechanical properties of the 
skin. 
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Fig. 1. Anatomy of the skin: dermis with fibroblasts and epidermis with keratinocytes 
 
Skin is also composed of a series of appendages known as anexa, such as hair follicles, sweat 
glands and sebaceous glands generally embedded in the dermis. Because the skin serves as 
a protective barrier against the outside world, any break in it must be rapidly and efficiently 
amended. (Jennings RW and  Hung TK 1982). The physiologic mechanism that coordinates 
the ordered repair of cutaneous tissues is generally referred to as wound healing and it 
consists in a well orchestrated series of temporary overlapping actions involving different 
cell and biochemical types. The process of wound healing involves interaction of a variety of 
different cell types and matrix components (R.A.F. Clark and P.M. Henson 1988). Different 
types of cells respond to environmental signals in a specific manner in order to carry out 
their genetic program of proliferation, differentiation and function. Cells synthesize 
different proteins necessary for their proliferation and migration, all of which are controlled 
in a phased manner (Zavan and Abatangelo 2004). Different phases are inflammation, 
granulation tissue formation, re-epithelialization, matrix production and remodelling Thus, 
each layer of skin plays its own pivotal role to play in the normal function of the skin, which 
otherwise can lead to several skin disorders. Healing of injured tissues involves both 
regeneration of the epidermis and repair of the dermis resulting in a scar tissue (M Calvin 
1998). 
 
dermis 
epidermis 
3. Wound Healing  
Wounds can arise either acutely from traumas such as burns, derive from surgical 
treatments such as skin graft harvesting or melanoma excision or also in a chronic fashion 
related to patho-physiological phenomena like insufficient vascularization, as in pressure 
wounds or diabetic foot ulcers. The underlying principles behind the use of skin substitutes 
to improve wound healing are valid for extensive wounds that cannot heal spontaneously 
because they are deep and affect a high percentage of the total body surface or for smaller 
wounds that cannot heal because of underlying factors (Auger and Lacroix 2009). 
The normal acute wound healing process takes place in 4 steps (FIG.2): 
1) hemostasis, 
2) inflammation,  
3) proliferation,  
4) remodeling. 
 
 
Fig. 2. Time table of wound healing process 
 
Hemostasis 
Unless there is severe arterial hemorrhage, hemostasis spontaneously begins immediately 
after the injury. It involves platelet aggregation, fibrin clot formation and activation of the 
coagulation pathways. Since the first aspects of wound treatment involve cleaning and 
debriding the wound, skin substitutes are rarely, if ever, used for hemostasis. However, it 
should be noted that chitosan dressings have been demonstrated to efficiently improve 
hemostasis compared to standard dressings, even with significant arterial hemorrhage 
[Garner and Brown R 2002] 
Inflammation 
Inflammation takes place 1–4 days after wounding. It involves the migration of neutrophils 
into the wound site, shortly followed by macrophages and later by lymphocytes. The fibrin 
clot matrix   provides a three-dimensional initial scaffold through which immune cells will 
initially migrate to the wound and secrete a host of signaling molecules that will act as 
chemoattractants and growth factors. Platelets will produce factors such as platelet-derived 
growth factor (PDGF), epidermal growth factor (EGF), transforming growth factor- (TGF-
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Fig. 1. Anatomy of the skin: dermis with fibroblasts and epidermis with keratinocytes 
 
Skin is also composed of a series of appendages known as anexa, such as hair follicles, sweat 
glands and sebaceous glands generally embedded in the dermis. Because the skin serves as 
a protective barrier against the outside world, any break in it must be rapidly and efficiently 
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types of cells respond to environmental signals in a specific manner in order to carry out 
their genetic program of proliferation, differentiation and function. Cells synthesize 
different proteins necessary for their proliferation and migration, all of which are controlled 
in a phased manner (Zavan and Abatangelo 2004). Different phases are inflammation, 
granulation tissue formation, re-epithelialization, matrix production and remodelling Thus, 
each layer of skin plays its own pivotal role to play in the normal function of the skin, which 
otherwise can lead to several skin disorders. Healing of injured tissues involves both 
regeneration of the epidermis and repair of the dermis resulting in a scar tissue (M Calvin 
1998). 
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3. Wound Healing  
Wounds can arise either acutely from traumas such as burns, derive from surgical 
treatments such as skin graft harvesting or melanoma excision or also in a chronic fashion 
related to patho-physiological phenomena like insufficient vascularization, as in pressure 
wounds or diabetic foot ulcers. The underlying principles behind the use of skin substitutes 
to improve wound healing are valid for extensive wounds that cannot heal spontaneously 
because they are deep and affect a high percentage of the total body surface or for smaller 
wounds that cannot heal because of underlying factors (Auger and Lacroix 2009). 
The normal acute wound healing process takes place in 4 steps (FIG.2): 
1) hemostasis, 
2) inflammation,  
3) proliferation,  
4) remodeling. 
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), transforming growth factor-  (TGF- ) and vascular endothelial growth factor (VEGF). 
[Werner and Grose 2003; Spiekstra et al. 2007].  
Proliferation 
Factors secreted during inflammation will trigger and drive the proliferation stage, which 
normally takes place between days 4 and 21 following wounding. During that stage, 
fibroblasts are stimulated by fibroblast growth factor (FGF) and PDGF to invade the wound 
site, and will produce  xtracellular matrix (ECM) components, such as collagen, elastin and 
glycosaminoglycans, to generate the granulation tissue. Fibroblasts secrete also FGF that 
can, along with the VEGF secreted by platelets and neutrophils, act as an angiogenic factor 
to stimulate endothelial cell proliferation and migration and thus promote vascularization at 
the healing site. While fibroblasts and endothelial cells mostly invade the wound site from 
its bed, keratinocytes at the margin of the wound undergo a transient burst of proliferation 
that will sustain epithelialization over the wound (FIG.3)[Laplante AF et al. 2001] 
 
 
Fig. 3. Cells involved on wound healing  
 
Remodeling 
The last step of normal acute wound healing is remodeling, during which the ECM 
components will be modified by the balanced mechanisms of proteolysis and new matrix 
secretion, and during which the wound becomes gradually less vascularized. The initial 
granulation tissue is weak but will gain in strength over time because of remodeling effects 
such as the gradual replacement of immature type III collagen by mature type I collagen. 
The complete maturation of a wound may take months or even years to complete, 
depending on its initial extent and various factors that can affect the healing process 
[[Johnstone and Farley 2005]. Excessive contraction in large wounds can lead to 
contractures, while excess formation of scar tissue will form hypertrophic scars or even, if 
the scar tissue extends into the healthy tissue around the wound, a keloid scar. Wound 
contraction starts taking place around 6 days after injury and can last long after the 
epithelialization phase. The myofibroblast is considered to be the major cell responsible for 
contraction and is easily distinguished from normal fibroblasts by the presence of -smooth 
muscle actin (-SMA). -SMA protein expression is undetectable until day 6 after 
wounding, after subsequently increases gradually for 15 days in the healing process and 
fades after 4 weeks [Brunicardi et al 2005].  
 
3.1 Clinical application 
Today, surgical grafting of split-thickness autologous skin is the mainstay for treatment of 
fullthickness burns and is often used to treat chronic wounds of all kinds. The depth of 
tissue destruction and the need to replace different functions will determine the type of skin 
substitute used:  
a) Rapid replacement of the epidermal layer is important to restore, as fast as 
possible, control over fluid loss, body temperature and protection against bacteria. 
Epidermal or bilayer substitutes that do not provide autologous keratinocytes or 
immunocompatible living tissue, such as cadaveric skin, xenografts and inert 
membranes like silicone, can only provide temporary coverage. They are indicated 
if availability and expected healing speed make them the best or the only option at 
the beginning of the treatment. However, live keratinocytes have to be present to 
achieve permanent wound coverage and restore the epidermal barrier. With 
epidermal substitutes, the presence of autologous living cells is thus necessary for 
proper healing of extensive areas where spontaneous epithelialization is impossible 
or would take too long to complete. Autologous living cells can also be desirable to 
improve the speed and/or quality of the healing in wounds that otherwise would 
be small enough to epithelialize on their own [Macri et Clarke 2009]. 
 
b) In cases where the dermal layer is still at least partially present even after 
debridement, epidermal substitutes that provide living autologous keratinocytes 
can be applied directly on the wound bed and eventually achieve permanent 
wound closure. However, in cases where the dermal layer has been destroyed, the 
application of even the best epidermal substitute is not enough to ensure optimal 
healing.The dermal layer is essential for better elasticity and mechanical resistance, 
the absence of epithelial-mesenchymal communication increases the frequency of 
developing fibrotic conditions [Sawicki et al 2005] and evidence indicates its 
presence allows highly complex ex vivo function of epidermal cells. Thus dermal 
reconstruction should be an essential part of the treatment in cases where none of 
the original dermis is left on the wound bed prepared for grafting. The presence of 
living fibroblasts is not a necessity in dermal substitutes. Such acellular products 
can be sufficient to provide a scaffold that will be repopulated, revascularized and 
remodeled with the patient’s own fibroblasts and endothelial cells. However, the 
presence of fibroblasts in dermal substitutes helps wound healing by providing 
factors of the FGF family, by the secretion of the ECM responsible for its 
mechanical properties and by the structuring effect they have on the formation of 
capillaries during angiogenesis [Mitrani et al 2005]. Dermal substitutes provide a 
crucial component to help repair full-thickness damage, but they do not create a 
barrier effect and need to be covered with an epidermal substitute to that end. 
 
Basically, there are three methods of skin repair and replacement: 
First: autografting.  
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This is a widely used method of treating organ loss. For instance, it is an effective procedure 
for the short-term treatment of full thickness skin loss, especially meshed skin in severely 
burned patients.  Although autologous skin grafts remain the first option in the current 
standard of care for burn patients, there are clinical circumstances where using the donor’s 
own skin might not be appropriate for reasons related to the quantity needed, as in the case 
of massive tissue injury such as extensive burns or because of healing deficiencies that lead 
to chronic wounds. The clinicians then need to turn towards alternative materials that will 
offer appropriate properties for the type and extent of the wound to be treated [Machens et 
al. 2000] 
Second: cadaver skin  
It has offered an alternate pathway to skin replacement for many years. Peter Medawar, in 
his early pioneer work on transplantation immunobiology during the 1930s and 1940s, used 
skin transplants in immunoincompatible animal models and thus outlined very early in the 
history of transplantation medicine that rejection and progressive loss of tissue is a major 
drawback for cadaver skin replacements. In recent decades the consequences of a 
promiscuous multiculture have taught us that additional problems are inherited with this 
type of surgery: hepatitis and the Aids virus are risks which cannot be excluded and make 
cadaver skin transplantation more and more obsolete. The potential of cadaveric allograft 
skin to transmit disease has been recognized as an increasing problem since the 1980s. 
Alternatives to cadaveric skin are represented by native biological substitutes, with or 
without living cells resumed in table 1.[Auger and Lacroix 2009] 
 
Product Commercial name 
Fresh cadaveric skin  
Cryopreserved cadaveric skin AllodermTM 
Glycerolized cadaveric skin  
Fresh xenografts Usually fresh 
porcine disinfected skin 
 
Cryopreserved amniotic 
membrane 
 
AmniograftTM 
Porcine small intestine 
submucosa 
 
OasisTM, 
FortaFlexTM 
 
Porcine skin PermacolTM 
Table 1. commercial natural skin 
 
Third: in vitro reconstructed skin 
This procedure relies on the hypothesis that tissue can, in principle, be cultured in vitro. 
During the several preceding decades, there have been breathtaking achievements in 
medical science in the field of in vitro cell cultivation, tissue engineering and new 
biopharmaceutical as well as recombinant genetic therapies. The skin has been the first 
tissue-engineered organ from the lab bench to the patient [Rheinwald and Green, 1975]. 
Rheinwald and Green took 3T3 cells derived from mouse embryos (the 3T3 cell line 
established by Rheinwald and Green in particular is known as 3T3-J2), irradiated them to 
eliminate their capacity to divide, and co-cultured them with epidermal keratinocytes, 
sufficiently  uppressing the differentiation of the latter to obtain cells with a high 
proliferative capacity (Hiroco, 2007). The greatest merit of cultured epidermis is that it 
enables the grafting of epidermal keratinocytes that have preserved sufficient proliferative 
capacity. 
(Metcalfe) Engineering design specification in skin has relied upon the creation of both 
artificial dermal and epidermal components, which when combined produce a replacement 
of the skin, that can be grafted in place ([Supp and Boyce 2005]. Materials used as artificial 
ECM to date include those derived from naturally occurring materials and those 
manufactured synthetically [MacNeil 2007]. Examples of natural materials include 
polypeptides, GAG’s, fibronectin, collagen, hydroxyapatites, hyaluronan, chitosan and 
alginates. These materials are advantageous in that they have low toxicity and a low chronic 
inflammatory response. Examples of synthetic materials include polyglycolide (PGA), 
polylactide (PLA) and polylactide-coglycolide (PLG), which have been used for sutures and 
meshes [[Metcalfe and Ferguson 2007]. Other examples include polytetrafluoroethylene 
(PTFE), polycaprolactone (PCL) and polyethylene terephthalate (PET). Matrices used 
routinely in therapeutic applications are made from polymers that are often resorbed by or 
degraded in the body. In the early days of tissue engineering, polymers were adapted from 
other surgical uses and over time have been shown to have deficiencies in terms of 
mechanical and degradation properties [Griffith 2002]. A greater challenge arises when 
functionalising these polymers into scaffolds that have defined shapes and a complex, 
porous internal architecture that can direct tissue growth  [Griffith and Schwartz 2006]. 
Current skin constructs that are commercially available are generally based on the following 
techniques: 
a) Epidermis: with only keratinocytes  
The minimum requirement for a viable skin construct is to reestablish a barrier function to 
avoid infection and water loss. The horny layer of the epidermis (the product of terminal 
keratinocyte differentiation) plays this role. As mentioned above, after the breakthroughs of 
Rheinwald and Green in the mid ‘70s, the technology of cultured epithelial autograft (CEA) 
is now available to a large number of hospitals worldwide. In addition, cell culture 
parameters, harvest procedures and usage indications have been strictly defined and CEA 
production is also being performed on an industrial basis.  
Epidermal substitutes 
 
Commercial name Cell source biomaterial 
EpicelTM autologous keratinocytes 
from skin  
petrolatum gauze backing 
EpidexTM autologous keratinocytes 
from hair follicles outer root 
sheath 
silicone membrane 
 
LaserskinTM, autologous keratinocytes esterified laser-perforated 
hyaluronic acid matrix 
 
BioSeed-STM Autologous oral mucosal 
cells 
fibrin matrix 
MyskinTM autologous keratinocytes specially treated silicone 
sheet 
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CellSprayTM autologous keratinocytes suspension for spray 
CryoskinTM Cryopreserved (viable cells) 
confluent allogeneic 
keratinocytes 
gel-like proprietary 
chemical surface 
 
The greatest merit of cultured epidermis is that it enables the grafting of epidermal 
keratinocytes that have preserved sufficient proliferative capacity. Whatever the 
circumstances, patients in whom epidermal damage has occurred all ultimately require an 
epidermis composed of epidermal keratinocytes. The only hope for patients with 
widespread epidermal damage, such as whole-body burns, is the localized capacity of 
surviving epidermal keratinocytes to divide and proliferate, and their treatment requires an 
extremely long period of time. Although autologous grafting of skin from other areas of the 
body is the surgical norm, the amount of skin that can be harvested is limited, and 
furthermore, new epidermal damage is created at the donor site. On the other hand, 
cultured epidermis is very thin, and its use is problematic in cases of deep skin damage such 
as for patients in whom the dermis has been completely destroyed. For this reason, other 
methods must be used in advance to create dermal tissue that can offer a favorable base for 
grafting. [Hichiro 2007] 
 
Fig. 4. Principal steps for in vitro epidermal skin reconstruction 
 
Technique: 
Keratinocytes are isolated from full-thickness skin biopsies (3×1 cm) (step1) obtained from 
healthy patients with ages ranging from 35 to 45 years. Keratinocytes are isolated and 
cultured according to a modified version of the Rheinwald and Green protocol. Briefly, 
dermal specimens are immersed in DMEM supplemented with 20% FBS and minced 
(step2).The small fragments obtained, are digested in 0.6 U/ml dispase II (Boehringer 
Mannheim) at 37° C for 1 h, at this time a manual separation between dermis and epidermis 
is performed (step2). The epidermis will be treated with trypsin ± EDTA (0.05%, 0.02 mM) 
solution (Seromed. Biochrom KG) for 10 min and the cells collected after a centrifugation 
and seeded in flask treated with a special keratinocytes attachment factors or in a feeder 
layer of 3T3 (step3). 
For 3D coltures, keratinocytes are plated in secondary cultures at a density of 2 × 104 
cells/cm2 onto the biomaterials (e.g. hyaluronic acid: LaserSkin membrane) in the presence 
of a feeder layer of nonproliferating 3T3 mouse fibroblasts (step4). 
 
 
b) Dermis: presences of fibroblasts.  
Fibroblasts are mesenchymal cells that can be readily cultured in the laboratory and play a 
significant role in epithelial–mesenchymal interactions, secreting various growth factors and 
cytokines that have a direct effect on epidermal proliferation, differentiation and formation 
of extracellular matrix. They have been incorporated into various tissue-engineered 
products such as Dermagraft_ (Advanced BioHealing, La Jolla, CA, U.S.A.) and Apligraf_ 
(Novartis, Basel, Switzerland) and used for a variety of clinical applications, including the 
treatment of burns, chronic venous ulcers and several other clinical applications in 
dermatology and plastic surgery. Fibroblasts are a heterogeneous population of cells found 
in numerous tissues and are of mesenchymal origin. Fibroblasts from different anatomical 
sites all have similar morphology but DNA-microarray studies have demonstrated that 
fibroblasts in different anatomical sites have their own gene-expression profile and 
characteristic phenotypes, synthesizing extracellular matrix (ECM) proteins and cytokines in 
a site-specific manner. Dermal fibroblasts have numerous functions, not only in 
synthesizing and depositing ECM components, but also proliferation and migration in 
response to chemotactic, mitogenic and modulatory cytokines, and also autocrine and 
paracrine interactions [Wong et al 2007]. 
Fibroblasts used in tissue engineering may be allogenic or autologous. In contrast to 
allogenic cells, autologous fibroblasts carry no risks of rejection or risk of cross-infection. 
Cultured dermis using fibroblasts falls within this field, and has been produced with a 
number of materials. As the basic element, collagen or other biodegradable material has 
been used as a scaffold to create a tissue consisting of dermis-derived fibroblasts. Treatment 
using cultured dermis makes use of the wound-healing effects brought about by the 
physiologically active substances produced by fiobroblasts. Normally, the creation of 
granulation tissue mediated by localized inflammation is observed as a biological reaction at 
the site of skin loss. The reconstruction of connective tissue increases with time, mainly by 
the action of fibroblasts from the surrounding area, as does capillary regeneration. Cultured 
dermis, by enabling cultured fibroblasts to produce physiologically active substances that 
are important in the reconstruction of connective tissue, promotes favorable wound 
treatment. The intended effect of cultured dermis is the promotion of wound treatment by 
means of the physiologically active substances produced by fibroblasts contained within the 
culture. As results this treatment is characterized by the lack of any significant difference in 
outcome whether the fibroblasts used are autologous or allogeneic cells. In emergency use 
for burns, for example, allogeneic cultured dermis made in advance from allogeneic cells is 
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the site of skin loss. The reconstruction of connective tissue increases with time, mainly by 
the action of fibroblasts from the surrounding area, as does capillary regeneration. Cultured 
dermis, by enabling cultured fibroblasts to produce physiologically active substances that 
are important in the reconstruction of connective tissue, promotes favorable wound 
treatment. The intended effect of cultured dermis is the promotion of wound treatment by 
means of the physiologically active substances produced by fibroblasts contained within the 
culture. As results this treatment is characterized by the lack of any significant difference in 
outcome whether the fibroblasts used are autologous or allogeneic cells. In emergency use 
for burns, for example, allogeneic cultured dermis made in advance from allogeneic cells is 
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of high clinical utility. It will be necessary to solve the variety of concerns related to the use 
of living cells, as well as to demonstrate this method’s clear therapeutic advantages over the 
use of pharmaceuticals alone through numerous examples of clinical application. [Hichiro 
2007] 
 
Dermal substitutes 
Commercial name Cell source biomaterial 
DermagraftTM Cryopreserved (viable cells) 
allogeneic fibroblast 
derived dermal matrix 
Hyalograft 3DTM autologous fibroblasts Esterified hyaluronic acid 
matrix 
AllodermTM  Acellular (freeze-dried) 
allogeneic dermis 
OasisTM  porcine small intestine 
submucosa 
EZ-DermTM  Aldehyde-crosslinked 
porcine dermal collagen 
RepliformTM  Acellular human dermal 
allograft 
CymetraTM  Micronized particulate 
acellular cadaveric dermal 
matrix 
FortaFlexTM  porcine small intestine 
submucosa 
BiobraneTM  Porcine collagen 
chemically bound to 
silicone/nylon membrane 
MatridermTM  Acellular scaffold made 
with bovine collagen types 
I, III, V and elastin 
 
Technique: 
Human dermal fibroblasts are prepared according to a modified version of the Rheinwald & 
Green protocol. After epithelial sheet dispase removal, dermis was cut into small pieces (2–3 
mm2) and fibroblasts were isolated by sequential trypsin (0,05%)  and collagenase type I 
digestion. Cells isolated are then cultured with DMEM medium supplemented with 10% 
Foetal Bovine Serum (FBS). At confluence fibroblasts are harvested and seeded at a density 
of 3 × 105/cm2 on squares of biomaterials (i.e. hyaluronan non woven meshes) (1.5 × 1.5 cm) 
in the above-mentioned medium containing sodium ascorbate (50 mg/mL) (step 5). The 
nonwoven squares could be fixed on culture plates either by means of stainless steel rings or 
through a fibrin clot. 
 
 
 
c) Co-coltures of fibroblasts and keratinocytes (Bilayer substitutes). 
After these first attempts, given that fibroblasts are the main constituent of the dermis and 
are normally used to grow keratinocytes, the concept of a co-culture was introduced in 
order to produce in vitro a composite skin replacement composed of an epithelial layer 
overlaid onto a dermal substitute. The presence of fibroblasts within the grafted region is 
thus a major advantage. Several lines of research are being pursued to define the best 
conditions of use. These include studies of allogenic fibroblast persistence in humans. Such 
fibroblasts persist in animals, but in humans, even if allogenic fibroblasts give similar results 
to autologous fibroblasts, their ultimate fate is unknown. Definition of fibroblast 
populations within the dermis has been undertaken. There is clear evidence that, depending 
on the anatomical region or the depth within the dermis, fibroblasts can be distinguished on 
the basis of functional criteria. It would be useful to have markers to select those cells that 
would be most efficient within dermal substitutes. At present despite active research in this 
field there is still no commercially available fibroblast marker. Lastly, the possibility of using 
mesenchymal stem cells collected from bone marrow or peripheral blood, which seem to 
participate in wound healing, is being evaluated. In addition to skin substitutes for 
permanent skin replacement, other applications can help to rapidly cover patients' wounds 
(despite eventual rejection of allogenic cells) or to accelerate healing. It is already known 
that allogenic epidermal cell cultures promote external ulcer healing, [Zavan and 
Abatangelo 2004] probably by secreting factors (matrix metalloproteinases, growth factors, 
etc.) that promote wound cleansing and stimulate the activity of cells present at the wound 
site. At the end, the importance of the scaffold for a dermal-like tissue must be stressed too. 
In fact, the design of a dermal-like tissue critically depends on the use of an ideal scaffold 
which must allow the dermis to develop into a three-dimensional architecture. One of the 
most important features of the scaffold is its porosity, which has to fit the neo-vessel 
ingrowth from the host tissue (angiogenesis) during the wound healing process. In addition, 
the biomaterial should be fully biocompatible and totally degradable being substituted by a 
full functional ECM in the long term. Finally, the material should be resistant to mechanical 
forces and easy to apply on the wound area. 
The following guidelines emerged from the clinical experience: 
 The homogeneity of the cultured epidermal sheet is crucial for a good cosmetic 
result. 
 One-step grafting of a cocultured dermis and epidermis is not yet satisfactory, and 
would be too lengthy for emergency use (e.g., burns). 
 Preliminary grafting of a collagen matrix is hemostatic, reduces pain, and prepares 
the graft bed. 
 Most importantly, the presence of living fibroblasts speeds up the reappearance of 
a functional neodermis (less than 1 year instead of 3 to 5years when the graft bed is 
prepared only with cryopreserved cadaver skin). 
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Bilayer substitutes 
Commercial name Cell source biomaterial 
OrCelTM Allogeneic keratinocytes 
seeded over dermal scaffold 
containing allogeneic 
fibroblasts 
bovine collagen 
sponge 
ApligrafTM Allogeneic keratinocytes 
seeded over dermal scaffold 
containing allogeneic 
fibroblasts 
bovine collagen 
sponge 
TissueTechTM autograft 
system 
 
Combination of Hyalograft 
3DTM and LaserskinTM 
 
PermaDermTM Autologous keratinocytes 
seeded onto dermal 
substitute made with 
autologous fibroblasts in 
bovine collagen matrix 
 
bovine collagen matrix 
 
IntegraTM  Temporary silicone 
epidermal substitute over 
dermal scaffold 
made of collagen and 
chondroitin-6 sulfate 
 
 
The success of a skin equivalent graft–take requires the viability of fibroblasts contained 
within and the keratinocytes 
adhering to the surface. When either keratinocytes or fibroblasts are directly introduced into 
a freshly made excisional 
wound, there is rapid necrosis of these transferred cells. When components are put together 
in vitro and transferred 
to an excisional wound site in vivo, the skin equivalent graft has optimal skinlike qualities. 
Technique: 
At confluence (10–12 days), pieces of membranes (1.5 × 1.5 cm) previously seed with 
keratinocytes (step 4) are laid down and fixed to the nonwoven meshes on which dermal 
fibroblasts had been grown for 15 days (step 5). The fibroblast–keratinocyte composite 
cultures were laid down carefully on sterile stainless steel grids and then cultivated for 15 
days at the air–liquid interface (step 6). 
 
 
4. Conclusion 
The many studies conducted so far reveal that Tissue Engineering of the skin is only at the 
beginning of its use in human applications. Burns patients were the first targets for such 
tissue substitutes, then chronic diseases, such as venous ulcers, have followed. The more 
experience is gained from the surgeon, the more feedback for the basic scientist to improve 
the product and to broaden clinical indications. Nowadays, progress in cell culture and 
biomedical material technologies have added two important spare parts: epidermis and 
dermis to the surgeon’s toolbox which can be reconstituted in the laboratory from small 
biopsies of the same recipient. Other parts will follow in a few years, with the final aim to 
generate a full transplantable replica of the skin with adnexa and vasculature.  
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